primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
141565505,14156550,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",12170.0,MG,D,U,,,,10.0,MG,TABLET,QD,2021,Q1,Acute kidney injury,,2021,Q1,5,F,20171010.0,20210223.0,20171103,20210305,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,28563.0,DY,,M,Y,,,20210305.0,,MD,GB,GB,2021,Q1,Elderly
141565505,14156550,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",12170.0,MG,D,U,,,,10.0,MG,TABLET,QD,2021,Q1,Epididymitis,,2021,Q1,5,F,20171010.0,20210223.0,20171103,20210305,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,28563.0,DY,,M,Y,,,20210305.0,,MD,GB,GB,2021,Q1,Elderly
141565505,14156550,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",12170.0,MG,D,U,,,,10.0,MG,TABLET,QD,2021,Q1,Hypotension,,2021,Q1,5,F,20171010.0,20210223.0,20171103,20210305,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,28563.0,DY,,M,Y,,,20210305.0,,MD,GB,GB,2021,Q1,Elderly
141565505,14156550,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",12170.0,MG,D,U,,,,10.0,MG,TABLET,QD,2021,Q1,Acute kidney injury,,2021,Q1,5,F,20171010.0,20210223.0,20171103,20210305,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,28563.0,DY,,M,Y,,,20210305.0,,MD,GB,GB,2021,Q1,Elderly
141565505,14156550,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",12170.0,MG,D,U,,,,10.0,MG,TABLET,QD,2021,Q1,Epididymitis,,2021,Q1,5,F,20171010.0,20210223.0,20171103,20210305,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,28563.0,DY,,M,Y,,,20210305.0,,MD,GB,GB,2021,Q1,Elderly
141565505,14156550,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, ONCE A DAY",12170.0,MG,D,U,,,,10.0,MG,TABLET,QD,2021,Q1,Hypotension,,2021,Q1,5,F,20171010.0,20210223.0,20171103,20210305,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,28563.0,DY,,M,Y,,,20210305.0,,MD,GB,GB,2021,Q1,Elderly
143271417,14327141,7,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,Y,,,,,10.0,MG,TABLET,QD,2021,Q1,Acute kidney injury,,2021,Q1,7,F,20171010.0,20210220.0,20171227,20210227,EXP,GB-ASTRAZENECA-2017SF05024,PHHY2017GB194207,NOVARTIS,,78.0,YR,,M,Y,,,20210227.0,,HP,GB,GB,2021,Q1,Elderly
143271417,14327141,7,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,Y,,,,,10.0,MG,TABLET,QD,2021,Q1,Epididymitis,,2021,Q1,7,F,20171010.0,20210220.0,20171227,20210227,EXP,GB-ASTRAZENECA-2017SF05024,PHHY2017GB194207,NOVARTIS,,78.0,YR,,M,Y,,,20210227.0,,HP,GB,GB,2021,Q1,Elderly
143271417,14327141,7,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,Y,,,,,10.0,MG,TABLET,QD,2021,Q1,Hypotension,,2021,Q1,7,F,20171010.0,20210220.0,20171227,20210227,EXP,GB-ASTRAZENECA-2017SF05024,PHHY2017GB194207,NOVARTIS,,78.0,YR,,M,Y,,,20210227.0,,HP,GB,GB,2021,Q1,Elderly
143271417,14327141,8,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,Y,,,,,10.0,MG,TABLET,QD,2021,Q1,Acute kidney injury,,2021,Q1,7,F,20171010.0,20210220.0,20171227,20210227,EXP,GB-ASTRAZENECA-2017SF05024,PHHY2017GB194207,NOVARTIS,,78.0,YR,,M,Y,,,20210227.0,,HP,GB,GB,2021,Q1,Elderly
143271417,14327141,8,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,Y,,,,,10.0,MG,TABLET,QD,2021,Q1,Epididymitis,,2021,Q1,7,F,20171010.0,20210220.0,20171227,20210227,EXP,GB-ASTRAZENECA-2017SF05024,PHHY2017GB194207,NOVARTIS,,78.0,YR,,M,Y,,,20210227.0,,HP,GB,GB,2021,Q1,Elderly
143271417,14327141,8,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",12170.0,MG,Y,,,,,10.0,MG,TABLET,QD,2021,Q1,Hypotension,,2021,Q1,7,F,20171010.0,20210220.0,20171227,20210227,EXP,GB-ASTRAZENECA-2017SF05024,PHHY2017GB194207,NOVARTIS,,78.0,YR,,M,Y,,,20210227.0,,HP,GB,GB,2021,Q1,Elderly
162890492,16289049,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 DF, QD",,,D,,,,,1.0,DF,,,2021,Q1,Blood pressure systolic increased,,2021,Q1,2,F,,20210120.0,20190509,20210128,EXP,,CA-APOTEX-2019AP013370,APOTEX,,68.0,YR,,F,Y,,,20210128.0,,CN,CA,CA,2021,Q1,Elderly
162890492,16289049,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 DF, QD",,,D,,,,,1.0,DF,,,2021,Q1,Cough,,2021,Q1,2,F,,20210120.0,20190509,20210128,EXP,,CA-APOTEX-2019AP013370,APOTEX,,68.0,YR,,F,Y,,,20210128.0,,CN,CA,CA,2021,Q1,Elderly
162890492,16289049,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 DF, QD",,,D,,,,,1.0,DF,,,2021,Q1,Dyspnoea,,2021,Q1,2,F,,20210120.0,20190509,20210128,EXP,,CA-APOTEX-2019AP013370,APOTEX,,68.0,YR,,F,Y,,,20210128.0,,CN,CA,CA,2021,Q1,Elderly
162890492,16289049,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 DF, QD",,,D,,,,,1.0,DF,,,2021,Q1,Fall,,2021,Q1,2,F,,20210120.0,20190509,20210128,EXP,,CA-APOTEX-2019AP013370,APOTEX,,68.0,YR,,F,Y,,,20210128.0,,CN,CA,CA,2021,Q1,Elderly
162890492,16289049,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 DF, QD",,,D,,,,,1.0,DF,,,2021,Q1,Gait disturbance,,2021,Q1,2,F,,20210120.0,20190509,20210128,EXP,,CA-APOTEX-2019AP013370,APOTEX,,68.0,YR,,F,Y,,,20210128.0,,CN,CA,CA,2021,Q1,Elderly
162890492,16289049,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 DF, QD",,,D,,,,,1.0,DF,,,2021,Q1,Lower respiratory tract infection,,2021,Q1,2,F,,20210120.0,20190509,20210128,EXP,,CA-APOTEX-2019AP013370,APOTEX,,68.0,YR,,F,Y,,,20210128.0,,CN,CA,CA,2021,Q1,Elderly
162890492,16289049,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 DF, QD",,,D,,,,,1.0,DF,,,2021,Q1,Musculoskeletal discomfort,,2021,Q1,2,F,,20210120.0,20190509,20210128,EXP,,CA-APOTEX-2019AP013370,APOTEX,,68.0,YR,,F,Y,,,20210128.0,,CN,CA,CA,2021,Q1,Elderly
162890492,16289049,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 DF, QD",,,D,,,,,1.0,DF,,,2021,Q1,Pneumonia,,2021,Q1,2,F,,20210120.0,20190509,20210128,EXP,,CA-APOTEX-2019AP013370,APOTEX,,68.0,YR,,F,Y,,,20210128.0,,CN,CA,CA,2021,Q1,Elderly
162890492,16289049,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 DF, QD",,,D,,,,,1.0,DF,,,2021,Q1,Spinal stenosis,,2021,Q1,2,F,,20210120.0,20190509,20210128,EXP,,CA-APOTEX-2019AP013370,APOTEX,,68.0,YR,,F,Y,,,20210128.0,,CN,CA,CA,2021,Q1,Elderly
162890492,16289049,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 DF, QD",,,D,,,,,1.0,DF,,,2021,Q1,Weight decreased,,2021,Q1,2,F,,20210120.0,20190509,20210128,EXP,,CA-APOTEX-2019AP013370,APOTEX,,68.0,YR,,F,Y,,,20210128.0,,CN,CA,CA,2021,Q1,Elderly
165699223,16569922,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Acute coronary syndrome,,2021,Q1,3,F,,20210308.0,20190715,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20210317.0,,MD,CA,CA,2021,Q1,Adult
165699223,16569922,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Angina unstable,,2021,Q1,3,F,,20210308.0,20190715,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20210317.0,,MD,CA,CA,2021,Q1,Adult
165699223,16569922,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Blood cholesterol increased,,2021,Q1,3,F,,20210308.0,20190715,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20210317.0,,MD,CA,CA,2021,Q1,Adult
165699223,16569922,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Blood creatine phosphokinase increased,,2021,Q1,3,F,,20210308.0,20190715,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20210317.0,,MD,CA,CA,2021,Q1,Adult
165699223,16569922,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Blood parathyroid hormone increased,,2021,Q1,3,F,,20210308.0,20190715,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20210317.0,,MD,CA,CA,2021,Q1,Adult
165699223,16569922,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Blood triglycerides increased,,2021,Q1,3,F,,20210308.0,20190715,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20210317.0,,MD,CA,CA,2021,Q1,Adult
165699223,16569922,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Coronary artery stenosis,,2021,Q1,3,F,,20210308.0,20190715,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20210317.0,,MD,CA,CA,2021,Q1,Adult
165699223,16569922,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,High density lipoprotein decreased,,2021,Q1,3,F,,20210308.0,20190715,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20210317.0,,MD,CA,CA,2021,Q1,Adult
165699223,16569922,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Low density lipoprotein increased,,2021,Q1,3,F,,20210308.0,20190715,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20210317.0,,MD,CA,CA,2021,Q1,Adult
165699223,16569922,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Muscular weakness,,2021,Q1,3,F,,20210308.0,20190715,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20210317.0,,MD,CA,CA,2021,Q1,Adult
165699223,16569922,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Myalgia,,2021,Q1,3,F,,20210308.0,20190715,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20210317.0,,MD,CA,CA,2021,Q1,Adult
165699223,16569922,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Myopathy,,2021,Q1,3,F,,20210308.0,20190715,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20210317.0,,MD,CA,CA,2021,Q1,Adult
165699223,16569922,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Total cholesterol/HDL ratio increased,,2021,Q1,3,F,,20210308.0,20190715,20210317,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20210317.0,,MD,CA,CA,2021,Q1,Adult
1724538411,17245384,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,2.5 MILLIGRAM,,,U,,,,,2.5,MG,,,2021,Q1,Myocarditis,,2021,Q1,11,F,20191225.0,20210128.0,20200108,20210203,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-124057,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,79.0,KG,20210203.0,,HP,JP,JP,2021,Q1,Adult
175467546,17546754,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Lethargy,,2021,Q1,6,F,20190624.0,20210118.0,20200316,20210128,EXP,,GB-NOVOPROD-710766,NOVO NORDISK,,61.0,YR,,M,Y,99.0,KG,20210128.0,,MD,GB,GB,2021,Q1,Adult
175467546,17546754,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Nausea,,2021,Q1,6,F,20190624.0,20210118.0,20200316,20210128,EXP,,GB-NOVOPROD-710766,NOVO NORDISK,,61.0,YR,,M,Y,99.0,KG,20210128.0,,MD,GB,GB,2021,Q1,Adult
175467546,17546754,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Pancreatic cyst,,2021,Q1,6,F,20190624.0,20210118.0,20200316,20210128,EXP,,GB-NOVOPROD-710766,NOVO NORDISK,,61.0,YR,,M,Y,99.0,KG,20210128.0,,MD,GB,GB,2021,Q1,Adult
175467546,17546754,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Vomiting,,2021,Q1,6,F,20190624.0,20210118.0,20200316,20210128,EXP,,GB-NOVOPROD-710766,NOVO NORDISK,,61.0,YR,,M,Y,99.0,KG,20210128.0,,MD,GB,GB,2021,Q1,Adult
178703175,17870317,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Anal incontinence,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Fall,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Fatigue,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Haemarthrosis,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Hypotension,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Loss of consciousness,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Musculoskeletal pain,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Pleural effusion,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Renal cyst,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Seizure,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Syncope,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Anal incontinence,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Fall,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Fatigue,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Haemarthrosis,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Hypotension,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Loss of consciousness,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Musculoskeletal pain,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Pleural effusion,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Renal cyst,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Seizure,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Syncope,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Anal incontinence,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Fall,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Fatigue,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Haemarthrosis,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Hypotension,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Loss of consciousness,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Musculoskeletal pain,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Pleural effusion,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Renal cyst,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Seizure,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178703175,17870317,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",200.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Syncope,,2021,Q1,5,F,20200502.0,20210208.0,20200608,20210223,EXP,,CA-PFIZER INC-2020221646,PFIZER,,75.0,YR,,M,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
178854865,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q1,Back pain,,2021,Q1,5,F,2020.0,20210318.0,20200611,20210327,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210327.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
178854865,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q1,Malaise,,2021,Q1,5,F,2020.0,20210318.0,20200611,20210327,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210327.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
178854865,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q1,Musculoskeletal stiffness,,2021,Q1,5,F,2020.0,20210318.0,20200611,20210327,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210327.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
178854865,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q1,Nephrolithiasis,,2021,Q1,5,F,2020.0,20210318.0,20200611,20210327,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210327.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
178854865,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q1,Pain,,2021,Q1,5,F,2020.0,20210318.0,20200611,20210327,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210327.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
178854865,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q1,Psoriasis,,2021,Q1,5,F,2020.0,20210318.0,20200611,20210327,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210327.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
178854865,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q1,Psoriatic arthropathy,,2021,Q1,5,F,2020.0,20210318.0,20200611,20210327,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210327.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Decreased appetite,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Diarrhoea,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Dyspepsia,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Fatigue,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Feeding disorder,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Flatulence,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Heart rate irregular,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Herpes zoster,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Hyperhidrosis,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Nausea,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Pruritus,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Retching,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Syncope,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,12,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MILLIGRAM,,,D,,,,,5.0,MG,,,2021,Q1,Vomiting,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Decreased appetite,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Diarrhoea,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Dyspepsia,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Fatigue,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Feeding disorder,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Flatulence,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Heart rate irregular,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Herpes zoster,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Hyperhidrosis,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Nausea,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Pruritus,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Retching,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Syncope,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
180653682,18065368,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM,,,D,,,,,10.0,MG,,,2021,Q1,Vomiting,,2021,Q1,2,F,,20210212.0,20200724,20210222,EXP,,CA-APOTEX-2020AP014157,APOTEX,,69.0,YR,,M,Y,83.0,KG,20210222.0,,CN,CA,CA,2021,Q1,Elderly
185726032,18572603,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Atypical pneumonia,,2021,Q1,2,F,20201115.0,20210128.0,20201202,20210204,EXP,,US-ELI_LILLY_AND_COMPANY-US202011010153,ELI LILLY AND CO,,58.0,YR,,M,Y,86.2,KG,20210204.0,,PH,US,US,2021,Q1,Adult
185726032,18572603,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,COVID-19 pneumonia,,2021,Q1,2,F,20201115.0,20210128.0,20201202,20210204,EXP,,US-ELI_LILLY_AND_COMPANY-US202011010153,ELI LILLY AND CO,,58.0,YR,,M,Y,86.2,KG,20210204.0,,PH,US,US,2021,Q1,Adult
185726032,18572603,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,2,F,20201115.0,20210128.0,20201202,20210204,EXP,,US-ELI_LILLY_AND_COMPANY-US202011010153,ELI LILLY AND CO,,58.0,YR,,M,Y,86.2,KG,20210204.0,,PH,US,US,2021,Q1,Adult
186149972,18614997,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Abdominal distension,,2021,Q1,2,F,20171101.0,20210310.0,20201214,20210323,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20210323.0,,HP,US,US,2021,Q1,Adult
186149972,18614997,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,2,F,20171101.0,20210310.0,20201214,20210323,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20210323.0,,HP,US,US,2021,Q1,Adult
186149972,18614997,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Abdominal pain upper,,2021,Q1,2,F,20171101.0,20210310.0,20201214,20210323,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20210323.0,,HP,US,US,2021,Q1,Adult
186149972,18614997,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Dehydration,,2021,Q1,2,F,20171101.0,20210310.0,20201214,20210323,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20210323.0,,HP,US,US,2021,Q1,Adult
186149972,18614997,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Diarrhoea,,2021,Q1,2,F,20171101.0,20210310.0,20201214,20210323,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20210323.0,,HP,US,US,2021,Q1,Adult
186149972,18614997,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Hypovolaemia,,2021,Q1,2,F,20171101.0,20210310.0,20201214,20210323,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20210323.0,,HP,US,US,2021,Q1,Adult
186149972,18614997,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,2,F,20171101.0,20210310.0,20201214,20210323,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20210323.0,,HP,US,US,2021,Q1,Adult
186149972,18614997,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Pancreatitis acute,,2021,Q1,2,F,20171101.0,20210310.0,20201214,20210323,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20210323.0,,HP,US,US,2021,Q1,Adult
186149972,18614997,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,2,F,20171101.0,20210310.0,20201214,20210323,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20210323.0,,HP,US,US,2021,Q1,Adult
186552173,18655217,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Transcatheter aortic valve implantation,,2021,Q1,3,F,202003.0,20210219.0,20201223,20210301,EXP,,GB-NOVOPROD-775933,NOVO NORDISK,,81.0,YR,,F,Y,,,20210301.0,,MD,GB,GB,2021,Q1,Elderly
186816944,18681694,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Atrial fibrillation,,2021,Q1,4,F,202012.0,20210304.0,20201230,20210317,EXP,,NVSJ2020JP013977,NOVARTIS,,49.0,YR,,M,Y,,,20210317.0,,PH,JP,JP,2021,Q1,Adult
186816944,18681694,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Cardiac failure,,2021,Q1,4,F,202012.0,20210304.0,20201230,20210317,EXP,,NVSJ2020JP013977,NOVARTIS,,49.0,YR,,M,Y,,,20210317.0,,PH,JP,JP,2021,Q1,Adult
186938761,18693876,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,,20201224.0,20210104,20210104,EXP,,TR-ASTRAZENECA-2020SF74102,ASTRAZENECA,,40.0,YR,,F,Y,,,20210104.0,,HP,TR,TR,2021,Q1,Adult
186993851,18699385,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Ketoacidosis,,2021,Q1,1,I,,20201228.0,20210105,20210105,EXP,,DE-ASTRAZENECA-2020SF75604,ASTRAZENECA,,61.0,YR,,F,Y,,,20210105.0,,MD,DE,DE,2021,Q1,Adult
186993851,18699385,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Metabolic acidosis,,2021,Q1,1,I,,20201228.0,20210105,20210105,EXP,,DE-ASTRAZENECA-2020SF75604,ASTRAZENECA,,61.0,YR,,F,Y,,,20210105.0,,MD,DE,DE,2021,Q1,Adult
187001291,18700129,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20201228.0,20210105,20210105,EXP,GB-MHRA-EYC 00235193,NVSC2020GB344465,NOVARTIS,,50.0,YR,,F,Y,87.0,KG,20210105.0,,HP,GB,GB,2021,Q1,Adult
187001291,18700129,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Confusional state,,2021,Q1,1,I,,20201228.0,20210105,20210105,EXP,GB-MHRA-EYC 00235193,NVSC2020GB344465,NOVARTIS,,50.0,YR,,F,Y,87.0,KG,20210105.0,,HP,GB,GB,2021,Q1,Adult
187001291,18700129,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Myalgia,,2021,Q1,1,I,,20201228.0,20210105,20210105,EXP,GB-MHRA-EYC 00235193,NVSC2020GB344465,NOVARTIS,,50.0,YR,,F,Y,87.0,KG,20210105.0,,HP,GB,GB,2021,Q1,Adult
187014061,18701406,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,,10.0,MG,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,20201211.0,20201230.0,20210105,20210105,EXP,,GB-ASTRAZENECA-2020SF76378,ASTRAZENECA,,58.0,YR,,M,Y,88.9,KG,20210105.0,,,GB,GB,2021,Q1,Adult
187086631,18708663,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,110.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Constipation,,2021,Q1,1,I,20201206.0,20201230.0,20210106,20210106,EXP,,GB-ASTRAZENECA-2020SF76371,ASTRAZENECA,,58.0,YR,,M,Y,81.2,KG,20210106.0,,HP,GB,GB,2021,Q1,Adult
187086631,18708663,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,110.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Rectal haemorrhage,,2021,Q1,1,I,20201206.0,20201230.0,20210106,20210106,EXP,,GB-ASTRAZENECA-2020SF76371,ASTRAZENECA,,58.0,YR,,M,Y,81.2,KG,20210106.0,,HP,GB,GB,2021,Q1,Adult
187260611,18726061,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Drug interaction,,2021,Q1,1,I,20201209.0,20201228.0,20210111,20210111,EXP,,GB-DEXPHARM-20201199,DEXCEL,,64.0,YR,A,F,Y,,,20210111.0,,HP,GB,GB,2021,Q1,Adult
187260611,18726061,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Pancytopenia,,2021,Q1,1,I,20201209.0,20201228.0,20210111,20210111,EXP,,GB-DEXPHARM-20201199,DEXCEL,,64.0,YR,A,F,Y,,,20210111.0,,HP,GB,GB,2021,Q1,Adult
187260611,18726061,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Thrombocytopenia,,2021,Q1,1,I,20201209.0,20201228.0,20210111,20210111,EXP,,GB-DEXPHARM-20201199,DEXCEL,,64.0,YR,A,F,Y,,,20210111.0,,HP,GB,GB,2021,Q1,Adult
187261251,18726125,4,I,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",1200.0,MG,,," 2004114,2007030",,,10.0,MG,,QD,2021,Q1,Drug interaction,,2021,Q1,1,I,20201221.0,20210107.0,20210111,20210111,EXP,,CN-BAYER-2021-016942,BAYER,,80.0,YR,E,F,Y,60.0,KG,20210111.0,,HP,CN,CN,2021,Q1,Elderly
187261251,18726125,4,I,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",1200.0,MG,,," 2004114,2007030",,,10.0,MG,,QD,2021,Q1,Hypoglycaemic coma,,2021,Q1,1,I,20201221.0,20210107.0,20210111,20210111,EXP,,CN-BAYER-2021-016942,BAYER,,80.0,YR,E,F,Y,60.0,KG,20210111.0,,HP,CN,CN,2021,Q1,Elderly
187261251,18726125,4,I,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",1200.0,MG,,," 2004114,2007030",,,10.0,MG,,QD,2021,Q1,Loss of consciousness,,2021,Q1,1,I,20201221.0,20210107.0,20210111,20210111,EXP,,CN-BAYER-2021-016942,BAYER,,80.0,YR,E,F,Y,60.0,KG,20210111.0,,HP,CN,CN,2021,Q1,Elderly
187261251,18726125,4,I,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",1200.0,MG,,," 2004114,2007030",,,10.0,MG,,QD,2021,Q1,Unresponsive to stimuli,,2021,Q1,1,I,20201221.0,20210107.0,20210111,20210111,EXP,,CN-BAYER-2021-016942,BAYER,,80.0,YR,E,F,Y,60.0,KG,20210111.0,,HP,CN,CN,2021,Q1,Elderly
187261251,18726125,4,I,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",1200.0,MG,,," 2004114,2007030",,,10.0,MG,,QD,2021,Q1,Urinary incontinence,,2021,Q1,1,I,20201221.0,20210107.0,20210111,20210111,EXP,,CN-BAYER-2021-016942,BAYER,,80.0,YR,E,F,Y,60.0,KG,20210111.0,,HP,CN,CN,2021,Q1,Elderly
187304421,18730442,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210107.0,20210112,20210112,EXP,GB-MHRA-EYC 00235193,GB-PFIZER INC-2021009358,PFIZER,,50.0,YR,,F,Y,87.0,KG,20210112.0,,CN,GB,GB,2021,Q1,Adult
187304421,18730442,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Confusional state,,2021,Q1,1,I,,20210107.0,20210112,20210112,EXP,GB-MHRA-EYC 00235193,GB-PFIZER INC-2021009358,PFIZER,,50.0,YR,,F,Y,87.0,KG,20210112.0,,CN,GB,GB,2021,Q1,Adult
187304421,18730442,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Myalgia,,2021,Q1,1,I,,20210107.0,20210112,20210112,EXP,GB-MHRA-EYC 00235193,GB-PFIZER INC-2021009358,PFIZER,,50.0,YR,,F,Y,87.0,KG,20210112.0,,CN,GB,GB,2021,Q1,Adult
187313121,18731312,1,PS,FORXIGA (DAPAGLIFLOZIN),DAPAGLIFLOZIN,1,Oral,,1200.0,MG,Y,," 2004114,2007030",,202293.0,10.0,MG,TABLET,QD,2021,Q1,Hypoglycaemic coma,,2021,Q1,1,I,20201221.0,20210107.0,20210112,20210112,EXP,,CN-ASTRAZENECA-2021A003645,ASTRAZENECA,,80.0,YR,,F,Y,60.0,KG,20210112.0,,HP,CN,CN,2021,Q1,Elderly
187313121,18731312,1,PS,FORXIGA (DAPAGLIFLOZIN),DAPAGLIFLOZIN,1,Oral,,1200.0,MG,Y,," 2004114,2007030",,202293.0,10.0,MG,TABLET,QD,2021,Q1,Urinary incontinence,,2021,Q1,1,I,20201221.0,20210107.0,20210112,20210112,EXP,,CN-ASTRAZENECA-2021A003645,ASTRAZENECA,,80.0,YR,,F,Y,60.0,KG,20210112.0,,HP,CN,CN,2021,Q1,Elderly
187336201,18733620,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,5.0,MG,,,2021,Q1,Pericardial haemorrhage,,2021,Q1,1,I,,20201231.0,20210113,20210113,EXP,,GB-ACCORD-213822,ACCORD,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT? RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REP. 2020 DEC 28?13(12):E238047",86.0,YR,,M,Y,,,20210113.0,,HP,GB,GB,2021,Q1,Elderly
187402913,18740291,10,C,DAPAGLIFLOZIN/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2021,Q1,Burning sensation,,2021,Q1,3,F,20201101.0,20210303.0,20210114,20210325,EXP,,AU-PFIZER INC-2020456015,PFIZER,,75.0,YR,,M,Y,,,20210325.0,,PH,AU,AU,2021,Q1,Elderly
187402913,18740291,10,C,DAPAGLIFLOZIN/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,3,F,20201101.0,20210303.0,20210114,20210325,EXP,,AU-PFIZER INC-2020456015,PFIZER,,75.0,YR,,M,Y,,,20210325.0,,PH,AU,AU,2021,Q1,Elderly
187402913,18740291,10,C,DAPAGLIFLOZIN/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2021,Q1,Poor quality product administered,,2021,Q1,3,F,20201101.0,20210303.0,20210114,20210325,EXP,,AU-PFIZER INC-2020456015,PFIZER,,75.0,YR,,M,Y,,,20210325.0,,PH,AU,AU,2021,Q1,Elderly
187402913,18740291,10,C,DAPAGLIFLOZIN/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2021,Q1,Product physical issue,,2021,Q1,3,F,20201101.0,20210303.0,20210114,20210325,EXP,,AU-PFIZER INC-2020456015,PFIZER,,75.0,YR,,M,Y,,,20210325.0,,PH,AU,AU,2021,Q1,Elderly
187402913,18740291,10,C,DAPAGLIFLOZIN/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2021,Q1,Wrong technique in product usage process,,2021,Q1,3,F,20201101.0,20210303.0,20210114,20210325,EXP,,AU-PFIZER INC-2020456015,PFIZER,,75.0,YR,,M,Y,,,20210325.0,,PH,AU,AU,2021,Q1,Elderly
187404071,18740407,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,,20210105.0,20210114,20210114,EXP,,TW-ASTRAZENECA-2021A001563,ASTRAZENECA,,70.0,YR,,M,Y,,,20210114.0,,HP,TW,TW,2021,Q1,Elderly
187459771,18745977,3,C,dapagliflozin?metformin HCL ER 5/1000mg,,2,,,,,,,,,,,,,,2021,Q1,Dyspnoea exertional,,2021,Q1,1,I,20210110.0,,20210114,20210114,DIR,,,FDA-CTU,,60.0,YR,,M,N,73.0,KG,20210114.0,Y,HP,US,US,2021,Q1,Adult
187459771,18745977,3,C,dapagliflozin?metformin HCL ER 5/1000mg,,2,,,,,,,,,,,,,,2021,Q1,Lung infiltration,,2021,Q1,1,I,20210110.0,,20210114,20210114,DIR,,,FDA-CTU,,60.0,YR,,M,N,73.0,KG,20210114.0,Y,HP,US,US,2021,Q1,Adult
187459771,18745977,3,C,dapagliflozin?metformin HCL ER 5/1000mg,,2,,,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,1,I,20210110.0,,20210114,20210114,DIR,,,FDA-CTU,,60.0,YR,,M,N,73.0,KG,20210114.0,Y,HP,US,US,2021,Q1,Adult
187657812,18765781,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,5MG,,,,,,,,,,,,2021,Q1,Cardiac failure,,2021,Q1,2,F,,20210216.0,20210121,20210217,EXP,,JP-JNJFOC-20210127083,JOHNSON AND JOHNSON,,83.0,YR,E,M,Y,,,20210217.0,,MD,JP,JP,2021,Q1,Elderly
187657812,18765781,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,5MG,,,,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,2,F,,20210216.0,20210121,20210217,EXP,,JP-JNJFOC-20210127083,JOHNSON AND JOHNSON,,83.0,YR,E,M,Y,,,20210217.0,,MD,JP,JP,2021,Q1,Elderly
187706801,18770680,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,Y,,,,,5.0,MG,,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,202101.0,20210118.0,20210121,20210121,EXP,GB-MHRA-ADR 24605249,NVSC2021GB012821,NOVARTIS,,85.0,YR,,M,Y,96.0,KG,20210121.0,,HP,GB,GB,2021,Q1,Elderly
187706801,18770680,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,Y,,,,,5.0,MG,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,202101.0,20210118.0,20210121,20210121,EXP,GB-MHRA-ADR 24605249,NVSC2021GB012821,NOVARTIS,,85.0,YR,,M,Y,96.0,KG,20210121.0,,HP,GB,GB,2021,Q1,Elderly
187706801,18770680,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,Y,,,,,5.0,MG,,,2021,Q1,Malaise,,2021,Q1,1,I,202101.0,20210118.0,20210121,20210121,EXP,GB-MHRA-ADR 24605249,NVSC2021GB012821,NOVARTIS,,85.0,YR,,M,Y,96.0,KG,20210121.0,,HP,GB,GB,2021,Q1,Elderly
187706801,18770680,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,Y,,,,,5.0,MG,,,2021,Q1,Pneumonia,,2021,Q1,1,I,202101.0,20210118.0,20210121,20210121,EXP,GB-MHRA-ADR 24605249,NVSC2021GB012821,NOVARTIS,,85.0,YR,,M,Y,96.0,KG,20210121.0,,HP,GB,GB,2021,Q1,Elderly
187739841,18773984,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MILLIGRAM,,,Y,U,,,,5.0,MG,,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,202101.0,20210120.0,20210122,20210122,EXP,GB-MHRA-EYC 00237964,GB-MYLANLABS-2021M1003869,MYLAN,,85.0,YR,,M,Y,96.0,KG,20210122.0,,HP,GB,GB,2021,Q1,Elderly
187739841,18773984,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MILLIGRAM,,,Y,U,,,,5.0,MG,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,202101.0,20210120.0,20210122,20210122,EXP,GB-MHRA-EYC 00237964,GB-MYLANLABS-2021M1003869,MYLAN,,85.0,YR,,M,Y,96.0,KG,20210122.0,,HP,GB,GB,2021,Q1,Elderly
187739841,18773984,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MILLIGRAM,,,Y,U,,,,5.0,MG,,,2021,Q1,Malaise,,2021,Q1,1,I,202101.0,20210120.0,20210122,20210122,EXP,GB-MHRA-EYC 00237964,GB-MYLANLABS-2021M1003869,MYLAN,,85.0,YR,,M,Y,96.0,KG,20210122.0,,HP,GB,GB,2021,Q1,Elderly
187739841,18773984,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MILLIGRAM,,,Y,U,,,,5.0,MG,,,2021,Q1,Pneumonia,,2021,Q1,1,I,202101.0,20210120.0,20210122,20210122,EXP,GB-MHRA-EYC 00237964,GB-MYLANLABS-2021M1003869,MYLAN,,85.0,YR,,M,Y,96.0,KG,20210122.0,,HP,GB,GB,2021,Q1,Elderly
187764091,18776409,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN DOSE AND FREQUENCY,,,U,N,,,,,,TABLET,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,2015.0,20210114.0,20210122,20210122,EXP,,DE-ANIPHARMA-2021-DE-000010,ANI,,72.0,YR,,F,Y,89.0,KG,20210122.0,,MD,DE,DE,2021,Q1,Elderly
187764091,18776409,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN DOSE AND FREQUENCY,,,U,N,,,,,,TABLET,,2021,Q1,Blood pressure increased,,2021,Q1,1,I,2015.0,20210114.0,20210122,20210122,EXP,,DE-ANIPHARMA-2021-DE-000010,ANI,,72.0,YR,,F,Y,89.0,KG,20210122.0,,MD,DE,DE,2021,Q1,Elderly
187764091,18776409,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN DOSE AND FREQUENCY,,,U,N,,,,,,TABLET,,2021,Q1,Glomerular filtration rate decreased,,2021,Q1,1,I,2015.0,20210114.0,20210122,20210122,EXP,,DE-ANIPHARMA-2021-DE-000010,ANI,,72.0,YR,,F,Y,89.0,KG,20210122.0,,MD,DE,DE,2021,Q1,Elderly
187764091,18776409,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN DOSE AND FREQUENCY,,,U,N,,,,,,TABLET,,2021,Q1,Low density lipoprotein increased,,2021,Q1,1,I,2015.0,20210114.0,20210122,20210122,EXP,,DE-ANIPHARMA-2021-DE-000010,ANI,,72.0,YR,,F,Y,89.0,KG,20210122.0,,MD,DE,DE,2021,Q1,Elderly
187851221,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q1,Acute kidney injury,,2021,Q1,1,I,,20210118.0,20210125,20210125,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:ARTICLE #E238047",86.0,YR,E,M,Y,,,20210125.0,,HP,GB,GB,2021,Q1,Elderly
187851221,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q1,Cardiac tamponade,,2021,Q1,1,I,,20210118.0,20210125,20210125,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:ARTICLE #E238047",86.0,YR,E,M,Y,,,20210125.0,,HP,GB,GB,2021,Q1,Elderly
187851221,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q1,Pericardial haemorrhage,,2021,Q1,1,I,,20210118.0,20210125,20210125,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:ARTICLE #E238047",86.0,YR,E,M,Y,,,20210125.0,,HP,GB,GB,2021,Q1,Elderly
187851311,18785131,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,202101.0,20210120.0,20210125,20210125,EXP,GB-MHRA-EYC 00237964,GB-EMD SERONO-E2B_90082096,EMD SERONO INC,,85.0,YR,E,M,Y,96.0,KG,20210125.0,,HP,GB,GB,2021,Q1,Elderly
187851311,18785131,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,202101.0,20210120.0,20210125,20210125,EXP,GB-MHRA-EYC 00237964,GB-EMD SERONO-E2B_90082096,EMD SERONO INC,,85.0,YR,E,M,Y,96.0,KG,20210125.0,,HP,GB,GB,2021,Q1,Elderly
187851311,18785131,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q1,Malaise,,2021,Q1,1,I,202101.0,20210120.0,20210125,20210125,EXP,GB-MHRA-EYC 00237964,GB-EMD SERONO-E2B_90082096,EMD SERONO INC,,85.0,YR,E,M,Y,96.0,KG,20210125.0,,HP,GB,GB,2021,Q1,Elderly
187851311,18785131,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q1,Pneumonia,,2021,Q1,1,I,202101.0,20210120.0,20210125,20210125,EXP,GB-MHRA-EYC 00237964,GB-EMD SERONO-E2B_90082096,EMD SERONO INC,,85.0,YR,E,M,Y,96.0,KG,20210125.0,,HP,GB,GB,2021,Q1,Elderly
187852661,18785266,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,70.0,MG,U,, MA3245,,,10.0,MG,TABLET,QD,2021,Q1,Ketoacidosis,,2021,Q1,1,I,20210108.0,20210116.0,20210125,20210125,EXP,,CN-ASTRAZENECA-2021A010958,ASTRAZENECA,,21185.0,DY,,M,Y,80.0,KG,20210125.0,,HP,CN,CN,2021,Q1,Elderly
187862101,18786210,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5, UNKNOWN",,,Y,, NOT AVAILABLE,,202293.0,,,TABLET,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,202101.0,20210124.0,20210125,20210125,EXP,,GB-ASTRAZENECA-2021A012959,ASTRAZENECA,,85.0,YR,,M,Y,96.0,KG,20210125.0,,HP,GB,GB,2021,Q1,Elderly
187862101,18786210,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5, UNKNOWN",,,Y,, NOT AVAILABLE,,202293.0,,,TABLET,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,202101.0,20210124.0,20210125,20210125,EXP,,GB-ASTRAZENECA-2021A012959,ASTRAZENECA,,85.0,YR,,M,Y,96.0,KG,20210125.0,,HP,GB,GB,2021,Q1,Elderly
187862101,18786210,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5, UNKNOWN",,,Y,, NOT AVAILABLE,,202293.0,,,TABLET,,2021,Q1,Malaise,,2021,Q1,1,I,202101.0,20210124.0,20210125,20210125,EXP,,GB-ASTRAZENECA-2021A012959,ASTRAZENECA,,85.0,YR,,M,Y,96.0,KG,20210125.0,,HP,GB,GB,2021,Q1,Elderly
187862101,18786210,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5, UNKNOWN",,,Y,, NOT AVAILABLE,,202293.0,,,TABLET,,2021,Q1,Pneumonia,,2021,Q1,1,I,202101.0,20210124.0,20210125,20210125,EXP,,GB-ASTRAZENECA-2021A012959,ASTRAZENECA,,85.0,YR,,M,Y,96.0,KG,20210125.0,,HP,GB,GB,2021,Q1,Elderly
187894642,18789464,4,I,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",120.0,MG,,, 2007143,,,10.0,MG,,QD,2021,Q1,Altered state of consciousness,,2021,Q1,2,F,20210116.0,20210123.0,20210126,20210324,EXP,,CN-BAYER-2021-037964,BAYER,,67.0,YR,E,F,Y,50.0,KG,20210324.0,,HP,CN,CN,2021,Q1,Elderly
187894642,18789464,4,I,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",120.0,MG,,, 2007143,,,10.0,MG,,QD,2021,Q1,Asthenia,,2021,Q1,2,F,20210116.0,20210123.0,20210126,20210324,EXP,,CN-BAYER-2021-037964,BAYER,,67.0,YR,E,F,Y,50.0,KG,20210324.0,,HP,CN,CN,2021,Q1,Elderly
187894642,18789464,4,I,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",120.0,MG,,, 2007143,,,10.0,MG,,QD,2021,Q1,Drug interaction,,2021,Q1,2,F,20210116.0,20210123.0,20210126,20210324,EXP,,CN-BAYER-2021-037964,BAYER,,67.0,YR,E,F,Y,50.0,KG,20210324.0,,HP,CN,CN,2021,Q1,Elderly
187894642,18789464,4,I,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",120.0,MG,,, 2007143,,,10.0,MG,,QD,2021,Q1,Hyperhidrosis,,2021,Q1,2,F,20210116.0,20210123.0,20210126,20210324,EXP,,CN-BAYER-2021-037964,BAYER,,67.0,YR,E,F,Y,50.0,KG,20210324.0,,HP,CN,CN,2021,Q1,Elderly
187894642,18789464,4,I,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",120.0,MG,,, 2007143,,,10.0,MG,,QD,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,20210116.0,20210123.0,20210126,20210324,EXP,,CN-BAYER-2021-037964,BAYER,,67.0,YR,E,F,Y,50.0,KG,20210324.0,,HP,CN,CN,2021,Q1,Elderly
187894642,18789464,4,I,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",120.0,MG,,, 2007143,,,10.0,MG,,QD,2021,Q1,Speech disorder,,2021,Q1,2,F,20210116.0,20210123.0,20210126,20210324,EXP,,CN-BAYER-2021-037964,BAYER,,67.0,YR,E,F,Y,50.0,KG,20210324.0,,HP,CN,CN,2021,Q1,Elderly
187928102,18792810,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 EVERY DAY,,,U,,,,202293.0,,,TABLET,,2021,Q1,Balance disorder,,2021,Q1,2,F,20210106.0,20210125.0,20210127,20210202,EXP,,GB-ASTRAZENECA-2021A015612,ASTRAZENECA,,57.0,YR,,F,Y,,,20210202.0,,PH,GB,GB,2021,Q1,Adult
187928102,18792810,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 EVERY DAY,,,U,,,,202293.0,,,TABLET,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,2,F,20210106.0,20210125.0,20210127,20210202,EXP,,GB-ASTRAZENECA-2021A015612,ASTRAZENECA,,57.0,YR,,F,Y,,,20210202.0,,PH,GB,GB,2021,Q1,Adult
187928102,18792810,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 EVERY DAY,,,U,,,,202293.0,,,TABLET,,2021,Q1,Dizziness,,2021,Q1,2,F,20210106.0,20210125.0,20210127,20210202,EXP,,GB-ASTRAZENECA-2021A015612,ASTRAZENECA,,57.0,YR,,F,Y,,,20210202.0,,PH,GB,GB,2021,Q1,Adult
187952841,18795284,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,,QD,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,,20210124.0,20210127,20210127,EXP,,GB-ASTRAZENECA-2021A013719,ASTRAZENECA,,73.0,YR,,F,Y,69.8,KG,20210127.0,,PH,GB,GB,2021,Q1,Elderly
187953111,18795311,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, BID",,,,,,,,5.0,MG,,Q12H,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210122.0,20210127,20210127,EXP,,DE-DSJP-DSE-2021-102055,DAIICHI,,73.0,YR,,M,Y,,,20210127.0,,MD,DE,DE,2021,Q1,Elderly
187953111,18795311,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, BID",,,,,,,,5.0,MG,,Q12H,2021,Q1,Haematoma,,2021,Q1,1,I,,20210122.0,20210127,20210127,EXP,,DE-DSJP-DSE-2021-102055,DAIICHI,,73.0,YR,,M,Y,,,20210127.0,,MD,DE,DE,2021,Q1,Elderly
187953111,18795311,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, BID",,,,,,,,5.0,MG,,Q12H,2021,Q1,Oedema peripheral,,2021,Q1,1,I,,20210122.0,20210127,20210127,EXP,,DE-DSJP-DSE-2021-102055,DAIICHI,,73.0,YR,,M,Y,,,20210127.0,,MD,DE,DE,2021,Q1,Elderly
187953111,18795311,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, BID",,,,,,,,5.0,MG,,Q12H,2021,Q1,Skin irritation,,2021,Q1,1,I,,20210122.0,20210127,20210127,EXP,,DE-DSJP-DSE-2021-102055,DAIICHI,,73.0,YR,,M,Y,,,20210127.0,,MD,DE,DE,2021,Q1,Elderly
187964681,18796468,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MILLIGRAM,1?0?1?0",,,U,,,,,5.0,MG,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210119.0,20210127,20210127,EXP,,DE-AUROBINDO-AUR-APL-2021-002894,AUROBINDO,,73.0,YR,,M,Y,,,20210128.0,,MD,DE,DE,2021,Q1,Elderly
187964681,18796468,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MILLIGRAM,1?0?1?0",,,U,,,,,5.0,MG,,,2021,Q1,Haematoma,,2021,Q1,1,I,,20210119.0,20210127,20210127,EXP,,DE-AUROBINDO-AUR-APL-2021-002894,AUROBINDO,,73.0,YR,,M,Y,,,20210128.0,,MD,DE,DE,2021,Q1,Elderly
187964681,18796468,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MILLIGRAM,1?0?1?0",,,U,,,,,5.0,MG,,,2021,Q1,Oedema peripheral,,2021,Q1,1,I,,20210119.0,20210127,20210127,EXP,,DE-AUROBINDO-AUR-APL-2021-002894,AUROBINDO,,73.0,YR,,M,Y,,,20210128.0,,MD,DE,DE,2021,Q1,Elderly
187964681,18796468,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MILLIGRAM,1?0?1?0",,,U,,,,,5.0,MG,,,2021,Q1,Skin irritation,,2021,Q1,1,I,,20210119.0,20210127,20210127,EXP,,DE-AUROBINDO-AUR-APL-2021-002894,AUROBINDO,,73.0,YR,,M,Y,,,20210128.0,,MD,DE,DE,2021,Q1,Elderly
187965911,18796591,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MILLIGRAM,,,Y,U, NOT AVAILABLE,,,5.0,MG,,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,202101.0,20210120.0,20210128,20210128,EXP,,GB-AUROBINDO-AUR-APL-2021-002847,AUROBINDO,,85.0,YR,,M,Y,96.0,KG,20210128.0,,HP,GB,GB,2021,Q1,Elderly
187965911,18796591,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MILLIGRAM,,,Y,U, NOT AVAILABLE,,,5.0,MG,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,202101.0,20210120.0,20210128,20210128,EXP,,GB-AUROBINDO-AUR-APL-2021-002847,AUROBINDO,,85.0,YR,,M,Y,96.0,KG,20210128.0,,HP,GB,GB,2021,Q1,Elderly
187965911,18796591,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MILLIGRAM,,,Y,U, NOT AVAILABLE,,,5.0,MG,,,2021,Q1,Malaise,,2021,Q1,1,I,202101.0,20210120.0,20210128,20210128,EXP,,GB-AUROBINDO-AUR-APL-2021-002847,AUROBINDO,,85.0,YR,,M,Y,96.0,KG,20210128.0,,HP,GB,GB,2021,Q1,Elderly
187965911,18796591,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MILLIGRAM,,,Y,U, NOT AVAILABLE,,,5.0,MG,,,2021,Q1,Pneumonia,,2021,Q1,1,I,202101.0,20210120.0,20210128,20210128,EXP,,GB-AUROBINDO-AUR-APL-2021-002847,AUROBINDO,,85.0,YR,,M,Y,96.0,KG,20210128.0,,HP,GB,GB,2021,Q1,Elderly
187980111,18798011,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, BID (5 MG, 1?0?1?0)",,,U,,,,,5.0,MG,,BID,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210121.0,20210128,20210128,EXP,DE-ADRED-06117-01,NVSC2021DE015538,NOVARTIS,,73.0,YR,,M,Y,,,20210128.0,,HP,DE,DE,2021,Q1,Elderly
187980111,18798011,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, BID (5 MG, 1?0?1?0)",,,U,,,,,5.0,MG,,BID,2021,Q1,Haematoma,,2021,Q1,1,I,,20210121.0,20210128,20210128,EXP,DE-ADRED-06117-01,NVSC2021DE015538,NOVARTIS,,73.0,YR,,M,Y,,,20210128.0,,HP,DE,DE,2021,Q1,Elderly
187980111,18798011,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, BID (5 MG, 1?0?1?0)",,,U,,,,,5.0,MG,,BID,2021,Q1,Oedema peripheral,,2021,Q1,1,I,,20210121.0,20210128,20210128,EXP,DE-ADRED-06117-01,NVSC2021DE015538,NOVARTIS,,73.0,YR,,M,Y,,,20210128.0,,HP,DE,DE,2021,Q1,Elderly
187980111,18798011,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, BID (5 MG, 1?0?1?0)",,,U,,,,,5.0,MG,,BID,2021,Q1,Skin irritation,,2021,Q1,1,I,,20210121.0,20210128,20210128,EXP,DE-ADRED-06117-01,NVSC2021DE015538,NOVARTIS,,73.0,YR,,M,Y,,,20210128.0,,HP,DE,DE,2021,Q1,Elderly
188069921,18806992,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MILLIGRAM,,,Y,, UNK,,,5.0,MG,,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,202101.0,20210120.0,20210129,20210129,EXP,GB-MHRA-ADR 24605249,GB-EMCURE PHARMACEUTICALS LTD-2021-EPL-000215,EMCURE,,85.0,YR,,M,Y,96.0,KG,20210129.0,,HP,GB,GB,2021,Q1,Elderly
188069921,18806992,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MILLIGRAM,,,Y,, UNK,,,5.0,MG,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,202101.0,20210120.0,20210129,20210129,EXP,GB-MHRA-ADR 24605249,GB-EMCURE PHARMACEUTICALS LTD-2021-EPL-000215,EMCURE,,85.0,YR,,M,Y,96.0,KG,20210129.0,,HP,GB,GB,2021,Q1,Elderly
188069921,18806992,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MILLIGRAM,,,Y,, UNK,,,5.0,MG,,,2021,Q1,Malaise,,2021,Q1,1,I,202101.0,20210120.0,20210129,20210129,EXP,GB-MHRA-ADR 24605249,GB-EMCURE PHARMACEUTICALS LTD-2021-EPL-000215,EMCURE,,85.0,YR,,M,Y,96.0,KG,20210129.0,,HP,GB,GB,2021,Q1,Elderly
188069921,18806992,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MILLIGRAM,,,Y,, UNK,,,5.0,MG,,,2021,Q1,Pneumonia,,2021,Q1,1,I,202101.0,20210120.0,20210129,20210129,EXP,GB-MHRA-ADR 24605249,GB-EMCURE PHARMACEUTICALS LTD-2021-EPL-000215,EMCURE,,85.0,YR,,M,Y,96.0,KG,20210129.0,,HP,GB,GB,2021,Q1,Elderly
188091041,18809104,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,Y,,,,,10.0,MG,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,20210116.0,20210124.0,20210129,20210129,EXP,,GB-ASTRAZENECA-2021A013614,ASTRAZENECA,,62.0,YR,,F,Y,,,20210129.0,,PH,GB,GB,2021,Q1,Adult
188142831,18814283,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1?0?1?0,,,,,,,,5.0,MG,,BID,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210124.0,20210201,20210201,EXP,,DE-TEVA-2021-DE-1873691,TEVA,,73.0,YR,E,M,Y,,,20210201.0,,MD,DE,DE,2021,Q1,Elderly
188142831,18814283,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1?0?1?0,,,,,,,,5.0,MG,,BID,2021,Q1,Haematoma,,2021,Q1,1,I,,20210124.0,20210201,20210201,EXP,,DE-TEVA-2021-DE-1873691,TEVA,,73.0,YR,E,M,Y,,,20210201.0,,MD,DE,DE,2021,Q1,Elderly
188142831,18814283,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1?0?1?0,,,,,,,,5.0,MG,,BID,2021,Q1,Oedema peripheral,,2021,Q1,1,I,,20210124.0,20210201,20210201,EXP,,DE-TEVA-2021-DE-1873691,TEVA,,73.0,YR,E,M,Y,,,20210201.0,,MD,DE,DE,2021,Q1,Elderly
188142831,18814283,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1?0?1?0,,,,,,,,5.0,MG,,BID,2021,Q1,Skin irritation,,2021,Q1,1,I,,20210124.0,20210201,20210201,EXP,,DE-TEVA-2021-DE-1873691,TEVA,,73.0,YR,E,M,Y,,,20210201.0,,MD,DE,DE,2021,Q1,Elderly
188173372,18817337,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q1,Fatigue,,2021,Q1,2,F,20210117.0,20210207.0,20210201,20210216,EXP,,NVSC2021KE011733,NOVARTIS,,69.0,YR,,M,Y,,,20210216.0,,CN,KE,KE,2021,Q1,Elderly
188173372,18817337,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q1,Product use in unapproved indication,,2021,Q1,2,F,20210117.0,20210207.0,20210201,20210216,EXP,,NVSC2021KE011733,NOVARTIS,,69.0,YR,,M,Y,,,20210216.0,,CN,KE,KE,2021,Q1,Elderly
188201431,18820143,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, 1?0?1?0 ()",,,U,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210119.0,20210202,20210202,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-278586,RANBAXY,,73.0,YR,,M,Y,,,20210202.0,,HP,NL,DE,2021,Q1,Elderly
188201431,18820143,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, 1?0?1?0 ()",,,U,,,,,,,,,2021,Q1,Haematoma,,2021,Q1,1,I,,20210119.0,20210202,20210202,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-278586,RANBAXY,,73.0,YR,,M,Y,,,20210202.0,,HP,NL,DE,2021,Q1,Elderly
188201431,18820143,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, 1?0?1?0 ()",,,U,,,,,,,,,2021,Q1,Oedema peripheral,,2021,Q1,1,I,,20210119.0,20210202,20210202,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-278586,RANBAXY,,73.0,YR,,M,Y,,,20210202.0,,HP,NL,DE,2021,Q1,Elderly
188201431,18820143,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, 1?0?1?0 ()",,,U,,,,,,,,,2021,Q1,Skin irritation,,2021,Q1,1,I,,20210119.0,20210202,20210202,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-278586,RANBAXY,,73.0,YR,,M,Y,,,20210202.0,,HP,NL,DE,2021,Q1,Elderly
188208911,18820891,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, 1?0?1?0",,,U,,,,,5.0,MG,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210122.0,20210202,20210202,EXP,DE-ADRED-06117-01,DE-TORRENT-00019517,TORRENT,,73.0,YR,E,M,Y,,,20210202.0,,MD,DE,DE,2021,Q1,Elderly
188208911,18820891,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, 1?0?1?0",,,U,,,,,5.0,MG,,,2021,Q1,Haematoma,,2021,Q1,1,I,,20210122.0,20210202,20210202,EXP,DE-ADRED-06117-01,DE-TORRENT-00019517,TORRENT,,73.0,YR,E,M,Y,,,20210202.0,,MD,DE,DE,2021,Q1,Elderly
188208911,18820891,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, 1?0?1?0",,,U,,,,,5.0,MG,,,2021,Q1,Oedema peripheral,,2021,Q1,1,I,,20210122.0,20210202,20210202,EXP,DE-ADRED-06117-01,DE-TORRENT-00019517,TORRENT,,73.0,YR,E,M,Y,,,20210202.0,,MD,DE,DE,2021,Q1,Elderly
188208911,18820891,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, 1?0?1?0",,,U,,,,,5.0,MG,,,2021,Q1,Skin irritation,,2021,Q1,1,I,,20210122.0,20210202,20210202,EXP,DE-ADRED-06117-01,DE-TORRENT-00019517,TORRENT,,73.0,YR,E,M,Y,,,20210202.0,,MD,DE,DE,2021,Q1,Elderly
188218551,18821855,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,N,,,,,10.0,MG,TABLET,QD,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,20210117.0,20210124.0,20210202,20210202,EXP,,GB-ASTRAZENECA-2021A014172,ASTRAZENECA,,64.0,YR,,M,Y,,,20210202.0,,PH,GB,GB,2021,Q1,Adult
188220771,18822077,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,20210110.0,20210121.0,20210202,20210202,EXP,,US-ELI_LILLY_AND_COMPANY-US202101009568,ELI LILLY AND CO,,60.0,YR,,M,Y,73.0,KG,20210202.0,,HP,US,US,2021,Q1,Adult
188220771,18822077,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,1,I,20210110.0,20210121.0,20210202,20210202,EXP,,US-ELI_LILLY_AND_COMPANY-US202101009568,ELI LILLY AND CO,,60.0,YR,,M,Y,73.0,KG,20210202.0,,HP,US,US,2021,Q1,Adult
188233381,18823338,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210121.0,20210202,20210202,EXP,,AU-ASTRAZENECA-2021A015700,ASTRAZENECA,,69.0,YR,,F,Y,,,20210202.0,,,AU,AU,2021,Q1,Elderly
188329491,18832949,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,U,,,202293.0,10.0,MG,TABLET,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210121.0,20210203,20210203,EXP,,AU-ASTRAZENECA-2021A017253,ASTRAZENECA,,53.0,YR,,M,Y,,,20210203.0,,HP,AU,AU,2021,Q1,Adult
188329501,18832950,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,5.0,MG,TABLET,QD,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210121.0,20210203,20210203,EXP,,AU-ASTRAZENECA-2021A017135,ASTRAZENECA,,45.0,YR,,F,Y,,,20210203.0,,,AU,AU,2021,Q1,Adult
188423051,18842305,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, 1?0?1?0",,,,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210122.0,20210204,20210204,EXP,DE-BFARM-20014131,DE-ACCORD-216152,ACCORD,,73.0,YR,E,M,Y,,,20210204.0,,MD,DE,DE,2021,Q1,Elderly
188423051,18842305,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, 1?0?1?0",,,,,,,,,,,,2021,Q1,Haematoma,,2021,Q1,1,I,,20210122.0,20210204,20210204,EXP,DE-BFARM-20014131,DE-ACCORD-216152,ACCORD,,73.0,YR,E,M,Y,,,20210204.0,,MD,DE,DE,2021,Q1,Elderly
188423051,18842305,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, 1?0?1?0",,,,,,,,,,,,2021,Q1,Oedema peripheral,,2021,Q1,1,I,,20210122.0,20210204,20210204,EXP,DE-BFARM-20014131,DE-ACCORD-216152,ACCORD,,73.0,YR,E,M,Y,,,20210204.0,,MD,DE,DE,2021,Q1,Elderly
188423051,18842305,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, 1?0?1?0",,,,,,,,,,,,2021,Q1,Skin irritation,,2021,Q1,1,I,,20210122.0,20210204,20210204,EXP,DE-BFARM-20014131,DE-ACCORD-216152,ACCORD,,73.0,YR,E,M,Y,,,20210204.0,,MD,DE,DE,2021,Q1,Elderly
188450451,18845045,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, (1?0?1?0)",,,U,,,,,5.0,MG,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210122.0,20210204,20210204,EXP,,DE-SA-2021SA028222,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20210204.0,,MD,DE,DE,2021,Q1,Elderly
188450451,18845045,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, (1?0?1?0)",,,U,,,,,5.0,MG,,,2021,Q1,Haematoma,,2021,Q1,1,I,,20210122.0,20210204,20210204,EXP,,DE-SA-2021SA028222,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20210204.0,,MD,DE,DE,2021,Q1,Elderly
188450451,18845045,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, (1?0?1?0)",,,U,,,,,5.0,MG,,,2021,Q1,Oedema peripheral,,2021,Q1,1,I,,20210122.0,20210204,20210204,EXP,,DE-SA-2021SA028222,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20210204.0,,MD,DE,DE,2021,Q1,Elderly
188450451,18845045,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"5 MG, (1?0?1?0)",,,U,,,,,5.0,MG,,,2021,Q1,Skin irritation,,2021,Q1,1,I,,20210122.0,20210204,20210204,EXP,,DE-SA-2021SA028222,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20210204.0,,MD,DE,DE,2021,Q1,Elderly
188484411,18848441,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U, NOT AVAILABLE,,,5.0,MG,,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,202101.0,20210120.0,20210204,20210204,EXP,GB-MHRA-EYC 00237964,GB-TEVA-2021-GB-1873204,TEVA,,85.0,YR,E,M,Y,96.0,KG,20210204.0,,HP,GB,GB,2021,Q1,Elderly
188484411,18848441,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U, NOT AVAILABLE,,,5.0,MG,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,202101.0,20210120.0,20210204,20210204,EXP,GB-MHRA-EYC 00237964,GB-TEVA-2021-GB-1873204,TEVA,,85.0,YR,E,M,Y,96.0,KG,20210204.0,,HP,GB,GB,2021,Q1,Elderly
188484411,18848441,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U, NOT AVAILABLE,,,5.0,MG,,,2021,Q1,Malaise,,2021,Q1,1,I,202101.0,20210120.0,20210204,20210204,EXP,GB-MHRA-EYC 00237964,GB-TEVA-2021-GB-1873204,TEVA,,85.0,YR,E,M,Y,96.0,KG,20210204.0,,HP,GB,GB,2021,Q1,Elderly
188484411,18848441,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U, NOT AVAILABLE,,,5.0,MG,,,2021,Q1,Pneumonia,,2021,Q1,1,I,202101.0,20210120.0,20210204,20210204,EXP,GB-MHRA-EYC 00237964,GB-TEVA-2021-GB-1873204,TEVA,,85.0,YR,E,M,Y,96.0,KG,20210204.0,,HP,GB,GB,2021,Q1,Elderly
188514561,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q1,Acute myocardial infarction,,2021,Q1,1,I,201504.0,20210201.0,20210205,20210205,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210205.0,,MD,JP,JP,2021,Q1,Elderly
188514561,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q1,Atrial fibrillation,,2021,Q1,1,I,201504.0,20210201.0,20210205,20210205,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210205.0,,MD,JP,JP,2021,Q1,Elderly
188514561,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q1,Cardiac failure chronic,,2021,Q1,1,I,201504.0,20210201.0,20210205,20210205,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210205.0,,MD,JP,JP,2021,Q1,Elderly
188514561,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q1,Cardio-respiratory arrest,,2021,Q1,1,I,201504.0,20210201.0,20210205,20210205,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210205.0,,MD,JP,JP,2021,Q1,Elderly
188514561,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q1,Chronic kidney disease,,2021,Q1,1,I,201504.0,20210201.0,20210205,20210205,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210205.0,,MD,JP,JP,2021,Q1,Elderly
188514561,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q1,Mitral valve incompetence,,2021,Q1,1,I,201504.0,20210201.0,20210205,20210205,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210205.0,,MD,JP,JP,2021,Q1,Elderly
188514561,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q1,Oedema,,2021,Q1,1,I,201504.0,20210201.0,20210205,20210205,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210205.0,,MD,JP,JP,2021,Q1,Elderly
188514561,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q1,Weight increased,,2021,Q1,1,I,201504.0,20210201.0,20210205,20210205,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210205.0,,MD,JP,JP,2021,Q1,Elderly
188530121,18853012,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,Y,,,,,,,TABLET,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210127.0,20210205,20210205,EXP,,GB-ASTRAZENECA-2021A018962,ASTRAZENECA,,76.0,YR,,F,Y,,,20210205.0,,HP,GB,GB,2021,Q1,Elderly
188565382,18856538,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q1,Alopecia,,2021,Q1,2,F,,20210226.0,20210207,20210305,EXP,,EE-AUROBINDO-AUR-APL-2021-004540,AUROBINDO,ROSPU P. HAIGUSJUHUD: DIABEEDIRAVIMITE REDUTSEERIMINE EAKATEL. PEREARST. 2020?69:71?72,70.0,YR,,F,Y,,,20210306.0,,MD,EE,EE,2021,Q1,Elderly
188565382,18856538,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,,20210226.0,20210207,20210305,EXP,,EE-AUROBINDO-AUR-APL-2021-004540,AUROBINDO,ROSPU P. HAIGUSJUHUD: DIABEEDIRAVIMITE REDUTSEERIMINE EAKATEL. PEREARST. 2020?69:71?72,70.0,YR,,F,Y,,,20210306.0,,MD,EE,EE,2021,Q1,Elderly
188565382,18856538,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q1,Renal impairment,,2021,Q1,2,F,,20210226.0,20210207,20210305,EXP,,EE-AUROBINDO-AUR-APL-2021-004540,AUROBINDO,ROSPU P. HAIGUSJUHUD: DIABEEDIRAVIMITE REDUTSEERIMINE EAKATEL. PEREARST. 2020?69:71?72,70.0,YR,,F,Y,,,20210306.0,,MD,EE,EE,2021,Q1,Elderly
188565382,18856538,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q1,Therapeutic product effect incomplete,,2021,Q1,2,F,,20210226.0,20210207,20210305,EXP,,EE-AUROBINDO-AUR-APL-2021-004540,AUROBINDO,ROSPU P. HAIGUSJUHUD: DIABEEDIRAVIMITE REDUTSEERIMINE EAKATEL. PEREARST. 2020?69:71?72,70.0,YR,,F,Y,,,20210306.0,,MD,EE,EE,2021,Q1,Elderly
188565382,18856538,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Alopecia,,2021,Q1,2,F,,20210226.0,20210207,20210305,EXP,,EE-AUROBINDO-AUR-APL-2021-004540,AUROBINDO,ROSPU P. HAIGUSJUHUD: DIABEEDIRAVIMITE REDUTSEERIMINE EAKATEL. PEREARST. 2020?69:71?72,70.0,YR,,F,Y,,,20210306.0,,MD,EE,EE,2021,Q1,Elderly
188565382,18856538,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,,20210226.0,20210207,20210305,EXP,,EE-AUROBINDO-AUR-APL-2021-004540,AUROBINDO,ROSPU P. HAIGUSJUHUD: DIABEEDIRAVIMITE REDUTSEERIMINE EAKATEL. PEREARST. 2020?69:71?72,70.0,YR,,F,Y,,,20210306.0,,MD,EE,EE,2021,Q1,Elderly
188565382,18856538,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,2,F,,20210226.0,20210207,20210305,EXP,,EE-AUROBINDO-AUR-APL-2021-004540,AUROBINDO,ROSPU P. HAIGUSJUHUD: DIABEEDIRAVIMITE REDUTSEERIMINE EAKATEL. PEREARST. 2020?69:71?72,70.0,YR,,F,Y,,,20210306.0,,MD,EE,EE,2021,Q1,Elderly
188565382,18856538,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Therapeutic product effect incomplete,,2021,Q1,2,F,,20210226.0,20210207,20210305,EXP,,EE-AUROBINDO-AUR-APL-2021-004540,AUROBINDO,ROSPU P. HAIGUSJUHUD: DIABEEDIRAVIMITE REDUTSEERIMINE EAKATEL. PEREARST. 2020?69:71?72,70.0,YR,,F,Y,,,20210306.0,,MD,EE,EE,2021,Q1,Elderly
188575652,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q1,Body temperature increased,,2021,Q1,2,F,202101.0,20210222.0,20210208,20210308,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210308.0,,MD,FI,FI,2021,Q1,Elderly
188575652,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q1,Cognitive disorder,,2021,Q1,2,F,202101.0,20210222.0,20210208,20210308,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210308.0,,MD,FI,FI,2021,Q1,Elderly
188575652,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q1,Confusional state,,2021,Q1,2,F,202101.0,20210222.0,20210208,20210308,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210308.0,,MD,FI,FI,2021,Q1,Elderly
188575652,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q1,Disorientation,,2021,Q1,2,F,202101.0,20210222.0,20210208,20210308,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210308.0,,MD,FI,FI,2021,Q1,Elderly
188575652,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q1,Feeling hot,,2021,Q1,2,F,202101.0,20210222.0,20210208,20210308,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210308.0,,MD,FI,FI,2021,Q1,Elderly
188575652,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q1,Headache,,2021,Q1,2,F,202101.0,20210222.0,20210208,20210308,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210308.0,,MD,FI,FI,2021,Q1,Elderly
188575652,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q1,Leukocytosis,,2021,Q1,2,F,202101.0,20210222.0,20210208,20210308,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210308.0,,MD,FI,FI,2021,Q1,Elderly
188575652,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q1,Malaise,,2021,Q1,2,F,202101.0,20210222.0,20210208,20210308,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210308.0,,MD,FI,FI,2021,Q1,Elderly
188575652,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q1,Product use issue,,2021,Q1,2,F,202101.0,20210222.0,20210208,20210308,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210308.0,,MD,FI,FI,2021,Q1,Elderly
188671172,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Basophil count increased,,2021,Q1,2,F,20210215.0,20210215.0,20210209,20210222,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210222.0,,MD,GB,GB,2021,Q1,Young Adult
188671172,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Gastroenteritis,,2021,Q1,2,F,20210215.0,20210215.0,20210209,20210222,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210222.0,,MD,GB,GB,2021,Q1,Young Adult
188671172,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Hospitalisation,,2021,Q1,2,F,20210215.0,20210215.0,20210209,20210222,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210222.0,,MD,GB,GB,2021,Q1,Young Adult
188671172,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Lymphocyte count decreased,,2021,Q1,2,F,20210215.0,20210215.0,20210209,20210222,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210222.0,,MD,GB,GB,2021,Q1,Young Adult
188671172,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Monocyte count increased,,2021,Q1,2,F,20210215.0,20210215.0,20210209,20210222,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210222.0,,MD,GB,GB,2021,Q1,Young Adult
188671172,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Neutrophil count increased,,2021,Q1,2,F,20210215.0,20210215.0,20210209,20210222,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210222.0,,MD,GB,GB,2021,Q1,Young Adult
188671172,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Platelet count decreased,,2021,Q1,2,F,20210215.0,20210215.0,20210209,20210222,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210222.0,,MD,GB,GB,2021,Q1,Young Adult
188671172,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Schizophrenia,,2021,Q1,2,F,20210215.0,20210215.0,20210209,20210222,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210222.0,,MD,GB,GB,2021,Q1,Young Adult
188671172,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q1,White blood cell count increased,,2021,Q1,2,F,20210215.0,20210215.0,20210209,20210222,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210222.0,,MD,GB,GB,2021,Q1,Young Adult
188727981,18872798,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"UNK UNK, TOTAL",,,D,,,,,,,TABLET,,2021,Q1,Intentional overdose,,2021,Q1,1,I,20191019.0,20191104.0,20210210,20210210,EXP,,DE-MYLANLABS-2019M1110234,MYLAN,,78.0,YR,,F,Y,,,20210210.0,,MD,DE,DE,2021,Q1,Elderly
188727981,18872798,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"UNK UNK, TOTAL",,,D,,,,,,,TABLET,,2021,Q1,Suicide attempt,,2021,Q1,1,I,20191019.0,20191104.0,20210210,20210210,EXP,,DE-MYLANLABS-2019M1110234,MYLAN,,78.0,YR,,F,Y,,,20210210.0,,MD,DE,DE,2021,Q1,Elderly
188727981,18872798,16,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,D,,,,,,,TABLET,,2021,Q1,Intentional overdose,,2021,Q1,1,I,20191019.0,20191104.0,20210210,20210210,EXP,,DE-MYLANLABS-2019M1110234,MYLAN,,78.0,YR,,F,Y,,,20210210.0,,MD,DE,DE,2021,Q1,Elderly
188727981,18872798,16,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,D,,,,,,,TABLET,,2021,Q1,Suicide attempt,,2021,Q1,1,I,20191019.0,20191104.0,20210210,20210210,EXP,,DE-MYLANLABS-2019M1110234,MYLAN,,78.0,YR,,F,Y,,,20210210.0,,MD,DE,DE,2021,Q1,Elderly
188738281,18873828,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",20.0,MG,U,,,,,10.0,MG,TABLET,QD,2021,Q1,Generalised oedema,,2021,Q1,1,I,20210113.0,20210202.0,20210210,20210210,EXP,,NVSC2021CN028102,NOVARTIS,,70.0,YR,,F,Y,56.0,KG,20210210.0,,HP,CN,CN,2021,Q1,Elderly
188770601,18877060,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Atrial fibrillation,,2021,Q1,1,I,,20210203.0,20210211,20210211,EXP,,DE-ASTRAZENECA-2021A030146,ASTRAZENECA,,53.0,YR,,M,Y,,,20210211.0,,MD,DE,DE,2021,Q1,Adult
188770601,18877060,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Coronary artery disease,,2021,Q1,1,I,,20210203.0,20210211,20210211,EXP,,DE-ASTRAZENECA-2021A030146,ASTRAZENECA,,53.0,YR,,M,Y,,,20210211.0,,MD,DE,DE,2021,Q1,Adult
188770601,18877060,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Dyspnoea exertional,,2021,Q1,1,I,,20210203.0,20210211,20210211,EXP,,DE-ASTRAZENECA-2021A030146,ASTRAZENECA,,53.0,YR,,M,Y,,,20210211.0,,MD,DE,DE,2021,Q1,Adult
188770601,18877060,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Hypertensive heart disease,,2021,Q1,1,I,,20210203.0,20210211,20210211,EXP,,DE-ASTRAZENECA-2021A030146,ASTRAZENECA,,53.0,YR,,M,Y,,,20210211.0,,MD,DE,DE,2021,Q1,Adult
188770601,18877060,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Tachycardia induced cardiomyopathy,,2021,Q1,1,I,,20210203.0,20210211,20210211,EXP,,DE-ASTRAZENECA-2021A030146,ASTRAZENECA,,53.0,YR,,M,Y,,,20210211.0,,MD,DE,DE,2021,Q1,Adult
188795001,18879500,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210202.0,20210211,20210211,EXP,,US-ASTRAZENECA-2021A041707,ASTRAZENECA,,38.0,YR,,F,Y,,,20210211.0,,HP,US,US,2021,Q1,Adult
188818402,18881840,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,TABLET,,2021,Q1,Alopecia,,2021,Q1,2,F,,20210222.0,20210211,20210223,EXP,,EE-ASTRAZENECA-2021A027762,ASTRAZENECA,ROSPU P.. CASE STUDY: REDUCTION OF ANTIDIABETIC DRUGS. PEREARST. 2020?11:67?72.,70.0,YR,,F,Y,,,20210223.0,,MD,EE,EE,2021,Q1,Elderly
188818402,18881840,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,TABLET,,2021,Q1,Renal impairment,,2021,Q1,2,F,,20210222.0,20210211,20210223,EXP,,EE-ASTRAZENECA-2021A027762,ASTRAZENECA,ROSPU P.. CASE STUDY: REDUCTION OF ANTIDIABETIC DRUGS. PEREARST. 2020?11:67?72.,70.0,YR,,F,Y,,,20210223.0,,MD,EE,EE,2021,Q1,Elderly
188891751,18889175,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2021,Q1,Syncope,,2021,Q1,1,I,,20210208.0,20210212,20210212,EXP,,CA-ASTRAZENECA-2021A039167,ASTRAZENECA,,75.0,YR,,M,Y,,,20210212.0,,HP,CA,CA,2021,Q1,Elderly
188891751,18889175,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Syncope,,2021,Q1,1,I,,20210208.0,20210212,20210212,EXP,,CA-ASTRAZENECA-2021A039167,ASTRAZENECA,,75.0,YR,,M,Y,,,20210212.0,,HP,CA,CA,2021,Q1,Elderly
188956881,18895688,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q1,Alopecia,,2021,Q1,1,I,,20210201.0,20210215,20210215,EXP,,EE-BAUSCH-BL-2021-004204,BAUSCH AND LOMB,"ROSPU P, UNKNOWN. CASE STUDY: REDUCTION OF ANTIDIABETIC DRUGS IN THE ELDERLY. PEREARST. 2020?11:67?72.",70.0,YR,,F,Y,,,20210215.0,,MD,EE,EE,2021,Q1,Elderly
188956881,18895688,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q1,Renal impairment,,2021,Q1,1,I,,20210201.0,20210215,20210215,EXP,,EE-BAUSCH-BL-2021-004204,BAUSCH AND LOMB,"ROSPU P, UNKNOWN. CASE STUDY: REDUCTION OF ANTIDIABETIC DRUGS IN THE ELDERLY. PEREARST. 2020?11:67?72.",70.0,YR,,F,Y,,,20210215.0,,MD,EE,EE,2021,Q1,Elderly
188957873,18895787,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,QD,2021,Q1,Dermatitis allergic,,2021,Q1,3,F,2020.0,20210225.0,20210215,20210305,EXP,,"EC-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-066561",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,92.0,KG,20210305.0,,MD,EC,EC,2021,Q1,Adult
188957873,18895787,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,QD,2021,Q1,Drug ineffective,,2021,Q1,3,F,2020.0,20210225.0,20210215,20210305,EXP,,"EC-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-066561",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,92.0,KG,20210305.0,,MD,EC,EC,2021,Q1,Adult
188957873,18895787,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,QD,2021,Q1,Rash,,2021,Q1,3,F,2020.0,20210225.0,20210215,20210305,EXP,,"EC-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-066561",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,92.0,KG,20210305.0,,MD,EC,EC,2021,Q1,Adult
188993461,18899346,1,PS,DAPAGLIFLOZIN/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,205649.0,,,TABLET,,2021,Q1,Hyponatraemia,,2021,Q1,1,I,,20210208.0,20210216,20210216,EXP,,CA-ASTRAZENECA-2021A038391,ASTRAZENECA,,79.0,YR,,F,Y,,,20210216.0,,HP,CA,CA,2021,Q1,Elderly
189021831,18902183,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Immune-mediated hepatitis,,2021,Q1,1,I,,20210210.0,20210216,20210216,EXP,,CA-CELGENEUS-CAN-20210203220,CELGENE,,65.0,YR,,M,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Elderly
189039961,18903996,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Burning sensation,,2021,Q1,1,I,20210205.0,20210210.0,20210217,20210217,EXP,GB-MHRA-APPCOVID-20210208124223,GB-GLAXOSMITHKLINE-GB2021035940,GLAXOSMITHKLINE,,76.0,YR,,F,Y,89.0,KG,20210217.0,,CN,GB,GB,2021,Q1,Elderly
189039961,18903996,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Erythema,,2021,Q1,1,I,20210205.0,20210210.0,20210217,20210217,EXP,GB-MHRA-APPCOVID-20210208124223,GB-GLAXOSMITHKLINE-GB2021035940,GLAXOSMITHKLINE,,76.0,YR,,F,Y,89.0,KG,20210217.0,,CN,GB,GB,2021,Q1,Elderly
189039961,18903996,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,20210205.0,20210210.0,20210217,20210217,EXP,GB-MHRA-APPCOVID-20210208124223,GB-GLAXOSMITHKLINE-GB2021035940,GLAXOSMITHKLINE,,76.0,YR,,F,Y,89.0,KG,20210217.0,,CN,GB,GB,2021,Q1,Elderly
189039961,18903996,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Malaise,,2021,Q1,1,I,20210205.0,20210210.0,20210217,20210217,EXP,GB-MHRA-APPCOVID-20210208124223,GB-GLAXOSMITHKLINE-GB2021035940,GLAXOSMITHKLINE,,76.0,YR,,F,Y,89.0,KG,20210217.0,,CN,GB,GB,2021,Q1,Elderly
189090821,18909082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Immune-mediated hepatitis,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,CA-CELGENEUS-CAN-20210203166,CELGENE,,65.0,YR,,M,Y,,,20210218.0,,MD,CA,CA,2021,Q1,Elderly
189106261,18910626,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,40.0,MG,N,, MC3226,,,10.0,MG,TABLET,QD,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,20210205.0,20210209.0,20210218,20210218,EXP,,CN-ASTRAZENECA-2021A057464,ASTRAZENECA,,2621.0,WK,,F,Y,82.0,KG,20210218.0,,HP,CN,CN,2021,Q1,Elderly
189147181,18914718,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Arteriosclerosis,,2021,Q1,1,I,20200318.0,20210205.0,20210219,20210219,EXP,,NVSC2021TH029655,NOVARTIS,,57.0,YR,,F,Y,,,20210219.0,,MD,TH,TH,2021,Q1,Adult
189147181,18914718,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Arteriosclerosis coronary artery,,2021,Q1,1,I,20200318.0,20210205.0,20210219,20210219,EXP,,NVSC2021TH029655,NOVARTIS,,57.0,YR,,F,Y,,,20210219.0,,MD,TH,TH,2021,Q1,Adult
189147181,18914718,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Brain natriuretic peptide increased,,2021,Q1,1,I,20200318.0,20210205.0,20210219,20210219,EXP,,NVSC2021TH029655,NOVARTIS,,57.0,YR,,F,Y,,,20210219.0,,MD,TH,TH,2021,Q1,Adult
189147181,18914718,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Congestive cardiomyopathy,,2021,Q1,1,I,20200318.0,20210205.0,20210219,20210219,EXP,,NVSC2021TH029655,NOVARTIS,,57.0,YR,,F,Y,,,20210219.0,,MD,TH,TH,2021,Q1,Adult
189147181,18914718,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Metastasis,,2021,Q1,1,I,20200318.0,20210205.0,20210219,20210219,EXP,,NVSC2021TH029655,NOVARTIS,,57.0,YR,,F,Y,,,20210219.0,,MD,TH,TH,2021,Q1,Adult
189147181,18914718,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Stenosis,,2021,Q1,1,I,20200318.0,20210205.0,20210219,20210219,EXP,,NVSC2021TH029655,NOVARTIS,,57.0,YR,,F,Y,,,20210219.0,,MD,TH,TH,2021,Q1,Adult
189232941,18923294,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210211.0,20210222,20210222,EXP,,GB-ASTRAZENECA-2021A051954,ASTRAZENECA,,55.0,YR,,M,Y,,,20210222.0,,MD,GB,GB,2021,Q1,Adult
189277283,18927728,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q1,Asthenia,,2021,Q1,3,F,202101.0,20210322.0,20210223,20210324,EXP,,NVSC2021NG040819,NOVARTIS,,60.0,YR,,M,Y,,,20210324.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q1,Adult
189277283,18927728,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q1,Cerebrovascular accident,,2021,Q1,3,F,202101.0,20210322.0,20210223,20210324,EXP,,NVSC2021NG040819,NOVARTIS,,60.0,YR,,M,Y,,,20210324.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q1,Adult
189277283,18927728,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q1,Decreased appetite,,2021,Q1,3,F,202101.0,20210322.0,20210223,20210324,EXP,,NVSC2021NG040819,NOVARTIS,,60.0,YR,,M,Y,,,20210324.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q1,Adult
189277283,18927728,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q1,Fatigue,,2021,Q1,3,F,202101.0,20210322.0,20210223,20210324,EXP,,NVSC2021NG040819,NOVARTIS,,60.0,YR,,M,Y,,,20210324.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q1,Adult
189277283,18927728,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q1,Hypokinesia,,2021,Q1,3,F,202101.0,20210322.0,20210223,20210324,EXP,,NVSC2021NG040819,NOVARTIS,,60.0,YR,,M,Y,,,20210324.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q1,Adult
189277283,18927728,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q1,Palpitations,,2021,Q1,3,F,202101.0,20210322.0,20210223,20210324,EXP,,NVSC2021NG040819,NOVARTIS,,60.0,YR,,M,Y,,,20210324.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q1,Adult
189277283,18927728,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q1,Prescribed underdose,,2021,Q1,3,F,202101.0,20210322.0,20210223,20210324,EXP,,NVSC2021NG040819,NOVARTIS,,60.0,YR,,M,Y,,,20210324.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q1,Adult
189277283,18927728,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q1,Respiratory rate increased,,2021,Q1,3,F,202101.0,20210322.0,20210223,20210324,EXP,,NVSC2021NG040819,NOVARTIS,,60.0,YR,,M,Y,,,20210324.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q1,Adult
189277283,18927728,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q1,Wrong technique in product usage process,,2021,Q1,3,F,202101.0,20210322.0,20210223,20210324,EXP,,NVSC2021NG040819,NOVARTIS,,60.0,YR,,M,Y,,,20210324.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q1,Adult
189284101,18928410,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10MG ONCE DAILY,,,,,,,202293.0,,,,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,20210211.0,20210214.0,20210223,20210223,EXP,,GB-ASTRAZENECA-2021A055341,ASTRAZENECA,,54.0,YR,,F,Y,70.0,KG,20210223.0,,PH,GB,GB,2021,Q1,Adult
189324211,18932421,2,SS,DAPAGLIFLOZIN;METFORMIN;SAXAGLIPTIN,DAPAGLIFLOZIN\METFORMIN HYDROCHLORIDE\SAXAGLIPTIN HYDROCHLORIDE,1,Oral,UNK,,,U,U,,,,,,TABLET,,2021,Q1,Hyponatraemia,,2021,Q1,1,I,,20210212.0,20210223,20210223,EXP,,CA-AUROBINDO-AUR-APL-2021-007207,AUROBINDO,,79.0,YR,,F,Y,,,20210223.0,,HP,CA,CA,2021,Q1,Elderly
189349832,18934983,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,280.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Fournier's gangrene,,2021,Q1,2,F,20210213.0,20210227.0,20210224,20210304,EXP,,PT-ASTRAZENECA-2021A072400,ASTRAZENECA,,54.0,YR,,M,Y,91.0,KG,20210304.0,,MD,PT,PT,2021,Q1,Adult
189349832,18934983,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,280.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Multiple organ dysfunction syndrome,,2021,Q1,2,F,20210213.0,20210227.0,20210224,20210304,EXP,,PT-ASTRAZENECA-2021A072400,ASTRAZENECA,,54.0,YR,,M,Y,91.0,KG,20210304.0,,MD,PT,PT,2021,Q1,Adult
189349832,18934983,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,280.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Septic shock,,2021,Q1,2,F,20210213.0,20210227.0,20210224,20210304,EXP,,PT-ASTRAZENECA-2021A072400,ASTRAZENECA,,54.0,YR,,M,Y,91.0,KG,20210304.0,,MD,PT,PT,2021,Q1,Adult
189349832,18934983,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,280.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Fournier's gangrene,,2021,Q1,2,F,20210213.0,20210227.0,20210224,20210304,EXP,,PT-ASTRAZENECA-2021A072400,ASTRAZENECA,,54.0,YR,,M,Y,91.0,KG,20210304.0,,MD,PT,PT,2021,Q1,Adult
189349832,18934983,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,280.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Multiple organ dysfunction syndrome,,2021,Q1,2,F,20210213.0,20210227.0,20210224,20210304,EXP,,PT-ASTRAZENECA-2021A072400,ASTRAZENECA,,54.0,YR,,M,Y,91.0,KG,20210304.0,,MD,PT,PT,2021,Q1,Adult
189349832,18934983,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,280.0,MG,,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Septic shock,,2021,Q1,2,F,20210213.0,20210227.0,20210224,20210304,EXP,,PT-ASTRAZENECA-2021A072400,ASTRAZENECA,,54.0,YR,,M,Y,91.0,KG,20210304.0,,MD,PT,PT,2021,Q1,Adult
189397181,18939718,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Alanine aminotransferase increased,,2021,Q1,1,I,20210214.0,20210218.0,20210224,20210224,EXP,GB-MHRA-WEBCOVID-202102161503292160,GB-ROCHE-2773795,ROCHE,,46.0,YR,,M,Y,114.0,KG,20210225.0,,PH,GB,GB,2021,Q1,Adult
189476941,18947694,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,D,, UNKNOWN,,,10.0,MG,,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210216.0,20210227,20210227,EXP,,AU-LUPIN PHARMACEUTICALS INC.-2021-02389,LUPIN,,53.0,YR,,M,Y,,,20210227.0,,HP,AU,AU,2021,Q1,Adult
189476941,18947694,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210216.0,20210227,20210227,EXP,,AU-LUPIN PHARMACEUTICALS INC.-2021-02389,LUPIN,,53.0,YR,,M,Y,,,20210227.0,,HP,AU,AU,2021,Q1,Adult
189480112,18948011,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Burning sensation,,2021,Q1,2,F,20190821.0,20210305.0,20210226,20210315,EXP,,NVSC2020GB025909,NOVARTIS,,59.0,YR,,F,Y,97.0,KG,20210315.0,,HP,GB,GB,2021,Q1,Adult
189480112,18948011,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Drug ineffective,,2021,Q1,2,F,20190821.0,20210305.0,20210226,20210315,EXP,,NVSC2020GB025909,NOVARTIS,,59.0,YR,,F,Y,97.0,KG,20210315.0,,HP,GB,GB,2021,Q1,Adult
189480112,18948011,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Gait disturbance,,2021,Q1,2,F,20190821.0,20210305.0,20210226,20210315,EXP,,NVSC2020GB025909,NOVARTIS,,59.0,YR,,F,Y,97.0,KG,20210315.0,,HP,GB,GB,2021,Q1,Adult
189480112,18948011,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Hypersensitivity,,2021,Q1,2,F,20190821.0,20210305.0,20210226,20210315,EXP,,NVSC2020GB025909,NOVARTIS,,59.0,YR,,F,Y,97.0,KG,20210315.0,,HP,GB,GB,2021,Q1,Adult
189480112,18948011,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Incorrect route of product administration,,2021,Q1,2,F,20190821.0,20210305.0,20210226,20210315,EXP,,NVSC2020GB025909,NOVARTIS,,59.0,YR,,F,Y,97.0,KG,20210315.0,,HP,GB,GB,2021,Q1,Adult
189480112,18948011,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Inflammatory marker increased,,2021,Q1,2,F,20190821.0,20210305.0,20210226,20210315,EXP,,NVSC2020GB025909,NOVARTIS,,59.0,YR,,F,Y,97.0,KG,20210315.0,,HP,GB,GB,2021,Q1,Adult
189480112,18948011,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Injection site bruising,,2021,Q1,2,F,20190821.0,20210305.0,20210226,20210315,EXP,,NVSC2020GB025909,NOVARTIS,,59.0,YR,,F,Y,97.0,KG,20210315.0,,HP,GB,GB,2021,Q1,Adult
189480112,18948011,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Injection site erythema,,2021,Q1,2,F,20190821.0,20210305.0,20210226,20210315,EXP,,NVSC2020GB025909,NOVARTIS,,59.0,YR,,F,Y,97.0,KG,20210315.0,,HP,GB,GB,2021,Q1,Adult
189480112,18948011,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Injection site pain,,2021,Q1,2,F,20190821.0,20210305.0,20210226,20210315,EXP,,NVSC2020GB025909,NOVARTIS,,59.0,YR,,F,Y,97.0,KG,20210315.0,,HP,GB,GB,2021,Q1,Adult
189480112,18948011,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Mycobacterium tuberculosis complex test positive,,2021,Q1,2,F,20190821.0,20210305.0,20210226,20210315,EXP,,NVSC2020GB025909,NOVARTIS,,59.0,YR,,F,Y,97.0,KG,20210315.0,,HP,GB,GB,2021,Q1,Adult
189480112,18948011,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Rheumatoid arthritis,,2021,Q1,2,F,20190821.0,20210305.0,20210226,20210315,EXP,,NVSC2020GB025909,NOVARTIS,,59.0,YR,,F,Y,97.0,KG,20210315.0,,HP,GB,GB,2021,Q1,Adult
189480112,18948011,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Rheumatoid nodule,,2021,Q1,2,F,20190821.0,20210305.0,20210226,20210315,EXP,,NVSC2020GB025909,NOVARTIS,,59.0,YR,,F,Y,97.0,KG,20210315.0,,HP,GB,GB,2021,Q1,Adult
189480112,18948011,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q1,Tuberculosis,,2021,Q1,2,F,20190821.0,20210305.0,20210226,20210315,EXP,,NVSC2020GB025909,NOVARTIS,,59.0,YR,,F,Y,97.0,KG,20210315.0,,HP,GB,GB,2021,Q1,Adult
189482461,18948246,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,D,, UNKNOWN,,,10.0,MG,,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210216.0,20210227,20210227,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-02387,LUPIN,,69.0,YR,,F,Y,,,20210227.0,,HP,AU,AU,2021,Q1,Elderly
189482521,18948252,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MILLIGRAM, QD",,,D,, UNKNOWN,,,5.0,MG,,QD,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210216.0,20210227,20210227,EXP,,AU-LUPIN PHARMACEUTICALS INC.-2021-02423,LUPIN,,45.0,YR,,F,Y,,,20210227.0,,HP,AU,AU,2021,Q1,Adult
189482521,18948252,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210216.0,20210227,20210227,EXP,,AU-LUPIN PHARMACEUTICALS INC.-2021-02423,LUPIN,,45.0,YR,,F,Y,,,20210227.0,,HP,AU,AU,2021,Q1,Adult
189562241,18956224,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Brain natriuretic peptide abnormal,,2021,Q1,1,I,201207.0,20210224.0,20210301,20210301,EXP,,DE-ASTRAZENECA-2021A092674,ASTRAZENECA,,862.0,MON,,F,Y,42.0,KG,20210301.0,,MD,DE,DE,2021,Q1,Elderly
189562241,18956224,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Cardiac failure,,2021,Q1,1,I,201207.0,20210224.0,20210301,20210301,EXP,,DE-ASTRAZENECA-2021A092674,ASTRAZENECA,,862.0,MON,,F,Y,42.0,KG,20210301.0,,MD,DE,DE,2021,Q1,Elderly
189562241,18956224,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Dizziness,,2021,Q1,1,I,201207.0,20210224.0,20210301,20210301,EXP,,DE-ASTRAZENECA-2021A092674,ASTRAZENECA,,862.0,MON,,F,Y,42.0,KG,20210301.0,,MD,DE,DE,2021,Q1,Elderly
189562241,18956224,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Dyspnoea,,2021,Q1,1,I,201207.0,20210224.0,20210301,20210301,EXP,,DE-ASTRAZENECA-2021A092674,ASTRAZENECA,,862.0,MON,,F,Y,42.0,KG,20210301.0,,MD,DE,DE,2021,Q1,Elderly
189562241,18956224,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Fatigue,,2021,Q1,1,I,201207.0,20210224.0,20210301,20210301,EXP,,DE-ASTRAZENECA-2021A092674,ASTRAZENECA,,862.0,MON,,F,Y,42.0,KG,20210301.0,,MD,DE,DE,2021,Q1,Elderly
189562241,18956224,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,General physical health deterioration,,2021,Q1,1,I,201207.0,20210224.0,20210301,20210301,EXP,,DE-ASTRAZENECA-2021A092674,ASTRAZENECA,,862.0,MON,,F,Y,42.0,KG,20210301.0,,MD,DE,DE,2021,Q1,Elderly
189562241,18956224,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Malaise,,2021,Q1,1,I,201207.0,20210224.0,20210301,20210301,EXP,,DE-ASTRAZENECA-2021A092674,ASTRAZENECA,,862.0,MON,,F,Y,42.0,KG,20210301.0,,MD,DE,DE,2021,Q1,Elderly
189562241,18956224,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Performance status decreased,,2021,Q1,1,I,201207.0,20210224.0,20210301,20210301,EXP,,DE-ASTRAZENECA-2021A092674,ASTRAZENECA,,862.0,MON,,F,Y,42.0,KG,20210301.0,,MD,DE,DE,2021,Q1,Elderly
189562241,18956224,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Respiratory failure,,2021,Q1,1,I,201207.0,20210224.0,20210301,20210301,EXP,,DE-ASTRAZENECA-2021A092674,ASTRAZENECA,,862.0,MON,,F,Y,42.0,KG,20210301.0,,MD,DE,DE,2021,Q1,Elderly
189562241,18956224,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Therapeutic product effect decreased,,2021,Q1,1,I,201207.0,20210224.0,20210301,20210301,EXP,,DE-ASTRAZENECA-2021A092674,ASTRAZENECA,,862.0,MON,,F,Y,42.0,KG,20210301.0,,MD,DE,DE,2021,Q1,Elderly
189562241,18956224,2,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Weight decreased,,2021,Q1,1,I,201207.0,20210224.0,20210301,20210301,EXP,,DE-ASTRAZENECA-2021A092674,ASTRAZENECA,,862.0,MON,,F,Y,42.0,KG,20210301.0,,MD,DE,DE,2021,Q1,Elderly
189573471,18957347,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,Y,, UNK,,,10.0,MG,TABLET,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,20171010.0,20171026.0,20210302,20210302,EXP,GB-MHRA-ADR 24225544,GB-EMCURE PHARMACEUTICALS LTD-2017-EPL-000950,EMCURE,,78.0,YR,,M,Y,,,20210302.0,,MD,GB,GB,2021,Q1,Elderly
189573471,18957347,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,Y,, UNK,,,10.0,MG,TABLET,,2021,Q1,Epididymitis,,2021,Q1,1,I,20171010.0,20171026.0,20210302,20210302,EXP,GB-MHRA-ADR 24225544,GB-EMCURE PHARMACEUTICALS LTD-2017-EPL-000950,EMCURE,,78.0,YR,,M,Y,,,20210302.0,,MD,GB,GB,2021,Q1,Elderly
189573471,18957347,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,Y,, UNK,,,10.0,MG,TABLET,,2021,Q1,Hypotension,,2021,Q1,1,I,20171010.0,20171026.0,20210302,20210302,EXP,GB-MHRA-ADR 24225544,GB-EMCURE PHARMACEUTICALS LTD-2017-EPL-000950,EMCURE,,78.0,YR,,M,Y,,,20210302.0,,MD,GB,GB,2021,Q1,Elderly
189573471,18957347,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,Y,, UNK,,,10.0,MG,TABLET,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,20171010.0,20171026.0,20210302,20210302,EXP,GB-MHRA-ADR 24225544,GB-EMCURE PHARMACEUTICALS LTD-2017-EPL-000950,EMCURE,,78.0,YR,,M,Y,,,20210302.0,,MD,GB,GB,2021,Q1,Elderly
189573471,18957347,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,Y,, UNK,,,10.0,MG,TABLET,,2021,Q1,Epididymitis,,2021,Q1,1,I,20171010.0,20171026.0,20210302,20210302,EXP,GB-MHRA-ADR 24225544,GB-EMCURE PHARMACEUTICALS LTD-2017-EPL-000950,EMCURE,,78.0,YR,,M,Y,,,20210302.0,,MD,GB,GB,2021,Q1,Elderly
189573471,18957347,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,Y,, UNK,,,10.0,MG,TABLET,,2021,Q1,Hypotension,,2021,Q1,1,I,20171010.0,20171026.0,20210302,20210302,EXP,GB-MHRA-ADR 24225544,GB-EMCURE PHARMACEUTICALS LTD-2017-EPL-000950,EMCURE,,78.0,YR,,M,Y,,,20210302.0,,MD,GB,GB,2021,Q1,Elderly
189587891,18958789,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210221.0,20210302,20210302,EXP,,US-ASTRAZENECA-2021A081675,ASTRAZENECA,,71.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Elderly
189602201,18960220,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,201912.0,20201029.0,20210302,20210302,EXP,,BR-NOVOPROD-790142,NOVO NORDISK,,68.0,YR,,M,Y,74.8,KG,20210302.0,,MD,BR,BR,2021,Q1,Elderly
189602201,18960220,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q1,Depression,,2021,Q1,1,I,201912.0,20201029.0,20210302,20210302,EXP,,BR-NOVOPROD-790142,NOVO NORDISK,,68.0,YR,,M,Y,74.8,KG,20210302.0,,MD,BR,BR,2021,Q1,Elderly
189602201,18960220,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q1,Hyperglycaemic hyperosmolar nonketotic syndrome,,2021,Q1,1,I,201912.0,20201029.0,20210302,20210302,EXP,,BR-NOVOPROD-790142,NOVO NORDISK,,68.0,YR,,M,Y,74.8,KG,20210302.0,,MD,BR,BR,2021,Q1,Elderly
189602201,18960220,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q1,Hypoaesthesia,,2021,Q1,1,I,201912.0,20201029.0,20210302,20210302,EXP,,BR-NOVOPROD-790142,NOVO NORDISK,,68.0,YR,,M,Y,74.8,KG,20210302.0,,MD,BR,BR,2021,Q1,Elderly
189602201,18960220,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q1,Sarcopenia,,2021,Q1,1,I,201912.0,20201029.0,20210302,20210302,EXP,,BR-NOVOPROD-790142,NOVO NORDISK,,68.0,YR,,M,Y,74.8,KG,20210302.0,,MD,BR,BR,2021,Q1,Elderly
189602201,18960220,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q1,Visual impairment,,2021,Q1,1,I,201912.0,20201029.0,20210302,20210302,EXP,,BR-NOVOPROD-790142,NOVO NORDISK,,68.0,YR,,M,Y,74.8,KG,20210302.0,,MD,BR,BR,2021,Q1,Elderly
189629941,18962994,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,10.0,MG,TABLET,QD,2021,Q1,Acute kidney injury,,2021,Q1,1,I,20171010.0,20171026.0,20210303,20210303,EXP,,GB-EMD SERONO-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20210303.0,,MD,GB,GB,2021,Q1,Elderly
189629941,18962994,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,10.0,MG,TABLET,QD,2021,Q1,Epididymitis,,2021,Q1,1,I,20171010.0,20171026.0,20210303,20210303,EXP,,GB-EMD SERONO-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20210303.0,,MD,GB,GB,2021,Q1,Elderly
189629941,18962994,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,10.0,MG,TABLET,QD,2021,Q1,Hypotension,,2021,Q1,1,I,20171010.0,20171026.0,20210303,20210303,EXP,,GB-EMD SERONO-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20210303.0,,MD,GB,GB,2021,Q1,Elderly
189629941,18962994,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,10.0,MG,TABLET,QD,2021,Q1,Acute kidney injury,,2021,Q1,1,I,20171010.0,20171026.0,20210303,20210303,EXP,,GB-EMD SERONO-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20210303.0,,MD,GB,GB,2021,Q1,Elderly
189629941,18962994,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,10.0,MG,TABLET,QD,2021,Q1,Epididymitis,,2021,Q1,1,I,20171010.0,20171026.0,20210303,20210303,EXP,,GB-EMD SERONO-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20210303.0,,MD,GB,GB,2021,Q1,Elderly
189629941,18962994,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,D,U,,,,10.0,MG,TABLET,QD,2021,Q1,Hypotension,,2021,Q1,1,I,20171010.0,20171026.0,20210303,20210303,EXP,,GB-EMD SERONO-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20210303.0,,MD,GB,GB,2021,Q1,Elderly
189631221,18963122,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,,10.0,MG,TABLET,QD,2021,Q1,Ketoacidosis,,2021,Q1,1,I,20210217.0,20210226.0,20210303,20210303,EXP,,DE-ASTRAZENECA-2021A087163,ASTRAZENECA,,29.0,YR,,F,Y,83.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Young Adult
189635641,18963564,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,, UNK,,,,,TABLET,,2021,Q1,Deep vein thrombosis,,2021,Q1,1,I,,20210226.0,20210303,20210303,EXP,,CA-FRESENIUS KABI-FK202101988,FRESENIUS KABI,,69.0,YR,,M,Y,,,20210303.0,,PH,CA,CA,2021,Q1,Elderly
189635641,18963564,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,, UNK,,,,,TABLET,,2021,Q1,Heparin-induced thrombocytopenia,,2021,Q1,1,I,,20210226.0,20210303,20210303,EXP,,CA-FRESENIUS KABI-FK202101988,FRESENIUS KABI,,69.0,YR,,M,Y,,,20210303.0,,PH,CA,CA,2021,Q1,Elderly
189635641,18963564,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,, UNK,,,,,TABLET,,2021,Q1,Pulmonary embolism,,2021,Q1,1,I,,20210226.0,20210303,20210303,EXP,,CA-FRESENIUS KABI-FK202101988,FRESENIUS KABI,,69.0,YR,,M,Y,,,20210303.0,,PH,CA,CA,2021,Q1,Elderly
189635641,18963564,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,, UNK,,,,,TABLET,,2021,Q1,Pulmonary infarction,,2021,Q1,1,I,,20210226.0,20210303,20210303,EXP,,CA-FRESENIUS KABI-FK202101988,FRESENIUS KABI,,69.0,YR,,M,Y,,,20210303.0,,PH,CA,CA,2021,Q1,Elderly
189643651,18964365,2,SS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 DOSAGE FORM, DAILY",,,U,,,,,1.0,DF,TABLET,QD,2021,Q1,Diverticulum intestinal,,2021,Q1,1,I,,20210223.0,20210303,20210303,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011333,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20210303.0,,CN,CA,CA,2021,Q1,Adult
189643651,18964365,2,SS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 DOSAGE FORM, DAILY",,,U,,,,,1.0,DF,TABLET,QD,2021,Q1,Nephrolithiasis,,2021,Q1,1,I,,20210223.0,20210303,20210303,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011333,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20210303.0,,CN,CA,CA,2021,Q1,Adult
189662641,18966264,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG DAILY,,,U,N,,,,,,,,2021,Q1,Brain natriuretic peptide abnormal,,2021,Q1,1,I,201207.0,20210224.0,20210303,20210303,EXP,,DE-ANIPHARMA-2021-DE-000031,ANI,,71.0,YR,,F,Y,42.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189662641,18966264,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG DAILY,,,U,N,,,,,,,,2021,Q1,Cardiac failure,,2021,Q1,1,I,201207.0,20210224.0,20210303,20210303,EXP,,DE-ANIPHARMA-2021-DE-000031,ANI,,71.0,YR,,F,Y,42.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189662641,18966264,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG DAILY,,,U,N,,,,,,,,2021,Q1,Dizziness,,2021,Q1,1,I,201207.0,20210224.0,20210303,20210303,EXP,,DE-ANIPHARMA-2021-DE-000031,ANI,,71.0,YR,,F,Y,42.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189662641,18966264,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG DAILY,,,U,N,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,201207.0,20210224.0,20210303,20210303,EXP,,DE-ANIPHARMA-2021-DE-000031,ANI,,71.0,YR,,F,Y,42.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189662641,18966264,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG DAILY,,,U,N,,,,,,,,2021,Q1,Fatigue,,2021,Q1,1,I,201207.0,20210224.0,20210303,20210303,EXP,,DE-ANIPHARMA-2021-DE-000031,ANI,,71.0,YR,,F,Y,42.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189662641,18966264,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG DAILY,,,U,N,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,201207.0,20210224.0,20210303,20210303,EXP,,DE-ANIPHARMA-2021-DE-000031,ANI,,71.0,YR,,F,Y,42.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189662641,18966264,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG DAILY,,,U,N,,,,,,,,2021,Q1,Malaise,,2021,Q1,1,I,201207.0,20210224.0,20210303,20210303,EXP,,DE-ANIPHARMA-2021-DE-000031,ANI,,71.0,YR,,F,Y,42.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189662641,18966264,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG DAILY,,,U,N,,,,,,,,2021,Q1,Performance status decreased,,2021,Q1,1,I,201207.0,20210224.0,20210303,20210303,EXP,,DE-ANIPHARMA-2021-DE-000031,ANI,,71.0,YR,,F,Y,42.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189662641,18966264,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG DAILY,,,U,N,,,,,,,,2021,Q1,Respiratory failure,,2021,Q1,1,I,201207.0,20210224.0,20210303,20210303,EXP,,DE-ANIPHARMA-2021-DE-000031,ANI,,71.0,YR,,F,Y,42.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189662641,18966264,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG DAILY,,,U,N,,,,,,,,2021,Q1,Therapeutic product effect decreased,,2021,Q1,1,I,201207.0,20210224.0,20210303,20210303,EXP,,DE-ANIPHARMA-2021-DE-000031,ANI,,71.0,YR,,F,Y,42.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189662641,18966264,6,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG DAILY,,,U,N,,,,,,,,2021,Q1,Weight decreased,,2021,Q1,1,I,201207.0,20210224.0,20210303,20210303,EXP,,DE-ANIPHARMA-2021-DE-000031,ANI,,71.0,YR,,F,Y,42.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189777162,18977716,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, 1X",,,U,,,,,10.0,MG,,,2021,Q1,Acute myocardial infarction,,2021,Q1,2,F,2015.0,20210303.0,20210306,20210311,EXP,,NVSC2021HU048992,NOVARTIS,,67.0,YR,,M,Y,,,20210311.0,,MD,HU,HU,2021,Q1,Elderly
189777162,18977716,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, 1X",,,U,,,,,10.0,MG,,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,2,F,2015.0,20210303.0,20210306,20210311,EXP,,NVSC2021HU048992,NOVARTIS,,67.0,YR,,M,Y,,,20210311.0,,MD,HU,HU,2021,Q1,Elderly
189777162,18977716,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, 1X",,,U,,,,,10.0,MG,,,2021,Q1,Hypertension,,2021,Q1,2,F,2015.0,20210303.0,20210306,20210311,EXP,,NVSC2021HU048992,NOVARTIS,,67.0,YR,,M,Y,,,20210311.0,,MD,HU,HU,2021,Q1,Elderly
189777162,18977716,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, 1X",,,U,,,,,10.0,MG,,,2021,Q1,Obesity,,2021,Q1,2,F,2015.0,20210303.0,20210306,20210311,EXP,,NVSC2021HU048992,NOVARTIS,,67.0,YR,,M,Y,,,20210311.0,,MD,HU,HU,2021,Q1,Elderly
189880021,18988002,1,PS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,80.0,MG,Y,, RL281,,202293.0,10.0,MG,,QD,2021,Q1,Loss of bladder sensation,,2021,Q1,1,I,20210217.0,20210228.0,20210309,20210309,EXP,,GB-ASTRAZENECA-2021A092276,ASTRAZENECA,,71.0,YR,,F,Y,98.4,KG,20210309.0,,CN,GB,GB,2021,Q1,Elderly
189880021,18988002,1,PS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,80.0,MG,Y,, RL281,,202293.0,10.0,MG,,QD,2021,Q1,Perineal pain,,2021,Q1,1,I,20210217.0,20210228.0,20210309,20210309,EXP,,GB-ASTRAZENECA-2021A092276,ASTRAZENECA,,71.0,YR,,F,Y,98.4,KG,20210309.0,,CN,GB,GB,2021,Q1,Elderly
189880021,18988002,1,PS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,80.0,MG,Y,, RL281,,202293.0,10.0,MG,,QD,2021,Q1,Urinary incontinence,,2021,Q1,1,I,20210217.0,20210228.0,20210309,20210309,EXP,,GB-ASTRAZENECA-2021A092276,ASTRAZENECA,,71.0,YR,,F,Y,98.4,KG,20210309.0,,CN,GB,GB,2021,Q1,Elderly
189972931,18997293,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5,,,Y,,,,202293.0,,,,,2021,Q1,Peripheral ischaemia,,2021,Q1,1,I,20210201.0,20210304.0,20210311,20210311,EXP,,GB-ASTRAZENECA-2021A105350,ASTRAZENECA,,50.0,YR,,M,Y,,,20210311.0,,MD,GB,GB,2021,Q1,Adult
190033861,19003386,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5.0MG UNKNOWN,,,U,,,,202293.0,5.0,MG,TABLET,,2021,Q1,Lactic acidosis,,2021,Q1,1,I,20201228.0,20210309.0,20210312,20210312,EXP,,DE-ASTRAZENECA-2021A116052,ASTRAZENECA,,67.0,YR,,M,Y,95.0,KG,20210312.0,,,DE,DE,2021,Q1,Elderly
190037961,19003796,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,N,,,,202293.0,10.0,MG,,,2021,Q1,Diabetic hyperosmolar coma,,2021,Q1,1,I,20201209.0,20210305.0,20210312,20210312,EXP,,DE-ASTRAZENECA-2021A106876,ASTRAZENECA,,79.0,YR,,F,Y,,,20210312.0,,,DE,DE,2021,Q1,Elderly
190037961,19003796,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,N,,,,202293.0,10.0,MG,,,2021,Q1,Ketoacidosis,,2021,Q1,1,I,20201209.0,20210305.0,20210312,20210312,EXP,,DE-ASTRAZENECA-2021A106876,ASTRAZENECA,,79.0,YR,,F,Y,,,20210312.0,,,DE,DE,2021,Q1,Elderly
190041852,19004185,5,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"1 DOSAGE FORM, QD",,,,,,,,1.0,DF,,QD,2021,Q1,Cognitive disorder,,2021,Q1,2,F,20210215.0,20210319.0,20210313,20210326,PER,,ES-AMGEN-ESPSP2021036585,AMGEN,,73.0,YR,E,M,Y,,,20210326.0,,HP,ES,ES,2021,Q1,Elderly
190041852,19004185,5,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"1 DOSAGE FORM, QD",,,,,,,,1.0,DF,,QD,2021,Q1,Intentional self-injury,,2021,Q1,2,F,20210215.0,20210319.0,20210313,20210326,PER,,ES-AMGEN-ESPSP2021036585,AMGEN,,73.0,YR,E,M,Y,,,20210326.0,,HP,ES,ES,2021,Q1,Elderly
190067161,19006716,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,, MC3244,,,40.0,MG,TABLET,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210221.0,20210306.0,20210315,20210315,EXP,,"CN-JIANGSU HENGRUI MEDICINE CO., LTD.-2107973",JIANGSU HENGRUI MEDICINE,,77.0,YR,,F,Y,66.0,KG,20210315.0,,MD,CN,CN,2021,Q1,Elderly
190067161,19006716,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,, MC3244,,,40.0,MG,TABLET,,2021,Q1,Blood potassium decreased,,2021,Q1,1,I,20210221.0,20210306.0,20210315,20210315,EXP,,"CN-JIANGSU HENGRUI MEDICINE CO., LTD.-2107973",JIANGSU HENGRUI MEDICINE,,77.0,YR,,F,Y,66.0,KG,20210315.0,,MD,CN,CN,2021,Q1,Elderly
190067161,19006716,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,, MC3244,,,40.0,MG,TABLET,,2021,Q1,Decreased appetite,,2021,Q1,1,I,20210221.0,20210306.0,20210315,20210315,EXP,,"CN-JIANGSU HENGRUI MEDICINE CO., LTD.-2107973",JIANGSU HENGRUI MEDICINE,,77.0,YR,,F,Y,66.0,KG,20210315.0,,MD,CN,CN,2021,Q1,Elderly
190067161,19006716,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,, MC3244,,,40.0,MG,TABLET,,2021,Q1,Diarrhoea,,2021,Q1,1,I,20210221.0,20210306.0,20210315,20210315,EXP,,"CN-JIANGSU HENGRUI MEDICINE CO., LTD.-2107973",JIANGSU HENGRUI MEDICINE,,77.0,YR,,F,Y,66.0,KG,20210315.0,,MD,CN,CN,2021,Q1,Elderly
190076652,19007665,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Cardiomegaly,,2021,Q1,2,F,,20210323.0,20210315,20210330,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190076652,19007665,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Emphysema,,2021,Q1,2,F,,20210323.0,20210315,20210330,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190076652,19007665,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Hyperkalaemia,,2021,Q1,2,F,,20210323.0,20210315,20210330,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190076652,19007665,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Hyperthyroidism,,2021,Q1,2,F,,20210323.0,20210315,20210330,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190076652,19007665,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Pneumonia,,2021,Q1,2,F,,20210323.0,20210315,20210330,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190076652,19007665,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Pulmonary hypertension,,2021,Q1,2,F,,20210323.0,20210315,20210330,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190076652,19007665,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Pulmonary oedema,,2021,Q1,2,F,,20210323.0,20210315,20210330,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190082822,19008282,10,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q1,Cardiomegaly,,2021,Q1,2,F,,20210320.0,20210316,20210330,EXP,,PL-AUROBINDO-AUR-APL-2021-009872,AUROBINDO,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190082822,19008282,10,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q1,Emphysema,,2021,Q1,2,F,,20210320.0,20210316,20210330,EXP,,PL-AUROBINDO-AUR-APL-2021-009872,AUROBINDO,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190082822,19008282,10,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q1,Hyperkalaemia,,2021,Q1,2,F,,20210320.0,20210316,20210330,EXP,,PL-AUROBINDO-AUR-APL-2021-009872,AUROBINDO,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190082822,19008282,10,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q1,Hyperthyroidism,,2021,Q1,2,F,,20210320.0,20210316,20210330,EXP,,PL-AUROBINDO-AUR-APL-2021-009872,AUROBINDO,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190082822,19008282,10,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q1,Pneumonia,,2021,Q1,2,F,,20210320.0,20210316,20210330,EXP,,PL-AUROBINDO-AUR-APL-2021-009872,AUROBINDO,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190082822,19008282,10,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q1,Pulmonary hypertension,,2021,Q1,2,F,,20210320.0,20210316,20210330,EXP,,PL-AUROBINDO-AUR-APL-2021-009872,AUROBINDO,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190082822,19008282,10,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q1,Pulmonary oedema,,2021,Q1,2,F,,20210320.0,20210316,20210330,EXP,,PL-AUROBINDO-AUR-APL-2021-009872,AUROBINDO,,64.0,YR,,M,Y,,,20210330.0,,CN,PL,PL,2021,Q1,Adult
190091402,19009140,16,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Cardiomegaly,,2021,Q1,2,F,,20210325.0,20210315,20210327,EXP,,PL-ORGANON-O2103POL001570,ORGANON,,64.0,YR,,M,Y,,,20210327.0,,CN,PL,PL,2021,Q1,Adult
190091402,19009140,16,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Emphysema,,2021,Q1,2,F,,20210325.0,20210315,20210327,EXP,,PL-ORGANON-O2103POL001570,ORGANON,,64.0,YR,,M,Y,,,20210327.0,,CN,PL,PL,2021,Q1,Adult
190091402,19009140,16,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Hyperkalaemia,,2021,Q1,2,F,,20210325.0,20210315,20210327,EXP,,PL-ORGANON-O2103POL001570,ORGANON,,64.0,YR,,M,Y,,,20210327.0,,CN,PL,PL,2021,Q1,Adult
190091402,19009140,16,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Hyperthyroidism,,2021,Q1,2,F,,20210325.0,20210315,20210327,EXP,,PL-ORGANON-O2103POL001570,ORGANON,,64.0,YR,,M,Y,,,20210327.0,,CN,PL,PL,2021,Q1,Adult
190091402,19009140,16,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Pneumonia,,2021,Q1,2,F,,20210325.0,20210315,20210327,EXP,,PL-ORGANON-O2103POL001570,ORGANON,,64.0,YR,,M,Y,,,20210327.0,,CN,PL,PL,2021,Q1,Adult
190091402,19009140,16,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Pulmonary hypertension,,2021,Q1,2,F,,20210325.0,20210315,20210327,EXP,,PL-ORGANON-O2103POL001570,ORGANON,,64.0,YR,,M,Y,,,20210327.0,,CN,PL,PL,2021,Q1,Adult
190091402,19009140,16,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q1,Pulmonary oedema,,2021,Q1,2,F,,20210325.0,20210315,20210327,EXP,,PL-ORGANON-O2103POL001570,ORGANON,,64.0,YR,,M,Y,,,20210327.0,,CN,PL,PL,2021,Q1,Adult
190142891,19014289,7,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DOSAGE FORM: TABLET,,,U,, MC3244,,,10.0,MG,,QD,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210221.0,20210306.0,20210316,20210316,EXP,,CN-BAXTER-2021BAX004735,BAXTER,,77.0,YR,,F,Y,66.0,KG,20210316.0,,MD,CN,CN,2021,Q1,Elderly
190142891,19014289,7,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DOSAGE FORM: TABLET,,,U,, MC3244,,,10.0,MG,,QD,2021,Q1,Blood potassium decreased,,2021,Q1,1,I,20210221.0,20210306.0,20210316,20210316,EXP,,CN-BAXTER-2021BAX004735,BAXTER,,77.0,YR,,F,Y,66.0,KG,20210316.0,,MD,CN,CN,2021,Q1,Elderly
190142891,19014289,7,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DOSAGE FORM: TABLET,,,U,, MC3244,,,10.0,MG,,QD,2021,Q1,Coma,,2021,Q1,1,I,20210221.0,20210306.0,20210316,20210316,EXP,,CN-BAXTER-2021BAX004735,BAXTER,,77.0,YR,,F,Y,66.0,KG,20210316.0,,MD,CN,CN,2021,Q1,Elderly
190142891,19014289,7,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DOSAGE FORM: TABLET,,,U,, MC3244,,,10.0,MG,,QD,2021,Q1,Decreased appetite,,2021,Q1,1,I,20210221.0,20210306.0,20210316,20210316,EXP,,CN-BAXTER-2021BAX004735,BAXTER,,77.0,YR,,F,Y,66.0,KG,20210316.0,,MD,CN,CN,2021,Q1,Elderly
190142891,19014289,7,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,DOSAGE FORM: TABLET,,,U,, MC3244,,,10.0,MG,,QD,2021,Q1,Diarrhoea,,2021,Q1,1,I,20210221.0,20210306.0,20210316,20210316,EXP,,CN-BAXTER-2021BAX004735,BAXTER,,77.0,YR,,F,Y,66.0,KG,20210316.0,,MD,CN,CN,2021,Q1,Elderly
190190991,19019099,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 UNITS,,,Y,,,,202293.0,,,,,2021,Q1,Abdominal pain,,2021,Q1,1,I,20210303.0,20210309.0,20210316,20210316,EXP,,GB-ASTRAZENECA-2021A115460,ASTRAZENECA,,41.0,YR,,F,Y,,,20210316.0,,HP,GB,GB,2021,Q1,Adult
190196321,19019632,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2021,Q1,Cardiomegaly,,2021,Q1,1,I,,20210308.0,20210316,20210316,EXP,,PL-ASTRAZENECA-2021A111397,ASTRAZENECA,,64.0,YR,,M,Y,,,20210316.0,,MD,PL,PL,2021,Q1,Adult
190196321,19019632,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2021,Q1,Emphysema,,2021,Q1,1,I,,20210308.0,20210316,20210316,EXP,,PL-ASTRAZENECA-2021A111397,ASTRAZENECA,,64.0,YR,,M,Y,,,20210316.0,,MD,PL,PL,2021,Q1,Adult
190196321,19019632,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2021,Q1,Hyperkalaemia,,2021,Q1,1,I,,20210308.0,20210316,20210316,EXP,,PL-ASTRAZENECA-2021A111397,ASTRAZENECA,,64.0,YR,,M,Y,,,20210316.0,,MD,PL,PL,2021,Q1,Adult
190196321,19019632,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2021,Q1,Hyperthyroidism,,2021,Q1,1,I,,20210308.0,20210316,20210316,EXP,,PL-ASTRAZENECA-2021A111397,ASTRAZENECA,,64.0,YR,,M,Y,,,20210316.0,,MD,PL,PL,2021,Q1,Adult
190196321,19019632,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2021,Q1,Pneumonia,,2021,Q1,1,I,,20210308.0,20210316,20210316,EXP,,PL-ASTRAZENECA-2021A111397,ASTRAZENECA,,64.0,YR,,M,Y,,,20210316.0,,MD,PL,PL,2021,Q1,Adult
190196321,19019632,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2021,Q1,Pulmonary hypertension,,2021,Q1,1,I,,20210308.0,20210316,20210316,EXP,,PL-ASTRAZENECA-2021A111397,ASTRAZENECA,,64.0,YR,,M,Y,,,20210316.0,,MD,PL,PL,2021,Q1,Adult
190196321,19019632,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2021,Q1,Pulmonary oedema,,2021,Q1,1,I,,20210308.0,20210316,20210316,EXP,,PL-ASTRAZENECA-2021A111397,ASTRAZENECA,,64.0,YR,,M,Y,,,20210316.0,,MD,PL,PL,2021,Q1,Adult
190213601,19021360,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q1,Cardiomegaly,,2021,Q1,1,I,,20210306.0,20210317,20210317,EXP,,PL-TEVA-2021-PL-1891801,TEVA,,64.0,YR,A,M,Y,,,20210317.0,,HP,PL,PL,2021,Q1,Adult
190213601,19021360,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q1,Emphysema,,2021,Q1,1,I,,20210306.0,20210317,20210317,EXP,,PL-TEVA-2021-PL-1891801,TEVA,,64.0,YR,A,M,Y,,,20210317.0,,HP,PL,PL,2021,Q1,Adult
190213601,19021360,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q1,Hyperkalaemia,,2021,Q1,1,I,,20210306.0,20210317,20210317,EXP,,PL-TEVA-2021-PL-1891801,TEVA,,64.0,YR,A,M,Y,,,20210317.0,,HP,PL,PL,2021,Q1,Adult
190213601,19021360,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q1,Hyperthyroidism,,2021,Q1,1,I,,20210306.0,20210317,20210317,EXP,,PL-TEVA-2021-PL-1891801,TEVA,,64.0,YR,A,M,Y,,,20210317.0,,HP,PL,PL,2021,Q1,Adult
190213601,19021360,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q1,Pneumonia,,2021,Q1,1,I,,20210306.0,20210317,20210317,EXP,,PL-TEVA-2021-PL-1891801,TEVA,,64.0,YR,A,M,Y,,,20210317.0,,HP,PL,PL,2021,Q1,Adult
190213601,19021360,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q1,Pulmonary hypertension,,2021,Q1,1,I,,20210306.0,20210317,20210317,EXP,,PL-TEVA-2021-PL-1891801,TEVA,,64.0,YR,A,M,Y,,,20210317.0,,HP,PL,PL,2021,Q1,Adult
190213601,19021360,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q1,Pulmonary oedema,,2021,Q1,1,I,,20210306.0,20210317,20210317,EXP,,PL-TEVA-2021-PL-1891801,TEVA,,64.0,YR,A,M,Y,,,20210317.0,,HP,PL,PL,2021,Q1,Adult
190281821,19028182,1,PS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,Y,,,,,10.0,MG,,QD,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,20210208.0,20210309.0,20210318,20210318,EXP,,GB-ASTRAZENECA-2021A119276,ASTRAZENECA,,65.0,YR,,F,Y,,,20210318.0,,PH,GB,GB,2021,Q1,Elderly
190281821,19028182,2,SS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,Y,,,,,10.0,MG,,QD,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,20210208.0,20210309.0,20210318,20210318,EXP,,GB-ASTRAZENECA-2021A119276,ASTRAZENECA,,65.0,YR,,F,Y,,,20210318.0,,PH,GB,GB,2021,Q1,Elderly
190301021,19030102,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,50/1000,,,D,,,,,5.0,MG,,,2021,Q1,Lactic acidosis,,2021,Q1,1,I,20201228.0,20210311.0,20210319,20210319,EXP,DE-BFARM-21002314,DE-009507513-2103DEU003281,MERCK,,67.0,YR,,M,Y,95.0,KG,20210319.0,,MD,DE,DE,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Arthralgia,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Asthenia,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Asthma,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Back pain,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Chest discomfort,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Chills,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Drug hypersensitivity,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Dysuria,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Erythema,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Fatigue,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Nausea,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Nocturia,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Pain in extremity,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Pollakiuria,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Pruritus,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Pyrexia,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Rash,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Skin hypertrophy,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Urine abnormality,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q1,Urine output increased,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Arthralgia,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Asthenia,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Asthma,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Back pain,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Chest discomfort,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Chills,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Drug hypersensitivity,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Dysuria,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Erythema,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Fatigue,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Nausea,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Nocturia,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Pain in extremity,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Pollakiuria,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Pruritus,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Pyrexia,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Rash,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Skin hypertrophy,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Urine abnormality,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190322461,19032246,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2009070MC,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Urine output increased,,2021,Q1,1,I,20210212.0,20210313.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A159998,ASTRAZENECA,,23176.0,DY,,M,Y,85.0,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190345491,19034549,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,90.0,MG,,, MB3094,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Drug-induced liver injury,,2021,Q1,1,I,20210214.0,20210314.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A151167,ASTRAZENECA,,10967.0,DY,,M,Y,46.5,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190345491,19034549,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,90.0,MG,,, MB3094,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Transaminases increased,,2021,Q1,1,I,20210214.0,20210314.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A151167,ASTRAZENECA,,10967.0,DY,,M,Y,46.5,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190358521,19035852,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"50/1000 , UNIT DOSE : 5 MG",,,U,, UNKNOWN,,,5.0,MG,,,2021,Q1,Lactic acidosis,,2021,Q1,1,I,20201228.0,20210310.0,20210321,20210321,EXP,,DE-TEVA-2021-DE-1891215,TEVA,,67.0,YR,E,M,Y,95.0,KG,20210320.0,,MD,DE,DE,2021,Q1,Elderly
190400351,19040035,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10MG OD,,,N,,,,,,,,,2021,Q1,Ketoacidosis,,2021,Q1,1,I,20210310.0,20210316.0,20210322,20210322,EXP,,GB-ASTRAZENECA-2021A149539,ASTRAZENECA,,74.0,YR,,F,Y,70.0,KG,20210322.0,,MD,GB,GB,2021,Q1,Elderly
190418263,19041826,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",90.0,MG,,, MB3094,,,10.0,MG,,QD,2021,Q1,Drug-induced liver injury,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190418263,19041826,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",90.0,MG,,, MB3094,,,10.0,MG,,QD,2021,Q1,Transaminases increased,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190420151,19042015,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Cellulitis,,2021,Q1,1,I,,20210311.0,20210323,20210323,EXP,,NVSJ2021JP004387,NOVARTIS,,51.0,YR,,M,Y,65.0,KG,20210323.0,,MD,JP,JP,2021,Q1,Adult
190464991,19046499,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,10.0,MG,,QD,2021,Q1,Dyspnoea,,2021,Q1,1,I,20210216.0,20210316.0,20210323,20210323,EXP,,GB-ASTRAZENECA-2021A148416,ASTRAZENECA,,57.0,YR,,F,Y,70.0,KG,20210323.0,,PH,GB,GB,2021,Q1,Adult
190464991,19046499,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,10.0,MG,,QD,2021,Q1,Hot flush,,2021,Q1,1,I,20210216.0,20210316.0,20210323,20210323,EXP,,GB-ASTRAZENECA-2021A148416,ASTRAZENECA,,57.0,YR,,F,Y,70.0,KG,20210323.0,,PH,GB,GB,2021,Q1,Adult
190464991,19046499,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,10.0,MG,,QD,2021,Q1,Paraesthesia,,2021,Q1,1,I,20210216.0,20210316.0,20210323,20210323,EXP,,GB-ASTRAZENECA-2021A148416,ASTRAZENECA,,57.0,YR,,F,Y,70.0,KG,20210323.0,,PH,GB,GB,2021,Q1,Adult
190464991,19046499,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,10.0,MG,,QD,2021,Q1,Sleep disorder,,2021,Q1,1,I,20210216.0,20210316.0,20210323,20210323,EXP,,GB-ASTRAZENECA-2021A148416,ASTRAZENECA,,57.0,YR,,F,Y,70.0,KG,20210323.0,,PH,GB,GB,2021,Q1,Adult
190464991,19046499,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,10.0,MG,,QD,2021,Q1,Vision blurred,,2021,Q1,1,I,20210216.0,20210316.0,20210323,20210323,EXP,,GB-ASTRAZENECA-2021A148416,ASTRAZENECA,,57.0,YR,,F,Y,70.0,KG,20210323.0,,PH,GB,GB,2021,Q1,Adult
190464991,19046499,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,10.0,MG,,QD,2021,Q1,Vulvovaginitis,,2021,Q1,1,I,20210216.0,20210316.0,20210323,20210323,EXP,,GB-ASTRAZENECA-2021A148416,ASTRAZENECA,,57.0,YR,,F,Y,70.0,KG,20210323.0,,PH,GB,GB,2021,Q1,Adult
190490611,19049061,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q1,Nodular vasculitis,,2021,Q1,1,I,,20210315.0,20210323,20210323,EXP,,TR-ASTRAZENECA-2021A175099,ASTRAZENECA,,36.0,YR,,M,Y,47.3,KG,20210323.0,,MD,TR,TR,2021,Q1,Adult
190519381,19051938,2,SS,DAPA [DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE],DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,U,U,,,,,,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,20201214.0,20210315.0,20210324,20210324,EXP,,PK-NOVOPROD-796690,NOVO NORDISK,,60.0,YR,,F,Y,,,20210324.0,,CN,PK,PK,2021,Q1,Adult
190570171,19057017,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Bundle branch block left,,2021,Q1,1,I,20210319.0,,20210325,20210325,DIR,,,FDA-CTU,,63.0,YR,,F,N,133.65,KG,20210325.0,Y,HP,US,US,2021,Q1,Adult
190570171,19057017,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Confusional state,,2021,Q1,1,I,20210319.0,,20210325,20210325,DIR,,,FDA-CTU,,63.0,YR,,F,N,133.65,KG,20210325.0,Y,HP,US,US,2021,Q1,Adult
190570171,19057017,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Dizziness,,2021,Q1,1,I,20210319.0,,20210325,20210325,DIR,,,FDA-CTU,,63.0,YR,,F,N,133.65,KG,20210325.0,Y,HP,US,US,2021,Q1,Adult
190570171,19057017,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Heart rate decreased,,2021,Q1,1,I,20210319.0,,20210325,20210325,DIR,,,FDA-CTU,,63.0,YR,,F,N,133.65,KG,20210325.0,Y,HP,US,US,2021,Q1,Adult
190570171,19057017,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,1,I,20210319.0,,20210325,20210325,DIR,,,FDA-CTU,,63.0,YR,,F,N,133.65,KG,20210325.0,Y,HP,US,US,2021,Q1,Adult
190570171,19057017,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,1,I,20210319.0,,20210325,20210325,DIR,,,FDA-CTU,,63.0,YR,,F,N,133.65,KG,20210325.0,Y,HP,US,US,2021,Q1,Adult
190570171,19057017,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Bundle branch block left,,2021,Q1,1,I,20210319.0,,20210325,20210325,DIR,,,FDA-CTU,,63.0,YR,,F,N,133.65,KG,20210325.0,Y,HP,US,US,2021,Q1,Adult
190570171,19057017,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Confusional state,,2021,Q1,1,I,20210319.0,,20210325,20210325,DIR,,,FDA-CTU,,63.0,YR,,F,N,133.65,KG,20210325.0,Y,HP,US,US,2021,Q1,Adult
190570171,19057017,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Dizziness,,2021,Q1,1,I,20210319.0,,20210325,20210325,DIR,,,FDA-CTU,,63.0,YR,,F,N,133.65,KG,20210325.0,Y,HP,US,US,2021,Q1,Adult
190570171,19057017,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Heart rate decreased,,2021,Q1,1,I,20210319.0,,20210325,20210325,DIR,,,FDA-CTU,,63.0,YR,,F,N,133.65,KG,20210325.0,Y,HP,US,US,2021,Q1,Adult
190570171,19057017,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,1,I,20210319.0,,20210325,20210325,DIR,,,FDA-CTU,,63.0,YR,,F,N,133.65,KG,20210325.0,Y,HP,US,US,2021,Q1,Adult
190570171,19057017,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,1,I,20210319.0,,20210325,20210325,DIR,,,FDA-CTU,,63.0,YR,,F,N,133.65,KG,20210325.0,Y,HP,US,US,2021,Q1,Adult
190715601,19071560,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Pancytopenia,,2021,Q1,1,I,20210312.0,20210321.0,20210330,20210330,EXP,,GB-AUROBINDO-AUR-APL-2021-012710,AUROBINDO,,58.0,YR,,F,Y,,,20210330.0,,PH,GB,GB,2021,Q1,Adult
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Abdominal pain lower,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Cellulitis,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Diabetes mellitus,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Erythema,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Essential hypertension,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Fournier's gangrene,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Groin abscess,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Groin pain,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Hyperlipidaemia,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Hypertension,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Inflammation,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Lumbar spinal stenosis,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Obesity,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Perineal abscess,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Rash,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Scrotal abscess,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Scrotal swelling,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190740691,19074069,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Type 2 diabetes mellitus,,2021,Q1,1,I,20170617.0,20210322.0,20210330,20210330,EXP,,US-ASTRAZENECA-2021A188176,ASTRAZENECA,,17065.0,DY,,M,Y,162.8,KG,20210330.0,,,US,US,2021,Q1,Elderly
190742051,19074205,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q1,Pancytopenia,,2021,Q1,1,I,20210312.0,20210321.0,20210330,20210330,EXP,GB-MHRA-EYC 00244580,GB-PFIZER INC-2021306962,PFIZER,,58.0,YR,,F,Y,,,20210330.0,,PH,GB,GB,2021,Q1,Adult
190743771,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q1,Blood pressure decreased,,2021,Q1,1,I,,20210318.0,20210330,20210330,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210330.0,,MD,PL,PL,2021,Q1,Elderly
190743771,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q1,COVID-19 pneumonia,,2021,Q1,1,I,,20210318.0,20210330,20210330,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210330.0,,MD,PL,PL,2021,Q1,Elderly
190743771,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q1,Cardiac failure chronic,,2021,Q1,1,I,,20210318.0,20210330,20210330,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210330.0,,MD,PL,PL,2021,Q1,Elderly
190743771,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q1,Dyspnoea exertional,,2021,Q1,1,I,,20210318.0,20210330,20210330,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210330.0,,MD,PL,PL,2021,Q1,Elderly
190743771,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q1,Glomerular filtration rate abnormal,,2021,Q1,1,I,,20210318.0,20210330,20210330,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210330.0,,MD,PL,PL,2021,Q1,Elderly
190743771,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q1,Hypertrophy,,2021,Q1,1,I,,20210318.0,20210330,20210330,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210330.0,,MD,PL,PL,2021,Q1,Elderly
190743771,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q1,N-terminal prohormone brain natriuretic peptide abnormal,,2021,Q1,1,I,,20210318.0,20210330,20210330,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210330.0,,MD,PL,PL,2021,Q1,Elderly
190743771,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q1,Renal atrophy,,2021,Q1,1,I,,20210318.0,20210330,20210330,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210330.0,,MD,PL,PL,2021,Q1,Elderly
190743771,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q1,Urosepsis,,2021,Q1,1,I,,20210318.0,20210330,20210330,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210330.0,,MD,PL,PL,2021,Q1,Elderly
190756531,19075653,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,202103.0,20210318.0,20210330,20210330,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202103009583,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20210330.0,,MD,CN,CN,2021,Q1,Elderly
190756531,19075653,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q1,Diarrhoea,,2021,Q1,1,I,202103.0,20210318.0,20210330,20210330,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202103009583,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20210330.0,,MD,CN,CN,2021,Q1,Elderly
190783671,19078367,5,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2021,Q1,Enthesopathy,,2021,Q1,1,I,,20210323.0,20210331,20210331,EXP,,CA-PFIZER INC-2021324363,PFIZER,,55.0,YR,,M,Y,,,20210331.0,,HP,CA,CA,2021,Q1,Adult
190783671,19078367,5,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 MG, 1X/DAY",,,,,,,,10.0,MG,,QD,2021,Q1,Polyarthritis,,2021,Q1,1,I,,20210323.0,20210331,20210331,EXP,,CA-PFIZER INC-2021324363,PFIZER,,55.0,YR,,M,Y,,,20210331.0,,HP,CA,CA,2021,Q1,Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Blood creatine phosphokinase increased,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Body mass index increased,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Cardiac dysfunction,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Cardiomyopathy,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Drug ineffective,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Dyslipidaemia,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Ejection fraction decreased,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Influenza like illness,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Left ventricular dysfunction,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Pleural effusion,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Seizure,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Suspected COVID-19,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
158554665,15855466,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Weight increased,,2021,Q2,5,F,2009.0,20210331.0,20190122,20210408,EXP,,PHHY2019AU008305,NOVARTIS,,29.0,YR,,M,Y,,,20210408.0,,HP,AU,AU,2021,Q2,Young Adult
166141432,16614143,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Acute coronary syndrome,,2021,Q2,2,F,,20210527.0,20190723,20210604,EXP,,CA-APOTEX-2019AP018594,APOTEX,,56.0,YR,,M,Y,82.0,KG,20210604.0,,CN,CA,CA,2021,Q2,Adult
166141432,16614143,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Angina unstable,,2021,Q2,2,F,,20210527.0,20190723,20210604,EXP,,CA-APOTEX-2019AP018594,APOTEX,,56.0,YR,,M,Y,82.0,KG,20210604.0,,CN,CA,CA,2021,Q2,Adult
166141432,16614143,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Blood cholesterol increased,,2021,Q2,2,F,,20210527.0,20190723,20210604,EXP,,CA-APOTEX-2019AP018594,APOTEX,,56.0,YR,,M,Y,82.0,KG,20210604.0,,CN,CA,CA,2021,Q2,Adult
166141432,16614143,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Blood creatine phosphokinase increased,,2021,Q2,2,F,,20210527.0,20190723,20210604,EXP,,CA-APOTEX-2019AP018594,APOTEX,,56.0,YR,,M,Y,82.0,KG,20210604.0,,CN,CA,CA,2021,Q2,Adult
166141432,16614143,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Blood parathyroid hormone increased,,2021,Q2,2,F,,20210527.0,20190723,20210604,EXP,,CA-APOTEX-2019AP018594,APOTEX,,56.0,YR,,M,Y,82.0,KG,20210604.0,,CN,CA,CA,2021,Q2,Adult
166141432,16614143,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Blood triglycerides increased,,2021,Q2,2,F,,20210527.0,20190723,20210604,EXP,,CA-APOTEX-2019AP018594,APOTEX,,56.0,YR,,M,Y,82.0,KG,20210604.0,,CN,CA,CA,2021,Q2,Adult
166141432,16614143,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Coronary artery stenosis,,2021,Q2,2,F,,20210527.0,20190723,20210604,EXP,,CA-APOTEX-2019AP018594,APOTEX,,56.0,YR,,M,Y,82.0,KG,20210604.0,,CN,CA,CA,2021,Q2,Adult
166141432,16614143,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,High density lipoprotein decreased,,2021,Q2,2,F,,20210527.0,20190723,20210604,EXP,,CA-APOTEX-2019AP018594,APOTEX,,56.0,YR,,M,Y,82.0,KG,20210604.0,,CN,CA,CA,2021,Q2,Adult
166141432,16614143,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Low density lipoprotein increased,,2021,Q2,2,F,,20210527.0,20190723,20210604,EXP,,CA-APOTEX-2019AP018594,APOTEX,,56.0,YR,,M,Y,82.0,KG,20210604.0,,CN,CA,CA,2021,Q2,Adult
166141432,16614143,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Muscular weakness,,2021,Q2,2,F,,20210527.0,20190723,20210604,EXP,,CA-APOTEX-2019AP018594,APOTEX,,56.0,YR,,M,Y,82.0,KG,20210604.0,,CN,CA,CA,2021,Q2,Adult
166141432,16614143,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Myalgia,,2021,Q2,2,F,,20210527.0,20190723,20210604,EXP,,CA-APOTEX-2019AP018594,APOTEX,,56.0,YR,,M,Y,82.0,KG,20210604.0,,CN,CA,CA,2021,Q2,Adult
166141432,16614143,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Myopathy,,2021,Q2,2,F,,20210527.0,20190723,20210604,EXP,,CA-APOTEX-2019AP018594,APOTEX,,56.0,YR,,M,Y,82.0,KG,20210604.0,,CN,CA,CA,2021,Q2,Adult
166141432,16614143,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Total cholesterol/HDL ratio increased,,2021,Q2,2,F,,20210527.0,20190723,20210604,EXP,,CA-APOTEX-2019AP018594,APOTEX,,56.0,YR,,M,Y,82.0,KG,20210604.0,,CN,CA,CA,2021,Q2,Adult
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Abdominal pain,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood pressure diastolic abnormal,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood pressure diastolic decreased,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood pressure systolic abnormal,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood pressure systolic increased,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Chronic obstructive pulmonary disease,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cough,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Eczema,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Gastritis,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Gastrointestinal disorder,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Gout,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Heart rate increased,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Oropharyngeal pain,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Oxygen saturation decreased,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
172170842,17217084,7,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Sleep disorder,,2021,Q2,2,F,,20210324.0,20191231,20210402,EXP,,CA-AUROBINDO-AUR-APL-2019-107136,AUROBINDO,,69.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Elderly
173156302,17315630,3,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE W/METFO,,2,,,,,,,,,,,,,,2021,Q2,Drug delivery system malfunction,,2021,Q2,2,F,201905.0,20210622.0,20200124,20210629,EXP,,BR-JNJFOC-20190727320,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20210629.0,,CN,BR,BR,2021,Q2,Elderly
173156302,17315630,3,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE W/METFO,,2,,,,,,,,,,,,,,2021,Q2,Oesophageal carcinoma,,2021,Q2,2,F,201905.0,20210622.0,20200124,20210629,EXP,,BR-JNJFOC-20190727320,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20210629.0,,CN,BR,BR,2021,Q2,Elderly
173156302,17315630,3,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE W/METFO,,2,,,,,,,,,,,,,,2021,Q2,Product dose omission issue,,2021,Q2,2,F,201905.0,20210622.0,20200124,20210629,EXP,,BR-JNJFOC-20190727320,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20210629.0,,CN,BR,BR,2021,Q2,Elderly
174145672,17414567,9,C,DAPAGLIFLOZIN 5 MG,DAPAGLIFLOZIN,1,,,,,,,,,,,,TABLET,,2021,Q2,Colon cancer stage III,,2021,Q2,2,F,,20200403.0,20200213,20210617,EXP,,US-TEVA-2020-US-1183402,TEVA,,73.0,YR,E,M,Y,127.12,KG,20210617.0,,MD,US,US,2021,Q2,Elderly
177169092,17716909,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Ketoacidosis,,2021,Q2,2,F,20200408.0,20210519.0,20200428,20210522,EXP,DE-BFARM-20004692,DE-009507513-2004DEU006732,MERCK,,67.0,YR,,M,Y,108.0,KG,20210522.0,,MD,DE,DE,2021,Q2,Elderly
184292523,18429252,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, UNKNOWN",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Cardiac ventricular thrombosis,,2021,Q2,3,F,20200828.0,20210329.0,20201026,20210408,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20210408.0,,MD,CN,CN,2021,Q2,Adult
184292523,18429252,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, UNKNOWN",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Ventricular arrhythmia,,2021,Q2,3,F,20200828.0,20210329.0,20201026,20210408,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20210408.0,,MD,CN,CN,2021,Q2,Adult
186389994,18638999,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Acute myocardial infarction,,2021,Q2,4,F,20201207.0,20210401.0,20201218,20210408,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-107734,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,,,20210408.0,,HP,BR,BR,2021,Q2,Elderly
186389994,18638999,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Cardiac failure,,2021,Q2,4,F,20201207.0,20210401.0,20201218,20210408,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-107734,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,,,20210408.0,,HP,BR,BR,2021,Q2,Elderly
187336203,18733620,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Drug clearance decreased,,2021,Q2,3,F,,20210507.0,20210113,20210520,EXP,,GB-ACCORD-213822,ACCORD,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT? RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REP. 2020 DEC 28?13(12):E238047",86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187336203,18733620,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Drug interaction,,2021,Q2,3,F,,20210507.0,20210113,20210520,EXP,,GB-ACCORD-213822,ACCORD,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT? RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REP. 2020 DEC 28?13(12):E238047",86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187336203,18733620,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Fluid overload,,2021,Q2,3,F,,20210507.0,20210113,20210520,EXP,,GB-ACCORD-213822,ACCORD,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT? RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REP. 2020 DEC 28?13(12):E238047",86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187336203,18733620,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Hyperkalaemia,,2021,Q2,3,F,,20210507.0,20210113,20210520,EXP,,GB-ACCORD-213822,ACCORD,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT? RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REP. 2020 DEC 28?13(12):E238047",86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187336203,18733620,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Hypotension,,2021,Q2,3,F,,20210507.0,20210113,20210520,EXP,,GB-ACCORD-213822,ACCORD,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT? RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REP. 2020 DEC 28?13(12):E238047",86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187336203,18733620,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Metabolic acidosis,,2021,Q2,3,F,,20210507.0,20210113,20210520,EXP,,GB-ACCORD-213822,ACCORD,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT? RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REP. 2020 DEC 28?13(12):E238047",86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187336203,18733620,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Pericardial haemorrhage,,2021,Q2,3,F,,20210507.0,20210113,20210520,EXP,,GB-ACCORD-213822,ACCORD,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT? RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REP. 2020 DEC 28?13(12):E238047",86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187336203,18733620,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Pleural effusion,,2021,Q2,3,F,,20210507.0,20210113,20210520,EXP,,GB-ACCORD-213822,ACCORD,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT? RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REP. 2020 DEC 28?13(12):E238047",86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187336203,18733620,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Renal failure,,2021,Q2,3,F,,20210507.0,20210113,20210520,EXP,,GB-ACCORD-213822,ACCORD,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT? RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REP. 2020 DEC 28?13(12):E238047",86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187851223,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Acute kidney injury,,2021,Q2,3,F,,20210507.0,20210125,20210520,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187851223,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Cardiac tamponade,,2021,Q2,3,F,,20210507.0,20210125,20210520,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187851223,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Drug clearance decreased,,2021,Q2,3,F,,20210507.0,20210125,20210520,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187851223,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Drug interaction,,2021,Q2,3,F,,20210507.0,20210125,20210520,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187851223,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Fluid overload,,2021,Q2,3,F,,20210507.0,20210125,20210520,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187851223,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Hyperkalaemia,,2021,Q2,3,F,,20210507.0,20210125,20210520,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187851223,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Hypotension,,2021,Q2,3,F,,20210507.0,20210125,20210520,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187851223,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Metabolic acidosis,,2021,Q2,3,F,,20210507.0,20210125,20210520,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187851223,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Pericardial haemorrhage,,2021,Q2,3,F,,20210507.0,20210125,20210520,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187851223,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Pleural effusion,,2021,Q2,3,F,,20210507.0,20210125,20210520,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
187851223,18785122,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Renal failure,,2021,Q2,3,F,,20210507.0,20210125,20210520,EXP,,GB-JNJFOC-20210135006,JOHNSON AND JOHNSON,,86.0,YR,E,M,Y,,,20210520.0,,HP,GB,GB,2021,Q2,Elderly
188173374,18817337,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Fatigue,,2021,Q2,4,F,20190401.0,20210504.0,20210201,20210517,EXP,,NVSC2021KE011733,NOVARTIS,,69.0,YR,,M,Y,,,20210517.0,,CN,KE,KE,2021,Q2,Elderly
188173374,18817337,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Product use in unapproved indication,,2021,Q2,4,F,20190401.0,20210504.0,20210201,20210517,EXP,,NVSC2021KE011733,NOVARTIS,,69.0,YR,,M,Y,,,20210517.0,,CN,KE,KE,2021,Q2,Elderly
188514562,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Acute myocardial infarction,,2021,Q2,2,F,201504.0,20210625.0,20210205,20210630,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210630.0,,MD,JP,JP,2021,Q2,Elderly
188514562,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Atrial fibrillation,,2021,Q2,2,F,201504.0,20210625.0,20210205,20210630,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210630.0,,MD,JP,JP,2021,Q2,Elderly
188514562,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Cardiac failure chronic,,2021,Q2,2,F,201504.0,20210625.0,20210205,20210630,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210630.0,,MD,JP,JP,2021,Q2,Elderly
188514562,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Cardio-respiratory arrest,,2021,Q2,2,F,201504.0,20210625.0,20210205,20210630,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210630.0,,MD,JP,JP,2021,Q2,Elderly
188514562,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Chronic kidney disease,,2021,Q2,2,F,201504.0,20210625.0,20210205,20210630,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210630.0,,MD,JP,JP,2021,Q2,Elderly
188514562,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Mitral valve incompetence,,2021,Q2,2,F,201504.0,20210625.0,20210205,20210630,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210630.0,,MD,JP,JP,2021,Q2,Elderly
188514562,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Oedema,,2021,Q2,2,F,201504.0,20210625.0,20210205,20210630,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210630.0,,MD,JP,JP,2021,Q2,Elderly
188514562,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Weight increased,,2021,Q2,2,F,201504.0,20210625.0,20210205,20210630,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210630.0,,MD,JP,JP,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Blood albumin decreased,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Blood bicarbonate increased,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Blood gases abnormal,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Blood glucose abnormal,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Body temperature increased,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Calcium ionised increased,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Cognitive disorder,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Confusional state,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Disorientation,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Eosinophil count decreased,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Feeling hot,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Headache,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Leukocytosis,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Lymphocyte count increased,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Malaise,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Mean cell haemoglobin concentration decreased,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Neutrophil count increased,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188575653,18857565,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10MG,,,U,,,,,10.0,MG,FILM-COATED TABLET,,2021,Q2,Red blood cell count increased,,2021,Q2,3,F,202101.0,20210222.0,20210208,20210421,EXP,,FI-SA-2021SA036130,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210421.0,,MD,FI,FI,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Arthralgia,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Asthenia,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Blood pressure decreased,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Dyspnoea,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Fatigue,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Feeling hot,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Gait disturbance,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Hypertension,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Hypotension,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Localised oedema,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Movement disorder,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Oedema peripheral,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Pain in extremity,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Respiratory rate increased,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188800566,18880056,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Underdose,,2021,Q2,6,F,202101.0,20210409.0,20210211,20210421,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20210421.0,,CN,NG,NG,2021,Q2,Elderly
188834368,18883436,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Abdominal rigidity,,2021,Q2,8,F,20210120.0,20210416.0,20210212,20210527,EXP,,NVSC2021NG029346,NOVARTIS,,58.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Adult
188834368,18883436,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Heart rate irregular,,2021,Q2,8,F,20210120.0,20210416.0,20210212,20210527,EXP,,NVSC2021NG029346,NOVARTIS,,58.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Adult
188834368,18883436,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Musculoskeletal chest pain,,2021,Q2,8,F,20210120.0,20210416.0,20210212,20210527,EXP,,NVSC2021NG029346,NOVARTIS,,58.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Adult
188834368,18883436,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Pain,,2021,Q2,8,F,20210120.0,20210416.0,20210212,20210527,EXP,,NVSC2021NG029346,NOVARTIS,,58.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Adult
188834368,18883436,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Product use in unapproved indication,,2021,Q2,8,F,20210120.0,20210416.0,20210212,20210527,EXP,,NVSC2021NG029346,NOVARTIS,,58.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Adult
188834368,18883436,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,1 DF,,,U,,,,,1.0,DF,,,2021,Q2,Renal disorder,,2021,Q2,8,F,20210120.0,20210416.0,20210212,20210527,EXP,,NVSC2021NG029346,NOVARTIS,,58.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Adult
189210023,18921002,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q2,Blood pressure systolic increased,,2021,Q2,3,F,,20210524.0,20210222,20210606,EXP,,NVSJ2021JP002667,NOVARTIS,,80.0,YR,,F,Y,,,20210607.0,,CN,JP,JP,2021,Q2,Elderly
189210023,18921002,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q2,Dizziness postural,,2021,Q2,3,F,,20210524.0,20210222,20210606,EXP,,NVSJ2021JP002667,NOVARTIS,,80.0,YR,,F,Y,,,20210607.0,,CN,JP,JP,2021,Q2,Elderly
189210023,18921002,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q2,Product use in unapproved indication,,2021,Q2,3,F,,20210524.0,20210222,20210606,EXP,,NVSJ2021JP002667,NOVARTIS,,80.0,YR,,F,Y,,,20210607.0,,CN,JP,JP,2021,Q2,Elderly
189210023,18921002,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q2,Product use issue,,2021,Q2,3,F,,20210524.0,20210222,20210606,EXP,,NVSJ2021JP002667,NOVARTIS,,80.0,YR,,F,Y,,,20210607.0,,CN,JP,JP,2021,Q2,Elderly
189572923,18957292,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Atrial fibrillation,,2021,Q2,3,F,202101.0,20210524.0,20210302,20210607,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20210607.0,,CN,JP,JP,2021,Q2,Elderly
189572923,18957292,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Cardiac failure,,2021,Q2,3,F,202101.0,20210524.0,20210302,20210607,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20210607.0,,CN,JP,JP,2021,Q2,Elderly
189572923,18957292,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Cardiac failure congestive,,2021,Q2,3,F,202101.0,20210524.0,20210302,20210607,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20210607.0,,CN,JP,JP,2021,Q2,Elderly
189572923,18957292,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Dehydration,,2021,Q2,3,F,202101.0,20210524.0,20210302,20210607,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20210607.0,,CN,JP,JP,2021,Q2,Elderly
189572923,18957292,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Dizziness,,2021,Q2,3,F,202101.0,20210524.0,20210302,20210607,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20210607.0,,CN,JP,JP,2021,Q2,Elderly
189572923,18957292,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Hypotension,,2021,Q2,3,F,202101.0,20210524.0,20210302,20210607,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20210607.0,,CN,JP,JP,2021,Q2,Elderly
189572923,18957292,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Product use issue,,2021,Q2,3,F,202101.0,20210524.0,20210302,20210607,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20210607.0,,CN,JP,JP,2021,Q2,Elderly
189572923,18957292,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Septic shock,,2021,Q2,3,F,202101.0,20210524.0,20210302,20210607,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20210607.0,,CN,JP,JP,2021,Q2,Elderly
189572923,18957292,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Urinary tract infection,,2021,Q2,3,F,202101.0,20210524.0,20210302,20210607,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20210607.0,,CN,JP,JP,2021,Q2,Elderly
189605212,18960521,14,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Cardiomegaly,,2021,Q2,2,F,,20210324.0,20210302,20210401,EXP,,NVSC2021PL044801,NOVARTIS,,64.0,YR,,M,Y,,,20210401.0,,HP,PL,PL,2021,Q2,Adult
189605212,18960521,14,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Emphysema,,2021,Q2,2,F,,20210324.0,20210302,20210401,EXP,,NVSC2021PL044801,NOVARTIS,,64.0,YR,,M,Y,,,20210401.0,,HP,PL,PL,2021,Q2,Adult
189605212,18960521,14,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Hyperkalaemia,,2021,Q2,2,F,,20210324.0,20210302,20210401,EXP,,NVSC2021PL044801,NOVARTIS,,64.0,YR,,M,Y,,,20210401.0,,HP,PL,PL,2021,Q2,Adult
189605212,18960521,14,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Hyperthyroidism,,2021,Q2,2,F,,20210324.0,20210302,20210401,EXP,,NVSC2021PL044801,NOVARTIS,,64.0,YR,,M,Y,,,20210401.0,,HP,PL,PL,2021,Q2,Adult
189605212,18960521,14,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Pneumonia,,2021,Q2,2,F,,20210324.0,20210302,20210401,EXP,,NVSC2021PL044801,NOVARTIS,,64.0,YR,,M,Y,,,20210401.0,,HP,PL,PL,2021,Q2,Adult
189605212,18960521,14,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Pulmonary hypertension,,2021,Q2,2,F,,20210324.0,20210302,20210401,EXP,,NVSC2021PL044801,NOVARTIS,,64.0,YR,,M,Y,,,20210401.0,,HP,PL,PL,2021,Q2,Adult
189605212,18960521,14,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Pulmonary oedema,,2021,Q2,2,F,,20210324.0,20210302,20210401,EXP,,NVSC2021PL044801,NOVARTIS,,64.0,YR,,M,Y,,,20210401.0,,HP,PL,PL,2021,Q2,Adult
190125077,19012507,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MEQ,TABLETS,,2021,Q2,Hypertensive crisis,,2021,Q2,7,F,20210311.0,20210503.0,20210315,20210506,EXP,,AU-EISAI MEDICAL RESEARCH-EC-2021-089609,EISAI,,63.0,YR,A,F,Y,77.1,KG,20210506.0,,MD,AU,AU,2021,Q2,Adult
190125077,19012507,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MEQ,TABLETS,,2021,Q2,Status epilepticus,,2021,Q2,7,F,20210311.0,20210503.0,20210315,20210506,EXP,,AU-EISAI MEDICAL RESEARCH-EC-2021-089609,EISAI,,63.0,YR,A,F,Y,77.1,KG,20210506.0,,MD,AU,AU,2021,Q2,Adult
190420152,19042015,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Arthropod sting,,2021,Q2,2,F,202102.0,20210422.0,20210323,20210505,EXP,,NVSJ2021JP004387,NOVARTIS,,51.0,YR,,M,Y,65.0,KG,20210505.0,,MD,JP,JP,2021,Q2,Adult
190420152,19042015,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cellulitis,,2021,Q2,2,F,202102.0,20210422.0,20210323,20210505,EXP,,NVSJ2021JP004387,NOVARTIS,,51.0,YR,,M,Y,65.0,KG,20210505.0,,MD,JP,JP,2021,Q2,Adult
190732372,19073237,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Asthma,,2021,Q2,2,F,202012.0,20210329.0,20210330,20210406,EXP,,NVSC2021NG047172,NOVARTIS,,36.0,YR,,F,Y,,,20210406.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Adult
190732372,19073237,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Dyspnoea,,2021,Q2,2,F,202012.0,20210329.0,20210330,20210406,EXP,,NVSC2021NG047172,NOVARTIS,,36.0,YR,,F,Y,,,20210406.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Adult
190732372,19073237,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Underdose,,2021,Q2,2,F,202012.0,20210329.0,20210330,20210406,EXP,,NVSC2021NG047172,NOVARTIS,,36.0,YR,,F,Y,,,20210406.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Adult
190732372,19073237,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Wrong technique in product usage process,,2021,Q2,2,F,202012.0,20210329.0,20210330,20210406,EXP,,NVSC2021NG047172,NOVARTIS,,36.0,YR,,F,Y,,,20210406.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Adult
190743772,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Blood pressure decreased,,2021,Q2,2,F,,20210531.0,20210330,20210604,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210604.0,,HP,PL,PL,2021,Q2,Elderly
190743772,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,COVID-19 pneumonia,,2021,Q2,2,F,,20210531.0,20210330,20210604,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210604.0,,HP,PL,PL,2021,Q2,Elderly
190743772,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Cardiac failure chronic,,2021,Q2,2,F,,20210531.0,20210330,20210604,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210604.0,,HP,PL,PL,2021,Q2,Elderly
190743772,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Dyspnoea exertional,,2021,Q2,2,F,,20210531.0,20210330,20210604,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210604.0,,HP,PL,PL,2021,Q2,Elderly
190743772,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Glomerular filtration rate abnormal,,2021,Q2,2,F,,20210531.0,20210330,20210604,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210604.0,,HP,PL,PL,2021,Q2,Elderly
190743772,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Hypertrophy,,2021,Q2,2,F,,20210531.0,20210330,20210604,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210604.0,,HP,PL,PL,2021,Q2,Elderly
190743772,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,N-terminal prohormone brain natriuretic peptide abnormal,,2021,Q2,2,F,,20210531.0,20210330,20210604,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210604.0,,HP,PL,PL,2021,Q2,Elderly
190743772,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Renal atrophy,,2021,Q2,2,F,,20210531.0,20210330,20210604,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210604.0,,HP,PL,PL,2021,Q2,Elderly
190743772,19074377,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Urosepsis,,2021,Q2,2,F,,20210531.0,20210330,20210604,EXP,,NVSC2021PL064846,NOVARTIS,,70.0,YR,,M,Y,,,20210604.0,,HP,PL,PL,2021,Q2,Elderly
190745572,19074557,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Blood pressure decreased,,2021,Q2,2,F,20210202.0,20210401.0,20210330,20210414,EXP,,NVSJ2021JP004506,NOVARTIS,,72.0,YR,,M,Y,,,20210414.0,,MD,JP,JP,2021,Q2,Elderly
190745572,19074557,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Mitral valve incompetence,,2021,Q2,2,F,20210202.0,20210401.0,20210330,20210414,EXP,,NVSJ2021JP004506,NOVARTIS,,72.0,YR,,M,Y,,,20210414.0,,MD,JP,JP,2021,Q2,Elderly
190745572,19074557,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Tricuspid valve incompetence,,2021,Q2,2,F,20210202.0,20210401.0,20210330,20210414,EXP,,NVSJ2021JP004506,NOVARTIS,,72.0,YR,,M,Y,,,20210414.0,,MD,JP,JP,2021,Q2,Elderly
190803981,19080398,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q2,Diverticulitis,,2021,Q2,1,I,20201209.0,20210323.0,20210401,20210401,PER,,GB-AMGEN-GBRSP2021045588,AMGEN,,61.0,YR,A,M,Y,82.0,KG,20210331.0,,HP,GB,GB,2021,Q2,Adult
190803981,19080398,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q2,Renal cyst,,2021,Q2,1,I,20201209.0,20210323.0,20210401,20210401,PER,,GB-AMGEN-GBRSP2021045588,AMGEN,,61.0,YR,A,M,Y,82.0,KG,20210331.0,,HP,GB,GB,2021,Q2,Adult
190804331,19080433,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,COVID-19,,2021,Q2,1,I,,20210324.0,20210401,20210401,EXP,,CA-JNJFOC-20210353133,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,87.0,KG,20210401.0,,HP,CA,CA,2021,Q2,Elderly
190804331,19080433,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Chills,,2021,Q2,1,I,,20210324.0,20210401,20210401,EXP,,CA-JNJFOC-20210353133,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,87.0,KG,20210401.0,,HP,CA,CA,2021,Q2,Elderly
190804331,19080433,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210324.0,20210401,20210401,EXP,,CA-JNJFOC-20210353133,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,87.0,KG,20210401.0,,HP,CA,CA,2021,Q2,Elderly
190804331,19080433,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Cough,,2021,Q2,1,I,,20210324.0,20210401,20210401,EXP,,CA-JNJFOC-20210353133,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,87.0,KG,20210401.0,,HP,CA,CA,2021,Q2,Elderly
190804331,19080433,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Headache,,2021,Q2,1,I,,20210324.0,20210401,20210401,EXP,,CA-JNJFOC-20210353133,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,87.0,KG,20210401.0,,HP,CA,CA,2021,Q2,Elderly
190804331,19080433,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Off label use,,2021,Q2,1,I,,20210324.0,20210401,20210401,EXP,,CA-JNJFOC-20210353133,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,87.0,KG,20210401.0,,HP,CA,CA,2021,Q2,Elderly
190804331,19080433,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Pyrexia,,2021,Q2,1,I,,20210324.0,20210401,20210401,EXP,,CA-JNJFOC-20210353133,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,87.0,KG,20210401.0,,HP,CA,CA,2021,Q2,Elderly
190853111,19085311,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,20210319.0,20210325.0,20210401,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202103013146,ELI LILLY AND CO,,63.0,YR,,F,Y,134.69,KG,20210401.0,,HP,US,US,2021,Q2,Adult
190853111,19085311,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,1,I,20210319.0,20210325.0,20210401,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202103013146,ELI LILLY AND CO,,63.0,YR,,F,Y,134.69,KG,20210401.0,,HP,US,US,2021,Q2,Adult
190853111,19085311,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q2,Heart rate decreased,,2021,Q2,1,I,20210319.0,20210325.0,20210401,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202103013146,ELI LILLY AND CO,,63.0,YR,,F,Y,134.69,KG,20210401.0,,HP,US,US,2021,Q2,Adult
190853111,19085311,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q2,Nausea,,2021,Q2,1,I,20210319.0,20210325.0,20210401,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202103013146,ELI LILLY AND CO,,63.0,YR,,F,Y,134.69,KG,20210401.0,,HP,US,US,2021,Q2,Adult
190853111,19085311,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q2,Oxygen saturation decreased,,2021,Q2,1,I,20210319.0,20210325.0,20210401,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202103013146,ELI LILLY AND CO,,63.0,YR,,F,Y,134.69,KG,20210401.0,,HP,US,US,2021,Q2,Adult
190868781,19086878,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,Y,, NK,,,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210121.0,20210325.0,20210402,20210402,EXP,,GB-ASTRAZENECA-2021A207393,ASTRAZENECA,,51.0,YR,,M,Y,99.4,KG,20210402.0,,MD,GB,GB,2021,Q2,Adult
190885401,19088540,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,,20190514.0,20210402,20210402,EXP,PT-EMA-DD-20190508-KUMARSINGH_A-133720,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000636,VALIDUS,"FONSECA L., OLIVEIRA A., SANTOS T, S?LVA F, FERREIRA T, VILAVERDE J ET., AL. P059 DIABETIC KETOACIDOSIS: A REALITY OF THE INHIBITORS OF SGLT2 TO BE CONSIDERED. REVISTA PORTUGUESA DE DIABETE. 2019?14(1):47?122",69.0,YR,,F,Y,,,20210402.0,,HP,PT,PT,2021,Q2,Elderly
190885401,19088540,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Cardiac failure,,2021,Q2,1,I,,20190514.0,20210402,20210402,EXP,PT-EMA-DD-20190508-KUMARSINGH_A-133720,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000636,VALIDUS,"FONSECA L., OLIVEIRA A., SANTOS T, S?LVA F, FERREIRA T, VILAVERDE J ET., AL. P059 DIABETIC KETOACIDOSIS: A REALITY OF THE INHIBITORS OF SGLT2 TO BE CONSIDERED. REVISTA PORTUGUESA DE DIABETE. 2019?14(1):47?122",69.0,YR,,F,Y,,,20210402.0,,HP,PT,PT,2021,Q2,Elderly
190885401,19088540,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Dehydration,,2021,Q2,1,I,,20190514.0,20210402,20210402,EXP,PT-EMA-DD-20190508-KUMARSINGH_A-133720,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000636,VALIDUS,"FONSECA L., OLIVEIRA A., SANTOS T, S?LVA F, FERREIRA T, VILAVERDE J ET., AL. P059 DIABETIC KETOACIDOSIS: A REALITY OF THE INHIBITORS OF SGLT2 TO BE CONSIDERED. REVISTA PORTUGUESA DE DIABETE. 2019?14(1):47?122",69.0,YR,,F,Y,,,20210402.0,,HP,PT,PT,2021,Q2,Elderly
190885401,19088540,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20190514.0,20210402,20210402,EXP,PT-EMA-DD-20190508-KUMARSINGH_A-133720,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000636,VALIDUS,"FONSECA L., OLIVEIRA A., SANTOS T, S?LVA F, FERREIRA T, VILAVERDE J ET., AL. P059 DIABETIC KETOACIDOSIS: A REALITY OF THE INHIBITORS OF SGLT2 TO BE CONSIDERED. REVISTA PORTUGUESA DE DIABETE. 2019?14(1):47?122",69.0,YR,,F,Y,,,20210402.0,,HP,PT,PT,2021,Q2,Elderly
190885401,19088540,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Diabetic metabolic decompensation,,2021,Q2,1,I,,20190514.0,20210402,20210402,EXP,PT-EMA-DD-20190508-KUMARSINGH_A-133720,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000636,VALIDUS,"FONSECA L., OLIVEIRA A., SANTOS T, S?LVA F, FERREIRA T, VILAVERDE J ET., AL. P059 DIABETIC KETOACIDOSIS: A REALITY OF THE INHIBITORS OF SGLT2 TO BE CONSIDERED. REVISTA PORTUGUESA DE DIABETE. 2019?14(1):47?122",69.0,YR,,F,Y,,,20210402.0,,HP,PT,PT,2021,Q2,Elderly
190885401,19088540,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20190514.0,20210402,20210402,EXP,PT-EMA-DD-20190508-KUMARSINGH_A-133720,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000636,VALIDUS,"FONSECA L., OLIVEIRA A., SANTOS T, S?LVA F, FERREIRA T, VILAVERDE J ET., AL. P059 DIABETIC KETOACIDOSIS: A REALITY OF THE INHIBITORS OF SGLT2 TO BE CONSIDERED. REVISTA PORTUGUESA DE DIABETE. 2019?14(1):47?122",69.0,YR,,F,Y,,,20210402.0,,HP,PT,PT,2021,Q2,Elderly
190885401,19088540,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Drug interaction,,2021,Q2,1,I,,20190514.0,20210402,20210402,EXP,PT-EMA-DD-20190508-KUMARSINGH_A-133720,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000636,VALIDUS,"FONSECA L., OLIVEIRA A., SANTOS T, S?LVA F, FERREIRA T, VILAVERDE J ET., AL. P059 DIABETIC KETOACIDOSIS: A REALITY OF THE INHIBITORS OF SGLT2 TO BE CONSIDERED. REVISTA PORTUGUESA DE DIABETE. 2019?14(1):47?122",69.0,YR,,F,Y,,,20210402.0,,HP,PT,PT,2021,Q2,Elderly
190885401,19088540,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Fatigue,,2021,Q2,1,I,,20190514.0,20210402,20210402,EXP,PT-EMA-DD-20190508-KUMARSINGH_A-133720,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000636,VALIDUS,"FONSECA L., OLIVEIRA A., SANTOS T, S?LVA F, FERREIRA T, VILAVERDE J ET., AL. P059 DIABETIC KETOACIDOSIS: A REALITY OF THE INHIBITORS OF SGLT2 TO BE CONSIDERED. REVISTA PORTUGUESA DE DIABETE. 2019?14(1):47?122",69.0,YR,,F,Y,,,20210402.0,,HP,PT,PT,2021,Q2,Elderly
190885401,19088540,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Food refusal,,2021,Q2,1,I,,20190514.0,20210402,20210402,EXP,PT-EMA-DD-20190508-KUMARSINGH_A-133720,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000636,VALIDUS,"FONSECA L., OLIVEIRA A., SANTOS T, S?LVA F, FERREIRA T, VILAVERDE J ET., AL. P059 DIABETIC KETOACIDOSIS: A REALITY OF THE INHIBITORS OF SGLT2 TO BE CONSIDERED. REVISTA PORTUGUESA DE DIABETE. 2019?14(1):47?122",69.0,YR,,F,Y,,,20210402.0,,HP,PT,PT,2021,Q2,Elderly
190885401,19088540,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Hypernatraemia,,2021,Q2,1,I,,20190514.0,20210402,20210402,EXP,PT-EMA-DD-20190508-KUMARSINGH_A-133720,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000636,VALIDUS,"FONSECA L., OLIVEIRA A., SANTOS T, S?LVA F, FERREIRA T, VILAVERDE J ET., AL. P059 DIABETIC KETOACIDOSIS: A REALITY OF THE INHIBITORS OF SGLT2 TO BE CONSIDERED. REVISTA PORTUGUESA DE DIABETE. 2019?14(1):47?122",69.0,YR,,F,Y,,,20210402.0,,HP,PT,PT,2021,Q2,Elderly
190885401,19088540,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Metabolic acidosis,,2021,Q2,1,I,,20190514.0,20210402,20210402,EXP,PT-EMA-DD-20190508-KUMARSINGH_A-133720,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000636,VALIDUS,"FONSECA L., OLIVEIRA A., SANTOS T, S?LVA F, FERREIRA T, VILAVERDE J ET., AL. P059 DIABETIC KETOACIDOSIS: A REALITY OF THE INHIBITORS OF SGLT2 TO BE CONSIDERED. REVISTA PORTUGUESA DE DIABETE. 2019?14(1):47?122",69.0,YR,,F,Y,,,20210402.0,,HP,PT,PT,2021,Q2,Elderly
190885401,19088540,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Off label use,,2021,Q2,1,I,,20190514.0,20210402,20210402,EXP,PT-EMA-DD-20190508-KUMARSINGH_A-133720,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000636,VALIDUS,"FONSECA L., OLIVEIRA A., SANTOS T, S?LVA F, FERREIRA T, VILAVERDE J ET., AL. P059 DIABETIC KETOACIDOSIS: A REALITY OF THE INHIBITORS OF SGLT2 TO BE CONSIDERED. REVISTA PORTUGUESA DE DIABETE. 2019?14(1):47?122",69.0,YR,,F,Y,,,20210402.0,,HP,PT,PT,2021,Q2,Elderly
190885401,19088540,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,,2021,Q2,Urine ketone body present,,2021,Q2,1,I,,20190514.0,20210402,20210402,EXP,PT-EMA-DD-20190508-KUMARSINGH_A-133720,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000636,VALIDUS,"FONSECA L., OLIVEIRA A., SANTOS T, S?LVA F, FERREIRA T, VILAVERDE J ET., AL. P059 DIABETIC KETOACIDOSIS: A REALITY OF THE INHIBITORS OF SGLT2 TO BE CONSIDERED. REVISTA PORTUGUESA DE DIABETE. 2019?14(1):47?122",69.0,YR,,F,Y,,,20210402.0,,HP,PT,PT,2021,Q2,Elderly
190922802,19092280,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,2,F,,20210507.0,20210405,20210512,EXP,,CA-JNJFOC-20210402265,JOHNSON AND JOHNSON,,49.0,YR,A,M,Y,,,20210512.0,,CN,CA,CA,2021,Q2,Adult
190922802,19092280,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,2,F,,20210507.0,20210405,20210512,EXP,,CA-JNJFOC-20210402265,JOHNSON AND JOHNSON,,49.0,YR,A,M,Y,,,20210512.0,,CN,CA,CA,2021,Q2,Adult
190922802,19092280,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Fall,,2021,Q2,2,F,,20210507.0,20210405,20210512,EXP,,CA-JNJFOC-20210402265,JOHNSON AND JOHNSON,,49.0,YR,A,M,Y,,,20210512.0,,CN,CA,CA,2021,Q2,Adult
190922802,19092280,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Loss of consciousness,,2021,Q2,2,F,,20210507.0,20210405,20210512,EXP,,CA-JNJFOC-20210402265,JOHNSON AND JOHNSON,,49.0,YR,A,M,Y,,,20210512.0,,CN,CA,CA,2021,Q2,Adult
190939869,19093986,61,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Cardiac failure,,2021,Q2,9,F,20210319.0,20210621.0,20210405,20210628,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,63.0,KG,20210628.0,,MD,CN,CN,2021,Q2,Elderly
190939869,19093986,61,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Hyperthyroidism,,2021,Q2,9,F,20210319.0,20210621.0,20210405,20210628,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,63.0,KG,20210628.0,,MD,CN,CN,2021,Q2,Elderly
190939869,19093986,61,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Myelosuppression,,2021,Q2,9,F,20210319.0,20210621.0,20210405,20210628,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,63.0,KG,20210628.0,,MD,CN,CN,2021,Q2,Elderly
190939869,19093986,61,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Urinary retention,,2021,Q2,9,F,20210319.0,20210621.0,20210405,20210628,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,63.0,KG,20210628.0,,MD,CN,CN,2021,Q2,Elderly
190940101,19094010,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 TABLET, 1 PER DAY, IN THE MORNING",,,U,,,,202293.0,,,TABLET,,2021,Q2,Blister,,2021,Q2,1,I,20210325.0,20210328.0,20210405,20210405,EXP,,CN-ASTRAZENECA-2021A256996,ASTRAZENECA,,50.0,YR,,M,Y,,,20210405.0,,,CN,CN,2021,Q2,Adult
190940101,19094010,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 TABLET, 1 PER DAY, IN THE MORNING",,,U,,,,202293.0,,,TABLET,,2021,Q2,Hypersensitivity,,2021,Q2,1,I,20210325.0,20210328.0,20210405,20210405,EXP,,CN-ASTRAZENECA-2021A256996,ASTRAZENECA,,50.0,YR,,M,Y,,,20210405.0,,,CN,CN,2021,Q2,Adult
190940101,19094010,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 TABLET, 1 PER DAY, IN THE MORNING",,,U,,,,202293.0,,,TABLET,,2021,Q2,Oedema,,2021,Q2,1,I,20210325.0,20210328.0,20210405,20210405,EXP,,CN-ASTRAZENECA-2021A256996,ASTRAZENECA,,50.0,YR,,M,Y,,,20210405.0,,,CN,CN,2021,Q2,Adult
190940101,19094010,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 TABLET, 1 PER DAY, IN THE MORNING",,,U,,,,202293.0,,,TABLET,,2021,Q2,Pruritus,,2021,Q2,1,I,20210325.0,20210328.0,20210405,20210405,EXP,,CN-ASTRAZENECA-2021A256996,ASTRAZENECA,,50.0,YR,,M,Y,,,20210405.0,,,CN,CN,2021,Q2,Adult
190940101,19094010,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 TABLET, 1 PER DAY, IN THE MORNING",,,U,,,,202293.0,,,TABLET,,2021,Q2,Pustule,,2021,Q2,1,I,20210325.0,20210328.0,20210405,20210405,EXP,,CN-ASTRAZENECA-2021A256996,ASTRAZENECA,,50.0,YR,,M,Y,,,20210405.0,,,CN,CN,2021,Q2,Adult
190978811,19097881,12,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q2,Cardiomegaly,,2021,Q2,1,I,,20210322.0,20210406,20210406,EXP,,PL-TEVA-2021-PL-1898742,TEVA,,64.0,YR,A,M,Y,,,20210406.0,,MD,PL,PL,2021,Q2,Adult
190978811,19097881,12,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q2,Emphysema,,2021,Q2,1,I,,20210322.0,20210406,20210406,EXP,,PL-TEVA-2021-PL-1898742,TEVA,,64.0,YR,A,M,Y,,,20210406.0,,MD,PL,PL,2021,Q2,Adult
190978811,19097881,12,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q2,Hyperkalaemia,,2021,Q2,1,I,,20210322.0,20210406,20210406,EXP,,PL-TEVA-2021-PL-1898742,TEVA,,64.0,YR,A,M,Y,,,20210406.0,,MD,PL,PL,2021,Q2,Adult
190978811,19097881,12,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q2,Hyperthyroidism,,2021,Q2,1,I,,20210322.0,20210406,20210406,EXP,,PL-TEVA-2021-PL-1898742,TEVA,,64.0,YR,A,M,Y,,,20210406.0,,MD,PL,PL,2021,Q2,Adult
190978811,19097881,12,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q2,Pneumonia,,2021,Q2,1,I,,20210322.0,20210406,20210406,EXP,,PL-TEVA-2021-PL-1898742,TEVA,,64.0,YR,A,M,Y,,,20210406.0,,MD,PL,PL,2021,Q2,Adult
190978811,19097881,12,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q2,Pulmonary hypertension,,2021,Q2,1,I,,20210322.0,20210406,20210406,EXP,,PL-TEVA-2021-PL-1898742,TEVA,,64.0,YR,A,M,Y,,,20210406.0,,MD,PL,PL,2021,Q2,Adult
190978811,19097881,12,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,U,,,,,,,,,2021,Q2,Pulmonary oedema,,2021,Q2,1,I,,20210322.0,20210406,20210406,EXP,,PL-TEVA-2021-PL-1898742,TEVA,,64.0,YR,A,M,Y,,,20210406.0,,MD,PL,PL,2021,Q2,Adult
191005331,19100533,5,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 MILLIGRAM, ONCE A DAY",,,,,,,,10.0,MG,,QD,2021,Q2,Enthesopathy,,2021,Q2,1,I,,20210329.0,20210407,20210407,EXP,,CA-AUROBINDO-AUR-APL-2021-014006,AUROBINDO,,55.0,YR,,M,Y,,,20210407.0,,HP,CA,CA,2021,Q2,Adult
191005331,19100533,5,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 MILLIGRAM, ONCE A DAY",,,,,,,,10.0,MG,,QD,2021,Q2,Polyarthritis,,2021,Q2,1,I,,20210329.0,20210407,20210407,EXP,,CA-AUROBINDO-AUR-APL-2021-014006,AUROBINDO,,55.0,YR,,M,Y,,,20210407.0,,HP,CA,CA,2021,Q2,Adult
191007611,19100761,8,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,1,I,,20210330.0,20210407,20210407,EXP,,CA-AUROBINDO-AUR-APL-2021-014238,AUROBINDO,,49.0,YR,,M,Y,,,20210407.0,,HP,CA,CA,2021,Q2,Adult
191007611,19100761,8,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20210330.0,20210407,20210407,EXP,,CA-AUROBINDO-AUR-APL-2021-014238,AUROBINDO,,49.0,YR,,M,Y,,,20210407.0,,HP,CA,CA,2021,Q2,Adult
191007611,19100761,8,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Fall,,2021,Q2,1,I,,20210330.0,20210407,20210407,EXP,,CA-AUROBINDO-AUR-APL-2021-014238,AUROBINDO,,49.0,YR,,M,Y,,,20210407.0,,HP,CA,CA,2021,Q2,Adult
191007611,19100761,8,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Loss of consciousness,,2021,Q2,1,I,,20210330.0,20210407,20210407,EXP,,CA-AUROBINDO-AUR-APL-2021-014238,AUROBINDO,,49.0,YR,,M,Y,,,20210407.0,,HP,CA,CA,2021,Q2,Adult
191010103,19101010,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Blood pressure systolic decreased,,2021,Q2,3,F,,20210602.0,20210407,20210614,EXP,,NVSJ2021JP005137,NOVARTIS,,35.0,YR,,F,Y,,,20210615.0,,MD,JP,JP,2021,Q2,Adult
191010103,19101010,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Contraindicated product administered,,2021,Q2,3,F,,20210602.0,20210407,20210614,EXP,,NVSJ2021JP005137,NOVARTIS,,35.0,YR,,F,Y,,,20210615.0,,MD,JP,JP,2021,Q2,Adult
191049841,19104984,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MILLIGRAM,,,Y,U,,,,10.0,MG,,,2021,Q2,Ketoacidosis,,2021,Q2,1,I,20210323.0,20210331.0,20210408,20210408,EXP,,DE-AUROBINDO-AUR-APL-2021-014452,AUROBINDO,,30.0,YR,,M,Y,95.0,KG,20210408.0,,MD,DE,DE,2021,Q2,Young Adult
191091931,19109193,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,, MF2891,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Gastrointestinal disorder,,2021,Q2,1,I,20210318.0,20210331.0,20210408,20210408,EXP,,CN-ASTRAZENECA-2021A263105,ASTRAZENECA,,13514.0,DY,,M,Y,57.0,KG,20210408.0,,HP,CN,CN,2021,Q2,Elderly
191091931,19109193,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,, MF2891,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Metabolic acidosis,,2021,Q2,1,I,20210318.0,20210331.0,20210408,20210408,EXP,,CN-ASTRAZENECA-2021A263105,ASTRAZENECA,,13514.0,DY,,M,Y,57.0,KG,20210408.0,,HP,CN,CN,2021,Q2,Elderly
191093252,19109325,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORM, ONCE A DAY",,,U,U,,,,1.0,DF,TABLET,QD,2021,Q2,Blood pressure decreased,,2021,Q2,2,F,,20210517.0,20210409,20210526,EXP,,PL-AUROBINDO-AUR-APL-2021-014781,AUROBINDO,,70.0,YR,,M,Y,,,20210527.0,,HP,PL,PL,2021,Q2,Elderly
191093252,19109325,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORM, ONCE A DAY",,,U,U,,,,1.0,DF,TABLET,QD,2021,Q2,COVID-19 pneumonia,,2021,Q2,2,F,,20210517.0,20210409,20210526,EXP,,PL-AUROBINDO-AUR-APL-2021-014781,AUROBINDO,,70.0,YR,,M,Y,,,20210527.0,,HP,PL,PL,2021,Q2,Elderly
191093252,19109325,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORM, ONCE A DAY",,,U,U,,,,1.0,DF,TABLET,QD,2021,Q2,Cardiac failure chronic,,2021,Q2,2,F,,20210517.0,20210409,20210526,EXP,,PL-AUROBINDO-AUR-APL-2021-014781,AUROBINDO,,70.0,YR,,M,Y,,,20210527.0,,HP,PL,PL,2021,Q2,Elderly
191093252,19109325,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORM, ONCE A DAY",,,U,U,,,,1.0,DF,TABLET,QD,2021,Q2,Dyspnoea exertional,,2021,Q2,2,F,,20210517.0,20210409,20210526,EXP,,PL-AUROBINDO-AUR-APL-2021-014781,AUROBINDO,,70.0,YR,,M,Y,,,20210527.0,,HP,PL,PL,2021,Q2,Elderly
191093252,19109325,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORM, ONCE A DAY",,,U,U,,,,1.0,DF,TABLET,QD,2021,Q2,Glomerular filtration rate abnormal,,2021,Q2,2,F,,20210517.0,20210409,20210526,EXP,,PL-AUROBINDO-AUR-APL-2021-014781,AUROBINDO,,70.0,YR,,M,Y,,,20210527.0,,HP,PL,PL,2021,Q2,Elderly
191093252,19109325,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORM, ONCE A DAY",,,U,U,,,,1.0,DF,TABLET,QD,2021,Q2,Hypertrophy,,2021,Q2,2,F,,20210517.0,20210409,20210526,EXP,,PL-AUROBINDO-AUR-APL-2021-014781,AUROBINDO,,70.0,YR,,M,Y,,,20210527.0,,HP,PL,PL,2021,Q2,Elderly
191093252,19109325,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORM, ONCE A DAY",,,U,U,,,,1.0,DF,TABLET,QD,2021,Q2,N-terminal prohormone brain natriuretic peptide abnormal,,2021,Q2,2,F,,20210517.0,20210409,20210526,EXP,,PL-AUROBINDO-AUR-APL-2021-014781,AUROBINDO,,70.0,YR,,M,Y,,,20210527.0,,HP,PL,PL,2021,Q2,Elderly
191093252,19109325,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORM, ONCE A DAY",,,U,U,,,,1.0,DF,TABLET,QD,2021,Q2,Renal atrophy,,2021,Q2,2,F,,20210517.0,20210409,20210526,EXP,,PL-AUROBINDO-AUR-APL-2021-014781,AUROBINDO,,70.0,YR,,M,Y,,,20210527.0,,HP,PL,PL,2021,Q2,Elderly
191093252,19109325,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORM, ONCE A DAY",,,U,U,,,,1.0,DF,TABLET,QD,2021,Q2,Urosepsis,,2021,Q2,2,F,,20210517.0,20210409,20210526,EXP,,PL-AUROBINDO-AUR-APL-2021-014781,AUROBINDO,,70.0,YR,,M,Y,,,20210527.0,,HP,PL,PL,2021,Q2,Elderly
191107821,19110782,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,Y,,,,,10.0,MG,,,2021,Q2,Ketoacidosis,,2021,Q2,1,I,20210323.0,20210401.0,20210408,20210408,EXP,DE-BFARM-21003213,NVSC2021DE074482,NOVARTIS,,30.0,YR,,M,Y,95.0,KG,20210408.0,,HP,DE,DE,2021,Q2,Young Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Abdominal discomfort,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Arthralgia,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Arthritis,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Blood glucose abnormal,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Cataract,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Cholelithiasis,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Dizziness,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Ear discomfort,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Erythema,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Facial neuralgia,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Groin pain,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Headache,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Hypotension,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Joint stiffness,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Labyrinthitis,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Muscle spasms,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Nausea,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Rheumatoid arthritis,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Visual impairment,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191109951,19110995,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, QD",,,U,,,,,5.0,MG,,,2021,Q2,Vomiting,,2021,Q2,1,I,,20210331.0,20210409,20210409,EXP,,CA-APOTEX-2021AP008421,APOTEX,,55.0,YR,,M,Y,,,20210409.0,,CN,CA,CA,2021,Q2,Adult
191160321,19116032,12,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,TABLET,,2021,Q2,Chest pain,,2021,Q2,1,I,,20190702.0,20210409,20210409,EXP,PT-EMA-DD-20181204-KUMARVN_P-105153,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000461,VALIDUS,,54.0,YR,,F,Y,,,20210409.0,,HP,PT,PT,2021,Q2,Adult
191160321,19116032,12,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,TABLET,,2021,Q2,Headache,,2021,Q2,1,I,,20190702.0,20210409,20210409,EXP,PT-EMA-DD-20181204-KUMARVN_P-105153,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000461,VALIDUS,,54.0,YR,,F,Y,,,20210409.0,,HP,PT,PT,2021,Q2,Adult
191160321,19116032,12,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,TABLET,,2021,Q2,Ischaemic stroke,,2021,Q2,1,I,,20190702.0,20210409,20210409,EXP,PT-EMA-DD-20181204-KUMARVN_P-105153,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000461,VALIDUS,,54.0,YR,,F,Y,,,20210409.0,,HP,PT,PT,2021,Q2,Adult
191176142,19117614,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,, UNK,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20210202.0,20210513.0,20210409,20210515,EXP,DE-BFARM-21003357,NVSC2021DE080824,NOVARTIS,,56.0,YR,,M,Y,128.0,KG,20210515.0,,HP,DE,DE,2021,Q2,Adult
191176142,19117614,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,, UNK,,,,,,,2021,Q2,Metabolic acidosis,,2021,Q2,2,F,20210202.0,20210513.0,20210409,20210515,EXP,DE-BFARM-21003357,NVSC2021DE080824,NOVARTIS,,56.0,YR,,M,Y,128.0,KG,20210515.0,,HP,DE,DE,2021,Q2,Adult
191176142,19117614,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,, UNK,,,,,,,2021,Q2,Vomiting,,2021,Q2,2,F,20210202.0,20210513.0,20210409,20210515,EXP,DE-BFARM-21003357,NVSC2021DE080824,NOVARTIS,,56.0,YR,,M,Y,128.0,KG,20210515.0,,HP,DE,DE,2021,Q2,Adult
191226631,19122663,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,,10.0,MG,,,2021,Q2,Ketoacidosis,,2021,Q2,1,I,20210323.0,20210401.0,20210412,20210412,EXP,,DE-ASTRAZENECA-2021A251668,ASTRAZENECA,,30.0,YR,,M,Y,95.0,KG,20210412.0,,MD,DE,DE,2021,Q2,Young Adult
191267731,19126773,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, BID (2X1000/5 MG)",,,U,,,,,1.0,DF,,BID,2021,Q2,Asthenia,,2021,Q2,1,I,,20210402.0,20210413,20210413,EXP,,NVSC2021HR078215,NOVARTIS,,62.0,YR,,M,Y,95.0,KG,20210413.0,,MD,HR,HR,2021,Q2,Adult
191267731,19126773,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, BID (2X1000/5 MG)",,,U,,,,,1.0,DF,,BID,2021,Q2,Blood pressure decreased,,2021,Q2,1,I,,20210402.0,20210413,20210413,EXP,,NVSC2021HR078215,NOVARTIS,,62.0,YR,,M,Y,95.0,KG,20210413.0,,MD,HR,HR,2021,Q2,Adult
191267731,19126773,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, BID (2X1000/5 MG)",,,U,,,,,1.0,DF,,BID,2021,Q2,Cardiac failure chronic,,2021,Q2,1,I,,20210402.0,20210413,20210413,EXP,,NVSC2021HR078215,NOVARTIS,,62.0,YR,,M,Y,95.0,KG,20210413.0,,MD,HR,HR,2021,Q2,Adult
191267731,19126773,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, BID (2X1000/5 MG)",,,U,,,,,1.0,DF,,BID,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210402.0,20210413,20210413,EXP,,NVSC2021HR078215,NOVARTIS,,62.0,YR,,M,Y,95.0,KG,20210413.0,,MD,HR,HR,2021,Q2,Adult
191267731,19126773,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, BID (2X1000/5 MG)",,,U,,,,,1.0,DF,,BID,2021,Q2,Ejection fraction decreased,,2021,Q2,1,I,,20210402.0,20210413,20210413,EXP,,NVSC2021HR078215,NOVARTIS,,62.0,YR,,M,Y,95.0,KG,20210413.0,,MD,HR,HR,2021,Q2,Adult
191267731,19126773,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, BID (2X1000/5 MG)",,,U,,,,,1.0,DF,,BID,2021,Q2,Fatigue,,2021,Q2,1,I,,20210402.0,20210413,20210413,EXP,,NVSC2021HR078215,NOVARTIS,,62.0,YR,,M,Y,95.0,KG,20210413.0,,MD,HR,HR,2021,Q2,Adult
191267731,19126773,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, BID (2X1000/5 MG)",,,U,,,,,1.0,DF,,BID,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210402.0,20210413,20210413,EXP,,NVSC2021HR078215,NOVARTIS,,62.0,YR,,M,Y,95.0,KG,20210413.0,,MD,HR,HR,2021,Q2,Adult
191267731,19126773,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, BID (2X1000/5 MG)",,,U,,,,,1.0,DF,,BID,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210402.0,20210413,20210413,EXP,,NVSC2021HR078215,NOVARTIS,,62.0,YR,,M,Y,95.0,KG,20210413.0,,MD,HR,HR,2021,Q2,Adult
191267731,19126773,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, BID (2X1000/5 MG)",,,U,,,,,1.0,DF,,BID,2021,Q2,Loss of consciousness,,2021,Q2,1,I,,20210402.0,20210413,20210413,EXP,,NVSC2021HR078215,NOVARTIS,,62.0,YR,,M,Y,95.0,KG,20210413.0,,MD,HR,HR,2021,Q2,Adult
191267731,19126773,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, BID (2X1000/5 MG)",,,U,,,,,1.0,DF,,BID,2021,Q2,Oedema,,2021,Q2,1,I,,20210402.0,20210413,20210413,EXP,,NVSC2021HR078215,NOVARTIS,,62.0,YR,,M,Y,95.0,KG,20210413.0,,MD,HR,HR,2021,Q2,Adult
191267731,19126773,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, BID (2X1000/5 MG)",,,U,,,,,1.0,DF,,BID,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210402.0,20210413,20210413,EXP,,NVSC2021HR078215,NOVARTIS,,62.0,YR,,M,Y,95.0,KG,20210413.0,,MD,HR,HR,2021,Q2,Adult
191318431,19131843,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,Y,,,,,10.0,MG,,,2021,Q2,Ketoacidosis,,2021,Q2,1,I,20210323.0,20210406.0,20210414,20210414,EXP,DE-BFARM-21003213,DE-EMD SERONO-E2B_90083092,EMD SERONO INC,,30.0,YR,A,M,Y,95.0,KG,20210414.0,,MD,DE,DE,2021,Q2,Young Adult
191326701,19132670,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,20210202.0,20210409.0,20210414,20210414,EXP,,DE-ASTRAZENECA-2021A288945,ASTRAZENECA,,56.0,YR,,M,Y,128.0,KG,20210414.0,,MD,DE,DE,2021,Q2,Adult
191326701,19132670,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,,,2021,Q2,Metabolic acidosis,,2021,Q2,1,I,20210202.0,20210409.0,20210414,20210414,EXP,,DE-ASTRAZENECA-2021A288945,ASTRAZENECA,,56.0,YR,,M,Y,128.0,KG,20210414.0,,MD,DE,DE,2021,Q2,Adult
191326701,19132670,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,20210202.0,20210409.0,20210414,20210414,EXP,,DE-ASTRAZENECA-2021A288945,ASTRAZENECA,,56.0,YR,,M,Y,128.0,KG,20210414.0,,MD,DE,DE,2021,Q2,Adult
191338351,19133835,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,,,2021,Q2,Ketoacidosis,,2021,Q2,1,I,20210323.0,20210401.0,20210414,20210414,EXP,DE-BFARM-21003213,DE-BAUSCH-BL-2021-011525,BAUSCH AND LOMB,,30.0,YR,,M,Y,95.0,KG,20210414.0,,MD,DE,DE,2021,Q2,Young Adult
191341971,19134197,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,,,,,202293.0,10.0,MG,,,2021,Q2,Toe amputation,,2021,Q2,1,I,,20210409.0,20210414,20210414,EXP,,GB-ASTRAZENECA-2021A289034,ASTRAZENECA,,67.0,YR,,M,Y,,,20210414.0,,PH,GB,GB,2021,Q2,Elderly
191377841,19137784,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20210406.0,20210414,20210414,EXP,,US-ASTRAZENECA-2021A276190,ASTRAZENECA,,59.0,YR,,F,Y,,,20210414.0,,HP,US,US,2021,Q2,Adult
191383722,19138372,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20210202.0,20210512.0,20210415,20210521,EXP,,DE-AUROBINDO-AUR-APL-2021-015320,AUROBINDO,,56.0,YR,,M,Y,128.0,KG,20210521.0,,HP,FR,DE,2021,Q2,Adult
191383722,19138372,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2021,Q2,Metabolic acidosis,,2021,Q2,2,F,20210202.0,20210512.0,20210415,20210521,EXP,,DE-AUROBINDO-AUR-APL-2021-015320,AUROBINDO,,56.0,YR,,M,Y,128.0,KG,20210521.0,,HP,FR,DE,2021,Q2,Adult
191383722,19138372,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2021,Q2,Vomiting,,2021,Q2,2,F,20210202.0,20210512.0,20210415,20210521,EXP,,DE-AUROBINDO-AUR-APL-2021-015320,AUROBINDO,,56.0,YR,,M,Y,128.0,KG,20210521.0,,HP,FR,DE,2021,Q2,Adult
191413801,19141380,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MILLIGRAM DAILY; 1?0?0?0,,,,,,,,10.0,MG,,QD,2021,Q2,Acute kidney injury,,2021,Q2,1,I,20210113.0,20210405.0,20210415,20210415,EXP,,DE-TEVA-2021-DE-1899924,TEVA,,71.0,YR,E,F,Y,117.0,KG,20210415.0,,MD,DE,DE,2021,Q2,Elderly
191435472,19143547,2,SS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q2,Urinary tract infection,,2021,Q2,2,F,,20210604.0,20210415,20210617,EXP,,NVSJ2021JP005677,NOVARTIS,,80.0,YR,,M,Y,,,20210618.0,,MD,JP,JP,2021,Q2,Elderly
191440491,19144049,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,, UNKNOWN,,202293.0,,,TABLET,,2021,Q2,COVID-19 pneumonia,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,DE-ASTRAZENECA-2021A300553,ASTRAZENECA,,61.0,YR,,M,Y,,,20210416.0,,MD,DE,DE,2021,Q2,Adult
191440491,19144049,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,, UNKNOWN,,202293.0,,,TABLET,,2021,Q2,SARS-CoV-2 test positive,,2021,Q2,1,I,,20210409.0,20210416,20210416,EXP,,DE-ASTRAZENECA-2021A300553,ASTRAZENECA,,61.0,YR,,M,Y,,,20210416.0,,MD,DE,DE,2021,Q2,Adult
191441354,19144135,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,4,F,20210202.0,20210517.0,20210416,20210527,EXP,DE-BFARM-21003357,DE-EMD SERONO-E2B_90083164,EMD SERONO INC,,56.0,YR,A,M,Y,128.0,KG,20210527.0,,HP,DE,DE,2021,Q2,Adult
191441354,19144135,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2021,Q2,Metabolic acidosis,,2021,Q2,4,F,20210202.0,20210517.0,20210416,20210527,EXP,DE-BFARM-21003357,DE-EMD SERONO-E2B_90083164,EMD SERONO INC,,56.0,YR,A,M,Y,128.0,KG,20210527.0,,HP,DE,DE,2021,Q2,Adult
191441354,19144135,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,4,F,20210202.0,20210517.0,20210416,20210527,EXP,DE-BFARM-21003357,DE-EMD SERONO-E2B_90083164,EMD SERONO INC,,56.0,YR,A,M,Y,128.0,KG,20210527.0,,HP,DE,DE,2021,Q2,Adult
191450961,19145096,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,400.0,MG,N,, Y1684A,,202293.0,10.0,MG,,QD,2021,Q2,Blood potassium abnormal,,2021,Q2,1,I,20210312.0,20210413.0,20210416,20210416,EXP,,GB-ASTRAZENECA-2021A303778,ASTRAZENECA,,61.0,YR,,F,Y,75.0,KG,20210416.0,,HP,GB,GB,2021,Q2,Adult
191459681,19145968,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Asthenia,,2021,Q2,1,I,,20210405.0,20210416,20210416,EXP,,NVSC2021PT080084,NOVARTIS,,74.0,YR,,M,Y,92.5,KG,20210416.0,,MD,PT,PT,2021,Q2,Elderly
191459681,19145968,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Bradycardia,,2021,Q2,1,I,,20210405.0,20210416,20210416,EXP,,NVSC2021PT080084,NOVARTIS,,74.0,YR,,M,Y,92.5,KG,20210416.0,,MD,PT,PT,2021,Q2,Elderly
191459681,19145968,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Hyperkalaemia,,2021,Q2,1,I,,20210405.0,20210416,20210416,EXP,,NVSC2021PT080084,NOVARTIS,,74.0,YR,,M,Y,92.5,KG,20210416.0,,MD,PT,PT,2021,Q2,Elderly
191459681,19145968,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Hypotension,,2021,Q2,1,I,,20210405.0,20210416,20210416,EXP,,NVSC2021PT080084,NOVARTIS,,74.0,YR,,M,Y,92.5,KG,20210416.0,,MD,PT,PT,2021,Q2,Elderly
191462541,19146254,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,, 2011066,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketosis,,2021,Q2,1,I,20210129.0,20210326.0,20210416,20210416,EXP,,CN-ASTRAZENECA-2021A237279,ASTRAZENECA,,12731.0,DY,,F,Y,94.0,KG,20210416.0,,HP,CN,CN,2021,Q2,Elderly
191462541,19146254,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,, 2011066,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Diarrhoea,,2021,Q2,1,I,20210129.0,20210326.0,20210416,20210416,EXP,,CN-ASTRAZENECA-2021A237279,ASTRAZENECA,,12731.0,DY,,F,Y,94.0,KG,20210416.0,,HP,CN,CN,2021,Q2,Elderly
191462541,19146254,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,, 2011066,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Discomfort,,2021,Q2,1,I,20210129.0,20210326.0,20210416,20210416,EXP,,CN-ASTRAZENECA-2021A237279,ASTRAZENECA,,12731.0,DY,,F,Y,94.0,KG,20210416.0,,HP,CN,CN,2021,Q2,Elderly
191462541,19146254,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,, 2011066,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Hiccups,,2021,Q2,1,I,20210129.0,20210326.0,20210416,20210416,EXP,,CN-ASTRAZENECA-2021A237279,ASTRAZENECA,,12731.0,DY,,F,Y,94.0,KG,20210416.0,,HP,CN,CN,2021,Q2,Elderly
191462541,19146254,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,, 2011066,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Nausea,,2021,Q2,1,I,20210129.0,20210326.0,20210416,20210416,EXP,,CN-ASTRAZENECA-2021A237279,ASTRAZENECA,,12731.0,DY,,F,Y,94.0,KG,20210416.0,,HP,CN,CN,2021,Q2,Elderly
191462541,19146254,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,, 2011066,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Vomiting,,2021,Q2,1,I,20210129.0,20210326.0,20210416,20210416,EXP,,CN-ASTRAZENECA-2021A237279,ASTRAZENECA,,12731.0,DY,,F,Y,94.0,KG,20210416.0,,HP,CN,CN,2021,Q2,Elderly
191489263,19148926,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2021,Q2,Death,,2021,Q2,3,F,20210409.0,20210503.0,20210416,20210506,EXP,,DE-PFIZER INC-2021404820,PFIZER,,74.0,YR,,M,Y,73.0,KG,20210506.0,,HP,DE,DE,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Abdominal pain,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Blood pressure diastolic abnormal,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Blood pressure diastolic decreased,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Blood pressure systolic abnormal,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Blood pressure systolic increased,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Chronic obstructive pulmonary disease,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Cough,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Eczema,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Gastritis,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Gastrointestinal disorder,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Gout,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Heart rate increased,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Oropharyngeal pain,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Oxygen saturation decreased,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191536041,19153604,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Sleep disorder,,2021,Q2,1,I,,20210412.0,20210419,20210419,EXP,,CA-ROCHE-2810514,ROCHE,,69.0,YR,,F,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Elderly
191567902,19156790,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Blood pressure decreased,,2021,Q2,2,F,,20210420.0,20210420,20210504,EXP,PL-002147023-NVSC2021PL064846,PL-TOPROL-2021000069,TOPROL ACQUISITION,,70.0,YR,E,M,Y,,,20210504.0,,CN,SE,PL,2021,Q2,Elderly
191567902,19156790,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,COVID-19 pneumonia,,2021,Q2,2,F,,20210420.0,20210420,20210504,EXP,PL-002147023-NVSC2021PL064846,PL-TOPROL-2021000069,TOPROL ACQUISITION,,70.0,YR,E,M,Y,,,20210504.0,,CN,SE,PL,2021,Q2,Elderly
191567902,19156790,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Cardiac failure chronic,,2021,Q2,2,F,,20210420.0,20210420,20210504,EXP,PL-002147023-NVSC2021PL064846,PL-TOPROL-2021000069,TOPROL ACQUISITION,,70.0,YR,E,M,Y,,,20210504.0,,CN,SE,PL,2021,Q2,Elderly
191567902,19156790,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Dyspnoea exertional,,2021,Q2,2,F,,20210420.0,20210420,20210504,EXP,PL-002147023-NVSC2021PL064846,PL-TOPROL-2021000069,TOPROL ACQUISITION,,70.0,YR,E,M,Y,,,20210504.0,,CN,SE,PL,2021,Q2,Elderly
191567902,19156790,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Glomerular filtration rate abnormal,,2021,Q2,2,F,,20210420.0,20210420,20210504,EXP,PL-002147023-NVSC2021PL064846,PL-TOPROL-2021000069,TOPROL ACQUISITION,,70.0,YR,E,M,Y,,,20210504.0,,CN,SE,PL,2021,Q2,Elderly
191567902,19156790,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Hypertrophy,,2021,Q2,2,F,,20210420.0,20210420,20210504,EXP,PL-002147023-NVSC2021PL064846,PL-TOPROL-2021000069,TOPROL ACQUISITION,,70.0,YR,E,M,Y,,,20210504.0,,CN,SE,PL,2021,Q2,Elderly
191567902,19156790,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,N-terminal prohormone brain natriuretic peptide abnormal,,2021,Q2,2,F,,20210420.0,20210420,20210504,EXP,PL-002147023-NVSC2021PL064846,PL-TOPROL-2021000069,TOPROL ACQUISITION,,70.0,YR,E,M,Y,,,20210504.0,,CN,SE,PL,2021,Q2,Elderly
191567902,19156790,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Renal atrophy,,2021,Q2,2,F,,20210420.0,20210420,20210504,EXP,PL-002147023-NVSC2021PL064846,PL-TOPROL-2021000069,TOPROL ACQUISITION,,70.0,YR,E,M,Y,,,20210504.0,,CN,SE,PL,2021,Q2,Elderly
191567902,19156790,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Urosepsis,,2021,Q2,2,F,,20210420.0,20210420,20210504,EXP,PL-002147023-NVSC2021PL064846,PL-TOPROL-2021000069,TOPROL ACQUISITION,,70.0,YR,E,M,Y,,,20210504.0,,CN,SE,PL,2021,Q2,Elderly
191574541,19157454,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Encephalopathy,,2021,Q2,1,I,201710.0,20210408.0,20210420,20210420,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20210420.0,,MD,HU,HU,2021,Q2,Adult
191574541,19157454,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Gastritis,,2021,Q2,1,I,201710.0,20210408.0,20210420,20210420,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20210420.0,,MD,HU,HU,2021,Q2,Adult
191574541,19157454,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Gastrointestinal hypomotility,,2021,Q2,1,I,201710.0,20210408.0,20210420,20210420,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20210420.0,,MD,HU,HU,2021,Q2,Adult
191574541,19157454,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Nausea,,2021,Q2,1,I,201710.0,20210408.0,20210420,20210420,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20210420.0,,MD,HU,HU,2021,Q2,Adult
191574541,19157454,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Polyneuropathy,,2021,Q2,1,I,201710.0,20210408.0,20210420,20210420,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20210420.0,,MD,HU,HU,2021,Q2,Adult
191588061,19158806,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10,,,Y,,,,202293.0,,,,,2021,Q2,Abdominal tenderness,,2021,Q2,1,I,20210409.0,20210416.0,20210420,20210420,EXP,,GB-ASTRAZENECA-2021A315903,ASTRAZENECA,,39.0,YR,,F,Y,,,20210420.0,,HP,GB,GB,2021,Q2,Adult
191588061,19158806,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10,,,Y,,,,202293.0,,,,,2021,Q2,Euglycaemic diabetic ketoacidosis,,2021,Q2,1,I,20210409.0,20210416.0,20210420,20210420,EXP,,GB-ASTRAZENECA-2021A315903,ASTRAZENECA,,39.0,YR,,F,Y,,,20210420.0,,HP,GB,GB,2021,Q2,Adult
191588061,19158806,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10,,,Y,,,,202293.0,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,20210409.0,20210416.0,20210420,20210420,EXP,,GB-ASTRAZENECA-2021A315903,ASTRAZENECA,,39.0,YR,,F,Y,,,20210420.0,,HP,GB,GB,2021,Q2,Adult
191596471,19159647,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Cerebrovascular accident,,2021,Q2,1,I,20210407.0,20210412.0,20210420,20210420,EXP,,PL-JNJFOC-20210429420,JOHNSON AND JOHNSON,,70.0,YR,E,F,Y,,,20210420.0,,MD,PL,PL,2021,Q2,Elderly
191597112,19159711,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20210202.0,20210513.0,20210420,20210525,EXP,DE-BFARM-21003357,DE-BAUSCH-BL-2021-012941,BAUSCH AND LOMB,,56.0,YR,,M,Y,128.0,KG,20210525.0,,HP,DE,DE,2021,Q2,Adult
191597112,19159711,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2021,Q2,Metabolic acidosis,,2021,Q2,2,F,20210202.0,20210513.0,20210420,20210525,EXP,DE-BFARM-21003357,DE-BAUSCH-BL-2021-012941,BAUSCH AND LOMB,,56.0,YR,,M,Y,128.0,KG,20210525.0,,HP,DE,DE,2021,Q2,Adult
191597112,19159711,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,2,F,20210202.0,20210513.0,20210420,20210525,EXP,DE-BFARM-21003357,DE-BAUSCH-BL-2021-012941,BAUSCH AND LOMB,,56.0,YR,,M,Y,128.0,KG,20210525.0,,HP,DE,DE,2021,Q2,Adult
191604341,19160434,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,N,,,,202293.0,5.0,MG,TABLET,QD,2021,Q2,Dyspnoea,,2021,Q2,1,I,20210323.0,20210408.0,20210420,20210420,EXP,,GB-ASTRAZENECA-2021A284650,ASTRAZENECA,,79.0,YR,,F,Y,,,20210420.0,,PH,GB,GB,2021,Q2,Elderly
191671272,19167127,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Blood creatinine increased,,2021,Q2,2,F,20201106.0,20210518.0,20210422,20210531,EXP,,NVSJ2021JP006112,NOVARTIS,,79.0,YR,,M,Y,,,20210531.0,,MD,JP,JP,2021,Q2,Elderly
191671272,19167127,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Glomerular filtration rate decreased,,2021,Q2,2,F,20201106.0,20210518.0,20210422,20210531,EXP,,NVSJ2021JP006112,NOVARTIS,,79.0,YR,,M,Y,,,20210531.0,,MD,JP,JP,2021,Q2,Elderly
191671272,19167127,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Malaise,,2021,Q2,2,F,20201106.0,20210518.0,20210422,20210531,EXP,,NVSJ2021JP006112,NOVARTIS,,79.0,YR,,M,Y,,,20210531.0,,MD,JP,JP,2021,Q2,Elderly
191671272,19167127,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Renal impairment,,2021,Q2,2,F,20201106.0,20210518.0,20210422,20210531,EXP,,NVSJ2021JP006112,NOVARTIS,,79.0,YR,,M,Y,,,20210531.0,,MD,JP,JP,2021,Q2,Elderly
191671272,19167127,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Sinus arrest,,2021,Q2,2,F,20201106.0,20210518.0,20210422,20210531,EXP,,NVSJ2021JP006112,NOVARTIS,,79.0,YR,,M,Y,,,20210531.0,,MD,JP,JP,2021,Q2,Elderly
191688141,19168814,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2021,Q2,Fournier's gangrene,,2021,Q2,1,I,,20210419.0,20210422,20210422,EXP,,SE-TEVA-2021-SE-1904445,TEVA,"ELLEGARD L, PRYTZ M. FOURNIER^S GANGRENE UNDER SGLT?2 INHIBITOR THERAPY: A LITERATURE REVIEW AND CASE REPORT. INT?J?SURG?CASE?REP 2020?77:692?694.",52.0,YR,A,F,Y,,,20210422.0,,HP,SE,SE,2021,Q2,Adult
191696032,19169603,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, UNKNOWN,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20210202.0,20210519.0,20210422,20210531,EXP,DE-BFARM-21003357,DE-TEVA-2021-DE-1901845,TEVA,,56.0,YR,A,M,Y,128.0,KG,20210529.0,,HP,DE,DE,2021,Q2,Adult
191696032,19169603,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, UNKNOWN,,,,,,,2021,Q2,Metabolic acidosis,,2021,Q2,2,F,20210202.0,20210519.0,20210422,20210531,EXP,DE-BFARM-21003357,DE-TEVA-2021-DE-1901845,TEVA,,56.0,YR,A,M,Y,128.0,KG,20210529.0,,HP,DE,DE,2021,Q2,Adult
191696032,19169603,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, UNKNOWN,,,,,,,2021,Q2,Vomiting,,2021,Q2,2,F,20210202.0,20210519.0,20210422,20210531,EXP,DE-BFARM-21003357,DE-TEVA-2021-DE-1901845,TEVA,,56.0,YR,A,M,Y,128.0,KG,20210529.0,,HP,DE,DE,2021,Q2,Adult
191699592,19169959,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,,,,,,,,TABLET,QD,2021,Q2,Blood pressure decreased,,2021,Q2,2,F,,20210422.0,20210422,20210430,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20210430.0,,MD,PL,PL,2021,Q2,Elderly
191699592,19169959,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,,,,,,,,TABLET,QD,2021,Q2,COVID-19 pneumonia,,2021,Q2,2,F,,20210422.0,20210422,20210430,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20210430.0,,MD,PL,PL,2021,Q2,Elderly
191699592,19169959,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,,,,,,,,TABLET,QD,2021,Q2,Cardiac failure chronic,,2021,Q2,2,F,,20210422.0,20210422,20210430,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20210430.0,,MD,PL,PL,2021,Q2,Elderly
191699592,19169959,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,,,,,,,,TABLET,QD,2021,Q2,Dyspnoea exertional,,2021,Q2,2,F,,20210422.0,20210422,20210430,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20210430.0,,MD,PL,PL,2021,Q2,Elderly
191699592,19169959,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,,,,,,,,TABLET,QD,2021,Q2,Glomerular filtration rate abnormal,,2021,Q2,2,F,,20210422.0,20210422,20210430,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20210430.0,,MD,PL,PL,2021,Q2,Elderly
191699592,19169959,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,,,,,,,,TABLET,QD,2021,Q2,N-terminal prohormone brain natriuretic peptide abnormal,,2021,Q2,2,F,,20210422.0,20210422,20210430,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20210430.0,,MD,PL,PL,2021,Q2,Elderly
191699592,19169959,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,,,,,,,,TABLET,QD,2021,Q2,Prostatomegaly,,2021,Q2,2,F,,20210422.0,20210422,20210430,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20210430.0,,MD,PL,PL,2021,Q2,Elderly
191699592,19169959,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,,,,,,,,TABLET,QD,2021,Q2,Renal atrophy,,2021,Q2,2,F,,20210422.0,20210422,20210430,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20210430.0,,MD,PL,PL,2021,Q2,Elderly
191699592,19169959,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,,,,,,,,TABLET,QD,2021,Q2,Urosepsis,,2021,Q2,2,F,,20210422.0,20210422,20210430,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20210430.0,,MD,PL,PL,2021,Q2,Elderly
191736442,19173644,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Supraventricular tachycardia,,2021,Q2,2,F,20210405.0,20210423.0,20210423,20210505,EXP,,CA-GILEAD-2021-0525089,GILEAD,,61.0,YR,A,F,Y,190.0,KG,20210505.0,,HP,CA,CA,2021,Q2,Adult
191761502,19176150,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Dizziness,,2021,Q2,2,F,,20210421.0,20210424,20210426,EXP,,NVSC2021GB083276,NOVARTIS,,35.0,YR,,F,Y,,,20210426.0,,HP,GB,GB,2021,Q2,Adult
191761502,19176150,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Drug intolerance,,2021,Q2,2,F,,20210421.0,20210424,20210426,EXP,,NVSC2021GB083276,NOVARTIS,,35.0,YR,,F,Y,,,20210426.0,,HP,GB,GB,2021,Q2,Adult
191761502,19176150,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Dyspnoea,,2021,Q2,2,F,,20210421.0,20210424,20210426,EXP,,NVSC2021GB083276,NOVARTIS,,35.0,YR,,F,Y,,,20210426.0,,HP,GB,GB,2021,Q2,Adult
191761502,19176150,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Dyspnoea exertional,,2021,Q2,2,F,,20210421.0,20210424,20210426,EXP,,NVSC2021GB083276,NOVARTIS,,35.0,YR,,F,Y,,,20210426.0,,HP,GB,GB,2021,Q2,Adult
191761502,19176150,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Exercise tolerance decreased,,2021,Q2,2,F,,20210421.0,20210424,20210426,EXP,,NVSC2021GB083276,NOVARTIS,,35.0,YR,,F,Y,,,20210426.0,,HP,GB,GB,2021,Q2,Adult
191761502,19176150,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Fatigue,,2021,Q2,2,F,,20210421.0,20210424,20210426,EXP,,NVSC2021GB083276,NOVARTIS,,35.0,YR,,F,Y,,,20210426.0,,HP,GB,GB,2021,Q2,Adult
191761502,19176150,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Joint swelling,,2021,Q2,2,F,,20210421.0,20210424,20210426,EXP,,NVSC2021GB083276,NOVARTIS,,35.0,YR,,F,Y,,,20210426.0,,HP,GB,GB,2021,Q2,Adult
191761502,19176150,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Lethargy,,2021,Q2,2,F,,20210421.0,20210424,20210426,EXP,,NVSC2021GB083276,NOVARTIS,,35.0,YR,,F,Y,,,20210426.0,,HP,GB,GB,2021,Q2,Adult
191761502,19176150,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Oedema,,2021,Q2,2,F,,20210421.0,20210424,20210426,EXP,,NVSC2021GB083276,NOVARTIS,,35.0,YR,,F,Y,,,20210426.0,,HP,GB,GB,2021,Q2,Adult
191761502,19176150,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Orthopnoea,,2021,Q2,2,F,,20210421.0,20210424,20210426,EXP,,NVSC2021GB083276,NOVARTIS,,35.0,YR,,F,Y,,,20210426.0,,HP,GB,GB,2021,Q2,Adult
191761502,19176150,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Peripartum cardiomyopathy,,2021,Q2,2,F,,20210421.0,20210424,20210426,EXP,,NVSC2021GB083276,NOVARTIS,,35.0,YR,,F,Y,,,20210426.0,,HP,GB,GB,2021,Q2,Adult
191761502,19176150,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q2,Peripheral swelling,,2021,Q2,2,F,,20210421.0,20210424,20210426,EXP,,NVSC2021GB083276,NOVARTIS,,35.0,YR,,F,Y,,,20210426.0,,HP,GB,GB,2021,Q2,Adult
191771231,19177123,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,,10.0,MG,,,2021,Q2,Euglycaemic diabetic ketoacidosis,,2021,Q2,1,I,20210411.0,20210413.0,20210424,20210424,EXP,,GB-ASTRAZENECA-2021A304274,ASTRAZENECA,,61.0,YR,,M,Y,,,20210424.0,,MD,GB,GB,2021,Q2,Adult
191861291,19186129,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q2,Acute myocardial infarction,,2021,Q2,1,I,201508.0,20201022.0,20210427,20210427,EXP,,BR-NOVOPROD-805412,NOVO NORDISK,,70.0,YR,,M,Y,,,20210427.0,,MD,BR,BR,2021,Q2,Elderly
191861291,19186129,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q2,Aortic stenosis,,2021,Q2,1,I,201508.0,20201022.0,20210427,20210427,EXP,,BR-NOVOPROD-805412,NOVO NORDISK,,70.0,YR,,M,Y,,,20210427.0,,MD,BR,BR,2021,Q2,Elderly
191866611,19186661,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Blood pressure decreased,,2021,Q2,1,I,,20210419.0,20210427,20210427,EXP,,NVSC2021PL089787,NOVARTIS,,70.0,YR,,M,Y,,,20210427.0,,HP,PL,PL,2021,Q2,Elderly
191866611,19186661,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,COVID-19 pneumonia,,2021,Q2,1,I,,20210419.0,20210427,20210427,EXP,,NVSC2021PL089787,NOVARTIS,,70.0,YR,,M,Y,,,20210427.0,,HP,PL,PL,2021,Q2,Elderly
191866611,19186661,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Cardiac failure chronic,,2021,Q2,1,I,,20210419.0,20210427,20210427,EXP,,NVSC2021PL089787,NOVARTIS,,70.0,YR,,M,Y,,,20210427.0,,HP,PL,PL,2021,Q2,Elderly
191866611,19186661,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Dyspnoea exertional,,2021,Q2,1,I,,20210419.0,20210427,20210427,EXP,,NVSC2021PL089787,NOVARTIS,,70.0,YR,,M,Y,,,20210427.0,,HP,PL,PL,2021,Q2,Elderly
191866611,19186661,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Glomerular filtration rate abnormal,,2021,Q2,1,I,,20210419.0,20210427,20210427,EXP,,NVSC2021PL089787,NOVARTIS,,70.0,YR,,M,Y,,,20210427.0,,HP,PL,PL,2021,Q2,Elderly
191866611,19186661,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Hypertrophy,,2021,Q2,1,I,,20210419.0,20210427,20210427,EXP,,NVSC2021PL089787,NOVARTIS,,70.0,YR,,M,Y,,,20210427.0,,HP,PL,PL,2021,Q2,Elderly
191866611,19186661,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,N-terminal prohormone brain natriuretic peptide,,2021,Q2,1,I,,20210419.0,20210427,20210427,EXP,,NVSC2021PL089787,NOVARTIS,,70.0,YR,,M,Y,,,20210427.0,,HP,PL,PL,2021,Q2,Elderly
191866611,19186661,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Renal atrophy,,2021,Q2,1,I,,20210419.0,20210427,20210427,EXP,,NVSC2021PL089787,NOVARTIS,,70.0,YR,,M,Y,,,20210427.0,,HP,PL,PL,2021,Q2,Elderly
191866611,19186661,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q2,Urosepsis,,2021,Q2,1,I,,20210419.0,20210427,20210427,EXP,,NVSC2021PL089787,NOVARTIS,,70.0,YR,,M,Y,,,20210427.0,,HP,PL,PL,2021,Q2,Elderly
191882572,19188257,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20201127.0,20210603.0,20210428,20210615,EXP,,NVSJ2020JP013119,NOVARTIS,,82.0,YR,,M,Y,51.0,KG,20210616.0,,MD,JP,JP,2021,Q2,Elderly
191882572,19188257,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Bradycardia,,2021,Q2,2,F,20201127.0,20210603.0,20210428,20210615,EXP,,NVSJ2020JP013119,NOVARTIS,,82.0,YR,,M,Y,51.0,KG,20210616.0,,MD,JP,JP,2021,Q2,Elderly
191882572,19188257,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Hyperkalaemia,,2021,Q2,2,F,20201127.0,20210603.0,20210428,20210615,EXP,,NVSJ2020JP013119,NOVARTIS,,82.0,YR,,M,Y,51.0,KG,20210616.0,,MD,JP,JP,2021,Q2,Elderly
191882572,19188257,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Urine output decreased,,2021,Q2,2,F,20201127.0,20210603.0,20210428,20210615,EXP,,NVSJ2020JP013119,NOVARTIS,,82.0,YR,,M,Y,51.0,KG,20210616.0,,MD,JP,JP,2021,Q2,Elderly
191923131,19192313,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210108.0,20210423.0,20210429,20210429,EXP,,CN-ROCHE-2817538,ROCHE,,71.0,YR,,M,Y,,,20210429.0,,MD,CN,CN,2021,Q2,Elderly
191923131,19192313,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2021,Q2,Hypokalaemia,,2021,Q2,1,I,20210108.0,20210423.0,20210429,20210429,EXP,,CN-ROCHE-2817538,ROCHE,,71.0,YR,,M,Y,,,20210429.0,,MD,CN,CN,2021,Q2,Elderly
191923131,19192313,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2021,Q2,Off label use,,2021,Q2,1,I,20210108.0,20210423.0,20210429,20210429,EXP,,CN-ROCHE-2817538,ROCHE,,71.0,YR,,M,Y,,,20210429.0,,MD,CN,CN,2021,Q2,Elderly
191936863,19193686,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Apnoea test abnormal,,2021,Q2,3,F,,20210602.0,20210429,20210614,EXP,,NVSJ2021JP006584,NOVARTIS,,86.0,YR,,M,Y,,,20210615.0,,CN,JP,JP,2021,Q2,Elderly
191936863,19193686,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Product use issue,,2021,Q2,3,F,,20210602.0,20210429,20210614,EXP,,NVSJ2021JP006584,NOVARTIS,,86.0,YR,,M,Y,,,20210615.0,,CN,JP,JP,2021,Q2,Elderly
191936863,19193686,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Renal impairment,,2021,Q2,3,F,,20210602.0,20210429,20210614,EXP,,NVSJ2021JP006584,NOVARTIS,,86.0,YR,,M,Y,,,20210615.0,,CN,JP,JP,2021,Q2,Elderly
191945051,19194505,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Euglycaemic diabetic ketoacidosis,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,US-ASTRAZENECA-2021A347772,ASTRAZENECA,,79.0,YR,,M,Y,,,20210429.0,,HP,US,US,2021,Q2,Elderly
192012731,19201273,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10MG, UNKNOWN",,,U,,,,,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20210423.0,20210430,20210430,EXP,,GB-ASTRAZENECA-2021A352283,ASTRAZENECA,,82.0,YR,,F,Y,,,20210430.0,,HP,GB,GB,2021,Q2,Elderly
192026212,19202621,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Dizziness,,2021,Q2,2,F,,20210523.0,20210430,20210527,EXP,,GB-MYLANLABS-2021M1024976,MYLAN,,35.0,YR,,F,Y,,,20210527.0,,HP,GB,GB,2021,Q2,Adult
192026212,19202621,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Drug intolerance,,2021,Q2,2,F,,20210523.0,20210430,20210527,EXP,,GB-MYLANLABS-2021M1024976,MYLAN,,35.0,YR,,F,Y,,,20210527.0,,HP,GB,GB,2021,Q2,Adult
192026212,19202621,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Dyspnoea,,2021,Q2,2,F,,20210523.0,20210430,20210527,EXP,,GB-MYLANLABS-2021M1024976,MYLAN,,35.0,YR,,F,Y,,,20210527.0,,HP,GB,GB,2021,Q2,Adult
192026212,19202621,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Dyspnoea exertional,,2021,Q2,2,F,,20210523.0,20210430,20210527,EXP,,GB-MYLANLABS-2021M1024976,MYLAN,,35.0,YR,,F,Y,,,20210527.0,,HP,GB,GB,2021,Q2,Adult
192026212,19202621,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Exercise tolerance decreased,,2021,Q2,2,F,,20210523.0,20210430,20210527,EXP,,GB-MYLANLABS-2021M1024976,MYLAN,,35.0,YR,,F,Y,,,20210527.0,,HP,GB,GB,2021,Q2,Adult
192026212,19202621,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Fatigue,,2021,Q2,2,F,,20210523.0,20210430,20210527,EXP,,GB-MYLANLABS-2021M1024976,MYLAN,,35.0,YR,,F,Y,,,20210527.0,,HP,GB,GB,2021,Q2,Adult
192026212,19202621,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Joint swelling,,2021,Q2,2,F,,20210523.0,20210430,20210527,EXP,,GB-MYLANLABS-2021M1024976,MYLAN,,35.0,YR,,F,Y,,,20210527.0,,HP,GB,GB,2021,Q2,Adult
192026212,19202621,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Lethargy,,2021,Q2,2,F,,20210523.0,20210430,20210527,EXP,,GB-MYLANLABS-2021M1024976,MYLAN,,35.0,YR,,F,Y,,,20210527.0,,HP,GB,GB,2021,Q2,Adult
192026212,19202621,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Oedema,,2021,Q2,2,F,,20210523.0,20210430,20210527,EXP,,GB-MYLANLABS-2021M1024976,MYLAN,,35.0,YR,,F,Y,,,20210527.0,,HP,GB,GB,2021,Q2,Adult
192026212,19202621,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Orthopnoea,,2021,Q2,2,F,,20210523.0,20210430,20210527,EXP,,GB-MYLANLABS-2021M1024976,MYLAN,,35.0,YR,,F,Y,,,20210527.0,,HP,GB,GB,2021,Q2,Adult
192026212,19202621,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Peripartum cardiomyopathy,,2021,Q2,2,F,,20210523.0,20210430,20210527,EXP,,GB-MYLANLABS-2021M1024976,MYLAN,,35.0,YR,,F,Y,,,20210527.0,,HP,GB,GB,2021,Q2,Adult
192026212,19202621,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Peripheral swelling,,2021,Q2,2,F,,20210523.0,20210430,20210527,EXP,,GB-MYLANLABS-2021M1024976,MYLAN,,35.0,YR,,F,Y,,,20210527.0,,HP,GB,GB,2021,Q2,Adult
192084961,19208496,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210422.0,20210503,20210503,EXP,,BR-NOVOPROD-807667,NOVO NORDISK,,62.0,YR,,F,Y,79.4,KG,20210503.0,,MD,BR,BR,2021,Q2,Adult
192084961,19208496,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Diabetic retinopathy,,2021,Q2,1,I,,20210422.0,20210503,20210503,EXP,,BR-NOVOPROD-807667,NOVO NORDISK,,62.0,YR,,F,Y,79.4,KG,20210503.0,,MD,BR,BR,2021,Q2,Adult
192084961,19208496,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Diastolic dysfunction,,2021,Q2,1,I,,20210422.0,20210503,20210503,EXP,,BR-NOVOPROD-807667,NOVO NORDISK,,62.0,YR,,F,Y,79.4,KG,20210503.0,,MD,BR,BR,2021,Q2,Adult
192084961,19208496,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210422.0,20210503,20210503,EXP,,BR-NOVOPROD-807667,NOVO NORDISK,,62.0,YR,,F,Y,79.4,KG,20210503.0,,MD,BR,BR,2021,Q2,Adult
192084961,19208496,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Maculopathy,,2021,Q2,1,I,,20210422.0,20210503,20210503,EXP,,BR-NOVOPROD-807667,NOVO NORDISK,,62.0,YR,,F,Y,79.4,KG,20210503.0,,MD,BR,BR,2021,Q2,Adult
192084961,19208496,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Peripheral motor neuropathy,,2021,Q2,1,I,,20210422.0,20210503,20210503,EXP,,BR-NOVOPROD-807667,NOVO NORDISK,,62.0,YR,,F,Y,79.4,KG,20210503.0,,MD,BR,BR,2021,Q2,Adult
192085071,19208507,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Breast cancer,,2021,Q2,1,I,20210302.0,20210422.0,20210503,20210503,EXP,,BR-NOVOPROD-807308,NOVO NORDISK,,57.0,YR,,F,Y,73.5,KG,20210503.0,,MD,BR,BR,2021,Q2,Adult
192085071,19208507,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Off label use,,2021,Q2,1,I,20210302.0,20210422.0,20210503,20210503,EXP,,BR-NOVOPROD-807308,NOVO NORDISK,,57.0,YR,,F,Y,73.5,KG,20210503.0,,MD,BR,BR,2021,Q2,Adult
192124211,19212421,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,, H20170206,,,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210415.0,20210428.0,20210504,20210504,EXP,,CN-ASTRAZENECA-2021A375396,ASTRAZENECA,,18993.0,DY,,F,Y,61.0,KG,20210504.0,,HP,CN,CN,2021,Q2,Elderly
192130411,19213041,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Dizziness,,2021,Q2,1,I,,20210425.0,20210504,20210504,EXP,,GB-BAXTER-2021BAX009023,BAXTER,,35.0,YR,,F,Y,,,20210504.0,,HP,GB,GB,2021,Q2,Adult
192130411,19213041,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Drug intolerance,,2021,Q2,1,I,,20210425.0,20210504,20210504,EXP,,GB-BAXTER-2021BAX009023,BAXTER,,35.0,YR,,F,Y,,,20210504.0,,HP,GB,GB,2021,Q2,Adult
192130411,19213041,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210425.0,20210504,20210504,EXP,,GB-BAXTER-2021BAX009023,BAXTER,,35.0,YR,,F,Y,,,20210504.0,,HP,GB,GB,2021,Q2,Adult
192130411,19213041,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Dyspnoea exertional,,2021,Q2,1,I,,20210425.0,20210504,20210504,EXP,,GB-BAXTER-2021BAX009023,BAXTER,,35.0,YR,,F,Y,,,20210504.0,,HP,GB,GB,2021,Q2,Adult
192130411,19213041,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Exercise tolerance decreased,,2021,Q2,1,I,,20210425.0,20210504,20210504,EXP,,GB-BAXTER-2021BAX009023,BAXTER,,35.0,YR,,F,Y,,,20210504.0,,HP,GB,GB,2021,Q2,Adult
192130411,19213041,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Fatigue,,2021,Q2,1,I,,20210425.0,20210504,20210504,EXP,,GB-BAXTER-2021BAX009023,BAXTER,,35.0,YR,,F,Y,,,20210504.0,,HP,GB,GB,2021,Q2,Adult
192130411,19213041,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Joint swelling,,2021,Q2,1,I,,20210425.0,20210504,20210504,EXP,,GB-BAXTER-2021BAX009023,BAXTER,,35.0,YR,,F,Y,,,20210504.0,,HP,GB,GB,2021,Q2,Adult
192130411,19213041,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Lethargy,,2021,Q2,1,I,,20210425.0,20210504,20210504,EXP,,GB-BAXTER-2021BAX009023,BAXTER,,35.0,YR,,F,Y,,,20210504.0,,HP,GB,GB,2021,Q2,Adult
192130411,19213041,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Oedema,,2021,Q2,1,I,,20210425.0,20210504,20210504,EXP,,GB-BAXTER-2021BAX009023,BAXTER,,35.0,YR,,F,Y,,,20210504.0,,HP,GB,GB,2021,Q2,Adult
192130411,19213041,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Orthopnoea,,2021,Q2,1,I,,20210425.0,20210504,20210504,EXP,,GB-BAXTER-2021BAX009023,BAXTER,,35.0,YR,,F,Y,,,20210504.0,,HP,GB,GB,2021,Q2,Adult
192130411,19213041,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Peripartum cardiomyopathy,,2021,Q2,1,I,,20210425.0,20210504,20210504,EXP,,GB-BAXTER-2021BAX009023,BAXTER,,35.0,YR,,F,Y,,,20210504.0,,HP,GB,GB,2021,Q2,Adult
192130411,19213041,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Peripheral swelling,,2021,Q2,1,I,,20210425.0,20210504,20210504,EXP,,GB-BAXTER-2021BAX009023,BAXTER,,35.0,YR,,F,Y,,,20210504.0,,HP,GB,GB,2021,Q2,Adult
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Acute kidney injury,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Anuria,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Blood creatinine increased,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Cardiac tamponade,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Drug clearance decreased,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Drug interaction,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Fluid overload,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,General physical health deterioration,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Hyperkalaemia,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Hypotension,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Inferior vena cava dilatation,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Metabolic acidosis,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Pericardial effusion,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Pericardial haemorrhage,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Pleural effusion,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Renal failure,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Right ventricular diastolic collapse,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192131971,19213197,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q2,Urine output decreased,,2021,Q2,1,I,,20210302.0,20210504,20210504,EXP,,GB-SA-2021SA075966,SANOFI AVENTIS,"LEFAS A, BODAGH N, PAN J, VAZIR A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE. BMJ CASE REPORTS. 2020?13:12:1?4",86.0,YR,E,M,Y,,,20210504.0,,MD,GB,GB,2021,Q2,Elderly
192155091,19215509,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,,2021,Q2,Dizziness,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-AUROBINDO-AUR-APL-2021-017783,AUROBINDO,,35.0,YR,,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192155091,19215509,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,,2021,Q2,Drug intolerance,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-AUROBINDO-AUR-APL-2021-017783,AUROBINDO,,35.0,YR,,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192155091,19215509,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-AUROBINDO-AUR-APL-2021-017783,AUROBINDO,,35.0,YR,,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192155091,19215509,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,,2021,Q2,Dyspnoea exertional,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-AUROBINDO-AUR-APL-2021-017783,AUROBINDO,,35.0,YR,,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192155091,19215509,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,,2021,Q2,Exercise tolerance decreased,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-AUROBINDO-AUR-APL-2021-017783,AUROBINDO,,35.0,YR,,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192155091,19215509,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-AUROBINDO-AUR-APL-2021-017783,AUROBINDO,,35.0,YR,,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192155091,19215509,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,,2021,Q2,Joint swelling,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-AUROBINDO-AUR-APL-2021-017783,AUROBINDO,,35.0,YR,,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192155091,19215509,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,,2021,Q2,Lethargy,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-AUROBINDO-AUR-APL-2021-017783,AUROBINDO,,35.0,YR,,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192155091,19215509,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,,2021,Q2,Oedema,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-AUROBINDO-AUR-APL-2021-017783,AUROBINDO,,35.0,YR,,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192155091,19215509,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,,2021,Q2,Orthopnoea,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-AUROBINDO-AUR-APL-2021-017783,AUROBINDO,,35.0,YR,,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192155091,19215509,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,,2021,Q2,Peripartum cardiomyopathy,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-AUROBINDO-AUR-APL-2021-017783,AUROBINDO,,35.0,YR,,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192155091,19215509,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,,,2021,Q2,Peripheral swelling,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-AUROBINDO-AUR-APL-2021-017783,AUROBINDO,,35.0,YR,,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192156103,19215610,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, ONCE A DAY",,,Y,,,,,5.0,MG,,QD,2021,Q2,Cardiac tamponade,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, ONCE A DAY",,,Y,,,,,5.0,MG,,QD,2021,Q2,Drug clearance decreased,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, ONCE A DAY",,,Y,,,,,5.0,MG,,QD,2021,Q2,Drug interaction,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, ONCE A DAY",,,Y,,,,,5.0,MG,,QD,2021,Q2,Fluid overload,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, ONCE A DAY",,,Y,,,,,5.0,MG,,QD,2021,Q2,Hyperkalaemia,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, ONCE A DAY",,,Y,,,,,5.0,MG,,QD,2021,Q2,Hypotension,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, ONCE A DAY",,,Y,,,,,5.0,MG,,QD,2021,Q2,Metabolic acidosis,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, ONCE A DAY",,,Y,,,,,5.0,MG,,QD,2021,Q2,Pericardial haemorrhage,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, ONCE A DAY",,,Y,,,,,5.0,MG,,QD,2021,Q2,Pleural effusion,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, ONCE A DAY",,,Y,,,,,5.0,MG,,QD,2021,Q2,Renal failure,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Cardiac tamponade,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Drug clearance decreased,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Drug interaction,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Fluid overload,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Hyperkalaemia,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Hypotension,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Metabolic acidosis,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Pericardial haemorrhage,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Pleural effusion,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156103,19215610,11,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Renal failure,,2021,Q2,3,F,,20210507.0,20210505,20210519,EXP,,GB-AUROBINDO-AUR-APL-2021-017775,AUROBINDO,,86.0,YR,,M,Y,,,20210519.0,,HP,GB,GB,2021,Q2,Elderly
192156821,19215682,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2021,Q2,Dizziness,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-TEVA-2021-GB-1906427,TEVA,,35.0,YR,A,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192156821,19215682,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2021,Q2,Drug intolerance,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-TEVA-2021-GB-1906427,TEVA,,35.0,YR,A,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192156821,19215682,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-TEVA-2021-GB-1906427,TEVA,,35.0,YR,A,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192156821,19215682,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2021,Q2,Dyspnoea exertional,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-TEVA-2021-GB-1906427,TEVA,,35.0,YR,A,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192156821,19215682,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2021,Q2,Exercise tolerance decreased,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-TEVA-2021-GB-1906427,TEVA,,35.0,YR,A,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192156821,19215682,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2021,Q2,Fatigue,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-TEVA-2021-GB-1906427,TEVA,,35.0,YR,A,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192156821,19215682,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2021,Q2,Joint swelling,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-TEVA-2021-GB-1906427,TEVA,,35.0,YR,A,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192156821,19215682,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2021,Q2,Lethargy,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-TEVA-2021-GB-1906427,TEVA,,35.0,YR,A,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192156821,19215682,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2021,Q2,Oedema,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-TEVA-2021-GB-1906427,TEVA,,35.0,YR,A,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192156821,19215682,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2021,Q2,Orthopnoea,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-TEVA-2021-GB-1906427,TEVA,,35.0,YR,A,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192156821,19215682,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2021,Q2,Peripartum cardiomyopathy,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-TEVA-2021-GB-1906427,TEVA,,35.0,YR,A,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192156821,19215682,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM DAILY;,,,,,,,,10.0,MG,,QD,2021,Q2,Peripheral swelling,,2021,Q2,1,I,,20210425.0,20210505,20210505,EXP,,GB-TEVA-2021-GB-1906427,TEVA,,35.0,YR,A,F,Y,,,20210505.0,,HP,GB,GB,2021,Q2,Adult
192159401,19215940,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Atrial fibrillation,,2021,Q2,1,I,,20210420.0,20210505,20210505,EXP,,NVSJ2021JP006663,NOVARTIS,,84.0,YR,,F,Y,,,20210505.0,,MD,JP,JP,2021,Q2,Elderly
192159401,19215940,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Cardiac failure,,2021,Q2,1,I,,20210420.0,20210505,20210505,EXP,,NVSJ2021JP006663,NOVARTIS,,84.0,YR,,F,Y,,,20210505.0,,MD,JP,JP,2021,Q2,Elderly
192159401,19215940,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Cardiomegaly,,2021,Q2,1,I,,20210420.0,20210505,20210505,EXP,,NVSJ2021JP006663,NOVARTIS,,84.0,YR,,F,Y,,,20210505.0,,MD,JP,JP,2021,Q2,Elderly
192159401,19215940,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Chronic kidney disease,,2021,Q2,1,I,,20210420.0,20210505,20210505,EXP,,NVSJ2021JP006663,NOVARTIS,,84.0,YR,,F,Y,,,20210505.0,,MD,JP,JP,2021,Q2,Elderly
192159401,19215940,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Diabetes mellitus,,2021,Q2,1,I,,20210420.0,20210505,20210505,EXP,,NVSJ2021JP006663,NOVARTIS,,84.0,YR,,F,Y,,,20210505.0,,MD,JP,JP,2021,Q2,Elderly
192159401,19215940,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Pulmonary congestion,,2021,Q2,1,I,,20210420.0,20210505,20210505,EXP,,NVSJ2021JP006663,NOVARTIS,,84.0,YR,,F,Y,,,20210505.0,,MD,JP,JP,2021,Q2,Elderly
192182271,19218227,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Diabetes mellitus,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Fascial infection,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Folliculitis,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Groin abscess,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Hypertension,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Necrotising fasciitis,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Obesity,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Scrotal cellulitis,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Sepsis,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Diabetes mellitus,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Fascial infection,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Folliculitis,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Groin abscess,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Hypertension,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Necrotising fasciitis,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Obesity,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Scrotal cellulitis,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192182271,19218227,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Sepsis,,2021,Q2,1,I,20160222.0,20210423.0,20210502,20210502,EXP,,US-ASTRAZENECA-2021A358044,ASTRAZENECA,,17522.0,DY,,M,Y,134.0,KG,20210502.0,,,US,US,2021,Q2,Elderly
192183501,19218350,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,50/1000,,,U,,,,,5.0,MG,,,2021,Q2,Lactic acidosis,,2021,Q2,1,I,20201228.0,20210422.0,20210505,20210505,EXP,DE-BFARM-21002314,DE-ACCORD-223839,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20210505.0,,MD,DE,DE,2021,Q2,Elderly
192215051,19221505,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Ventricular fibrillation,,2021,Q2,1,I,,20210409.0,20210505,20210505,EXP,,TW-ASTRAZENECA-2021A374875,ASTRAZENECA,,64.0,YR,,M,Y,,,20210505.0,,MD,TW,TW,2021,Q2,Adult
192219341,19221934,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Cardiac tamponade,,2021,Q2,1,I,,20210426.0,20210506,20210506,EXP,,GB-TORRENT-00025560,TORRENT,,86.0,YR,E,M,Y,,,20210506.0,,HP,GB,GB,2021,Q2,Elderly
192219341,19221934,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Drug clearance decreased,,2021,Q2,1,I,,20210426.0,20210506,20210506,EXP,,GB-TORRENT-00025560,TORRENT,,86.0,YR,E,M,Y,,,20210506.0,,HP,GB,GB,2021,Q2,Elderly
192219341,19221934,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Drug interaction,,2021,Q2,1,I,,20210426.0,20210506,20210506,EXP,,GB-TORRENT-00025560,TORRENT,,86.0,YR,E,M,Y,,,20210506.0,,HP,GB,GB,2021,Q2,Elderly
192219341,19221934,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Fluid overload,,2021,Q2,1,I,,20210426.0,20210506,20210506,EXP,,GB-TORRENT-00025560,TORRENT,,86.0,YR,E,M,Y,,,20210506.0,,HP,GB,GB,2021,Q2,Elderly
192219341,19221934,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Hyperkalaemia,,2021,Q2,1,I,,20210426.0,20210506,20210506,EXP,,GB-TORRENT-00025560,TORRENT,,86.0,YR,E,M,Y,,,20210506.0,,HP,GB,GB,2021,Q2,Elderly
192219341,19221934,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Hypotension,,2021,Q2,1,I,,20210426.0,20210506,20210506,EXP,,GB-TORRENT-00025560,TORRENT,,86.0,YR,E,M,Y,,,20210506.0,,HP,GB,GB,2021,Q2,Elderly
192219341,19221934,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Metabolic acidosis,,2021,Q2,1,I,,20210426.0,20210506,20210506,EXP,,GB-TORRENT-00025560,TORRENT,,86.0,YR,E,M,Y,,,20210506.0,,HP,GB,GB,2021,Q2,Elderly
192219341,19221934,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Pericardial haemorrhage,,2021,Q2,1,I,,20210426.0,20210506,20210506,EXP,,GB-TORRENT-00025560,TORRENT,,86.0,YR,E,M,Y,,,20210506.0,,HP,GB,GB,2021,Q2,Elderly
192219341,19221934,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Pleural effusion,,2021,Q2,1,I,,20210426.0,20210506,20210506,EXP,,GB-TORRENT-00025560,TORRENT,,86.0,YR,E,M,Y,,,20210506.0,,HP,GB,GB,2021,Q2,Elderly
192219341,19221934,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,,,2021,Q2,Renal failure,,2021,Q2,1,I,,20210426.0,20210506,20210506,EXP,,GB-TORRENT-00025560,TORRENT,,86.0,YR,E,M,Y,,,20210506.0,,HP,GB,GB,2021,Q2,Elderly
192225102,19222510,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Dizziness,,2021,Q2,2,F,,20210523.0,20210506,20210603,EXP,GB-MHRA-ADR 25192672,GB-ACCORD-224232,ACCORD,,35.0,YR,,F,Y,,,20210603.0,,HP,GB,GB,2021,Q2,Adult
192225102,19222510,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Drug intolerance,,2021,Q2,2,F,,20210523.0,20210506,20210603,EXP,GB-MHRA-ADR 25192672,GB-ACCORD-224232,ACCORD,,35.0,YR,,F,Y,,,20210603.0,,HP,GB,GB,2021,Q2,Adult
192225102,19222510,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Dyspnoea,,2021,Q2,2,F,,20210523.0,20210506,20210603,EXP,GB-MHRA-ADR 25192672,GB-ACCORD-224232,ACCORD,,35.0,YR,,F,Y,,,20210603.0,,HP,GB,GB,2021,Q2,Adult
192225102,19222510,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Dyspnoea exertional,,2021,Q2,2,F,,20210523.0,20210506,20210603,EXP,GB-MHRA-ADR 25192672,GB-ACCORD-224232,ACCORD,,35.0,YR,,F,Y,,,20210603.0,,HP,GB,GB,2021,Q2,Adult
192225102,19222510,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Exercise tolerance decreased,,2021,Q2,2,F,,20210523.0,20210506,20210603,EXP,GB-MHRA-ADR 25192672,GB-ACCORD-224232,ACCORD,,35.0,YR,,F,Y,,,20210603.0,,HP,GB,GB,2021,Q2,Adult
192225102,19222510,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Fatigue,,2021,Q2,2,F,,20210523.0,20210506,20210603,EXP,GB-MHRA-ADR 25192672,GB-ACCORD-224232,ACCORD,,35.0,YR,,F,Y,,,20210603.0,,HP,GB,GB,2021,Q2,Adult
192225102,19222510,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Joint swelling,,2021,Q2,2,F,,20210523.0,20210506,20210603,EXP,GB-MHRA-ADR 25192672,GB-ACCORD-224232,ACCORD,,35.0,YR,,F,Y,,,20210603.0,,HP,GB,GB,2021,Q2,Adult
192225102,19222510,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Lethargy,,2021,Q2,2,F,,20210523.0,20210506,20210603,EXP,GB-MHRA-ADR 25192672,GB-ACCORD-224232,ACCORD,,35.0,YR,,F,Y,,,20210603.0,,HP,GB,GB,2021,Q2,Adult
192225102,19222510,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Oedema,,2021,Q2,2,F,,20210523.0,20210506,20210603,EXP,GB-MHRA-ADR 25192672,GB-ACCORD-224232,ACCORD,,35.0,YR,,F,Y,,,20210603.0,,HP,GB,GB,2021,Q2,Adult
192225102,19222510,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Orthopnoea,,2021,Q2,2,F,,20210523.0,20210506,20210603,EXP,GB-MHRA-ADR 25192672,GB-ACCORD-224232,ACCORD,,35.0,YR,,F,Y,,,20210603.0,,HP,GB,GB,2021,Q2,Adult
192225102,19222510,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Peripartum cardiomyopathy,,2021,Q2,2,F,,20210523.0,20210506,20210603,EXP,GB-MHRA-ADR 25192672,GB-ACCORD-224232,ACCORD,,35.0,YR,,F,Y,,,20210603.0,,HP,GB,GB,2021,Q2,Adult
192225102,19222510,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Peripheral swelling,,2021,Q2,2,F,,20210523.0,20210506,20210603,EXP,GB-MHRA-ADR 25192672,GB-ACCORD-224232,ACCORD,,35.0,YR,,F,Y,,,20210603.0,,HP,GB,GB,2021,Q2,Adult
192238281,19223828,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,, MJ3034,,,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210401.0,20210427.0,20210506,20210506,EXP,,CN-ASTRAZENECA-2021A382808,ASTRAZENECA,,71.0,YR,,F,Y,,,20210506.0,,HP,CN,CN,2021,Q2,Elderly
192289742,19228974,20,C,Dapagliflozin/metformin (Xigduo),,2,Unknown,5/1000MG BID,,,,,,,,,,UNKNOWN,,2021,Q2,Acute myocardial infarction,,2021,Q2,2,F,202102.0,20210517.0,20210507,20210527,EXP,,PT-BIOGEN-2021BI00984369,BIOGEN,,49.0,YR,,M,Y,,,20210527.0,,MD,PT,PT,2021,Q2,Adult
192289742,19228974,20,C,Dapagliflozin/metformin (Xigduo),,2,Unknown,5/1000MG BID,,,,,,,,,,UNKNOWN,,2021,Q2,Left ventricular failure,,2021,Q2,2,F,202102.0,20210517.0,20210507,20210527,EXP,,PT-BIOGEN-2021BI00984369,BIOGEN,,49.0,YR,,M,Y,,,20210527.0,,MD,PT,PT,2021,Q2,Adult
192301091,19230109,1,PS,METFORMIN/DAPAGLIFLOZIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,,,,,205649.0,,,TABLET,,2021,Q2,Cystitis,,2021,Q2,1,I,202101.0,20210430.0,20210507,20210507,EXP,,CR-ASTRAZENECA-2021A396694,ASTRAZENECA,,531.0,MON,,F,Y,,,20210507.0,,,CR,CR,2021,Q2,Elderly
192301091,19230109,1,PS,METFORMIN/DAPAGLIFLOZIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,,,,,205649.0,,,TABLET,,2021,Q2,Infection,,2021,Q2,1,I,202101.0,20210430.0,20210507,20210507,EXP,,CR-ASTRAZENECA-2021A396694,ASTRAZENECA,,531.0,MON,,F,Y,,,20210507.0,,,CR,CR,2021,Q2,Elderly
192323691,19232369,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Ventricular arrhythmia,,2021,Q2,1,I,202003.0,20210409.0,20210507,20210507,EXP,,TW-ASTRAZENECA-2021A375061,ASTRAZENECA,,78.0,YR,,M,Y,,,20210507.0,,MD,TW,TW,2021,Q2,Elderly
192325961,19232596,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"AMERICA, ASTRAZENECA",300.0,MG,Y,,,,,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210418.0,20210501.0,20210507,20210507,EXP,,CN-ASTRAZENECA-2021A385478,ASTRAZENECA,,11351.0,DY,,M,Y,56.0,KG,20210507.0,,HP,CN,CN,2021,Q2,Elderly
192336361,19233636,17,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,U,,,,,,,TABLET,,2021,Q2,Alopecia,,2021,Q2,1,I,202104.0,20210429.0,20210507,20210507,PER,,US-SA-2021SA149853,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20210507.0,,CN,US,US,2021,Q2,Adult
192336361,19233636,17,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,U,,,,,,,TABLET,,2021,Q2,COVID-19,,2021,Q2,1,I,202104.0,20210429.0,20210507,20210507,PER,,US-SA-2021SA149853,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20210507.0,,CN,US,US,2021,Q2,Adult
192336361,19233636,17,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,U,,,,,,,TABLET,,2021,Q2,Diarrhoea,,2021,Q2,1,I,202104.0,20210429.0,20210507,20210507,PER,,US-SA-2021SA149853,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20210507.0,,CN,US,US,2021,Q2,Adult
192337711,19233771,1,PS,"DAPAGLIFLOZIN PROPANDIOL, MONOHYDRAT",DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5MG,,,,,,,202293.0,,,,,2021,Q2,Peripheral arterial occlusive disease,,2021,Q2,1,I,,20210413.0,20210507,20210507,EXP,,GB-ASTRAZENECA-2021A308944,ASTRAZENECA,,60.0,YR,,M,Y,83.0,KG,20210507.0,,MD,GB,GB,2021,Q2,Adult
192357271,19235727,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202103.0,20210426.0,20210510,20210510,EXP,,BR-NOVOPROD-810193,NOVO NORDISK,,58.0,YR,,F,Y,74.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192357271,19235727,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 MG,,,,, UNKNOWN,,,,,,,2021,Q2,COVID-19,,2021,Q2,1,I,202103.0,20210426.0,20210510,20210510,EXP,,BR-NOVOPROD-810193,NOVO NORDISK,,58.0,YR,,F,Y,74.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192357271,19235727,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Cataract operation,,2021,Q2,1,I,202103.0,20210426.0,20210510,20210510,EXP,,BR-NOVOPROD-810193,NOVO NORDISK,,58.0,YR,,F,Y,74.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192357271,19235727,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Depressive symptom,,2021,Q2,1,I,202103.0,20210426.0,20210510,20210510,EXP,,BR-NOVOPROD-810193,NOVO NORDISK,,58.0,YR,,F,Y,74.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192357271,19235727,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,202103.0,20210426.0,20210510,20210510,EXP,,BR-NOVOPROD-810193,NOVO NORDISK,,58.0,YR,,F,Y,74.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192357271,19235727,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Pain,,2021,Q2,1,I,202103.0,20210426.0,20210510,20210510,EXP,,BR-NOVOPROD-810193,NOVO NORDISK,,58.0,YR,,F,Y,74.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192357271,19235727,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Thirst,,2021,Q2,1,I,202103.0,20210426.0,20210510,20210510,EXP,,BR-NOVOPROD-810193,NOVO NORDISK,,58.0,YR,,F,Y,74.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192357271,19235727,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Urine output decreased,,2021,Q2,1,I,202103.0,20210426.0,20210510,20210510,EXP,,BR-NOVOPROD-810193,NOVO NORDISK,,58.0,YR,,F,Y,74.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192357271,19235727,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Vision blurred,,2021,Q2,1,I,202103.0,20210426.0,20210510,20210510,EXP,,BR-NOVOPROD-810193,NOVO NORDISK,,58.0,YR,,F,Y,74.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192360611,19236061,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q2,Arthralgia,,2021,Q2,1,I,201304.0,20210429.0,20210510,20210510,EXP,,BR-NOVOPROD-809604,NOVO NORDISK,,76.0,YR,,M,Y,,,20210510.0,,MD,BR,BR,2021,Q2,Elderly
192360611,19236061,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q2,Back pain,,2021,Q2,1,I,201304.0,20210429.0,20210510,20210510,EXP,,BR-NOVOPROD-809604,NOVO NORDISK,,76.0,YR,,M,Y,,,20210510.0,,MD,BR,BR,2021,Q2,Elderly
192360611,19236061,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q2,Coronary revascularisation,,2021,Q2,1,I,201304.0,20210429.0,20210510,20210510,EXP,,BR-NOVOPROD-809604,NOVO NORDISK,,76.0,YR,,M,Y,,,20210510.0,,MD,BR,BR,2021,Q2,Elderly
192409911,19240991,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Intestinal obstruction,,2021,Q2,1,I,20210504.0,20210504.0,20210511,20210511,EXP,,CN-NOVOPROD-810325,NOVO NORDISK,,54.0,YR,,F,Y,,,20210511.0,,MD,CN,CN,2021,Q2,Adult
192409911,19240991,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Loss of consciousness,,2021,Q2,1,I,20210504.0,20210504.0,20210511,20210511,EXP,,CN-NOVOPROD-810325,NOVO NORDISK,,54.0,YR,,F,Y,,,20210511.0,,MD,CN,CN,2021,Q2,Adult
192409911,19240991,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Multiple organ dysfunction syndrome,,2021,Q2,1,I,20210504.0,20210504.0,20210511,20210511,EXP,,CN-NOVOPROD-810325,NOVO NORDISK,,54.0,YR,,F,Y,,,20210511.0,,MD,CN,CN,2021,Q2,Adult
192441731,19244173,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q2,Benign prostatic hyperplasia,,2021,Q2,1,I,,20210503.0,20210512,20210512,EXP,,PL-JNJFOC-20210513381,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,,,20210512.0,,MD,PL,PL,2021,Q2,Elderly
192441731,19244173,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q2,COVID-19 pneumonia,,2021,Q2,1,I,,20210503.0,20210512,20210512,EXP,,PL-JNJFOC-20210513381,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,,,20210512.0,,MD,PL,PL,2021,Q2,Elderly
192441731,19244173,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q2,Cardiac failure chronic,,2021,Q2,1,I,,20210503.0,20210512,20210512,EXP,,PL-JNJFOC-20210513381,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,,,20210512.0,,MD,PL,PL,2021,Q2,Elderly
192441731,19244173,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q2,Dyspnoea exertional,,2021,Q2,1,I,,20210503.0,20210512,20210512,EXP,,PL-JNJFOC-20210513381,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,,,20210512.0,,MD,PL,PL,2021,Q2,Elderly
192441731,19244173,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q2,Glomerular filtration rate abnormal,,2021,Q2,1,I,,20210503.0,20210512,20210512,EXP,,PL-JNJFOC-20210513381,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,,,20210512.0,,MD,PL,PL,2021,Q2,Elderly
192441731,19244173,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q2,Hypotension,,2021,Q2,1,I,,20210503.0,20210512,20210512,EXP,,PL-JNJFOC-20210513381,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,,,20210512.0,,MD,PL,PL,2021,Q2,Elderly
192441731,19244173,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q2,N-terminal prohormone brain natriuretic peptide increased,,2021,Q2,1,I,,20210503.0,20210512,20210512,EXP,,PL-JNJFOC-20210513381,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,,,20210512.0,,MD,PL,PL,2021,Q2,Elderly
192441731,19244173,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q2,Renal atrophy,,2021,Q2,1,I,,20210503.0,20210512,20210512,EXP,,PL-JNJFOC-20210513381,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,,,20210512.0,,MD,PL,PL,2021,Q2,Elderly
192441731,19244173,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q2,Urosepsis,,2021,Q2,1,I,,20210503.0,20210512,20210512,EXP,,PL-JNJFOC-20210513381,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,,,20210512.0,,MD,PL,PL,2021,Q2,Elderly
192451791,19245179,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Cataract,,2021,Q2,1,I,2020.0,20210501.0,20210512,20210512,EXP,,BR-NOVOPROD-810136,NOVO NORDISK,,69.0,YR,,F,Y,75.2,KG,20210512.0,,MD,BR,BR,2021,Q2,Elderly
192451791,19245179,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,2020.0,20210501.0,20210512,20210512,EXP,,BR-NOVOPROD-810136,NOVO NORDISK,,69.0,YR,,F,Y,75.2,KG,20210512.0,,MD,BR,BR,2021,Q2,Elderly
192451791,19245179,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Gliosis,,2021,Q2,1,I,2020.0,20210501.0,20210512,20210512,EXP,,BR-NOVOPROD-810136,NOVO NORDISK,,69.0,YR,,F,Y,75.2,KG,20210512.0,,MD,BR,BR,2021,Q2,Elderly
192451791,19245179,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,2020.0,20210501.0,20210512,20210512,EXP,,BR-NOVOPROD-810136,NOVO NORDISK,,69.0,YR,,F,Y,75.2,KG,20210512.0,,MD,BR,BR,2021,Q2,Elderly
192451791,19245179,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Weight increased,,2021,Q2,1,I,2020.0,20210501.0,20210512,20210512,EXP,,BR-NOVOPROD-810136,NOVO NORDISK,,69.0,YR,,F,Y,75.2,KG,20210512.0,,MD,BR,BR,2021,Q2,Elderly
192476821,19247682,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORMS DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,, ASKU,,,1.0,DF,TABLET,QD,2021,Q2,Blood pressure decreased,,2021,Q2,1,I,,20210504.0,20210512,20210512,EXP,,PL-TEVA-2021-PL-1909616,TEVA,,70.0,YR,E,M,Y,,,20210512.0,,HP,PL,PL,2021,Q2,Elderly
192476821,19247682,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORMS DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,, ASKU,,,1.0,DF,TABLET,QD,2021,Q2,COVID-19 pneumonia,,2021,Q2,1,I,,20210504.0,20210512,20210512,EXP,,PL-TEVA-2021-PL-1909616,TEVA,,70.0,YR,E,M,Y,,,20210512.0,,HP,PL,PL,2021,Q2,Elderly
192476821,19247682,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORMS DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,, ASKU,,,1.0,DF,TABLET,QD,2021,Q2,Cardiac failure chronic,,2021,Q2,1,I,,20210504.0,20210512,20210512,EXP,,PL-TEVA-2021-PL-1909616,TEVA,,70.0,YR,E,M,Y,,,20210512.0,,HP,PL,PL,2021,Q2,Elderly
192476821,19247682,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORMS DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,, ASKU,,,1.0,DF,TABLET,QD,2021,Q2,Dyspnoea exertional,,2021,Q2,1,I,,20210504.0,20210512,20210512,EXP,,PL-TEVA-2021-PL-1909616,TEVA,,70.0,YR,E,M,Y,,,20210512.0,,HP,PL,PL,2021,Q2,Elderly
192476821,19247682,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORMS DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,, ASKU,,,1.0,DF,TABLET,QD,2021,Q2,Glomerular filtration rate abnormal,,2021,Q2,1,I,,20210504.0,20210512,20210512,EXP,,PL-TEVA-2021-PL-1909616,TEVA,,70.0,YR,E,M,Y,,,20210512.0,,HP,PL,PL,2021,Q2,Elderly
192476821,19247682,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORMS DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,, ASKU,,,1.0,DF,TABLET,QD,2021,Q2,Hypertrophy,,2021,Q2,1,I,,20210504.0,20210512,20210512,EXP,,PL-TEVA-2021-PL-1909616,TEVA,,70.0,YR,E,M,Y,,,20210512.0,,HP,PL,PL,2021,Q2,Elderly
192476821,19247682,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORMS DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,, ASKU,,,1.0,DF,TABLET,QD,2021,Q2,N-terminal prohormone brain natriuretic peptide abnormal,,2021,Q2,1,I,,20210504.0,20210512,20210512,EXP,,PL-TEVA-2021-PL-1909616,TEVA,,70.0,YR,E,M,Y,,,20210512.0,,HP,PL,PL,2021,Q2,Elderly
192476821,19247682,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORMS DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,, ASKU,,,1.0,DF,TABLET,QD,2021,Q2,Renal atrophy,,2021,Q2,1,I,,20210504.0,20210512,20210512,EXP,,PL-TEVA-2021-PL-1909616,TEVA,,70.0,YR,E,M,Y,,,20210512.0,,HP,PL,PL,2021,Q2,Elderly
192476821,19247682,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DOSAGE FORMS DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,, ASKU,,,1.0,DF,TABLET,QD,2021,Q2,Urosepsis,,2021,Q2,1,I,,20210504.0,20210512,20210512,EXP,,PL-TEVA-2021-PL-1909616,TEVA,,70.0,YR,E,M,Y,,,20210512.0,,HP,PL,PL,2021,Q2,Elderly
192478151,19247815,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,4770.0,MG,U,,,,202293.0,10.0,MG,,QD,2021,Q2,Depressed level of consciousness,,2021,Q2,1,I,20210422.0,20210504.0,20210512,20210512,EXP,,DE-ASTRAZENECA-2021A390823,ASTRAZENECA,,81.0,YR,,F,Y,55.0,KG,20210512.0,,CN,DE,DE,2021,Q2,Elderly
192478151,19247815,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,4770.0,MG,U,,,,202293.0,10.0,MG,,QD,2021,Q2,Euglycaemic diabetic ketoacidosis,,2021,Q2,1,I,20210422.0,20210504.0,20210512,20210512,EXP,,DE-ASTRAZENECA-2021A390823,ASTRAZENECA,,81.0,YR,,F,Y,55.0,KG,20210512.0,,CN,DE,DE,2021,Q2,Elderly
192478151,19247815,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,4770.0,MG,U,,,,202293.0,10.0,MG,,QD,2021,Q2,Hypovolaemia,,2021,Q2,1,I,20210422.0,20210504.0,20210512,20210512,EXP,,DE-ASTRAZENECA-2021A390823,ASTRAZENECA,,81.0,YR,,F,Y,55.0,KG,20210512.0,,CN,DE,DE,2021,Q2,Elderly
192478151,19247815,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,4770.0,MG,U,,,,202293.0,10.0,MG,,QD,2021,Q2,Shock,,2021,Q2,1,I,20210422.0,20210504.0,20210512,20210512,EXP,,DE-ASTRAZENECA-2021A390823,ASTRAZENECA,,81.0,YR,,F,Y,55.0,KG,20210512.0,,CN,DE,DE,2021,Q2,Elderly
192482331,19248233,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Ankle fracture,,2021,Q2,1,I,2021.0,20210502.0,20210512,20210512,EXP,,BR-NOVOPROD-810250,NOVO NORDISK,,80.0,YR,,F,Y,157.0,KG,20210512.0,,MD,BR,BR,2021,Q2,Elderly
192482331,19248233,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Fall,,2021,Q2,1,I,2021.0,20210502.0,20210512,20210512,EXP,,BR-NOVOPROD-810250,NOVO NORDISK,,80.0,YR,,F,Y,157.0,KG,20210512.0,,MD,BR,BR,2021,Q2,Elderly
192482331,19248233,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Weight decreased,,2021,Q2,1,I,2021.0,20210502.0,20210512,20210512,EXP,,BR-NOVOPROD-810250,NOVO NORDISK,,80.0,YR,,F,Y,157.0,KG,20210512.0,,MD,BR,BR,2021,Q2,Elderly
192517071,19251707,2,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 / 1000MG,,,,, UNKNOWN,,,,,,,2021,Q2,Acute myocardial infarction,,2021,Q2,1,I,201904.0,20210503.0,20210513,20210513,EXP,,BR-NOVOPROD-811093,NOVO NORDISK,,72.0,YR,,F,Y,71.5,KG,20210513.0,,MD,BR,BR,2021,Q2,Elderly
192517071,19251707,2,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 / 1000MG,,,,, UNKNOWN,,,,,,,2021,Q2,Cardiac failure,,2021,Q2,1,I,201904.0,20210503.0,20210513,20210513,EXP,,BR-NOVOPROD-811093,NOVO NORDISK,,72.0,YR,,F,Y,71.5,KG,20210513.0,,MD,BR,BR,2021,Q2,Elderly
192517071,19251707,2,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 / 1000MG,,,,, UNKNOWN,,,,,,,2021,Q2,Renal impairment,,2021,Q2,1,I,201904.0,20210503.0,20210513,20210513,EXP,,BR-NOVOPROD-811093,NOVO NORDISK,,72.0,YR,,F,Y,71.5,KG,20210513.0,,MD,BR,BR,2021,Q2,Elderly
192519771,19251977,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,TAKE ONE DAILY,,,,,,,,,,UNKNOWN,,2021,Q2,Adverse drug reaction,,2021,Q2,1,I,20210504.0,20210505.0,20210513,20210513,EXP,GB-MHRA-TPP18947208C6212165YC1620126719214,GB-JNJFOC-20210511320,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,101.0,KG,20210513.0,,PH,GB,GB,2021,Q2,Elderly
192519771,19251977,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,TAKE ONE DAILY,,,,,,,,,,UNKNOWN,,2021,Q2,Glomerular filtration rate decreased,,2021,Q2,1,I,20210504.0,20210505.0,20210513,20210513,EXP,GB-MHRA-TPP18947208C6212165YC1620126719214,GB-JNJFOC-20210511320,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,101.0,KG,20210513.0,,PH,GB,GB,2021,Q2,Elderly
192519771,19251977,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,TAKE ONE DAILY,,,,,,,,,,UNKNOWN,,2021,Q2,Off label use,,2021,Q2,1,I,20210504.0,20210505.0,20210513,20210513,EXP,GB-MHRA-TPP18947208C6212165YC1620126719214,GB-JNJFOC-20210511320,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,101.0,KG,20210513.0,,PH,GB,GB,2021,Q2,Elderly
192519771,19251977,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,TAKE ONE DAILY,,,,,,,,,,UNKNOWN,,2021,Q2,Product use in unapproved indication,,2021,Q2,1,I,20210504.0,20210505.0,20210513,20210513,EXP,GB-MHRA-TPP18947208C6212165YC1620126719214,GB-JNJFOC-20210511320,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,101.0,KG,20210513.0,,PH,GB,GB,2021,Q2,Elderly
192524571,19252457,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2021,Q2,Necrotising fasciitis,,2021,Q2,1,I,,20210511.0,20210513,20210513,EXP,,GB-ASTRAZENECA-2021A417430,ASTRAZENECA,,59.0,YR,,M,Y,,,20210513.0,,HP,GB,GB,2021,Q2,Adult
192587851,19258785,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10MG,,,N,, UNKNOWN,,,,,,,2021,Q2,Euglycaemic diabetic ketoacidosis,,2021,Q2,1,I,20210428.0,20210506.0,20210514,20210514,EXP,,GB-ASTRAZENECA-2021A401608,ASTRAZENECA,,57.0,YR,,F,Y,70.0,KG,20210514.0,,HP,GB,GB,2021,Q2,Adult
192589201,19258920,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Cardiac tamponade,,2021,Q2,1,I,,20210507.0,20210514,20210514,EXP,,GB-MYLANLABS-2021M1027476,MYLAN,"LEFAS A, BODAGH N, PAN J, VAZIR A.. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS. 2020?13 (12):E238047",86.0,YR,,M,Y,,,20210514.0,,HP,GB,GB,2021,Q2,Elderly
192589201,19258920,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Drug clearance decreased,,2021,Q2,1,I,,20210507.0,20210514,20210514,EXP,,GB-MYLANLABS-2021M1027476,MYLAN,"LEFAS A, BODAGH N, PAN J, VAZIR A.. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS. 2020?13 (12):E238047",86.0,YR,,M,Y,,,20210514.0,,HP,GB,GB,2021,Q2,Elderly
192589201,19258920,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Drug interaction,,2021,Q2,1,I,,20210507.0,20210514,20210514,EXP,,GB-MYLANLABS-2021M1027476,MYLAN,"LEFAS A, BODAGH N, PAN J, VAZIR A.. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS. 2020?13 (12):E238047",86.0,YR,,M,Y,,,20210514.0,,HP,GB,GB,2021,Q2,Elderly
192589201,19258920,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Fluid overload,,2021,Q2,1,I,,20210507.0,20210514,20210514,EXP,,GB-MYLANLABS-2021M1027476,MYLAN,"LEFAS A, BODAGH N, PAN J, VAZIR A.. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS. 2020?13 (12):E238047",86.0,YR,,M,Y,,,20210514.0,,HP,GB,GB,2021,Q2,Elderly
192589201,19258920,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Hyperkalaemia,,2021,Q2,1,I,,20210507.0,20210514,20210514,EXP,,GB-MYLANLABS-2021M1027476,MYLAN,"LEFAS A, BODAGH N, PAN J, VAZIR A.. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS. 2020?13 (12):E238047",86.0,YR,,M,Y,,,20210514.0,,HP,GB,GB,2021,Q2,Elderly
192589201,19258920,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Hypotension,,2021,Q2,1,I,,20210507.0,20210514,20210514,EXP,,GB-MYLANLABS-2021M1027476,MYLAN,"LEFAS A, BODAGH N, PAN J, VAZIR A.. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS. 2020?13 (12):E238047",86.0,YR,,M,Y,,,20210514.0,,HP,GB,GB,2021,Q2,Elderly
192589201,19258920,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Metabolic acidosis,,2021,Q2,1,I,,20210507.0,20210514,20210514,EXP,,GB-MYLANLABS-2021M1027476,MYLAN,"LEFAS A, BODAGH N, PAN J, VAZIR A.. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS. 2020?13 (12):E238047",86.0,YR,,M,Y,,,20210514.0,,HP,GB,GB,2021,Q2,Elderly
192589201,19258920,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Pericardial haemorrhage,,2021,Q2,1,I,,20210507.0,20210514,20210514,EXP,,GB-MYLANLABS-2021M1027476,MYLAN,"LEFAS A, BODAGH N, PAN J, VAZIR A.. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS. 2020?13 (12):E238047",86.0,YR,,M,Y,,,20210514.0,,HP,GB,GB,2021,Q2,Elderly
192589201,19258920,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Pleural effusion,,2021,Q2,1,I,,20210507.0,20210514,20210514,EXP,,GB-MYLANLABS-2021M1027476,MYLAN,"LEFAS A, BODAGH N, PAN J, VAZIR A.. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS. 2020?13 (12):E238047",86.0,YR,,M,Y,,,20210514.0,,HP,GB,GB,2021,Q2,Elderly
192589201,19258920,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, QD",,,,,,,,5.0,MG,,QD,2021,Q2,Renal failure,,2021,Q2,1,I,,20210507.0,20210514,20210514,EXP,,GB-MYLANLABS-2021M1027476,MYLAN,"LEFAS A, BODAGH N, PAN J, VAZIR A.. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS. 2020?13 (12):E238047",86.0,YR,,M,Y,,,20210514.0,,HP,GB,GB,2021,Q2,Elderly
192629221,19262922,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Urinary tract infection,,2021,Q2,1,I,,20210505.0,20210517,20210517,EXP,,BR-NOVOPROD-811655,NOVO NORDISK,,73.0,YR,,M,Y,,,20210517.0,,MD,BR,BR,2021,Q2,Elderly
192656091,19265609,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,, MC3219,,,10.0,MG,TABLET,QD,2021,Q2,Ketosis,,2021,Q2,1,I,20210113.0,20210426.0,20210517,20210517,EXP,,CN-ASTRAZENECA-2021A373752,ASTRAZENECA,,14976.0,DY,,F,Y,,,20210517.0,,HP,CN,CN,2021,Q2,Elderly
192656091,19265609,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,, MC3219,,,10.0,MG,TABLET,QD,2021,Q2,Ketosis,,2021,Q2,1,I,20210113.0,20210426.0,20210517,20210517,EXP,,CN-ASTRAZENECA-2021A373752,ASTRAZENECA,,14976.0,DY,,F,Y,,,20210517.0,,HP,CN,CN,2021,Q2,Elderly
192678391,19267839,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Cardiac tamponade,,2021,Q2,1,I,,20210507.0,20210517,20210517,EXP,,GB-TEVA-2021-GB-1911052,TEVA,LEFAS A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS.. 2020?13(12):.,86.0,YR,E,M,Y,,,20210517.0,,HP,GB,GB,2021,Q2,Elderly
192678391,19267839,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Drug clearance decreased,,2021,Q2,1,I,,20210507.0,20210517,20210517,EXP,,GB-TEVA-2021-GB-1911052,TEVA,LEFAS A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS.. 2020?13(12):.,86.0,YR,E,M,Y,,,20210517.0,,HP,GB,GB,2021,Q2,Elderly
192678391,19267839,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Drug interaction,,2021,Q2,1,I,,20210507.0,20210517,20210517,EXP,,GB-TEVA-2021-GB-1911052,TEVA,LEFAS A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS.. 2020?13(12):.,86.0,YR,E,M,Y,,,20210517.0,,HP,GB,GB,2021,Q2,Elderly
192678391,19267839,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Fluid overload,,2021,Q2,1,I,,20210507.0,20210517,20210517,EXP,,GB-TEVA-2021-GB-1911052,TEVA,LEFAS A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS.. 2020?13(12):.,86.0,YR,E,M,Y,,,20210517.0,,HP,GB,GB,2021,Q2,Elderly
192678391,19267839,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Hyperkalaemia,,2021,Q2,1,I,,20210507.0,20210517,20210517,EXP,,GB-TEVA-2021-GB-1911052,TEVA,LEFAS A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS.. 2020?13(12):.,86.0,YR,E,M,Y,,,20210517.0,,HP,GB,GB,2021,Q2,Elderly
192678391,19267839,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Hypotension,,2021,Q2,1,I,,20210507.0,20210517,20210517,EXP,,GB-TEVA-2021-GB-1911052,TEVA,LEFAS A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS.. 2020?13(12):.,86.0,YR,E,M,Y,,,20210517.0,,HP,GB,GB,2021,Q2,Elderly
192678391,19267839,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Metabolic acidosis,,2021,Q2,1,I,,20210507.0,20210517,20210517,EXP,,GB-TEVA-2021-GB-1911052,TEVA,LEFAS A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS.. 2020?13(12):.,86.0,YR,E,M,Y,,,20210517.0,,HP,GB,GB,2021,Q2,Elderly
192678391,19267839,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Pericardial haemorrhage,,2021,Q2,1,I,,20210507.0,20210517,20210517,EXP,,GB-TEVA-2021-GB-1911052,TEVA,LEFAS A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS.. 2020?13(12):.,86.0,YR,E,M,Y,,,20210517.0,,HP,GB,GB,2021,Q2,Elderly
192678391,19267839,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Pleural effusion,,2021,Q2,1,I,,20210507.0,20210517,20210517,EXP,,GB-TEVA-2021-GB-1911052,TEVA,LEFAS A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS.. 2020?13(12):.,86.0,YR,E,M,Y,,,20210517.0,,HP,GB,GB,2021,Q2,Elderly
192678391,19267839,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,5 MG,,,,,,,,5.0,MG,,,2021,Q2,Renal failure,,2021,Q2,1,I,,20210507.0,20210517,20210517,EXP,,GB-TEVA-2021-GB-1911052,TEVA,LEFAS A. CARDIAC TAMPONADE FROM ANTICOAGULANT?RELATED SPONTANEOUS HAEMOPERICARDIUM IN A PATIENT WITH ISCHAEMIC CARDIOMYOPATHY AND HEART FAILURE.. BMJ CASE REPORTS.. 2020?13(12):.,86.0,YR,E,M,Y,,,20210517.0,,HP,GB,GB,2021,Q2,Elderly
192722651,19272265,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5/1000 MG (2X / DAY),,,,, UNKNOWN,,,,,,,2021,Q2,Acute myocardial infarction,,2021,Q2,1,I,201810.0,20210508.0,20210519,20210519,EXP,,BR-NOVOPROD-812497,NOVO NORDISK,,72.0,YR,,M,Y,82.0,KG,20210519.0,,MD,BR,BR,2021,Q2,Elderly
192756431,19275643,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210407.0,20210519,20210519,EXP,,BR-NOVOPROD-812602,NOVO NORDISK,,52.0,YR,,M,Y,103.7,KG,20210519.0,,MD,BR,BR,2021,Q2,Adult
192756431,19275643,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,, UNKNOWN,,,,,,,2021,Q2,Surgery,,2021,Q2,1,I,,20210407.0,20210519,20210519,EXP,,BR-NOVOPROD-812602,NOVO NORDISK,,52.0,YR,,M,Y,103.7,KG,20210519.0,,MD,BR,BR,2021,Q2,Adult
192790651,19279065,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210513.0,20210520,20210520,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202105006944,ELI LILLY AND CO,,57.0,YR,,F,Y,70.0,KG,20210520.0,,CN,CN,CN,2021,Q2,Adult
192799231,19279923,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20210511.0,20210520,20210520,EXP,,CN-ASTRAZENECA-2021A427450,ASTRAZENECA,,50.0,YR,,F,Y,,,20210520.0,,MD,CN,CN,2021,Q2,Adult
192799241,19279924,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20210511.0,20210520,20210520,EXP,,CN-ASTRAZENECA-2021A427454,ASTRAZENECA,,51.0,YR,,M,Y,100.0,KG,20210520.0,,HP,CN,CN,2021,Q2,Adult
192799281,19279928,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20210511.0,20210520,20210520,EXP,,CN-ASTRAZENECA-2021A427451,ASTRAZENECA,,55.0,YR,,M,Y,,,20210520.0,,MD,CN,CN,2021,Q2,Adult
192820091,19282009,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Arthralgia,,2021,Q2,1,I,,20210511.0,20210521,20210521,EXP,,CA-APOTEX-2021AP012016,APOTEX,,68.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Elderly
192820091,19282009,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Bursitis,,2021,Q2,1,I,,20210511.0,20210521,20210521,EXP,,CA-APOTEX-2021AP012016,APOTEX,,68.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Elderly
192820091,19282009,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Eyelid irritation,,2021,Q2,1,I,,20210511.0,20210521,20210521,EXP,,CA-APOTEX-2021AP012016,APOTEX,,68.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Elderly
192820091,19282009,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Pleural effusion,,2021,Q2,1,I,,20210511.0,20210521,20210521,EXP,,CA-APOTEX-2021AP012016,APOTEX,,68.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Elderly
192903131,19290313,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Fall,,2021,Q2,1,I,,20210427.0,20210522,20210522,EXP,,NVSC2021PT097165,NOVARTIS,,82.0,YR,,F,Y,,,20210522.0,,CN,COUNTRY NOT SPECIFIED,PT,2021,Q2,Elderly
192903131,19290313,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Rib fracture,,2021,Q2,1,I,,20210427.0,20210522,20210522,EXP,,NVSC2021PT097165,NOVARTIS,,82.0,YR,,F,Y,,,20210522.0,,CN,COUNTRY NOT SPECIFIED,PT,2021,Q2,Elderly
192903131,19290313,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Soft tissue infection,,2021,Q2,1,I,,20210427.0,20210522,20210522,EXP,,NVSC2021PT097165,NOVARTIS,,82.0,YR,,F,Y,,,20210522.0,,CN,COUNTRY NOT SPECIFIED,PT,2021,Q2,Elderly
192991641,19299164,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,D,,,,10.0,MG,,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210523.0,,20210524,20210524,DIR,,,FDA-CTU,,68.0,YR,,M,N,100.9,KG,20210524.0,N,PH,US,US,2021,Q2,Elderly
193041112,19304111,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,,,2021,Q2,Blood pressure decreased,,2021,Q2,2,F,201911.0,20210614.0,20210525,20210622,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210622.0,,HP,PL,PL,2021,Q2,Elderly
193041112,19304111,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,,,2021,Q2,Concomitant disease aggravated,,2021,Q2,2,F,201911.0,20210614.0,20210525,20210622,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210622.0,,HP,PL,PL,2021,Q2,Elderly
193041112,19304111,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,,,2021,Q2,Ejection fraction decreased,,2021,Q2,2,F,201911.0,20210614.0,20210525,20210622,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210622.0,,HP,PL,PL,2021,Q2,Elderly
193041112,19304111,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,,,2021,Q2,Glomerular filtration rate decreased,,2021,Q2,2,F,201911.0,20210614.0,20210525,20210622,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210622.0,,HP,PL,PL,2021,Q2,Elderly
193041112,19304111,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,,,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,2,F,201911.0,20210614.0,20210525,20210622,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210622.0,,HP,PL,PL,2021,Q2,Elderly
193041112,19304111,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,,,2021,Q2,Haemoglobin decreased,,2021,Q2,2,F,201911.0,20210614.0,20210525,20210622,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210622.0,,HP,PL,PL,2021,Q2,Elderly
193041112,19304111,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,,,2021,Q2,Heart rate decreased,,2021,Q2,2,F,201911.0,20210614.0,20210525,20210622,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210622.0,,HP,PL,PL,2021,Q2,Elderly
193041112,19304111,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,,,2021,Q2,Mitral valve calcification,,2021,Q2,2,F,201911.0,20210614.0,20210525,20210622,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210622.0,,HP,PL,PL,2021,Q2,Elderly
193041112,19304111,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,,,2021,Q2,Mitral valve incompetence,,2021,Q2,2,F,201911.0,20210614.0,20210525,20210622,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210622.0,,HP,PL,PL,2021,Q2,Elderly
193041112,19304111,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,,,2021,Q2,Mitral valve thickening,,2021,Q2,2,F,201911.0,20210614.0,20210525,20210622,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210622.0,,HP,PL,PL,2021,Q2,Elderly
193041112,19304111,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,,,2021,Q2,N-terminal prohormone brain natriuretic peptide increased,,2021,Q2,2,F,201911.0,20210614.0,20210525,20210622,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210622.0,,HP,PL,PL,2021,Q2,Elderly
193041112,19304111,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,,,2021,Q2,Platelet count decreased,,2021,Q2,2,F,201911.0,20210614.0,20210525,20210622,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210622.0,,HP,PL,PL,2021,Q2,Elderly
193041112,19304111,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,,,2021,Q2,Pulmonary oedema,,2021,Q2,2,F,201911.0,20210614.0,20210525,20210622,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210622.0,,HP,PL,PL,2021,Q2,Elderly
193169431,19316943,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,,10.0,MG,TABLET,,2021,Q2,Euglycaemic diabetic ketoacidosis,,2021,Q2,1,I,,20210423.0,20210527,20210527,EXP,,AE-ASTRAZENECA-2021A467286,ASTRAZENECA,,65.0,YR,,F,Y,,,20210527.0,,HP,AE,AE,2021,Q2,Elderly
193173511,19317351,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210515.0,20210518.0,20210527,20210527,EXP,,GB-ASTRAZENECA-2021A441426,ASTRAZENECA,,57.0,YR,,M,Y,82.5,KG,20210527.0,,PH,GB,GB,2021,Q2,Adult
193173521,19317352,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10,,,Y,,,,,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210517.0,20210519.0,20210527,20210527,EXP,,GB-ASTRAZENECA-2021A445766,ASTRAZENECA,,73.0,YR,,F,Y,,,20210527.0,,HP,GB,GB,2021,Q2,Elderly
193216291,19321629,24,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,TABLET,QD,2021,Q2,Diarrhoea,,2021,Q2,1,I,202105.0,20210517.0,20210528,20210528,EXP,,IE-JNJFOC-20210536773,JOHNSON AND JOHNSON,,67.0,YR,E,F,Y,,,20210528.0,,HP,IE,IE,2021,Q2,Elderly
193216291,19321629,24,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,TABLET,QD,2021,Q2,Liver disorder,,2021,Q2,1,I,202105.0,20210517.0,20210528,20210528,EXP,,IE-JNJFOC-20210536773,JOHNSON AND JOHNSON,,67.0,YR,E,F,Y,,,20210528.0,,HP,IE,IE,2021,Q2,Elderly
193216291,19321629,24,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,TABLET,QD,2021,Q2,Osteomyelitis,,2021,Q2,1,I,202105.0,20210517.0,20210528,20210528,EXP,,IE-JNJFOC-20210536773,JOHNSON AND JOHNSON,,67.0,YR,E,F,Y,,,20210528.0,,HP,IE,IE,2021,Q2,Elderly
193216291,19321629,24,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,TABLET,QD,2021,Q2,Pancreatitis,,2021,Q2,1,I,202105.0,20210517.0,20210528,20210528,EXP,,IE-JNJFOC-20210536773,JOHNSON AND JOHNSON,,67.0,YR,E,F,Y,,,20210528.0,,HP,IE,IE,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Back pain,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Confusional state,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Coordination abnormal,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Depressed level of consciousness,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Feeling abnormal,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Impaired work ability,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Intervertebral disc degeneration,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Knee arthroplasty,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Movement disorder,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Muscle contracture,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Nerve compression,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Radiculopathy,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Renal disorder,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Somnolence,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193275001,19327500,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Speech disorder,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,ES-SA-2021SA169742,SANOFI AVENTIS,,80.0,YR,E,F,Y,65.0,KG,20210528.0,,CN,ES,ES,2021,Q2,Elderly
193516691,19351669,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,, MF2885,,,10.0,MG,TABLET,QD,2021,Q2,Ketoacidosis,,2021,Q2,1,I,20210502.0,20210522.0,20210531,20210531,EXP,,CN-ASTRAZENECA-2021A462716,ASTRAZENECA,,47.0,YR,,F,Y,47.0,KG,20210531.0,,HP,CN,CN,2021,Q2,Adult
193582131,19358213,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,5 MILLIGRAM,,,,,,,,5.0,MG,,,2021,Q2,Contraindicated product administered,,2021,Q2,1,I,,20210513.0,20210602,20210602,PER,,US-009507513-2105USA004232,MERCK,"KUHADIYA ND, ISRAA M. EFFECTS OF CONCOMITANT COMBINATION OF SGLT?2 INHIBITOR AND GLP?1 RECEPTOR AGONIST ON RENAL OUTCOMES IN T2D WITH EGFR BELOW 30 AND MACROALBUMINURIA: A CASE SERIES. CLINICAL CASE REPORTS. 2021?9(9):2310?6",62.0,YR,,M,Y,87.1,KG,20210602.0,,HP,US,US,2021,Q2,Adult
193583911,19358391,6,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10MG+1G BID,,,,, UNKNOWN,,,,,,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,202012.0,20210521.0,20210602,20210602,EXP,,BR-NOVOPROD-816210,NOVO NORDISK,,63.0,YR,,M,Y,118.0,KG,20210602.0,,MD,BR,BR,2021,Q2,Adult
193583911,19358391,6,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10MG+1G BID,,,,, UNKNOWN,,,,,,,2021,Q2,COVID-19,,2021,Q2,1,I,202012.0,20210521.0,20210602,20210602,EXP,,BR-NOVOPROD-816210,NOVO NORDISK,,63.0,YR,,M,Y,118.0,KG,20210602.0,,MD,BR,BR,2021,Q2,Adult
193583911,19358391,6,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10MG+1G BID,,,,, UNKNOWN,,,,,,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,202012.0,20210521.0,20210602,20210602,EXP,,BR-NOVOPROD-816210,NOVO NORDISK,,63.0,YR,,M,Y,118.0,KG,20210602.0,,MD,BR,BR,2021,Q2,Adult
193585391,19358539,2,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,2018.0,20210520.0,20210602,20210602,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202105009745,ELI LILLY AND CO,,56.0,YR,,F,Y,123.0,KG,20210602.0,,MD,LV,LV,2021,Q2,Adult
193585391,19358539,2,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,2018.0,20210520.0,20210602,20210602,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202105009745,ELI LILLY AND CO,,56.0,YR,,F,Y,123.0,KG,20210602.0,,MD,LV,LV,2021,Q2,Adult
193585391,19358539,2,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q2,Diabetic metabolic decompensation,,2021,Q2,1,I,2018.0,20210520.0,20210602,20210602,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202105009745,ELI LILLY AND CO,,56.0,YR,,F,Y,123.0,KG,20210602.0,,MD,LV,LV,2021,Q2,Adult
193585391,19358539,2,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q2,Drug ineffective,,2021,Q2,1,I,2018.0,20210520.0,20210602,20210602,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202105009745,ELI LILLY AND CO,,56.0,YR,,F,Y,123.0,KG,20210602.0,,MD,LV,LV,2021,Q2,Adult
193585391,19358539,2,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,1,I,2018.0,20210520.0,20210602,20210602,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202105009745,ELI LILLY AND CO,,56.0,YR,,F,Y,123.0,KG,20210602.0,,MD,LV,LV,2021,Q2,Adult
193585391,19358539,2,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q2,Urinary tract infection,,2021,Q2,1,I,2018.0,20210520.0,20210602,20210602,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202105009745,ELI LILLY AND CO,,56.0,YR,,F,Y,123.0,KG,20210602.0,,MD,LV,LV,2021,Q2,Adult
193610561,19361056,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,470.0,MG,N,,,,202293.0,10.0,MG,,QD,2021,Q2,Alopecia,,2021,Q2,1,I,,20210526.0,20210602,20210602,EXP,,IE-ASTRAZENECA-2021A468261,ASTRAZENECA,,72.0,YR,,M,Y,79.0,KG,20210602.0,,HP,IE,IE,2021,Q2,Elderly
193610561,19361056,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,470.0,MG,N,,,,202293.0,10.0,MG,,QD,2021,Q2,Breast enlargement,,2021,Q2,1,I,,20210526.0,20210602,20210602,EXP,,IE-ASTRAZENECA-2021A468261,ASTRAZENECA,,72.0,YR,,M,Y,79.0,KG,20210602.0,,HP,IE,IE,2021,Q2,Elderly
193610561,19361056,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,470.0,MG,N,,,,202293.0,10.0,MG,,QD,2021,Q2,Breast tenderness,,2021,Q2,1,I,,20210526.0,20210602,20210602,EXP,,IE-ASTRAZENECA-2021A468261,ASTRAZENECA,,72.0,YR,,M,Y,79.0,KG,20210602.0,,HP,IE,IE,2021,Q2,Elderly
193632122,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Asthenia,,2021,Q2,2,F,202012.0,20210602.0,20210602,20210624,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210624.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Elderly
193632122,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Dyspnoea,,2021,Q2,2,F,202012.0,20210602.0,20210602,20210624,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210624.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Elderly
193632122,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Increased appetite,,2021,Q2,2,F,202012.0,20210602.0,20210602,20210624,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210624.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Elderly
193632122,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Penile abscess,,2021,Q2,2,F,202012.0,20210602.0,20210602,20210624,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210624.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Elderly
193632122,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Product use in unapproved indication,,2021,Q2,2,F,202012.0,20210602.0,20210602,20210624,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210624.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Elderly
193632122,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Ulcer,,2021,Q2,2,F,202012.0,20210602.0,20210602,20210624,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210624.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Elderly
193632122,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Vomiting,,2021,Q2,2,F,202012.0,20210602.0,20210602,20210624,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210624.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q2,Elderly
193697281,19369728,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,, UNK,,,,,,,2021,Q2,Hyperthyroidism,,2021,Q2,1,I,20210503.0,20210527.0,20210603,20210603,EXP,,ES-EXELIXIS-XL18421040902,EXELIXIS,,58.0,YR,,M,Y,70.8,KG,20210603.0,,MD,ES,ES,2021,Q2,Adult
193753451,19375345,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Asthenia,,2021,Q2,1,I,20190305.0,20210525.0,20210604,20210604,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20210604.0,,MD,PT,PT,2021,Q2,Elderly
193753451,19375345,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Blood creatinine abnormal,,2021,Q2,1,I,20190305.0,20210525.0,20210604,20210604,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20210604.0,,MD,PT,PT,2021,Q2,Elderly
193753451,19375345,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Blood urea abnormal,,2021,Q2,1,I,20190305.0,20210525.0,20210604,20210604,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20210604.0,,MD,PT,PT,2021,Q2,Elderly
193753451,19375345,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Bradycardia,,2021,Q2,1,I,20190305.0,20210525.0,20210604,20210604,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20210604.0,,MD,PT,PT,2021,Q2,Elderly
193753451,19375345,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Congestive cardiomyopathy,,2021,Q2,1,I,20190305.0,20210525.0,20210604,20210604,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20210604.0,,MD,PT,PT,2021,Q2,Elderly
193753451,19375345,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Heart sounds abnormal,,2021,Q2,1,I,20190305.0,20210525.0,20210604,20210604,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20210604.0,,MD,PT,PT,2021,Q2,Elderly
193753451,19375345,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Hyperkalaemia,,2021,Q2,1,I,20190305.0,20210525.0,20210604,20210604,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20210604.0,,MD,PT,PT,2021,Q2,Elderly
193753451,19375345,17,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,, UNKNOWN,,,10.0,MG,,QD,2021,Q2,Hypotension,,2021,Q2,1,I,20190305.0,20210525.0,20210604,20210604,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20210604.0,,MD,PT,PT,2021,Q2,Elderly
193818991,19381899,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,, 2102031,,,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210524.0,20210528.0,20210607,20210607,EXP,,CN-ASTRAZENECA-2021A484679,ASTRAZENECA,,13404.0,DY,,M,Y,115.0,KG,20210607.0,,HP,CN,CN,2021,Q2,Elderly
193818991,19381899,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,, 2102031,,,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210524.0,20210528.0,20210607,20210607,EXP,,CN-ASTRAZENECA-2021A484679,ASTRAZENECA,,13404.0,DY,,M,Y,115.0,KG,20210607.0,,HP,CN,CN,2021,Q2,Elderly
193818991,19381899,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,, 2102031,,,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210524.0,20210528.0,20210607,20210607,EXP,,CN-ASTRAZENECA-2021A484679,ASTRAZENECA,,13404.0,DY,,M,Y,115.0,KG,20210607.0,,HP,CN,CN,2021,Q2,Elderly
193819051,19381905,1,PS,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10MG EACH MORNING,,,Y,, UNKNOWN,,202293.0,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210525.0,20210527.0,20210607,20210607,EXP,,GB-ASTRAZENECA-2021A472149,ASTRAZENECA,,73.0,YR,,F,Y,54.0,KG,20210607.0,,PH,GB,GB,2021,Q2,Elderly
193916491,19391649,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNK,,,10.0,MG,,QD,2021,Q2,Atrioventricular block,,2021,Q2,1,I,20210409.0,20210529.0,20210609,20210609,EXP,CN-NMPA-8201011028531202100983,CN-NOVOPROD-817664,NOVO NORDISK,,65.0,YR,,M,Y,76.0,KG,20210609.0,,HP,CN,CN,2021,Q2,Elderly
193916491,19391649,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNK,,,10.0,MG,,QD,2021,Q2,Bradycardia,,2021,Q2,1,I,20210409.0,20210529.0,20210609,20210609,EXP,CN-NMPA-8201011028531202100983,CN-NOVOPROD-817664,NOVO NORDISK,,65.0,YR,,M,Y,76.0,KG,20210609.0,,HP,CN,CN,2021,Q2,Elderly
193997191,19399719,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, H20170206,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Euglycaemic diabetic ketoacidosis,,2021,Q2,1,I,,20210601.0,20210610,20210610,EXP,,CN-ASTRAZENECA-2021A500477,ASTRAZENECA,,31.0,YR,,F,Y,,,20210610.0,,HP,CN,CN,2021,Q2,Young Adult
193997191,19399719,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, H20170206,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Ketoacidosis,,2021,Q2,1,I,,20210601.0,20210610,20210610,EXP,,CN-ASTRAZENECA-2021A500477,ASTRAZENECA,,31.0,YR,,F,Y,,,20210610.0,,HP,CN,CN,2021,Q2,Young Adult
193997191,19399719,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, H20170206,,202293.0,5.0,MG,TABLET,QD,2021,Q2,Euglycaemic diabetic ketoacidosis,,2021,Q2,1,I,,20210601.0,20210610,20210610,EXP,,CN-ASTRAZENECA-2021A500477,ASTRAZENECA,,31.0,YR,,F,Y,,,20210610.0,,HP,CN,CN,2021,Q2,Young Adult
193997191,19399719,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, H20170206,,202293.0,5.0,MG,TABLET,QD,2021,Q2,Ketoacidosis,,2021,Q2,1,I,,20210601.0,20210610,20210610,EXP,,CN-ASTRAZENECA-2021A500477,ASTRAZENECA,,31.0,YR,,F,Y,,,20210610.0,,HP,CN,CN,2021,Q2,Young Adult
193997681,19399768,6,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Benign prostatic hyperplasia,,2021,Q2,1,I,,20210531.0,20210610,20210610,EXP,,BR-NOVOPROD-819131,NOVO NORDISK,,72.0,YR,,M,Y,108.0,KG,20210610.0,,MD,BR,BR,2021,Q2,Elderly
193997681,19399768,6,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210531.0,20210610,20210610,EXP,,BR-NOVOPROD-819131,NOVO NORDISK,,72.0,YR,,M,Y,108.0,KG,20210610.0,,MD,BR,BR,2021,Q2,Elderly
193997681,19399768,6,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Corneal bleeding,,2021,Q2,1,I,,20210531.0,20210610,20210610,EXP,,BR-NOVOPROD-819131,NOVO NORDISK,,72.0,YR,,M,Y,108.0,KG,20210610.0,,MD,BR,BR,2021,Q2,Elderly
193997681,19399768,6,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Fall,,2021,Q2,1,I,,20210531.0,20210610,20210610,EXP,,BR-NOVOPROD-819131,NOVO NORDISK,,72.0,YR,,M,Y,108.0,KG,20210610.0,,MD,BR,BR,2021,Q2,Elderly
193997681,19399768,6,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Fractured coccyx,,2021,Q2,1,I,,20210531.0,20210610,20210610,EXP,,BR-NOVOPROD-819131,NOVO NORDISK,,72.0,YR,,M,Y,108.0,KG,20210610.0,,MD,BR,BR,2021,Q2,Elderly
193997681,19399768,6,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,1,I,,20210531.0,20210610,20210610,EXP,,BR-NOVOPROD-819131,NOVO NORDISK,,72.0,YR,,M,Y,108.0,KG,20210610.0,,MD,BR,BR,2021,Q2,Elderly
193997681,19399768,6,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q2,Obstruction gastric,,2021,Q2,1,I,,20210531.0,20210610,20210610,EXP,,BR-NOVOPROD-819131,NOVO NORDISK,,72.0,YR,,M,Y,108.0,KG,20210610.0,,MD,BR,BR,2021,Q2,Elderly
194072601,19407260,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Acute coronary syndrome,,2021,Q2,1,I,,20210602.0,20210612,20210612,EXP,,CA-TEVA-2021-CA-1919779,TEVA,,56.0,YR,A,M,Y,82.0,KG,20210612.0,,MD,CA,CA,2021,Q2,Adult
194072601,19407260,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Angina unstable,,2021,Q2,1,I,,20210602.0,20210612,20210612,EXP,,CA-TEVA-2021-CA-1919779,TEVA,,56.0,YR,A,M,Y,82.0,KG,20210612.0,,MD,CA,CA,2021,Q2,Adult
194072601,19407260,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood cholesterol increased,,2021,Q2,1,I,,20210602.0,20210612,20210612,EXP,,CA-TEVA-2021-CA-1919779,TEVA,,56.0,YR,A,M,Y,82.0,KG,20210612.0,,MD,CA,CA,2021,Q2,Adult
194072601,19407260,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood creatine phosphokinase increased,,2021,Q2,1,I,,20210602.0,20210612,20210612,EXP,,CA-TEVA-2021-CA-1919779,TEVA,,56.0,YR,A,M,Y,82.0,KG,20210612.0,,MD,CA,CA,2021,Q2,Adult
194072601,19407260,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood parathyroid hormone increased,,2021,Q2,1,I,,20210602.0,20210612,20210612,EXP,,CA-TEVA-2021-CA-1919779,TEVA,,56.0,YR,A,M,Y,82.0,KG,20210612.0,,MD,CA,CA,2021,Q2,Adult
194072601,19407260,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood triglycerides increased,,2021,Q2,1,I,,20210602.0,20210612,20210612,EXP,,CA-TEVA-2021-CA-1919779,TEVA,,56.0,YR,A,M,Y,82.0,KG,20210612.0,,MD,CA,CA,2021,Q2,Adult
194072601,19407260,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Coronary artery stenosis,,2021,Q2,1,I,,20210602.0,20210612,20210612,EXP,,CA-TEVA-2021-CA-1919779,TEVA,,56.0,YR,A,M,Y,82.0,KG,20210612.0,,MD,CA,CA,2021,Q2,Adult
194072601,19407260,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,High density lipoprotein decreased,,2021,Q2,1,I,,20210602.0,20210612,20210612,EXP,,CA-TEVA-2021-CA-1919779,TEVA,,56.0,YR,A,M,Y,82.0,KG,20210612.0,,MD,CA,CA,2021,Q2,Adult
194072601,19407260,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Low density lipoprotein increased,,2021,Q2,1,I,,20210602.0,20210612,20210612,EXP,,CA-TEVA-2021-CA-1919779,TEVA,,56.0,YR,A,M,Y,82.0,KG,20210612.0,,MD,CA,CA,2021,Q2,Adult
194072601,19407260,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Muscular weakness,,2021,Q2,1,I,,20210602.0,20210612,20210612,EXP,,CA-TEVA-2021-CA-1919779,TEVA,,56.0,YR,A,M,Y,82.0,KG,20210612.0,,MD,CA,CA,2021,Q2,Adult
194072601,19407260,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Myalgia,,2021,Q2,1,I,,20210602.0,20210612,20210612,EXP,,CA-TEVA-2021-CA-1919779,TEVA,,56.0,YR,A,M,Y,82.0,KG,20210612.0,,MD,CA,CA,2021,Q2,Adult
194072601,19407260,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Myopathy,,2021,Q2,1,I,,20210602.0,20210612,20210612,EXP,,CA-TEVA-2021-CA-1919779,TEVA,,56.0,YR,A,M,Y,82.0,KG,20210612.0,,MD,CA,CA,2021,Q2,Adult
194072601,19407260,7,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q2,Total cholesterol/HDL ratio increased,,2021,Q2,1,I,,20210602.0,20210612,20210612,EXP,,CA-TEVA-2021-CA-1919779,TEVA,,56.0,YR,A,M,Y,82.0,KG,20210612.0,,MD,CA,CA,2021,Q2,Adult
194090161,19409016,6,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q2,Spinal compression fracture,,2021,Q2,1,I,,20210531.0,20210613,20210613,EXP,,NVSJ2021JP008703,NOVARTIS,,95.0,YR,,F,Y,38.0,KG,20210614.0,,MD,JP,JP,2021,Q2,Elderly
194123701,19412370,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,, 2011203,,,10.0,MG,TABLET,QD,2021,Q2,Ketosis,,2021,Q2,1,I,20210504.0,20210522.0,20210614,20210614,EXP,,CN-ASTRAZENECA-2021A467715,ASTRAZENECA,,7196.0,DY,,M,Y,102.0,KG,20210614.0,,HP,CN,CN,2021,Q2,Elderly
194123762,19412376,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,ONE TABLET A DAY,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Ketoacidosis,,2021,Q2,2,F,20210523.0,20210617.0,20210614,20210625,EXP,,CN-ASTRAZENECA-2021A507638,ASTRAZENECA,,54.0,YR,,F,Y,104.0,KG,20210625.0,,,CN,CN,2021,Q2,Adult
194154513,19415451,2,SS,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,U,,,,,,,TABLET,,2021,Q2,Hyponatraemia,,2021,Q2,3,F,,20210604.0,20210615,20210616,EXP,,CA-APOTEX-2021AP013956,APOTEX,,79.0,YR,,F,Y,,,20210616.0,,CN,CA,CA,2021,Q2,Elderly
194174481,19417448,1,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q2,Gangrene,,2021,Q2,1,I,,20210531.0,20210615,20210615,EXP,,KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-300199,RANBAXY,"MOON JY, LEE MR, KIM JH, HA GW. FOURNIER GANGRENE IN A PATIENT WITH TYPE 2 DIABETES MELLITUS TREATED WITH DAPAGLIFLOZIN: A CASE REPORT. ANN COLOPROCTOL. 2021?28:52",66.0,YR,,M,Y,,,20210615.0,,HP,KR,KR,2021,Q2,Elderly
194174931,19417493,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q2,Pruritus genital,,2021,Q2,1,I,20210527.0,20210608.0,20210615,20210615,EXP,,SG-EMD SERONO-9244044,EMD SERONO INC,,56.0,YR,A,M,Y,,,20210615.0,,HP,SG,SG,2021,Q2,Adult
194206271,19420627,2,SS,DAPAGLIFLOZIN/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,TABLET,,2021,Q2,Hyponatraemia,,2021,Q2,1,I,,20210607.0,20210616,20210616,EXP,,CA-TEVA-2021-CA-1921692,TEVA,,79.0,YR,E,F,Y,,,20210616.0,,HP,CA,CA,2021,Q2,Elderly
194220373,19422037,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2021,Q2,Hypertension,,2021,Q2,3,F,20200715.0,20210617.0,20210616,20210623,EXP,,ES-ROCHE-2737089,ROCHE,,69.0,YR,,M,Y,84.9,KG,20210623.0,,MD,ES,ES,2021,Q2,Elderly
194220373,19422037,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2021,Q2,Liver function test increased,,2021,Q2,3,F,20200715.0,20210617.0,20210616,20210623,EXP,,ES-ROCHE-2737089,ROCHE,,69.0,YR,,M,Y,84.9,KG,20210623.0,,MD,ES,ES,2021,Q2,Elderly
194220373,19422037,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2021,Q2,Renal failure,,2021,Q2,3,F,20200715.0,20210617.0,20210616,20210623,EXP,,ES-ROCHE-2737089,ROCHE,,69.0,YR,,M,Y,84.9,KG,20210623.0,,MD,ES,ES,2021,Q2,Elderly
194291271,19429127,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,,2021,Q2,Blood pressure decreased,,2021,Q2,1,I,,20210603.0,20210617,20210617,EXP,PL-EMA-DD-20210422-KAKWANI_D-113848,PL-ACCORD-228130,ACCORD,,70.0,YR,,M,Y,,,20210617.0,,MD,PL,PL,2021,Q2,Elderly
194291271,19429127,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,,2021,Q2,COVID-19 pneumonia,,2021,Q2,1,I,,20210603.0,20210617,20210617,EXP,PL-EMA-DD-20210422-KAKWANI_D-113848,PL-ACCORD-228130,ACCORD,,70.0,YR,,M,Y,,,20210617.0,,MD,PL,PL,2021,Q2,Elderly
194291271,19429127,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,,2021,Q2,Cardiac failure chronic,,2021,Q2,1,I,,20210603.0,20210617,20210617,EXP,PL-EMA-DD-20210422-KAKWANI_D-113848,PL-ACCORD-228130,ACCORD,,70.0,YR,,M,Y,,,20210617.0,,MD,PL,PL,2021,Q2,Elderly
194291271,19429127,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,,2021,Q2,Dyspnoea exertional,,2021,Q2,1,I,,20210603.0,20210617,20210617,EXP,PL-EMA-DD-20210422-KAKWANI_D-113848,PL-ACCORD-228130,ACCORD,,70.0,YR,,M,Y,,,20210617.0,,MD,PL,PL,2021,Q2,Elderly
194291271,19429127,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,,2021,Q2,Glomerular filtration rate abnormal,,2021,Q2,1,I,,20210603.0,20210617,20210617,EXP,PL-EMA-DD-20210422-KAKWANI_D-113848,PL-ACCORD-228130,ACCORD,,70.0,YR,,M,Y,,,20210617.0,,MD,PL,PL,2021,Q2,Elderly
194291271,19429127,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,,2021,Q2,Hypertrophy,,2021,Q2,1,I,,20210603.0,20210617,20210617,EXP,PL-EMA-DD-20210422-KAKWANI_D-113848,PL-ACCORD-228130,ACCORD,,70.0,YR,,M,Y,,,20210617.0,,MD,PL,PL,2021,Q2,Elderly
194291271,19429127,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,,2021,Q2,N-terminal prohormone brain natriuretic peptide abnormal,,2021,Q2,1,I,,20210603.0,20210617,20210617,EXP,PL-EMA-DD-20210422-KAKWANI_D-113848,PL-ACCORD-228130,ACCORD,,70.0,YR,,M,Y,,,20210617.0,,MD,PL,PL,2021,Q2,Elderly
194291271,19429127,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,,2021,Q2,Renal atrophy,,2021,Q2,1,I,,20210603.0,20210617,20210617,EXP,PL-EMA-DD-20210422-KAKWANI_D-113848,PL-ACCORD-228130,ACCORD,,70.0,YR,,M,Y,,,20210617.0,,MD,PL,PL,2021,Q2,Elderly
194291271,19429127,12,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,1.0,DF,TABLET,,2021,Q2,Urosepsis,,2021,Q2,1,I,,20210603.0,20210617,20210617,EXP,PL-EMA-DD-20210422-KAKWANI_D-113848,PL-ACCORD-228130,ACCORD,,70.0,YR,,M,Y,,,20210617.0,,MD,PL,PL,2021,Q2,Elderly
194333951,19433395,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM 1 EVERY 2 WEEKS,,,U,,,,,10.0,MG,,,2021,Q2,Arteriosclerosis coronary artery,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM 1 EVERY 2 WEEKS,,,U,,,,,10.0,MG,,,2021,Q2,Chest pain,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM 1 EVERY 2 WEEKS,,,U,,,,,10.0,MG,,,2021,Q2,Dyspnoea exertional,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,7,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM 1 EVERY 2 WEEKS,,,U,,,,,10.0,MG,,,2021,Q2,Pneumonia,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,8,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM 1 EVERY 2 WEEKS,,,U,,,,,50.0,MG,,,2021,Q2,Arteriosclerosis coronary artery,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,8,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM 1 EVERY 2 WEEKS,,,U,,,,,50.0,MG,,,2021,Q2,Chest pain,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,8,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM 1 EVERY 2 WEEKS,,,U,,,,,50.0,MG,,,2021,Q2,Dyspnoea exertional,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194333951,19433395,8,C,Dapagliflozin propanediol monohydrate,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MILLIGRAM 1 EVERY 2 WEEKS,,,U,,,,,50.0,MG,,,2021,Q2,Pneumonia,,2021,Q2,1,I,,20210607.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024806,AUROBINDO,,71.0,YR,,M,Y,,,20210618.0,,CN,CA,CA,2021,Q2,Elderly
194360011,19436001,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,30.0,MG,U,, MJ3055,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210527.0,20210611.0,20210618,20210618,EXP,,CN-ASTRAZENECA-2021A527739,ASTRAZENECA,,24472.0,DY,,F,Y,48.0,KG,20210618.0,,HP,CN,CN,2021,Q2,Elderly
194360011,19436001,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,30.0,MG,U,, MJ3055,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Subarachnoid haemorrhage,,2021,Q2,1,I,20210527.0,20210611.0,20210618,20210618,EXP,,CN-ASTRAZENECA-2021A527739,ASTRAZENECA,,24472.0,DY,,F,Y,48.0,KG,20210618.0,,HP,CN,CN,2021,Q2,Elderly
194361091,19436109,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q2,Immune-mediated hepatitis,,2021,Q2,1,I,,20210605.0,20210618,20210618,EXP,CA-MHPD-E2B-03498902,CA-ACCORD-227929,ACCORD,,65.0,YR,,M,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Elderly
194365661,19436566,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2021,Q2,Euglycaemic diabetic ketoacidosis,,2021,Q2,1,I,,20210609.0,20210618,20210618,EXP,,SG-ASTRAZENECA-2021A516916,ASTRAZENECA,TAN KT. THREE CASES OF EUGLYCAEMIC DIABETIC KETOACIDOSIS RELATED TO THE USE OF SODIUM?GLUCOSE CO?TRANSPORTER?2 INHIBITORS AND CALORIE RESTRICTION. SINGAPORE MED J 2021?62(3):153?154.,60.0,YR,,,Y,104.0,KG,20210618.0,,HP,SG,SG,2021,Q2,Adult
194365671,19436567,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MGS,,,,,,,,,,TABLET,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20210611.0,20210618,20210618,EXP,,GB-ASTRAZENECA-2021A520007,ASTRAZENECA,,63.0,YR,,F,Y,59.0,KG,20210618.0,,,GB,GB,2021,Q2,Adult
194365731,19436573,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2021,Q2,Euglycaemic diabetic ketoacidosis,,2021,Q2,1,I,,20210609.0,20210618,20210618,EXP,,SG-ASTRAZENECA-2021A516931,ASTRAZENECA,TAN KT. THREE CASES OF EUGLYCAEMIC DIABETIC KETOACIDOSIS RELATED TO THE USE OF SODIUM?GLUCOSE CO?TRANSPORTER?2 INHIBITORS AND CALORIE RESTRICTION. SINGAPORE MED J 2021?62(3):153?154.,39.0,YR,,,Y,83.5,KG,20210618.0,,HP,SG,SG,2021,Q2,Adult
194383413,19438341,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Balance disorder,,2021,Q2,3,F,20210605.0,20210611.0,20210618,20210624,EXP,GB-MHRA-EYC 00252596,GB-JNJFOC-20210629393,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,101.6,KG,20210624.0,,CN,GB,GB,2021,Q2,Elderly
194383413,19438341,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Dizziness,,2021,Q2,3,F,20210605.0,20210611.0,20210618,20210624,EXP,GB-MHRA-EYC 00252596,GB-JNJFOC-20210629393,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,101.6,KG,20210624.0,,CN,GB,GB,2021,Q2,Elderly
194383413,19438341,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Drug ineffective,,2021,Q2,3,F,20210605.0,20210611.0,20210618,20210624,EXP,GB-MHRA-EYC 00252596,GB-JNJFOC-20210629393,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,101.6,KG,20210624.0,,CN,GB,GB,2021,Q2,Elderly
194383413,19438341,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Headache,,2021,Q2,3,F,20210605.0,20210611.0,20210618,20210624,EXP,GB-MHRA-EYC 00252596,GB-JNJFOC-20210629393,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,101.6,KG,20210624.0,,CN,GB,GB,2021,Q2,Elderly
194383491,19438349,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10MG,,,N,, RR323,,202293.0,,,TABLET,,2021,Q2,Peripheral arterial occlusive disease,,2021,Q2,1,I,20210605.0,20210615.0,20210618,20210618,EXP,,GB-ASTRAZENECA-2021A531564,ASTRAZENECA,,72.0,YR,,M,Y,96.0,KG,20210618.0,,MD,GB,GB,2021,Q2,Elderly
194386011,19438601,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,1.0,DF,,QD,2021,Q2,Cardiac failure acute,,2021,Q2,1,I,202012.0,20210607.0,20210619,20210619,EXP,,NVSC2021VN130220,NOVARTIS,,62.0,YR,,M,Y,,,20210619.0,,MD,VN,VN,2021,Q2,Adult
194386011,19438601,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,1.0,DF,,QD,2021,Q2,Cardiac ventricular thrombosis,,2021,Q2,1,I,202012.0,20210607.0,20210619,20210619,EXP,,NVSC2021VN130220,NOVARTIS,,62.0,YR,,M,Y,,,20210619.0,,MD,VN,VN,2021,Q2,Adult
194386011,19438601,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,1.0,DF,,QD,2021,Q2,Dyspnoea,,2021,Q2,1,I,202012.0,20210607.0,20210619,20210619,EXP,,NVSC2021VN130220,NOVARTIS,,62.0,YR,,M,Y,,,20210619.0,,MD,VN,VN,2021,Q2,Adult
194386011,19438601,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,1.0,DF,,QD,2021,Q2,Oedema peripheral,,2021,Q2,1,I,202012.0,20210607.0,20210619,20210619,EXP,,NVSC2021VN130220,NOVARTIS,,62.0,YR,,M,Y,,,20210619.0,,MD,VN,VN,2021,Q2,Adult
194386011,19438601,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,1.0,DF,,QD,2021,Q2,Pleural effusion,,2021,Q2,1,I,202012.0,20210607.0,20210619,20210619,EXP,,NVSC2021VN130220,NOVARTIS,,62.0,YR,,M,Y,,,20210619.0,,MD,VN,VN,2021,Q2,Adult
194386011,19438601,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,1.0,DF,,QD,2021,Q2,Underdose,,2021,Q2,1,I,202012.0,20210607.0,20210619,20210619,EXP,,NVSC2021VN130220,NOVARTIS,,62.0,YR,,M,Y,,,20210619.0,,MD,VN,VN,2021,Q2,Adult
194386011,19438601,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,1.0,DF,,QD,2021,Q2,Wrong technique in product usage process,,2021,Q2,1,I,202012.0,20210607.0,20210619,20210619,EXP,,NVSC2021VN130220,NOVARTIS,,62.0,YR,,M,Y,,,20210619.0,,MD,VN,VN,2021,Q2,Adult
194392641,19439264,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q2,Immune-mediated hepatitis,,2021,Q2,1,I,,20210605.0,20210619,20210619,EXP,CA-MHPD-E2B_03498871,CA-ACCORD-227905,ACCORD,,65.0,YR,,M,Y,,,20210619.0,,MD,CA,CA,2021,Q2,Elderly
194402871,19440287,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5MG EVERY 12 HOURS,,,,,,,,,,TABLET,,2021,Q2,Paranoia,,2021,Q2,1,I,20210514.0,20210527.0,20210621,20210621,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-002000,ACADIA PHARMACEUTICALS,,70.0,YR,,F,Y,,,20210621.0,,HP,US,US,2021,Q2,Elderly
194411121,19441112,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Balance disorder,,2021,Q2,1,I,20210605.0,20210611.0,20210621,20210621,EXP,GB-MHRA-EYC 00252596,GB-TEVA-2021-GB-1923679,TEVA,,70.0,YR,E,M,Y,101.6,KG,20210621.0,,CN,GB,GB,2021,Q2,Elderly
194411121,19441112,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,1,I,20210605.0,20210611.0,20210621,20210621,EXP,GB-MHRA-EYC 00252596,GB-TEVA-2021-GB-1923679,TEVA,,70.0,YR,E,M,Y,101.6,KG,20210621.0,,CN,GB,GB,2021,Q2,Elderly
194411121,19441112,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,1,I,20210605.0,20210611.0,20210621,20210621,EXP,GB-MHRA-EYC 00252596,GB-TEVA-2021-GB-1923679,TEVA,,70.0,YR,E,M,Y,101.6,KG,20210621.0,,CN,GB,GB,2021,Q2,Elderly
194411121,19441112,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q2,Headache,,2021,Q2,1,I,20210605.0,20210611.0,20210621,20210621,EXP,GB-MHRA-EYC 00252596,GB-TEVA-2021-GB-1923679,TEVA,,70.0,YR,E,M,Y,101.6,KG,20210621.0,,CN,GB,GB,2021,Q2,Elderly
194422741,19442274,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,90.0,MG,U,, 2101253,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Condition aggravated,,2021,Q2,1,I,20210610.0,20210613.0,20210621,20210621,EXP,,CN-ASTRAZENECA-2021A534321,ASTRAZENECA,,15339.0,DY,,M,Y,75.0,KG,20210621.0,,HP,CN,CN,2021,Q2,Elderly
194422741,19442274,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,90.0,MG,U,, 2101253,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Ketoacidosis,,2021,Q2,1,I,20210610.0,20210613.0,20210621,20210621,EXP,,CN-ASTRAZENECA-2021A534321,ASTRAZENECA,,15339.0,DY,,M,Y,75.0,KG,20210621.0,,HP,CN,CN,2021,Q2,Elderly
194422741,19442274,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,90.0,MG,U,, 2101253,,202293.0,10.0,MG,TABLET,QD,2021,Q2,Respiratory alkalosis,,2021,Q2,1,I,20210610.0,20210613.0,20210621,20210621,EXP,,CN-ASTRAZENECA-2021A534321,ASTRAZENECA,,15339.0,DY,,M,Y,75.0,KG,20210621.0,,HP,CN,CN,2021,Q2,Elderly
194429371,19442937,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q2,Euglycaemic diabetic ketoacidosis,,2021,Q2,1,I,,20210616.0,20210621,20210621,EXP,,SI-ASTRAZENECA-2021A538742,ASTRAZENECA,,49.0,YR,,M,Y,,,20210621.0,,HP,SI,SI,2021,Q2,Adult
194488551,19448855,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10.0MG UNKNOWN,,,U,,,,,10.0,MG,,,2021,Q2,Ketoacidosis,,2021,Q2,1,I,20210211.0,20210617.0,20210622,20210622,EXP,,DE-ASTRAZENECA-2021A538352,ASTRAZENECA,,71.0,YR,,F,Y,,,20210622.0,,,DE,DE,2021,Q2,Elderly
194571001,19457100,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG ONCE/SINGLE ADMINISTRATION,,,Y,, UNKNOWN,,202293.0,10.0,MG,TABLET,,2021,Q2,Decreased appetite,,2021,Q2,1,I,20210528.0,20210618.0,20210624,20210624,EXP,,DE-ASTRAZENECA-2021A540103,ASTRAZENECA,,23558.0,DY,,F,Y,82.0,KG,20210624.0,,MD,DE,DE,2021,Q2,Elderly
194571001,19457100,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG ONCE/SINGLE ADMINISTRATION,,,Y,, UNKNOWN,,202293.0,10.0,MG,TABLET,,2021,Q2,Ketoacidosis,,2021,Q2,1,I,20210528.0,20210618.0,20210624,20210624,EXP,,DE-ASTRAZENECA-2021A540103,ASTRAZENECA,,23558.0,DY,,F,Y,82.0,KG,20210624.0,,MD,DE,DE,2021,Q2,Elderly
194571021,19457102,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG ONCE/SINGLE ADMINISTRATION,,,Y,,,,,10.0,MG,TABLET,,2021,Q2,Ketoacidosis,,2021,Q2,1,I,20210606.0,20210618.0,20210624,20210624,EXP,,DE-ASTRAZENECA-2021A553025,ASTRAZENECA,,23567.0,DY,,F,Y,82.0,KG,20210624.0,,MD,DE,DE,2021,Q2,Elderly
194606701,19460670,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2021,Q2,Accidental overdose,,2021,Q2,1,I,,20210610.0,20210625,20210625,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2021-03831,ALKEM,,58.0,YR,,M,Y,,,20210625.0,,HP,US,US,2021,Q2,Adult
194606701,19460670,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210610.0,20210625,20210625,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2021-03831,ALKEM,,58.0,YR,,M,Y,,,20210625.0,,HP,US,US,2021,Q2,Adult
194606701,19460670,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2021,Q2,Dizziness,,2021,Q2,1,I,,20210610.0,20210625,20210625,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2021-03831,ALKEM,,58.0,YR,,M,Y,,,20210625.0,,HP,US,US,2021,Q2,Adult
194606701,19460670,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210610.0,20210625,20210625,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2021-03831,ALKEM,,58.0,YR,,M,Y,,,20210625.0,,HP,US,US,2021,Q2,Adult
194606701,19460670,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2021,Q2,Hypophagia,,2021,Q2,1,I,,20210610.0,20210625,20210625,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2021-03831,ALKEM,,58.0,YR,,M,Y,,,20210625.0,,HP,US,US,2021,Q2,Adult
194606701,19460670,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2021,Q2,Lactic acidosis,,2021,Q2,1,I,,20210610.0,20210625,20210625,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2021-03831,ALKEM,,58.0,YR,,M,Y,,,20210625.0,,HP,US,US,2021,Q2,Adult
194606701,19460670,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2021,Q2,Lethargy,,2021,Q2,1,I,,20210610.0,20210625,20210625,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2021-03831,ALKEM,,58.0,YR,,M,Y,,,20210625.0,,HP,US,US,2021,Q2,Adult
194606701,19460670,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2021,Q2,Nausea,,2021,Q2,1,I,,20210610.0,20210625,20210625,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2021-03831,ALKEM,,58.0,YR,,M,Y,,,20210625.0,,HP,US,US,2021,Q2,Adult
194606701,19460670,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2021,Q2,Overdose,,2021,Q2,1,I,,20210610.0,20210625,20210625,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2021-03831,ALKEM,,58.0,YR,,M,Y,,,20210625.0,,HP,US,US,2021,Q2,Adult
194606701,19460670,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2021,Q2,Product appearance confusion,,2021,Q2,1,I,,20210610.0,20210625,20210625,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2021-03831,ALKEM,,58.0,YR,,M,Y,,,20210625.0,,HP,US,US,2021,Q2,Adult
194606701,19460670,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,, UNKNOWN,,,,,,,2021,Q2,Renal impairment,,2021,Q2,1,I,,20210610.0,20210625,20210625,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2021-03831,ALKEM,,58.0,YR,,M,Y,,,20210625.0,,HP,US,US,2021,Q2,Adult
194613212,19461321,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,, UNKNOWN,,,10.0,MG,,,2021,Q2,Blood pressure decreased,,2021,Q2,2,F,201911.0,20210618.0,20210625,20210629,EXP,,PL-PFIZER INC-2021732437,PFIZER,,65.0,YR,,M,Y,,,20210629.0,,CN,PL,PL,2021,Q2,Elderly
194613212,19461321,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,, UNKNOWN,,,10.0,MG,,,2021,Q2,Concomitant disease aggravated,,2021,Q2,2,F,201911.0,20210618.0,20210625,20210629,EXP,,PL-PFIZER INC-2021732437,PFIZER,,65.0,YR,,M,Y,,,20210629.0,,CN,PL,PL,2021,Q2,Elderly
194613212,19461321,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,, UNKNOWN,,,10.0,MG,,,2021,Q2,Ejection fraction decreased,,2021,Q2,2,F,201911.0,20210618.0,20210625,20210629,EXP,,PL-PFIZER INC-2021732437,PFIZER,,65.0,YR,,M,Y,,,20210629.0,,CN,PL,PL,2021,Q2,Elderly
194613212,19461321,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,, UNKNOWN,,,10.0,MG,,,2021,Q2,Glomerular filtration rate decreased,,2021,Q2,2,F,201911.0,20210618.0,20210625,20210629,EXP,,PL-PFIZER INC-2021732437,PFIZER,,65.0,YR,,M,Y,,,20210629.0,,CN,PL,PL,2021,Q2,Elderly
194613212,19461321,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,, UNKNOWN,,,10.0,MG,,,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,2,F,201911.0,20210618.0,20210625,20210629,EXP,,PL-PFIZER INC-2021732437,PFIZER,,65.0,YR,,M,Y,,,20210629.0,,CN,PL,PL,2021,Q2,Elderly
194613212,19461321,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,, UNKNOWN,,,10.0,MG,,,2021,Q2,Haemoglobin decreased,,2021,Q2,2,F,201911.0,20210618.0,20210625,20210629,EXP,,PL-PFIZER INC-2021732437,PFIZER,,65.0,YR,,M,Y,,,20210629.0,,CN,PL,PL,2021,Q2,Elderly
194613212,19461321,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,, UNKNOWN,,,10.0,MG,,,2021,Q2,Heart rate decreased,,2021,Q2,2,F,201911.0,20210618.0,20210625,20210629,EXP,,PL-PFIZER INC-2021732437,PFIZER,,65.0,YR,,M,Y,,,20210629.0,,CN,PL,PL,2021,Q2,Elderly
194613212,19461321,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,, UNKNOWN,,,10.0,MG,,,2021,Q2,Mitral valve calcification,,2021,Q2,2,F,201911.0,20210618.0,20210625,20210629,EXP,,PL-PFIZER INC-2021732437,PFIZER,,65.0,YR,,M,Y,,,20210629.0,,CN,PL,PL,2021,Q2,Elderly
194613212,19461321,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,, UNKNOWN,,,10.0,MG,,,2021,Q2,Mitral valve incompetence,,2021,Q2,2,F,201911.0,20210618.0,20210625,20210629,EXP,,PL-PFIZER INC-2021732437,PFIZER,,65.0,YR,,M,Y,,,20210629.0,,CN,PL,PL,2021,Q2,Elderly
194613212,19461321,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,, UNKNOWN,,,10.0,MG,,,2021,Q2,Mitral valve thickening,,2021,Q2,2,F,201911.0,20210618.0,20210625,20210629,EXP,,PL-PFIZER INC-2021732437,PFIZER,,65.0,YR,,M,Y,,,20210629.0,,CN,PL,PL,2021,Q2,Elderly
194613212,19461321,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,, UNKNOWN,,,10.0,MG,,,2021,Q2,N-terminal prohormone brain natriuretic peptide increased,,2021,Q2,2,F,201911.0,20210618.0,20210625,20210629,EXP,,PL-PFIZER INC-2021732437,PFIZER,,65.0,YR,,M,Y,,,20210629.0,,CN,PL,PL,2021,Q2,Elderly
194613212,19461321,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,, UNKNOWN,,,10.0,MG,,,2021,Q2,Platelet count decreased,,2021,Q2,2,F,201911.0,20210618.0,20210625,20210629,EXP,,PL-PFIZER INC-2021732437,PFIZER,,65.0,YR,,M,Y,,,20210629.0,,CN,PL,PL,2021,Q2,Elderly
194613212,19461321,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,, UNKNOWN,,,10.0,MG,,,2021,Q2,Pulmonary oedema,,2021,Q2,2,F,201911.0,20210618.0,20210625,20210629,EXP,,PL-PFIZER INC-2021732437,PFIZER,,65.0,YR,,M,Y,,,20210629.0,,CN,PL,PL,2021,Q2,Elderly
194628111,19462811,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Blood pressure decreased,,2021,Q2,1,I,201911.0,20210617.0,20210625,20210625,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210625.0,,CN,GB,PL,2021,Q2,Elderly
194628111,19462811,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Concomitant disease aggravated,,2021,Q2,1,I,201911.0,20210617.0,20210625,20210625,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210625.0,,CN,GB,PL,2021,Q2,Elderly
194628111,19462811,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Ejection fraction decreased,,2021,Q2,1,I,201911.0,20210617.0,20210625,20210625,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210625.0,,CN,GB,PL,2021,Q2,Elderly
194628111,19462811,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Glomerular filtration rate decreased,,2021,Q2,1,I,201911.0,20210617.0,20210625,20210625,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210625.0,,CN,GB,PL,2021,Q2,Elderly
194628111,19462811,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,1,I,201911.0,20210617.0,20210625,20210625,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210625.0,,CN,GB,PL,2021,Q2,Elderly
194628111,19462811,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Haemoglobin decreased,,2021,Q2,1,I,201911.0,20210617.0,20210625,20210625,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210625.0,,CN,GB,PL,2021,Q2,Elderly
194628111,19462811,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Heart rate decreased,,2021,Q2,1,I,201911.0,20210617.0,20210625,20210625,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210625.0,,CN,GB,PL,2021,Q2,Elderly
194628111,19462811,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Mitral valve calcification,,2021,Q2,1,I,201911.0,20210617.0,20210625,20210625,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210625.0,,CN,GB,PL,2021,Q2,Elderly
194628111,19462811,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Mitral valve incompetence,,2021,Q2,1,I,201911.0,20210617.0,20210625,20210625,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210625.0,,CN,GB,PL,2021,Q2,Elderly
194628111,19462811,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Mitral valve thickening,,2021,Q2,1,I,201911.0,20210617.0,20210625,20210625,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210625.0,,CN,GB,PL,2021,Q2,Elderly
194628111,19462811,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,N-terminal prohormone brain natriuretic peptide increased,,2021,Q2,1,I,201911.0,20210617.0,20210625,20210625,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210625.0,,CN,GB,PL,2021,Q2,Elderly
194628111,19462811,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Platelet count decreased,,2021,Q2,1,I,201911.0,20210617.0,20210625,20210625,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210625.0,,CN,GB,PL,2021,Q2,Elderly
194628111,19462811,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Pulmonary oedema,,2021,Q2,1,I,201911.0,20210617.0,20210625,20210625,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210625.0,,CN,GB,PL,2021,Q2,Elderly
194631131,19463113,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,, MK2953,,202293.0,10.0,MG,TABLET,,2021,Q2,Blood ketone body increased,,2021,Q2,1,I,20210602.0,20210618.0,20210625,20210625,EXP,,CN-ASTRAZENECA-2021A553813,ASTRAZENECA,,12755.0,DY,,M,Y,85.0,KG,20210625.0,,HP,CN,CN,2021,Q2,Elderly
194631131,19463113,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,, MK2953,,202293.0,10.0,MG,TABLET,,2021,Q2,Diabetic neuropathy,,2021,Q2,1,I,20210602.0,20210618.0,20210625,20210625,EXP,,CN-ASTRAZENECA-2021A553813,ASTRAZENECA,,12755.0,DY,,M,Y,85.0,KG,20210625.0,,HP,CN,CN,2021,Q2,Elderly
194641971,19464197,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q2,Blood pressure decreased,,2021,Q2,1,I,201911.0,20210615.0,20210627,20210627,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210627.0,,CN,PL,PL,2021,Q2,Elderly
194641971,19464197,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q2,Concomitant disease aggravated,,2021,Q2,1,I,201911.0,20210615.0,20210627,20210627,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210627.0,,CN,PL,PL,2021,Q2,Elderly
194641971,19464197,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q2,Ejection fraction decreased,,2021,Q2,1,I,201911.0,20210615.0,20210627,20210627,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210627.0,,CN,PL,PL,2021,Q2,Elderly
194641971,19464197,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q2,Glomerular filtration rate decreased,,2021,Q2,1,I,201911.0,20210615.0,20210627,20210627,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210627.0,,CN,PL,PL,2021,Q2,Elderly
194641971,19464197,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,1,I,201911.0,20210615.0,20210627,20210627,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210627.0,,CN,PL,PL,2021,Q2,Elderly
194641971,19464197,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q2,Haemoglobin decreased,,2021,Q2,1,I,201911.0,20210615.0,20210627,20210627,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210627.0,,CN,PL,PL,2021,Q2,Elderly
194641971,19464197,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q2,Heart rate decreased,,2021,Q2,1,I,201911.0,20210615.0,20210627,20210627,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210627.0,,CN,PL,PL,2021,Q2,Elderly
194641971,19464197,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q2,Mitral valve calcification,,2021,Q2,1,I,201911.0,20210615.0,20210627,20210627,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210627.0,,CN,PL,PL,2021,Q2,Elderly
194641971,19464197,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q2,Mitral valve incompetence,,2021,Q2,1,I,201911.0,20210615.0,20210627,20210627,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210627.0,,CN,PL,PL,2021,Q2,Elderly
194641971,19464197,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q2,Mitral valve thickening,,2021,Q2,1,I,201911.0,20210615.0,20210627,20210627,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210627.0,,CN,PL,PL,2021,Q2,Elderly
194641971,19464197,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q2,N-terminal prohormone brain natriuretic peptide increased,,2021,Q2,1,I,201911.0,20210615.0,20210627,20210627,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210627.0,,CN,PL,PL,2021,Q2,Elderly
194641971,19464197,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q2,Platelet count decreased,,2021,Q2,1,I,201911.0,20210615.0,20210627,20210627,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210627.0,,CN,PL,PL,2021,Q2,Elderly
194641971,19464197,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q2,Pulmonary oedema,,2021,Q2,1,I,201911.0,20210615.0,20210627,20210627,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210627.0,,CN,PL,PL,2021,Q2,Elderly
194673591,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Atrial fibrillation,,2021,Q2,1,I,,20210614.0,20210628,20210628,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210628.0,,MD,JP,JP,2021,Q2,Elderly
194673591,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Cardiac failure,,2021,Q2,1,I,,20210614.0,20210628,20210628,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210628.0,,MD,JP,JP,2021,Q2,Elderly
194673591,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Cardiomegaly,,2021,Q2,1,I,,20210614.0,20210628,20210628,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210628.0,,MD,JP,JP,2021,Q2,Elderly
194673591,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Congestive cardiomyopathy,,2021,Q2,1,I,,20210614.0,20210628,20210628,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210628.0,,MD,JP,JP,2021,Q2,Elderly
194673591,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Ejection fraction decreased,,2021,Q2,1,I,,20210614.0,20210628,20210628,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210628.0,,MD,JP,JP,2021,Q2,Elderly
194673591,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Mitral valve incompetence,,2021,Q2,1,I,,20210614.0,20210628,20210628,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210628.0,,MD,JP,JP,2021,Q2,Elderly
194673591,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Tricuspid valve incompetence,,2021,Q2,1,I,,20210614.0,20210628,20210628,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210628.0,,MD,JP,JP,2021,Q2,Elderly
194673591,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Ventricular internal diameter abnormal,,2021,Q2,1,I,,20210614.0,20210628,20210628,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210628.0,,MD,JP,JP,2021,Q2,Elderly
194673591,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q2,Ventricular tachycardia,,2021,Q2,1,I,,20210614.0,20210628,20210628,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210628.0,,MD,JP,JP,2021,Q2,Elderly
194682521,19468252,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,TABLET,QD,2021,Q2,Euglycaemic diabetic ketoacidosis,,2021,Q2,1,I,,20210617.0,20210628,20210628,EXP,,FR-ASTRAZENECA-2021A536594,ASTRAZENECA,,25.0,YR,,F,Y,78.0,KG,20210628.0,,HP,FR,FR,2021,Q2,Young Adult
194682581,19468258,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,490.0,MG,,,,,,10.0,MG,TABLET,QD,2021,Q2,Diabetic ketosis,,2021,Q2,1,I,20180213.0,20191130.0,20210628,20210628,EXP,,CN-ASTRAZENECA-2019SF73132,ASTRAZENECA,,20599.0,DY,,M,Y,,,20210628.0,,MD,CN,CN,2021,Q2,Elderly
194691591,19469159,5,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,,20210614.0,20210628,20210628,EXP,,TW-BAUSCH-BL-2021-021314,BAUSCH AND LOMB,"CHAN M, WENG C, HSU C, HUANG W, YEN T. DAPAGLIFLOZIN ASSOCIATED KETOACIDOSIS: A MUST KNOW FACT FOR NEPHROLOGISTS. ASIAN PACIFIC SOCIETY OF NEPHROLOGY. 192. DOI:10.1111/NEP.13039",64.0,YR,,F,Y,,,20210628.0,,HP,TW,TW,2021,Q2,Adult
139824502,13982450,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,TABLET,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,2,F,,20210713.0,20170918,20210721,EXP,,IE-ASTRAZENECA-2017SE91961,ASTRAZENECA,"GARRAHY A, BYRNE MM.. UNEXPECTED DIABETIC KETOACIDOSIS IN TWO PATIENTS WITH TYPE 2 DIABETES, CAUSE OR COINCIDENCE WITH USE OF SGLT2 INHIBITORS: A REPORT OF TWO CASES. 2017 ANNUAL CONFERENCE OF THE IRISH ENDOCRINE SOCIETY (ISE) 2017?22613141.",52.0,YR,,F,Y,,,20210721.0,,HP,IE,IE,2021,Q3,Adult
170998847,17099884,47,C,DAPAGLIFLOZINA,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Chorioretinopathy,,2021,Q3,7,F,20180301.0,20210804.0,20191202,20210811,EXP,,ES-ROCHE-2321521,ROCHE,,57.0,YR,,M,Y,83.0,KG,20210811.0,,MD,ES,ES,2021,Q3,Adult
170998847,17099884,47,C,DAPAGLIFLOZINA,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Nephritis,,2021,Q3,7,F,20180301.0,20210804.0,20191202,20210811,EXP,,ES-ROCHE-2321521,ROCHE,,57.0,YR,,M,Y,83.0,KG,20210811.0,,MD,ES,ES,2021,Q3,Adult
174134182,17413418,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,2,F,,20210721.0,20200213,20210726,EXP,,IT-ASTRAZENECA-2019SE55035,ASTRAZENECA,,47.0,YR,,F,Y,,,20210726.0,,,IT,IT,2021,Q3,Adult
178854867,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q3,Back pain,,2021,Q3,7,F,2020.0,20210716.0,20200611,20210729,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210729.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
178854867,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q3,Malaise,,2021,Q3,7,F,2020.0,20210716.0,20200611,20210729,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210729.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
178854867,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q3,Musculoskeletal stiffness,,2021,Q3,7,F,2020.0,20210716.0,20200611,20210729,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210729.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
178854867,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q3,Nephrolithiasis,,2021,Q3,7,F,2020.0,20210716.0,20200611,20210729,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210729.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
178854867,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q3,Pain,,2021,Q3,7,F,2020.0,20210716.0,20200611,20210729,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210729.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
178854867,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q3,Peripheral swelling,,2021,Q3,7,F,2020.0,20210716.0,20200611,20210729,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210729.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
178854867,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q3,Plantar fasciitis,,2021,Q3,7,F,2020.0,20210716.0,20200611,20210729,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210729.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
178854867,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q3,Psoriasis,,2021,Q3,7,F,2020.0,20210716.0,20200611,20210729,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210729.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
178854867,17885486,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q3,Psoriatic arthropathy,,2021,Q3,7,F,2020.0,20210716.0,20200611,20210729,EXP,,NVSC2020CA162184,NOVARTIS,,44.0,YR,,F,Y,,,20210729.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
184292524,18429252,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, UNKNOWN",,,U,,,,,10.0,MG,TABLET,,2021,Q3,Cardiac ventricular thrombosis,,2021,Q3,4,F,20200828.0,20210906.0,20201026,20210909,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20210909.0,,MD,CN,CN,2021,Q3,Adult
184292524,18429252,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, UNKNOWN",,,U,,,,,10.0,MG,TABLET,,2021,Q3,Ventricular arrhythmia,,2021,Q3,4,F,20200828.0,20210906.0,20201026,20210909,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20210909.0,,MD,CN,CN,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Adverse event,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Agitation,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Blood count abnormal,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Blood uric acid increased,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,COVID-19,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Cardiac disorder,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Catheter site infection,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Catheter site oedema,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Cough,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Diabetes mellitus,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Disorientation,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Gastritis,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Hodgkin's disease,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Hypokinesia,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Localised oedema,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Nephropathy,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Oedema,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Pain,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Pain in extremity,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Pneumonia,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Polyneuropathy,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Renal failure,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Weight decreased,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
1856104210,18561042,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,10,F,20210121.0,20210904.0,20201130,20210910,EXP,,CO-SEATTLE GENETICS-2020SGN02093,SEATTLE GENETICS,,57.0,YR,,M,Y,62.0,KG,20210910.0,,CN,CO,CO,2021,Q3,Adult
188514563,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q3,Acute myocardial infarction,,2021,Q3,3,F,201504.0,20210818.0,20210205,20210822,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210823.0,,MD,JP,JP,2021,Q3,Elderly
188514563,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q3,Atrial fibrillation,,2021,Q3,3,F,201504.0,20210818.0,20210205,20210822,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210823.0,,MD,JP,JP,2021,Q3,Elderly
188514563,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q3,Cardiac failure chronic,,2021,Q3,3,F,201504.0,20210818.0,20210205,20210822,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210823.0,,MD,JP,JP,2021,Q3,Elderly
188514563,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q3,Cardio-respiratory arrest,,2021,Q3,3,F,201504.0,20210818.0,20210205,20210822,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210823.0,,MD,JP,JP,2021,Q3,Elderly
188514563,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q3,Chronic kidney disease,,2021,Q3,3,F,201504.0,20210818.0,20210205,20210822,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210823.0,,MD,JP,JP,2021,Q3,Elderly
188514563,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,3,F,201504.0,20210818.0,20210205,20210822,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210823.0,,MD,JP,JP,2021,Q3,Elderly
188514563,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q3,Myocardial ischaemia,,2021,Q3,3,F,201504.0,20210818.0,20210205,20210822,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210823.0,,MD,JP,JP,2021,Q3,Elderly
188514563,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q3,Oedema,,2021,Q3,3,F,201504.0,20210818.0,20210205,20210822,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210823.0,,MD,JP,JP,2021,Q3,Elderly
188514563,18851456,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,5 MG,,,U,,,,,5.0,MG,,,2021,Q3,Weight increased,,2021,Q3,3,F,201504.0,20210818.0,20210205,20210822,EXP,,NVSJ2021JP001965,NOVARTIS,,77.0,YR,,M,Y,78.0,KG,20210823.0,,MD,JP,JP,2021,Q3,Elderly
188671174,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Basophil count increased,,2021,Q3,4,F,20210215.0,20210727.0,20210209,20210803,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210803.0,,HP,GB,GB,2021,Q3,Young Adult
188671174,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Gastroenteritis,,2021,Q3,4,F,20210215.0,20210727.0,20210209,20210803,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210803.0,,HP,GB,GB,2021,Q3,Young Adult
188671174,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Haemoglobin decreased,,2021,Q3,4,F,20210215.0,20210727.0,20210209,20210803,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210803.0,,HP,GB,GB,2021,Q3,Young Adult
188671174,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Hospitalisation,,2021,Q3,4,F,20210215.0,20210727.0,20210209,20210803,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210803.0,,HP,GB,GB,2021,Q3,Young Adult
188671174,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Lymphocyte count decreased,,2021,Q3,4,F,20210215.0,20210727.0,20210209,20210803,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210803.0,,HP,GB,GB,2021,Q3,Young Adult
188671174,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Monocyte count increased,,2021,Q3,4,F,20210215.0,20210727.0,20210209,20210803,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210803.0,,HP,GB,GB,2021,Q3,Young Adult
188671174,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Neutrophil count decreased,,2021,Q3,4,F,20210215.0,20210727.0,20210209,20210803,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210803.0,,HP,GB,GB,2021,Q3,Young Adult
188671174,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Neutrophil count increased,,2021,Q3,4,F,20210215.0,20210727.0,20210209,20210803,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210803.0,,HP,GB,GB,2021,Q3,Young Adult
188671174,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Platelet count decreased,,2021,Q3,4,F,20210215.0,20210727.0,20210209,20210803,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210803.0,,HP,GB,GB,2021,Q3,Young Adult
188671174,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Schizophrenia,,2021,Q3,4,F,20210215.0,20210727.0,20210209,20210803,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210803.0,,HP,GB,GB,2021,Q3,Young Adult
188671174,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q3,White blood cell count decreased,,2021,Q3,4,F,20210215.0,20210727.0,20210209,20210803,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210803.0,,HP,GB,GB,2021,Q3,Young Adult
188671174,18867117,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD",,,,,,,,10.0,MG,,QD,2021,Q3,White blood cell count increased,,2021,Q3,4,F,20210215.0,20210727.0,20210209,20210803,EXP,,GB-MYLANLABS-2021M1007645,MYLAN,,33.0,YR,,M,Y,89.0,KG,20210803.0,,HP,GB,GB,2021,Q3,Young Adult
1909398614,19093986,69,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Cardiac failure,,2021,Q3,14,F,20210319.0,20210823.0,20210405,20210828,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20210828.0,,MD,CN,CN,2021,Q3,Elderly
1909398614,19093986,69,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Hyperthyroidism,,2021,Q3,14,F,20210319.0,20210823.0,20210405,20210828,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20210828.0,,MD,CN,CN,2021,Q3,Elderly
1909398614,19093986,69,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Myelosuppression,,2021,Q3,14,F,20210319.0,20210823.0,20210405,20210828,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20210828.0,,MD,CN,CN,2021,Q3,Elderly
1909398614,19093986,69,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Urinary retention,,2021,Q3,14,F,20210319.0,20210823.0,20210405,20210828,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20210828.0,,MD,CN,CN,2021,Q3,Elderly
191618852,19161885,17,C,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2021,Q3,Atrial fibrillation,,2021,Q3,2,F,20210403.0,20210812.0,20210421,20210818,EXP,,CA-ROCHE-2809617,ROCHE,,61.0,YR,,M,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
192073682,19207368,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5 MG QD,,,U,U,,,,5.0,MG,,QD,2021,Q3,Bacteriuria,,2021,Q3,2,F,20210120.0,20210715.0,20210503,20210727,EXP,,US-NOVOPROD-806259,NOVO NORDISK,,68.0,YR,,M,Y,91.6,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
192073682,19207368,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5 MG QD,,,U,U,,,,5.0,MG,,QD,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,20210120.0,20210715.0,20210503,20210727,EXP,,US-NOVOPROD-806259,NOVO NORDISK,,68.0,YR,,M,Y,91.6,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
192073682,19207368,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5 MG QD,,,U,U,,,,5.0,MG,,QD,2021,Q3,Generalised tonic-clonic seizure,,2021,Q3,2,F,20210120.0,20210715.0,20210503,20210727,EXP,,US-NOVOPROD-806259,NOVO NORDISK,,68.0,YR,,M,Y,91.6,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
192073682,19207368,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5 MG QD,,,U,U,,,,5.0,MG,,QD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,2,F,20210120.0,20210715.0,20210503,20210727,EXP,,US-NOVOPROD-806259,NOVO NORDISK,,68.0,YR,,M,Y,91.6,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
192073682,19207368,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5 MG QD,,,U,U,,,,5.0,MG,,QD,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,20210120.0,20210715.0,20210503,20210727,EXP,,US-NOVOPROD-806259,NOVO NORDISK,,68.0,YR,,M,Y,91.6,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
192073682,19207368,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5 MG QD,,,U,U,,,,5.0,MG,,QD,2021,Q3,Partial seizures,,2021,Q3,2,F,20210120.0,20210715.0,20210503,20210727,EXP,,US-NOVOPROD-806259,NOVO NORDISK,,68.0,YR,,M,Y,91.6,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
192073682,19207368,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5 MG QD,,,U,U,,,,5.0,MG,,QD,2021,Q3,Platelet count decreased,,2021,Q3,2,F,20210120.0,20210715.0,20210503,20210727,EXP,,US-NOVOPROD-806259,NOVO NORDISK,,68.0,YR,,M,Y,91.6,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
192073682,19207368,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5 MG QD,,,U,U,,,,5.0,MG,,QD,2021,Q3,Postictal paralysis,,2021,Q3,2,F,20210120.0,20210715.0,20210503,20210727,EXP,,US-NOVOPROD-806259,NOVO NORDISK,,68.0,YR,,M,Y,91.6,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
192073682,19207368,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5 MG QD,,,U,U,,,,5.0,MG,,QD,2021,Q3,Pyuria,,2021,Q3,2,F,20210120.0,20210715.0,20210503,20210727,EXP,,US-NOVOPROD-806259,NOVO NORDISK,,68.0,YR,,M,Y,91.6,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
192159402,19215940,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Atrial fibrillation,,2021,Q3,2,F,,20210716.0,20210505,20210728,EXP,,NVSJ2021JP006663,NOVARTIS,,84.0,YR,,F,Y,,,20210728.0,,MD,JP,JP,2021,Q3,Elderly
192159402,19215940,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Cardiac failure,,2021,Q3,2,F,,20210716.0,20210505,20210728,EXP,,NVSJ2021JP006663,NOVARTIS,,84.0,YR,,F,Y,,,20210728.0,,MD,JP,JP,2021,Q3,Elderly
192159402,19215940,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Cardiomegaly,,2021,Q3,2,F,,20210716.0,20210505,20210728,EXP,,NVSJ2021JP006663,NOVARTIS,,84.0,YR,,F,Y,,,20210728.0,,MD,JP,JP,2021,Q3,Elderly
192159402,19215940,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Chronic kidney disease,,2021,Q3,2,F,,20210716.0,20210505,20210728,EXP,,NVSJ2021JP006663,NOVARTIS,,84.0,YR,,F,Y,,,20210728.0,,MD,JP,JP,2021,Q3,Elderly
192159402,19215940,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Diabetes mellitus,,2021,Q3,2,F,,20210716.0,20210505,20210728,EXP,,NVSJ2021JP006663,NOVARTIS,,84.0,YR,,F,Y,,,20210728.0,,MD,JP,JP,2021,Q3,Elderly
192159402,19215940,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Pulmonary congestion,,2021,Q3,2,F,,20210716.0,20210505,20210728,EXP,,NVSJ2021JP006663,NOVARTIS,,84.0,YR,,F,Y,,,20210728.0,,MD,JP,JP,2021,Q3,Elderly
193008599,19300859,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Cerebrovascular accident,,2021,Q3,9,F,2019.0,20210915.0,20210524,20210921,EXP,,NVSC2021US113361,NOVARTIS,,45.0,YR,,M,Y,,,20210921.0,,MD,US,US,2021,Q3,Adult
193008599,19300859,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Chest pain,,2021,Q3,9,F,2019.0,20210915.0,20210524,20210921,EXP,,NVSC2021US113361,NOVARTIS,,45.0,YR,,M,Y,,,20210921.0,,MD,US,US,2021,Q3,Adult
193008599,19300859,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Dizziness,,2021,Q3,9,F,2019.0,20210915.0,20210524,20210921,EXP,,NVSC2021US113361,NOVARTIS,,45.0,YR,,M,Y,,,20210921.0,,MD,US,US,2021,Q3,Adult
193008599,19300859,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Dyspnoea,,2021,Q3,9,F,2019.0,20210915.0,20210524,20210921,EXP,,NVSC2021US113361,NOVARTIS,,45.0,YR,,M,Y,,,20210921.0,,MD,US,US,2021,Q3,Adult
193008599,19300859,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Fatigue,,2021,Q3,9,F,2019.0,20210915.0,20210524,20210921,EXP,,NVSC2021US113361,NOVARTIS,,45.0,YR,,M,Y,,,20210921.0,,MD,US,US,2021,Q3,Adult
193008599,19300859,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Headache,,2021,Q3,9,F,2019.0,20210915.0,20210524,20210921,EXP,,NVSC2021US113361,NOVARTIS,,45.0,YR,,M,Y,,,20210921.0,,MD,US,US,2021,Q3,Adult
193008599,19300859,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Hypoaesthesia,,2021,Q3,9,F,2019.0,20210915.0,20210524,20210921,EXP,,NVSC2021US113361,NOVARTIS,,45.0,YR,,M,Y,,,20210921.0,,MD,US,US,2021,Q3,Adult
193008599,19300859,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Muscle spasms,,2021,Q3,9,F,2019.0,20210915.0,20210524,20210921,EXP,,NVSC2021US113361,NOVARTIS,,45.0,YR,,M,Y,,,20210921.0,,MD,US,US,2021,Q3,Adult
193008599,19300859,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Paraesthesia,,2021,Q3,9,F,2019.0,20210915.0,20210524,20210921,EXP,,NVSC2021US113361,NOVARTIS,,45.0,YR,,M,Y,,,20210921.0,,MD,US,US,2021,Q3,Adult
193008599,19300859,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Paraesthesia oral,,2021,Q3,9,F,2019.0,20210915.0,20210524,20210921,EXP,,NVSC2021US113361,NOVARTIS,,45.0,YR,,M,Y,,,20210921.0,,MD,US,US,2021,Q3,Adult
193008599,19300859,13,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Vision blurred,,2021,Q3,9,F,2019.0,20210915.0,20210524,20210921,EXP,,NVSC2021US113361,NOVARTIS,,45.0,YR,,M,Y,,,20210921.0,,MD,US,US,2021,Q3,Adult
193041113,19304111,34,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Blood pressure decreased,,2021,Q3,3,F,201911.0,20210714.0,20210525,20210721,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210721.0,,HP,PL,PL,2021,Q3,Elderly
193041113,19304111,34,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,3,F,201911.0,20210714.0,20210525,20210721,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210721.0,,HP,PL,PL,2021,Q3,Elderly
193041113,19304111,34,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,3,F,201911.0,20210714.0,20210525,20210721,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210721.0,,HP,PL,PL,2021,Q3,Elderly
193041113,19304111,34,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,3,F,201911.0,20210714.0,20210525,20210721,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210721.0,,HP,PL,PL,2021,Q3,Elderly
193041113,19304111,34,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,201911.0,20210714.0,20210525,20210721,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210721.0,,HP,PL,PL,2021,Q3,Elderly
193041113,19304111,34,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,3,F,201911.0,20210714.0,20210525,20210721,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210721.0,,HP,PL,PL,2021,Q3,Elderly
193041113,19304111,34,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,3,F,201911.0,20210714.0,20210525,20210721,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210721.0,,HP,PL,PL,2021,Q3,Elderly
193041113,19304111,34,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,3,F,201911.0,20210714.0,20210525,20210721,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210721.0,,HP,PL,PL,2021,Q3,Elderly
193041113,19304111,34,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,3,F,201911.0,20210714.0,20210525,20210721,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210721.0,,HP,PL,PL,2021,Q3,Elderly
193041113,19304111,34,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,3,F,201911.0,20210714.0,20210525,20210721,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210721.0,,HP,PL,PL,2021,Q3,Elderly
193041113,19304111,34,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,3,F,201911.0,20210714.0,20210525,20210721,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210721.0,,HP,PL,PL,2021,Q3,Elderly
193041113,19304111,34,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,3,F,201911.0,20210714.0,20210525,20210721,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210721.0,,HP,PL,PL,2021,Q3,Elderly
193041113,19304111,34,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,3,F,201911.0,20210714.0,20210525,20210721,EXP,PL-002147023-NVSC2021PL107808,NVSC2021PL107808,NOVARTIS,,65.0,YR,,M,Y,,,20210721.0,,HP,PL,PL,2021,Q3,Elderly
193302942,19330294,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Ischaemia,,2021,Q3,2,F,2021.0,20210707.0,20210528,20210715,EXP,,ES-ASTRAZENECA-2021A438560,ASTRAZENECA,,74.0,YR,,M,Y,,,20210715.0,,MD,ES,ES,2021,Q3,Elderly
193302942,19330294,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Necrosis,,2021,Q3,2,F,2021.0,20210707.0,20210528,20210715,EXP,,ES-ASTRAZENECA-2021A438560,ASTRAZENECA,,74.0,YR,,M,Y,,,20210715.0,,MD,ES,ES,2021,Q3,Elderly
193302942,19330294,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Pain in extremity,,2021,Q3,2,F,2021.0,20210707.0,20210528,20210715,EXP,,ES-ASTRAZENECA-2021A438560,ASTRAZENECA,,74.0,YR,,M,Y,,,20210715.0,,MD,ES,ES,2021,Q3,Elderly
193302942,19330294,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Postoperative wound infection,,2021,Q3,2,F,2021.0,20210707.0,20210528,20210715,EXP,,ES-ASTRAZENECA-2021A438560,ASTRAZENECA,,74.0,YR,,M,Y,,,20210715.0,,MD,ES,ES,2021,Q3,Elderly
193632123,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Asthenia,,2021,Q3,3,F,202012.0,20210713.0,20210602,20210721,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210721.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q3,Elderly
193632123,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Dyspnoea,,2021,Q3,3,F,202012.0,20210713.0,20210602,20210721,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210721.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q3,Elderly
193632123,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Increased appetite,,2021,Q3,3,F,202012.0,20210713.0,20210602,20210721,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210721.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q3,Elderly
193632123,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Penile abscess,,2021,Q3,3,F,202012.0,20210713.0,20210602,20210721,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210721.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q3,Elderly
193632123,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Product use in unapproved indication,,2021,Q3,3,F,202012.0,20210713.0,20210602,20210721,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210721.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q3,Elderly
193632123,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Ulcer,,2021,Q3,3,F,202012.0,20210713.0,20210602,20210721,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210721.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q3,Elderly
193632123,19363212,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Vomiting,,2021,Q3,3,F,202012.0,20210713.0,20210602,20210721,EXP,,NVSC2020NG338387,NOVARTIS,,67.0,YR,,M,Y,,,20210721.0,,CN,COUNTRY NOT SPECIFIED,NG,2021,Q3,Elderly
193662138,19366213,40,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Blood pressure decreased,,2021,Q3,8,F,201911.0,20210820.0,20210602,20210830,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052081,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210830.0,,MD,PL,PL,2021,Q3,Elderly
193662138,19366213,40,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,8,F,201911.0,20210820.0,20210602,20210830,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052081,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210830.0,,MD,PL,PL,2021,Q3,Elderly
193662138,19366213,40,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,8,F,201911.0,20210820.0,20210602,20210830,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052081,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210830.0,,MD,PL,PL,2021,Q3,Elderly
193662138,19366213,40,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,8,F,201911.0,20210820.0,20210602,20210830,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052081,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210830.0,,MD,PL,PL,2021,Q3,Elderly
193662138,19366213,40,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,8,F,201911.0,20210820.0,20210602,20210830,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052081,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210830.0,,MD,PL,PL,2021,Q3,Elderly
193662138,19366213,40,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,8,F,201911.0,20210820.0,20210602,20210830,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052081,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210830.0,,MD,PL,PL,2021,Q3,Elderly
193662138,19366213,40,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,8,F,201911.0,20210820.0,20210602,20210830,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052081,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210830.0,,MD,PL,PL,2021,Q3,Elderly
193662138,19366213,40,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,8,F,201911.0,20210820.0,20210602,20210830,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052081,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210830.0,,MD,PL,PL,2021,Q3,Elderly
193662138,19366213,40,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,8,F,201911.0,20210820.0,20210602,20210830,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052081,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210830.0,,MD,PL,PL,2021,Q3,Elderly
193662138,19366213,40,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,8,F,201911.0,20210820.0,20210602,20210830,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052081,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210830.0,,MD,PL,PL,2021,Q3,Elderly
193662138,19366213,40,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,8,F,201911.0,20210820.0,20210602,20210830,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052081,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210830.0,,MD,PL,PL,2021,Q3,Elderly
193662138,19366213,40,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,8,F,201911.0,20210820.0,20210602,20210830,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052081,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210830.0,,MD,PL,PL,2021,Q3,Elderly
193662138,19366213,40,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,8,F,201911.0,20210820.0,20210602,20210830,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052081,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20210830.0,,MD,PL,PL,2021,Q3,Elderly
193708295,19370829,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,UNKNOWN,,2021,Q3,Blood pressure decreased,,2021,Q3,5,F,201911.0,20210705.0,20210603,20210709,EXP,,PL-FRESENIUS KABI-FK202105588,FRESENIUS KABI,,65.0,YR,,M,Y,,,20210710.0,,HP,NL,PL,2021,Q3,Elderly
193708295,19370829,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,UNKNOWN,,2021,Q3,Concomitant disease aggravated,,2021,Q3,5,F,201911.0,20210705.0,20210603,20210709,EXP,,PL-FRESENIUS KABI-FK202105588,FRESENIUS KABI,,65.0,YR,,M,Y,,,20210710.0,,HP,NL,PL,2021,Q3,Elderly
193708295,19370829,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,UNKNOWN,,2021,Q3,Ejection fraction decreased,,2021,Q3,5,F,201911.0,20210705.0,20210603,20210709,EXP,,PL-FRESENIUS KABI-FK202105588,FRESENIUS KABI,,65.0,YR,,M,Y,,,20210710.0,,HP,NL,PL,2021,Q3,Elderly
193708295,19370829,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,UNKNOWN,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,5,F,201911.0,20210705.0,20210603,20210709,EXP,,PL-FRESENIUS KABI-FK202105588,FRESENIUS KABI,,65.0,YR,,M,Y,,,20210710.0,,HP,NL,PL,2021,Q3,Elderly
193708295,19370829,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,UNKNOWN,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,5,F,201911.0,20210705.0,20210603,20210709,EXP,,PL-FRESENIUS KABI-FK202105588,FRESENIUS KABI,,65.0,YR,,M,Y,,,20210710.0,,HP,NL,PL,2021,Q3,Elderly
193708295,19370829,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,UNKNOWN,,2021,Q3,Haemoglobin decreased,,2021,Q3,5,F,201911.0,20210705.0,20210603,20210709,EXP,,PL-FRESENIUS KABI-FK202105588,FRESENIUS KABI,,65.0,YR,,M,Y,,,20210710.0,,HP,NL,PL,2021,Q3,Elderly
193708295,19370829,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,UNKNOWN,,2021,Q3,Heart rate decreased,,2021,Q3,5,F,201911.0,20210705.0,20210603,20210709,EXP,,PL-FRESENIUS KABI-FK202105588,FRESENIUS KABI,,65.0,YR,,M,Y,,,20210710.0,,HP,NL,PL,2021,Q3,Elderly
193708295,19370829,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,UNKNOWN,,2021,Q3,Mitral valve calcification,,2021,Q3,5,F,201911.0,20210705.0,20210603,20210709,EXP,,PL-FRESENIUS KABI-FK202105588,FRESENIUS KABI,,65.0,YR,,M,Y,,,20210710.0,,HP,NL,PL,2021,Q3,Elderly
193708295,19370829,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,UNKNOWN,,2021,Q3,Mitral valve incompetence,,2021,Q3,5,F,201911.0,20210705.0,20210603,20210709,EXP,,PL-FRESENIUS KABI-FK202105588,FRESENIUS KABI,,65.0,YR,,M,Y,,,20210710.0,,HP,NL,PL,2021,Q3,Elderly
193708295,19370829,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,UNKNOWN,,2021,Q3,Mitral valve thickening,,2021,Q3,5,F,201911.0,20210705.0,20210603,20210709,EXP,,PL-FRESENIUS KABI-FK202105588,FRESENIUS KABI,,65.0,YR,,M,Y,,,20210710.0,,HP,NL,PL,2021,Q3,Elderly
193708295,19370829,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,UNKNOWN,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,5,F,201911.0,20210705.0,20210603,20210709,EXP,,PL-FRESENIUS KABI-FK202105588,FRESENIUS KABI,,65.0,YR,,M,Y,,,20210710.0,,HP,NL,PL,2021,Q3,Elderly
193708295,19370829,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,UNKNOWN,,2021,Q3,Platelet count decreased,,2021,Q3,5,F,201911.0,20210705.0,20210603,20210709,EXP,,PL-FRESENIUS KABI-FK202105588,FRESENIUS KABI,,65.0,YR,,M,Y,,,20210710.0,,HP,NL,PL,2021,Q3,Elderly
193708295,19370829,31,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,, UNKNOWN,,,10.0,MG,UNKNOWN,,2021,Q3,Pulmonary oedema,,2021,Q3,5,F,201911.0,20210705.0,20210603,20210709,EXP,,PL-FRESENIUS KABI-FK202105588,FRESENIUS KABI,,65.0,YR,,M,Y,,,20210710.0,,HP,NL,PL,2021,Q3,Elderly
193775315,19377531,36,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q3,Blood pressure decreased,,2021,Q3,5,F,201911.0,20210706.0,20210604,20210803,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210803.0,,CN,PL,PL,2021,Q3,Elderly
193775315,19377531,36,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,5,F,201911.0,20210706.0,20210604,20210803,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210803.0,,CN,PL,PL,2021,Q3,Elderly
193775315,19377531,36,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,5,F,201911.0,20210706.0,20210604,20210803,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210803.0,,CN,PL,PL,2021,Q3,Elderly
193775315,19377531,36,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,5,F,201911.0,20210706.0,20210604,20210803,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210803.0,,CN,PL,PL,2021,Q3,Elderly
193775315,19377531,36,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,5,F,201911.0,20210706.0,20210604,20210803,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210803.0,,CN,PL,PL,2021,Q3,Elderly
193775315,19377531,36,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,5,F,201911.0,20210706.0,20210604,20210803,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210803.0,,CN,PL,PL,2021,Q3,Elderly
193775315,19377531,36,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,5,F,201911.0,20210706.0,20210604,20210803,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210803.0,,CN,PL,PL,2021,Q3,Elderly
193775315,19377531,36,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,5,F,201911.0,20210706.0,20210604,20210803,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210803.0,,CN,PL,PL,2021,Q3,Elderly
193775315,19377531,36,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,5,F,201911.0,20210706.0,20210604,20210803,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210803.0,,CN,PL,PL,2021,Q3,Elderly
193775315,19377531,36,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,5,F,201911.0,20210706.0,20210604,20210803,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210803.0,,CN,PL,PL,2021,Q3,Elderly
193775315,19377531,36,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,5,F,201911.0,20210706.0,20210604,20210803,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210803.0,,CN,PL,PL,2021,Q3,Elderly
193775315,19377531,36,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,5,F,201911.0,20210706.0,20210604,20210803,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210803.0,,CN,PL,PL,2021,Q3,Elderly
193775315,19377531,36,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,5,F,201911.0,20210706.0,20210604,20210803,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20210803.0,,CN,PL,PL,2021,Q3,Elderly
193840626,19384062,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Blood pressure decreased,,2021,Q3,6,F,201911.0,20210831.0,20210608,20210909,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20210909.0,,HP,PL,PL,2021,Q3,Elderly
193840626,19384062,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,6,F,201911.0,20210831.0,20210608,20210909,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20210909.0,,HP,PL,PL,2021,Q3,Elderly
193840626,19384062,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,6,F,201911.0,20210831.0,20210608,20210909,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20210909.0,,HP,PL,PL,2021,Q3,Elderly
193840626,19384062,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,6,F,201911.0,20210831.0,20210608,20210909,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20210909.0,,HP,PL,PL,2021,Q3,Elderly
193840626,19384062,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,6,F,201911.0,20210831.0,20210608,20210909,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20210909.0,,HP,PL,PL,2021,Q3,Elderly
193840626,19384062,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,6,F,201911.0,20210831.0,20210608,20210909,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20210909.0,,HP,PL,PL,2021,Q3,Elderly
193840626,19384062,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,6,F,201911.0,20210831.0,20210608,20210909,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20210909.0,,HP,PL,PL,2021,Q3,Elderly
193840626,19384062,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,6,F,201911.0,20210831.0,20210608,20210909,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20210909.0,,HP,PL,PL,2021,Q3,Elderly
193840626,19384062,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,6,F,201911.0,20210831.0,20210608,20210909,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20210909.0,,HP,PL,PL,2021,Q3,Elderly
193840626,19384062,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,6,F,201911.0,20210831.0,20210608,20210909,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20210909.0,,HP,PL,PL,2021,Q3,Elderly
193840626,19384062,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,6,F,201911.0,20210831.0,20210608,20210909,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20210909.0,,HP,PL,PL,2021,Q3,Elderly
193840626,19384062,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,6,F,201911.0,20210831.0,20210608,20210909,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20210909.0,,HP,PL,PL,2021,Q3,Elderly
193840626,19384062,44,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,6,F,201911.0,20210831.0,20210608,20210909,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20210909.0,,HP,PL,PL,2021,Q3,Elderly
193855656,19385565,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q3,Blood pressure decreased,,2021,Q3,6,F,201911.0,20210721.0,20210608,20210804,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20210804.0,,CN,PL,PL,2021,Q3,Elderly
193855656,19385565,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,6,F,201911.0,20210721.0,20210608,20210804,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20210804.0,,CN,PL,PL,2021,Q3,Elderly
193855656,19385565,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q3,Ejection fraction decreased,,2021,Q3,6,F,201911.0,20210721.0,20210608,20210804,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20210804.0,,CN,PL,PL,2021,Q3,Elderly
193855656,19385565,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,6,F,201911.0,20210721.0,20210608,20210804,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20210804.0,,CN,PL,PL,2021,Q3,Elderly
193855656,19385565,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,6,F,201911.0,20210721.0,20210608,20210804,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20210804.0,,CN,PL,PL,2021,Q3,Elderly
193855656,19385565,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q3,Haemoglobin decreased,,2021,Q3,6,F,201911.0,20210721.0,20210608,20210804,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20210804.0,,CN,PL,PL,2021,Q3,Elderly
193855656,19385565,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q3,Heart rate decreased,,2021,Q3,6,F,201911.0,20210721.0,20210608,20210804,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20210804.0,,CN,PL,PL,2021,Q3,Elderly
193855656,19385565,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q3,Mitral valve calcification,,2021,Q3,6,F,201911.0,20210721.0,20210608,20210804,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20210804.0,,CN,PL,PL,2021,Q3,Elderly
193855656,19385565,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q3,Mitral valve incompetence,,2021,Q3,6,F,201911.0,20210721.0,20210608,20210804,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20210804.0,,CN,PL,PL,2021,Q3,Elderly
193855656,19385565,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q3,Mitral valve thickening,,2021,Q3,6,F,201911.0,20210721.0,20210608,20210804,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20210804.0,,CN,PL,PL,2021,Q3,Elderly
193855656,19385565,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,6,F,201911.0,20210721.0,20210608,20210804,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20210804.0,,CN,PL,PL,2021,Q3,Elderly
193855656,19385565,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q3,Platelet count decreased,,2021,Q3,6,F,201911.0,20210721.0,20210608,20210804,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20210804.0,,CN,PL,PL,2021,Q3,Elderly
193855656,19385565,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,,,,,2021,Q3,Pulmonary oedema,,2021,Q3,6,F,201911.0,20210721.0,20210608,20210804,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20210804.0,,CN,PL,PL,2021,Q3,Elderly
1939157413,19391574,55,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q3,Blood pressure decreased,,2021,Q3,13,F,201911.0,20210820.0,20210608,20210902,EXP,,PL-PFIZER INC-2021627445,PFIZER,,65.0,YR,,M,Y,,,20210902.0,,MD,PL,PL,2021,Q3,Elderly
1939157413,19391574,55,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,13,F,201911.0,20210820.0,20210608,20210902,EXP,,PL-PFIZER INC-2021627445,PFIZER,,65.0,YR,,M,Y,,,20210902.0,,MD,PL,PL,2021,Q3,Elderly
1939157413,19391574,55,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,13,F,201911.0,20210820.0,20210608,20210902,EXP,,PL-PFIZER INC-2021627445,PFIZER,,65.0,YR,,M,Y,,,20210902.0,,MD,PL,PL,2021,Q3,Elderly
1939157413,19391574,55,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,13,F,201911.0,20210820.0,20210608,20210902,EXP,,PL-PFIZER INC-2021627445,PFIZER,,65.0,YR,,M,Y,,,20210902.0,,MD,PL,PL,2021,Q3,Elderly
1939157413,19391574,55,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,13,F,201911.0,20210820.0,20210608,20210902,EXP,,PL-PFIZER INC-2021627445,PFIZER,,65.0,YR,,M,Y,,,20210902.0,,MD,PL,PL,2021,Q3,Elderly
1939157413,19391574,55,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,13,F,201911.0,20210820.0,20210608,20210902,EXP,,PL-PFIZER INC-2021627445,PFIZER,,65.0,YR,,M,Y,,,20210902.0,,MD,PL,PL,2021,Q3,Elderly
1939157413,19391574,55,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,13,F,201911.0,20210820.0,20210608,20210902,EXP,,PL-PFIZER INC-2021627445,PFIZER,,65.0,YR,,M,Y,,,20210902.0,,MD,PL,PL,2021,Q3,Elderly
1939157413,19391574,55,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,13,F,201911.0,20210820.0,20210608,20210902,EXP,,PL-PFIZER INC-2021627445,PFIZER,,65.0,YR,,M,Y,,,20210902.0,,MD,PL,PL,2021,Q3,Elderly
1939157413,19391574,55,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,13,F,201911.0,20210820.0,20210608,20210902,EXP,,PL-PFIZER INC-2021627445,PFIZER,,65.0,YR,,M,Y,,,20210902.0,,MD,PL,PL,2021,Q3,Elderly
1939157413,19391574,55,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,13,F,201911.0,20210820.0,20210608,20210902,EXP,,PL-PFIZER INC-2021627445,PFIZER,,65.0,YR,,M,Y,,,20210902.0,,MD,PL,PL,2021,Q3,Elderly
1939157413,19391574,55,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,13,F,201911.0,20210820.0,20210608,20210902,EXP,,PL-PFIZER INC-2021627445,PFIZER,,65.0,YR,,M,Y,,,20210902.0,,MD,PL,PL,2021,Q3,Elderly
1939157413,19391574,55,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,13,F,201911.0,20210820.0,20210608,20210902,EXP,,PL-PFIZER INC-2021627445,PFIZER,,65.0,YR,,M,Y,,,20210902.0,,MD,PL,PL,2021,Q3,Elderly
1939157413,19391574,55,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,13,F,201911.0,20210820.0,20210608,20210902,EXP,,PL-PFIZER INC-2021627445,PFIZER,,65.0,YR,,M,Y,,,20210902.0,,MD,PL,PL,2021,Q3,Elderly
194078283,19407828,32,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Blood pressure decreased,,2021,Q3,3,F,201911.0,20210624.0,20210611,20210709,EXP,,PL-GLAXOSMITHKLINE-PL2021EME121294,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210709.0,,CN,PL,PL,2021,Q3,Elderly
194078283,19407828,32,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,3,F,201911.0,20210624.0,20210611,20210709,EXP,,PL-GLAXOSMITHKLINE-PL2021EME121294,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210709.0,,CN,PL,PL,2021,Q3,Elderly
194078283,19407828,32,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,3,F,201911.0,20210624.0,20210611,20210709,EXP,,PL-GLAXOSMITHKLINE-PL2021EME121294,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210709.0,,CN,PL,PL,2021,Q3,Elderly
194078283,19407828,32,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,3,F,201911.0,20210624.0,20210611,20210709,EXP,,PL-GLAXOSMITHKLINE-PL2021EME121294,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210709.0,,CN,PL,PL,2021,Q3,Elderly
194078283,19407828,32,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,201911.0,20210624.0,20210611,20210709,EXP,,PL-GLAXOSMITHKLINE-PL2021EME121294,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210709.0,,CN,PL,PL,2021,Q3,Elderly
194078283,19407828,32,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,3,F,201911.0,20210624.0,20210611,20210709,EXP,,PL-GLAXOSMITHKLINE-PL2021EME121294,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210709.0,,CN,PL,PL,2021,Q3,Elderly
194078283,19407828,32,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,3,F,201911.0,20210624.0,20210611,20210709,EXP,,PL-GLAXOSMITHKLINE-PL2021EME121294,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210709.0,,CN,PL,PL,2021,Q3,Elderly
194078283,19407828,32,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,3,F,201911.0,20210624.0,20210611,20210709,EXP,,PL-GLAXOSMITHKLINE-PL2021EME121294,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210709.0,,CN,PL,PL,2021,Q3,Elderly
194078283,19407828,32,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,3,F,201911.0,20210624.0,20210611,20210709,EXP,,PL-GLAXOSMITHKLINE-PL2021EME121294,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210709.0,,CN,PL,PL,2021,Q3,Elderly
194078283,19407828,32,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,3,F,201911.0,20210624.0,20210611,20210709,EXP,,PL-GLAXOSMITHKLINE-PL2021EME121294,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210709.0,,CN,PL,PL,2021,Q3,Elderly
194078283,19407828,32,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,3,F,201911.0,20210624.0,20210611,20210709,EXP,,PL-GLAXOSMITHKLINE-PL2021EME121294,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210709.0,,CN,PL,PL,2021,Q3,Elderly
194078283,19407828,32,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,3,F,201911.0,20210624.0,20210611,20210709,EXP,,PL-GLAXOSMITHKLINE-PL2021EME121294,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210709.0,,CN,PL,PL,2021,Q3,Elderly
194078283,19407828,32,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,3,F,201911.0,20210624.0,20210611,20210709,EXP,,PL-GLAXOSMITHKLINE-PL2021EME121294,GLAXOSMITHKLINE,,65.0,YR,,M,Y,,,20210709.0,,CN,PL,PL,2021,Q3,Elderly
194173552,19417355,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Decreased activity,,2021,Q3,2,F,,20210630.0,20210614,20210712,EXP,,NVSJ2021JP008821,NOVARTIS,,86.0,YR,,F,Y,,,20210712.0,,PH,JP,JP,2021,Q3,Elderly
194173552,19417355,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Gastrointestinal haemorrhage,,2021,Q3,2,F,,20210630.0,20210614,20210712,EXP,,NVSJ2021JP008821,NOVARTIS,,86.0,YR,,F,Y,,,20210712.0,,PH,JP,JP,2021,Q3,Elderly
194173552,19417355,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,2,F,,20210630.0,20210614,20210712,EXP,,NVSJ2021JP008821,NOVARTIS,,86.0,YR,,F,Y,,,20210712.0,,PH,JP,JP,2021,Q3,Elderly
194173552,19417355,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,2,F,,20210630.0,20210614,20210712,EXP,,NVSJ2021JP008821,NOVARTIS,,86.0,YR,,F,Y,,,20210712.0,,PH,JP,JP,2021,Q3,Elderly
194364052,19436405,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Acidosis,,2021,Q3,2,F,20210605.0,20210621.0,20210618,20210702,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202106006089,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20210702.0,,MD,CN,CN,2021,Q3,Adult
194364052,19436405,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Blood creatinine increased,,2021,Q3,2,F,20210605.0,20210621.0,20210618,20210702,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202106006089,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20210702.0,,MD,CN,CN,2021,Q3,Adult
194364052,19436405,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Dehydration,,2021,Q3,2,F,20210605.0,20210621.0,20210618,20210702,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202106006089,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20210702.0,,MD,CN,CN,2021,Q3,Adult
194364052,19436405,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,2,F,20210605.0,20210621.0,20210618,20210702,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202106006089,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20210702.0,,MD,CN,CN,2021,Q3,Adult
194415045,19441504,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, O2L",,,,,,,,10.0,MG,,,2021,Q3,Blood creatinine increased,,2021,Q3,5,F,20210616.0,20210909.0,20210621,20210914,EXP,,NVSC2021ES137322,NOVARTIS,,71.0,YR,,F,Y,67.0,KG,20210914.0,,HP,ES,ES,2021,Q3,Elderly
194512473,19451247,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Blood pressure decreased,,2021,Q3,3,F,201911.0,20210706.0,20210623,20210723,EXP,,PL-SA-2021SA201970,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210723.0,,MD,PL,PL,2021,Q3,Elderly
194512473,19451247,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,3,F,201911.0,20210706.0,20210623,20210723,EXP,,PL-SA-2021SA201970,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210723.0,,MD,PL,PL,2021,Q3,Elderly
194512473,19451247,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,3,F,201911.0,20210706.0,20210623,20210723,EXP,,PL-SA-2021SA201970,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210723.0,,MD,PL,PL,2021,Q3,Elderly
194512473,19451247,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,3,F,201911.0,20210706.0,20210623,20210723,EXP,,PL-SA-2021SA201970,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210723.0,,MD,PL,PL,2021,Q3,Elderly
194512473,19451247,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,201911.0,20210706.0,20210623,20210723,EXP,,PL-SA-2021SA201970,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210723.0,,MD,PL,PL,2021,Q3,Elderly
194512473,19451247,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,3,F,201911.0,20210706.0,20210623,20210723,EXP,,PL-SA-2021SA201970,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210723.0,,MD,PL,PL,2021,Q3,Elderly
194512473,19451247,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,3,F,201911.0,20210706.0,20210623,20210723,EXP,,PL-SA-2021SA201970,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210723.0,,MD,PL,PL,2021,Q3,Elderly
194512473,19451247,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,3,F,201911.0,20210706.0,20210623,20210723,EXP,,PL-SA-2021SA201970,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210723.0,,MD,PL,PL,2021,Q3,Elderly
194512473,19451247,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,3,F,201911.0,20210706.0,20210623,20210723,EXP,,PL-SA-2021SA201970,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210723.0,,MD,PL,PL,2021,Q3,Elderly
194512473,19451247,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,3,F,201911.0,20210706.0,20210623,20210723,EXP,,PL-SA-2021SA201970,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210723.0,,MD,PL,PL,2021,Q3,Elderly
194512473,19451247,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,3,F,201911.0,20210706.0,20210623,20210723,EXP,,PL-SA-2021SA201970,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210723.0,,MD,PL,PL,2021,Q3,Elderly
194512473,19451247,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,3,F,201911.0,20210706.0,20210623,20210723,EXP,,PL-SA-2021SA201970,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210723.0,,MD,PL,PL,2021,Q3,Elderly
194512473,19451247,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,3,F,201911.0,20210706.0,20210623,20210723,EXP,,PL-SA-2021SA201970,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20210723.0,,MD,PL,PL,2021,Q3,Elderly
194628113,19462811,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Blood pressure decreased,,2021,Q3,3,F,201911.0,20210802.0,20210625,20210810,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210810.0,,HP,PL,PL,2021,Q3,Elderly
194628113,19462811,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,3,F,201911.0,20210802.0,20210625,20210810,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210810.0,,HP,PL,PL,2021,Q3,Elderly
194628113,19462811,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,3,F,201911.0,20210802.0,20210625,20210810,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210810.0,,HP,PL,PL,2021,Q3,Elderly
194628113,19462811,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,3,F,201911.0,20210802.0,20210625,20210810,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210810.0,,HP,PL,PL,2021,Q3,Elderly
194628113,19462811,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,201911.0,20210802.0,20210625,20210810,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210810.0,,HP,PL,PL,2021,Q3,Elderly
194628113,19462811,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,3,F,201911.0,20210802.0,20210625,20210810,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210810.0,,HP,PL,PL,2021,Q3,Elderly
194628113,19462811,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,3,F,201911.0,20210802.0,20210625,20210810,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210810.0,,HP,PL,PL,2021,Q3,Elderly
194628113,19462811,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,3,F,201911.0,20210802.0,20210625,20210810,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210810.0,,HP,PL,PL,2021,Q3,Elderly
194628113,19462811,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,3,F,201911.0,20210802.0,20210625,20210810,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210810.0,,HP,PL,PL,2021,Q3,Elderly
194628113,19462811,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,3,F,201911.0,20210802.0,20210625,20210810,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210810.0,,HP,PL,PL,2021,Q3,Elderly
194628113,19462811,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,3,F,201911.0,20210802.0,20210625,20210810,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210810.0,,HP,PL,PL,2021,Q3,Elderly
194628113,19462811,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,3,F,201911.0,20210802.0,20210625,20210810,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210810.0,,HP,PL,PL,2021,Q3,Elderly
194628113,19462811,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,3,F,201911.0,20210802.0,20210625,20210810,EXP,,NVSC2021PL139034,NOVARTIS,,65.0,YR,,M,Y,,,20210810.0,,HP,PL,PL,2021,Q3,Elderly
194641973,19464197,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Blood pressure decreased,,2021,Q3,3,F,201911.0,20210719.0,20210627,20210802,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210802.0,,CN,PL,PL,2021,Q3,Elderly
194641973,19464197,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,3,F,201911.0,20210719.0,20210627,20210802,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210802.0,,CN,PL,PL,2021,Q3,Elderly
194641973,19464197,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,3,F,201911.0,20210719.0,20210627,20210802,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210802.0,,CN,PL,PL,2021,Q3,Elderly
194641973,19464197,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,3,F,201911.0,20210719.0,20210627,20210802,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210802.0,,CN,PL,PL,2021,Q3,Elderly
194641973,19464197,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,201911.0,20210719.0,20210627,20210802,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210802.0,,CN,PL,PL,2021,Q3,Elderly
194641973,19464197,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,3,F,201911.0,20210719.0,20210627,20210802,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210802.0,,CN,PL,PL,2021,Q3,Elderly
194641973,19464197,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,3,F,201911.0,20210719.0,20210627,20210802,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210802.0,,CN,PL,PL,2021,Q3,Elderly
194641973,19464197,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,3,F,201911.0,20210719.0,20210627,20210802,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210802.0,,CN,PL,PL,2021,Q3,Elderly
194641973,19464197,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,3,F,201911.0,20210719.0,20210627,20210802,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210802.0,,CN,PL,PL,2021,Q3,Elderly
194641973,19464197,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,3,F,201911.0,20210719.0,20210627,20210802,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210802.0,,CN,PL,PL,2021,Q3,Elderly
194641973,19464197,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,3,F,201911.0,20210719.0,20210627,20210802,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210802.0,,CN,PL,PL,2021,Q3,Elderly
194641973,19464197,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,3,F,201911.0,20210719.0,20210627,20210802,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210802.0,,CN,PL,PL,2021,Q3,Elderly
194641973,19464197,33,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,3,F,201911.0,20210719.0,20210627,20210802,EXP,,PL-AUROBINDO-AUR-APL-2021-026181,AUROBINDO,,65.0,YR,,M,Y,,,20210802.0,,CN,PL,PL,2021,Q3,Elderly
194661672,19466167,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Blood pressure decreased,,2021,Q3,2,F,201911.0,20210705.0,20210624,20210715,EXP,,PL-BAXTER-2021BAX016706,BAXTER,,65.0,YR,,M,Y,,,20210715.0,,CN,PL,PL,2021,Q3,Elderly
194661672,19466167,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,2,F,201911.0,20210705.0,20210624,20210715,EXP,,PL-BAXTER-2021BAX016706,BAXTER,,65.0,YR,,M,Y,,,20210715.0,,CN,PL,PL,2021,Q3,Elderly
194661672,19466167,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,2,F,201911.0,20210705.0,20210624,20210715,EXP,,PL-BAXTER-2021BAX016706,BAXTER,,65.0,YR,,M,Y,,,20210715.0,,CN,PL,PL,2021,Q3,Elderly
194661672,19466167,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,2,F,201911.0,20210705.0,20210624,20210715,EXP,,PL-BAXTER-2021BAX016706,BAXTER,,65.0,YR,,M,Y,,,20210715.0,,CN,PL,PL,2021,Q3,Elderly
194661672,19466167,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,2,F,201911.0,20210705.0,20210624,20210715,EXP,,PL-BAXTER-2021BAX016706,BAXTER,,65.0,YR,,M,Y,,,20210715.0,,CN,PL,PL,2021,Q3,Elderly
194661672,19466167,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,2,F,201911.0,20210705.0,20210624,20210715,EXP,,PL-BAXTER-2021BAX016706,BAXTER,,65.0,YR,,M,Y,,,20210715.0,,CN,PL,PL,2021,Q3,Elderly
194661672,19466167,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,2,F,201911.0,20210705.0,20210624,20210715,EXP,,PL-BAXTER-2021BAX016706,BAXTER,,65.0,YR,,M,Y,,,20210715.0,,CN,PL,PL,2021,Q3,Elderly
194661672,19466167,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,2,F,201911.0,20210705.0,20210624,20210715,EXP,,PL-BAXTER-2021BAX016706,BAXTER,,65.0,YR,,M,Y,,,20210715.0,,CN,PL,PL,2021,Q3,Elderly
194661672,19466167,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,2,F,201911.0,20210705.0,20210624,20210715,EXP,,PL-BAXTER-2021BAX016706,BAXTER,,65.0,YR,,M,Y,,,20210715.0,,CN,PL,PL,2021,Q3,Elderly
194661672,19466167,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,2,F,201911.0,20210705.0,20210624,20210715,EXP,,PL-BAXTER-2021BAX016706,BAXTER,,65.0,YR,,M,Y,,,20210715.0,,CN,PL,PL,2021,Q3,Elderly
194661672,19466167,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,2,F,201911.0,20210705.0,20210624,20210715,EXP,,PL-BAXTER-2021BAX016706,BAXTER,,65.0,YR,,M,Y,,,20210715.0,,CN,PL,PL,2021,Q3,Elderly
194661672,19466167,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,2,F,201911.0,20210705.0,20210624,20210715,EXP,,PL-BAXTER-2021BAX016706,BAXTER,,65.0,YR,,M,Y,,,20210715.0,,CN,PL,PL,2021,Q3,Elderly
194661672,19466167,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,2,F,201911.0,20210705.0,20210624,20210715,EXP,,PL-BAXTER-2021BAX016706,BAXTER,,65.0,YR,,M,Y,,,20210715.0,,CN,PL,PL,2021,Q3,Elderly
194673592,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Atrial fibrillation,,2021,Q3,2,F,,20210714.0,20210628,20210726,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210726.0,,MD,JP,JP,2021,Q3,Elderly
194673592,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Cardiac failure,,2021,Q3,2,F,,20210714.0,20210628,20210726,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210726.0,,MD,JP,JP,2021,Q3,Elderly
194673592,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Cardiomegaly,,2021,Q3,2,F,,20210714.0,20210628,20210726,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210726.0,,MD,JP,JP,2021,Q3,Elderly
194673592,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Congestive cardiomyopathy,,2021,Q3,2,F,,20210714.0,20210628,20210726,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210726.0,,MD,JP,JP,2021,Q3,Elderly
194673592,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,2,F,,20210714.0,20210628,20210726,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210726.0,,MD,JP,JP,2021,Q3,Elderly
194673592,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,2,F,,20210714.0,20210628,20210726,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210726.0,,MD,JP,JP,2021,Q3,Elderly
194673592,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Tricuspid valve incompetence,,2021,Q3,2,F,,20210714.0,20210628,20210726,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210726.0,,MD,JP,JP,2021,Q3,Elderly
194673592,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Ventricular internal diameter abnormal,,2021,Q3,2,F,,20210714.0,20210628,20210726,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210726.0,,MD,JP,JP,2021,Q3,Elderly
194673592,19467359,11,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Ventricular tachycardia,,2021,Q3,2,F,,20210714.0,20210628,20210726,EXP,,NVSJ2021JP009449,NOVARTIS,,67.0,YR,,M,Y,,,20210726.0,,MD,JP,JP,2021,Q3,Elderly
194712752,19471275,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, UNK",,,U,,,,,10.0,MG,,,2021,Q3,Blood pressure decreased,,2021,Q3,2,F,201911.0,20210701.0,20210629,20210716,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302390,RANBAXY,,65.0,YR,,M,Y,,,20210716.0,,HP,NL,PL,2021,Q3,Elderly
194712752,19471275,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, UNK",,,U,,,,,10.0,MG,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,2,F,201911.0,20210701.0,20210629,20210716,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302390,RANBAXY,,65.0,YR,,M,Y,,,20210716.0,,HP,NL,PL,2021,Q3,Elderly
194712752,19471275,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, UNK",,,U,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,2,F,201911.0,20210701.0,20210629,20210716,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302390,RANBAXY,,65.0,YR,,M,Y,,,20210716.0,,HP,NL,PL,2021,Q3,Elderly
194712752,19471275,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, UNK",,,U,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,2,F,201911.0,20210701.0,20210629,20210716,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302390,RANBAXY,,65.0,YR,,M,Y,,,20210716.0,,HP,NL,PL,2021,Q3,Elderly
194712752,19471275,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, UNK",,,U,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,2,F,201911.0,20210701.0,20210629,20210716,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302390,RANBAXY,,65.0,YR,,M,Y,,,20210716.0,,HP,NL,PL,2021,Q3,Elderly
194712752,19471275,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, UNK",,,U,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,2,F,201911.0,20210701.0,20210629,20210716,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302390,RANBAXY,,65.0,YR,,M,Y,,,20210716.0,,HP,NL,PL,2021,Q3,Elderly
194712752,19471275,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, UNK",,,U,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,2,F,201911.0,20210701.0,20210629,20210716,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302390,RANBAXY,,65.0,YR,,M,Y,,,20210716.0,,HP,NL,PL,2021,Q3,Elderly
194712752,19471275,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, UNK",,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,2,F,201911.0,20210701.0,20210629,20210716,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302390,RANBAXY,,65.0,YR,,M,Y,,,20210716.0,,HP,NL,PL,2021,Q3,Elderly
194712752,19471275,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, UNK",,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,2,F,201911.0,20210701.0,20210629,20210716,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302390,RANBAXY,,65.0,YR,,M,Y,,,20210716.0,,HP,NL,PL,2021,Q3,Elderly
194712752,19471275,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, UNK",,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,2,F,201911.0,20210701.0,20210629,20210716,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302390,RANBAXY,,65.0,YR,,M,Y,,,20210716.0,,HP,NL,PL,2021,Q3,Elderly
194712752,19471275,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, UNK",,,U,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,2,F,201911.0,20210701.0,20210629,20210716,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302390,RANBAXY,,65.0,YR,,M,Y,,,20210716.0,,HP,NL,PL,2021,Q3,Elderly
194712752,19471275,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, UNK",,,U,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,2,F,201911.0,20210701.0,20210629,20210716,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302390,RANBAXY,,65.0,YR,,M,Y,,,20210716.0,,HP,NL,PL,2021,Q3,Elderly
194712752,19471275,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, UNK",,,U,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,2,F,201911.0,20210701.0,20210629,20210716,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302390,RANBAXY,,65.0,YR,,M,Y,,,20210716.0,,HP,NL,PL,2021,Q3,Elderly
194815771,19481577,17,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,1,I,20210511.0,20210624.0,20210701,20210701,EXP,CH-SM-2021-17019,CH-GLAXOSMITHKLINE-CH2021137783,GLAXOSMITHKLINE,,57.0,YR,,F,Y,,,20210701.0,,MD,CH,CH,2021,Q3,Adult
194815771,19481577,17,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Rash maculo-papular,,2021,Q3,1,I,20210511.0,20210624.0,20210701,20210701,EXP,CH-SM-2021-17019,CH-GLAXOSMITHKLINE-CH2021137783,GLAXOSMITHKLINE,,57.0,YR,,F,Y,,,20210701.0,,MD,CH,CH,2021,Q3,Adult
194851091,19485109,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Carotid artery stenosis,,2021,Q3,1,I,20180606.0,20210622.0,20210702,20210702,EXP,,BR-NOVOPROD-824140,NOVO NORDISK,,75.0,YR,,M,Y,113.6,KG,20210702.0,,MD,BR,BR,2021,Q3,Elderly
194851091,19485109,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,1,I,20180606.0,20210622.0,20210702,20210702,EXP,,BR-NOVOPROD-824140,NOVO NORDISK,,75.0,YR,,M,Y,113.6,KG,20210702.0,,MD,BR,BR,2021,Q3,Elderly
194851091,19485109,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Hepatic steatosis,,2021,Q3,1,I,20180606.0,20210622.0,20210702,20210702,EXP,,BR-NOVOPROD-824140,NOVO NORDISK,,75.0,YR,,M,Y,113.6,KG,20210702.0,,MD,BR,BR,2021,Q3,Elderly
194851091,19485109,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Left ventricular hypertrophy,,2021,Q3,1,I,20180606.0,20210622.0,20210702,20210702,EXP,,BR-NOVOPROD-824140,NOVO NORDISK,,75.0,YR,,M,Y,113.6,KG,20210702.0,,MD,BR,BR,2021,Q3,Elderly
194851091,19485109,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Pneumonia,,2021,Q3,1,I,20180606.0,20210622.0,20210702,20210702,EXP,,BR-NOVOPROD-824140,NOVO NORDISK,,75.0,YR,,M,Y,113.6,KG,20210702.0,,MD,BR,BR,2021,Q3,Elderly
194874101,19487410,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,20210427.0,20210628.0,20210702,20210702,EXP,,ES-ASTRAZENECA-2021A569428,ASTRAZENECA,,60.0,YR,,F,Y,,,20210702.0,,MD,ES,ES,2021,Q3,Adult
194885401,19488540,14,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,1,I,20210511.0,20210624.0,20210702,20210702,EXP,CH-SM-2021-17019,CH-LUNDBECK-DKLU3035119,LUNDBECK,,57.0,YR,A,F,Y,,,20210702.0,,MD,CH,CH,2021,Q3,Adult
194885401,19488540,14,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Rash maculo-papular,,2021,Q3,1,I,20210511.0,20210624.0,20210702,20210702,EXP,CH-SM-2021-17019,CH-LUNDBECK-DKLU3035119,LUNDBECK,,57.0,YR,A,F,Y,,,20210702.0,,MD,CH,CH,2021,Q3,Adult
194894471,19489447,6,C,Dapagliflozin/Metformin,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"2 DOSAGE FORMS DAILY; 5|1000 MG, 1?0?0?1",,,,, UNKNOWN,,,1.0,DF,TABLET,BID,2021,Q3,Fall,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928357,TEVA,,66.0,YR,E,F,Y,,,20210703.0,,MD,DE,DE,2021,Q3,Elderly
194894471,19489447,6,C,Dapagliflozin/Metformin,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"2 DOSAGE FORMS DAILY; 5|1000 MG, 1?0?0?1",,,,, UNKNOWN,,,1.0,DF,TABLET,BID,2021,Q3,Hyperkalaemia,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928357,TEVA,,66.0,YR,E,F,Y,,,20210703.0,,MD,DE,DE,2021,Q3,Elderly
194894471,19489447,6,C,Dapagliflozin/Metformin,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"2 DOSAGE FORMS DAILY; 5|1000 MG, 1?0?0?1",,,,, UNKNOWN,,,1.0,DF,TABLET,BID,2021,Q3,Sinus bradycardia,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928357,TEVA,,66.0,YR,E,F,Y,,,20210703.0,,MD,DE,DE,2021,Q3,Elderly
194913261,19491326,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0DF UNKNOWN,,,,,,,,10.0,DF,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,,20210624.0,20210705,20210705,EXP,,GB-ASTRAZENECA-2021A563263,ASTRAZENECA,,66.0,YR,,M,Y,112.0,KG,20210705.0,,HP,GB,GB,2021,Q3,Elderly
194913261,19491326,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0DF UNKNOWN,,,,,,,,10.0,DF,,,2021,Q3,Thirst,,2021,Q3,1,I,,20210624.0,20210705,20210705,EXP,,GB-ASTRAZENECA-2021A563263,ASTRAZENECA,,66.0,YR,,M,Y,112.0,KG,20210705.0,,HP,GB,GB,2021,Q3,Elderly
194936282,19493628,5,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2021,Q3,Bladder cancer,,2021,Q3,2,F,20210526.0,20210710.0,20210705,20210723,EXP,,NVSC2021CN146501,NOVARTIS,,59.0,YR,,M,Y,,,20210723.0,,CN,CN,CN,2021,Q3,Adult
194936282,19493628,5,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2021,Q3,Haematuria,,2021,Q3,2,F,20210526.0,20210710.0,20210705,20210723,EXP,,NVSC2021CN146501,NOVARTIS,,59.0,YR,,M,Y,,,20210723.0,,CN,CN,CN,2021,Q3,Adult
194936282,19493628,5,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2021,Q3,Product use in unapproved indication,,2021,Q3,2,F,20210526.0,20210710.0,20210705,20210723,EXP,,NVSC2021CN146501,NOVARTIS,,59.0,YR,,M,Y,,,20210723.0,,CN,CN,CN,2021,Q3,Adult
194936282,19493628,5,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2021,Q3,Proteinuria,,2021,Q3,2,F,20210526.0,20210710.0,20210705,20210723,EXP,,NVSC2021CN146501,NOVARTIS,,59.0,YR,,M,Y,,,20210723.0,,CN,CN,CN,2021,Q3,Adult
194936282,19493628,5,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2021,Q3,Wrong technique in product usage process,,2021,Q3,2,F,20210526.0,20210710.0,20210705,20210723,EXP,,NVSC2021CN146501,NOVARTIS,,59.0,YR,,M,Y,,,20210723.0,,CN,CN,CN,2021,Q3,Adult
194971831,19497183,13,C,DAPAGLIFLOZINE,DAPAGLIFLOZIN,1,,,,,,,,,7157.0,,,,,2021,Q3,Rash maculo-papular,,2021,Q3,1,I,20210527.0,20210624.0,20210706,20210706,EXP,CH-SM-2021-17019,CH-UCBSA-2021031742,UCB,,57.0,YR,,F,Y,,,20210706.0,,MD,CH,CH,2021,Q3,Adult
195024402,19502440,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF(10), QD",,,U,,,,,1.0,DF,,QD,2021,Q3,Ejection fraction decreased,,2021,Q3,2,F,,20210616.0,20210707,20210708,EXP,,NVSC2021TH137151,NOVARTIS,,23.0,YR,,M,Y,,,20210709.0,,MD,TH,TH,2021,Q3,Youth
195024402,19502440,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF(10), QD",,,U,,,,,1.0,DF,,QD,2021,Q3,Heart rate decreased,,2021,Q3,2,F,,20210616.0,20210707,20210708,EXP,,NVSC2021TH137151,NOVARTIS,,23.0,YR,,M,Y,,,20210709.0,,MD,TH,TH,2021,Q3,Youth
195024402,19502440,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF(10), QD",,,U,,,,,1.0,DF,,QD,2021,Q3,Heart sounds abnormal,,2021,Q3,2,F,,20210616.0,20210707,20210708,EXP,,NVSC2021TH137151,NOVARTIS,,23.0,YR,,M,Y,,,20210709.0,,MD,TH,TH,2021,Q3,Youth
195024402,19502440,18,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF(10), QD",,,U,,,,,1.0,DF,,QD,2021,Q3,Peripheral coldness,,2021,Q3,2,F,,20210616.0,20210707,20210708,EXP,,NVSC2021TH137151,NOVARTIS,,23.0,YR,,M,Y,,,20210709.0,,MD,TH,TH,2021,Q3,Youth
195024402,19502440,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF(10), QD",,,U,,,,,1.0,DF,,QD,2021,Q3,Ejection fraction decreased,,2021,Q3,2,F,,20210616.0,20210707,20210708,EXP,,NVSC2021TH137151,NOVARTIS,,23.0,YR,,M,Y,,,20210709.0,,MD,TH,TH,2021,Q3,Youth
195024402,19502440,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF(10), QD",,,U,,,,,1.0,DF,,QD,2021,Q3,Heart rate decreased,,2021,Q3,2,F,,20210616.0,20210707,20210708,EXP,,NVSC2021TH137151,NOVARTIS,,23.0,YR,,M,Y,,,20210709.0,,MD,TH,TH,2021,Q3,Youth
195024402,19502440,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF(10), QD",,,U,,,,,1.0,DF,,QD,2021,Q3,Heart sounds abnormal,,2021,Q3,2,F,,20210616.0,20210707,20210708,EXP,,NVSC2021TH137151,NOVARTIS,,23.0,YR,,M,Y,,,20210709.0,,MD,TH,TH,2021,Q3,Youth
195024402,19502440,19,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF(10), QD",,,U,,,,,1.0,DF,,QD,2021,Q3,Peripheral coldness,,2021,Q3,2,F,,20210616.0,20210707,20210708,EXP,,NVSC2021TH137151,NOVARTIS,,23.0,YR,,M,Y,,,20210709.0,,MD,TH,TH,2021,Q3,Youth
195051571,19505157,1,PS,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNKNOWN,,,,,,,202293.0,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210630.0,20210707,20210707,EXP,,GB-ASTRAZENECA-2021A579933,ASTRAZENECA,,89.0,YR,,M,Y,,,20210707.0,,,GB,GB,2021,Q3,Elderly
195051571,19505157,1,PS,DAPAGLIFLOZIN PROPANEDIOL.,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNKNOWN,,,,,,,202293.0,,,,,2021,Q3,Peripheral arterial occlusive disease,,2021,Q3,1,I,,20210630.0,20210707,20210707,EXP,,GB-ASTRAZENECA-2021A579933,ASTRAZENECA,,89.0,YR,,M,Y,,,20210707.0,,,GB,GB,2021,Q3,Elderly
195053711,19505371,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,N,D,,,,10.0,MG,,QD,2021,Q3,Fournier's gangrene,,2021,Q3,1,I,20210705.0,,20210707,20210707,DIR,,,FDA-CTU,,57.0,YR,,M,N,116.6,KG,20210707.0,N,PH,US,US,2021,Q3,Adult
195053711,19505371,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,N,D,,,,10.0,MG,,QD,2021,Q3,Infection,,2021,Q3,1,I,20210705.0,,20210707,20210707,DIR,,,FDA-CTU,,57.0,YR,,M,N,116.6,KG,20210707.0,N,PH,US,US,2021,Q3,Adult
195053711,19505371,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,N,D,,,,10.0,MG,,QD,2021,Q3,Necrotising fasciitis,,2021,Q3,1,I,20210705.0,,20210707,20210707,DIR,,,FDA-CTU,,57.0,YR,,M,N,116.6,KG,20210707.0,N,PH,US,US,2021,Q3,Adult
195070501,19507050,3,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2021,Q3,Enuresis,,2021,Q3,1,I,20210620.0,20210627.0,20210708,20210708,EXP,GB-MHRA-EYC 00254361,GB-MYLANLABS-2021M1038900,MYLAN,,51.0,YR,,F,Y,91.0,KG,20210708.0,,CN,GB,GB,2021,Q3,Adult
195070501,19507050,3,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2021,Q3,Stress urinary incontinence,,2021,Q3,1,I,20210620.0,20210627.0,20210708,20210708,EXP,GB-MHRA-EYC 00254361,GB-MYLANLABS-2021M1038900,MYLAN,,51.0,YR,,F,Y,91.0,KG,20210708.0,,CN,GB,GB,2021,Q3,Adult
195073051,19507305,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,220.0,MG,Y,, 2103051,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Asthenia,,2021,Q3,1,I,20210622.0,20210630.0,20210708,20210708,EXP,,CN-ASTRAZENECA-2021A585191,ASTRAZENECA,,21899.0,DY,,M,Y,65.0,KG,20210708.0,,HP,CN,CN,2021,Q3,Elderly
195073051,19507305,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,220.0,MG,Y,, 2103051,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Marasmus,,2021,Q3,1,I,20210622.0,20210630.0,20210708,20210708,EXP,,CN-ASTRAZENECA-2021A585191,ASTRAZENECA,,21899.0,DY,,M,Y,65.0,KG,20210708.0,,HP,CN,CN,2021,Q3,Elderly
195082161,19508216,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10MG DAILY,,,N,,,,202293.0,,,,,2021,Q3,Gangrene,,2021,Q3,1,I,,20210701.0,20210708,20210708,EXP,,GB-ASTRAZENECA-2021A583676,ASTRAZENECA,,58.0,YR,,M,Y,82.1,KG,20210708.0,,PH,GB,GB,2021,Q3,Adult
195211121,19521112,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN DOSE AND FREQUENCY,,,U,,,,,,,TABLET,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,2015.0,20210708.0,20210712,20210712,EXP,DE-ASTRAZENECA-2021A009294,DE-MYLANLABS-2021M1041541,MYLAN,,72.0,YR,,F,Y,89.0,KG,20210712.0,,MD,DE,DE,2021,Q3,Elderly
195211121,19521112,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN DOSE AND FREQUENCY,,,U,,,,,,,TABLET,,2021,Q3,Blood pressure increased,,2021,Q3,1,I,2015.0,20210708.0,20210712,20210712,EXP,DE-ASTRAZENECA-2021A009294,DE-MYLANLABS-2021M1041541,MYLAN,,72.0,YR,,F,Y,89.0,KG,20210712.0,,MD,DE,DE,2021,Q3,Elderly
195211121,19521112,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN DOSE AND FREQUENCY,,,U,,,,,,,TABLET,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,1,I,2015.0,20210708.0,20210712,20210712,EXP,DE-ASTRAZENECA-2021A009294,DE-MYLANLABS-2021M1041541,MYLAN,,72.0,YR,,F,Y,89.0,KG,20210712.0,,MD,DE,DE,2021,Q3,Elderly
195211121,19521112,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNKNOWN DOSE AND FREQUENCY,,,U,,,,,,,TABLET,,2021,Q3,Low density lipoprotein increased,,2021,Q3,1,I,2015.0,20210708.0,20210712,20210712,EXP,DE-ASTRAZENECA-2021A009294,DE-MYLANLABS-2021M1041541,MYLAN,,72.0,YR,,F,Y,89.0,KG,20210712.0,,MD,DE,DE,2021,Q3,Elderly
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Blood creatine phosphokinase increased,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Body mass index increased,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Cardiac dysfunction,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Cardiomyopathy,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Drug ineffective,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Dyslipidaemia,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Ejection fraction decreased,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Influenza like illness,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Left ventricular dysfunction,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Pleural effusion,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Seizure,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Suspected COVID-19,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Treatment noncompliance,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195332232,19533223,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNKNOWN,,2021,Q3,Weight increased,,2021,Q3,2,F,2009.0,20210711.0,20210714,20210718,EXP,,AU-JNJFOC-20210708797,JOHNSON AND JOHNSON,,30.0,YR,A,M,Y,,,20210718.0,,HP,AU,AU,2021,Q3,Young Adult
195339821,19533982,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"UNK (5 MG, 1?0?1?0)",,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,DE-ADRED-06117-01,DE-MYLANLABS-2021M1040662,MYLAN,,73.0,YR,,M,Y,,,20210713.0,,MD,DE,DE,2021,Q3,Elderly
195339821,19533982,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"UNK (5 MG, 1?0?1?0)",,,,,,,,,,,,2021,Q3,Haematoma,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,DE-ADRED-06117-01,DE-MYLANLABS-2021M1040662,MYLAN,,73.0,YR,,M,Y,,,20210713.0,,MD,DE,DE,2021,Q3,Elderly
195339821,19533982,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"UNK (5 MG, 1?0?1?0)",,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,DE-ADRED-06117-01,DE-MYLANLABS-2021M1040662,MYLAN,,73.0,YR,,M,Y,,,20210713.0,,MD,DE,DE,2021,Q3,Elderly
195339821,19533982,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"UNK (5 MG, 1?0?1?0)",,,,,,,,,,,,2021,Q3,Skin irritation,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,DE-ADRED-06117-01,DE-MYLANLABS-2021M1040662,MYLAN,,73.0,YR,,M,Y,,,20210713.0,,MD,DE,DE,2021,Q3,Elderly
195355391,19535539,5,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,,2021,Q3,Enthesopathy,,2021,Q3,1,I,,20210705.0,20210714,20210714,EXP,,CA-APOTEX-2021AP017135,APOTEX,,55.0,YR,,M,Y,,,20210714.0,,CN,CA,CA,2021,Q3,Adult
195355391,19535539,5,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 MILLIGRAM, QD",,,D,,,,,10.0,MG,,,2021,Q3,Polyarthritis,,2021,Q3,1,I,,20210705.0,20210714,20210714,EXP,,CA-APOTEX-2021AP017135,APOTEX,,55.0,YR,,M,Y,,,20210714.0,,CN,CA,CA,2021,Q3,Adult
195483421,19548342,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10MG ONCE DAILY,,,Y,,,,,,,TABLET,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210703.0,20210705.0,20210714,20210714,EXP,,GB-ASTRAZENECA-2021A595843,ASTRAZENECA,,52.0,YR,,F,Y,79.0,KG,20210714.0,,PH,GB,GB,2021,Q3,Adult
195497552,19549755,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Blood pressure decreased,,2021,Q3,2,F,201911.0,20210715.0,20210714,20210727,EXP,PL-EMA-2021611-AUTODUP-1623366920098,PL-ACCORD-231454,ACCORD,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195497552,19549755,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,2,F,201911.0,20210715.0,20210714,20210727,EXP,PL-EMA-2021611-AUTODUP-1623366920098,PL-ACCORD-231454,ACCORD,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195497552,19549755,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,2,F,201911.0,20210715.0,20210714,20210727,EXP,PL-EMA-2021611-AUTODUP-1623366920098,PL-ACCORD-231454,ACCORD,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195497552,19549755,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,2,F,201911.0,20210715.0,20210714,20210727,EXP,PL-EMA-2021611-AUTODUP-1623366920098,PL-ACCORD-231454,ACCORD,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195497552,19549755,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,2,F,201911.0,20210715.0,20210714,20210727,EXP,PL-EMA-2021611-AUTODUP-1623366920098,PL-ACCORD-231454,ACCORD,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195497552,19549755,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,2,F,201911.0,20210715.0,20210714,20210727,EXP,PL-EMA-2021611-AUTODUP-1623366920098,PL-ACCORD-231454,ACCORD,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195497552,19549755,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,2,F,201911.0,20210715.0,20210714,20210727,EXP,PL-EMA-2021611-AUTODUP-1623366920098,PL-ACCORD-231454,ACCORD,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195497552,19549755,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,2,F,201911.0,20210715.0,20210714,20210727,EXP,PL-EMA-2021611-AUTODUP-1623366920098,PL-ACCORD-231454,ACCORD,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195497552,19549755,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,2,F,201911.0,20210715.0,20210714,20210727,EXP,PL-EMA-2021611-AUTODUP-1623366920098,PL-ACCORD-231454,ACCORD,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195497552,19549755,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,2,F,201911.0,20210715.0,20210714,20210727,EXP,PL-EMA-2021611-AUTODUP-1623366920098,PL-ACCORD-231454,ACCORD,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195497552,19549755,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,2,F,201911.0,20210715.0,20210714,20210727,EXP,PL-EMA-2021611-AUTODUP-1623366920098,PL-ACCORD-231454,ACCORD,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195497552,19549755,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,2,F,201911.0,20210715.0,20210714,20210727,EXP,PL-EMA-2021611-AUTODUP-1623366920098,PL-ACCORD-231454,ACCORD,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195497552,19549755,14,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,2,F,201911.0,20210715.0,20210714,20210727,EXP,PL-EMA-2021611-AUTODUP-1623366920098,PL-ACCORD-231454,ACCORD,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195625723,19562572,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,U,,,,,10.0,MG,TABLET,,2021,Q3,Acute myocardial infarction,,2021,Q3,3,F,,20210818.0,20210716,20210823,EXP,,NVSJ2021JP010786,NOVARTIS,,84.0,YR,,M,Y,,,20210823.0,,MD,JP,JP,2021,Q3,Elderly
195625723,19562572,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,U,,,,,10.0,MG,TABLET,,2021,Q3,Cardiac failure,,2021,Q3,3,F,,20210818.0,20210716,20210823,EXP,,NVSJ2021JP010786,NOVARTIS,,84.0,YR,,M,Y,,,20210823.0,,MD,JP,JP,2021,Q3,Elderly
195625723,19562572,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,U,,,,,10.0,MG,TABLET,,2021,Q3,Cardiac failure congestive,,2021,Q3,3,F,,20210818.0,20210716,20210823,EXP,,NVSJ2021JP010786,NOVARTIS,,84.0,YR,,M,Y,,,20210823.0,,MD,JP,JP,2021,Q3,Elderly
195625723,19562572,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,U,,,,,10.0,MG,TABLET,,2021,Q3,Dyspnoea exertional,,2021,Q3,3,F,,20210818.0,20210716,20210823,EXP,,NVSJ2021JP010786,NOVARTIS,,84.0,YR,,M,Y,,,20210823.0,,MD,JP,JP,2021,Q3,Elderly
195625723,19562572,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,U,,,,,10.0,MG,TABLET,,2021,Q3,Pneumonia aspiration,,2021,Q3,3,F,,20210818.0,20210716,20210823,EXP,,NVSJ2021JP010786,NOVARTIS,,84.0,YR,,M,Y,,,20210823.0,,MD,JP,JP,2021,Q3,Elderly
195625723,19562572,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10 MG,,,U,,,,,10.0,MG,TABLET,,2021,Q3,Urinary tract infection,,2021,Q3,3,F,,20210818.0,20210716,20210823,EXP,,NVSJ2021JP010786,NOVARTIS,,84.0,YR,,M,Y,,,20210823.0,,MD,JP,JP,2021,Q3,Elderly
195701081,19570108,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DF, QD, 1?0?0",,,,,,,,1.0,DF,,QD,2021,Q3,Back pain,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DF, QD, 1?0?0",,,,,,,,1.0,DF,,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DF, QD, 1?0?0",,,,,,,,1.0,DF,,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DF, QD, 1?0?0",,,,,,,,1.0,DF,,QD,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DF, QD, 1?0?0",,,,,,,,1.0,DF,,QD,2021,Q3,Eating disorder,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DF, QD, 1?0?0",,,,,,,,1.0,DF,,QD,2021,Q3,Intentional product use issue,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DF, QD, 1?0?0",,,,,,,,1.0,DF,,QD,2021,Q3,Mobility decreased,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195701081,19570108,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DF, QD, 1?0?0",,,,,,,,1.0,DF,,QD,2021,Q3,Tooth injury,,2021,Q3,1,I,2021.0,20210701.0,20210715,20210715,EXP,,ES-BAUSCH-BL-2021-023139,BAUSCH AND LOMB,,80.0,YR,,F,Y,65.0,KG,20210715.0,,CN,ES,ES,2021,Q3,Elderly
195722644,19572264,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2021,Q3,Herpes zoster cutaneous disseminated,,2021,Q3,4,F,20210630.0,20210927.0,20210716,20210930,EXP,,SG-ABBVIE-21P-141-3979449-00,ABBVIE,,45.0,YR,,M,Y,113.0,KG,20210930.0,,MD,SG,SG,2021,Q3,Adult
195723641,19572364,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG?THERAPY START DATE: ?MAR?2021,,,,,,,,10.0,MG,,,2021,Q3,Blood pressure decreased,,2021,Q3,1,I,201911.0,20210706.0,20210716,20210716,EXP,,PL-EMD SERONO-E2B_90084240,EMD SERONO INC,,65.0,YR,E,M,Y,,,20210716.0,,CN,PL,PL,2021,Q3,Elderly
195723641,19572364,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG?THERAPY START DATE: ?MAR?2021,,,,,,,,10.0,MG,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,1,I,201911.0,20210706.0,20210716,20210716,EXP,,PL-EMD SERONO-E2B_90084240,EMD SERONO INC,,65.0,YR,E,M,Y,,,20210716.0,,CN,PL,PL,2021,Q3,Elderly
195723641,19572364,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG?THERAPY START DATE: ?MAR?2021,,,,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,1,I,201911.0,20210706.0,20210716,20210716,EXP,,PL-EMD SERONO-E2B_90084240,EMD SERONO INC,,65.0,YR,E,M,Y,,,20210716.0,,CN,PL,PL,2021,Q3,Elderly
195723641,19572364,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG?THERAPY START DATE: ?MAR?2021,,,,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,1,I,201911.0,20210706.0,20210716,20210716,EXP,,PL-EMD SERONO-E2B_90084240,EMD SERONO INC,,65.0,YR,E,M,Y,,,20210716.0,,CN,PL,PL,2021,Q3,Elderly
195723641,19572364,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG?THERAPY START DATE: ?MAR?2021,,,,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,1,I,201911.0,20210706.0,20210716,20210716,EXP,,PL-EMD SERONO-E2B_90084240,EMD SERONO INC,,65.0,YR,E,M,Y,,,20210716.0,,CN,PL,PL,2021,Q3,Elderly
195723641,19572364,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG?THERAPY START DATE: ?MAR?2021,,,,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,1,I,201911.0,20210706.0,20210716,20210716,EXP,,PL-EMD SERONO-E2B_90084240,EMD SERONO INC,,65.0,YR,E,M,Y,,,20210716.0,,CN,PL,PL,2021,Q3,Elderly
195723641,19572364,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG?THERAPY START DATE: ?MAR?2021,,,,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,1,I,201911.0,20210706.0,20210716,20210716,EXP,,PL-EMD SERONO-E2B_90084240,EMD SERONO INC,,65.0,YR,E,M,Y,,,20210716.0,,CN,PL,PL,2021,Q3,Elderly
195723641,19572364,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG?THERAPY START DATE: ?MAR?2021,,,,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,1,I,201911.0,20210706.0,20210716,20210716,EXP,,PL-EMD SERONO-E2B_90084240,EMD SERONO INC,,65.0,YR,E,M,Y,,,20210716.0,,CN,PL,PL,2021,Q3,Elderly
195723641,19572364,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG?THERAPY START DATE: ?MAR?2021,,,,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,1,I,201911.0,20210706.0,20210716,20210716,EXP,,PL-EMD SERONO-E2B_90084240,EMD SERONO INC,,65.0,YR,E,M,Y,,,20210716.0,,CN,PL,PL,2021,Q3,Elderly
195723641,19572364,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG?THERAPY START DATE: ?MAR?2021,,,,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,1,I,201911.0,20210706.0,20210716,20210716,EXP,,PL-EMD SERONO-E2B_90084240,EMD SERONO INC,,65.0,YR,E,M,Y,,,20210716.0,,CN,PL,PL,2021,Q3,Elderly
195723641,19572364,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG?THERAPY START DATE: ?MAR?2021,,,,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,1,I,201911.0,20210706.0,20210716,20210716,EXP,,PL-EMD SERONO-E2B_90084240,EMD SERONO INC,,65.0,YR,E,M,Y,,,20210716.0,,CN,PL,PL,2021,Q3,Elderly
195723641,19572364,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG?THERAPY START DATE: ?MAR?2021,,,,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,1,I,201911.0,20210706.0,20210716,20210716,EXP,,PL-EMD SERONO-E2B_90084240,EMD SERONO INC,,65.0,YR,E,M,Y,,,20210716.0,,CN,PL,PL,2021,Q3,Elderly
195723641,19572364,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG?THERAPY START DATE: ?MAR?2021,,,,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,1,I,201911.0,20210706.0,20210716,20210716,EXP,,PL-EMD SERONO-E2B_90084240,EMD SERONO INC,,65.0,YR,E,M,Y,,,20210716.0,,CN,PL,PL,2021,Q3,Elderly
195769141,19576914,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10, DAILY",,,,,,,,,,,,2021,Q3,Aneurysm,,2021,Q3,1,I,,20210706.0,20210719,20210719,EXP,,DE-ASTRAZENECA-2021A605372,ASTRAZENECA,,39.0,YR,,M,Y,,,20210719.0,,MD,DE,DE,2021,Q3,Adult
195769141,19576914,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10, DAILY",,,,,,,,,,,,2021,Q3,Cardiac failure,,2021,Q3,1,I,,20210706.0,20210719,20210719,EXP,,DE-ASTRAZENECA-2021A605372,ASTRAZENECA,,39.0,YR,,M,Y,,,20210719.0,,MD,DE,DE,2021,Q3,Adult
195769141,19576914,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10, DAILY",,,,,,,,,,,,2021,Q3,Coronary artery disease,,2021,Q3,1,I,,20210706.0,20210719,20210719,EXP,,DE-ASTRAZENECA-2021A605372,ASTRAZENECA,,39.0,YR,,M,Y,,,20210719.0,,MD,DE,DE,2021,Q3,Adult
195772771,19577277,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,, 2012123,,,10.0,MG,TABLET,QD,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210628.0,20210708.0,20210719,20210719,EXP,,CN-ASTRAZENECA-2021A613321,ASTRAZENECA,,36.0,YR,,M,Y,103.0,KG,20210719.0,,HP,CN,CN,2021,Q3,Adult
195814082,19581408,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Blood pressure decreased,,2021,Q3,2,F,201911.0,20210706.0,20210720,20210727,EXP,,PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2021-000061,VALIDUS,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195814082,19581408,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Concomitant disease aggravated,,2021,Q3,2,F,201911.0,20210706.0,20210720,20210727,EXP,,PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2021-000061,VALIDUS,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195814082,19581408,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Ejection fraction decreased,,2021,Q3,2,F,201911.0,20210706.0,20210720,20210727,EXP,,PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2021-000061,VALIDUS,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195814082,19581408,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,2,F,201911.0,20210706.0,20210720,20210727,EXP,,PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2021-000061,VALIDUS,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195814082,19581408,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,2,F,201911.0,20210706.0,20210720,20210727,EXP,,PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2021-000061,VALIDUS,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195814082,19581408,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Haemoglobin decreased,,2021,Q3,2,F,201911.0,20210706.0,20210720,20210727,EXP,,PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2021-000061,VALIDUS,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195814082,19581408,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Heart rate decreased,,2021,Q3,2,F,201911.0,20210706.0,20210720,20210727,EXP,,PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2021-000061,VALIDUS,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195814082,19581408,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Mitral valve calcification,,2021,Q3,2,F,201911.0,20210706.0,20210720,20210727,EXP,,PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2021-000061,VALIDUS,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195814082,19581408,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Mitral valve incompetence,,2021,Q3,2,F,201911.0,20210706.0,20210720,20210727,EXP,,PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2021-000061,VALIDUS,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195814082,19581408,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Mitral valve thickening,,2021,Q3,2,F,201911.0,20210706.0,20210720,20210727,EXP,,PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2021-000061,VALIDUS,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195814082,19581408,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,2,F,201911.0,20210706.0,20210720,20210727,EXP,,PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2021-000061,VALIDUS,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195814082,19581408,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Platelet count decreased,,2021,Q3,2,F,201911.0,20210706.0,20210720,20210727,EXP,,PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2021-000061,VALIDUS,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195814082,19581408,39,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Pulmonary oedema,,2021,Q3,2,F,201911.0,20210706.0,20210720,20210727,EXP,,PL-VALIDUS PHARMACEUTICALS LLC-PL-VDP-2021-000061,VALIDUS,,65.0,YR,,M,Y,,,20210727.0,,CN,PL,PL,2021,Q3,Elderly
195855041,19585504,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Dyspnoea,,2021,Q3,1,I,20201229.0,20201229.0,20210720,20210720,EXP,,US-ROCHE-2742010,ROCHE,,78.0,YR,,F,Y,118.49,KG,20210720.0,,CN,US,US,2021,Q3,Elderly
195884241,19588424,5,C,DAPAGLIFLOZIN/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5?1000 MG, 1?0?0?1, TABLET",,,,,,,,,,TABLET,,2021,Q3,Fall,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21006011,DE-ACCORD-232521,ACCORD,,66.0,YR,E,F,Y,,,20210721.0,,MD,DE,DE,2021,Q3,Elderly
195884241,19588424,5,C,DAPAGLIFLOZIN/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5?1000 MG, 1?0?0?1, TABLET",,,,,,,,,,TABLET,,2021,Q3,Hyperkalaemia,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21006011,DE-ACCORD-232521,ACCORD,,66.0,YR,E,F,Y,,,20210721.0,,MD,DE,DE,2021,Q3,Elderly
195884241,19588424,5,C,DAPAGLIFLOZIN/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5?1000 MG, 1?0?0?1, TABLET",,,,,,,,,,TABLET,,2021,Q3,Sinus bradycardia,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21006011,DE-ACCORD-232521,ACCORD,,66.0,YR,E,F,Y,,,20210721.0,,MD,DE,DE,2021,Q3,Elderly
195890821,19589082,5,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,10.0,MG,,QD,2021,Q3,Enthesopathy,,2021,Q3,1,I,,20210712.0,20210721,20210721,EXP,,CA-ASTRAZENECA-2021A621574,ASTRAZENECA,,55.0,YR,,M,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
195890821,19589082,5,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,10.0,MG,,QD,2021,Q3,Polyarthritis,,2021,Q3,1,I,,20210712.0,20210721,20210721,EXP,,CA-ASTRAZENECA-2021A621574,ASTRAZENECA,,55.0,YR,,M,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
195892281,19589228,1,PS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,202293.0,1.0,DF,TABLET,QD,2021,Q3,Diverticulum intestinal,,2021,Q3,1,I,,20210715.0,20210721,20210721,EXP,,CA-ASTRAZENECA-2021A624948,ASTRAZENECA,,58.0,YR,,F,Y,,,20210721.0,,CN,CA,CA,2021,Q3,Adult
195892281,19589228,1,PS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,202293.0,1.0,DF,TABLET,QD,2021,Q3,Nephrolithiasis,,2021,Q3,1,I,,20210715.0,20210721,20210721,EXP,,CA-ASTRAZENECA-2021A624948,ASTRAZENECA,,58.0,YR,,F,Y,,,20210721.0,,CN,CA,CA,2021,Q3,Adult
195897901,19589790,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,340.0,MG,Y,, JJ2073,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,20180717.0,20210713.0,20210721,20210721,EXP,,CN-ASTRAZENECA-2021A626430,ASTRAZENECA,,56.0,YR,,M,Y,72.0,KG,20210721.0,,HP,CN,CN,2021,Q3,Adult
195906151,19590615,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Blood pressure abnormal,,2021,Q3,1,I,201911.0,20210707.0,20210722,20210722,EXP,,PL-AUROBINDO-AUR-APL-2021-030068,AUROBINDO,,65.0,YR,,M,Y,,,20210722.0,,CN,PL,PL,2021,Q3,Elderly
195906151,19590615,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Ejection fraction decreased,,2021,Q3,1,I,201911.0,20210707.0,20210722,20210722,EXP,,PL-AUROBINDO-AUR-APL-2021-030068,AUROBINDO,,65.0,YR,,M,Y,,,20210722.0,,CN,PL,PL,2021,Q3,Elderly
195906151,19590615,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,1,I,201911.0,20210707.0,20210722,20210722,EXP,,PL-AUROBINDO-AUR-APL-2021-030068,AUROBINDO,,65.0,YR,,M,Y,,,20210722.0,,CN,PL,PL,2021,Q3,Elderly
195906151,19590615,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,1,I,201911.0,20210707.0,20210722,20210722,EXP,,PL-AUROBINDO-AUR-APL-2021-030068,AUROBINDO,,65.0,YR,,M,Y,,,20210722.0,,CN,PL,PL,2021,Q3,Elderly
195906151,19590615,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,1,I,201911.0,20210707.0,20210722,20210722,EXP,,PL-AUROBINDO-AUR-APL-2021-030068,AUROBINDO,,65.0,YR,,M,Y,,,20210722.0,,CN,PL,PL,2021,Q3,Elderly
195906151,19590615,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Heart rate decreased,,2021,Q3,1,I,201911.0,20210707.0,20210722,20210722,EXP,,PL-AUROBINDO-AUR-APL-2021-030068,AUROBINDO,,65.0,YR,,M,Y,,,20210722.0,,CN,PL,PL,2021,Q3,Elderly
195906151,19590615,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve calcification,,2021,Q3,1,I,201911.0,20210707.0,20210722,20210722,EXP,,PL-AUROBINDO-AUR-APL-2021-030068,AUROBINDO,,65.0,YR,,M,Y,,,20210722.0,,CN,PL,PL,2021,Q3,Elderly
195906151,19590615,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,1,I,201911.0,20210707.0,20210722,20210722,EXP,,PL-AUROBINDO-AUR-APL-2021-030068,AUROBINDO,,65.0,YR,,M,Y,,,20210722.0,,CN,PL,PL,2021,Q3,Elderly
195906151,19590615,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Mitral valve thickening,,2021,Q3,1,I,201911.0,20210707.0,20210722,20210722,EXP,,PL-AUROBINDO-AUR-APL-2021-030068,AUROBINDO,,65.0,YR,,M,Y,,,20210722.0,,CN,PL,PL,2021,Q3,Elderly
195906151,19590615,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,N-terminal prohormone brain natriuretic peptide increased,,2021,Q3,1,I,201911.0,20210707.0,20210722,20210722,EXP,,PL-AUROBINDO-AUR-APL-2021-030068,AUROBINDO,,65.0,YR,,M,Y,,,20210722.0,,CN,PL,PL,2021,Q3,Elderly
195906151,19590615,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Platelet count decreased,,2021,Q3,1,I,201911.0,20210707.0,20210722,20210722,EXP,,PL-AUROBINDO-AUR-APL-2021-030068,AUROBINDO,,65.0,YR,,M,Y,,,20210722.0,,CN,PL,PL,2021,Q3,Elderly
195906151,19590615,30,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,1,I,201911.0,20210707.0,20210722,20210722,EXP,,PL-AUROBINDO-AUR-APL-2021-030068,AUROBINDO,,65.0,YR,,M,Y,,,20210722.0,,CN,PL,PL,2021,Q3,Elderly
195975021,19597502,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q3,Acetonaemia,,2021,Q3,1,I,,20210713.0,20210723,20210723,EXP,,IE-ASTRAZENECA-2021A617848,ASTRAZENECA,"GARRAHY A., BYRNE M.M... UNEXPECTED DIABETIC KETOACIDOSIS IN TWO PATIENTS WITH TYPE 2 DIABETES, CAUSE OR COINCIDENCE WITH USE OF SGLT2 INHIBITORS: A REPORT OF TWO CASES.. IRISH JOURNAL OF MEDICAL SCIENCE. 2017?186(9  (SUPP 1)):S365.",52.0,YR,,F,Y,,,20210722.0,,HP,IE,IE,2021,Q3,Adult
195975021,19597502,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,,20210713.0,20210723,20210723,EXP,,IE-ASTRAZENECA-2021A617848,ASTRAZENECA,"GARRAHY A., BYRNE M.M... UNEXPECTED DIABETIC KETOACIDOSIS IN TWO PATIENTS WITH TYPE 2 DIABETES, CAUSE OR COINCIDENCE WITH USE OF SGLT2 INHIBITORS: A REPORT OF TWO CASES.. IRISH JOURNAL OF MEDICAL SCIENCE. 2017?186(9  (SUPP 1)):S365.",52.0,YR,,F,Y,,,20210722.0,,HP,IE,IE,2021,Q3,Adult
195975021,19597502,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210713.0,20210723,20210723,EXP,,IE-ASTRAZENECA-2021A617848,ASTRAZENECA,"GARRAHY A., BYRNE M.M... UNEXPECTED DIABETIC KETOACIDOSIS IN TWO PATIENTS WITH TYPE 2 DIABETES, CAUSE OR COINCIDENCE WITH USE OF SGLT2 INHIBITORS: A REPORT OF TWO CASES.. IRISH JOURNAL OF MEDICAL SCIENCE. 2017?186(9  (SUPP 1)):S365.",52.0,YR,,F,Y,,,20210722.0,,HP,IE,IE,2021,Q3,Adult
195975021,19597502,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,TABLET,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210713.0,20210723,20210723,EXP,,IE-ASTRAZENECA-2021A617848,ASTRAZENECA,"GARRAHY A., BYRNE M.M... UNEXPECTED DIABETIC KETOACIDOSIS IN TWO PATIENTS WITH TYPE 2 DIABETES, CAUSE OR COINCIDENCE WITH USE OF SGLT2 INHIBITORS: A REPORT OF TWO CASES.. IRISH JOURNAL OF MEDICAL SCIENCE. 2017?186(9  (SUPP 1)):S365.",52.0,YR,,F,Y,,,20210722.0,,HP,IE,IE,2021,Q3,Adult
195976651,19597665,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Breast cancer,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,BR-NOVOPROD-830193,NOVO NORDISK,,80.0,YR,,F,Y,82.7,KG,20210723.0,,MD,BR,BR,2021,Q3,Elderly
195976651,19597665,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,BR-NOVOPROD-830193,NOVO NORDISK,,80.0,YR,,F,Y,82.7,KG,20210723.0,,MD,BR,BR,2021,Q3,Elderly
195979871,19597987,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,110.0,MG,Y,, MJ3030,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Hepatic function abnormal,,2021,Q3,1,I,20210701.0,20210714.0,20210723,20210723,EXP,,CN-ASTRAZENECA-2021A627804,ASTRAZENECA,,60.0,YR,,M,Y,45.0,KG,20210722.0,,HP,CN,CN,2021,Q3,Adult
196021571,19602157,1,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Cough,,2021,Q3,1,I,,20210713.0,20210723,20210723,EXP,,US-SA-2021SA234783,SANOFI AVENTIS,"GABI J., ELKADRY A.H.. SODIUM?GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITOR INDUCED KETOACIDOSIS IN A PATIENT MISDIAGNOSED AS A TYPE 2 DIABETIC. ENDOCRINE REVIEWS. 2017?38 :3 SUPP 1:UNKNOWN",29.0,YR,A,F,Y,,,20210723.0,,HP,US,US,2021,Q3,Young Adult
196021571,19602157,1,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,,20210713.0,20210723,20210723,EXP,,US-SA-2021SA234783,SANOFI AVENTIS,"GABI J., ELKADRY A.H.. SODIUM?GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITOR INDUCED KETOACIDOSIS IN A PATIENT MISDIAGNOSED AS A TYPE 2 DIABETIC. ENDOCRINE REVIEWS. 2017?38 :3 SUPP 1:UNKNOWN",29.0,YR,A,F,Y,,,20210723.0,,HP,US,US,2021,Q3,Young Adult
196021571,19602157,1,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210713.0,20210723,20210723,EXP,,US-SA-2021SA234783,SANOFI AVENTIS,"GABI J., ELKADRY A.H.. SODIUM?GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITOR INDUCED KETOACIDOSIS IN A PATIENT MISDIAGNOSED AS A TYPE 2 DIABETIC. ENDOCRINE REVIEWS. 2017?38 :3 SUPP 1:UNKNOWN",29.0,YR,A,F,Y,,,20210723.0,,HP,US,US,2021,Q3,Young Adult
196021571,19602157,1,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Vomiting,,2021,Q3,1,I,,20210713.0,20210723,20210723,EXP,,US-SA-2021SA234783,SANOFI AVENTIS,"GABI J., ELKADRY A.H.. SODIUM?GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITOR INDUCED KETOACIDOSIS IN A PATIENT MISDIAGNOSED AS A TYPE 2 DIABETIC. ENDOCRINE REVIEWS. 2017?38 :3 SUPP 1:UNKNOWN",29.0,YR,A,F,Y,,,20210723.0,,HP,US,US,2021,Q3,Young Adult
196038381,19603838,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,, N/A,,,10.0,MG,TABLET,QD,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,20210707.0,20210714.0,20210723,20210723,EXP,,GB-ASTRAZENECA-2021A622380,ASTRAZENECA,,67.0,YR,,F,Y,67.0,KG,20210723.0,,PH,GB,GB,2021,Q3,Elderly
196061352,19606135,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,, 2101254,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Ketosis,,2021,Q3,2,F,20210629.0,20210716.0,20210723,20210830,EXP,,CN-ASTRAZENECA-2021A630561,ASTRAZENECA,,10532.0,DY,,F,Y,77.0,KG,20210830.0,,HP,CN,CN,2021,Q3,Elderly
196061352,19606135,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,, 2101254,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Metabolic acidosis,,2021,Q3,2,F,20210629.0,20210716.0,20210723,20210830,EXP,,CN-ASTRAZENECA-2021A630561,ASTRAZENECA,,10532.0,DY,,F,Y,77.0,KG,20210830.0,,HP,CN,CN,2021,Q3,Elderly
196070461,19607046,1,PS,"DAPAGLIFLOZIN PROPANDIOL, MONOHYDRAT",DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 MG,,,U,, NOT KNOWN,,202293.0,,,TABLET,,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,20210707.0,20210718.0,20210726,20210726,EXP,,GB-ASTRAZENECA-2021A628041,ASTRAZENECA,,67.0,YR,,F,Y,70.0,KG,20210726.0,,MD,GB,GB,2021,Q3,Elderly
196070461,19607046,1,PS,"DAPAGLIFLOZIN PROPANDIOL, MONOHYDRAT",DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 MG,,,U,, NOT KNOWN,,202293.0,,,TABLET,,2021,Q3,Medication error,,2021,Q3,1,I,20210707.0,20210718.0,20210726,20210726,EXP,,GB-ASTRAZENECA-2021A628041,ASTRAZENECA,,67.0,YR,,F,Y,70.0,KG,20210726.0,,MD,GB,GB,2021,Q3,Elderly
196082571,19608257,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,20210211.0,20210722.0,20210726,20210726,EXP,DE-DCGMA-21188536,NVSC2021DE166229,NOVARTIS,,73.0,YR,,F,Y,145.0,KG,20210726.0,,HP,DE,DE,2021,Q3,Elderly
196082571,19608257,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Ketonuria,,2021,Q3,1,I,20210211.0,20210722.0,20210726,20210726,EXP,DE-DCGMA-21188536,NVSC2021DE166229,NOVARTIS,,73.0,YR,,F,Y,145.0,KG,20210726.0,,HP,DE,DE,2021,Q3,Elderly
196082571,19608257,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Lactic acidosis,,2021,Q3,1,I,20210211.0,20210722.0,20210726,20210726,EXP,DE-DCGMA-21188536,NVSC2021DE166229,NOVARTIS,,73.0,YR,,F,Y,145.0,KG,20210726.0,,HP,DE,DE,2021,Q3,Elderly
196090093,19609009,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Drug eruption,,2021,Q3,3,F,20210716.0,20210824.0,20210726,20210831,EXP,,CN-SA-2021SA243300,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20210831.0,,HP,CN,CN,2021,Q3,Elderly
196090093,19609009,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Dry skin,,2021,Q3,3,F,20210716.0,20210824.0,20210726,20210831,EXP,,CN-SA-2021SA243300,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20210831.0,,HP,CN,CN,2021,Q3,Elderly
196090093,19609009,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Erythema,,2021,Q3,3,F,20210716.0,20210824.0,20210726,20210831,EXP,,CN-SA-2021SA243300,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20210831.0,,HP,CN,CN,2021,Q3,Elderly
196090093,19609009,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Hospitalisation,,2021,Q3,3,F,20210716.0,20210824.0,20210726,20210831,EXP,,CN-SA-2021SA243300,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20210831.0,,HP,CN,CN,2021,Q3,Elderly
196090093,19609009,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Macule,,2021,Q3,3,F,20210716.0,20210824.0,20210726,20210831,EXP,,CN-SA-2021SA243300,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20210831.0,,HP,CN,CN,2021,Q3,Elderly
196090093,19609009,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Papule,,2021,Q3,3,F,20210716.0,20210824.0,20210726,20210831,EXP,,CN-SA-2021SA243300,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20210831.0,,HP,CN,CN,2021,Q3,Elderly
196090093,19609009,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Pruritus,,2021,Q3,3,F,20210716.0,20210824.0,20210726,20210831,EXP,,CN-SA-2021SA243300,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20210831.0,,HP,CN,CN,2021,Q3,Elderly
196090093,19609009,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Scab,,2021,Q3,3,F,20210716.0,20210824.0,20210726,20210831,EXP,,CN-SA-2021SA243300,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20210831.0,,HP,CN,CN,2021,Q3,Elderly
196090093,19609009,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Scratch,,2021,Q3,3,F,20210716.0,20210824.0,20210726,20210831,EXP,,CN-SA-2021SA243300,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20210831.0,,HP,CN,CN,2021,Q3,Elderly
196099261,19609926,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10MG ? DOSE COMMMENCED BY GP UNKNOWN DATE.,,,Y,,,,202293.0,,,,,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,20210710.0,20210715.0,20210726,20210726,EXP,,GB-ASTRAZENECA-2021A629589,ASTRAZENECA,,56.0,YR,,M,Y,103.0,KG,20210726.0,,HP,GB,GB,2021,Q3,Adult
196099261,19609926,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10MG ? DOSE COMMMENCED BY GP UNKNOWN DATE.,,,Y,,,,202293.0,,,,,2021,Q3,Medication error,,2021,Q3,1,I,20210710.0,20210715.0,20210726,20210726,EXP,,GB-ASTRAZENECA-2021A629589,ASTRAZENECA,,56.0,YR,,M,Y,103.0,KG,20210726.0,,HP,GB,GB,2021,Q3,Adult
196100031,19610003,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,, 2102040,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Ketoacidosis,,2021,Q3,1,I,20210710.0,20210717.0,20210726,20210726,EXP,,CN-ASTRAZENECA-2021A632322,ASTRAZENECA,,43.0,YR,,F,Y,55.0,KG,20210726.0,,HP,CN,CN,2021,Q3,Adult
196100031,19610003,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,, 2102040,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Ketoacidosis,,2021,Q3,1,I,20210710.0,20210717.0,20210726,20210726,EXP,,CN-ASTRAZENECA-2021A632322,ASTRAZENECA,,43.0,YR,,F,Y,55.0,KG,20210726.0,,HP,CN,CN,2021,Q3,Adult
196100301,19610030,8,C,QTERN [DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE;SAXAGLIPTIN HYDROCHLORIDE,,2,Oral,"1 DF, QD",,,,,,,,1.0,DF,,QD,2021,Q3,Cardiac failure,,2021,Q3,1,I,202007.0,20210720.0,20210726,20210726,PER,,PL-AMGEN-POLSP2021113611,AMGEN,,54.0,YR,A,F,Y,,,20210726.0,,MD,PL,PL,2021,Q3,Adult
196100301,19610030,8,C,QTERN [DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE;SAXAGLIPTIN HYDROCHLORIDE,,2,Oral,"1 DF, QD",,,,,,,,1.0,DF,,QD,2021,Q3,Macular oedema,,2021,Q3,1,I,202007.0,20210720.0,20210726,20210726,PER,,PL-AMGEN-POLSP2021113611,AMGEN,,54.0,YR,A,F,Y,,,20210726.0,,MD,PL,PL,2021,Q3,Adult
196100301,19610030,8,C,QTERN [DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE;SAXAGLIPTIN HYDROCHLORIDE,,2,Oral,"1 DF, QD",,,,,,,,1.0,DF,,QD,2021,Q3,Myocarditis,,2021,Q3,1,I,202007.0,20210720.0,20210726,20210726,PER,,PL-AMGEN-POLSP2021113611,AMGEN,,54.0,YR,A,F,Y,,,20210726.0,,MD,PL,PL,2021,Q3,Adult
196100301,19610030,8,C,QTERN [DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE;SAXAGLIPTIN HYDROCHLORIDE,,2,Oral,"1 DF, QD",,,,,,,,1.0,DF,,QD,2021,Q3,Product use issue,,2021,Q3,1,I,202007.0,20210720.0,20210726,20210726,PER,,PL-AMGEN-POLSP2021113611,AMGEN,,54.0,YR,A,F,Y,,,20210726.0,,MD,PL,PL,2021,Q3,Adult
196100301,19610030,8,C,QTERN [DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE;SAXAGLIPTIN HYDROCHLORIDE,,2,Oral,"1 DF, QD",,,,,,,,1.0,DF,,QD,2021,Q3,Retinal disorder,,2021,Q3,1,I,202007.0,20210720.0,20210726,20210726,PER,,PL-AMGEN-POLSP2021113611,AMGEN,,54.0,YR,A,F,Y,,,20210726.0,,MD,PL,PL,2021,Q3,Adult
196100301,19610030,8,C,QTERN [DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE;SAXAGLIPTIN HYDROCHLORIDE,,2,Oral,"1 DF, QD",,,,,,,,1.0,DF,,QD,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,1,I,202007.0,20210720.0,20210726,20210726,PER,,PL-AMGEN-POLSP2021113611,AMGEN,,54.0,YR,A,F,Y,,,20210726.0,,MD,PL,PL,2021,Q3,Adult
196100301,19610030,8,C,QTERN [DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE;SAXAGLIPTIN HYDROCHLORIDE,,2,Oral,"1 DF, QD",,,,,,,,1.0,DF,,QD,2021,Q3,Visual impairment,,2021,Q3,1,I,202007.0,20210720.0,20210726,20210726,PER,,PL-AMGEN-POLSP2021113611,AMGEN,,54.0,YR,A,F,Y,,,20210726.0,,MD,PL,PL,2021,Q3,Adult
196145191,19614519,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10MG,,,Y,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210711.0,20210718.0,20210727,20210727,EXP,,GB-ASTRAZENECA-2021A627908,ASTRAZENECA,,48.0,YR,,M,Y,111.0,KG,20210727.0,,PH,GB,GB,2021,Q3,Adult
196250161,19625016,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210714.0,20210729,20210729,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-04570,ALKEM,,44.0,YR,,M,Y,,,20210729.0,,HP,AU,AU,2021,Q3,Adult
196250161,19625016,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Mental impairment,,2021,Q3,1,I,,20210714.0,20210729,20210729,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-04570,ALKEM,,44.0,YR,,M,Y,,,20210729.0,,HP,AU,AU,2021,Q3,Adult
196250161,19625016,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Mitral valve incompetence,,2021,Q3,1,I,,20210714.0,20210729,20210729,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-04570,ALKEM,,44.0,YR,,M,Y,,,20210729.0,,HP,AU,AU,2021,Q3,Adult
196250161,19625016,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Myocarditis,,2021,Q3,1,I,,20210714.0,20210729,20210729,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-04570,ALKEM,,44.0,YR,,M,Y,,,20210729.0,,HP,AU,AU,2021,Q3,Adult
196250161,19625016,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Pulmonary valve incompetence,,2021,Q3,1,I,,20210714.0,20210729,20210729,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-04570,ALKEM,,44.0,YR,,M,Y,,,20210729.0,,HP,AU,AU,2021,Q3,Adult
196250161,19625016,15,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Tricuspid valve incompetence,,2021,Q3,1,I,,20210714.0,20210729,20210729,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-04570,ALKEM,,44.0,YR,,M,Y,,,20210729.0,,HP,AU,AU,2021,Q3,Adult
196312081,19631208,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,, UNKNOWN,,,10.0,MG,TABLET,QD,2021,Q3,Hypertensive heart disease,,2021,Q3,1,I,,20210721.0,20210729,20210729,EXP,,DE-ASTRAZENECA-2021A637895,ASTRAZENECA,,53.0,YR,,M,Y,,,20210729.0,,MD,DE,DE,2021,Q3,Adult
196312081,19631208,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,, UNKNOWN,,,10.0,MG,TABLET,QD,2021,Q3,Tachycardia induced cardiomyopathy,,2021,Q3,1,I,,20210721.0,20210729,20210729,EXP,,DE-ASTRAZENECA-2021A637895,ASTRAZENECA,,53.0,YR,,M,Y,,,20210729.0,,MD,DE,DE,2021,Q3,Adult
196426821,19642682,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Transitional cell carcinoma,,2021,Q3,1,I,2015.0,20210720.0,20210730,20210730,EXP,,BR-EMD SERONO-9253919,EMD SERONO INC,,72.0,YR,E,M,Y,,,20210730.0,,MD,BR,BR,2021,Q3,Elderly
196434541,19643454,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,, 2101137,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Perineal pain,,2021,Q3,1,I,20210718.0,20210722.0,20210730,20210730,EXP,,CN-ASTRAZENECA-2021A643747,ASTRAZENECA,,23376.0,DY,,F,Y,63.0,KG,20210730.0,,HP,CN,CN,2021,Q3,Elderly
196434541,19643454,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,, 2101137,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Pruritus,,2021,Q3,1,I,20210718.0,20210722.0,20210730,20210730,EXP,,CN-ASTRAZENECA-2021A643747,ASTRAZENECA,,23376.0,DY,,F,Y,63.0,KG,20210730.0,,HP,CN,CN,2021,Q3,Elderly
196436421,19643642,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2021,Q3,Cholecystectomy,,2021,Q3,1,I,,20210720.0,20210731,20210731,EXP,,BR-EMD SERONO-9254681,EMD SERONO INC,,72.0,YR,E,M,Y,,,20210731.0,,MD,BR,BR,2021,Q3,Elderly
196436421,19643642,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2021,Q3,Lens extraction,,2021,Q3,1,I,,20210720.0,20210731,20210731,EXP,,BR-EMD SERONO-9254681,EMD SERONO INC,,72.0,YR,E,M,Y,,,20210731.0,,MD,BR,BR,2021,Q3,Elderly
196437021,19643702,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2021,Q3,Anxiety,,2021,Q3,1,I,2019.0,20210720.0,20210731,20210731,EXP,,BR-EMD SERONO-9254687,EMD SERONO INC,,72.0,YR,E,M,Y,84.0,KG,20210731.0,,MD,BR,BR,2021,Q3,Elderly
196437021,19643702,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2021,Q3,Bladder hypertrophy,,2021,Q3,1,I,2019.0,20210720.0,20210731,20210731,EXP,,BR-EMD SERONO-9254687,EMD SERONO INC,,72.0,YR,E,M,Y,84.0,KG,20210731.0,,MD,BR,BR,2021,Q3,Elderly
196437021,19643702,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2021,Q3,Diverticulitis,,2021,Q3,1,I,2019.0,20210720.0,20210731,20210731,EXP,,BR-EMD SERONO-9254687,EMD SERONO INC,,72.0,YR,E,M,Y,84.0,KG,20210731.0,,MD,BR,BR,2021,Q3,Elderly
196437021,19643702,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2021,Q3,Hepatic steatosis,,2021,Q3,1,I,2019.0,20210720.0,20210731,20210731,EXP,,BR-EMD SERONO-9254687,EMD SERONO INC,,72.0,YR,E,M,Y,84.0,KG,20210731.0,,MD,BR,BR,2021,Q3,Elderly
196437021,19643702,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2021,Q3,Pelvic cyst,,2021,Q3,1,I,2019.0,20210720.0,20210731,20210731,EXP,,BR-EMD SERONO-9254687,EMD SERONO INC,,72.0,YR,E,M,Y,84.0,KG,20210731.0,,MD,BR,BR,2021,Q3,Elderly
196437021,19643702,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2021,Q3,Supraventricular tachycardia,,2021,Q3,1,I,2019.0,20210720.0,20210731,20210731,EXP,,BR-EMD SERONO-9254687,EMD SERONO INC,,72.0,YR,E,M,Y,84.0,KG,20210731.0,,MD,BR,BR,2021,Q3,Elderly
196437021,19643702,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2021,Q3,Weight decreased,,2021,Q3,1,I,2019.0,20210720.0,20210731,20210731,EXP,,BR-EMD SERONO-9254687,EMD SERONO INC,,72.0,YR,E,M,Y,84.0,KG,20210731.0,,MD,BR,BR,2021,Q3,Elderly
196457461,19645746,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,U,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,20210211.0,20210720.0,20210802,20210802,EXP,,DE-AUROBINDO-AUR-APL-2021-032461,AUROBINDO,,73.0,YR,,F,Y,145.0,KG,20210802.0,,MD,DE,DE,2021,Q3,Elderly
196457461,19645746,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,U,,,,,,,,2021,Q3,Ketonuria,,2021,Q3,1,I,20210211.0,20210720.0,20210802,20210802,EXP,,DE-AUROBINDO-AUR-APL-2021-032461,AUROBINDO,,73.0,YR,,F,Y,145.0,KG,20210802.0,,MD,DE,DE,2021,Q3,Elderly
196457461,19645746,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,U,,,,,,,,2021,Q3,Lactic acidosis,,2021,Q3,1,I,20210211.0,20210720.0,20210802,20210802,EXP,,DE-AUROBINDO-AUR-APL-2021-032461,AUROBINDO,,73.0,YR,,F,Y,145.0,KG,20210802.0,,MD,DE,DE,2021,Q3,Elderly
196468291,19646829,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,, UNKNOWN,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,20210211.0,20210725.0,20210802,20210802,EXP,,DE-TEVA-2021-DE-1937005,TEVA,,73.0,YR,E,F,Y,145.0,KG,20210802.0,,MD,DE,DE,2021,Q3,Elderly
196468291,19646829,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,, UNKNOWN,,,,,,,2021,Q3,Ketonuria,,2021,Q3,1,I,20210211.0,20210725.0,20210802,20210802,EXP,,DE-TEVA-2021-DE-1937005,TEVA,,73.0,YR,E,F,Y,145.0,KG,20210802.0,,MD,DE,DE,2021,Q3,Elderly
196468291,19646829,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,,, UNKNOWN,,,,,,,2021,Q3,Lactic acidosis,,2021,Q3,1,I,20210211.0,20210725.0,20210802,20210802,EXP,,DE-TEVA-2021-DE-1937005,TEVA,,73.0,YR,E,F,Y,145.0,KG,20210802.0,,MD,DE,DE,2021,Q3,Elderly
196472441,19647244,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,20210211.0,20210723.0,20210802,20210802,EXP,,DE-EMD SERONO-E2B_90084421,EMD SERONO INC,,73.0,YR,E,F,Y,145.0,KG,20210802.0,,MD,DE,DE,2021,Q3,Elderly
196472441,19647244,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Ketonuria,,2021,Q3,1,I,20210211.0,20210723.0,20210802,20210802,EXP,,DE-EMD SERONO-E2B_90084421,EMD SERONO INC,,73.0,YR,E,F,Y,145.0,KG,20210802.0,,MD,DE,DE,2021,Q3,Elderly
196472441,19647244,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Lactic acidosis,,2021,Q3,1,I,20210211.0,20210723.0,20210802,20210802,EXP,,DE-EMD SERONO-E2B_90084421,EMD SERONO INC,,73.0,YR,E,F,Y,145.0,KG,20210802.0,,MD,DE,DE,2021,Q3,Elderly
196508212,19650821,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Cardiac failure,,2021,Q3,2,F,20210718.0,20210807.0,20210803,20210810,EXP,,NVSC2021BR172989,NOVARTIS,,64.0,YR,,F,Y,65.0,KG,20210810.0,,HP,BR,BR,2021,Q3,Adult
196508212,19650821,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,U,,,,,10.0,MG,,QD,2021,Q3,Condition aggravated,,2021,Q3,2,F,20210718.0,20210807.0,20210803,20210810,EXP,,NVSC2021BR172989,NOVARTIS,,64.0,YR,,F,Y,65.0,KG,20210810.0,,HP,BR,BR,2021,Q3,Adult
196543631,19654363,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Ankle operation,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,BR-NOVOPROD-833872,NOVO NORDISK,,56.0,YR,,F,Y,84.0,KG,20210804.0,,MD,BR,BR,2021,Q3,Adult
196543631,19654363,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Anxiety,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,BR-NOVOPROD-833872,NOVO NORDISK,,56.0,YR,,F,Y,84.0,KG,20210804.0,,MD,BR,BR,2021,Q3,Adult
196543631,19654363,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,BR-NOVOPROD-833872,NOVO NORDISK,,56.0,YR,,F,Y,84.0,KG,20210804.0,,MD,BR,BR,2021,Q3,Adult
196543631,19654363,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Dry mouth,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,BR-NOVOPROD-833872,NOVO NORDISK,,56.0,YR,,F,Y,84.0,KG,20210804.0,,MD,BR,BR,2021,Q3,Adult
196543631,19654363,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Hepatic steatosis,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,BR-NOVOPROD-833872,NOVO NORDISK,,56.0,YR,,F,Y,84.0,KG,20210804.0,,MD,BR,BR,2021,Q3,Adult
196543631,19654363,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Insomnia,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,BR-NOVOPROD-833872,NOVO NORDISK,,56.0,YR,,F,Y,84.0,KG,20210804.0,,MD,BR,BR,2021,Q3,Adult
196543631,19654363,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Mood altered,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,BR-NOVOPROD-833872,NOVO NORDISK,,56.0,YR,,F,Y,84.0,KG,20210804.0,,MD,BR,BR,2021,Q3,Adult
196543631,19654363,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Polyuria,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,BR-NOVOPROD-833872,NOVO NORDISK,,56.0,YR,,F,Y,84.0,KG,20210804.0,,MD,BR,BR,2021,Q3,Adult
196543631,19654363,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Vulval disorder,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,BR-NOVOPROD-833872,NOVO NORDISK,,56.0,YR,,F,Y,84.0,KG,20210804.0,,MD,BR,BR,2021,Q3,Adult
196543631,19654363,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,BR-NOVOPROD-833872,NOVO NORDISK,,56.0,YR,,F,Y,84.0,KG,20210804.0,,MD,BR,BR,2021,Q3,Adult
196579621,19657962,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,20210211.0,20210722.0,20210805,20210805,EXP,DE-DCGMA-21188536,DE-BAUSCH-BL-2021-026043,BAUSCH AND LOMB,,73.0,YR,,F,Y,145.0,KG,20210805.0,,MD,DE,DE,2021,Q3,Elderly
196579621,19657962,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2021,Q3,Ketonuria,,2021,Q3,1,I,20210211.0,20210722.0,20210805,20210805,EXP,DE-DCGMA-21188536,DE-BAUSCH-BL-2021-026043,BAUSCH AND LOMB,,73.0,YR,,F,Y,145.0,KG,20210805.0,,MD,DE,DE,2021,Q3,Elderly
196579621,19657962,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2021,Q3,Lactic acidosis,,2021,Q3,1,I,20210211.0,20210722.0,20210805,20210805,EXP,DE-DCGMA-21188536,DE-BAUSCH-BL-2021-026043,BAUSCH AND LOMB,,73.0,YR,,F,Y,145.0,KG,20210805.0,,MD,DE,DE,2021,Q3,Elderly
196655361,19665536,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,Y,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Disease progression,,2021,Q3,1,I,,20210722.0,20210806,20210806,EXP,,FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2021-04790,ALKEM,,74.0,YR,,F,Y,,,20210806.0,,HP,FR,FR,2021,Q3,Elderly
196655361,19665536,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,Y,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210722.0,20210806,20210806,EXP,,FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2021-04790,ALKEM,,74.0,YR,,F,Y,,,20210806.0,,HP,FR,FR,2021,Q3,Elderly
196655361,19665536,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD",,,Y,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210722.0,20210806,20210806,EXP,,FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2021-04790,ALKEM,,74.0,YR,,F,Y,,,20210806.0,,HP,FR,FR,2021,Q3,Elderly
196667911,19666791,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,ACCIDENTAL TAKING OF HER HUSBAND PILLS OF DAPAGLIFLOZIN IN HIGH DOSES,,,D,,,,202293.0,,,TABLET,,2021,Q3,Ketoacidosis,,2021,Q3,1,I,,20210731.0,20210806,20210806,EXP,,GR-ASTRAZENECA-2021A659415,ASTRAZENECA,,72.0,YR,,F,Y,,,20210806.0,,HP,GR,GR,2021,Q3,Elderly
196667911,19666791,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,ACCIDENTAL TAKING OF HER HUSBAND PILLS OF DAPAGLIFLOZIN IN HIGH DOSES,,,D,,,,202293.0,,,TABLET,,2021,Q3,Wrong product administered,,2021,Q3,1,I,,20210731.0,20210806,20210806,EXP,,GR-ASTRAZENECA-2021A659415,ASTRAZENECA,,72.0,YR,,F,Y,,,20210806.0,,HP,GR,GR,2021,Q3,Elderly
196670571,19667057,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,U,, 2104155,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Hypoglycaemic coma,,2021,Q3,1,I,20210730.0,20210801.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660391,ASTRAZENECA,,28490.0,DY,,M,Y,60.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196670571,19667057,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,U,, 2104155,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Vomiting,,2021,Q3,1,I,20210730.0,20210801.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660391,ASTRAZENECA,,28490.0,DY,,M,Y,60.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196670571,19667057,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,U,, 2104155,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Hypoglycaemic coma,,2021,Q3,1,I,20210730.0,20210801.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660391,ASTRAZENECA,,28490.0,DY,,M,Y,60.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196670571,19667057,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,60.0,MG,U,, 2104155,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Vomiting,,2021,Q3,1,I,20210730.0,20210801.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660391,ASTRAZENECA,,28490.0,DY,,M,Y,60.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196687561,19668756,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,, MM3052,,202293.0,5.0,MG,TABLET,QD,2021,Q3,Altered state of consciousness,,2021,Q3,1,I,20210728.0,20210731.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660895,ASTRAZENECA,,19213.0,DY,,M,Y,85.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196687561,19668756,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,, MM3052,,202293.0,5.0,MG,TABLET,QD,2021,Q3,Cerebral infarction,,2021,Q3,1,I,20210728.0,20210731.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660895,ASTRAZENECA,,19213.0,DY,,M,Y,85.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196687561,19668756,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,, MM3052,,202293.0,5.0,MG,TABLET,QD,2021,Q3,Dizziness,,2021,Q3,1,I,20210728.0,20210731.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660895,ASTRAZENECA,,19213.0,DY,,M,Y,85.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196687561,19668756,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,, MM3052,,202293.0,5.0,MG,TABLET,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210728.0,20210731.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660895,ASTRAZENECA,,19213.0,DY,,M,Y,85.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196687561,19668756,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,, MM3052,,202293.0,5.0,MG,TABLET,QD,2021,Q3,Hypoglycaemic coma,,2021,Q3,1,I,20210728.0,20210731.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660895,ASTRAZENECA,,19213.0,DY,,M,Y,85.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196687561,19668756,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,, MM3052,,202293.0,5.0,MG,TABLET,QD,2021,Q3,Seizure,,2021,Q3,1,I,20210728.0,20210731.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660895,ASTRAZENECA,,19213.0,DY,,M,Y,85.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196687561,19668756,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,, MM3052,,202293.0,5.0,MG,TABLET,QD,2021,Q3,Altered state of consciousness,,2021,Q3,1,I,20210728.0,20210731.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660895,ASTRAZENECA,,19213.0,DY,,M,Y,85.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196687561,19668756,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,, MM3052,,202293.0,5.0,MG,TABLET,QD,2021,Q3,Cerebral infarction,,2021,Q3,1,I,20210728.0,20210731.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660895,ASTRAZENECA,,19213.0,DY,,M,Y,85.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196687561,19668756,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,, MM3052,,202293.0,5.0,MG,TABLET,QD,2021,Q3,Dizziness,,2021,Q3,1,I,20210728.0,20210731.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660895,ASTRAZENECA,,19213.0,DY,,M,Y,85.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196687561,19668756,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,, MM3052,,202293.0,5.0,MG,TABLET,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210728.0,20210731.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660895,ASTRAZENECA,,19213.0,DY,,M,Y,85.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196687561,19668756,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,, MM3052,,202293.0,5.0,MG,TABLET,QD,2021,Q3,Hypoglycaemic coma,,2021,Q3,1,I,20210728.0,20210731.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660895,ASTRAZENECA,,19213.0,DY,,M,Y,85.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196687561,19668756,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,, MM3052,,202293.0,5.0,MG,TABLET,QD,2021,Q3,Seizure,,2021,Q3,1,I,20210728.0,20210731.0,20210806,20210806,EXP,,CN-ASTRAZENECA-2021A660895,ASTRAZENECA,,19213.0,DY,,M,Y,85.0,KG,20210806.0,,HP,CN,CN,2021,Q3,Elderly
196700724,19670072,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",6150.0,MG,U,,,,,10.0,MG,,QD,2021,Q3,Neutropenia,,2021,Q3,4,F,20210802.0,20210825.0,20210806,20210902,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-076891,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,52.0,KG,20210902.0,,HP,ES,ES,2021,Q3,Adult
196700724,19670072,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",6150.0,MG,U,,,,,10.0,MG,,QD,2021,Q3,Neutropenic sepsis,,2021,Q3,4,F,20210802.0,20210825.0,20210806,20210902,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-076891,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,52.0,KG,20210902.0,,HP,ES,ES,2021,Q3,Adult
196749831,19674983,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,2021.0,20210729.0,20210809,20210809,EXP,CN-NMPA-1401051519956202100531,CN-NOVOPROD-834953,NOVO NORDISK,,53.0,YR,,M,Y,95.0,KG,20210809.0,,HP,CN,CN,2021,Q3,Adult
196749831,19674983,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,2021.0,20210729.0,20210809,20210809,EXP,CN-NMPA-1401051519956202100531,CN-NOVOPROD-834953,NOVO NORDISK,,53.0,YR,,M,Y,95.0,KG,20210809.0,,HP,CN,CN,2021,Q3,Adult
196749831,19674983,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2021,Q3,Treatment noncompliance,,2021,Q3,1,I,2021.0,20210729.0,20210809,20210809,EXP,CN-NMPA-1401051519956202100531,CN-NOVOPROD-834953,NOVO NORDISK,,53.0,YR,,M,Y,95.0,KG,20210809.0,,HP,CN,CN,2021,Q3,Adult
196759931,19675993,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,TABLET,,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,,20210731.0,20210809,20210809,EXP,,GR-ASTRAZENECA-2021A659544,ASTRAZENECA,"SACHLA Z, SIDERAS L, CHRISTANTONIOU G, GKOGKOS K. EUGLYCEMIC DIABETIC KETOACIDOSIS ASSOCIATED WITH DAPAGLIFLOZIN IN A PATIENT WITH UNDERLYING. 11TH INTERNATIONAL CONGRESS OF INTERNAL MEDICINE ? EUROPEAN FEDERATION OF INTERNAL MEDICINE 2021?",62.0,YR,,M,Y,,,20210809.0,,HP,GR,GR,2021,Q3,Adult
196808902,19680890,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,Y,U,,,,10.0,MG,,QD,2021,Q3,Fournier's gangrene,,2021,Q3,2,F,,20210812.0,20210810,20210820,EXP,,KR-SA-2021SA259761,SANOFI AVENTIS,MOON J.Y.? LEE M.R.? KIM J.H.? HA G.W.. FOURNIER GANGRENE IN A PATIENT WITH TYPE 2 DIABETES MELLITUS TREATED WITH DAPAGLIFLOZIN A CASE REPORT. ANNALS OF COLOPROCTOLOGY. 2021?37(1):S48?S50,66.0,YR,E,M,Y,,,20210820.0,,MD,KR,KR,2021,Q3,Elderly
196808902,19680890,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,Y,U,,,,10.0,MG,,QD,2021,Q3,Perineal pain,,2021,Q3,2,F,,20210812.0,20210810,20210820,EXP,,KR-SA-2021SA259761,SANOFI AVENTIS,MOON J.Y.? LEE M.R.? KIM J.H.? HA G.W.. FOURNIER GANGRENE IN A PATIENT WITH TYPE 2 DIABETES MELLITUS TREATED WITH DAPAGLIFLOZIN A CASE REPORT. ANNALS OF COLOPROCTOLOGY. 2021?37(1):S48?S50,66.0,YR,E,M,Y,,,20210820.0,,MD,KR,KR,2021,Q3,Elderly
196808902,19680890,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",,,Y,U,,,,10.0,MG,,QD,2021,Q3,Scrotal pain,,2021,Q3,2,F,,20210812.0,20210810,20210820,EXP,,KR-SA-2021SA259761,SANOFI AVENTIS,MOON J.Y.? LEE M.R.? KIM J.H.? HA G.W.. FOURNIER GANGRENE IN A PATIENT WITH TYPE 2 DIABETES MELLITUS TREATED WITH DAPAGLIFLOZIN A CASE REPORT. ANNALS OF COLOPROCTOLOGY. 2021?37(1):S48?S50,66.0,YR,E,M,Y,,,20210820.0,,MD,KR,KR,2021,Q3,Elderly
196918611,19691861,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10MG10.0MG UNKNOWN,,,Y,, NOT KNOWN,,,10.0,MG,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210802.0,20210806.0,20210812,20210812,EXP,,GB-ASTRAZENECA-2021A672018,ASTRAZENECA,,51.0,YR,,,Y,,,20210812.0,,HP,GB,GB,2021,Q3,Adult
196941691,19694169,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,,,,,2021,Q3,Diastolic dysfunction,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196941691,19694169,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196941691,19694169,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,,,,,2021,Q3,Hyperhidrosis,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196941691,19694169,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,,,,,2021,Q3,Left atrial enlargement,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196951351,19695135,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,80.0,G,Y,, MH2841,,202293.0,10.0,G,TABLET,QD,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210602.0,20210806.0,20210813,20210813,EXP,,CN-ASTRAZENECA-2021A675275,ASTRAZENECA,,21550.0,DY,,M,Y,,,20210813.0,,HP,CN,CN,2021,Q3,Elderly
196951351,19695135,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,80.0,G,Y,, MH2841,,202293.0,10.0,G,TABLET,QD,2021,Q3,Tachypnoea,,2021,Q3,1,I,20210602.0,20210806.0,20210813,20210813,EXP,,CN-ASTRAZENECA-2021A675275,ASTRAZENECA,,21550.0,DY,,M,Y,,,20210813.0,,HP,CN,CN,2021,Q3,Elderly
197002091,19700209,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2101251(MK),,202293.0,1.0,DF,TABLET,QD,2021,Q3,Blood creatinine increased,,2021,Q3,1,I,202107.0,20210807.0,20210813,20210813,EXP,,CN-ASTRAZENECA-2021A676795,ASTRAZENECA,,71.0,YR,,M,Y,70.0,KG,20210813.0,,HP,CN,CN,2021,Q3,Elderly
197002091,19700209,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,, 2101251(MK),,202293.0,1.0,DF,TABLET,QD,2021,Q3,Blood potassium increased,,2021,Q3,1,I,202107.0,20210807.0,20210813,20210813,EXP,,CN-ASTRAZENECA-2021A676795,ASTRAZENECA,,71.0,YR,,M,Y,70.0,KG,20210813.0,,HP,CN,CN,2021,Q3,Elderly
197003481,19700348,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2021,Q3,Confusional state,,2021,Q3,1,I,20210131.0,20210808.0,20210813,20210813,EXP,,GB-ASTRAZENECA-2021A672281,ASTRAZENECA,,55.0,YR,,M,Y,114.0,KG,20210813.0,,,GB,GB,2021,Q3,Adult
197003481,19700348,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2021,Q3,Hallucination,,2021,Q3,1,I,20210131.0,20210808.0,20210813,20210813,EXP,,GB-ASTRAZENECA-2021A672281,ASTRAZENECA,,55.0,YR,,M,Y,114.0,KG,20210813.0,,,GB,GB,2021,Q3,Adult
197003481,19700348,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,TAKE ONE DAILY,,,,,,,,1.0,DF,,QD,2021,Q3,Confusional state,,2021,Q3,1,I,20210131.0,20210808.0,20210813,20210813,EXP,,GB-ASTRAZENECA-2021A672281,ASTRAZENECA,,55.0,YR,,M,Y,114.0,KG,20210813.0,,,GB,GB,2021,Q3,Adult
197003481,19700348,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,TAKE ONE DAILY,,,,,,,,1.0,DF,,QD,2021,Q3,Hallucination,,2021,Q3,1,I,20210131.0,20210808.0,20210813,20210813,EXP,,GB-ASTRAZENECA-2021A672281,ASTRAZENECA,,55.0,YR,,M,Y,114.0,KG,20210813.0,,,GB,GB,2021,Q3,Adult
197046162,19704616,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 TABLET IN THE MORNING, ONCE A DAY",,,,, UNKNOWN,,,,,TABLET,,2021,Q3,Abdominal discomfort,,2021,Q3,2,F,20210801.0,20210809.0,20210816,20210819,EXP,,CN-ASTRAZENECA-2021A675856,ASTRAZENECA,,57.0,YR,,M,Y,90.0,KG,20210819.0,,CN,CN,CN,2021,Q3,Adult
197046162,19704616,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 TABLET IN THE MORNING, ONCE A DAY",,,,, UNKNOWN,,,,,TABLET,,2021,Q3,Cardiac discomfort,,2021,Q3,2,F,20210801.0,20210809.0,20210816,20210819,EXP,,CN-ASTRAZENECA-2021A675856,ASTRAZENECA,,57.0,YR,,M,Y,90.0,KG,20210819.0,,CN,CN,CN,2021,Q3,Adult
197046162,19704616,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 TABLET IN THE MORNING, ONCE A DAY",,,,, UNKNOWN,,,,,TABLET,,2021,Q3,Heart rate increased,,2021,Q3,2,F,20210801.0,20210809.0,20210816,20210819,EXP,,CN-ASTRAZENECA-2021A675856,ASTRAZENECA,,57.0,YR,,M,Y,90.0,KG,20210819.0,,CN,CN,CN,2021,Q3,Adult
197046162,19704616,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"1 TABLET IN THE MORNING, ONCE A DAY",,,,, UNKNOWN,,,,,TABLET,,2021,Q3,Vision blurred,,2021,Q3,2,F,20210801.0,20210809.0,20210816,20210819,EXP,,CN-ASTRAZENECA-2021A675856,ASTRAZENECA,,57.0,YR,,M,Y,90.0,KG,20210819.0,,CN,CN,CN,2021,Q3,Adult
197076901,19707690,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,U,U, 2102032,,,10.0,MG,TABLET,QD,2021,Q3,Ketosis,,2021,Q3,1,I,20210715.0,20210724.0,20210817,20210817,EXP,,CN-ASTRAZENECA-2021A646269,ASTRAZENECA,,31.0,YR,,M,Y,78.2,KG,20210817.0,,HP,CN,CN,2021,Q3,Young Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Apathy,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Asthenia,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,COVID-19,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Cardio-respiratory arrest,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Diabetes mellitus,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Fatigue,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Increased appetite,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Infection,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Micturition urgency,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Respiratory failure,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Thirst,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Visual impairment,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197120641,19712064,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,,20201130.0,20210816,20210816,EXP,,BR-NOVOPROD-814119,NOVO NORDISK,,38.0,YR,,M,Y,62.0,KG,20210816.0,,MD,BR,BR,2021,Q3,Adult
197147921,19714792,2,SS,DAPAGLIFLOZIN/METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,,,,TABLET,,2021,Q3,Hyponatraemia,,2021,Q3,1,I,,20210807.0,20210818,20210818,EXP,CA-MHPD-E2B_03411597,CA-ACCORD-235279,ACCORD,,79.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Elderly
197167002,19716700,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",50.0,MG,Y,U, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Diabetic ketoacidosis,,2021,Q3,2,F,20210624.0,20210830.0,20210818,20210908,EXP,,JP-NOVOPROD-833232,NOVO NORDISK,,80.0,YR,,F,Y,39.2,KG,20210908.0,,MD,JP,JP,2021,Q3,Elderly
197167002,19716700,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",50.0,MG,Y,U, UNKNOWN,,,10.0,MG,,QD,2021,Q3,Vomiting,,2021,Q3,2,F,20210624.0,20210830.0,20210818,20210908,EXP,,JP-NOVOPROD-833232,NOVO NORDISK,,80.0,YR,,F,Y,39.2,KG,20210908.0,,MD,JP,JP,2021,Q3,Elderly
197169281,19716928,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, ONCE PER DAY",,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Constipation,,2021,Q3,1,I,2021.0,20210813.0,20210818,20210818,EXP,,CN-009507513-2108CHN003898,MERCK,,54.0,YR,,F,Y,71.0,KG,20210818.0,,HP,CN,CN,2021,Q3,Adult
197169281,19716928,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, ONCE PER DAY",,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Dizziness,,2021,Q3,1,I,2021.0,20210813.0,20210818,20210818,EXP,,CN-009507513-2108CHN003898,MERCK,,54.0,YR,,F,Y,71.0,KG,20210818.0,,HP,CN,CN,2021,Q3,Adult
197169281,19716928,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, ONCE PER DAY",,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Nausea,,2021,Q3,1,I,2021.0,20210813.0,20210818,20210818,EXP,,CN-009507513-2108CHN003898,MERCK,,54.0,YR,,F,Y,71.0,KG,20210818.0,,HP,CN,CN,2021,Q3,Adult
197169281,19716928,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, ONCE PER DAY",,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Secondary hypertension,,2021,Q3,1,I,2021.0,20210813.0,20210818,20210818,EXP,,CN-009507513-2108CHN003898,MERCK,,54.0,YR,,F,Y,71.0,KG,20210818.0,,HP,CN,CN,2021,Q3,Adult
197169281,19716928,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, ONCE PER DAY",,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,1,I,2021.0,20210813.0,20210818,20210818,EXP,,CN-009507513-2108CHN003898,MERCK,,54.0,YR,,F,Y,71.0,KG,20210818.0,,HP,CN,CN,2021,Q3,Adult
197172141,19717214,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,, ML3042,,,10.0,MG,TABLET,QD,2021,Q3,Ketosis,,2021,Q3,1,I,20210723.0,20210730.0,20210818,20210818,EXP,,CN-ASTRAZENECA-2021A664506,ASTRAZENECA,,41.0,YR,,M,Y,,,20210818.0,,HP,CN,CN,2021,Q3,Adult
197193272,19719327,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"5 MILLIGRAM, 50/1000",,,D,,,,,5.0,MG,,,2021,Q3,Lactic acidosis,,2021,Q3,2,F,20201228.0,20210816.0,20210819,20210823,EXP,,DE-MYLANLABS-2021M1053406,MYLAN,,67.0,YR,,M,Y,95.0,KG,20210823.0,,MD,DE,DE,2021,Q3,Elderly
197196631,19719663,4,C,dapagliflozin?metformin XR 5?1000mg,,2,,,,,,,,,,,,,,2021,Q3,Anaphylactic reaction,,2021,Q3,1,I,20210818.0,,20210819,20210819,DIR,,,FDA-CTU,,54.0,YR,,F,N,82.0,KG,20210819.0,Y,PH,US,US,2021,Q3,Adult
197196631,19719663,4,C,dapagliflozin?metformin XR 5?1000mg,,2,,,,,,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,1,I,20210818.0,,20210819,20210819,DIR,,,FDA-CTU,,54.0,YR,,F,N,82.0,KG,20210819.0,Y,PH,US,US,2021,Q3,Adult
197196631,19719663,4,C,dapagliflozin?metformin XR 5?1000mg,,2,,,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,20210818.0,,20210819,20210819,DIR,,,FDA-CTU,,54.0,YR,,F,N,82.0,KG,20210819.0,Y,PH,US,US,2021,Q3,Adult
197196631,19719663,4,C,dapagliflozin?metformin XR 5?1000mg,,2,,,,,,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,20210818.0,,20210819,20210819,DIR,,,FDA-CTU,,54.0,YR,,F,N,82.0,KG,20210819.0,Y,PH,US,US,2021,Q3,Adult
197196631,19719663,4,C,dapagliflozin?metformin XR 5?1000mg,,2,,,,,,,,,,,,,,2021,Q3,Mean arterial pressure decreased,,2021,Q3,1,I,20210818.0,,20210819,20210819,DIR,,,FDA-CTU,,54.0,YR,,F,N,82.0,KG,20210819.0,Y,PH,US,US,2021,Q3,Adult
197196631,19719663,4,C,dapagliflozin?metformin XR 5?1000mg,,2,,,,,,,,,,,,,,2021,Q3,Oxygen saturation decreased,,2021,Q3,1,I,20210818.0,,20210819,20210819,DIR,,,FDA-CTU,,54.0,YR,,F,N,82.0,KG,20210819.0,Y,PH,US,US,2021,Q3,Adult
197196631,19719663,4,C,dapagliflozin?metformin XR 5?1000mg,,2,,,,,,,,,,,,,,2021,Q3,Pruritus,,2021,Q3,1,I,20210818.0,,20210819,20210819,DIR,,,FDA-CTU,,54.0,YR,,F,N,82.0,KG,20210819.0,Y,PH,US,US,2021,Q3,Adult
197196631,19719663,4,C,dapagliflozin?metformin XR 5?1000mg,,2,,,,,,,,,,,,,,2021,Q3,Urticaria,,2021,Q3,1,I,20210818.0,,20210819,20210819,DIR,,,FDA-CTU,,54.0,YR,,F,N,82.0,KG,20210819.0,Y,PH,US,US,2021,Q3,Adult
197222781,19722278,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Brain natriuretic peptide abnormal,,2021,Q3,1,I,201207.0,20210812.0,20210819,20210819,EXP,,DE-MYLANLABS-2021M1052092,MYLAN,,862.0,MON,,F,Y,42.0,KG,20210819.0,,MD,DE,DE,2021,Q3,Elderly
197222781,19722278,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Cardiac failure,,2021,Q3,1,I,201207.0,20210812.0,20210819,20210819,EXP,,DE-MYLANLABS-2021M1052092,MYLAN,,862.0,MON,,F,Y,42.0,KG,20210819.0,,MD,DE,DE,2021,Q3,Elderly
197222781,19722278,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Dizziness,,2021,Q3,1,I,201207.0,20210812.0,20210819,20210819,EXP,,DE-MYLANLABS-2021M1052092,MYLAN,,862.0,MON,,F,Y,42.0,KG,20210819.0,,MD,DE,DE,2021,Q3,Elderly
197222781,19722278,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Dyspnoea,,2021,Q3,1,I,201207.0,20210812.0,20210819,20210819,EXP,,DE-MYLANLABS-2021M1052092,MYLAN,,862.0,MON,,F,Y,42.0,KG,20210819.0,,MD,DE,DE,2021,Q3,Elderly
197222781,19722278,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Fatigue,,2021,Q3,1,I,201207.0,20210812.0,20210819,20210819,EXP,,DE-MYLANLABS-2021M1052092,MYLAN,,862.0,MON,,F,Y,42.0,KG,20210819.0,,MD,DE,DE,2021,Q3,Elderly
197222781,19722278,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,General physical health deterioration,,2021,Q3,1,I,201207.0,20210812.0,20210819,20210819,EXP,,DE-MYLANLABS-2021M1052092,MYLAN,,862.0,MON,,F,Y,42.0,KG,20210819.0,,MD,DE,DE,2021,Q3,Elderly
197222781,19722278,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Malaise,,2021,Q3,1,I,201207.0,20210812.0,20210819,20210819,EXP,,DE-MYLANLABS-2021M1052092,MYLAN,,862.0,MON,,F,Y,42.0,KG,20210819.0,,MD,DE,DE,2021,Q3,Elderly
197222781,19722278,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Performance status decreased,,2021,Q3,1,I,201207.0,20210812.0,20210819,20210819,EXP,,DE-MYLANLABS-2021M1052092,MYLAN,,862.0,MON,,F,Y,42.0,KG,20210819.0,,MD,DE,DE,2021,Q3,Elderly
197222781,19722278,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Respiratory failure,,2021,Q3,1,I,201207.0,20210812.0,20210819,20210819,EXP,,DE-MYLANLABS-2021M1052092,MYLAN,,862.0,MON,,F,Y,42.0,KG,20210819.0,,MD,DE,DE,2021,Q3,Elderly
197222781,19722278,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Therapeutic product effect decreased,,2021,Q3,1,I,201207.0,20210812.0,20210819,20210819,EXP,,DE-MYLANLABS-2021M1052092,MYLAN,,862.0,MON,,F,Y,42.0,KG,20210819.0,,MD,DE,DE,2021,Q3,Elderly
197222781,19722278,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,201207.0,20210812.0,20210819,20210819,EXP,,DE-MYLANLABS-2021M1052092,MYLAN,,862.0,MON,,F,Y,42.0,KG,20210819.0,,MD,DE,DE,2021,Q3,Elderly
197222791,19722279,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q3,Cardiomegaly,,2021,Q3,1,I,,20210816.0,20210819,20210819,EXP,,PL-MYLANLABS-2021M1052829,MYLAN,,64.0,YR,,M,Y,,,20210819.0,,MD,PL,PL,2021,Q3,Adult
197222791,19722279,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q3,Emphysema,,2021,Q3,1,I,,20210816.0,20210819,20210819,EXP,,PL-MYLANLABS-2021M1052829,MYLAN,,64.0,YR,,M,Y,,,20210819.0,,MD,PL,PL,2021,Q3,Adult
197222791,19722279,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q3,Hyperkalaemia,,2021,Q3,1,I,,20210816.0,20210819,20210819,EXP,,PL-MYLANLABS-2021M1052829,MYLAN,,64.0,YR,,M,Y,,,20210819.0,,MD,PL,PL,2021,Q3,Adult
197222791,19722279,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q3,Hyperthyroidism,,2021,Q3,1,I,,20210816.0,20210819,20210819,EXP,,PL-MYLANLABS-2021M1052829,MYLAN,,64.0,YR,,M,Y,,,20210819.0,,MD,PL,PL,2021,Q3,Adult
197222791,19722279,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q3,Pneumonia,,2021,Q3,1,I,,20210816.0,20210819,20210819,EXP,,PL-MYLANLABS-2021M1052829,MYLAN,,64.0,YR,,M,Y,,,20210819.0,,MD,PL,PL,2021,Q3,Adult
197222791,19722279,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q3,Pulmonary hypertension,,2021,Q3,1,I,,20210816.0,20210819,20210819,EXP,,PL-MYLANLABS-2021M1052829,MYLAN,,64.0,YR,,M,Y,,,20210819.0,,MD,PL,PL,2021,Q3,Adult
197222791,19722279,15,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MILLIGRAM,,,U,U,,,,10.0,MG,,,2021,Q3,Pulmonary oedema,,2021,Q3,1,I,,20210816.0,20210819,20210819,EXP,,PL-MYLANLABS-2021M1052829,MYLAN,,64.0,YR,,M,Y,,,20210819.0,,MD,PL,PL,2021,Q3,Adult
197241231,19724123,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2021,Q3,Fournier's gangrene,,2021,Q3,1,I,,20210811.0,20210819,20210819,EXP,,NL-ASTRAZENECA-2021A677120,ASTRAZENECA,,41.0,YR,,M,Y,,,20210819.0,,HP,NL,EG,2021,Q3,Adult
197241231,19724123,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2021,Q3,Neuralgia,,2021,Q3,1,I,,20210811.0,20210819,20210819,EXP,,NL-ASTRAZENECA-2021A677120,ASTRAZENECA,,41.0,YR,,M,Y,,,20210819.0,,HP,NL,EG,2021,Q3,Adult
197241231,19724123,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2021,Q3,Pain,,2021,Q3,1,I,,20210811.0,20210819,20210819,EXP,,NL-ASTRAZENECA-2021A677120,ASTRAZENECA,,41.0,YR,,M,Y,,,20210819.0,,HP,NL,EG,2021,Q3,Adult
197241231,19724123,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2021,Q3,Penile pain,,2021,Q3,1,I,,20210811.0,20210819,20210819,EXP,,NL-ASTRAZENECA-2021A677120,ASTRAZENECA,,41.0,YR,,M,Y,,,20210819.0,,HP,NL,EG,2021,Q3,Adult
197241231,19724123,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2021,Q3,Perineal pain,,2021,Q3,1,I,,20210811.0,20210819,20210819,EXP,,NL-ASTRAZENECA-2021A677120,ASTRAZENECA,,41.0,YR,,M,Y,,,20210819.0,,HP,NL,EG,2021,Q3,Adult
197241231,19724123,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,TABLET,,2021,Q3,Testicular pain,,2021,Q3,1,I,,20210811.0,20210819,20210819,EXP,,NL-ASTRAZENECA-2021A677120,ASTRAZENECA,,41.0,YR,,M,Y,,,20210819.0,,HP,NL,EG,2021,Q3,Adult
197243171,19724317,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,140.0,MG,Y,, ML3010,,202293.0,10.0,MG,TABLET,BID,2021,Q3,Abdominal discomfort,,2021,Q3,1,I,20210629.0,20210811.0,20210819,20210819,EXP,,CN-ASTRAZENECA-2021A680817,ASTRAZENECA,,25568.0,DY,,M,Y,72.0,KG,20210819.0,,HP,CN,CN,2021,Q3,Elderly
197243171,19724317,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,140.0,MG,Y,, ML3010,,202293.0,10.0,MG,TABLET,BID,2021,Q3,Decreased appetite,,2021,Q3,1,I,20210629.0,20210811.0,20210819,20210819,EXP,,CN-ASTRAZENECA-2021A680817,ASTRAZENECA,,25568.0,DY,,M,Y,72.0,KG,20210819.0,,HP,CN,CN,2021,Q3,Elderly
197243171,19724317,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,140.0,MG,Y,, ML3010,,202293.0,10.0,MG,TABLET,BID,2021,Q3,Dysgeusia,,2021,Q3,1,I,20210629.0,20210811.0,20210819,20210819,EXP,,CN-ASTRAZENECA-2021A680817,ASTRAZENECA,,25568.0,DY,,M,Y,72.0,KG,20210819.0,,HP,CN,CN,2021,Q3,Elderly
197243171,19724317,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,140.0,MG,Y,, ML3010,,202293.0,10.0,MG,TABLET,BID,2021,Q3,Muscular weakness,,2021,Q3,1,I,20210629.0,20210811.0,20210819,20210819,EXP,,CN-ASTRAZENECA-2021A680817,ASTRAZENECA,,25568.0,DY,,M,Y,72.0,KG,20210819.0,,HP,CN,CN,2021,Q3,Elderly
197247041,19724704,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10,,,Y,,,,202293.0,,,TABLET,,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,20210728.0,20210813.0,20210819,20210819,EXP,,GB-ASTRAZENECA-2021A682096,ASTRAZENECA,,44.0,YR,,M,Y,82.1,KG,20210819.0,,HP,GB,GB,2021,Q3,Adult
197247041,19724704,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10,,,Y,,,,202293.0,,,TABLET,,2021,Q3,Vomiting,,2021,Q3,1,I,20210728.0,20210813.0,20210819,20210819,EXP,,GB-ASTRAZENECA-2021A682096,ASTRAZENECA,,44.0,YR,,M,Y,82.1,KG,20210819.0,,HP,GB,GB,2021,Q3,Adult
197294131,19729413,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,69.0,DF,Y,, ML3040,,,1.0,DF,TABLET,QD,2021,Q3,Ketoacidosis,,2021,Q3,1,I,20210713.0,20210813.0,20210820,20210820,EXP,,CN-ASTRAZENECA-2021A687419,ASTRAZENECA,,11998.0,DY,,M,Y,,,20210820.0,,HP,CN,CN,2021,Q3,Elderly
197303241,19730324,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2021,Q3,Altered visual depth perception,,2021,Q3,1,I,20210707.0,20210813.0,20210820,20210820,EXP,,GB-ASTRAZENECA-2021A682080,ASTRAZENECA,,71.0,YR,,M,Y,78.0,KG,20210820.0,,HP,GB,GB,2021,Q3,Elderly
197303241,19730324,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2021,Q3,Dizziness,,2021,Q3,1,I,20210707.0,20210813.0,20210820,20210820,EXP,,GB-ASTRAZENECA-2021A682080,ASTRAZENECA,,71.0,YR,,M,Y,78.0,KG,20210820.0,,HP,GB,GB,2021,Q3,Elderly
197303241,19730324,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2021,Q3,Photophobia,,2021,Q3,1,I,20210707.0,20210813.0,20210820,20210820,EXP,,GB-ASTRAZENECA-2021A682080,ASTRAZENECA,,71.0,YR,,M,Y,78.0,KG,20210820.0,,HP,GB,GB,2021,Q3,Elderly
197303241,19730324,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2021,Q3,Photopsia,,2021,Q3,1,I,20210707.0,20210813.0,20210820,20210820,EXP,,GB-ASTRAZENECA-2021A682080,ASTRAZENECA,,71.0,YR,,M,Y,78.0,KG,20210820.0,,HP,GB,GB,2021,Q3,Elderly
197303241,19730324,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2021,Q3,Vision blurred,,2021,Q3,1,I,20210707.0,20210813.0,20210820,20210820,EXP,,GB-ASTRAZENECA-2021A682080,ASTRAZENECA,,71.0,YR,,M,Y,78.0,KG,20210820.0,,HP,GB,GB,2021,Q3,Elderly
197303241,19730324,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,,,,202293.0,10.0,MG,TABLET,,2021,Q3,Visual impairment,,2021,Q3,1,I,20210707.0,20210813.0,20210820,20210820,EXP,,GB-ASTRAZENECA-2021A682080,ASTRAZENECA,,71.0,YR,,M,Y,78.0,KG,20210820.0,,HP,GB,GB,2021,Q3,Elderly
197303321,19730332,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,, MM3589,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Blood ketone body increased,,2021,Q3,1,I,20210714.0,20210812.0,20210820,20210820,EXP,,CN-ASTRAZENECA-2021A683722,ASTRAZENECA,,32.0,YR,,F,Y,,,20210820.0,,HP,CN,CN,2021,Q3,Young Adult
197303321,19730332,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,, MM3589,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Ketoacidosis,,2021,Q3,1,I,20210714.0,20210812.0,20210820,20210820,EXP,,CN-ASTRAZENECA-2021A683722,ASTRAZENECA,,32.0,YR,,F,Y,,,20210820.0,,HP,CN,CN,2021,Q3,Young Adult
197310391,19731039,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1680.0,MG,U,, 2006113MA2096,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Condition aggravated,,2021,Q3,1,I,20210617.0,20210812.0,20210820,20210820,EXP,,CN-ASTRAZENECA-2021A683432,ASTRAZENECA,,32757.0,DY,,F,Y,,,20210820.0,,HP,CN,CN,2021,Q3,Elderly
197310391,19731039,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1680.0,MG,U,, 2006113MA2096,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Renal impairment,,2021,Q3,1,I,20210617.0,20210812.0,20210820,20210820,EXP,,CN-ASTRAZENECA-2021A683432,ASTRAZENECA,,32757.0,DY,,F,Y,,,20210820.0,,HP,CN,CN,2021,Q3,Elderly
197316681,19731668,1,PS,DAPAGLIFLOZIN TABLETS,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,, MK2978,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210726.0,20210812.0,20210820,20210820,EXP,,CN-ASTRAZENECA-2021A681379,ASTRAZENECA,,59.0,YR,,F,Y,65.5,KG,20210820.0,,HP,CN,CN,2021,Q3,Adult
197400411,19740041,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD (10 MG, 1X)",,,U,U,,,,10.0,MG,,QD,2021,Q3,Acute myocardial infarction,,2021,Q3,1,I,2015.0,20210817.0,20210824,20210824,EXP,,HU-MYLANLABS-2021M1053787,MYLAN,,67.0,YR,,M,Y,,,20210824.0,,MD,HU,HU,2021,Q3,Elderly
197400411,19740041,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD (10 MG, 1X)",,,U,U,,,,10.0,MG,,QD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,1,I,2015.0,20210817.0,20210824,20210824,EXP,,HU-MYLANLABS-2021M1053787,MYLAN,,67.0,YR,,M,Y,,,20210824.0,,MD,HU,HU,2021,Q3,Elderly
197400411,19740041,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD (10 MG, 1X)",,,U,U,,,,10.0,MG,,QD,2021,Q3,Hypertension,,2021,Q3,1,I,2015.0,20210817.0,20210824,20210824,EXP,,HU-MYLANLABS-2021M1053787,MYLAN,,67.0,YR,,M,Y,,,20210824.0,,MD,HU,HU,2021,Q3,Elderly
197400411,19740041,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MILLIGRAM, QD (10 MG, 1X)",,,U,U,,,,10.0,MG,,QD,2021,Q3,Obesity,,2021,Q3,1,I,2015.0,20210817.0,20210824,20210824,EXP,,HU-MYLANLABS-2021M1053787,MYLAN,,67.0,YR,,M,Y,,,20210824.0,,MD,HU,HU,2021,Q3,Elderly
197405031,19740503,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,U, LC3182,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Diabetic ketosis,,2021,Q3,1,I,20210722.0,20210814.0,20210824,20210824,EXP,,CN-ASTRAZENECA-2021A689570,ASTRAZENECA,,17306.0,DY,,F,Y,61.0,KG,20210824.0,,HP,CN,CN,2021,Q3,Elderly
197418481,19741848,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1680.0,MG,U,, 2006113MA2096,,,10.0,MG,,QD,2021,Q3,Condition aggravated,,2021,Q3,1,I,20210617.0,20210812.0,20210825,20210825,EXP,CN-ASTRAZENECA-2021A683432,CN-TOPROL-2021000175,TOPROL ACQUISITION,,89.0,YR,E,F,Y,,,20210825.0,,CN,SE,CN,2021,Q3,Elderly
197418481,19741848,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1680.0,MG,U,, 2006113MA2096,,,10.0,MG,,QD,2021,Q3,Renal impairment,,2021,Q3,1,I,20210617.0,20210812.0,20210825,20210825,EXP,CN-ASTRAZENECA-2021A683432,CN-TOPROL-2021000175,TOPROL ACQUISITION,,89.0,YR,E,F,Y,,,20210825.0,,CN,SE,CN,2021,Q3,Elderly
197446661,19744666,8,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, Q.O.WK.",,,D,,,,,5.0,MG,,QOW,2021,Q3,Arteriosclerosis coronary artery,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,8,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, Q.O.WK.",,,D,,,,,5.0,MG,,QOW,2021,Q3,Chest pain,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,8,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, Q.O.WK.",,,D,,,,,5.0,MG,,QOW,2021,Q3,Dyspnoea exertional,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,8,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 MILLIGRAM, Q.O.WK.",,,D,,,,,5.0,MG,,QOW,2021,Q3,Pneumonia,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 MILLIGRAM, Q.O.WK.",,,D,,,,,10.0,MG,,QOW,2021,Q3,Arteriosclerosis coronary artery,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 MILLIGRAM, Q.O.WK.",,,D,,,,,10.0,MG,,QOW,2021,Q3,Chest pain,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 MILLIGRAM, Q.O.WK.",,,D,,,,,10.0,MG,,QOW,2021,Q3,Dyspnoea exertional,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197446661,19744666,9,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 MILLIGRAM, Q.O.WK.",,,D,,,,,10.0,MG,,QOW,2021,Q3,Pneumonia,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,CA-APOTEX-2021AP035906,APOTEX,,71.0,YR,,M,Y,,,20210825.0,,CN,CA,CA,2021,Q3,Elderly
197526641,19752664,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,290.0,MG,,,,,202293.0,10.0,MG,,QD,2021,Q3,Bacterial infection,,2021,Q3,1,I,20210622.0,20210819.0,20210826,20210826,EXP,,GB-ASTRAZENECA-2021A690035,ASTRAZENECA,,69.0,YR,,M,Y,84.0,KG,20210826.0,,MD,GB,GB,2021,Q3,Elderly
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Aortic valve incompetence,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Aortic valve sclerosis,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Cardiac valve disease,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Fall,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Fluid overload,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Haemoglobin decreased,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Hirsutism,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Hypermobility syndrome,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Inferior vena cava dilatation,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Left atrial dilatation,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Left ventricular hypertrophy,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Mitral valve incompetence,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Pain in extremity,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Pericardial effusion,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Pneumonia,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Pulmonary hypertension,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Respiratory failure,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Right atrial dilatation,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Right ventricular dilatation,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Systolic dysfunction,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Vulvovaginal candidiasis,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197562341,19756234,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,,,,,,10.0,MG,,QD,2021,Q3,Weight increased,,2021,Q3,1,I,20160410.0,20210818.0,20210827,20210827,EXP,,AU-OTSUKA-2021_029159,OTSUKA,,38.0,YR,,F,Y,,,20210827.0,,MD,AU,AU,2021,Q3,Adult
197584931,19758493,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, ONCE IN A DAY",,,Y,,,,,10.0,MG,TABLET,QD,2021,Q3,Asthenia,,2021,Q3,1,I,202108.0,20210823.0,20210827,20210827,EXP,,CN-009507513-2108CHN006939,MERCK,,86.0,YR,,F,Y,50.0,KG,20210827.0,,HP,CN,CN,2021,Q3,Elderly
197584931,19758493,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, ONCE IN A DAY",,,Y,,,,,10.0,MG,TABLET,QD,2021,Q3,Diabetes mellitus,,2021,Q3,1,I,202108.0,20210823.0,20210827,20210827,EXP,,CN-009507513-2108CHN006939,MERCK,,86.0,YR,,F,Y,50.0,KG,20210827.0,,HP,CN,CN,2021,Q3,Elderly
197584931,19758493,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, ONCE IN A DAY",,,Y,,,,,10.0,MG,TABLET,QD,2021,Q3,Hyperhidrosis,,2021,Q3,1,I,202108.0,20210823.0,20210827,20210827,EXP,,CN-009507513-2108CHN006939,MERCK,,86.0,YR,,F,Y,50.0,KG,20210827.0,,HP,CN,CN,2021,Q3,Elderly
197584931,19758493,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, ONCE IN A DAY",,,Y,,,,,10.0,MG,TABLET,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,202108.0,20210823.0,20210827,20210827,EXP,,CN-009507513-2108CHN006939,MERCK,,86.0,YR,,F,Y,50.0,KG,20210827.0,,HP,CN,CN,2021,Q3,Elderly
197626672,19762667,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, MANE",,,,,,,,10.0,MG,,,2021,Q3,Anaemia,,2021,Q3,2,F,20210809.0,20210831.0,20210828,20210906,EXP,,NVSC2021AU181084,NOVARTIS,,74.0,YR,,M,Y,78.3,KG,20210907.0,,HP,AU,AU,2021,Q3,Elderly
197626672,19762667,9,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, MANE",,,,,,,,10.0,MG,,,2021,Q3,Febrile neutropenia,,2021,Q3,2,F,20210809.0,20210831.0,20210828,20210906,EXP,,NVSC2021AU181084,NOVARTIS,,74.0,YR,,M,Y,78.3,KG,20210907.0,,HP,AU,AU,2021,Q3,Elderly
197641781,19764178,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 1 PILL PER DAY,,,,, UNK,,,,,,,2021,Q3,Angioplasty,,2021,Q3,1,I,202104.0,20210817.0,20210830,20210830,EXP,,BR-NOVOPROD-840317,NOVO NORDISK,,74.0,YR,,,Y,65.0,KG,20210830.0,,MD,BR,BR,2021,Q3,Elderly
197641781,19764178,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 1 PILL PER DAY,,,,, UNK,,,,,,,2021,Q3,Blood creatinine increased,,2021,Q3,1,I,202104.0,20210817.0,20210830,20210830,EXP,,BR-NOVOPROD-840317,NOVO NORDISK,,74.0,YR,,,Y,65.0,KG,20210830.0,,MD,BR,BR,2021,Q3,Elderly
197641781,19764178,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 1 PILL PER DAY,,,,, UNK,,,,,,,2021,Q3,COVID-19,,2021,Q3,1,I,202104.0,20210817.0,20210830,20210830,EXP,,BR-NOVOPROD-840317,NOVO NORDISK,,74.0,YR,,,Y,65.0,KG,20210830.0,,MD,BR,BR,2021,Q3,Elderly
197641781,19764178,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 1 PILL PER DAY,,,,, UNK,,,,,,,2021,Q3,Catheterisation cardiac,,2021,Q3,1,I,202104.0,20210817.0,20210830,20210830,EXP,,BR-NOVOPROD-840317,NOVO NORDISK,,74.0,YR,,,Y,65.0,KG,20210830.0,,MD,BR,BR,2021,Q3,Elderly
197641781,19764178,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 1 PILL PER DAY,,,,, UNK,,,,,,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,1,I,202104.0,20210817.0,20210830,20210830,EXP,,BR-NOVOPROD-840317,NOVO NORDISK,,74.0,YR,,,Y,65.0,KG,20210830.0,,MD,BR,BR,2021,Q3,Elderly
197641781,19764178,3,C,DAPAGLIFLOZIN;METFORMIN,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 1 PILL PER DAY,,,,, UNK,,,,,,,2021,Q3,Off label use,,2021,Q3,1,I,202104.0,20210817.0,20210830,20210830,EXP,,BR-NOVOPROD-840317,NOVO NORDISK,,74.0,YR,,,Y,65.0,KG,20210830.0,,MD,BR,BR,2021,Q3,Elderly
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Aortic valve incompetence,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Aortic valve sclerosis,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Cardiac valve disease,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Fall,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Fluid overload,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Haemoglobin decreased,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Hirsutism,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Hypermobility syndrome,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Inferior vena cava dilatation,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Left atrial dilatation,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Left ventricular hypertrophy,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Mitral valve incompetence,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Pain in extremity,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Pericardial effusion,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Pneumonia,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Pulmonary hypertension,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Respiratory failure,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Right atrial dilatation,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Right ventricular dilatation,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Systolic dysfunction,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Underdose,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Vulvovaginal candidiasis,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197650822,19765082,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,,,,,,10.0,MG,,,2021,Q3,Weight increased,,2021,Q3,2,F,20160410.0,20210913.0,20210830,20210927,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20210927.0,,HP,AU,AU,2021,Q3,Adult
197689591,19768959,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,, UNKNOWN,,202293.0,10.0,MG,TABLET,,2021,Q3,Peripheral arterial occlusive disease,,2021,Q3,1,I,20210818.0,20210825.0,20210831,20210831,EXP,,GB-ASTRAZENECA-2021A698291,ASTRAZENECA,,51.0,YR,,M,Y,,,20210831.0,,,GB,GB,2021,Q3,Adult
197689591,19768959,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,Y,, UNKNOWN,,202293.0,10.0,MG,TABLET,,2021,Q3,Peripheral ischaemia,,2021,Q3,1,I,20210818.0,20210825.0,20210831,20210831,EXP,,GB-ASTRAZENECA-2021A698291,ASTRAZENECA,,51.0,YR,,M,Y,,,20210831.0,,,GB,GB,2021,Q3,Adult
197708572,19770857,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,, MM3582/2103098,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Vulvovaginal pruritus,,2021,Q3,2,F,20210722.0,20210823.0,20210831,20210831,EXP,,CN-ASTRAZENECA-2021A701885,ASTRAZENECA,,29470.0,DY,,F,Y,56.0,KG,20210831.0,,HP,CN,CN,2021,Q3,Elderly
197709151,19770915,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,, 2103152,,,10.0,MG,TABLET,QD,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210604.0,20210823.0,20210901,20210901,EXP,,CN-ASTRAZENECA-2021A701876,ASTRAZENECA,,69.0,YR,,F,Y,,,20210901.0,,HP,CN,CN,2021,Q3,Elderly
197727532,19772753,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,970.0,MG,U,, 2011204,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Fatigue,,2021,Q3,2,F,20210817.0,20210823.0,20210831,20210831,EXP,,CN-ASTRAZENECA-2021A699627,ASTRAZENECA,,31692.0,DY,,F,Y,50.0,KG,20210831.0,,HP,CN,CN,2021,Q3,Elderly
197727532,19772753,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,970.0,MG,U,, 2011204,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Hyperhidrosis,,2021,Q3,2,F,20210817.0,20210823.0,20210831,20210831,EXP,,CN-ASTRAZENECA-2021A699627,ASTRAZENECA,,31692.0,DY,,F,Y,50.0,KG,20210831.0,,HP,CN,CN,2021,Q3,Elderly
197727532,19772753,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,970.0,MG,U,, 2011204,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20210817.0,20210823.0,20210831,20210831,EXP,,CN-ASTRAZENECA-2021A699627,ASTRAZENECA,,31692.0,DY,,F,Y,50.0,KG,20210831.0,,HP,CN,CN,2021,Q3,Elderly
197775002,19777500,7,SS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 MG, QD",,,D,,,,,10.0,MG,,QD,2021,Q3,Cardiac arrest,,2021,Q3,2,F,20210310.0,20210901.0,20210901,20210906,EXP,,NVSJ2021JP012974,NOVARTIS,,81.0,YR,,M,Y,50.6,KG,20210907.0,,CN,JP,JP,2021,Q3,Elderly
197775002,19777500,7,SS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 MG, QD",,,D,,,,,10.0,MG,,QD,2021,Q3,Cardiac failure chronic,,2021,Q3,2,F,20210310.0,20210901.0,20210901,20210906,EXP,,NVSJ2021JP012974,NOVARTIS,,81.0,YR,,M,Y,50.6,KG,20210907.0,,CN,JP,JP,2021,Q3,Elderly
197775002,19777500,7,SS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 MG, QD",,,D,,,,,10.0,MG,,QD,2021,Q3,Dyspnoea exertional,,2021,Q3,2,F,20210310.0,20210901.0,20210901,20210906,EXP,,NVSJ2021JP012974,NOVARTIS,,81.0,YR,,M,Y,50.6,KG,20210907.0,,CN,JP,JP,2021,Q3,Elderly
197775002,19777500,7,SS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 MG, QD",,,D,,,,,10.0,MG,,QD,2021,Q3,Ejection fraction decreased,,2021,Q3,2,F,20210310.0,20210901.0,20210901,20210906,EXP,,NVSJ2021JP012974,NOVARTIS,,81.0,YR,,M,Y,50.6,KG,20210907.0,,CN,JP,JP,2021,Q3,Elderly
197811511,19781151,10,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"10 MILLIGRAM, QD, 10 MG, 1?0?0?0",,,,,,,,10.0,MG,,QD,2021,Q3,Acute kidney injury,,2021,Q3,1,I,20210113.0,20210831.0,20210902,20210902,EXP,,DE-MYLANLABS-2021M1058343,MYLAN,,71.0,YR,,F,Y,117.0,KG,20210902.0,,MD,DE,DE,2021,Q3,Elderly
197822111,19782211,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Cardiac failure acute,,2021,Q3,1,I,20210708.0,20210828.0,20210902,20210902,EXP,,CN-ASTRAZENECA-2021A706446,ASTRAZENECA,,75.0,YR,,F,Y,,,20210902.0,,HP,CN,CN,2021,Q3,Elderly
197822111,19782211,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Cardio-respiratory arrest,,2021,Q3,1,I,20210708.0,20210828.0,20210902,20210902,EXP,,CN-ASTRAZENECA-2021A706446,ASTRAZENECA,,75.0,YR,,F,Y,,,20210902.0,,HP,CN,CN,2021,Q3,Elderly
197822111,19782211,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Condition aggravated,,2021,Q3,1,I,20210708.0,20210828.0,20210902,20210902,EXP,,CN-ASTRAZENECA-2021A706446,ASTRAZENECA,,75.0,YR,,F,Y,,,20210902.0,,HP,CN,CN,2021,Q3,Elderly
197822111,19782211,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Drug-induced liver injury,,2021,Q3,1,I,20210708.0,20210828.0,20210902,20210902,EXP,,CN-ASTRAZENECA-2021A706446,ASTRAZENECA,,75.0,YR,,F,Y,,,20210902.0,,HP,CN,CN,2021,Q3,Elderly
197822111,19782211,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Hepatic function abnormal,,2021,Q3,1,I,20210708.0,20210828.0,20210902,20210902,EXP,,CN-ASTRAZENECA-2021A706446,ASTRAZENECA,,75.0,YR,,F,Y,,,20210902.0,,HP,CN,CN,2021,Q3,Elderly
197822111,19782211,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,TABLET,QD,2021,Q3,Respiratory failure,,2021,Q3,1,I,20210708.0,20210828.0,20210902,20210902,EXP,,CN-ASTRAZENECA-2021A706446,ASTRAZENECA,,75.0,YR,,F,Y,,,20210902.0,,HP,CN,CN,2021,Q3,Elderly
197859981,19785998,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,ONE TABLET QD,,,Y,U, ML3040,,,,,TABLET,,2021,Q3,Ketosis,,2021,Q3,1,I,20210726.0,20210813.0,20210903,20210903,EXP,,CN-ASTRAZENECA-2021A686948,ASTRAZENECA,,8176.0,DY,,M,Y,83.0,KG,20210903.0,,HP,CN,CN,2021,Q3,Elderly
197913731,19791373,3,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210826.0,20210906,20210906,EXP,CA- HEALTHCANVIG- E2B_03851596,CA-NOVOPROD-842145,NOVO NORDISK,,74.0,YR,,F,Y,81.0,KG,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197913731,19791373,3,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Myocardial infarction,,2021,Q3,1,I,,20210826.0,20210906,20210906,EXP,CA- HEALTHCANVIG- E2B_03851596,CA-NOVOPROD-842145,NOVO NORDISK,,74.0,YR,,F,Y,81.0,KG,20210906.0,,CN,CA,CA,2021,Q3,Elderly
197913801,19791380,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Dizziness,,2021,Q3,1,I,20210801.0,20210825.0,20210906,20210906,EXP,GB-MHRA-EYC 00259122,GB-NOVOPROD-841738,NOVO NORDISK,,60.0,YR,,M,Y,85.0,KG,20210906.0,,MD,GB,GB,2021,Q3,Adult
197913841,19791384,3,SS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,U,U,,,,,,,,2021,Q3,Diverticulum intestinal,,2021,Q3,1,I,,20210826.0,20210906,20210906,EXP,CA- HEALTHCANVIG-E2B_03851738,CA-NOVOPROD-842032,NOVO NORDISK,,58.0,YR,,F,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Adult
197913841,19791384,3,SS,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,U,U,,,,,,,,2021,Q3,Nephrolithiasis,,2021,Q3,1,I,,20210826.0,20210906,20210906,EXP,CA- HEALTHCANVIG-E2B_03851738,CA-NOVOPROD-842032,NOVO NORDISK,,58.0,YR,,F,Y,,,20210906.0,,CN,CA,CA,2021,Q3,Adult
197975541,19797554,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,300,,,,,,,,,,TABLET,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210901.0,20210903.0,20210907,20210907,EXP,,GB-ASTRAZENECA-2021A711860,ASTRAZENECA,,41.0,YR,,F,Y,80.0,KG,20210907.0,,,GB,GB,2021,Q3,Adult
198037922,19803792,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,2,F,,20210909.0,20210908,20210914,EXP,,PK-ASTRAZENECA-2021A709408,ASTRAZENECA,,55.0,YR,,F,Y,,,20210914.0,,HP,PK,PK,2021,Q3,Adult
198037941,19803794,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,61.0,DF,Y,, 2006114,,,1.0,DF,TABLET,QD,2021,Q3,Abdominal discomfort,,2021,Q3,1,I,,20210901.0,20210908,20210908,EXP,,CN-ASTRAZENECA-2021A713393,ASTRAZENECA,,41.0,YR,,F,Y,63.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198037941,19803794,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,61.0,DF,Y,, 2006114,,,1.0,DF,TABLET,QD,2021,Q3,Ketoacidosis,,2021,Q3,1,I,,20210901.0,20210908,20210908,EXP,,CN-ASTRAZENECA-2021A713393,ASTRAZENECA,,41.0,YR,,F,Y,63.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198060121,19806012,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2021,Q3,Haemoglobin decreased,,2021,Q3,1,I,20210517.0,20210901.0,20210909,20210909,EXP,PT-INFARMED-T202108-1717,PT-VIFOR (INTERNATIONAL) INC.-VIT-2021-07184,VIFOR,,72.0,YR,,F,Y,63.0,KG,20210909.0,,PH,PT,PT,2021,Q3,Elderly
198107221,19810722,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,30.0,MG,U,, 2103051,,,10.0,MG,TABLET,QD,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210814.0,20210831.0,20210909,20210909,EXP,,CN-ASTRAZENECA-2021A710461,ASTRAZENECA,,18628.0,DY,,M,Y,,,20210909.0,,HP,CN,CN,2021,Q3,Elderly
198108771,19810877,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,TID,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,,20210831.0,20210909,20210909,EXP,,CN-ASTRAZENECA-2021A711206,ASTRAZENECA,ANALYSIS OF 2 CASES OF DIABETIC EUGLYCEMIC KETOACIDOSIS INDUCED BY DAPAGLIFLOZIN AND RELATED LITERATURE REVIEW. WORLD CLINICAL DRUGS 2021?42(7):599?602.,50.0,YR,,F,Y,,,20210909.0,,HP,CN,CN,2021,Q3,Adult
198122741,19812274,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Cold sweat,,2021,Q3,1,I,20210903.0,20210906.0,20210909,20210909,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-MYLANLABS-2021M1060164,MYLAN,,50.0,YR,,M,Y,75.0,KG,20210909.0,,CN,GB,GB,2021,Q3,Adult
198122741,19812274,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210903.0,20210906.0,20210909,20210909,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-MYLANLABS-2021M1060164,MYLAN,,50.0,YR,,M,Y,75.0,KG,20210909.0,,CN,GB,GB,2021,Q3,Adult
198122741,19812274,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,20210903.0,20210906.0,20210909,20210909,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-MYLANLABS-2021M1060164,MYLAN,,50.0,YR,,M,Y,75.0,KG,20210909.0,,CN,GB,GB,2021,Q3,Adult
198122741,19812274,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Gastrointestinal carcinoma,,2021,Q3,1,I,20210903.0,20210906.0,20210909,20210909,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-MYLANLABS-2021M1060164,MYLAN,,50.0,YR,,M,Y,75.0,KG,20210909.0,,CN,GB,GB,2021,Q3,Adult
198122741,19812274,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Hot flush,,2021,Q3,1,I,20210903.0,20210906.0,20210909,20210909,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-MYLANLABS-2021M1060164,MYLAN,,50.0,YR,,M,Y,75.0,KG,20210909.0,,CN,GB,GB,2021,Q3,Adult
198122741,19812274,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,20210903.0,20210906.0,20210909,20210909,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-MYLANLABS-2021M1060164,MYLAN,,50.0,YR,,M,Y,75.0,KG,20210909.0,,CN,GB,GB,2021,Q3,Adult
198122741,19812274,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,20210903.0,20210906.0,20210909,20210909,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-MYLANLABS-2021M1060164,MYLAN,,50.0,YR,,M,Y,75.0,KG,20210909.0,,CN,GB,GB,2021,Q3,Adult
198138471,19813847,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,870.0,MG,Y,, ML3028,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Dysuria,,2021,Q3,1,I,20210816.0,20210902.0,20210910,20210910,EXP,,CN-ASTRAZENECA-2021A713017,ASTRAZENECA,,21955.0,DY,,F,Y,70.0,KG,20210910.0,,HP,CN,CN,2021,Q3,Elderly
198138471,19813847,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,870.0,MG,Y,, ML3028,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Micturition urgency,,2021,Q3,1,I,20210816.0,20210902.0,20210910,20210910,EXP,,CN-ASTRAZENECA-2021A713017,ASTRAZENECA,,21955.0,DY,,F,Y,70.0,KG,20210910.0,,HP,CN,CN,2021,Q3,Elderly
198138471,19813847,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,870.0,MG,Y,, ML3028,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Pain,,2021,Q3,1,I,20210816.0,20210902.0,20210910,20210910,EXP,,CN-ASTRAZENECA-2021A713017,ASTRAZENECA,,21955.0,DY,,F,Y,70.0,KG,20210910.0,,HP,CN,CN,2021,Q3,Elderly
198138471,19813847,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,870.0,MG,Y,, ML3028,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Pollakiuria,,2021,Q3,1,I,20210816.0,20210902.0,20210910,20210910,EXP,,CN-ASTRAZENECA-2021A713017,ASTRAZENECA,,21955.0,DY,,F,Y,70.0,KG,20210910.0,,HP,CN,CN,2021,Q3,Elderly
198138471,19813847,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,870.0,MG,Y,, ML3028,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Urinary tract infection,,2021,Q3,1,I,20210816.0,20210902.0,20210910,20210910,EXP,,CN-ASTRAZENECA-2021A713017,ASTRAZENECA,,21955.0,DY,,F,Y,70.0,KG,20210910.0,,HP,CN,CN,2021,Q3,Elderly
198143191,19814319,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,, UNKNOWN,,202293.0,10.0,MG,TABLET,,2021,Q3,Anion gap,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-ASTRAZENECA-2021A714193,ASTRAZENECA,,54.0,YR,,F,Y,93.0,KG,20210910.0,,MD,DE,DE,2021,Q3,Adult
198143191,19814319,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,, UNKNOWN,,202293.0,10.0,MG,TABLET,,2021,Q3,Ketoacidosis,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-ASTRAZENECA-2021A714193,ASTRAZENECA,,54.0,YR,,F,Y,93.0,KG,20210910.0,,MD,DE,DE,2021,Q3,Adult
198143191,19814319,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,10.0MG UNKNOWN,,,U,, UNKNOWN,,202293.0,10.0,MG,TABLET,,2021,Q3,Pneumonia,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-ASTRAZENECA-2021A714193,ASTRAZENECA,,54.0,YR,,F,Y,93.0,KG,20210910.0,,MD,DE,DE,2021,Q3,Adult
198196081,19819608,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Benign breast neoplasm,,2021,Q3,1,I,2015.0,20210831.0,20210913,20210913,EXP,,BR-NOVOPROD-844240,NOVO NORDISK,,61.0,YR,,F,Y,59.15,KG,20210913.0,,MD,BR,BR,2021,Q3,Adult
198196081,19819608,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Blood pressure increased,,2021,Q3,1,I,2015.0,20210831.0,20210913,20210913,EXP,,BR-NOVOPROD-844240,NOVO NORDISK,,61.0,YR,,F,Y,59.15,KG,20210913.0,,MD,BR,BR,2021,Q3,Adult
198196081,19819608,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Candida infection,,2021,Q3,1,I,2015.0,20210831.0,20210913,20210913,EXP,,BR-NOVOPROD-844240,NOVO NORDISK,,61.0,YR,,F,Y,59.15,KG,20210913.0,,MD,BR,BR,2021,Q3,Adult
198196081,19819608,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Carotid artery disease,,2021,Q3,1,I,2015.0,20210831.0,20210913,20210913,EXP,,BR-NOVOPROD-844240,NOVO NORDISK,,61.0,YR,,F,Y,59.15,KG,20210913.0,,MD,BR,BR,2021,Q3,Adult
198196081,19819608,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Diabetic retinopathy,,2021,Q3,1,I,2015.0,20210831.0,20210913,20210913,EXP,,BR-NOVOPROD-844240,NOVO NORDISK,,61.0,YR,,F,Y,59.15,KG,20210913.0,,MD,BR,BR,2021,Q3,Adult
198196081,19819608,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Hepatic steatosis,,2021,Q3,1,I,2015.0,20210831.0,20210913,20210913,EXP,,BR-NOVOPROD-844240,NOVO NORDISK,,61.0,YR,,F,Y,59.15,KG,20210913.0,,MD,BR,BR,2021,Q3,Adult
198196081,19819608,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Herpes zoster,,2021,Q3,1,I,2015.0,20210831.0,20210913,20210913,EXP,,BR-NOVOPROD-844240,NOVO NORDISK,,61.0,YR,,F,Y,59.15,KG,20210913.0,,MD,BR,BR,2021,Q3,Adult
198196081,19819608,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Hysterectomy,,2021,Q3,1,I,2015.0,20210831.0,20210913,20210913,EXP,,BR-NOVOPROD-844240,NOVO NORDISK,,61.0,YR,,F,Y,59.15,KG,20210913.0,,MD,BR,BR,2021,Q3,Adult
198196081,19819608,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Osteopenia,,2021,Q3,1,I,2015.0,20210831.0,20210913,20210913,EXP,,BR-NOVOPROD-844240,NOVO NORDISK,,61.0,YR,,F,Y,59.15,KG,20210913.0,,MD,BR,BR,2021,Q3,Adult
198196081,19819608,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Perineoplasty,,2021,Q3,1,I,2015.0,20210831.0,20210913,20210913,EXP,,BR-NOVOPROD-844240,NOVO NORDISK,,61.0,YR,,F,Y,59.15,KG,20210913.0,,MD,BR,BR,2021,Q3,Adult
198196081,19819608,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q3,Thyroid cyst,,2021,Q3,1,I,2015.0,20210831.0,20210913,20210913,EXP,,BR-NOVOPROD-844240,NOVO NORDISK,,61.0,YR,,F,Y,59.15,KG,20210913.0,,MD,BR,BR,2021,Q3,Adult
198237471,19823747,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Cold sweat,,2021,Q3,1,I,20210903.0,20210906.0,20210913,20210913,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-EMD SERONO-E2B_90085130,EMD SERONO INC,,50.0,YR,A,M,Y,75.0,KG,20210913.0,,CN,GB,GB,2021,Q3,Adult
198237471,19823747,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210903.0,20210906.0,20210913,20210913,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-EMD SERONO-E2B_90085130,EMD SERONO INC,,50.0,YR,A,M,Y,75.0,KG,20210913.0,,CN,GB,GB,2021,Q3,Adult
198237471,19823747,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,20210903.0,20210906.0,20210913,20210913,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-EMD SERONO-E2B_90085130,EMD SERONO INC,,50.0,YR,A,M,Y,75.0,KG,20210913.0,,CN,GB,GB,2021,Q3,Adult
198237471,19823747,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Gastrointestinal disorder,,2021,Q3,1,I,20210903.0,20210906.0,20210913,20210913,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-EMD SERONO-E2B_90085130,EMD SERONO INC,,50.0,YR,A,M,Y,75.0,KG,20210913.0,,CN,GB,GB,2021,Q3,Adult
198237471,19823747,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Hot flush,,2021,Q3,1,I,20210903.0,20210906.0,20210913,20210913,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-EMD SERONO-E2B_90085130,EMD SERONO INC,,50.0,YR,A,M,Y,75.0,KG,20210913.0,,CN,GB,GB,2021,Q3,Adult
198237471,19823747,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,20210903.0,20210906.0,20210913,20210913,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-EMD SERONO-E2B_90085130,EMD SERONO INC,,50.0,YR,A,M,Y,75.0,KG,20210913.0,,CN,GB,GB,2021,Q3,Adult
198237471,19823747,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,20210903.0,20210906.0,20210913,20210913,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-EMD SERONO-E2B_90085130,EMD SERONO INC,,50.0,YR,A,M,Y,75.0,KG,20210913.0,,CN,GB,GB,2021,Q3,Adult
198243042,19824304,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DOSAGE FORM, QD, 1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q3,Blood pressure decreased,,2021,Q3,2,F,,20210918.0,20210913,20210922,EXP,,PL-MYLANLABS-2021M1060861,MYLAN,,70.0,YR,,M,Y,,,20210922.0,,MD,PL,PL,2021,Q3,Elderly
198243042,19824304,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DOSAGE FORM, QD, 1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q3,COVID-19 pneumonia,,2021,Q3,2,F,,20210918.0,20210913,20210922,EXP,,PL-MYLANLABS-2021M1060861,MYLAN,,70.0,YR,,M,Y,,,20210922.0,,MD,PL,PL,2021,Q3,Elderly
198243042,19824304,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DOSAGE FORM, QD, 1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q3,Cardiac failure chronic,,2021,Q3,2,F,,20210918.0,20210913,20210922,EXP,,PL-MYLANLABS-2021M1060861,MYLAN,,70.0,YR,,M,Y,,,20210922.0,,MD,PL,PL,2021,Q3,Elderly
198243042,19824304,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DOSAGE FORM, QD, 1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q3,Dyspnoea exertional,,2021,Q3,2,F,,20210918.0,20210913,20210922,EXP,,PL-MYLANLABS-2021M1060861,MYLAN,,70.0,YR,,M,Y,,,20210922.0,,MD,PL,PL,2021,Q3,Elderly
198243042,19824304,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DOSAGE FORM, QD, 1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q3,Glomerular filtration rate abnormal,,2021,Q3,2,F,,20210918.0,20210913,20210922,EXP,,PL-MYLANLABS-2021M1060861,MYLAN,,70.0,YR,,M,Y,,,20210922.0,,MD,PL,PL,2021,Q3,Elderly
198243042,19824304,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DOSAGE FORM, QD, 1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q3,Hypertrophy,,2021,Q3,2,F,,20210918.0,20210913,20210922,EXP,,PL-MYLANLABS-2021M1060861,MYLAN,,70.0,YR,,M,Y,,,20210922.0,,MD,PL,PL,2021,Q3,Elderly
198243042,19824304,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DOSAGE FORM, QD, 1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q3,N-terminal prohormone brain natriuretic peptide abnormal,,2021,Q3,2,F,,20210918.0,20210913,20210922,EXP,,PL-MYLANLABS-2021M1060861,MYLAN,,70.0,YR,,M,Y,,,20210922.0,,MD,PL,PL,2021,Q3,Elderly
198243042,19824304,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DOSAGE FORM, QD, 1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q3,Renal atrophy,,2021,Q3,2,F,,20210918.0,20210913,20210922,EXP,,PL-MYLANLABS-2021M1060861,MYLAN,,70.0,YR,,M,Y,,,20210922.0,,MD,PL,PL,2021,Q3,Elderly
198243042,19824304,16,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,"1 DOSAGE FORM, QD, 1 DF, QD",,,,,,,,1.0,DF,TABLET,QD,2021,Q3,Urosepsis,,2021,Q3,2,F,,20210918.0,20210913,20210922,EXP,,PL-MYLANLABS-2021M1060861,MYLAN,,70.0,YR,,M,Y,,,20210922.0,,MD,PL,PL,2021,Q3,Elderly
198244731,19824473,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,,20210831.0,20210913,20210913,EXP,,CN-ASTRAZENECA-2021A711188,ASTRAZENECA,,43.0,YR,,M,Y,,,20210913.0,,HP,CN,CN,2021,Q3,Adult
198290791,19829079,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q3,Glycosylated haemoglobin abnormal,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CN-SA-2021SA298066,SANOFI AVENTIS,,36.0,YR,A,M,Y,80.0,KG,20210914.0,,CN,CN,CN,2021,Q3,Adult
198290791,19829079,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q3,Product storage error,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CN-SA-2021SA298066,SANOFI AVENTIS,,36.0,YR,A,M,Y,80.0,KG,20210914.0,,CN,CN,CN,2021,Q3,Adult
198290791,19829079,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q3,Protein urine present,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CN-SA-2021SA298066,SANOFI AVENTIS,,36.0,YR,A,M,Y,80.0,KG,20210914.0,,CN,CN,CN,2021,Q3,Adult
198290791,19829079,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,U,,,,,1.0,DF,TABLET,QD,2021,Q3,Renal injury,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CN-SA-2021SA298066,SANOFI AVENTIS,,36.0,YR,A,M,Y,80.0,KG,20210914.0,,CN,CN,CN,2021,Q3,Adult
198324541,19832454,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1170.0,MG,U,, 2008057,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Urine ketone body present,,2021,Q3,1,I,20210406.0,20210908.0,20210915,20210915,EXP,,CN-ASTRAZENECA-2021A721670,ASTRAZENECA,,59.0,YR,,F,Y,62.9,KG,20210915.0,,HP,CN,CN,2021,Q3,Adult
198324541,19832454,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1170.0,MG,U,, 2008057,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Weight decreased,,2021,Q3,1,I,20210406.0,20210908.0,20210915,20210915,EXP,,CN-ASTRAZENECA-2021A721670,ASTRAZENECA,,59.0,YR,,F,Y,62.9,KG,20210915.0,,HP,CN,CN,2021,Q3,Adult
198349381,19834938,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,SINCE 5 YEARS,,,D,,,,202293.0,,,TABLET,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,,20210902.0,20210915,20210915,EXP,,IN-ASTRAZENECA-2021A710920,ASTRAZENECA,,56.0,YR,,M,Y,,,20210915.0,,HP,IN,IN,2021,Q3,Adult
198401191,19840119,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Cold sweat,,2021,Q3,1,I,20210903.0,20210906.0,20210916,20210916,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-TEVA-2021-GB-1951832,TEVA,,50.0,YR,A,M,Y,75.0,KG,20210916.0,,CN,GB,GB,2021,Q3,Adult
198401191,19840119,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210903.0,20210906.0,20210916,20210916,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-TEVA-2021-GB-1951832,TEVA,,50.0,YR,A,M,Y,75.0,KG,20210916.0,,CN,GB,GB,2021,Q3,Adult
198401191,19840119,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,20210903.0,20210906.0,20210916,20210916,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-TEVA-2021-GB-1951832,TEVA,,50.0,YR,A,M,Y,75.0,KG,20210916.0,,CN,GB,GB,2021,Q3,Adult
198401191,19840119,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Gastrointestinal disorder,,2021,Q3,1,I,20210903.0,20210906.0,20210916,20210916,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-TEVA-2021-GB-1951832,TEVA,,50.0,YR,A,M,Y,75.0,KG,20210916.0,,CN,GB,GB,2021,Q3,Adult
198401191,19840119,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Hot flush,,2021,Q3,1,I,20210903.0,20210906.0,20210916,20210916,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-TEVA-2021-GB-1951832,TEVA,,50.0,YR,A,M,Y,75.0,KG,20210916.0,,CN,GB,GB,2021,Q3,Adult
198401191,19840119,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,20210903.0,20210906.0,20210916,20210916,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-TEVA-2021-GB-1951832,TEVA,,50.0,YR,A,M,Y,75.0,KG,20210916.0,,CN,GB,GB,2021,Q3,Adult
198401191,19840119,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,20210903.0,20210906.0,20210916,20210916,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,GB-TEVA-2021-GB-1951832,TEVA,,50.0,YR,A,M,Y,75.0,KG,20210916.0,,CN,GB,GB,2021,Q3,Adult
198442941,19844294,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,, 2103046,,205649.0,5.0,MG,TABLET,QD,2021,Q3,Mental impairment,,2021,Q3,1,I,20210828.0,20210908.0,20210916,20210916,EXP,,CN-ASTRAZENECA-2021A720596,ASTRAZENECA,,14569.0,DY,,M,Y,84.5,KG,20210916.0,,HP,CN,CN,2021,Q3,Elderly
198442941,19844294,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,, 2103046,,205649.0,5.0,MG,TABLET,QD,2021,Q3,Nausea,,2021,Q3,1,I,20210828.0,20210908.0,20210916,20210916,EXP,,CN-ASTRAZENECA-2021A720596,ASTRAZENECA,,14569.0,DY,,M,Y,84.5,KG,20210916.0,,HP,CN,CN,2021,Q3,Elderly
198442941,19844294,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,, 2103046,,205649.0,5.0,MG,TABLET,QD,2021,Q3,Urine output decreased,,2021,Q3,1,I,20210828.0,20210908.0,20210916,20210916,EXP,,CN-ASTRAZENECA-2021A720596,ASTRAZENECA,,14569.0,DY,,M,Y,84.5,KG,20210916.0,,HP,CN,CN,2021,Q3,Elderly
198442941,19844294,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,, 2103046,,205649.0,5.0,MG,TABLET,QD,2021,Q3,Vomiting,,2021,Q3,1,I,20210828.0,20210908.0,20210916,20210916,EXP,,CN-ASTRAZENECA-2021A720596,ASTRAZENECA,,14569.0,DY,,M,Y,84.5,KG,20210916.0,,HP,CN,CN,2021,Q3,Elderly
198470861,19847086,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,,,2021,Q3,Biliary sepsis,,2021,Q3,1,I,,20210912.0,20210917,20210917,EXP,,GB-ASTRAZENECA-2021A722609,ASTRAZENECA,,85.0,YR,,M,Y,66.7,KG,20210917.0,,,GB,GB,2021,Q3,Elderly
198470861,19847086,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,,,2021,Q3,Diabetic foot infection,,2021,Q3,1,I,,20210912.0,20210917,20210917,EXP,,GB-ASTRAZENECA-2021A722609,ASTRAZENECA,,85.0,YR,,M,Y,66.7,KG,20210917.0,,,GB,GB,2021,Q3,Elderly
198470861,19847086,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,,,2021,Q3,Livedo reticularis,,2021,Q3,1,I,,20210912.0,20210917,20210917,EXP,,GB-ASTRAZENECA-2021A722609,ASTRAZENECA,,85.0,YR,,M,Y,66.7,KG,20210917.0,,,GB,GB,2021,Q3,Elderly
198470861,19847086,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,,,2021,Q3,Necrosis,,2021,Q3,1,I,,20210912.0,20210917,20210917,EXP,,GB-ASTRAZENECA-2021A722609,ASTRAZENECA,,85.0,YR,,M,Y,66.7,KG,20210917.0,,,GB,GB,2021,Q3,Elderly
198470861,19847086,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,,,2021,Q3,Skin ulcer,,2021,Q3,1,I,,20210912.0,20210917,20210917,EXP,,GB-ASTRAZENECA-2021A722609,ASTRAZENECA,,85.0,YR,,M,Y,66.7,KG,20210917.0,,,GB,GB,2021,Q3,Elderly
198470861,19847086,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,,2021,Q3,Biliary sepsis,,2021,Q3,1,I,,20210912.0,20210917,20210917,EXP,,GB-ASTRAZENECA-2021A722609,ASTRAZENECA,,85.0,YR,,M,Y,66.7,KG,20210917.0,,,GB,GB,2021,Q3,Elderly
198470861,19847086,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,,2021,Q3,Diabetic foot infection,,2021,Q3,1,I,,20210912.0,20210917,20210917,EXP,,GB-ASTRAZENECA-2021A722609,ASTRAZENECA,,85.0,YR,,M,Y,66.7,KG,20210917.0,,,GB,GB,2021,Q3,Elderly
198470861,19847086,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,,2021,Q3,Livedo reticularis,,2021,Q3,1,I,,20210912.0,20210917,20210917,EXP,,GB-ASTRAZENECA-2021A722609,ASTRAZENECA,,85.0,YR,,M,Y,66.7,KG,20210917.0,,,GB,GB,2021,Q3,Elderly
198470861,19847086,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,,2021,Q3,Necrosis,,2021,Q3,1,I,,20210912.0,20210917,20210917,EXP,,GB-ASTRAZENECA-2021A722609,ASTRAZENECA,,85.0,YR,,M,Y,66.7,KG,20210917.0,,,GB,GB,2021,Q3,Elderly
198470861,19847086,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,TABLET,,2021,Q3,Skin ulcer,,2021,Q3,1,I,,20210912.0,20210917,20210917,EXP,,GB-ASTRAZENECA-2021A722609,ASTRAZENECA,,85.0,YR,,M,Y,66.7,KG,20210917.0,,,GB,GB,2021,Q3,Elderly
198503541,19850354,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Cold sweat,,2021,Q3,1,I,20210903.0,20210906.0,20210917,20210917,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,NVSC2021GB202310,NOVARTIS,,50.0,YR,,M,Y,75.0,KG,20210917.0,,HP,GB,GB,2021,Q3,Adult
198503541,19850354,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210903.0,20210906.0,20210917,20210917,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,NVSC2021GB202310,NOVARTIS,,50.0,YR,,M,Y,75.0,KG,20210917.0,,HP,GB,GB,2021,Q3,Adult
198503541,19850354,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,20210903.0,20210906.0,20210917,20210917,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,NVSC2021GB202310,NOVARTIS,,50.0,YR,,M,Y,75.0,KG,20210917.0,,HP,GB,GB,2021,Q3,Adult
198503541,19850354,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Gastrointestinal disorder,,2021,Q3,1,I,20210903.0,20210906.0,20210917,20210917,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,NVSC2021GB202310,NOVARTIS,,50.0,YR,,M,Y,75.0,KG,20210917.0,,HP,GB,GB,2021,Q3,Adult
198503541,19850354,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Hot flush,,2021,Q3,1,I,20210903.0,20210906.0,20210917,20210917,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,NVSC2021GB202310,NOVARTIS,,50.0,YR,,M,Y,75.0,KG,20210917.0,,HP,GB,GB,2021,Q3,Adult
198503541,19850354,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,20210903.0,20210906.0,20210917,20210917,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,NVSC2021GB202310,NOVARTIS,,50.0,YR,,M,Y,75.0,KG,20210917.0,,HP,GB,GB,2021,Q3,Adult
198503541,19850354,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,20210903.0,20210906.0,20210917,20210917,EXP,GB-MHRA-WEBRADR-202109052008089950-N1DZL,NVSC2021GB202310,NOVARTIS,,50.0,YR,,M,Y,75.0,KG,20210917.0,,HP,GB,GB,2021,Q3,Adult
198539481,19853948,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q3,Cold sweat,,2021,Q3,1,I,20210903.0,20210906.0,20210920,20210920,EXP,,GB-AUROBINDO-AUR-APL-2021-038689,AUROBINDO,,50.0,YR,,M,Y,75.0,KG,20210920.0,,CN,GB,GB,2021,Q3,Adult
198539481,19853948,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210903.0,20210906.0,20210920,20210920,EXP,,GB-AUROBINDO-AUR-APL-2021-038689,AUROBINDO,,50.0,YR,,M,Y,75.0,KG,20210920.0,,CN,GB,GB,2021,Q3,Adult
198539481,19853948,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,20210903.0,20210906.0,20210920,20210920,EXP,,GB-AUROBINDO-AUR-APL-2021-038689,AUROBINDO,,50.0,YR,,M,Y,75.0,KG,20210920.0,,CN,GB,GB,2021,Q3,Adult
198539481,19853948,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q3,Gastrointestinal disorder,,2021,Q3,1,I,20210903.0,20210906.0,20210920,20210920,EXP,,GB-AUROBINDO-AUR-APL-2021-038689,AUROBINDO,,50.0,YR,,M,Y,75.0,KG,20210920.0,,CN,GB,GB,2021,Q3,Adult
198539481,19853948,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q3,Hot flush,,2021,Q3,1,I,20210903.0,20210906.0,20210920,20210920,EXP,,GB-AUROBINDO-AUR-APL-2021-038689,AUROBINDO,,50.0,YR,,M,Y,75.0,KG,20210920.0,,CN,GB,GB,2021,Q3,Adult
198539481,19853948,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,20210903.0,20210906.0,20210920,20210920,EXP,,GB-AUROBINDO-AUR-APL-2021-038689,AUROBINDO,,50.0,YR,,M,Y,75.0,KG,20210920.0,,CN,GB,GB,2021,Q3,Adult
198539481,19853948,2,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,20210903.0,20210906.0,20210920,20210920,EXP,,GB-AUROBINDO-AUR-APL-2021-038689,AUROBINDO,,50.0,YR,,M,Y,75.0,KG,20210920.0,,CN,GB,GB,2021,Q3,Adult
198565381,19856538,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,, ML3005,,,10.0,MG,TABLET,QD,2021,Q3,Ketoacidosis,,2021,Q3,1,I,20210904.0,20210911.0,20210920,20210920,EXP,,CN-ASTRAZENECA-2021A727349,ASTRAZENECA,,19241.0,DY,,F,Y,58.0,KG,20210920.0,,HP,CN,CN,2021,Q3,Elderly
198569281,19856928,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,,20210914.0,20210920,20210920,EXP,,NVSC2021US209281,NOVARTIS,"CHA BM, DAVOUDI R, DIVITA MC, FAN AM, KAMATH MY. SODIUM?GLUCOSE COTRANSPORTER?2 INHIBITOR?ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS AFTER ORTHOTOPIC HEART TRANSPLANT IN A PREDIABETIC PATIENT: A CASE REPORT. TRANSPLANTATION PROCEEDINGS. 2021?000:1?4",55.0,YR,,M,Y,,,20210920.0,,HP,US,US,2021,Q3,Adult
198569281,19856928,3,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"5 MG, QD",,,Y,,,,,5.0,MG,,QD,2021,Q3,Product use in unapproved indication,,2021,Q3,1,I,,20210914.0,20210920,20210920,EXP,,NVSC2021US209281,NOVARTIS,"CHA BM, DAVOUDI R, DIVITA MC, FAN AM, KAMATH MY. SODIUM?GLUCOSE COTRANSPORTER?2 INHIBITOR?ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS AFTER ORTHOTOPIC HEART TRANSPLANT IN A PREDIABETIC PATIENT: A CASE REPORT. TRANSPLANTATION PROCEEDINGS. 2021?000:1?4",55.0,YR,,M,Y,,,20210920.0,,HP,US,US,2021,Q3,Adult
198569281,19856928,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,,20210914.0,20210920,20210920,EXP,,NVSC2021US209281,NOVARTIS,"CHA BM, DAVOUDI R, DIVITA MC, FAN AM, KAMATH MY. SODIUM?GLUCOSE COTRANSPORTER?2 INHIBITOR?ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS AFTER ORTHOTOPIC HEART TRANSPLANT IN A PREDIABETIC PATIENT: A CASE REPORT. TRANSPLANTATION PROCEEDINGS. 2021?000:1?4",55.0,YR,,M,Y,,,20210920.0,,HP,US,US,2021,Q3,Adult
198569281,19856928,4,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,"10 MG, QD",,,Y,,,,,10.0,MG,,QD,2021,Q3,Product use in unapproved indication,,2021,Q3,1,I,,20210914.0,20210920,20210920,EXP,,NVSC2021US209281,NOVARTIS,"CHA BM, DAVOUDI R, DIVITA MC, FAN AM, KAMATH MY. SODIUM?GLUCOSE COTRANSPORTER?2 INHIBITOR?ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS AFTER ORTHOTOPIC HEART TRANSPLANT IN A PREDIABETIC PATIENT: A CASE REPORT. TRANSPLANTATION PROCEEDINGS. 2021?000:1?4",55.0,YR,,M,Y,,,20210920.0,,HP,US,US,2021,Q3,Adult
198572391,19857239,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Atrial flutter,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,NVSJ2021JP013959,NOVARTIS,,63.0,YR,,M,Y,,,20210921.0,,CN,JP,JP,2021,Q3,Adult
198572391,19857239,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Cardiac failure,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,NVSJ2021JP013959,NOVARTIS,,63.0,YR,,M,Y,,,20210921.0,,CN,JP,JP,2021,Q3,Adult
198572391,19857239,7,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,10 MG,,,U,,,,,10.0,MG,,,2021,Q3,Hypertension,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,NVSJ2021JP013959,NOVARTIS,,63.0,YR,,M,Y,,,20210921.0,,CN,JP,JP,2021,Q3,Adult
198599331,19859933,8,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,20UNITS TWICE A DAY,,,,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210907.0,20210912.0,20210921,20210921,EXP,GB-MHRA-EYC 00260259,GB-NOVOPROD-846603,NOVO NORDISK,,59.0,YR,,M,Y,96.16,KG,20210921.0,,PH,GB,GB,2021,Q3,Adult
198613271,19861327,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",1600.0,MG,Y,, 2004065,,,10.0,MG,TABLET,QD,2021,Q3,Asthenia,,2021,Q3,1,I,20210617.0,20210914.0,20210920,20210920,EXP,,NVSC2021CN211894,NOVARTIS,,89.0,YR,,F,Y,,,20210920.0,,HP,CN,CN,2021,Q3,Elderly
198613271,19861327,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD",1600.0,MG,Y,, 2004065,,,10.0,MG,TABLET,QD,2021,Q3,Hyperkalaemia,,2021,Q3,1,I,20210617.0,20210914.0,20210920,20210920,EXP,,NVSC2021CN211894,NOVARTIS,,89.0,YR,,F,Y,,,20210920.0,,HP,CN,CN,2021,Q3,Elderly
198656411,19865641,43,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,, UNKNOWN,,,10.0,MG,,,2021,Q3,Urinary tract infection,,2021,Q3,1,I,20190815.0,20210913.0,20210921,20210921,EXP,,DE-FRESENIUS KABI-FK202109984,FRESENIUS KABI,,74.0,YR,,F,Y,,,20210921.0,,HP,NL,DE,2021,Q3,Elderly
198656411,19865641,44,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,, UNKNOWN,,,,,,,2021,Q3,Urinary tract infection,,2021,Q3,1,I,20190815.0,20210913.0,20210921,20210921,EXP,,DE-FRESENIUS KABI-FK202109984,FRESENIUS KABI,,74.0,YR,,F,Y,,,20210921.0,,HP,NL,DE,2021,Q3,Elderly
198685761,19868576,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Appendicitis,,2021,Q3,1,I,20210604.0,20210921.0,20210922,20210922,EXP,GB-MHRA-WEBCOVID-202109201220283940-JZS9Z,GB-BAYER-2021A214841,BAYER,,43.0,YR,A,F,Y,,,20210922.0,,HP,GB,GB,2021,Q3,Adult
198685761,19868576,5,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q3,Menstrual disorder,,2021,Q3,1,I,20210604.0,20210921.0,20210922,20210922,EXP,GB-MHRA-WEBCOVID-202109201220283940-JZS9Z,GB-BAYER-2021A214841,BAYER,,43.0,YR,A,F,Y,,,20210922.0,,HP,GB,GB,2021,Q3,Adult
198696631,19869663,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,U,Y, 2101247,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Paraesthesia,,2021,Q3,1,I,20210831.0,20210914.0,20210922,20210922,EXP,,CN-ASTRAZENECA-2021A730300,ASTRAZENECA,,24837.0,DY,,F,Y,75.0,KG,20210922.0,,HP,CN,CN,2021,Q3,Elderly
198696631,19869663,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,U,Y, 2101247,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Pollakiuria,,2021,Q3,1,I,20210831.0,20210914.0,20210922,20210922,EXP,,CN-ASTRAZENECA-2021A730300,ASTRAZENECA,,24837.0,DY,,F,Y,75.0,KG,20210922.0,,HP,CN,CN,2021,Q3,Elderly
198696631,19869663,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,U,Y, 2101247,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Polyuria,,2021,Q3,1,I,20210831.0,20210914.0,20210922,20210922,EXP,,CN-ASTRAZENECA-2021A730300,ASTRAZENECA,,24837.0,DY,,F,Y,75.0,KG,20210922.0,,HP,CN,CN,2021,Q3,Elderly
198696631,19869663,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,U,Y, 2101247,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Urinary retention,,2021,Q3,1,I,20210831.0,20210914.0,20210922,20210922,EXP,,CN-ASTRAZENECA-2021A730300,ASTRAZENECA,,24837.0,DY,,F,Y,75.0,KG,20210922.0,,HP,CN,CN,2021,Q3,Elderly
198696631,19869663,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,20.0,MG,U,Y, 2101247,,202293.0,10.0,MG,TABLET,QD,2021,Q3,White blood cell count increased,,2021,Q3,1,I,20210831.0,20210914.0,20210922,20210922,EXP,,CN-ASTRAZENECA-2021A730300,ASTRAZENECA,,24837.0,DY,,F,Y,75.0,KG,20210922.0,,HP,CN,CN,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Anaphylactoid reaction,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Blood pressure fluctuation,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,COVID-19,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Chills,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Cough,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Erythema,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Flushing,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Heart rate irregular,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Off label use,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Oxygen saturation abnormal,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Product use issue,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198729241,19872924,3,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,,,,,,,,,,2021,Q3,Respiratory rate increased,,2021,Q3,1,I,,20210914.0,20210923,20210923,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-22159,SAMSUNG BIOEPIS,,71.0,YR,E,F,Y,87.0,KG,20210923.0,,HP,CA,CA,2021,Q3,Elderly
198859911,19885991,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2021,Q3,Anaemia,,2021,Q3,1,I,2015.0,20210906.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109002431,ELI LILLY AND CO,,72.0,YR,,F,Y,65.0,KG,20210927.0,,CN,CN,CN,2021,Q3,Elderly
198859911,19885991,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,2015.0,20210906.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109002431,ELI LILLY AND CO,,72.0,YR,,F,Y,65.0,KG,20210927.0,,CN,CN,CN,2021,Q3,Elderly
198859911,19885991,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2021,Q3,Body height decreased,,2021,Q3,1,I,2015.0,20210906.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109002431,ELI LILLY AND CO,,72.0,YR,,F,Y,65.0,KG,20210927.0,,CN,CN,CN,2021,Q3,Elderly
198859911,19885991,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2021,Q3,Cerebral infarction,,2021,Q3,1,I,2015.0,20210906.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109002431,ELI LILLY AND CO,,72.0,YR,,F,Y,65.0,KG,20210927.0,,CN,CN,CN,2021,Q3,Elderly
198859911,19885991,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2021,Q3,Coronary artery disease,,2021,Q3,1,I,2015.0,20210906.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109002431,ELI LILLY AND CO,,72.0,YR,,F,Y,65.0,KG,20210927.0,,CN,CN,CN,2021,Q3,Elderly
198859911,19885991,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2021,Q3,Drug ineffective,,2021,Q3,1,I,2015.0,20210906.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109002431,ELI LILLY AND CO,,72.0,YR,,F,Y,65.0,KG,20210927.0,,CN,CN,CN,2021,Q3,Elderly
198859911,19885991,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2021,Q3,Gastric haemorrhage,,2021,Q3,1,I,2015.0,20210906.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109002431,ELI LILLY AND CO,,72.0,YR,,F,Y,65.0,KG,20210927.0,,CN,CN,CN,2021,Q3,Elderly
198859911,19885991,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2021,Q3,Generalised oedema,,2021,Q3,1,I,2015.0,20210906.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109002431,ELI LILLY AND CO,,72.0,YR,,F,Y,65.0,KG,20210927.0,,CN,CN,CN,2021,Q3,Elderly
198859911,19885991,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2021,Q3,Hypertension,,2021,Q3,1,I,2015.0,20210906.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109002431,ELI LILLY AND CO,,72.0,YR,,F,Y,65.0,KG,20210927.0,,CN,CN,CN,2021,Q3,Elderly
198859911,19885991,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2021,Q3,Lung neoplasm malignant,,2021,Q3,1,I,2015.0,20210906.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109002431,ELI LILLY AND CO,,72.0,YR,,F,Y,65.0,KG,20210927.0,,CN,CN,CN,2021,Q3,Elderly
198859911,19885991,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2021,Q3,Memory impairment,,2021,Q3,1,I,2015.0,20210906.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109002431,ELI LILLY AND CO,,72.0,YR,,F,Y,65.0,KG,20210927.0,,CN,CN,CN,2021,Q3,Elderly
198859911,19885991,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2021,Q3,Thyroid cancer,,2021,Q3,1,I,2015.0,20210906.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109002431,ELI LILLY AND CO,,72.0,YR,,F,Y,65.0,KG,20210927.0,,CN,CN,CN,2021,Q3,Elderly
198859911,19885991,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,TABLET,,2021,Q3,Weight decreased,,2021,Q3,1,I,2015.0,20210906.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109002431,ELI LILLY AND CO,,72.0,YR,,F,Y,65.0,KG,20210927.0,,CN,CN,CN,2021,Q3,Elderly
198871051,19887105,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,1100.0,MG,Y,, 2104231,,,5.0,MG,TABLET,QD,2021,Q3,Ketoacidosis,,2021,Q3,1,I,20210908.0,20210917.0,20210927,20210927,EXP,,CN-ASTRAZENECA-2021A734336,ASTRAZENECA,,21185.0,DY,,F,Y,45.0,KG,20210927.0,,HP,CN,CN,2021,Q3,Elderly
198882661,19888266,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD AFTER BREAKFAST",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Cardiac failure,,2021,Q3,1,I,,20210921.0,20210927,20210927,EXP,,NVSJ2021JP014160,NOVARTIS,,73.0,YR,,M,Y,,,20210927.0,,MD,JP,JP,2021,Q3,Elderly
198882661,19888266,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD AFTER BREAKFAST",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210921.0,20210927,20210927,EXP,,NVSJ2021JP014160,NOVARTIS,,73.0,YR,,M,Y,,,20210927.0,,MD,JP,JP,2021,Q3,Elderly
198882661,19888266,6,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MG, QD AFTER BREAKFAST",,,U,,,,,10.0,MG,TABLET,QD,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,1,I,,20210921.0,20210927,20210927,EXP,,NVSJ2021JP014160,NOVARTIS,,73.0,YR,,M,Y,,,20210927.0,,MD,JP,JP,2021,Q3,Elderly
198888401,19888840,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10MG, UNK",,,,,,,,,,,,2021,Q3,Cardiac failure,,2021,Q3,1,I,,20210917.0,20210927,20210927,EXP,,JP-OTSUKA-2021_032667,OTSUKA,,7.0,DEC,,M,Y,,,20210927.0,,MD,JP,JP,2021,Q3,Child
198888401,19888840,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10MG, UNK",,,,,,,,,,,,2021,Q3,Pleural effusion,,2021,Q3,1,I,,20210917.0,20210927,20210927,EXP,,JP-OTSUKA-2021_032667,OTSUKA,,7.0,DEC,,M,Y,,,20210927.0,,MD,JP,JP,2021,Q3,Child
198888401,19888840,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10MG, UNK",,,,,,,,,,,,2021,Q3,Pulmonary congestion,,2021,Q3,1,I,,20210917.0,20210927,20210927,EXP,,JP-OTSUKA-2021_032667,OTSUKA,,7.0,DEC,,M,Y,,,20210927.0,,MD,JP,JP,2021,Q3,Child
198888401,19888840,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10MG, UNK",,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210917.0,20210927,20210927,EXP,,JP-OTSUKA-2021_032667,OTSUKA,,7.0,DEC,,M,Y,,,20210927.0,,MD,JP,JP,2021,Q3,Child
198888401,19888840,13,C,DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10MG, UNK",,,,,,,,,,,,2021,Q3,Underdose,,2021,Q3,1,I,,20210917.0,20210927,20210927,EXP,,JP-OTSUKA-2021_032667,OTSUKA,,7.0,DEC,,M,Y,,,20210927.0,,MD,JP,JP,2021,Q3,Child
198916281,19891628,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,20210202.0,20210902.0,20210928,20210928,EXP,DE-BFARM-21003357,DE-MYLANLABS-2021M1058973,MYLAN,,56.0,YR,,M,Y,128.0,KG,20210928.0,,HP,DE,DE,2021,Q3,Adult
198916281,19891628,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2021,Q3,Metabolic acidosis,,2021,Q3,1,I,20210202.0,20210902.0,20210928,20210928,EXP,DE-BFARM-21003357,DE-MYLANLABS-2021M1058973,MYLAN,,56.0,YR,,M,Y,128.0,KG,20210928.0,,HP,DE,DE,2021,Q3,Adult
198916281,19891628,2,SS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,20210202.0,20210902.0,20210928,20210928,EXP,DE-BFARM-21003357,DE-MYLANLABS-2021M1058973,MYLAN,,56.0,YR,,M,Y,128.0,KG,20210928.0,,HP,DE,DE,2021,Q3,Adult
198945221,19894522,4,C,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,"10 MILLIGRAM, QD",4250.0,MG,,,,,,10.0,MG,,QD,2021,Q3,Angina pectoris,,2021,Q3,1,I,20210918.0,20210922.0,20210929,20210929,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-096387,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,90.1,KG,20210929.0,,HP,GB,GB,2021,Q3,Adult
198963011,19896301,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,, UNKNOWN,,202293.0,10.0,MG,TABLET,BID,2021,Q3,Cardiac failure,,2021,Q3,1,I,,20210922.0,20210929,20210929,EXP,,DE-ASTRAZENECA-2021A746634,ASTRAZENECA,,84.0,YR,,M,Y,,,20210929.0,,MD,DE,DE,2021,Q3,Elderly
198963011,19896301,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,, UNKNOWN,,202293.0,10.0,MG,TABLET,BID,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210922.0,20210929,20210929,EXP,,DE-ASTRAZENECA-2021A746634,ASTRAZENECA,,84.0,YR,,M,Y,,,20210929.0,,MD,DE,DE,2021,Q3,Elderly
198963011,19896301,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,, UNKNOWN,,202293.0,10.0,MG,TABLET,BID,2021,Q3,Left ventricular dysfunction,,2021,Q3,1,I,,20210922.0,20210929,20210929,EXP,,DE-ASTRAZENECA-2021A746634,ASTRAZENECA,,84.0,YR,,M,Y,,,20210929.0,,MD,DE,DE,2021,Q3,Elderly
198963011,19896301,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,, UNKNOWN,,202293.0,10.0,MG,TABLET,BID,2021,Q3,Mitral valve incompetence,,2021,Q3,1,I,,20210922.0,20210929,20210929,EXP,,DE-ASTRAZENECA-2021A746634,ASTRAZENECA,,84.0,YR,,M,Y,,,20210929.0,,MD,DE,DE,2021,Q3,Elderly
198963011,19896301,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,, UNKNOWN,,202293.0,10.0,MG,TABLET,BID,2021,Q3,Pleural effusion,,2021,Q3,1,I,,20210922.0,20210929,20210929,EXP,,DE-ASTRAZENECA-2021A746634,ASTRAZENECA,,84.0,YR,,M,Y,,,20210929.0,,MD,DE,DE,2021,Q3,Elderly
198963011,19896301,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,, UNKNOWN,,202293.0,10.0,MG,TABLET,BID,2021,Q3,Tricuspid valve incompetence,,2021,Q3,1,I,,20210922.0,20210929,20210929,EXP,,DE-ASTRAZENECA-2021A746634,ASTRAZENECA,,84.0,YR,,M,Y,,,20210929.0,,MD,DE,DE,2021,Q3,Elderly
198963011,19896301,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,,,U,, UNKNOWN,,202293.0,10.0,MG,TABLET,BID,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,1,I,,20210922.0,20210929,20210929,EXP,,DE-ASTRAZENECA-2021A746634,ASTRAZENECA,,84.0,YR,,M,Y,,,20210929.0,,MD,DE,DE,2021,Q3,Elderly
198964831,19896483,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,100.0,MG,Y,U, MP2432,,,5.0,MG,TABLET,QD,2021,Q3,Ketosis,,2021,Q3,1,I,20210908.0,20210914.0,20210929,20210929,EXP,,CN-ASTRAZENECA-2021A730278,ASTRAZENECA,,23322.0,DY,,M,Y,75.0,KG,20210929.0,,HP,CN,CN,2021,Q3,Elderly
198964831,19896483,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,100.0,MG,Y,U, MP2432,,,5.0,MG,TABLET,QD,2021,Q3,Urinary tract infection,,2021,Q3,1,I,20210908.0,20210914.0,20210929,20210929,EXP,,CN-ASTRAZENECA-2021A730278,ASTRAZENECA,,23322.0,DY,,M,Y,75.0,KG,20210929.0,,HP,CN,CN,2021,Q3,Elderly
198964861,19896486,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,380.0,MG,Y,, ML3032,,,10.0,MG,TABLET,QD,2021,Q3,Ketoacidosis,,2021,Q3,1,I,20210913.0,20210920.0,20210929,20210929,EXP,,CN-ASTRAZENECA-2021A744721,ASTRAZENECA,,20461.0,DY,,M,Y,60.0,KG,20210929.0,,,CN,CN,2021,Q3,Elderly
199007661,19900766,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,4140.0,MG,Y,, MP2049,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Dysuria,,2021,Q3,1,I,20210829.0,20210923.0,20210930,20210930,EXP,,CN-ASTRAZENECA-2021A746579,ASTRAZENECA,,27394.0,DY,,F,Y,56.9,KG,20210930.0,,,CN,CN,2021,Q3,Elderly
199007661,19900766,1,PS,DAPAGLIFLOZIN.,DAPAGLIFLOZIN,1,Oral,,4140.0,MG,Y,, MP2049,,202293.0,10.0,MG,TABLET,QD,2021,Q3,Peripheral swelling,,2021,Q3,1,I,20210829.0,20210923.0,20210930,20210930,EXP,,CN-ASTRAZENECA-2021A746579,ASTRAZENECA,,27394.0,DY,,F,Y,56.9,KG,20210930.0,,,CN,CN,2021,Q3,Elderly
199053831,19905383,9,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Amnesia,,2021,Q3,1,I,2015.0,20201209.0,20210930,20210930,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,,,20210930.0,,CN,CO,CO,2021,Q3,Adult
199053831,19905383,9,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Aphasia,,2021,Q3,1,I,2015.0,20201209.0,20210930,20210930,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,,,20210930.0,,CN,CO,CO,2021,Q3,Adult
199053831,19905383,9,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Arthralgia,,2021,Q3,1,I,2015.0,20201209.0,20210930,20210930,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,,,20210930.0,,CN,CO,CO,2021,Q3,Adult
199053831,19905383,9,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Demyelination,,2021,Q3,1,I,2015.0,20201209.0,20210930,20210930,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,,,20210930.0,,CN,CO,CO,2021,Q3,Adult
199053831,19905383,9,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Diabetes mellitus,,2021,Q3,1,I,2015.0,20201209.0,20210930,20210930,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,,,20210930.0,,CN,CO,CO,2021,Q3,Adult
199053831,19905383,9,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Headache,,2021,Q3,1,I,2015.0,20201209.0,20210930,20210930,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,,,20210930.0,,CN,CO,CO,2021,Q3,Adult
199053831,19905383,9,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Hemiparesis,,2021,Q3,1,I,2015.0,20201209.0,20210930,20210930,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,,,20210930.0,,CN,CO,CO,2021,Q3,Adult
199053831,19905383,9,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Limb discomfort,,2021,Q3,1,I,2015.0,20201209.0,20210930,20210930,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,,,20210930.0,,CN,CO,CO,2021,Q3,Adult
199053831,19905383,9,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Myocardial infarction,,2021,Q3,1,I,2015.0,20201209.0,20210930,20210930,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,,,20210930.0,,CN,CO,CO,2021,Q3,Adult
199053831,19905383,9,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Paralysis,,2021,Q3,1,I,2015.0,20201209.0,20210930,20210930,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,,,20210930.0,,CN,CO,CO,2021,Q3,Adult
199053831,19905383,9,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Thrombosis,,2021,Q3,1,I,2015.0,20201209.0,20210930,20210930,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,,,20210930.0,,CN,CO,CO,2021,Q3,Adult
199053831,19905383,9,C,Dapagliflozine,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q3,Weight decreased,,2021,Q3,1,I,2015.0,20201209.0,20210930,20210930,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,,,20210930.0,,CN,CO,CO,2021,Q3,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Haemorrhoids,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Nausea,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Asthenia,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Ageusia,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Allergic cough,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Abdominal distension,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Ascites,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Terminal state,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Blood pressure abnormal,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Fluid retention,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Peripheral swelling,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Umbilical hernia perforation,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Dysgeusia,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Malignant neoplasm progression,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Hypophagia,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Vision blurred,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Malaise,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Back pain,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Hypertension,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Tremor,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Anal fissure,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Sleep disorder,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
105233145,10523314,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Headache,,2021,Q4,5,F,20131001.0,20160308.0,20141016,20211224,EXP,,PHHY2014BR132221,NOVARTIS,,59.0,YR,,F,Y,69.0,KG,20211224.0,,CN,BR,BR,2021,Q4,Adult
140920496,14092049,46,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD (after meal)",,,U,,,,,,,,QD,2021,Q4,Blood creatinine increased,,2021,Q4,6,F,20160511.0,20211006.0,20171016,20211019,EXP,,PHHY2017TH148880,NOVARTIS,,72.0,YR,,M,Y,,,20211019.0,,MD,TH,TH,2021,Q4,Elderly
140920496,14092049,46,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD (after meal)",,,U,,,,,,,,QD,2021,Q4,Blood pressure fluctuation,,2021,Q4,6,F,20160511.0,20211006.0,20171016,20211019,EXP,,PHHY2017TH148880,NOVARTIS,,72.0,YR,,M,Y,,,20211019.0,,MD,TH,TH,2021,Q4,Elderly
140920496,14092049,47,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD (after meal)",,,U,,,,,,,,QD,2021,Q4,Blood creatinine increased,,2021,Q4,6,F,20160511.0,20211006.0,20171016,20211019,EXP,,PHHY2017TH148880,NOVARTIS,,72.0,YR,,M,Y,,,20211019.0,,MD,TH,TH,2021,Q4,Elderly
140920496,14092049,47,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD (after meal)",,,U,,,,,,,,QD,2021,Q4,Blood pressure fluctuation,,2021,Q4,6,F,20160511.0,20211006.0,20171016,20211019,EXP,,PHHY2017TH148880,NOVARTIS,,72.0,YR,,M,Y,,,20211019.0,,MD,TH,TH,2021,Q4,Elderly
140920496,14092049,48,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD (after meal)",,,U,,,,,,,,QD,2021,Q4,Blood creatinine increased,,2021,Q4,6,F,20160511.0,20211006.0,20171016,20211019,EXP,,PHHY2017TH148880,NOVARTIS,,72.0,YR,,M,Y,,,20211019.0,,MD,TH,TH,2021,Q4,Elderly
140920496,14092049,48,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD (after meal)",,,U,,,,,,,,QD,2021,Q4,Blood pressure fluctuation,,2021,Q4,6,F,20160511.0,20211006.0,20171016,20211019,EXP,,PHHY2017TH148880,NOVARTIS,,72.0,YR,,M,Y,,,20211019.0,,MD,TH,TH,2021,Q4,Elderly
140920496,14092049,49,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD (after meal)",,,U,,,,,,,,QD,2021,Q4,Blood creatinine increased,,2021,Q4,6,F,20160511.0,20211006.0,20171016,20211019,EXP,,PHHY2017TH148880,NOVARTIS,,72.0,YR,,M,Y,,,20211019.0,,MD,TH,TH,2021,Q4,Elderly
140920496,14092049,49,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD (after meal)",,,U,,,,,,,,QD,2021,Q4,Blood pressure fluctuation,,2021,Q4,6,F,20160511.0,20211006.0,20171016,20211019,EXP,,PHHY2017TH148880,NOVARTIS,,72.0,YR,,M,Y,,,20211019.0,,MD,TH,TH,2021,Q4,Elderly
140920496,14092049,50,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD (after meal)",,,U,,,,,,,,QD,2021,Q4,Blood creatinine increased,,2021,Q4,6,F,20160511.0,20211006.0,20171016,20211019,EXP,,PHHY2017TH148880,NOVARTIS,,72.0,YR,,M,Y,,,20211019.0,,MD,TH,TH,2021,Q4,Elderly
140920496,14092049,50,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD (after meal)",,,U,,,,,,,,QD,2021,Q4,Blood pressure fluctuation,,2021,Q4,6,F,20160511.0,20211006.0,20171016,20211019,EXP,,PHHY2017TH148880,NOVARTIS,,72.0,YR,,M,Y,,,20211019.0,,MD,TH,TH,2021,Q4,Elderly
151354076,15135407,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Nasal congestion,,2021,Q4,6,F,20170101.0,20211217.0,20180712,20211222,EXP,,CA-TAKEDA-2018TUS001303,TAKEDA,,68.0,YR,,M,Y,,,20211222.0,,MD,CA,CA,2021,Q4,Elderly
151354076,15135407,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,6,F,20170101.0,20211217.0,20180712,20211222,EXP,,CA-TAKEDA-2018TUS001303,TAKEDA,,68.0,YR,,M,Y,,,20211222.0,,MD,CA,CA,2021,Q4,Elderly
151354076,15135407,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Eyelid oedema,,2021,Q4,6,F,20170101.0,20211217.0,20180712,20211222,EXP,,CA-TAKEDA-2018TUS001303,TAKEDA,,68.0,YR,,M,Y,,,20211222.0,,MD,CA,CA,2021,Q4,Elderly
151354076,15135407,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Heterophoria,,2021,Q4,6,F,20170101.0,20211217.0,20180712,20211222,EXP,,CA-TAKEDA-2018TUS001303,TAKEDA,,68.0,YR,,M,Y,,,20211222.0,,MD,CA,CA,2021,Q4,Elderly
151354076,15135407,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Eyelid operation,,2021,Q4,6,F,20170101.0,20211217.0,20180712,20211222,EXP,,CA-TAKEDA-2018TUS001303,TAKEDA,,68.0,YR,,M,Y,,,20211222.0,,MD,CA,CA,2021,Q4,Elderly
151354076,15135407,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Nasal discharge discolouration,,2021,Q4,6,F,20170101.0,20211217.0,20180712,20211222,EXP,,CA-TAKEDA-2018TUS001303,TAKEDA,,68.0,YR,,M,Y,,,20211222.0,,MD,CA,CA,2021,Q4,Elderly
151354076,15135407,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,6,F,20170101.0,20211217.0,20180712,20211222,EXP,,CA-TAKEDA-2018TUS001303,TAKEDA,,68.0,YR,,M,Y,,,20211222.0,,MD,CA,CA,2021,Q4,Elderly
151354076,15135407,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Sleep apnoea syndrome,,2021,Q4,6,F,20170101.0,20211217.0,20180712,20211222,EXP,,CA-TAKEDA-2018TUS001303,TAKEDA,,68.0,YR,,M,Y,,,20211222.0,,MD,CA,CA,2021,Q4,Elderly
151354076,15135407,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Abdominal pain upper,,2021,Q4,6,F,20170101.0,20211217.0,20180712,20211222,EXP,,CA-TAKEDA-2018TUS001303,TAKEDA,,68.0,YR,,M,Y,,,20211222.0,,MD,CA,CA,2021,Q4,Elderly
151354076,15135407,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,6,F,20170101.0,20211217.0,20180712,20211222,EXP,,CA-TAKEDA-2018TUS001303,TAKEDA,,68.0,YR,,M,Y,,,20211222.0,,MD,CA,CA,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Eating disorder,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Acidosis,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Drug ineffective,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Cardiac failure,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Acute kidney injury,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Off label use,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Metabolic acidosis,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Fatigue,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Food refusal,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Drug interaction,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Dehydration,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Hypernatraemia,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Urine ketone body present,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Eating disorder,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Acidosis,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Cardiac failure,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Off label use,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Food refusal,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Drug interaction,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Dehydration,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Hypernatraemia,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
161403716,16140371,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Urine ketone body present,,2021,Q4,6,F,,20211012.0,20190401,20211016,EXP,,PHHY2019PT072916,NOVARTIS,"Fonseca L, Oliveira A, Santos T, Silva F, Ferreira T, Vilaverde J et al.. P059 Diabetic ketoacidosis: a reality of the inhibitors of Sglt2 to be considered. REVISTA PORTUGUESA DE DIABETES [PORTUGUESE DIABETES JOURNAL]. 2019;14 (1) Suppl 79:47-122",69.0,YR,,F,Y,,,20211016.0,,HP,PT,PT,2021,Q4,Elderly
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Throat irritation,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Abdominal pain,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Lactic acidosis,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Rheumatoid arthritis,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Herpes zoster,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Diabetes mellitus,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Asthenia,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Therapeutic product effect decreased,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Peripheral swelling,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Ear infection,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Nausea,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Dehydration,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Sinusitis,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Metabolic alkalosis,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Nasopharyngitis,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Flushing,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Renal failure,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Blood pressure increased,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Abdominal pain upper,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Vomiting,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
164439295,16443929,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Clumsiness,,2021,Q4,5,F,,20211028.0,20190618,20211030,EXP,,CA-AUROBINDO-AUR-APL-2019-033838,AUROBINDO,,52.0,YR,,F,Y,,,20211030.0,,PH,CA,CA,2021,Q4,Adult
165699224,16569922,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Coronary artery stenosis,,2021,Q4,4,F,,20211030.0,20190715,20211112,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20211112.0,,MD,CA,CA,2021,Q4,Adult
165699224,16569922,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Angina unstable,,2021,Q4,4,F,,20211030.0,20190715,20211112,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20211112.0,,MD,CA,CA,2021,Q4,Adult
165699224,16569922,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood triglycerides increased,,2021,Q4,4,F,,20211030.0,20190715,20211112,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20211112.0,,MD,CA,CA,2021,Q4,Adult
165699224,16569922,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Myopathy,,2021,Q4,4,F,,20211030.0,20190715,20211112,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20211112.0,,MD,CA,CA,2021,Q4,Adult
165699224,16569922,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Total cholesterol/HDL ratio increased,,2021,Q4,4,F,,20211030.0,20190715,20211112,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20211112.0,,MD,CA,CA,2021,Q4,Adult
165699224,16569922,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood creatine phosphokinase increased,,2021,Q4,4,F,,20211030.0,20190715,20211112,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20211112.0,,MD,CA,CA,2021,Q4,Adult
165699224,16569922,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Myalgia,,2021,Q4,4,F,,20211030.0,20190715,20211112,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20211112.0,,MD,CA,CA,2021,Q4,Adult
165699224,16569922,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Muscular weakness,,2021,Q4,4,F,,20211030.0,20190715,20211112,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20211112.0,,MD,CA,CA,2021,Q4,Adult
165699224,16569922,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood parathyroid hormone increased,,2021,Q4,4,F,,20211030.0,20190715,20211112,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20211112.0,,MD,CA,CA,2021,Q4,Adult
165699224,16569922,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Acute coronary syndrome,,2021,Q4,4,F,,20211030.0,20190715,20211112,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20211112.0,,MD,CA,CA,2021,Q4,Adult
165699224,16569922,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood cholesterol increased,,2021,Q4,4,F,,20211030.0,20190715,20211112,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20211112.0,,MD,CA,CA,2021,Q4,Adult
165699224,16569922,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Low density lipoprotein increased,,2021,Q4,4,F,,20211030.0,20190715,20211112,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20211112.0,,MD,CA,CA,2021,Q4,Adult
165699224,16569922,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,High density lipoprotein decreased,,2021,Q4,4,F,,20211030.0,20190715,20211112,EXP,,CA-AUROBINDO-AUR-APL-2019-038917,AUROBINDO,,56.0,YR,,M,Y,82.0,KG,20211112.0,,MD,CA,CA,2021,Q4,Adult
170369824,17036982,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,155.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Dehydration,,2021,Q4,4,F,20190517.0,20211124.0,20191115,20211130,EXP,,JP-AstraZeneca-2019SF60067,ASTRAZENECA,"Yamazaki Y, et al.. 1C-10 A case of type 2 diabetes mellitus who developed drug-induced hypoglycaemic attack, lactic acidosis and ketoacidosis. The 57th Kyushu Regional Meeting of Japan Diabetes Society 2019;182.",53.0,YR,,M,Y,86.0,KG,20211130.0,,MD,JP,,2021,Q4,Adult
170369824,17036982,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,155.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,4,F,20190517.0,20211124.0,20191115,20211130,EXP,,JP-AstraZeneca-2019SF60067,ASTRAZENECA,"Yamazaki Y, et al.. 1C-10 A case of type 2 diabetes mellitus who developed drug-induced hypoglycaemic attack, lactic acidosis and ketoacidosis. The 57th Kyushu Regional Meeting of Japan Diabetes Society 2019;182.",53.0,YR,,M,Y,86.0,KG,20211130.0,,MD,JP,,2021,Q4,Adult
170369824,17036982,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,155.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Lactic acidosis,,2021,Q4,4,F,20190517.0,20211124.0,20191115,20211130,EXP,,JP-AstraZeneca-2019SF60067,ASTRAZENECA,"Yamazaki Y, et al.. 1C-10 A case of type 2 diabetes mellitus who developed drug-induced hypoglycaemic attack, lactic acidosis and ketoacidosis. The 57th Kyushu Regional Meeting of Japan Diabetes Society 2019;182.",53.0,YR,,M,Y,86.0,KG,20211130.0,,MD,JP,,2021,Q4,Adult
170369824,17036982,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,155.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Hypoglycaemia,,2021,Q4,4,F,20190517.0,20211124.0,20191115,20211130,EXP,,JP-AstraZeneca-2019SF60067,ASTRAZENECA,"Yamazaki Y, et al.. 1C-10 A case of type 2 diabetes mellitus who developed drug-induced hypoglycaemic attack, lactic acidosis and ketoacidosis. The 57th Kyushu Regional Meeting of Japan Diabetes Society 2019;182.",53.0,YR,,M,Y,86.0,KG,20211130.0,,MD,JP,,2021,Q4,Adult
174076962,17407696,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2021,Q4,Hypernatraemia,,2021,Q4,2,F,,20211005.0,20200212,20211012,EXP,,JP-ASTRAZENECA-2020SE19929,ASTRAZENECA,"Tanaka K, et al. P-20 A case of ketoacidosis while on dapagliflozin, leading to hospitalisation where hypernatraemia developed immediately after the admission. Japanese Journal Of Pharmaceutical And Diabetes 2021;S:152-.",49.0,YR,,F,Y,,,20211012.0,,PH,JP,JP,2021,Q4,Adult
174076962,17407696,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2021,Q4,Ketoacidosis,,2021,Q4,2,F,,20211005.0,20200212,20211012,EXP,,JP-ASTRAZENECA-2020SE19929,ASTRAZENECA,"Tanaka K, et al. P-20 A case of ketoacidosis while on dapagliflozin, leading to hospitalisation where hypernatraemia developed immediately after the admission. Japanese Journal Of Pharmaceutical And Diabetes 2021;S:152-.",49.0,YR,,F,Y,,,20211012.0,,PH,JP,JP,2021,Q4,Adult
174843632,17484363,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10mg per day,,,,,,,,,,,,2021,Q4,Incorrect dose administered by device,,2021,Q4,2,F,20200223.0,20211013.0,20200302,20211021,EXP,,AU-ASTRAZENECA-2020SE29538,ASTRAZENECA,,84.0,YR,,M,Y,,,20211021.0,,CN,AU,AU,2021,Q4,Elderly
174843632,17484363,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10mg per day,,,,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20200223.0,20211013.0,20200302,20211021,EXP,,AU-ASTRAZENECA-2020SE29538,ASTRAZENECA,,84.0,YR,,M,Y,,,20211021.0,,CN,AU,AU,2021,Q4,Elderly
174843632,17484363,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10mg per day,,,,,,,,,,,,2021,Q4,Device issue,,2021,Q4,2,F,20200223.0,20211013.0,20200302,20211021,EXP,,AU-ASTRAZENECA-2020SE29538,ASTRAZENECA,,84.0,YR,,M,Y,,,20211021.0,,CN,AU,AU,2021,Q4,Elderly
178464253,17846425,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,QD,2021,Q4,General physical health deterioration,,2021,Q4,3,F,20200523.0,20211212.0,20200601,20211217,EXP,,JP-AstraZeneca-2020SE69909,ASTRAZENECA,,72.0,YR,,F,Y,65.0,KG,20211217.0,,MD,JP,,2021,Q4,Elderly
178464253,17846425,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Cardio-respiratory arrest,,2021,Q4,3,F,20200523.0,20211212.0,20200601,20211217,EXP,,JP-AstraZeneca-2020SE69909,ASTRAZENECA,,72.0,YR,,F,Y,65.0,KG,20211217.0,,MD,JP,,2021,Q4,Elderly
178464253,17846425,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Intestinal ischaemia,,2021,Q4,3,F,20200523.0,20211212.0,20200601,20211217,EXP,,JP-AstraZeneca-2020SE69909,ASTRAZENECA,,72.0,YR,,F,Y,65.0,KG,20211217.0,,MD,JP,,2021,Q4,Elderly
180111504,18011150,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Enthesopathy,,2021,Q4,4,F,20180101.0,20210930.0,20200712,20211007,EXP,,PHHY2018CA197391,NOVARTIS,,48.0,YR,,M,Y,,,20211007.0,,MD,CA,CA,2021,Q4,Adult
180111504,18011150,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Rotator cuff syndrome,,2021,Q4,4,F,20180101.0,20210930.0,20200712,20211007,EXP,,PHHY2018CA197391,NOVARTIS,,48.0,YR,,M,Y,,,20211007.0,,MD,CA,CA,2021,Q4,Adult
180111504,18011150,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Tendonitis,,2021,Q4,4,F,20180101.0,20210930.0,20200712,20211007,EXP,,PHHY2018CA197391,NOVARTIS,,48.0,YR,,M,Y,,,20211007.0,,MD,CA,CA,2021,Q4,Adult
180111504,18011150,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Inflammation,,2021,Q4,4,F,20180101.0,20210930.0,20200712,20211007,EXP,,PHHY2018CA197391,NOVARTIS,,48.0,YR,,M,Y,,,20211007.0,,MD,CA,CA,2021,Q4,Adult
180111504,18011150,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Product dose omission issue,,2021,Q4,4,F,20180101.0,20210930.0,20200712,20211007,EXP,,PHHY2018CA197391,NOVARTIS,,48.0,YR,,M,Y,,,20211007.0,,MD,CA,CA,2021,Q4,Adult
180111504,18011150,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Diabetes mellitus,,2021,Q4,4,F,20180101.0,20210930.0,20200712,20211007,EXP,,PHHY2018CA197391,NOVARTIS,,48.0,YR,,M,Y,,,20211007.0,,MD,CA,CA,2021,Q4,Adult
180111504,18011150,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Thyroid disorder,,2021,Q4,4,F,20180101.0,20210930.0,20200712,20211007,EXP,,PHHY2018CA197391,NOVARTIS,,48.0,YR,,M,Y,,,20211007.0,,MD,CA,CA,2021,Q4,Adult
180111504,18011150,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Back pain,,2021,Q4,4,F,20180101.0,20210930.0,20200712,20211007,EXP,,PHHY2018CA197391,NOVARTIS,,48.0,YR,,M,Y,,,20211007.0,,MD,CA,CA,2021,Q4,Adult
180111504,18011150,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dysstasia,,2021,Q4,4,F,20180101.0,20210930.0,20200712,20211007,EXP,,PHHY2018CA197391,NOVARTIS,,48.0,YR,,M,Y,,,20211007.0,,MD,CA,CA,2021,Q4,Adult
180111504,18011150,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Spondyloarthropathy,,2021,Q4,4,F,20180101.0,20210930.0,20200712,20211007,EXP,,PHHY2018CA197391,NOVARTIS,,48.0,YR,,M,Y,,,20211007.0,,MD,CA,CA,2021,Q4,Adult
180111504,18011150,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Pain,,2021,Q4,4,F,20180101.0,20210930.0,20200712,20211007,EXP,,PHHY2018CA197391,NOVARTIS,,48.0,YR,,M,Y,,,20211007.0,,MD,CA,CA,2021,Q4,Adult
185764403,18576440,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Crohn's disease,,2021,Q4,3,F,20200810.0,20211004.0,20201203,20211008,EXP,,CA-TAKEDA-2020TUS019415,TAKEDA,,70.0,YR,,M,Y,,,20211008.0,,MD,CA,CA,2021,Q4,Elderly
185764403,18576440,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,3,F,20200810.0,20211004.0,20201203,20211008,EXP,,CA-TAKEDA-2020TUS019415,TAKEDA,,70.0,YR,,M,Y,,,20211008.0,,MD,CA,CA,2021,Q4,Elderly
185764403,18576440,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,3,F,20200810.0,20211004.0,20201203,20211008,EXP,,CA-TAKEDA-2020TUS019415,TAKEDA,,70.0,YR,,M,Y,,,20211008.0,,MD,CA,CA,2021,Q4,Elderly
186149973,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Dehydration,,2021,Q4,3,F,20171101.0,20210920.0,20201214,20211001,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20211001.0,,HP,US,US,2021,Q4,Adult
186149973,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Pancreatitis acute,,2021,Q4,3,F,20171101.0,20210920.0,20201214,20211001,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20211001.0,,HP,US,US,2021,Q4,Adult
186149973,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,3,F,20171101.0,20210920.0,20201214,20211001,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20211001.0,,HP,US,US,2021,Q4,Adult
186149973,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Hypovolaemia,,2021,Q4,3,F,20171101.0,20210920.0,20201214,20211001,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20211001.0,,HP,US,US,2021,Q4,Adult
186149973,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Hypokalaemia,,2021,Q4,3,F,20171101.0,20210920.0,20201214,20211001,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20211001.0,,HP,US,US,2021,Q4,Adult
186149973,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Abdominal pain upper,,2021,Q4,3,F,20171101.0,20210920.0,20201214,20211001,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20211001.0,,HP,US,US,2021,Q4,Adult
186149973,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Leukocytosis,,2021,Q4,3,F,20171101.0,20210920.0,20201214,20211001,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20211001.0,,HP,US,US,2021,Q4,Adult
186149973,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,3,F,20171101.0,20210920.0,20201214,20211001,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20211001.0,,HP,US,US,2021,Q4,Adult
186149973,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,3,F,20171101.0,20210920.0,20201214,20211001,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20211001.0,,HP,US,US,2021,Q4,Adult
186149973,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,3,F,20171101.0,20210920.0,20201214,20211001,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20211001.0,,HP,US,US,2021,Q4,Adult
186149973,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Abdominal distension,,2021,Q4,3,F,20171101.0,20210920.0,20201214,20211001,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20211001.0,,HP,US,US,2021,Q4,Adult
186149973,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Hypophosphataemia,,2021,Q4,3,F,20171101.0,20210920.0,20201214,20211001,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20211001.0,,HP,US,US,2021,Q4,Adult
187533073,18753307,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,D,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,3,F,20210110.0,20211130.0,20210118,20211203,EXP,,JP-AstraZeneca-2021A006828,ASTRAZENECA,,59.0,YR,,M,Y,83.0,KG,20211203.0,,MD,JP,,2021,Q4,Adult
188777333,18877733,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"20 milligram, qd",1830.0,MG,Y,,,,,20.0,MG,Tablet,QD,2021,Q4,Weight decreased,,2021,Q4,3,F,20140401.0,20211101.0,20210211,20211121,EXP,,BR-009507513-2102BRA004118,MERCK,,70.0,YR,,M,Y,70.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Elderly
188777333,18877733,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"20 milligram, qd",1830.0,MG,Y,,,,,20.0,MG,Tablet,QD,2021,Q4,Ischaemic stroke,,2021,Q4,3,F,20140401.0,20211101.0,20210211,20211121,EXP,,BR-009507513-2102BRA004118,MERCK,,70.0,YR,,M,Y,70.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Elderly
188777333,18877733,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"20 milligram, qd",1830.0,MG,Y,,,,,20.0,MG,Tablet,QD,2021,Q4,Off label use,,2021,Q4,3,F,20140401.0,20211101.0,20210211,20211121,EXP,,BR-009507513-2102BRA004118,MERCK,,70.0,YR,,M,Y,70.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Elderly
188777333,18877733,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"20 milligram, qd",1830.0,MG,Y,,,,,20.0,MG,Tablet,QD,2021,Q4,Fatigue,,2021,Q4,3,F,20140401.0,20211101.0,20210211,20211121,EXP,,BR-009507513-2102BRA004118,MERCK,,70.0,YR,,M,Y,70.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Elderly
188779042,18877904,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",3660.0,MG,,,,,,10.0,MG,Tablet,QD,2021,Q4,Arterial occlusive disease,,2021,Q4,2,F,20150901.0,20211101.0,20210211,20211112,EXP,,BR-009507513-2102BRA004091,MERCK,,804.0,MON,,M,Y,,,20211112.0,,CN,BR,BR,2021,Q4,Elderly
189210024,18921002,10,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2021,Q4,Blood pressure systolic increased,,2021,Q4,4,F,,20211019.0,20210222,20211025,EXP,,NVSJ2021JP002667,NOVARTIS,,80.0,YR,,F,Y,,,20211025.0,,MD,JP,JP,2021,Q4,Elderly
189210024,18921002,10,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2021,Q4,Dizziness postural,,2021,Q4,4,F,,20211019.0,20210222,20211025,EXP,,NVSJ2021JP002667,NOVARTIS,,80.0,YR,,F,Y,,,20211025.0,,MD,JP,JP,2021,Q4,Elderly
189210024,18921002,10,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2021,Q4,Product use issue,,2021,Q4,4,F,,20211019.0,20210222,20211025,EXP,,NVSJ2021JP002667,NOVARTIS,,80.0,YR,,F,Y,,,20211025.0,,MD,JP,JP,2021,Q4,Elderly
189210024,18921002,10,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2021,Q4,Product use in unapproved indication,,2021,Q4,4,F,,20211019.0,20210222,20211025,EXP,,NVSJ2021JP002667,NOVARTIS,,80.0,YR,,F,Y,,,20211025.0,,MD,JP,JP,2021,Q4,Elderly
189572924,18957292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Dehydration,,2021,Q4,4,F,20210101.0,20211019.0,20210302,20211022,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20211022.0,,MD,JP,JP,2021,Q4,Elderly
189572924,18957292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Product use issue,,2021,Q4,4,F,20210101.0,20211019.0,20210302,20211022,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20211022.0,,MD,JP,JP,2021,Q4,Elderly
189572924,18957292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Hypotension,,2021,Q4,4,F,20210101.0,20211019.0,20210302,20211022,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20211022.0,,MD,JP,JP,2021,Q4,Elderly
189572924,18957292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Dizziness,,2021,Q4,4,F,20210101.0,20211019.0,20210302,20211022,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20211022.0,,MD,JP,JP,2021,Q4,Elderly
189572924,18957292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Urinary tract infection,,2021,Q4,4,F,20210101.0,20211019.0,20210302,20211022,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20211022.0,,MD,JP,JP,2021,Q4,Elderly
189572924,18957292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Septic shock,,2021,Q4,4,F,20210101.0,20211019.0,20210302,20211022,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20211022.0,,MD,JP,JP,2021,Q4,Elderly
189572924,18957292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Atrial fibrillation,,2021,Q4,4,F,20210101.0,20211019.0,20210302,20211022,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20211022.0,,MD,JP,JP,2021,Q4,Elderly
189572924,18957292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Cardiac failure congestive,,2021,Q4,4,F,20210101.0,20211019.0,20210302,20211022,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20211022.0,,MD,JP,JP,2021,Q4,Elderly
189572924,18957292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Cardiac failure,,2021,Q4,4,F,20210101.0,20211019.0,20210302,20211022,EXP,,NVSJ2021JP002674,NOVARTIS,,94.0,YR,,F,Y,,,20211022.0,,MD,JP,JP,2021,Q4,Elderly
190667172,19066717,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2021,Q4,Subcutaneous abscess,,2021,Q4,2,F,20210101.0,20211203.0,20210328,20211209,EXP,,FR-AstraZeneca-2021A183925,ASTRAZENECA,,50.0,YR,,F,Y,79.0,KG,20211209.0,,MD,FR,,2021,Q4,Adult
190667172,19066717,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2021,Q4,Vulvovaginal mycotic infection,,2021,Q4,2,F,20210101.0,20211203.0,20210328,20211209,EXP,,FR-AstraZeneca-2021A183925,ASTRAZENECA,,50.0,YR,,F,Y,79.0,KG,20211209.0,,MD,FR,,2021,Q4,Adult
190667172,19066717,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20210101.0,20211203.0,20210328,20211209,EXP,,FR-AstraZeneca-2021A183925,ASTRAZENECA,,50.0,YR,,F,Y,79.0,KG,20211209.0,,MD,FR,,2021,Q4,Adult
190667172,19066717,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2021,Q4,Vulvovaginal mycotic infection,,2021,Q4,2,F,20210101.0,20211203.0,20210328,20211209,EXP,,FR-AstraZeneca-2021A183925,ASTRAZENECA,,50.0,YR,,F,Y,79.0,KG,20211209.0,,MD,FR,,2021,Q4,Adult
190869263,19086926,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,3,F,20170101.0,20211005.0,20210402,20211014,EXP,,JP-ASTRAZENECA-2021A208721,ASTRAZENECA,,41.0,YR,,F,Y,,,20211014.0,,MD,JP,JP,2021,Q4,Adult
190869263,19086926,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Insulin resistance,,2021,Q4,3,F,20170101.0,20211005.0,20210402,20211014,EXP,,JP-ASTRAZENECA-2021A208721,ASTRAZENECA,,41.0,YR,,F,Y,,,20211014.0,,MD,JP,JP,2021,Q4,Adult
190869263,19086926,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Urinary tract infection,,2021,Q4,3,F,20170101.0,20211005.0,20210402,20211014,EXP,,JP-ASTRAZENECA-2021A208721,ASTRAZENECA,,41.0,YR,,F,Y,,,20211014.0,,MD,JP,JP,2021,Q4,Adult
191005332,19100533,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Enthesopathy,,2021,Q4,2,F,,20211125.0,20210407,20211206,EXP,,CA-AUROBINDO-AUR-APL-2021-014006,AUROBINDO,,55.0,YR,,M,Y,,,20211207.0,,HP,CA,CA,2021,Q4,Adult
191005332,19100533,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Polyarthritis,,2021,Q4,2,F,,20211125.0,20210407,20211206,EXP,,CA-AUROBINDO-AUR-APL-2021-014006,AUROBINDO,,55.0,YR,,M,Y,,,20211207.0,,HP,CA,CA,2021,Q4,Adult
191387383,19138738,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day",,,U,,,,,,,,QD,2021,Q4,Listless,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day",,,U,,,,,,,,QD,2021,Q4,Blood glucose increased,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day",,,U,,,,,,,,QD,2021,Q4,Gait disturbance,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day",,,U,,,,,,,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day",,,U,,,,,,,,QD,2021,Q4,Poor quality sleep,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day",,,U,,,,,,,,QD,2021,Q4,Sciatica,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day",,,U,,,,,,,,QD,2021,Q4,Extremity contracture,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day",,,U,,,,,,,,QD,2021,Q4,Pain in extremity,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day",,,U,,,,,,,,QD,2021,Q4,Limb discomfort,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Listless,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Blood glucose increased,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Gait disturbance,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Poor quality sleep,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Sciatica,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Extremity contracture,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Pain in extremity,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191387383,19138738,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Limb discomfort,,2021,Q4,3,F,20210301.0,20211101.0,20210415,20211115,EXP,,ES-AUROBINDO-AUR-APL-2021-015538,AUROBINDO,,79.0,YR,,F,Y,52.6,KG,20211115.0,,CN,ES,ES,2021,Q4,Elderly
191775723,19177572,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Cardiac failure,,2021,Q4,3,F,20210202.0,20210929.0,20210425,20211005,EXP,,NVSJ2021JP006390,NOVARTIS,,85.0,YR,,M,Y,52.0,KG,20211005.0,,PH,JP,JP,2021,Q4,Elderly
191775723,19177572,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Urine output decreased,,2021,Q4,3,F,20210202.0,20210929.0,20210425,20211005,EXP,,NVSJ2021JP006390,NOVARTIS,,85.0,YR,,M,Y,52.0,KG,20211005.0,,PH,JP,JP,2021,Q4,Elderly
191775723,19177572,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Weight increased,,2021,Q4,3,F,20210202.0,20210929.0,20210425,20211005,EXP,,NVSJ2021JP006390,NOVARTIS,,85.0,YR,,M,Y,52.0,KG,20211005.0,,PH,JP,JP,2021,Q4,Elderly
191775723,19177572,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Hypotension,,2021,Q4,3,F,20210202.0,20210929.0,20210425,20211005,EXP,,NVSJ2021JP006390,NOVARTIS,,85.0,YR,,M,Y,52.0,KG,20211005.0,,PH,JP,JP,2021,Q4,Elderly
191775723,19177572,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Cardiac failure,,2021,Q4,3,F,20210202.0,20210929.0,20210425,20211005,EXP,,NVSJ2021JP006390,NOVARTIS,,85.0,YR,,M,Y,52.0,KG,20211005.0,,PH,JP,JP,2021,Q4,Elderly
191775723,19177572,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Urine output decreased,,2021,Q4,3,F,20210202.0,20210929.0,20210425,20211005,EXP,,NVSJ2021JP006390,NOVARTIS,,85.0,YR,,M,Y,52.0,KG,20211005.0,,PH,JP,JP,2021,Q4,Elderly
191775723,19177572,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Weight increased,,2021,Q4,3,F,20210202.0,20210929.0,20210425,20211005,EXP,,NVSJ2021JP006390,NOVARTIS,,85.0,YR,,M,Y,52.0,KG,20211005.0,,PH,JP,JP,2021,Q4,Elderly
191775723,19177572,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Hypotension,,2021,Q4,3,F,20210202.0,20210929.0,20210425,20211005,EXP,,NVSJ2021JP006390,NOVARTIS,,85.0,YR,,M,Y,52.0,KG,20211005.0,,PH,JP,JP,2021,Q4,Elderly
191787662,19178766,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,KK0036,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Suspected counterfeit product,,2021,Q4,2,F,,20211213.0,20210426,20211217,EXP,,MX-AstraZeneca-2021A343375,ASTRAZENECA,,77.0,YR,,F,Y,56.0,KG,20211217.0,,CN,MX,,2021,Q4,Elderly
191787662,19178766,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,KK0036,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Liver function test abnormal,,2021,Q4,2,F,,20211213.0,20210426,20211217,EXP,,MX-AstraZeneca-2021A343375,ASTRAZENECA,,77.0,YR,,F,Y,56.0,KG,20211217.0,,CN,MX,,2021,Q4,Elderly
191787662,19178766,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,KK0036,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Liver disorder,,2021,Q4,2,F,,20211213.0,20210426,20211217,EXP,,MX-AstraZeneca-2021A343375,ASTRAZENECA,,77.0,YR,,F,Y,56.0,KG,20211217.0,,CN,MX,,2021,Q4,Elderly
191787662,19178766,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Suspected counterfeit product,,2021,Q4,2,F,,20211213.0,20210426,20211217,EXP,,MX-AstraZeneca-2021A343375,ASTRAZENECA,,77.0,YR,,F,Y,56.0,KG,20211217.0,,CN,MX,,2021,Q4,Elderly
191787662,19178766,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Liver function test abnormal,,2021,Q4,2,F,,20211213.0,20210426,20211217,EXP,,MX-AstraZeneca-2021A343375,ASTRAZENECA,,77.0,YR,,F,Y,56.0,KG,20211217.0,,CN,MX,,2021,Q4,Elderly
191787662,19178766,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Liver disorder,,2021,Q4,2,F,,20211213.0,20210426,20211217,EXP,,MX-AstraZeneca-2021A343375,ASTRAZENECA,,77.0,YR,,F,Y,56.0,KG,20211217.0,,CN,MX,,2021,Q4,Elderly
192226183,19222618,5,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"2 IU, qd(capsule)",,,,,,,,2.0,IU,,QD,2021,Q4,Atrial fibrillation,,2021,Q4,3,F,20201122.0,20210929.0,20210506,20211011,EXP,,ES-NOVOPROD-798303,NOVO NORDISK,,66.0,YR,,F,Y,94.5,KG,20211011.0,,MD,ES,ES,2021,Q4,Elderly
192226183,19222618,5,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"2 IU, qd(capsule)",,,,,,,,2.0,IU,,QD,2021,Q4,Left ventricular failure,,2021,Q4,3,F,20201122.0,20210929.0,20210506,20211011,EXP,,ES-NOVOPROD-798303,NOVO NORDISK,,66.0,YR,,F,Y,94.5,KG,20211011.0,,MD,ES,ES,2021,Q4,Elderly
192519772,19251977,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,take one daily,,,,,,,,,,,QD,2021,Q4,Off label use,,2021,Q4,2,F,20210504.0,20211116.0,20210513,20211123,EXP,GB-MHRA-TPP18947208C6212165YC1620126719214,GB-JNJFOC-20210511320,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,101.0,KG,20211123.0,,PH,GB,GB,2021,Q4,Elderly
192519772,19251977,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,take one daily,,,,,,,,,,,QD,2021,Q4,Rash,,2021,Q4,2,F,20210504.0,20211116.0,20210513,20211123,EXP,GB-MHRA-TPP18947208C6212165YC1620126719214,GB-JNJFOC-20210511320,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,101.0,KG,20211123.0,,PH,GB,GB,2021,Q4,Elderly
192519772,19251977,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,take one daily,,,,,,,,,,,QD,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,2,F,20210504.0,20211116.0,20210513,20211123,EXP,GB-MHRA-TPP18947208C6212165YC1620126719214,GB-JNJFOC-20210511320,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,101.0,KG,20211123.0,,PH,GB,GB,2021,Q4,Elderly
192519772,19251977,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,take one daily,,,,,,,,,,,QD,2021,Q4,Blister,,2021,Q4,2,F,20210504.0,20211116.0,20210513,20211123,EXP,GB-MHRA-TPP18947208C6212165YC1620126719214,GB-JNJFOC-20210511320,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,101.0,KG,20211123.0,,PH,GB,GB,2021,Q4,Elderly
192519772,19251977,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,take one daily,,,,,,,,,,,QD,2021,Q4,Product use in unapproved indication,,2021,Q4,2,F,20210504.0,20211116.0,20210513,20211123,EXP,GB-MHRA-TPP18947208C6212165YC1620126719214,GB-JNJFOC-20210511320,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,101.0,KG,20211123.0,,PH,GB,GB,2021,Q4,Elderly
193043123,19304312,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,,2021,Q4,Adrenal insufficiency,,2021,Q4,3,F,20210405.0,20211201.0,20210525,20211203,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-050170,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,106.0,KG,20211203.0,,HP,CA,CA,2021,Q4,Elderly
193266812,19326681,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5mg *1/day,,,,,,,,5.0,MG,,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,20160811.0,20211208.0,20210528,20211213,EXP,,JP-009507513-2105JPN006556,MERCK,"Teraishi M, Oguro T, Kusume E, Kobashi H, Sano H, Fujioka A, et al.. Pralatrexate for refractory mycosis fungoides in two Japanese patients. Journal of Dermatology. 2021;48 (5):667-71",56.0,YR,,M,Y,49.0,KG,20211213.0,,MD,JP,JP,2021,Q4,Adult
193266812,19326681,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5mg *1/day,,,,,,,,5.0,MG,,QD,2021,Q4,Hepatic function abnormal,,2021,Q4,2,F,20160811.0,20211208.0,20210528,20211213,EXP,,JP-009507513-2105JPN006556,MERCK,"Teraishi M, Oguro T, Kusume E, Kobashi H, Sano H, Fujioka A, et al.. Pralatrexate for refractory mycosis fungoides in two Japanese patients. Journal of Dermatology. 2021;48 (5):667-71",56.0,YR,,M,Y,49.0,KG,20211213.0,,MD,JP,JP,2021,Q4,Adult
193266812,19326681,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5mg *1/day,,,,,,,,5.0,MG,,QD,2021,Q4,Drug-induced liver injury,,2021,Q4,2,F,20160811.0,20211208.0,20210528,20211213,EXP,,JP-009507513-2105JPN006556,MERCK,"Teraishi M, Oguro T, Kusume E, Kobashi H, Sano H, Fujioka A, et al.. Pralatrexate for refractory mycosis fungoides in two Japanese patients. Journal of Dermatology. 2021;48 (5):667-71",56.0,YR,,M,Y,49.0,KG,20211213.0,,MD,JP,JP,2021,Q4,Adult
193697283,19369728,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNK,,,,,,,2021,Q4,Hyperthyroidism,,2021,Q4,3,F,20210503.0,20211018.0,20210603,20211027,EXP,,ES-EXELIXIS-XL18421040902,EXELIXIS,,58.0,YR,,M,Y,70.8,KG,20211027.0,,MD,ES,ES,2021,Q4,Adult
193697283,19369728,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNK,,,,,,,2021,Q4,Aspartate aminotransferase increased,,2021,Q4,3,F,20210503.0,20211018.0,20210603,20211027,EXP,,ES-EXELIXIS-XL18421040902,EXELIXIS,,58.0,YR,,M,Y,70.8,KG,20211027.0,,MD,ES,ES,2021,Q4,Adult
193697283,19369728,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Hyperthyroidism,,2021,Q4,3,F,20210503.0,20211018.0,20210603,20211027,EXP,,ES-EXELIXIS-XL18421040902,EXELIXIS,,58.0,YR,,M,Y,70.8,KG,20211027.0,,MD,ES,ES,2021,Q4,Adult
193697283,19369728,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Aspartate aminotransferase increased,,2021,Q4,3,F,20210503.0,20211018.0,20210603,20211027,EXP,,ES-EXELIXIS-XL18421040902,EXELIXIS,,58.0,YR,,M,Y,70.8,KG,20211027.0,,MD,ES,ES,2021,Q4,Adult
193753452,19375345,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,,QD,2021,Q4,Heart sounds abnormal,,2021,Q4,2,F,20190305.0,20210525.0,20210604,20211119,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20211119.0,,MD,PT,PT,2021,Q4,Elderly
193753452,19375345,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,,QD,2021,Q4,Bradycardia,,2021,Q4,2,F,20190305.0,20210525.0,20210604,20211119,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20211119.0,,MD,PT,PT,2021,Q4,Elderly
193753452,19375345,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,,QD,2021,Q4,Hypotension,,2021,Q4,2,F,20190305.0,20210525.0,20210604,20211119,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20211119.0,,MD,PT,PT,2021,Q4,Elderly
193753452,19375345,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,,QD,2021,Q4,Asthenia,,2021,Q4,2,F,20190305.0,20210525.0,20210604,20211119,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20211119.0,,MD,PT,PT,2021,Q4,Elderly
193753452,19375345,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,,QD,2021,Q4,Hyperkalaemia,,2021,Q4,2,F,20190305.0,20210525.0,20210604,20211119,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20211119.0,,MD,PT,PT,2021,Q4,Elderly
193753452,19375345,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,2,F,20190305.0,20210525.0,20210604,20211119,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20211119.0,,MD,PT,PT,2021,Q4,Elderly
193753452,19375345,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,,QD,2021,Q4,Blood urea increased,,2021,Q4,2,F,20190305.0,20210525.0,20210604,20211119,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20211119.0,,MD,PT,PT,2021,Q4,Elderly
193753452,19375345,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,,QD,2021,Q4,Blood creatinine increased,,2021,Q4,2,F,20190305.0,20210525.0,20210604,20211119,EXP,,NVSC2021PT121670,NOVARTIS,,74.0,YR,,M,Y,94.0,KG,20211119.0,,MD,PT,PT,2021,Q4,Elderly
193775316,19377531,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,6,F,20191101.0,20210706.0,20210604,20211125,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211125.0,,MD,PL,PL,2021,Q4,Elderly
193775316,19377531,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Pulmonary oedema,,2021,Q4,6,F,20191101.0,20210706.0,20210604,20211125,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211125.0,,MD,PL,PL,2021,Q4,Elderly
193775316,19377531,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,6,F,20191101.0,20210706.0,20210604,20211125,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211125.0,,MD,PL,PL,2021,Q4,Elderly
193775316,19377531,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,6,F,20191101.0,20210706.0,20210604,20211125,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211125.0,,MD,PL,PL,2021,Q4,Elderly
193775316,19377531,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,6,F,20191101.0,20210706.0,20210604,20211125,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211125.0,,MD,PL,PL,2021,Q4,Elderly
193775316,19377531,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Haemoglobin decreased,,2021,Q4,6,F,20191101.0,20210706.0,20210604,20211125,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211125.0,,MD,PL,PL,2021,Q4,Elderly
193775316,19377531,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Mitral valve incompetence,,2021,Q4,6,F,20191101.0,20210706.0,20210604,20211125,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211125.0,,MD,PL,PL,2021,Q4,Elderly
193775316,19377531,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Mitral valve thickening,,2021,Q4,6,F,20191101.0,20210706.0,20210604,20211125,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211125.0,,MD,PL,PL,2021,Q4,Elderly
193775316,19377531,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Ejection fraction decreased,,2021,Q4,6,F,20191101.0,20210706.0,20210604,20211125,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211125.0,,MD,PL,PL,2021,Q4,Elderly
193775316,19377531,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Platelet count decreased,,2021,Q4,6,F,20191101.0,20210706.0,20210604,20211125,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211125.0,,MD,PL,PL,2021,Q4,Elderly
193775316,19377531,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Concomitant disease aggravated,,2021,Q4,6,F,20191101.0,20210706.0,20210604,20211125,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211125.0,,MD,PL,PL,2021,Q4,Elderly
193775316,19377531,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Heart rate decreased,,2021,Q4,6,F,20191101.0,20210706.0,20210604,20211125,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211125.0,,MD,PL,PL,2021,Q4,Elderly
193775316,19377531,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Mitral valve calcification,,2021,Q4,6,F,20191101.0,20210706.0,20210604,20211125,EXP,,PL-BAUSCH-BL-2021-019446,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20211125.0,,MD,PL,PL,2021,Q4,Elderly
193820096,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q4,Carcinoid tumour,,2021,Q4,6,F,20160401.0,20211019.0,20210607,20211026,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20211026.0,,CN,CA,CA,2021,Q4,Elderly
193820096,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q4,Malignant neoplasm progression,,2021,Q4,6,F,20160401.0,20211019.0,20210607,20211026,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20211026.0,,CN,CA,CA,2021,Q4,Elderly
193820096,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q4,Injection site warmth,,2021,Q4,6,F,20160401.0,20211019.0,20210607,20211026,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20211026.0,,CN,CA,CA,2021,Q4,Elderly
193820096,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q4,Blood insulin increased,,2021,Q4,6,F,20160401.0,20211019.0,20210607,20211026,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20211026.0,,CN,CA,CA,2021,Q4,Elderly
193820096,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q4,Heart rate increased,,2021,Q4,6,F,20160401.0,20211019.0,20210607,20211026,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20211026.0,,CN,CA,CA,2021,Q4,Elderly
193820096,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q4,Stress,,2021,Q4,6,F,20160401.0,20211019.0,20210607,20211026,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20211026.0,,CN,CA,CA,2021,Q4,Elderly
193820096,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q4,General physical health deterioration,,2021,Q4,6,F,20160401.0,20211019.0,20210607,20211026,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20211026.0,,CN,CA,CA,2021,Q4,Elderly
193820096,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q4,Lymphadenopathy,,2021,Q4,6,F,20160401.0,20211019.0,20210607,20211026,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20211026.0,,CN,CA,CA,2021,Q4,Elderly
193820096,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q4,Diarrhoea,,2021,Q4,6,F,20160401.0,20211019.0,20210607,20211026,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20211026.0,,CN,CA,CA,2021,Q4,Elderly
193820096,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q4,Blood pressure increased,,2021,Q4,6,F,20160401.0,20211019.0,20210607,20211026,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20211026.0,,CN,CA,CA,2021,Q4,Elderly
193820096,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q4,Arthralgia,,2021,Q4,6,F,20160401.0,20211019.0,20210607,20211026,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20211026.0,,CN,CA,CA,2021,Q4,Elderly
193820096,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q4,Osteoarthritis,,2021,Q4,6,F,20160401.0,20211019.0,20210607,20211026,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20211026.0,,CN,CA,CA,2021,Q4,Elderly
193855657,19385565,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Pulmonary oedema,,2021,Q4,7,F,20191101.0,20210706.0,20210608,20211202,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20211203.0,,MD,PL,PL,2021,Q4,Elderly
193855657,19385565,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,7,F,20191101.0,20210706.0,20210608,20211202,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20211203.0,,MD,PL,PL,2021,Q4,Elderly
193855657,19385565,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,7,F,20191101.0,20210706.0,20210608,20211202,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20211203.0,,MD,PL,PL,2021,Q4,Elderly
193855657,19385565,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Haemoglobin decreased,,2021,Q4,7,F,20191101.0,20210706.0,20210608,20211202,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20211203.0,,MD,PL,PL,2021,Q4,Elderly
193855657,19385565,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,7,F,20191101.0,20210706.0,20210608,20211202,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20211203.0,,MD,PL,PL,2021,Q4,Elderly
193855657,19385565,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,7,F,20191101.0,20210706.0,20210608,20211202,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20211203.0,,MD,PL,PL,2021,Q4,Elderly
193855657,19385565,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Ejection fraction decreased,,2021,Q4,7,F,20191101.0,20210706.0,20210608,20211202,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20211203.0,,MD,PL,PL,2021,Q4,Elderly
193855657,19385565,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Heart rate decreased,,2021,Q4,7,F,20191101.0,20210706.0,20210608,20211202,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20211203.0,,MD,PL,PL,2021,Q4,Elderly
193855657,19385565,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Mitral valve thickening,,2021,Q4,7,F,20191101.0,20210706.0,20210608,20211202,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20211203.0,,MD,PL,PL,2021,Q4,Elderly
193855657,19385565,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Mitral valve incompetence,,2021,Q4,7,F,20191101.0,20210706.0,20210608,20211202,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20211203.0,,MD,PL,PL,2021,Q4,Elderly
193855657,19385565,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Mitral valve calcification,,2021,Q4,7,F,20191101.0,20210706.0,20210608,20211202,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20211203.0,,MD,PL,PL,2021,Q4,Elderly
193855657,19385565,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Concomitant disease aggravated,,2021,Q4,7,F,20191101.0,20210706.0,20210608,20211202,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20211203.0,,MD,PL,PL,2021,Q4,Elderly
193855657,19385565,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,7,F,20191101.0,20210706.0,20210608,20211202,EXP,,PL-TEVA-2021-PL-1921306,TEVA,,65.0,YR,E,M,Y,,,20211203.0,,MD,PL,PL,2021,Q4,Elderly
193997182,19399718,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Ketoacidosis,,2021,Q4,2,F,20210321.0,20211102.0,20210610,20211111,EXP,,ES-AstraZeneca-2021A494579,ASTRAZENECA,,3531.0,WK,,F,Y,102.6,KG,20211111.0,,MD,ES,,2021,Q4,Elderly
193997182,19399718,2,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,1000/5 MG EVERY 12 H,,,U,,,,,,,Tablet,BID,2021,Q4,Ketoacidosis,,2021,Q4,2,F,20210321.0,20211102.0,20210610,20211111,EXP,,ES-AstraZeneca-2021A494579,ASTRAZENECA,,3531.0,WK,,F,Y,102.6,KG,20211111.0,,MD,ES,,2021,Q4,Elderly
194161445,19416144,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in the morning,,,,,,,,,,,QD,2021,Q4,Somnolence,,2021,Q4,5,F,20170101.0,20211101.0,20210614,20211121,EXP,,BR-009507513-2106BRA003181,MERCK,,52.0,YR,,M,Y,115.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Adult
194161445,19416144,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in the morning,,,,,,,,,,,QD,2021,Q4,Hepatic cirrhosis,,2021,Q4,5,F,20170101.0,20211101.0,20210614,20211121,EXP,,BR-009507513-2106BRA003181,MERCK,,52.0,YR,,M,Y,115.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Adult
194161445,19416144,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in the morning,,,,,,,,,,,QD,2021,Q4,Cholecystectomy,,2021,Q4,5,F,20170101.0,20211101.0,20210614,20211121,EXP,,BR-009507513-2106BRA003181,MERCK,,52.0,YR,,M,Y,115.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Adult
194161445,19416144,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in the morning,,,,,,,,,,,QD,2021,Q4,Respiration abnormal,,2021,Q4,5,F,20170101.0,20211101.0,20210614,20211121,EXP,,BR-009507513-2106BRA003181,MERCK,,52.0,YR,,M,Y,115.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Adult
194161445,19416144,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in the morning,,,,,,,,,,,QD,2021,Q4,Fatigue,,2021,Q4,5,F,20170101.0,20211101.0,20210614,20211121,EXP,,BR-009507513-2106BRA003181,MERCK,,52.0,YR,,M,Y,115.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Adult
194161445,19416144,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in the morning,,,,,,,,,,,QD,2021,Q4,Product dose omission issue,,2021,Q4,5,F,20170101.0,20211101.0,20210614,20211121,EXP,,BR-009507513-2106BRA003181,MERCK,,52.0,YR,,M,Y,115.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Adult
194161445,19416144,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in the morning,,,,,,,,,,,QD,2021,Q4,Blood glucose abnormal,,2021,Q4,5,F,20170101.0,20211101.0,20210614,20211121,EXP,,BR-009507513-2106BRA003181,MERCK,,52.0,YR,,M,Y,115.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Adult
194161445,19416144,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in the morning,,,,,,,,,,,QD,2021,Q4,Vitamin D deficiency,,2021,Q4,5,F,20170101.0,20211101.0,20210614,20211121,EXP,,BR-009507513-2106BRA003181,MERCK,,52.0,YR,,M,Y,115.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Adult
194161445,19416144,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in the morning,,,,,,,,,,,QD,2021,Q4,Diabetic complication,,2021,Q4,5,F,20170101.0,20211101.0,20210614,20211121,EXP,,BR-009507513-2106BRA003181,MERCK,,52.0,YR,,M,Y,115.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Adult
194161445,19416144,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in the morning,,,,,,,,,,,QD,2021,Q4,Peripheral swelling,,2021,Q4,5,F,20170101.0,20211101.0,20210614,20211121,EXP,,BR-009507513-2106BRA003181,MERCK,,52.0,YR,,M,Y,115.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Adult
194161445,19416144,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in the morning,,,,,,,,,,,QD,2021,Q4,Pollakiuria,,2021,Q4,5,F,20170101.0,20211101.0,20210614,20211121,EXP,,BR-009507513-2106BRA003181,MERCK,,52.0,YR,,M,Y,115.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Adult
194161445,19416144,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in the morning,,,,,,,,,,,QD,2021,Q4,Thirst,,2021,Q4,5,F,20170101.0,20211101.0,20210614,20211121,EXP,,BR-009507513-2106BRA003181,MERCK,,52.0,YR,,M,Y,115.0,KG,20211121.0,,CN,BR,BR,2021,Q4,Adult
194416715,19441671,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,unk,,,10.0,MG,,QD,2021,Q4,Unevaluable event,,2021,Q4,5,F,,20211213.0,20210621,20211220,EXP,,DK-NOVOPROD-821997,NOVO NORDISK,,83.0,YR,,M,Y,,,20211220.0,,CN,DK,DK,2021,Q4,Elderly
194416715,19441671,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,unk,,,10.0,MG,,QD,2021,Q4,Product appearance confusion,,2021,Q4,5,F,,20211213.0,20210621,20211220,EXP,,DK-NOVOPROD-821997,NOVO NORDISK,,83.0,YR,,M,Y,,,20211220.0,,CN,DK,DK,2021,Q4,Elderly
194416715,19441671,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,unk,,,10.0,MG,,QD,2021,Q4,Wrong product administered,,2021,Q4,5,F,,20211213.0,20210621,20211220,EXP,,DK-NOVOPROD-821997,NOVO NORDISK,,83.0,YR,,M,Y,,,20211220.0,,CN,DK,DK,2021,Q4,Elderly
194416715,19441671,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,unk,,,10.0,MG,,QD,2021,Q4,Accidental overdose,,2021,Q4,5,F,,20211213.0,20210621,20211220,EXP,,DK-NOVOPROD-821997,NOVO NORDISK,,83.0,YR,,M,Y,,,20211220.0,,CN,DK,DK,2021,Q4,Elderly
194443933,19444393,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,,,,,,10.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,3,F,20210520.0,20211111.0,20210621,20211116,EXP,,JP-AstraZeneca-2021A539721,ASTRAZENECA,,82.0,YR,,F,Y,52.0,KG,20211116.0,,MD,JP,,2021,Q4,Elderly
194554172,19455417,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Vomiting,,2021,Q4,2,F,20210604.0,20210929.0,20210623,20211006,EXP,,NVSJ2021JP009140,NOVARTIS,,76.0,YR,,F,Y,,,20211007.0,,PH,JP,JP,2021,Q4,Elderly
194554172,19455417,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Hypotension,,2021,Q4,2,F,20210604.0,20210929.0,20210623,20211006,EXP,,NVSJ2021JP009140,NOVARTIS,,76.0,YR,,F,Y,,,20211007.0,,PH,JP,JP,2021,Q4,Elderly
194554172,19455417,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Anaphylactic reaction,,2021,Q4,2,F,20210604.0,20210929.0,20210623,20211006,EXP,,NVSJ2021JP009140,NOVARTIS,,76.0,YR,,F,Y,,,20211007.0,,PH,JP,JP,2021,Q4,Elderly
194554172,19455417,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Dyspnoea,,2021,Q4,2,F,20210604.0,20210929.0,20210623,20211006,EXP,,NVSJ2021JP009140,NOVARTIS,,76.0,YR,,F,Y,,,20211007.0,,PH,JP,JP,2021,Q4,Elderly
194663593,19466359,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Ischaemic enteritis,,2021,Q4,3,F,20210505.0,20211013.0,20210627,20211020,EXP,,NVSJ2021JP009301,NOVARTIS,,72.0,YR,,M,Y,,,20211020.0,,MD,JP,JP,2021,Q4,Elderly
194663593,19466359,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,3,F,20210505.0,20211013.0,20210627,20211020,EXP,,NVSJ2021JP009301,NOVARTIS,,72.0,YR,,M,Y,,,20211020.0,,MD,JP,JP,2021,Q4,Elderly
194663593,19466359,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Cholecystitis,,2021,Q4,3,F,20210505.0,20211013.0,20210627,20211020,EXP,,NVSJ2021JP009301,NOVARTIS,,72.0,YR,,M,Y,,,20211020.0,,MD,JP,JP,2021,Q4,Elderly
194880674,19488067,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2021,Q4,Hypokalaemia,,2021,Q4,4,F,,20210922.0,20210702,20211001,EXP,,JP-009507513-2107JPN000278,MERCK,,8.0,DEC,,M,Y,,,20211001.0,,MD,JP,JP,2021,Q4,Child
194880674,19488067,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2021,Q4,Blood creatinine increased,,2021,Q4,4,F,,20210922.0,20210702,20211001,EXP,,JP-009507513-2107JPN000278,MERCK,,8.0,DEC,,M,Y,,,20211001.0,,MD,JP,JP,2021,Q4,Child
194904572,19490457,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,unk,,,10.0,MG,,,2021,Q4,Spinal operation,,2021,Q4,2,F,,20210625.0,20210705,20211123,EXP,,ZA-NOVOPROD-825403,NOVO NORDISK,,64.0,YR,,M,Y,,,20211123.0,,CN,ZA,ZA,2021,Q4,Adult
195355392,19535539,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, qd",,,D,,,,,10.0,MG,,,2021,Q4,Polyarthritis,,2021,Q4,2,F,,20211122.0,20210714,20211130,EXP,,CA-APOTEX-2021AP017135,APOTEX,,55.0,YR,,M,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
195355392,19535539,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, qd",,,D,,,,,10.0,MG,,,2021,Q4,Enthesopathy,,2021,Q4,2,F,,20211122.0,20210714,20211130,EXP,,CA-APOTEX-2021AP017135,APOTEX,,55.0,YR,,M,Y,,,20211130.0,,HP,CA,CA,2021,Q4,Adult
195708112,19570811,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Penile oedema,,2021,Q4,2,F,20210217.0,20211118.0,20210716,20211126,EXP,,FR-AstraZeneca-2021A619430,ASTRAZENECA,,16729.0,DY,,M,Y,117.0,KG,20211126.0,,MD,FR,,2021,Q4,Elderly
195708112,19570811,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Penile oedema,,2021,Q4,2,F,20210217.0,20211118.0,20210716,20211126,EXP,,FR-AstraZeneca-2021A619430,ASTRAZENECA,,16729.0,DY,,M,Y,117.0,KG,20211126.0,,MD,FR,,2021,Q4,Elderly
195856492,19585649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1175.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Vaginal infection,,2021,Q4,2,F,20200916.0,20211021.0,20210720,20211029,EXP,,JP-ASTRAZENECA-2021A182297,ASTRAZENECA,,28885.0,DY,,F,Y,48.0,KG,20211029.0,,MD,JP,JP,2021,Q4,Elderly
195856492,19585649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1175.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Blood pressure decreased,,2021,Q4,2,F,20200916.0,20211021.0,20210720,20211029,EXP,,JP-ASTRAZENECA-2021A182297,ASTRAZENECA,,28885.0,DY,,F,Y,48.0,KG,20211029.0,,MD,JP,JP,2021,Q4,Elderly
195856492,19585649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1175.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Pyelonephritis,,2021,Q4,2,F,20200916.0,20211021.0,20210720,20211029,EXP,,JP-ASTRAZENECA-2021A182297,ASTRAZENECA,,28885.0,DY,,F,Y,48.0,KG,20211029.0,,MD,JP,JP,2021,Q4,Elderly
195856492,19585649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1175.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Cystitis,,2021,Q4,2,F,20200916.0,20211021.0,20210720,20211029,EXP,,JP-ASTRAZENECA-2021A182297,ASTRAZENECA,,28885.0,DY,,F,Y,48.0,KG,20211029.0,,MD,JP,JP,2021,Q4,Elderly
195856492,19585649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1175.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Sepsis,,2021,Q4,2,F,20200916.0,20211021.0,20210720,20211029,EXP,,JP-ASTRAZENECA-2021A182297,ASTRAZENECA,,28885.0,DY,,F,Y,48.0,KG,20211029.0,,MD,JP,JP,2021,Q4,Elderly
195975242,19597524,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,,,,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,20210313.0,20211129.0,20210723,20211208,EXP,,CA-AstraZeneca-2021A626928,ASTRAZENECA,,43.0,YR,,M,Y,,,20211208.0,,MD,CA,,2021,Q4,Adult
196053594,19605359,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 milligram,,,U,,,,,5.0,MG,,,2021,Q4,Anaphylactic reaction,,2021,Q4,4,F,20210721.0,20211020.0,20210723,20211022,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-071597,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,70.0,KG,20211022.0,,HP,JP,JP,2021,Q4,Elderly
196158902,19615890,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,202293.0,,,,,2021,Q4,Ketonuria,,2021,Q4,2,F,20210211.0,20211020.0,20210727,20211025,EXP,,DE-ASTRAZENECA-2021A635512,ASTRAZENECA,,74.0,YR,,F,Y,145.0,KG,20211025.0,,MD,DE,DE,2021,Q4,Elderly
196158902,19615890,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,202293.0,,,,,2021,Q4,Lactic acidosis,,2021,Q4,2,F,20210211.0,20211020.0,20210727,20211025,EXP,,DE-ASTRAZENECA-2021A635512,ASTRAZENECA,,74.0,YR,,F,Y,145.0,KG,20211025.0,,MD,DE,DE,2021,Q4,Elderly
196158902,19615890,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,202293.0,,,,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,20210211.0,20211020.0,20210727,20211025,EXP,,DE-ASTRAZENECA-2021A635512,ASTRAZENECA,,74.0,YR,,F,Y,145.0,KG,20211025.0,,MD,DE,DE,2021,Q4,Elderly
196468292,19646829,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,Unknown,,,,,,,2021,Q4,Ketonuria,,2021,Q4,2,F,20210211.0,20211007.0,20210802,20211015,EXP,,DE-TEVA-2021-DE-1937005,TEVA,,74.0,YR,E,F,Y,145.0,KG,20211015.0,,MD,DE,DE,2021,Q4,Elderly
196468292,19646829,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,Unknown,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,2,F,20210211.0,20211007.0,20210802,20211015,EXP,,DE-TEVA-2021-DE-1937005,TEVA,,74.0,YR,E,F,Y,145.0,KG,20211015.0,,MD,DE,DE,2021,Q4,Elderly
196468292,19646829,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,Unknown,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,20210211.0,20211007.0,20210802,20211015,EXP,,DE-TEVA-2021-DE-1937005,TEVA,,74.0,YR,E,F,Y,145.0,KG,20211015.0,,MD,DE,DE,2021,Q4,Elderly
196510124,19651012,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, BID",480.0,MG,Y,,,,,5.0,MG,Tablet,BID,2021,Q4,Polyuria,,2021,Q4,4,F,20210224.0,20211117.0,20210802,20211124,EXP,,NVSJ2021JP005700,NOVARTIS,,88.0,YR,,M,Y,49.0,KG,20211125.0,,MD,JP,JP,2021,Q4,Elderly
196510124,19651012,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, BID",480.0,MG,Y,,,,,5.0,MG,Tablet,BID,2021,Q4,Blood pressure decreased,,2021,Q4,4,F,20210224.0,20211117.0,20210802,20211124,EXP,,NVSJ2021JP005700,NOVARTIS,,88.0,YR,,M,Y,49.0,KG,20211125.0,,MD,JP,JP,2021,Q4,Elderly
196510124,19651012,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, BID",480.0,MG,Y,,,,,5.0,MG,Tablet,BID,2021,Q4,Shock,,2021,Q4,4,F,20210224.0,20211117.0,20210802,20211124,EXP,,NVSJ2021JP005700,NOVARTIS,,88.0,YR,,M,Y,49.0,KG,20211125.0,,MD,JP,JP,2021,Q4,Elderly
196510124,19651012,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, BID",480.0,MG,Y,,,,,5.0,MG,Tablet,BID,2021,Q4,Acute kidney injury,,2021,Q4,4,F,20210224.0,20211117.0,20210802,20211124,EXP,,NVSJ2021JP005700,NOVARTIS,,88.0,YR,,M,Y,49.0,KG,20211125.0,,MD,JP,JP,2021,Q4,Elderly
196510124,19651012,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, BID",480.0,MG,Y,,,,,5.0,MG,Tablet,BID,2021,Q4,Blood potassium increased,,2021,Q4,4,F,20210224.0,20211117.0,20210802,20211124,EXP,,NVSJ2021JP005700,NOVARTIS,,88.0,YR,,M,Y,49.0,KG,20211125.0,,MD,JP,JP,2021,Q4,Elderly
196510124,19651012,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, BID",480.0,MG,Y,,,,,5.0,MG,Tablet,BID,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,4,F,20210224.0,20211117.0,20210802,20211124,EXP,,NVSJ2021JP005700,NOVARTIS,,88.0,YR,,M,Y,49.0,KG,20211125.0,,MD,JP,JP,2021,Q4,Elderly
196759943,19675994,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1300.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Dizziness,,2021,Q4,3,F,20210801.0,20211007.0,20210809,20211019,EXP,,JP-ASTRAZENECA-2021A671082,ASTRAZENECA,,72.0,YR,,M,Y,60.0,KG,20211019.0,,MD,JP,JP,2021,Q4,Elderly
196759943,19675994,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1300.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,20210801.0,20211007.0,20210809,20211019,EXP,,JP-ASTRAZENECA-2021A671082,ASTRAZENECA,,72.0,YR,,M,Y,60.0,KG,20211019.0,,MD,JP,JP,2021,Q4,Elderly
196759943,19675994,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1300.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Urinary tract infection,,2021,Q4,3,F,20210801.0,20211007.0,20210809,20211019,EXP,,JP-ASTRAZENECA-2021A671082,ASTRAZENECA,,72.0,YR,,M,Y,60.0,KG,20211019.0,,MD,JP,JP,2021,Q4,Elderly
196784362,19678436,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,unk,,,,,,,2021,Q4,Knee operation,,2021,Q4,2,F,,20210730.0,20210810,20211123,EXP,,ZA-NOVOPROD-834554,NOVO NORDISK,,64.0,YR,,F,Y,,,20211123.0,,CN,ZA,ZA,2021,Q4,Adult
196784362,19678436,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,unk,,,,,,,2021,Q4,Cardiac operation,,2021,Q4,2,F,,20210730.0,20210810,20211123,EXP,,ZA-NOVOPROD-834554,NOVO NORDISK,,64.0,YR,,F,Y,,,20211123.0,,CN,ZA,ZA,2021,Q4,Adult
196845982,19684598,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Vomiting,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Dehydration,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Asthenia,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Renal failure,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Metabolic alkalosis,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Lactic acidosis,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Nausea,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Abdominal pain,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,7,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,7,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Vomiting,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,7,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Dehydration,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,7,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Asthenia,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,7,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Renal failure,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,7,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,7,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Metabolic alkalosis,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,7,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Lactic acidosis,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,7,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Nausea,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
196845982,19684598,7,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,,2021,Q4,Abdominal pain,,2021,Q4,2,F,,20211118.0,20210811,20211126,EXP,,CA-APOTEX-2021AP028619,APOTEX,,52.0,YR,,F,Y,,,20211126.0,,PH,CA,CA,2021,Q4,Adult
197641782,19764178,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 1 pill per day,,,,,unk,,,,,,,2021,Q4,Catheterisation cardiac,,2021,Q4,2,F,20210401.0,20211112.0,20210830,20211123,EXP,,BR-NOVOPROD-840317,NOVO NORDISK,,74.0,YR,,,Y,65.0,KG,20211123.0,,MD,BR,BR,2021,Q4,Elderly
197641782,19764178,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 1 pill per day,,,,,unk,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20210401.0,20211112.0,20210830,20211123,EXP,,BR-NOVOPROD-840317,NOVO NORDISK,,74.0,YR,,,Y,65.0,KG,20211123.0,,MD,BR,BR,2021,Q4,Elderly
197641782,19764178,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 1 pill per day,,,,,unk,,,,,,,2021,Q4,Angioplasty,,2021,Q4,2,F,20210401.0,20211112.0,20210830,20211123,EXP,,BR-NOVOPROD-840317,NOVO NORDISK,,74.0,YR,,,Y,65.0,KG,20211123.0,,MD,BR,BR,2021,Q4,Elderly
197641782,19764178,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 1 pill per day,,,,,unk,,,,,,,2021,Q4,COVID-19,,2021,Q4,2,F,20210401.0,20211112.0,20210830,20211123,EXP,,BR-NOVOPROD-840317,NOVO NORDISK,,74.0,YR,,,Y,65.0,KG,20211123.0,,MD,BR,BR,2021,Q4,Elderly
197641782,19764178,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 1 pill per day,,,,,unk,,,,,,,2021,Q4,Off label use,,2021,Q4,2,F,20210401.0,20211112.0,20210830,20211123,EXP,,BR-NOVOPROD-840317,NOVO NORDISK,,74.0,YR,,,Y,65.0,KG,20211123.0,,MD,BR,BR,2021,Q4,Elderly
197641782,19764178,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10/1000 1 pill per day,,,,,unk,,,,,,,2021,Q4,Blood creatinine increased,,2021,Q4,2,F,20210401.0,20211112.0,20210830,20211123,EXP,,BR-NOVOPROD-840317,NOVO NORDISK,,74.0,YR,,,Y,65.0,KG,20211123.0,,MD,BR,BR,2021,Q4,Elderly
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Pulmonary hypertension,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Aortic valve incompetence,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Aortic valve sclerosis,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Cardiac valve disease,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Hypervolaemia,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Hypermobility syndrome,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Inferior vena cava dilatation,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Left atrial dilatation,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Left ventricular hypertrophy,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Mitral valve incompetence,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Pericardial effusion,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Right atrial dilatation,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Right ventricular dilatation,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Systolic dysfunction,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Vulvovaginal candidiasis,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Respiratory failure,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Pneumonia,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Haemoglobin decreased,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Hirsutism,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Electrocardiogram abnormal,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Pain in extremity,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Fall,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Weight increased,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197650823,19765082,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Underdose,,2021,Q4,3,F,20160410.0,20211008.0,20210830,20211019,EXP,,AU-OTSUKA-2021_029683,OTSUKA,,38.0,YR,,F,Y,,,20211019.0,,HP,AU,AU,2021,Q4,Adult
197794802,19779480,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Hypertension,,2021,Q4,2,F,,20210919.0,20210902,20211004,EXP,,PL-PFIZER INC-202101094501,PFIZER,"Dobrowolski, P.. Beta-blockers in the treatment of arterial hypertension - optimal choice in particular clinical settings. Terapia. 2021;6:56-63",67.0,YR,,F,Y,,,20211004.0,,MD,PL,PL,2021,Q4,Elderly
197794802,19779480,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2021,Q4,Hypercholesterolaemia,,2021,Q4,2,F,,20210919.0,20210902,20211004,EXP,,PL-PFIZER INC-202101094501,PFIZER,"Dobrowolski, P.. Beta-blockers in the treatment of arterial hypertension - optimal choice in particular clinical settings. Terapia. 2021;6:56-63",67.0,YR,,F,Y,,,20211004.0,,MD,PL,PL,2021,Q4,Elderly
197797382,19779738,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1720.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2021,Q4,Toe amputation,,2021,Q4,2,F,20180606.0,20211026.0,20210902,20211103,EXP,,CA-AstraZeneca-2021A702842,ASTRAZENECA,,22172.0,DY,,M,Y,124.3,KG,20211103.0,,MD,CA,,2021,Q4,Elderly
197797382,19779738,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1720.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2021,Q4,Foot amputation,,2021,Q4,2,F,20180606.0,20211026.0,20210902,20211103,EXP,,CA-AstraZeneca-2021A702842,ASTRAZENECA,,22172.0,DY,,M,Y,124.3,KG,20211103.0,,MD,CA,,2021,Q4,Elderly
197797382,19779738,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1720.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2021,Q4,Bone disorder,,2021,Q4,2,F,20180606.0,20211026.0,20210902,20211103,EXP,,CA-AstraZeneca-2021A702842,ASTRAZENECA,,22172.0,DY,,M,Y,124.3,KG,20211103.0,,MD,CA,,2021,Q4,Elderly
197797382,19779738,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1720.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2021,Q4,Infection,,2021,Q4,2,F,20180606.0,20211026.0,20210902,20211103,EXP,,CA-AstraZeneca-2021A702842,ASTRAZENECA,,22172.0,DY,,M,Y,124.3,KG,20211103.0,,MD,CA,,2021,Q4,Elderly
197797382,19779738,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1720.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2021,Q4,Disease progression,,2021,Q4,2,F,20180606.0,20211026.0,20210902,20211103,EXP,,CA-AstraZeneca-2021A702842,ASTRAZENECA,,22172.0,DY,,M,Y,124.3,KG,20211103.0,,MD,CA,,2021,Q4,Elderly
197797382,19779738,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1720.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2021,Q4,Ischaemic skin ulcer,,2021,Q4,2,F,20180606.0,20211026.0,20210902,20211103,EXP,,CA-AstraZeneca-2021A702842,ASTRAZENECA,,22172.0,DY,,M,Y,124.3,KG,20211103.0,,MD,CA,,2021,Q4,Elderly
197882234,19788223,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd, Morning",,,U,,,,,,,Tablet,QD,2021,Q4,Pneumonia fungal,,2021,Q4,4,F,20210501.0,20211108.0,20210903,20211119,EXP,,JP-009507513-2108JPN002376J,MERCK,,41.0,YR,,M,Y,,,20211119.0,,MD,JP,JP,2021,Q4,Adult
197882234,19788223,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd, Morning",,,U,,,,,,,Tablet,QD,2021,Q4,Febrile neutropenia,,2021,Q4,4,F,20210501.0,20211108.0,20210903,20211119,EXP,,JP-009507513-2108JPN002376J,MERCK,,41.0,YR,,M,Y,,,20211119.0,,MD,JP,JP,2021,Q4,Adult
197882234,19788223,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd, Morning",,,U,,,,,,,Tablet,QD,2021,Q4,Pneumonia fungal,,2021,Q4,4,F,20210501.0,20211108.0,20210903,20211119,EXP,,JP-009507513-2108JPN002376J,MERCK,,41.0,YR,,M,Y,,,20211119.0,,MD,JP,JP,2021,Q4,Adult
197882234,19788223,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd, Morning",,,U,,,,,,,Tablet,QD,2021,Q4,Pneumonia fungal,,2021,Q4,4,F,20210501.0,20211108.0,20210903,20211119,EXP,,JP-009507513-2108JPN002376J,MERCK,,41.0,YR,,M,Y,,,20211119.0,,MD,JP,JP,2021,Q4,Adult
197882234,19788223,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd, Morning",,,U,,,,,,,Tablet,QD,2021,Q4,Infection,,2021,Q4,4,F,20210501.0,20211108.0,20210903,20211119,EXP,,JP-009507513-2108JPN002376J,MERCK,,41.0,YR,,M,Y,,,20211119.0,,MD,JP,JP,2021,Q4,Adult
197882234,19788223,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd, Morning",,,U,,,,,,,Tablet,QD,2021,Q4,Infection,,2021,Q4,4,F,20210501.0,20211108.0,20210903,20211119,EXP,,JP-009507513-2108JPN002376J,MERCK,,41.0,YR,,M,Y,,,20211119.0,,MD,JP,JP,2021,Q4,Adult
197882234,19788223,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd, Morning",,,U,,,,,,,Tablet,QD,2021,Q4,Infection,,2021,Q4,4,F,20210501.0,20211108.0,20210903,20211119,EXP,,JP-009507513-2108JPN002376J,MERCK,,41.0,YR,,M,Y,,,20211119.0,,MD,JP,JP,2021,Q4,Adult
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Malaise,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Wrong technique in product usage process,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Condition aggravated,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Illness,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Bladder neoplasm,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Confusional state,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,General physical health deterioration,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Prostate cancer metastatic,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Pollakiuria,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Hypotension,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Myocardial infarction,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Dizziness,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Atrophy,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Arrhythmia,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197890273,19789027,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNKNOWN",,,U,,,,,10.0,MG,,,2021,Q4,Insomnia,,2021,Q4,3,F,20210223.0,20211110.0,20210904,20211113,EXP,,NVSC2021PT173461,NOVARTIS,,84.0,YR,,M,Y,66.0,KG,20211113.0,,CN,PT,PT,2021,Q4,Elderly
197983634,19798363,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Concomitant disease aggravated,,2021,Q4,4,F,20210805.0,20211202.0,20210906,20211206,EXP,,NVSJ2021JP013202,NOVARTIS,,80.0,YR,,M,Y,,,20211206.0,,MD,JP,JP,2021,Q4,Elderly
197983634,19798363,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Myocardial infarction,,2021,Q4,4,F,20210805.0,20211202.0,20210906,20211206,EXP,,NVSJ2021JP013202,NOVARTIS,,80.0,YR,,M,Y,,,20211206.0,,MD,JP,JP,2021,Q4,Elderly
197983634,19798363,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,4,F,20210805.0,20211202.0,20210906,20211206,EXP,,NVSJ2021JP013202,NOVARTIS,,80.0,YR,,M,Y,,,20211206.0,,MD,JP,JP,2021,Q4,Elderly
197983634,19798363,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Hyperkalaemia,,2021,Q4,4,F,20210805.0,20211202.0,20210906,20211206,EXP,,NVSJ2021JP013202,NOVARTIS,,80.0,YR,,M,Y,,,20211206.0,,MD,JP,JP,2021,Q4,Elderly
197983634,19798363,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Chronic kidney disease,,2021,Q4,4,F,20210805.0,20211202.0,20210906,20211206,EXP,,NVSJ2021JP013202,NOVARTIS,,80.0,YR,,M,Y,,,20211206.0,,MD,JP,JP,2021,Q4,Elderly
197995513,19799551,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd(1 DF, QD)",,,U,U,,,,,,Tablet,QD,2021,Q4,Renal atrophy,,2021,Q4,3,F,,20210930.0,20210907,20211005,EXP,,PL-MYLANLABS-2021M1058225,MYLAN,,70.0,YR,,M,Y,,,20211005.0,,MD,PL,PL,2021,Q4,Elderly
197995513,19799551,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd(1 DF, QD)",,,U,U,,,,,,Tablet,QD,2021,Q4,Dyspnoea exertional,,2021,Q4,3,F,,20210930.0,20210907,20211005,EXP,,PL-MYLANLABS-2021M1058225,MYLAN,,70.0,YR,,M,Y,,,20211005.0,,MD,PL,PL,2021,Q4,Elderly
197995513,19799551,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd(1 DF, QD)",,,U,U,,,,,,Tablet,QD,2021,Q4,Blood pressure decreased,,2021,Q4,3,F,,20210930.0,20210907,20211005,EXP,,PL-MYLANLABS-2021M1058225,MYLAN,,70.0,YR,,M,Y,,,20211005.0,,MD,PL,PL,2021,Q4,Elderly
197995513,19799551,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd(1 DF, QD)",,,U,U,,,,,,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,3,F,,20210930.0,20210907,20211005,EXP,,PL-MYLANLABS-2021M1058225,MYLAN,,70.0,YR,,M,Y,,,20211005.0,,MD,PL,PL,2021,Q4,Elderly
197995513,19799551,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd(1 DF, QD)",,,U,U,,,,,,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide abnormal,,2021,Q4,3,F,,20210930.0,20210907,20211005,EXP,,PL-MYLANLABS-2021M1058225,MYLAN,,70.0,YR,,M,Y,,,20211005.0,,MD,PL,PL,2021,Q4,Elderly
197995513,19799551,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd(1 DF, QD)",,,U,U,,,,,,Tablet,QD,2021,Q4,Hypertrophy,,2021,Q4,3,F,,20210930.0,20210907,20211005,EXP,,PL-MYLANLABS-2021M1058225,MYLAN,,70.0,YR,,M,Y,,,20211005.0,,MD,PL,PL,2021,Q4,Elderly
197995513,19799551,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd(1 DF, QD)",,,U,U,,,,,,Tablet,QD,2021,Q4,Cardiac failure chronic,,2021,Q4,3,F,,20210930.0,20210907,20211005,EXP,,PL-MYLANLABS-2021M1058225,MYLAN,,70.0,YR,,M,Y,,,20211005.0,,MD,PL,PL,2021,Q4,Elderly
197995513,19799551,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd(1 DF, QD)",,,U,U,,,,,,Tablet,QD,2021,Q4,Urosepsis,,2021,Q4,3,F,,20210930.0,20210907,20211005,EXP,,PL-MYLANLABS-2021M1058225,MYLAN,,70.0,YR,,M,Y,,,20211005.0,,MD,PL,PL,2021,Q4,Elderly
197995513,19799551,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd(1 DF, QD)",,,U,U,,,,,,Tablet,QD,2021,Q4,COVID-19 pneumonia,,2021,Q4,3,F,,20210930.0,20210907,20211005,EXP,,PL-MYLANLABS-2021M1058225,MYLAN,,70.0,YR,,M,Y,,,20211005.0,,MD,PL,PL,2021,Q4,Elderly
198104762,19810476,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,U,,,202293.0,,,Tablet,,2021,Q4,Physical deconditioning,,2021,Q4,2,F,20210101.0,20210930.0,20210909,20211008,EXP,,JP-ASTRAZENECA-2021A715426,ASTRAZENECA,,91.0,YR,,M,Y,,,20211008.0,,MD,JP,JP,2021,Q4,Elderly
198104762,19810476,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,U,,,202293.0,,,Tablet,,2021,Q4,Dehydration,,2021,Q4,2,F,20210101.0,20210930.0,20210909,20211008,EXP,,JP-ASTRAZENECA-2021A715426,ASTRAZENECA,,91.0,YR,,M,Y,,,20211008.0,,MD,JP,JP,2021,Q4,Elderly
198104762,19810476,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Other,10.0mg UNKNOWN,,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Physical deconditioning,,2021,Q4,2,F,20210101.0,20210930.0,20210909,20211008,EXP,,JP-ASTRAZENECA-2021A715426,ASTRAZENECA,,91.0,YR,,M,Y,,,20211008.0,,MD,JP,JP,2021,Q4,Elderly
198104762,19810476,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Other,10.0mg UNKNOWN,,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Dehydration,,2021,Q4,2,F,20210101.0,20210930.0,20210909,20211008,EXP,,JP-ASTRAZENECA-2021A715426,ASTRAZENECA,,91.0,YR,,M,Y,,,20211008.0,,MD,JP,JP,2021,Q4,Elderly
198138083,19813808,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, daily",,,,,,,,5.0,MG,,QD,2021,Q4,Dehydration,,2021,Q4,3,F,20210225.0,20211027.0,20210910,20211105,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202108005130AA,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20211105.0,,CN,JP,JP,2021,Q4,Adult
198138083,19813808,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, daily",,,,,,,,5.0,MG,,QD,2021,Q4,Cholecystitis,,2021,Q4,3,F,20210225.0,20211027.0,20210910,20211105,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202108005130AA,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20211105.0,,CN,JP,JP,2021,Q4,Adult
198138083,19813808,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, daily",,,,,,,,5.0,MG,,QD,2021,Q4,Hepatic steatosis,,2021,Q4,3,F,20210225.0,20211027.0,20210910,20211105,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202108005130AA,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20211105.0,,CN,JP,JP,2021,Q4,Adult
198138083,19813808,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, daily",,,,,,,,5.0,MG,,QD,2021,Q4,Jaundice,,2021,Q4,3,F,20210225.0,20211027.0,20210910,20211105,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202108005130AA,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20211105.0,,CN,JP,JP,2021,Q4,Adult
198138083,19813808,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, daily",,,,,,,,5.0,MG,,QD,2021,Q4,Liver disorder,,2021,Q4,3,F,20210225.0,20211027.0,20210910,20211105,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202108005130AA,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20211105.0,,CN,JP,JP,2021,Q4,Adult
198138472,19813847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,870.0,MG,Y,,ML3028,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Micturition urgency,,2021,Q4,2,F,20210816.0,20210902.0,20210910,20211123,EXP,,CN-AstraZeneca-2021A713017,ASTRAZENECA,,21955.0,DY,,F,Y,70.0,KG,20211123.0,,MD,CN,,2021,Q4,Elderly
198138472,19813847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,870.0,MG,Y,,ML3028,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Dysuria,,2021,Q4,2,F,20210816.0,20210902.0,20210910,20211123,EXP,,CN-AstraZeneca-2021A713017,ASTRAZENECA,,21955.0,DY,,F,Y,70.0,KG,20211123.0,,MD,CN,,2021,Q4,Elderly
198138472,19813847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,870.0,MG,Y,,ML3028,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Pollakiuria,,2021,Q4,2,F,20210816.0,20210902.0,20210910,20211123,EXP,,CN-AstraZeneca-2021A713017,ASTRAZENECA,,21955.0,DY,,F,Y,70.0,KG,20211123.0,,MD,CN,,2021,Q4,Elderly
198138472,19813847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,870.0,MG,Y,,ML3028,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Urinary tract infection,,2021,Q4,2,F,20210816.0,20210902.0,20210910,20211123,EXP,,CN-AstraZeneca-2021A713017,ASTRAZENECA,,21955.0,DY,,F,Y,70.0,KG,20211123.0,,MD,CN,,2021,Q4,Elderly
198138472,19813847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,870.0,MG,Y,,ML3028,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Radiation associated pain,,2021,Q4,2,F,20210816.0,20210902.0,20210910,20211123,EXP,,CN-AstraZeneca-2021A713017,ASTRAZENECA,,21955.0,DY,,F,Y,70.0,KG,20211123.0,,MD,CN,,2021,Q4,Elderly
198141663,19814166,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd, 1 DF, QD (0-1-0)",,,,,,,,10.0,MG,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd, 1 DF, QD (0-1-0)",,,,,,,,10.0,MG,,QD,2021,Q4,Poor quality sleep,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd, 1 DF, QD (0-1-0)",,,,,,,,10.0,MG,,QD,2021,Q4,Gait disturbance,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd, 1 DF, QD (0-1-0)",,,,,,,,10.0,MG,,QD,2021,Q4,Limb discomfort,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd, 1 DF, QD (0-1-0)",,,,,,,,10.0,MG,,QD,2021,Q4,Pain in extremity,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd, 1 DF, QD (0-1-0)",,,,,,,,10.0,MG,,QD,2021,Q4,Listless,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd, 1 DF, QD (0-1-0)",,,,,,,,10.0,MG,,QD,2021,Q4,Blood glucose increased,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd, 1 DF, QD (0-1-0)",,,,,,,,10.0,MG,,QD,2021,Q4,Sciatica,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198141663,19814166,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd, 1 DF, QD (0-1-0)",,,,,,,,10.0,MG,,QD,2021,Q4,Extremity contracture,,2021,Q4,3,F,20210301.0,20211208.0,20210909,20211214,EXP,,ES-MYLANLABS-2021M1059263,MYLAN,,79.0,YR,,F,Y,52.6,KG,20211214.0,,CN,ES,ES,2021,Q4,Elderly
198194422,19819442,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Cardio-respiratory arrest,,2021,Q4,2,F,20210829.0,20211001.0,20210913,20211006,EXP,,NVSJ2021JP013301,NOVARTIS,,83.0,YR,,M,Y,,,20211007.0,,MD,JP,JP,2021,Q4,Elderly
198194422,19819442,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Bradycardia,,2021,Q4,2,F,20210829.0,20211001.0,20210913,20211006,EXP,,NVSJ2021JP013301,NOVARTIS,,83.0,YR,,M,Y,,,20211007.0,,MD,JP,JP,2021,Q4,Elderly
198194422,19819442,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Hyperkalaemia,,2021,Q4,2,F,20210829.0,20211001.0,20210913,20211006,EXP,,NVSJ2021JP013301,NOVARTIS,,83.0,YR,,M,Y,,,20211007.0,,MD,JP,JP,2021,Q4,Elderly
198194422,19819442,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Wrong technique in product usage process,,2021,Q4,2,F,20210829.0,20211001.0,20210913,20211006,EXP,,NVSJ2021JP013301,NOVARTIS,,83.0,YR,,M,Y,,,20211007.0,,MD,JP,JP,2021,Q4,Elderly
198194422,19819442,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Loss of consciousness,,2021,Q4,2,F,20210829.0,20211001.0,20210913,20211006,EXP,,NVSJ2021JP013301,NOVARTIS,,83.0,YR,,M,Y,,,20211007.0,,MD,JP,JP,2021,Q4,Elderly
198194422,19819442,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,2,F,20210829.0,20211001.0,20210913,20211006,EXP,,NVSJ2021JP013301,NOVARTIS,,83.0,YR,,M,Y,,,20211007.0,,MD,JP,JP,2021,Q4,Elderly
198194422,19819442,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Fall,,2021,Q4,2,F,20210829.0,20211001.0,20210913,20211006,EXP,,NVSJ2021JP013301,NOVARTIS,,83.0,YR,,M,Y,,,20211007.0,,MD,JP,JP,2021,Q4,Elderly
198194422,19819442,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Hypoxic-ischaemic encephalopathy,,2021,Q4,2,F,20210829.0,20211001.0,20210913,20211006,EXP,,NVSJ2021JP013301,NOVARTIS,,83.0,YR,,M,Y,,,20211007.0,,MD,JP,JP,2021,Q4,Elderly
198264053,19826405,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2021,Q4,Pseudoaldosteronism,,2021,Q4,3,F,20210728.0,20211005.0,20210914,20211013,EXP,,JP-ROCHE-2908739,ROCHE,,53.0,YR,,F,Y,56.3,KG,20211013.0,,PH,JP,JP,2021,Q4,Adult
198264053,19826405,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2021,Q4,Hypokalaemia,,2021,Q4,3,F,20210728.0,20211005.0,20210914,20211013,EXP,,JP-ROCHE-2908739,ROCHE,,53.0,YR,,F,Y,56.3,KG,20211013.0,,PH,JP,JP,2021,Q4,Adult
198264053,19826405,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2021,Q4,Sepsis,,2021,Q4,3,F,20210728.0,20211005.0,20210914,20211013,EXP,,JP-ROCHE-2908739,ROCHE,,53.0,YR,,F,Y,56.3,KG,20211013.0,,PH,JP,JP,2021,Q4,Adult
198264053,19826405,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2021,Q4,Aspiration,,2021,Q4,3,F,20210728.0,20211005.0,20210914,20211013,EXP,,JP-ROCHE-2908739,ROCHE,,53.0,YR,,F,Y,56.3,KG,20211013.0,,PH,JP,JP,2021,Q4,Adult
198264053,19826405,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2021,Q4,Gastrointestinal stoma necrosis,,2021,Q4,3,F,20210728.0,20211005.0,20210914,20211013,EXP,,JP-ROCHE-2908739,ROCHE,,53.0,YR,,F,Y,56.3,KG,20211013.0,,PH,JP,JP,2021,Q4,Adult
198264053,19826405,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2021,Q4,Febrile neutropenia,,2021,Q4,3,F,20210728.0,20211005.0,20210914,20211013,EXP,,JP-ROCHE-2908739,ROCHE,,53.0,YR,,F,Y,56.3,KG,20211013.0,,PH,JP,JP,2021,Q4,Adult
198264053,19826405,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2021,Q4,Large intestine perforation,,2021,Q4,3,F,20210728.0,20211005.0,20210914,20211013,EXP,,JP-ROCHE-2908739,ROCHE,,53.0,YR,,F,Y,56.3,KG,20211013.0,,PH,JP,JP,2021,Q4,Adult
198269685,19826968,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood triglycerides increased,,2021,Q4,5,F,20210903.0,20211120.0,20210914,20211123,EXP,,NVSC2021AU203112,NOVARTIS,,52.0,YR,,M,Y,,,20211123.0,,MD,AU,AU,2021,Q4,Adult
198408782,19840878,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2021,Q4,Hypothyroidism,,2021,Q4,2,F,,20211005.0,20210916,20211013,EXP,,JP-ROCHE-2911515,ROCHE,,81.0,YR,,M,Y,53.1,KG,20211013.0,,PH,JP,JP,2021,Q4,Elderly
198534723,19853472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tablet in the morning),,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Erythema,,2021,Q4,3,F,20210823.0,20210910.0,20210919,20211004,EXP,,NVSC2021BR208732,NOVARTIS,,53.0,YR,,M,Y,,,20211004.0,,CN,BR,BR,2021,Q4,Adult
198534723,19853472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tablet in the morning),,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Chills,,2021,Q4,3,F,20210823.0,20210910.0,20210919,20211004,EXP,,NVSC2021BR208732,NOVARTIS,,53.0,YR,,M,Y,,,20211004.0,,CN,BR,BR,2021,Q4,Adult
198534723,19853472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tablet in the morning),,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Weight decreased,,2021,Q4,3,F,20210823.0,20210910.0,20210919,20211004,EXP,,NVSC2021BR208732,NOVARTIS,,53.0,YR,,M,Y,,,20211004.0,,CN,BR,BR,2021,Q4,Adult
198534723,19853472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tablet in the morning),,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Emotional distress,,2021,Q4,3,F,20210823.0,20210910.0,20210919,20211004,EXP,,NVSC2021BR208732,NOVARTIS,,53.0,YR,,M,Y,,,20211004.0,,CN,BR,BR,2021,Q4,Adult
198534723,19853472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tablet in the morning),,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Fear,,2021,Q4,3,F,20210823.0,20210910.0,20210919,20211004,EXP,,NVSC2021BR208732,NOVARTIS,,53.0,YR,,M,Y,,,20211004.0,,CN,BR,BR,2021,Q4,Adult
198534723,19853472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tablet in the morning),,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Muscle twitching,,2021,Q4,3,F,20210823.0,20210910.0,20210919,20211004,EXP,,NVSC2021BR208732,NOVARTIS,,53.0,YR,,M,Y,,,20211004.0,,CN,BR,BR,2021,Q4,Adult
198534723,19853472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tablet in the morning),,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Memory impairment,,2021,Q4,3,F,20210823.0,20210910.0,20210919,20211004,EXP,,NVSC2021BR208732,NOVARTIS,,53.0,YR,,M,Y,,,20211004.0,,CN,BR,BR,2021,Q4,Adult
198534723,19853472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tablet in the morning),,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Skin exfoliation,,2021,Q4,3,F,20210823.0,20210910.0,20210919,20211004,EXP,,NVSC2021BR208732,NOVARTIS,,53.0,YR,,M,Y,,,20211004.0,,CN,BR,BR,2021,Q4,Adult
198534723,19853472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tablet in the morning),,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Hunger,,2021,Q4,3,F,20210823.0,20210910.0,20210919,20211004,EXP,,NVSC2021BR208732,NOVARTIS,,53.0,YR,,M,Y,,,20211004.0,,CN,BR,BR,2021,Q4,Adult
198534723,19853472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tablet in the morning),,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Pyrexia,,2021,Q4,3,F,20210823.0,20210910.0,20210919,20211004,EXP,,NVSC2021BR208732,NOVARTIS,,53.0,YR,,M,Y,,,20211004.0,,CN,BR,BR,2021,Q4,Adult
198534723,19853472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tablet in the morning),,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Nasopharyngitis,,2021,Q4,3,F,20210823.0,20210910.0,20210919,20211004,EXP,,NVSC2021BR208732,NOVARTIS,,53.0,YR,,M,Y,,,20211004.0,,CN,BR,BR,2021,Q4,Adult
198534723,19853472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tablet in the morning),,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Dry skin,,2021,Q4,3,F,20210823.0,20210910.0,20210919,20211004,EXP,,NVSC2021BR208732,NOVARTIS,,53.0,YR,,M,Y,,,20211004.0,,CN,BR,BR,2021,Q4,Adult
198546856,19854685,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Tablet,,2021,Q4,Abdominal pain,,2021,Q4,6,F,20210827.0,20211209.0,20210920,20211216,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109001846,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20211216.0,,CN,CN,CN,2021,Q4,Adult
198546856,19854685,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Tablet,,2021,Q4,Nausea,,2021,Q4,6,F,20210827.0,20211209.0,20210920,20211216,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109001846,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20211216.0,,CN,CN,CN,2021,Q4,Adult
198546856,19854685,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Tablet,,2021,Q4,Fatigue,,2021,Q4,6,F,20210827.0,20211209.0,20210920,20211216,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109001846,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20211216.0,,CN,CN,CN,2021,Q4,Adult
198546856,19854685,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Tablet,,2021,Q4,Regurgitation,,2021,Q4,6,F,20210827.0,20211209.0,20210920,20211216,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109001846,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20211216.0,,CN,CN,CN,2021,Q4,Adult
198572392,19857239,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Hypertension,,2021,Q4,2,F,,20211015.0,20210921,20211020,EXP,,NVSJ2021JP013959,NOVARTIS,,63.0,YR,,M,Y,,,20211021.0,,MD,JP,JP,2021,Q4,Adult
198572392,19857239,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Atrial flutter,,2021,Q4,2,F,,20211015.0,20210921,20211020,EXP,,NVSJ2021JP013959,NOVARTIS,,63.0,YR,,M,Y,,,20211021.0,,MD,JP,JP,2021,Q4,Adult
198572392,19857239,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Cardiac failure,,2021,Q4,2,F,,20211015.0,20210921,20211020,EXP,,NVSJ2021JP013959,NOVARTIS,,63.0,YR,,M,Y,,,20211021.0,,MD,JP,JP,2021,Q4,Adult
198587933,19858793,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Pancreatitis,,2021,Q4,3,F,20210804.0,20211117.0,20210920,20211125,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-094563,BRISTOL MYERS SQUIBB,,52.0,YR,,M,Y,86.0,KG,20211125.0,,HP,FR,FR,2021,Q4,Adult
198752013,19875201,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2021,Q4,COVID-19,,2021,Q4,3,F,20210101.0,20210930.0,20210923,20211008,EXP,,"VN-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-127862",BOEHRINGER INGELHEIM,,50.0,YR,A,F,Y,53.5,KG,20211008.0,,MD,VN,VN,2021,Q4,Adult
198820232,19882023,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Metabolic acidosis,,2021,Q4,2,F,20210820.0,20210920.0,20210924,20211005,EXP,PT-INFARMED-T202108-4080,PT-VIFOR (INTERNATIONAL) INC.-VIT-2021-07563,VIFOR,,67.0,YR,,M,Y,54.0,KG,20211006.0,,PH,PT,PT,2021,Q4,Elderly
198911512,19891151,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",,,,,Unknown,,,5.0,MG,,QD,2021,Q4,Hypoglycaemic unconsciousness,,2021,Q4,2,F,20210909.0,20211004.0,20210927,20211014,EXP,,JP-NOVOPROD-849701,NOVO NORDISK,,67.0,YR,,F,Y,,,20211014.0,,MD,JP,JP,2021,Q4,Elderly
198911512,19891151,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",,,,,Unknown,,,5.0,MG,,QD,2021,Q4,Blood creatine phosphokinase increased,,2021,Q4,2,F,20210909.0,20211004.0,20210927,20211014,EXP,,JP-NOVOPROD-849701,NOVO NORDISK,,67.0,YR,,F,Y,,,20211014.0,,MD,JP,JP,2021,Q4,Elderly
198948046,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Hyperuricaemia,,2021,Q4,6,F,,20211206.0,20210928,20211215,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
198948046,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Diabetes mellitus,,2021,Q4,6,F,,20211206.0,20210928,20211215,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
198948046,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,6,F,,20211206.0,20210928,20211215,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
198948046,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Blood pressure decreased,,2021,Q4,6,F,,20211206.0,20210928,20211215,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
198948046,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Obesity,,2021,Q4,6,F,,20211206.0,20210928,20211215,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
198948046,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Abdominal distension,,2021,Q4,6,F,,20211206.0,20210928,20211215,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
198948046,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Oedema peripheral,,2021,Q4,6,F,,20211206.0,20210928,20211215,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
198948046,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Hypertension,,2021,Q4,6,F,,20211206.0,20210928,20211215,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
198948046,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Fatigue,,2021,Q4,6,F,,20211206.0,20210928,20211215,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
198948046,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,6,F,,20211206.0,20210928,20211215,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
198960662,19896066,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,120.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Immune thrombocytopenia,,2021,Q4,2,F,20210917.0,20210928.0,20210929,20211005,EXP,,JP-ASTRAZENECA-2021A744968,ASTRAZENECA,,86.0,YR,,M,Y,,,20211005.0,,MD,JP,JP,2021,Q4,Elderly
198964802,19896480,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2820.0,MG,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Off label use,,2021,Q4,2,F,20210915.0,20210926.0,20210929,20211005,EXP,,SA-ASTRAZENECA-2021A743177,ASTRAZENECA,,17.0,YR,,F,Y,92.0,KG,20211005.0,,MD,SA,SA,2021,Q4,Youth
198964802,19896480,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2820.0,MG,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,2,F,20210915.0,20210926.0,20210929,20211005,EXP,,SA-ASTRAZENECA-2021A743177,ASTRAZENECA,,17.0,YR,,F,Y,92.0,KG,20211005.0,,MD,SA,SA,2021,Q4,Youth
198964842,19896484,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2021,Q4,Erythema multiforme,,2021,Q4,2,F,20210330.0,20211021.0,20210929,20211029,EXP,,JP-ASTRAZENECA-2021A746474,ASTRAZENECA,,80.0,YR,,M,Y,,,20211029.0,,MD,JP,JP,2021,Q4,Elderly
198999304,19899930,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Hypophagia,,2021,Q4,4,F,20210228.0,20211109.0,20210929,20211116,EXP,,JP-AstraZeneca-2021A746403,ASTRAZENECA,"Ariyoshi H, et al.. O-096 An case of the involvement of SGLT2 inhibitor in the onset of hypernatremia. The Japanese Journal of Nephrology. 2021;63(6-W):837.",74.0,YR,,F,Y,45.0,KG,20211116.0,,MD,JP,,2021,Q4,Elderly
198999304,19899930,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Dehydration,,2021,Q4,4,F,20210228.0,20211109.0,20210929,20211116,EXP,,JP-AstraZeneca-2021A746403,ASTRAZENECA,"Ariyoshi H, et al.. O-096 An case of the involvement of SGLT2 inhibitor in the onset of hypernatremia. The Japanese Journal of Nephrology. 2021;63(6-W):837.",74.0,YR,,F,Y,45.0,KG,20211116.0,,MD,JP,,2021,Q4,Elderly
198999304,19899930,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Hypernatraemia,,2021,Q4,4,F,20210228.0,20211109.0,20210929,20211116,EXP,,JP-AstraZeneca-2021A746403,ASTRAZENECA,"Ariyoshi H, et al.. O-096 An case of the involvement of SGLT2 inhibitor in the onset of hypernatremia. The Japanese Journal of Nephrology. 2021;63(6-W):837.",74.0,YR,,F,Y,45.0,KG,20211116.0,,MD,JP,,2021,Q4,Elderly
198999304,19899930,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Infection,,2021,Q4,4,F,20210228.0,20211109.0,20210929,20211116,EXP,,JP-AstraZeneca-2021A746403,ASTRAZENECA,"Ariyoshi H, et al.. O-096 An case of the involvement of SGLT2 inhibitor in the onset of hypernatremia. The Japanese Journal of Nephrology. 2021;63(6-W):837.",74.0,YR,,F,Y,45.0,KG,20211116.0,,MD,JP,,2021,Q4,Elderly
198999304,19899930,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Weight decreased,,2021,Q4,4,F,20210228.0,20211109.0,20210929,20211116,EXP,,JP-AstraZeneca-2021A746403,ASTRAZENECA,"Ariyoshi H, et al.. O-096 An case of the involvement of SGLT2 inhibitor in the onset of hypernatremia. The Japanese Journal of Nephrology. 2021;63(6-W):837.",74.0,YR,,F,Y,45.0,KG,20211116.0,,MD,JP,,2021,Q4,Elderly
198999304,19899930,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Pyrexia,,2021,Q4,4,F,20210228.0,20211109.0,20210929,20211116,EXP,,JP-AstraZeneca-2021A746403,ASTRAZENECA,"Ariyoshi H, et al.. O-096 An case of the involvement of SGLT2 inhibitor in the onset of hypernatremia. The Japanese Journal of Nephrology. 2021;63(6-W):837.",74.0,YR,,F,Y,45.0,KG,20211116.0,,MD,JP,,2021,Q4,Elderly
199040121,19904012,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1260.0,MG,Y,,ML3018,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Electrolyte imbalance,,2021,Q4,1,I,20210911.0,20210924.0,20211001,20211001,EXP,,CN-ASTRAZENECA-2021A750856,ASTRAZENECA,,84.0,YR,,F,Y,38.0,KG,20211001.0,,MD,CN,CN,2021,Q4,Elderly
199045341,19904534,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2021,Q4,Abdominal wall haemorrhage,,2021,Q4,1,I,,20210924.0,20211001,20211001,EXP,,GB-ASTRAZENECA-2021A746780,ASTRAZENECA,,61.0,YR,,M,Y,126.0,KG,20211001.0,,MD,GB,GB,2021,Q4,Adult
199045341,19904534,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2021,Q4,Medication error,,2021,Q4,1,I,,20210924.0,20211001,20211001,EXP,,GB-ASTRAZENECA-2021A746780,ASTRAZENECA,,61.0,YR,,M,Y,126.0,KG,20211001.0,,MD,GB,GB,2021,Q4,Adult
199051944,19905194,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,dose and frequency not provided,,,,,,,,,,,,2021,Q4,Liver carcinoma ruptured,,2021,Q4,4,F,20210923.0,20211119.0,20210930,20211122,EXP,,JP-Eisai Medical Research-EC-2021-100607,EISAI,,81.0,YR,E,M,Y,69.0,KG,20211122.0,,MD,JP,JP,2021,Q4,Elderly
199051944,19905194,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,dose and frequency not provided,,,,,,,,,,,,2021,Q4,Palmar-plantar erythrodysaesthesia syndrome,,2021,Q4,4,F,20210923.0,20211119.0,20210930,20211122,EXP,,JP-Eisai Medical Research-EC-2021-100607,EISAI,,81.0,YR,E,M,Y,69.0,KG,20211122.0,,MD,JP,JP,2021,Q4,Elderly
199052091,19905209,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2007143,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Urine abnormality,,2021,Q4,1,I,20210122.0,20210924.0,20211001,20211001,EXP,,CN-ASTRAZENECA-2021A751314,ASTRAZENECA,,65.0,YR,,F,Y,70.0,KG,20211001.0,,MD,CN,CN,2021,Q4,Elderly
199052091,19905209,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2007143,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Intermittent claudication,,2021,Q4,1,I,20210122.0,20210924.0,20211001,20211001,EXP,,CN-ASTRAZENECA-2021A751314,ASTRAZENECA,,65.0,YR,,F,Y,70.0,KG,20211001.0,,MD,CN,CN,2021,Q4,Elderly
199052091,19905209,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2007143,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Peripheral arterial occlusive disease,,2021,Q4,1,I,20210122.0,20210924.0,20211001,20211001,EXP,,CN-ASTRAZENECA-2021A751314,ASTRAZENECA,,65.0,YR,,F,Y,70.0,KG,20211001.0,,MD,CN,CN,2021,Q4,Elderly
199052091,19905209,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2007143,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Dysuria,,2021,Q4,1,I,20210122.0,20210924.0,20211001,20211001,EXP,,CN-ASTRAZENECA-2021A751314,ASTRAZENECA,,65.0,YR,,F,Y,70.0,KG,20211001.0,,MD,CN,CN,2021,Q4,Elderly
199052091,19905209,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2007143,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Vision blurred,,2021,Q4,1,I,20210122.0,20210924.0,20211001,20211001,EXP,,CN-ASTRAZENECA-2021A751314,ASTRAZENECA,,65.0,YR,,F,Y,70.0,KG,20211001.0,,MD,CN,CN,2021,Q4,Elderly
199052091,19905209,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2007143,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Pain in extremity,,2021,Q4,1,I,20210122.0,20210924.0,20211001,20211001,EXP,,CN-ASTRAZENECA-2021A751314,ASTRAZENECA,,65.0,YR,,F,Y,70.0,KG,20211001.0,,MD,CN,CN,2021,Q4,Elderly
199052091,19905209,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2007143,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Limb discomfort,,2021,Q4,1,I,20210122.0,20210924.0,20211001,20211001,EXP,,CN-ASTRAZENECA-2021A751314,ASTRAZENECA,,65.0,YR,,F,Y,70.0,KG,20211001.0,,MD,CN,CN,2021,Q4,Elderly
199052091,19905209,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2007143,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Pollakiuria,,2021,Q4,1,I,20210122.0,20210924.0,20211001,20211001,EXP,,CN-ASTRAZENECA-2021A751314,ASTRAZENECA,,65.0,YR,,F,Y,70.0,KG,20211001.0,,MD,CN,CN,2021,Q4,Elderly
199052091,19905209,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2007143,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Hypoaesthesia,,2021,Q4,1,I,20210122.0,20210924.0,20211001,20211001,EXP,,CN-ASTRAZENECA-2021A751314,ASTRAZENECA,,65.0,YR,,F,Y,70.0,KG,20211001.0,,MD,CN,CN,2021,Q4,Elderly
199053501,19905350,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Arrhythmia,,2021,Q4,1,I,,20210928.0,20211001,20211001,EXP,,FR-ASTRAZENECA-2021A753003,ASTRAZENECA,,66.0,YR,,M,Y,122.0,KG,20211001.0,,MD,FR,FR,2021,Q4,Elderly
199053501,19905350,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20210928.0,20211001,20211001,EXP,,FR-ASTRAZENECA-2021A753003,ASTRAZENECA,,66.0,YR,,M,Y,122.0,KG,20211001.0,,MD,FR,FR,2021,Q4,Elderly
199053501,19905350,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Cardiac arrest,,2021,Q4,1,I,,20210928.0,20211001,20211001,EXP,,FR-ASTRAZENECA-2021A753003,ASTRAZENECA,,66.0,YR,,M,Y,122.0,KG,20211001.0,,MD,FR,FR,2021,Q4,Elderly
199053501,19905350,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Arrhythmia,,2021,Q4,1,I,,20210928.0,20211001,20211001,EXP,,FR-ASTRAZENECA-2021A753003,ASTRAZENECA,,66.0,YR,,M,Y,122.0,KG,20211001.0,,MD,FR,FR,2021,Q4,Elderly
199053501,19905350,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20210928.0,20211001,20211001,EXP,,FR-ASTRAZENECA-2021A753003,ASTRAZENECA,,66.0,YR,,M,Y,122.0,KG,20211001.0,,MD,FR,FR,2021,Q4,Elderly
199053501,19905350,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Cardiac arrest,,2021,Q4,1,I,,20210928.0,20211001,20211001,EXP,,FR-ASTRAZENECA-2021A753003,ASTRAZENECA,,66.0,YR,,M,Y,122.0,KG,20211001.0,,MD,FR,FR,2021,Q4,Elderly
199053832,19905383,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Myocardial infarction,,2021,Q4,2,F,20150101.0,20211112.0,20210930,20211118,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,60.0,KG,20211118.0,,CN,CO,CO,2021,Q4,Adult
199053832,19905383,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Limb discomfort,,2021,Q4,2,F,20150101.0,20211112.0,20210930,20211118,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,60.0,KG,20211118.0,,CN,CO,CO,2021,Q4,Adult
199053832,19905383,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Thrombosis,,2021,Q4,2,F,20150101.0,20211112.0,20210930,20211118,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,60.0,KG,20211118.0,,CN,CO,CO,2021,Q4,Adult
199053832,19905383,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Hemiparesis,,2021,Q4,2,F,20150101.0,20211112.0,20210930,20211118,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,60.0,KG,20211118.0,,CN,CO,CO,2021,Q4,Adult
199053832,19905383,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Diabetes mellitus,,2021,Q4,2,F,20150101.0,20211112.0,20210930,20211118,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,60.0,KG,20211118.0,,CN,CO,CO,2021,Q4,Adult
199053832,19905383,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Paralysis,,2021,Q4,2,F,20150101.0,20211112.0,20210930,20211118,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,60.0,KG,20211118.0,,CN,CO,CO,2021,Q4,Adult
199053832,19905383,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Demyelination,,2021,Q4,2,F,20150101.0,20211112.0,20210930,20211118,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,60.0,KG,20211118.0,,CN,CO,CO,2021,Q4,Adult
199053832,19905383,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Amnesia,,2021,Q4,2,F,20150101.0,20211112.0,20210930,20211118,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,60.0,KG,20211118.0,,CN,CO,CO,2021,Q4,Adult
199053832,19905383,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Weight decreased,,2021,Q4,2,F,20150101.0,20211112.0,20210930,20211118,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,60.0,KG,20211118.0,,CN,CO,CO,2021,Q4,Adult
199053832,19905383,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Arthralgia,,2021,Q4,2,F,20150101.0,20211112.0,20210930,20211118,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,60.0,KG,20211118.0,,CN,CO,CO,2021,Q4,Adult
199053832,19905383,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Aphasia,,2021,Q4,2,F,20150101.0,20211112.0,20210930,20211118,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,60.0,KG,20211118.0,,CN,CO,CO,2021,Q4,Adult
199053832,19905383,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2021,Q4,Headache,,2021,Q4,2,F,20150101.0,20211112.0,20210930,20211118,EXP,,CO-ASTELLAS-2020US044022,ASTELLAS,,63.0,YR,,F,Y,60.0,KG,20211118.0,,CN,CO,CO,2021,Q4,Adult
199056501,19905650,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,500.0,MG,Y,,2105063,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Hepatic function abnormal,,2021,Q4,1,I,20210916.0,20210923.0,20211001,20211001,EXP,,CN-ASTRAZENECA-2021A748251,ASTRAZENECA,,21199.0,DY,,F,Y,,,20211001.0,,MD,CN,CN,2021,Q4,Elderly
199056511,19905651,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,,MM3066,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Renal impairment,,2021,Q4,1,I,20210913.0,20210925.0,20211001,20211001,EXP,,CN-ASTRAZENECA-2021A752358,ASTRAZENECA,,75.0,YR,,F,Y,62.0,KG,20211001.0,,MD,CN,CN,2021,Q4,Elderly
199056511,19905651,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,,MM3066,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Renal impairment,,2021,Q4,1,I,20210913.0,20210925.0,20211001,20211001,EXP,,CN-ASTRAZENECA-2021A752358,ASTRAZENECA,,75.0,YR,,F,Y,62.0,KG,20211001.0,,MD,CN,CN,2021,Q4,Elderly
199061937,19906193,37,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, start date: ??-MAR-2021",,,U,U,,,,10.0,MG,,,2021,Q4,Mitral valve calcification,,2021,Q4,7,F,20191101.0,20211109.0,20210930,20211117,EXP,,PL-MYLANLABS-2021M1066797,MYLAN,,65.0,YR,,M,Y,,,20211117.0,,MD,PL,PL,2021,Q4,Elderly
199061937,19906193,37,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, start date: ??-MAR-2021",,,U,U,,,,10.0,MG,,,2021,Q4,Heart rate decreased,,2021,Q4,7,F,20191101.0,20211109.0,20210930,20211117,EXP,,PL-MYLANLABS-2021M1066797,MYLAN,,65.0,YR,,M,Y,,,20211117.0,,MD,PL,PL,2021,Q4,Elderly
199061937,19906193,37,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, start date: ??-MAR-2021",,,U,U,,,,10.0,MG,,,2021,Q4,Pulmonary oedema,,2021,Q4,7,F,20191101.0,20211109.0,20210930,20211117,EXP,,PL-MYLANLABS-2021M1066797,MYLAN,,65.0,YR,,M,Y,,,20211117.0,,MD,PL,PL,2021,Q4,Elderly
199061937,19906193,37,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, start date: ??-MAR-2021",,,U,U,,,,10.0,MG,,,2021,Q4,Platelet count decreased,,2021,Q4,7,F,20191101.0,20211109.0,20210930,20211117,EXP,,PL-MYLANLABS-2021M1066797,MYLAN,,65.0,YR,,M,Y,,,20211117.0,,MD,PL,PL,2021,Q4,Elderly
199061937,19906193,37,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, start date: ??-MAR-2021",,,U,U,,,,10.0,MG,,,2021,Q4,Ejection fraction decreased,,2021,Q4,7,F,20191101.0,20211109.0,20210930,20211117,EXP,,PL-MYLANLABS-2021M1066797,MYLAN,,65.0,YR,,M,Y,,,20211117.0,,MD,PL,PL,2021,Q4,Elderly
199061937,19906193,37,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, start date: ??-MAR-2021",,,U,U,,,,10.0,MG,,,2021,Q4,Concomitant disease aggravated,,2021,Q4,7,F,20191101.0,20211109.0,20210930,20211117,EXP,,PL-MYLANLABS-2021M1066797,MYLAN,,65.0,YR,,M,Y,,,20211117.0,,MD,PL,PL,2021,Q4,Elderly
199061937,19906193,37,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, start date: ??-MAR-2021",,,U,U,,,,10.0,MG,,,2021,Q4,Mitral valve thickening,,2021,Q4,7,F,20191101.0,20211109.0,20210930,20211117,EXP,,PL-MYLANLABS-2021M1066797,MYLAN,,65.0,YR,,M,Y,,,20211117.0,,MD,PL,PL,2021,Q4,Elderly
199061937,19906193,37,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, start date: ??-MAR-2021",,,U,U,,,,10.0,MG,,,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,7,F,20191101.0,20211109.0,20210930,20211117,EXP,,PL-MYLANLABS-2021M1066797,MYLAN,,65.0,YR,,M,Y,,,20211117.0,,MD,PL,PL,2021,Q4,Elderly
199061937,19906193,37,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, start date: ??-MAR-2021",,,U,U,,,,10.0,MG,,,2021,Q4,Mitral valve incompetence,,2021,Q4,7,F,20191101.0,20211109.0,20210930,20211117,EXP,,PL-MYLANLABS-2021M1066797,MYLAN,,65.0,YR,,M,Y,,,20211117.0,,MD,PL,PL,2021,Q4,Elderly
199061937,19906193,37,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, start date: ??-MAR-2021",,,U,U,,,,10.0,MG,,,2021,Q4,Haemoglobin decreased,,2021,Q4,7,F,20191101.0,20211109.0,20210930,20211117,EXP,,PL-MYLANLABS-2021M1066797,MYLAN,,65.0,YR,,M,Y,,,20211117.0,,MD,PL,PL,2021,Q4,Elderly
199061937,19906193,37,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, start date: ??-MAR-2021",,,U,U,,,,10.0,MG,,,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,7,F,20191101.0,20211109.0,20210930,20211117,EXP,,PL-MYLANLABS-2021M1066797,MYLAN,,65.0,YR,,M,Y,,,20211117.0,,MD,PL,PL,2021,Q4,Elderly
199061937,19906193,37,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, start date: ??-MAR-2021",,,U,U,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,7,F,20191101.0,20211109.0,20210930,20211117,EXP,,PL-MYLANLABS-2021M1066797,MYLAN,,65.0,YR,,M,Y,,,20211117.0,,MD,PL,PL,2021,Q4,Elderly
199061937,19906193,37,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, start date: ??-MAR-2021",,,U,U,,,,10.0,MG,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,7,F,20191101.0,20211109.0,20210930,20211117,EXP,,PL-MYLANLABS-2021M1066797,MYLAN,,65.0,YR,,M,Y,,,20211117.0,,MD,PL,PL,2021,Q4,Elderly
199068461,19906846,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,410.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20210910.0,20210922.0,20211001,20211001,EXP,,SA-ASTRAZENECA-2021A743405,ASTRAZENECA,,60.0,YR,,M,Y,92.0,KG,20211001.0,,MD,SA,SA,2021,Q4,Adult
199068461,19906846,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,410.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20210910.0,20210922.0,20211001,20211001,EXP,,SA-ASTRAZENECA-2021A743405,ASTRAZENECA,,60.0,YR,,M,Y,92.0,KG,20211001.0,,MD,SA,SA,2021,Q4,Adult
199078821,19907882,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,850.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Skin ulcer,,2021,Q4,1,I,20210730.0,20210909.0,20211001,20211001,EXP,,ES-ASTRAZENECA-2021A724309,ASTRAZENECA,,82.0,YR,,F,Y,75.0,KG,20211001.0,,MD,ES,ES,2021,Q4,Elderly
199078821,19907882,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,850.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Septic shock,,2021,Q4,1,I,20210730.0,20210909.0,20211001,20211001,EXP,,ES-ASTRAZENECA-2021A724309,ASTRAZENECA,,82.0,YR,,F,Y,75.0,KG,20211001.0,,MD,ES,ES,2021,Q4,Elderly
199079811,19907981,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Death,,2021,Q4,1,I,20200812.0,20210928.0,20211001,20211001,EXP,,ZA-ASTRAZENECA-2021A752497,ASTRAZENECA,,22184.0,DY,,M,Y,,,20211001.0,,CN,ZA,ZA,2021,Q4,Elderly
199123891,19912389,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,320.0,MG,,,170119,,,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210909.0,20210924.0,20211004,20211004,EXP,,CN-ASTRAZENECA-2021A752283,ASTRAZENECA,,14977.0,DY,,F,Y,59.0,KG,20211004.0,,MD,CN,CN,2021,Q4,Elderly
199123901,19912390,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2013152 MM3051,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketosis,,2021,Q4,1,I,20210914.0,20210925.0,20211004,20211004,EXP,,CN-ASTRAZENECA-2021A752746,ASTRAZENECA,,19358.0,DY,,M,Y,72.0,KG,20211004.0,,MD,CN,CN,2021,Q4,Elderly
199123901,19912390,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2013152 MM3051,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketosis,,2021,Q4,1,I,20210914.0,20210925.0,20211004,20211004,EXP,,CN-ASTRAZENECA-2021A752746,ASTRAZENECA,,19358.0,DY,,M,Y,72.0,KG,20211004.0,,MD,CN,CN,2021,Q4,Elderly
199125531,19912553,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,U,,,,202293.0,,,Tablet,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20210908.0,20210924.0,20211004,20211004,EXP,,AT-ASTRAZENECA-2021A744887,ASTRAZENECA,,64.0,YR,,M,Y,,,20211004.0,,MD,AT,AT,2021,Q4,Adult
199134472,19913447,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Postoperative thoracic procedure complication,,2021,Q4,2,F,20210101.0,20211001.0,20211004,20211006,EXP,,FR-ASTRAZENECA-2021A753502,ASTRAZENECA,,70.0,YR,,M,Y,,,20211006.0,,MD,FR,FR,2021,Q4,Elderly
199134472,19913447,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Acne,,2021,Q4,2,F,20210101.0,20211001.0,20211004,20211006,EXP,,FR-ASTRAZENECA-2021A753502,ASTRAZENECA,,70.0,YR,,M,Y,,,20211006.0,,MD,FR,FR,2021,Q4,Elderly
199134472,19913447,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Mediastinitis,,2021,Q4,2,F,20210101.0,20211001.0,20211004,20211006,EXP,,FR-ASTRAZENECA-2021A753502,ASTRAZENECA,,70.0,YR,,M,Y,,,20211006.0,,MD,FR,FR,2021,Q4,Elderly
199134472,19913447,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Postoperative thoracic procedure complication,,2021,Q4,2,F,20210101.0,20211001.0,20211004,20211006,EXP,,FR-ASTRAZENECA-2021A753502,ASTRAZENECA,,70.0,YR,,M,Y,,,20211006.0,,MD,FR,FR,2021,Q4,Elderly
199134472,19913447,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Acne,,2021,Q4,2,F,20210101.0,20211001.0,20211004,20211006,EXP,,FR-ASTRAZENECA-2021A753502,ASTRAZENECA,,70.0,YR,,M,Y,,,20211006.0,,MD,FR,FR,2021,Q4,Elderly
199134472,19913447,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Mediastinitis,,2021,Q4,2,F,20210101.0,20211001.0,20211004,20211006,EXP,,FR-ASTRAZENECA-2021A753502,ASTRAZENECA,,70.0,YR,,M,Y,,,20211006.0,,MD,FR,FR,2021,Q4,Elderly
199144901,19914490,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Arrhythmia,,2021,Q4,1,I,,20210927.0,20211004,20211004,EXP,,NVSC2021SI222101,NOVARTIS,,80.0,YR,,M,Y,,,20211004.0,,MD,SI,SI,2021,Q4,Elderly
199214721,19921472,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Soft tissue inflammation,,2021,Q4,1,I,20210901.0,20210928.0,20211005,20211005,EXP,,GB-ASTRAZENECA-2021A750729,ASTRAZENECA,,62.0,YR,,M,Y,122.0,KG,20211005.0,,MD,GB,GB,2021,Q4,Adult
199214721,19921472,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,take one tablet each day,,,,,,,,,,,,2021,Q4,Soft tissue inflammation,,2021,Q4,1,I,20210901.0,20210928.0,20211005,20211005,EXP,,GB-ASTRAZENECA-2021A750729,ASTRAZENECA,,62.0,YR,,M,Y,122.0,KG,20211005.0,,MD,GB,GB,2021,Q4,Adult
199229511,19922951,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Sepsis,,2021,Q4,1,I,20210215.0,20210309.0,20211006,20211006,EXP,,NVSC2021CA058711,NOVARTIS,,66.0,YR,,M,Y,135.0,KG,20211006.0,,MD,CA,CA,2021,Q4,Elderly
199229511,19922951,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Psoriasis,,2021,Q4,1,I,20210215.0,20210309.0,20211006,20211006,EXP,,NVSC2021CA058711,NOVARTIS,,66.0,YR,,M,Y,135.0,KG,20211006.0,,MD,CA,CA,2021,Q4,Elderly
199229511,19922951,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Renal failure,,2021,Q4,1,I,20210215.0,20210309.0,20211006,20211006,EXP,,NVSC2021CA058711,NOVARTIS,,66.0,YR,,M,Y,135.0,KG,20211006.0,,MD,CA,CA,2021,Q4,Elderly
199231931,19923193,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2700.0,MG,Y,,2104148,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Ketosis,,2021,Q4,1,I,20210927.0,20211001.0,20211006,20211006,EXP,,CN-ASTRAZENECA-2021A755726,ASTRAZENECA,,54.0,YR,,M,Y,82.0,KG,20211006.0,,MD,CN,CN,2021,Q4,Adult
199243342,19924334,1,PS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,Non-az generic,,,,,,,,,,Tablet,,2021,Q4,Dry mouth,,2021,Q4,2,F,,20211001.0,20211006,20211011,EXP,,JP-ASTRAZENECA-2021A754632,ASTRAZENECA,,79.0,YR,,M,Y,,,20211011.0,,MD,JP,JP,2021,Q4,Elderly
199243342,19924334,1,PS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,Non-az generic,,,,,,,,,,Tablet,,2021,Q4,Nausea,,2021,Q4,2,F,,20211001.0,20211006,20211011,EXP,,JP-ASTRAZENECA-2021A754632,ASTRAZENECA,,79.0,YR,,M,Y,,,20211011.0,,MD,JP,JP,2021,Q4,Elderly
199243342,19924334,1,PS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,Non-az generic,,,,,,,,,,Tablet,,2021,Q4,Blood creatinine increased,,2021,Q4,2,F,,20211001.0,20211006,20211011,EXP,,JP-ASTRAZENECA-2021A754632,ASTRAZENECA,,79.0,YR,,M,Y,,,20211011.0,,MD,JP,JP,2021,Q4,Elderly
199243342,19924334,1,PS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,Non-az generic,,,,,,,,,,Tablet,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,,20211001.0,20211006,20211011,EXP,,JP-ASTRAZENECA-2021A754632,ASTRAZENECA,,79.0,YR,,M,Y,,,20211011.0,,MD,JP,JP,2021,Q4,Elderly
199243342,19924334,1,PS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,Non-az generic,,,,,,,,,,Tablet,,2021,Q4,Decreased appetite,,2021,Q4,2,F,,20211001.0,20211006,20211011,EXP,,JP-ASTRAZENECA-2021A754632,ASTRAZENECA,,79.0,YR,,M,Y,,,20211011.0,,MD,JP,JP,2021,Q4,Elderly
199244891,19924489,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,155.0,MG,U,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20210901.0,20210928.0,20211006,20211006,EXP,,JP-ASTRAZENECA-2021A754486,ASTRAZENECA,,89.0,YR,,F,Y,,,20211006.0,,MD,JP,JP,2021,Q4,Elderly
199245851,19924585,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,,,,Tablet,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210915.0,20210929.0,20211006,20211006,EXP,,GB-ASTRAZENECA-2021A752732,ASTRAZENECA,,68.0,YR,,M,Y,98.0,KG,20211006.0,,MD,GB,GB,2021,Q4,Elderly
199245881,19924588,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210925.0,20210928.0,20211006,20211006,EXP,,GB-ASTRAZENECA-2021A750678,ASTRAZENECA,,45.0,YR,,M,Y,,,20211006.0,,MD,GB,GB,2021,Q4,Adult
199246511,19924651,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211001.0,20211006,20211006,EXP,,IN-ASTRAZENECA-2021A758312,ASTRAZENECA,Kaur A. Euglycemic diabetic ketoacidosis: A rare side effect of SGLT-2 inhibitor in a patient with type 2 diabetes mellitus with left ventricular dysfunction. 8th Annual Conference of the Malwa Branch of the Association of Physicians of India (MAPICON) - Virtual 2021;,42.0,YR,,F,Y,,,20211006.0,,HP,IN,IN,2021,Q4,Adult
199246521,19924652,1,PS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 mg 1x1,18180.0,MG,N,,,,,10.0,MG,Tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20210917.0,20211001.0,20211006,20211006,EXP,,SE-ASTRAZENECA-2021A755199,ASTRAZENECA,,43.0,YR,,F,Y,65.0,KG,20211006.0,,MD,SE,SE,2021,Q4,Adult
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Cardiac disorder,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Pleural effusion,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Dyspnoea exertional,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Drug interaction,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Rhinorrhoea,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Myocardial infarction,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Heart rate irregular,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Multiple fractures,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Gait disturbance,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Haemorrhage,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Contusion,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Thirst,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Pain,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Back disorder,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Nasopharyngitis,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199259451,19925945,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Mood swings,,2021,Q4,1,I,,20210928.0,20211006,20211006,EXP,,AU-ASTRAZENECA-2021A754115,ASTRAZENECA,,69.0,YR,,M,Y,93.0,KG,20211006.0,,CN,AU,AU,2021,Q4,Elderly
199264521,19926452,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,,QD,2021,Q4,Insulin C-peptide decreased,,2021,Q4,1,I,20150430.0,20211004.0,20211006,20211006,EXP,,SE-ABBVIE-21K-150-4106768-00,ABBVIE,,50.0,YR,,M,Y,,,20211006.0,,MD,SE,SE,2021,Q4,Adult
199264521,19926452,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,20150430.0,20211004.0,20211006,20211006,EXP,,SE-ABBVIE-21K-150-4106768-00,ABBVIE,,50.0,YR,,M,Y,,,20211006.0,,MD,SE,SE,2021,Q4,Adult
199264521,19926452,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,,QD,2021,Q4,Asthenia,,2021,Q4,1,I,20150430.0,20211004.0,20211006,20211006,EXP,,SE-ABBVIE-21K-150-4106768-00,ABBVIE,,50.0,YR,,M,Y,,,20211006.0,,MD,SE,SE,2021,Q4,Adult
199264521,19926452,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20150430.0,20211004.0,20211006,20211006,EXP,,SE-ABBVIE-21K-150-4106768-00,ABBVIE,,50.0,YR,,M,Y,,,20211006.0,,MD,SE,SE,2021,Q4,Adult
199264521,19926452,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,,QD,2021,Q4,Dehydration,,2021,Q4,1,I,20150430.0,20211004.0,20211006,20211006,EXP,,SE-ABBVIE-21K-150-4106768-00,ABBVIE,,50.0,YR,,M,Y,,,20211006.0,,MD,SE,SE,2021,Q4,Adult
199264521,19926452,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,,QD,2021,Q4,Drug interaction,,2021,Q4,1,I,20150430.0,20211004.0,20211006,20211006,EXP,,SE-ABBVIE-21K-150-4106768-00,ABBVIE,,50.0,YR,,M,Y,,,20211006.0,,MD,SE,SE,2021,Q4,Adult
199264521,19926452,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,,QD,2021,Q4,Eating disorder,,2021,Q4,1,I,20150430.0,20211004.0,20211006,20211006,EXP,,SE-ABBVIE-21K-150-4106768-00,ABBVIE,,50.0,YR,,M,Y,,,20211006.0,,MD,SE,SE,2021,Q4,Adult
199264521,19926452,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20150430.0,20211004.0,20211006,20211006,EXP,,SE-ABBVIE-21K-150-4106768-00,ABBVIE,,50.0,YR,,M,Y,,,20211006.0,,MD,SE,SE,2021,Q4,Adult
199266703,19926670,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form=1 unit NOS,,,U,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,3,F,20210925.0,20211025.0,20211006,20211101,EXP,,AR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-099741,BRISTOL MYERS SQUIBB,,51.0,YR,,M,Y,86.0,KG,20211101.0,,HP,AR,AR,2021,Q4,Adult
199266703,19926670,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form=1 unit NOS,,,U,,,,,,,,,2021,Q4,Urinary tract obstruction,,2021,Q4,3,F,20210925.0,20211025.0,20211006,20211101,EXP,,AR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-099741,BRISTOL MYERS SQUIBB,,51.0,YR,,M,Y,86.0,KG,20211101.0,,HP,AR,AR,2021,Q4,Adult
199271782,19927178,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Oedema,,2021,Q4,2,F,20210524.0,20211214.0,20211006,20211221,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20211221.0,,MD,JP,JP,2021,Q4,Elderly
199271782,19927178,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Ventricular hyperkinesia,,2021,Q4,2,F,20210524.0,20211214.0,20211006,20211221,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20211221.0,,MD,JP,JP,2021,Q4,Elderly
199271782,19927178,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Dyspnoea exertional,,2021,Q4,2,F,20210524.0,20211214.0,20211006,20211221,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20211221.0,,MD,JP,JP,2021,Q4,Elderly
199271782,19927178,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac amyloidosis,,2021,Q4,2,F,20210524.0,20211214.0,20211006,20211221,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20211221.0,,MD,JP,JP,2021,Q4,Elderly
199271782,19927178,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac hypertrophy,,2021,Q4,2,F,20210524.0,20211214.0,20211006,20211221,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20211221.0,,MD,JP,JP,2021,Q4,Elderly
199271782,19927178,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Blood pressure decreased,,2021,Q4,2,F,20210524.0,20211214.0,20211006,20211221,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20211221.0,,MD,JP,JP,2021,Q4,Elderly
199271782,19927178,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,2,F,20210524.0,20211214.0,20211006,20211221,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20211221.0,,MD,JP,JP,2021,Q4,Elderly
199287201,19928720,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,unknown,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20200601.0,20210928.0,20211007,20211007,EXP,,CN-ASTRAZENECA-2021A754766,ASTRAZENECA,"Linna S, Chengxiang W. Euglycemic diabetic ketoacidosis induced by SGLT??2 inhibitors in a patient with type 2 diabetes mellitus. Chin J Gen Pract 2021;20(9):",24.0,YR,,M,Y,,,20211007.0,,MD,CN,CN,2021,Q4,Young Adult
199287231,19928723,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,D,,,,202293.0,,,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20210928.0,20211007,20211007,EXP,,JP-ASTRAZENECA-2021A754801,ASTRAZENECA,"Watahiki M, et al. A case of euglycaemic diabetic ketoacidosis due to SGLT2 inhibitor drug.. The 95th Chubu Regional Meeting of the Japan Diabetes Society; 2021;45-.",38.0,YR,,F,Y,,,20211007.0,,MD,JP,JP,2021,Q4,Adult
199287252,19928725,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7430.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,2,F,20210912.0,20211012.0,20211007,20211015,EXP,,ES-ASTRAZENECA-2021A756743,ASTRAZENECA,,44.0,YR,,F,Y,95.0,KG,20211015.0,,MD,ES,ES,2021,Q4,Adult
199287252,19928725,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7430.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Lactic acidosis,,2021,Q4,2,F,20210912.0,20211012.0,20211007,20211015,EXP,,ES-ASTRAZENECA-2021A756743,ASTRAZENECA,,44.0,YR,,F,Y,95.0,KG,20211015.0,,MD,ES,ES,2021,Q4,Adult
1993161310,19931613,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Herpes zoster,,2021,Q4,10,F,20210101.0,20211209.0,20211007,20211222,EXP,,DE-PFIZER INC-202101273507,PFIZER,,52.0,YR,,M,Y,,,20211222.0,,MD,DE,DE,2021,Q4,Adult
1993161310,19931613,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Rash,,2021,Q4,10,F,20210101.0,20211209.0,20211007,20211222,EXP,,DE-PFIZER INC-202101273507,PFIZER,,52.0,YR,,M,Y,,,20211222.0,,MD,DE,DE,2021,Q4,Adult
1993161310,19931613,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Disease recurrence,,2021,Q4,10,F,20210101.0,20211209.0,20211007,20211222,EXP,,DE-PFIZER INC-202101273507,PFIZER,,52.0,YR,,M,Y,,,20211222.0,,MD,DE,DE,2021,Q4,Adult
1993161310,19931613,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Vaccination failure,,2021,Q4,10,F,20210101.0,20211209.0,20211007,20211222,EXP,,DE-PFIZER INC-202101273507,PFIZER,,52.0,YR,,M,Y,,,20211222.0,,MD,DE,DE,2021,Q4,Adult
1993161310,19931613,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Pain,,2021,Q4,10,F,20210101.0,20211209.0,20211007,20211222,EXP,,DE-PFIZER INC-202101273507,PFIZER,,52.0,YR,,M,Y,,,20211222.0,,MD,DE,DE,2021,Q4,Adult
199337411,19933741,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Shock,,2021,Q4,1,I,,20210928.0,20211008,20211008,EXP,,US-ASTRAZENECA-2021A754439,ASTRAZENECA,"Cha BM, Davoudi R, DiVIta MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings 2021;000:1-4 (In Press).",55.0,YR,,M,Y,,,20211008.0,,MD,US,US,2021,Q4,Adult
199337411,19933741,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20210928.0,20211008,20211008,EXP,,US-ASTRAZENECA-2021A754439,ASTRAZENECA,"Cha BM, Davoudi R, DiVIta MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings 2021;000:1-4 (In Press).",55.0,YR,,M,Y,,,20211008.0,,MD,US,US,2021,Q4,Adult
199337411,19933741,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20210928.0,20211008,20211008,EXP,,US-ASTRAZENECA-2021A754439,ASTRAZENECA,"Cha BM, Davoudi R, DiVIta MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings 2021;000:1-4 (In Press).",55.0,YR,,M,Y,,,20211008.0,,MD,US,US,2021,Q4,Adult
199337411,19933741,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Shock,,2021,Q4,1,I,,20210928.0,20211008,20211008,EXP,,US-ASTRAZENECA-2021A754439,ASTRAZENECA,"Cha BM, Davoudi R, DiVIta MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings 2021;000:1-4 (In Press).",55.0,YR,,M,Y,,,20211008.0,,MD,US,US,2021,Q4,Adult
199337411,19933741,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20210928.0,20211008,20211008,EXP,,US-ASTRAZENECA-2021A754439,ASTRAZENECA,"Cha BM, Davoudi R, DiVIta MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings 2021;000:1-4 (In Press).",55.0,YR,,M,Y,,,20211008.0,,MD,US,US,2021,Q4,Adult
199337411,19933741,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20210928.0,20211008,20211008,EXP,,US-ASTRAZENECA-2021A754439,ASTRAZENECA,"Cha BM, Davoudi R, DiVIta MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings 2021;000:1-4 (In Press).",55.0,YR,,M,Y,,,20211008.0,,MD,US,US,2021,Q4,Adult
199337421,19933742,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,3420.0,MG,Y,,asked but unknown,,,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210918.0,20211004.0,20211008,20211008,EXP,,DK-ASTRAZENECA-2021A756680,ASTRAZENECA,,48.0,YR,,M,Y,,,20211008.0,,MD,DK,DK,2021,Q4,Adult
199341062,19934106,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,,,,,,10.0,MG,,,2021,Q4,Oliguria,,2021,Q4,2,F,20210923.0,20211010.0,20211008,20211014,EXP,,IL-PFIZER INC-202101316503,PFIZER,,90.0,YR,,M,Y,,,20211014.0,,MD,IL,IL,2021,Q4,Elderly
199341693,19934169,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,5.0,MG,,QD,2021,Q4,Dehydration,,2021,Q4,3,F,20210901.0,20211025.0,20211008,20211028,EXP,,JP-EMD SERONO-9271205,EMD SERONO INC,,30.0,YR,A,F,Y,,,20211028.0,,PH,JP,JP,2021,Q4,Young Adult
199341693,19934169,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,5.0,MG,,QD,2021,Q4,Diarrhoea,,2021,Q4,3,F,20210901.0,20211025.0,20211008,20211028,EXP,,JP-EMD SERONO-9271205,EMD SERONO INC,,30.0,YR,A,F,Y,,,20211028.0,,PH,JP,JP,2021,Q4,Young Adult
199343493,19934349,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q4,Syncope,,2021,Q4,3,F,,20211220.0,20211008,20211228,EXP,,JP-OTSUKA-2021_034451,OTSUKA,,94.0,YR,,F,Y,,,20211228.0,,PH,JP,JP,2021,Q4,Elderly
199343493,19934349,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q4,Loss of consciousness,,2021,Q4,3,F,,20211220.0,20211008,20211228,EXP,,JP-OTSUKA-2021_034451,OTSUKA,,94.0,YR,,F,Y,,,20211228.0,,PH,JP,JP,2021,Q4,Elderly
199344941,19934494,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2021,Q4,Dizziness,,2021,Q4,1,I,,20210930.0,20211008,20211008,EXP,,FR-ASTRAZENECA-2021A759370,ASTRAZENECA,,70.0,YR,,F,Y,,,20211008.0,,MD,FR,FR,2021,Q4,Elderly
199344941,19934494,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2021,Q4,Asthenia,,2021,Q4,1,I,,20210930.0,20211008,20211008,EXP,,FR-ASTRAZENECA-2021A759370,ASTRAZENECA,,70.0,YR,,F,Y,,,20211008.0,,MD,FR,FR,2021,Q4,Elderly
199344941,19934494,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2021,Q4,Dizziness,,2021,Q4,1,I,,20210930.0,20211008,20211008,EXP,,FR-ASTRAZENECA-2021A759370,ASTRAZENECA,,70.0,YR,,F,Y,,,20211008.0,,MD,FR,FR,2021,Q4,Elderly
199344941,19934494,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2021,Q4,Asthenia,,2021,Q4,1,I,,20210930.0,20211008,20211008,EXP,,FR-ASTRAZENECA-2021A759370,ASTRAZENECA,,70.0,YR,,F,Y,,,20211008.0,,MD,FR,FR,2021,Q4,Elderly
199346151,19934615,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,Y,MM3603,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Vulvovaginal pruritus,,2021,Q4,1,I,20210720.0,20211001.0,20211008,20211008,EXP,,CN-ASTRAZENECA-2021A761453,ASTRAZENECA,,21080.0,DY,,F,Y,67.0,KG,20211008.0,,MD,CN,CN,2021,Q4,Elderly
199346151,19934615,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,Y,MM3603,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic complication,,2021,Q4,1,I,20210720.0,20211001.0,20211008,20211008,EXP,,CN-ASTRAZENECA-2021A761453,ASTRAZENECA,,21080.0,DY,,F,Y,67.0,KG,20211008.0,,MD,CN,CN,2021,Q4,Elderly
199361322,19936132,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,,QD,2021,Q4,Ejection fraction decreased,,2021,Q4,2,F,20210501.0,20211011.0,20211009,20211019,EXP,,NVSC2021EG227157,NOVARTIS,,61.0,YR,,M,Y,,,20211019.0,,CN,EG,EG,2021,Q4,Adult
199361322,19936132,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,,QD,2021,Q4,Lung disorder,,2021,Q4,2,F,20210501.0,20211011.0,20211009,20211019,EXP,,NVSC2021EG227157,NOVARTIS,,61.0,YR,,M,Y,,,20211019.0,,CN,EG,EG,2021,Q4,Adult
199361322,19936132,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,,QD,2021,Q4,Allergic bronchitis,,2021,Q4,2,F,20210501.0,20211011.0,20211009,20211019,EXP,,NVSC2021EG227157,NOVARTIS,,61.0,YR,,M,Y,,,20211019.0,,CN,EG,EG,2021,Q4,Adult
199361322,19936132,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,,QD,2021,Q4,Productive cough,,2021,Q4,2,F,20210501.0,20211011.0,20211009,20211019,EXP,,NVSC2021EG227157,NOVARTIS,,61.0,YR,,M,Y,,,20211019.0,,CN,EG,EG,2021,Q4,Adult
199361322,19936132,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,,QD,2021,Q4,Fatigue,,2021,Q4,2,F,20210501.0,20211011.0,20211009,20211019,EXP,,NVSC2021EG227157,NOVARTIS,,61.0,YR,,M,Y,,,20211019.0,,CN,EG,EG,2021,Q4,Adult
199361322,19936132,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,,QD,2021,Q4,COVID-19,,2021,Q4,2,F,20210501.0,20211011.0,20211009,20211019,EXP,,NVSC2021EG227157,NOVARTIS,,61.0,YR,,M,Y,,,20211019.0,,CN,EG,EG,2021,Q4,Adult
199361322,19936132,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,,QD,2021,Q4,Incorrect dose administered,,2021,Q4,2,F,20210501.0,20211011.0,20211009,20211019,EXP,,NVSC2021EG227157,NOVARTIS,,61.0,YR,,M,Y,,,20211019.0,,CN,EG,EG,2021,Q4,Adult
199361322,19936132,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,,QD,2021,Q4,Dyspnoea exertional,,2021,Q4,2,F,20210501.0,20211011.0,20211009,20211019,EXP,,NVSC2021EG227157,NOVARTIS,,61.0,YR,,M,Y,,,20211019.0,,CN,EG,EG,2021,Q4,Adult
199399912,19939991,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Blood pressure increased,,2021,Q4,2,F,20210705.0,20211012.0,20211011,20211020,EXP,,KR-ASTRAZENECA-2021A764570,ASTRAZENECA,,78.0,YR,,F,Y,,,20211020.0,,MD,KR,KR,2021,Q4,Elderly
199399912,19939991,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Dyspnoea,,2021,Q4,2,F,20210705.0,20211012.0,20211011,20211020,EXP,,KR-ASTRAZENECA-2021A764570,ASTRAZENECA,,78.0,YR,,F,Y,,,20211020.0,,MD,KR,KR,2021,Q4,Elderly
199399912,19939991,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Hepatic enzyme increased,,2021,Q4,2,F,20210705.0,20211012.0,20211011,20211020,EXP,,KR-ASTRAZENECA-2021A764570,ASTRAZENECA,,78.0,YR,,F,Y,,,20211020.0,,MD,KR,KR,2021,Q4,Elderly
199405811,19940581,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210323.0,20211005.0,20211011,20211011,EXP,,DE-ASTRAZENECA-2021A758621,ASTRAZENECA,,62.0,YR,,M,Y,87.0,KG,20211011.0,,MD,DE,DE,2021,Q4,Adult
199405891,19940589,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6400.0,MG,Y,,,,,10.0,MG,,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20210929.0,20211001.0,20211011,20211011,EXP,,GB-ASTRAZENECA-2021A756325,ASTRAZENECA,,59.0,YR,,M,Y,105.0,KG,20211011.0,,MD,GB,GB,2021,Q4,Adult
199427141,19942714,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Depression,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,AU-ASTRAZENECA-2021A766095,ASTRAZENECA,,73.0,YR,,M,Y,,,20211012.0,,MD,AU,AU,2021,Q4,Elderly
199427141,19942714,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Chronic kidney disease,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,AU-ASTRAZENECA-2021A766095,ASTRAZENECA,,73.0,YR,,M,Y,,,20211012.0,,MD,AU,AU,2021,Q4,Elderly
199453591,19945359,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,U,,,202293.0,,,Tablet,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211003.0,20211012,20211012,EXP,,SA-ASTRAZENECA-2021A757831,ASTRAZENECA,Abdullah M. Alguwaihes. Safety of Dapagliflozin in Patients with Type 2. Diabetes Therapy 2021;1979-1992.,59.0,YR,,M,Y,74.5,KG,20211012.0,,MD,SA,SA,2021,Q4,Adult
199458882,19945888,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10,,,Y,,,,202293.0,,,,,2021,Q4,Medication error,,2021,Q4,2,F,20211003.0,20211008.0,20211012,20211013,EXP,,GB-ASTRAZENECA-2021A766476,ASTRAZENECA,,58.0,YR,,M,Y,,,20211013.0,,MD,GB,GB,2021,Q4,Adult
199458882,19945888,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10,,,Y,,,,202293.0,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,2,F,20211003.0,20211008.0,20211012,20211013,EXP,,GB-ASTRAZENECA-2021A766476,ASTRAZENECA,,58.0,YR,,M,Y,,,20211013.0,,MD,GB,GB,2021,Q4,Adult
199462931,19946293,10,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|1000 mg, 1-0-0-1, Tabletten",,,,,,,,,,Tablet,,2021,Q4,Hyperkalaemia,,2021,Q4,1,I,20210326.0,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070426,MYLAN,,66.0,YR,,F,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199462931,19946293,10,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|1000 mg, 1-0-0-1, Tabletten",,,,,,,,,,Tablet,,2021,Q4,Fall,,2021,Q4,1,I,20210326.0,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070426,MYLAN,,66.0,YR,,F,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199462931,19946293,10,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|1000 mg, 1-0-0-1, Tabletten",,,,,,,,,,Tablet,,2021,Q4,Medication error,,2021,Q4,1,I,20210326.0,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070426,MYLAN,,66.0,YR,,F,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199462931,19946293,10,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|1000 mg, 1-0-0-1, Tabletten",,,,,,,,,,Tablet,,2021,Q4,Sinus bradycardia,,2021,Q4,1,I,20210326.0,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070426,MYLAN,,66.0,YR,,F,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199480001,19948000,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,U,,unknown,,,,,Tablet,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20210927.0,20210929.0,20211012,20211012,EXP,,DE-ASTRAZENECA-2021A752876,ASTRAZENECA,,26751.0,DY,,F,Y,62.0,KG,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199491751,19949175,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,unk,,,10.0,MG,,QD,2021,Q4,Haemochromatosis,,2021,Q4,1,I,,20211002.0,20211013,20211013,EXP,,BR-NOVOPROD-854114,NOVO NORDISK,,63.0,YR,,M,Y,114.0,KG,20211013.0,,MD,BR,BR,2021,Q4,Adult
199501471,19950147,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,1,I,,20211005.0,20211013,20211013,EXP,,FR-ASTRAZENECA-2021A765439,ASTRAZENECA,,60.0,YR,,F,Y,,,20211013.0,,MD,FR,FR,2021,Q4,Adult
199501471,19950147,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,,20211005.0,20211013,20211013,EXP,,FR-ASTRAZENECA-2021A765439,ASTRAZENECA,,60.0,YR,,F,Y,,,20211013.0,,MD,FR,FR,2021,Q4,Adult
199501471,19950147,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Cardiac flutter,,2021,Q4,1,I,,20211005.0,20211013,20211013,EXP,,FR-ASTRAZENECA-2021A765439,ASTRAZENECA,,60.0,YR,,F,Y,,,20211013.0,,MD,FR,FR,2021,Q4,Adult
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Drug interaction,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Mental disorder,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Haemorrhage,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Myocardial infarction,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Heart rate irregular,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Contusion,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Mood swings,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Rhinorrhoea,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Thirst,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Hypervolaemia,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Pain,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199506372,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211207.0,20211013,20211220,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20211220.0,,CN,AU,AU,2021,Q4,Elderly
199507461,19950746,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Optic ischaemic neuropathy,,2021,Q4,1,I,,20211004.0,20211013,20211013,EXP,,AU-ROCHE-2931400,ROCHE,"Berry E, Mullany S, Quinlivan A, Craig A, New-Tolley J, Slattery J, Sukumaran S, Klebe S, Craig J, Siggs O and Wechalekar M. Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy. Journal of immunotherapy 2021 Sep 27;:1537-4513.",82.0,YR,,M,Y,,,20211013.0,,HP,AU,AU,2021,Q4,Elderly
199507461,19950746,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Giant cell arteritis,,2021,Q4,1,I,,20211004.0,20211013,20211013,EXP,,AU-ROCHE-2931400,ROCHE,"Berry E, Mullany S, Quinlivan A, Craig A, New-Tolley J, Slattery J, Sukumaran S, Klebe S, Craig J, Siggs O and Wechalekar M. Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy. Journal of immunotherapy 2021 Sep 27;:1537-4513.",82.0,YR,,M,Y,,,20211013.0,,HP,AU,AU,2021,Q4,Elderly
199516539,19951653,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2021,Q4,Oedema peripheral,,2021,Q4,9,F,,20211203.0,20211014,20211216,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20211216.0,,MD,PL,PL,2021,Q4,Adult
199516539,19951653,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,9,F,,20211203.0,20211014,20211216,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20211216.0,,MD,PL,PL,2021,Q4,Adult
199516539,19951653,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2021,Q4,Blood pressure decreased,,2021,Q4,9,F,,20211203.0,20211014,20211216,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20211216.0,,MD,PL,PL,2021,Q4,Adult
199516539,19951653,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2021,Q4,Obesity,,2021,Q4,9,F,,20211203.0,20211014,20211216,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20211216.0,,MD,PL,PL,2021,Q4,Adult
199516539,19951653,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2021,Q4,Hypertension,,2021,Q4,9,F,,20211203.0,20211014,20211216,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20211216.0,,MD,PL,PL,2021,Q4,Adult
199516539,19951653,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2021,Q4,Fatigue,,2021,Q4,9,F,,20211203.0,20211014,20211216,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20211216.0,,MD,PL,PL,2021,Q4,Adult
199516539,19951653,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,9,F,,20211203.0,20211014,20211216,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20211216.0,,MD,PL,PL,2021,Q4,Adult
199516539,19951653,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2021,Q4,Hyperuricaemia,,2021,Q4,9,F,,20211203.0,20211014,20211216,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20211216.0,,MD,PL,PL,2021,Q4,Adult
199516539,19951653,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2021,Q4,Diabetes mellitus,,2021,Q4,9,F,,20211203.0,20211014,20211216,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20211216.0,,MD,PL,PL,2021,Q4,Adult
199516539,19951653,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2021,Q4,Abdominal distension,,2021,Q4,9,F,,20211203.0,20211014,20211216,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20211216.0,,MD,PL,PL,2021,Q4,Adult
199537571,19953757,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Arrhythmia,,2021,Q4,1,I,,20211008.0,20211014,20211014,EXP,,SI-BAUSCH-BL-2021-034218,BAUSCH AND LOMB,,80.0,YR,,M,Y,,,20211014.0,,MD,SI,SI,2021,Q4,Elderly
199548831,19954883,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2021,Q4,Dizziness,,2021,Q4,1,I,20210901.0,20210929.0,20211014,20211014,PER,,ZA-LUPIN PHARMACEUTICALS INC.-2021-19000,LUPIN,,71.0,YR,,F,Y,,,20211014.0,,CN,ZA,ZA,2021,Q4,Elderly
199555992,19955599,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 mg, daily",,,U,,,,,5.0,MG,,QD,2021,Q4,Dehydration,,2021,Q4,2,F,20210406.0,20211019.0,20211014,20211029,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202110002445,ELI LILLY AND CO,,30.0,YR,,F,Y,,,20211029.0,,CN,JP,JP,2021,Q4,Young Adult
199555992,19955599,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 mg, daily",,,U,,,,,5.0,MG,,QD,2021,Q4,Diarrhoea,,2021,Q4,2,F,20210406.0,20211019.0,20211014,20211029,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202110002445,ELI LILLY AND CO,,30.0,YR,,F,Y,,,20211029.0,,CN,JP,JP,2021,Q4,Young Adult
199558121,19955812,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210915.0,20211004.0,20211014,20211014,EXP,,GB-ASTRAZENECA-2021A758249,ASTRAZENECA,,73.0,YR,,M,Y,,,20211014.0,,MD,GB,GB,2021,Q4,Elderly
199558162,19955816,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,20210427.0,20211022.0,20211014,20211101,EXP,,JP-AstraZeneca-2021A765456,ASTRAZENECA,,28.0,YR,,M,Y,,,20211101.0,,MD,JP,,2021,Q4,Young Adult
199559631,19955963,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,620.0,MG,Y,U,MM0082,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20210806.0,20211008.0,20211014,20211014,EXP,,MX-ASTRAZENECA-2021A767695,ASTRAZENECA,,2412.0,WK,,F,Y,96.0,KG,20211014.0,,CN,MX,MX,2021,Q4,Elderly
199559631,19955963,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,620.0,MG,Y,U,MM0082,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210806.0,20211008.0,20211014,20211014,EXP,,MX-ASTRAZENECA-2021A767695,ASTRAZENECA,,2412.0,WK,,F,Y,96.0,KG,20211014.0,,CN,MX,MX,2021,Q4,Elderly
199559642,19955964,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,,5.0,MG,Tablet,,2021,Q4,Ketoacidosis,,2021,Q4,2,F,20210630.0,20211022.0,20211014,20211101,EXP,,JP-AstraZeneca-2021A765683,ASTRAZENECA,,29.0,YR,,F,Y,,,20211101.0,,MD,JP,,2021,Q4,Young Adult
199568332,19956833,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,20210905.0,20211013.0,20211014,20211021,EXP,,MY-ASTRAZENECA-2021A767490,ASTRAZENECA,,2926.0,WK,,F,Y,60.0,KG,20211021.0,,MD,MY,MY,2021,Q4,Elderly
199568332,19956833,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Dehydration,,2021,Q4,2,F,20210905.0,20211013.0,20211014,20211021,EXP,,MY-ASTRAZENECA-2021A767490,ASTRAZENECA,,2926.0,WK,,F,Y,60.0,KG,20211021.0,,MD,MY,MY,2021,Q4,Elderly
199568332,19956833,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Illness,,2021,Q4,2,F,20210905.0,20211013.0,20211014,20211021,EXP,,MY-ASTRAZENECA-2021A767490,ASTRAZENECA,,2926.0,WK,,F,Y,60.0,KG,20211021.0,,MD,MY,MY,2021,Q4,Elderly
199568332,19956833,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Urosepsis,,2021,Q4,2,F,20210905.0,20211013.0,20211014,20211021,EXP,,MY-ASTRAZENECA-2021A767490,ASTRAZENECA,,2926.0,WK,,F,Y,60.0,KG,20211021.0,,MD,MY,MY,2021,Q4,Elderly
199572931,19957293,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210301.0,20211007.0,20211014,20211014,EXP,,JP-ASTRAZENECA-2021A767227,ASTRAZENECA,,67.0,YR,,F,Y,,,20211014.0,,MD,JP,JP,2021,Q4,Elderly
199572931,19957293,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20210301.0,20211007.0,20211014,20211014,EXP,,JP-ASTRAZENECA-2021A767227,ASTRAZENECA,,67.0,YR,,F,Y,,,20211014.0,,MD,JP,JP,2021,Q4,Elderly
199572931,19957293,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20210301.0,20211007.0,20211014,20211014,EXP,,JP-ASTRAZENECA-2021A767227,ASTRAZENECA,,67.0,YR,,F,Y,,,20211014.0,,MD,JP,JP,2021,Q4,Elderly
199580111,19958011,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2103149,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Nausea,,2021,Q4,1,I,20210823.0,20211009.0,20211015,20211015,EXP,,CN-ASTRAZENECA-2021A771925,ASTRAZENECA,,28742.0,DY,,F,Y,60.0,KG,20211015.0,,MD,CN,CN,2021,Q4,Elderly
199580111,19958011,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2103149,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Vomiting,,2021,Q4,1,I,20210823.0,20211009.0,20211015,20211015,EXP,,CN-ASTRAZENECA-2021A771925,ASTRAZENECA,,28742.0,DY,,F,Y,60.0,KG,20211015.0,,MD,CN,CN,2021,Q4,Elderly
199585112,19958511,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Joint injury,,2021,Q4,2,F,20210920.0,20211217.0,20211015,20211224,EXP,,JP-AstraZeneca-2021A768255,ASTRAZENECA,,69.0,YR,,M,Y,71.0,KG,20211224.0,,MD,JP,,2021,Q4,Elderly
199585112,19958511,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Spinal column injury,,2021,Q4,2,F,20210920.0,20211217.0,20211015,20211224,EXP,,JP-AstraZeneca-2021A768255,ASTRAZENECA,,69.0,YR,,M,Y,71.0,KG,20211224.0,,MD,JP,,2021,Q4,Elderly
199585112,19958511,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Chronic kidney disease,,2021,Q4,2,F,20210920.0,20211217.0,20211015,20211224,EXP,,JP-AstraZeneca-2021A768255,ASTRAZENECA,,69.0,YR,,M,Y,71.0,KG,20211224.0,,MD,JP,,2021,Q4,Elderly
199585112,19958511,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Dizziness,,2021,Q4,2,F,20210920.0,20211217.0,20211015,20211224,EXP,,JP-AstraZeneca-2021A768255,ASTRAZENECA,,69.0,YR,,M,Y,71.0,KG,20211224.0,,MD,JP,,2021,Q4,Elderly
199585112,19958511,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Carotid artery stenosis,,2021,Q4,2,F,20210920.0,20211217.0,20211015,20211224,EXP,,JP-AstraZeneca-2021A768255,ASTRAZENECA,,69.0,YR,,M,Y,71.0,KG,20211224.0,,MD,JP,,2021,Q4,Elderly
199585112,19958511,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Fall,,2021,Q4,2,F,20210920.0,20211217.0,20211015,20211224,EXP,,JP-AstraZeneca-2021A768255,ASTRAZENECA,,69.0,YR,,M,Y,71.0,KG,20211224.0,,MD,JP,,2021,Q4,Elderly
199585112,19958511,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Head injury,,2021,Q4,2,F,20210920.0,20211217.0,20211015,20211224,EXP,,JP-AstraZeneca-2021A768255,ASTRAZENECA,,69.0,YR,,M,Y,71.0,KG,20211224.0,,MD,JP,,2021,Q4,Elderly
199585112,19958511,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Cerebral infarction,,2021,Q4,2,F,20210920.0,20211217.0,20211015,20211224,EXP,,JP-AstraZeneca-2021A768255,ASTRAZENECA,,69.0,YR,,M,Y,71.0,KG,20211224.0,,MD,JP,,2021,Q4,Elderly
199587531,19958753,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Dehydration,,2021,Q4,1,I,20210827.0,20211006.0,20211015,20211015,EXP,DK-DKMA-WBS-0089077,DK-NOVOPROD-854242,NOVO NORDISK,,84.0,YR,,M,Y,84.0,KG,20211015.0,,MD,DK,DK,2021,Q4,Elderly
199587531,19958753,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,20210827.0,20211006.0,20211015,20211015,EXP,DK-DKMA-WBS-0089077,DK-NOVOPROD-854242,NOVO NORDISK,,84.0,YR,,M,Y,84.0,KG,20211015.0,,MD,DK,DK,2021,Q4,Elderly
199587531,19958753,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Oliguria,,2021,Q4,1,I,20210827.0,20211006.0,20211015,20211015,EXP,DK-DKMA-WBS-0089077,DK-NOVOPROD-854242,NOVO NORDISK,,84.0,YR,,M,Y,84.0,KG,20211015.0,,MD,DK,DK,2021,Q4,Elderly
199587531,19958753,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Coagulopathy,,2021,Q4,1,I,20210827.0,20211006.0,20211015,20211015,EXP,DK-DKMA-WBS-0089077,DK-NOVOPROD-854242,NOVO NORDISK,,84.0,YR,,M,Y,84.0,KG,20211015.0,,MD,DK,DK,2021,Q4,Elderly
199587531,19958753,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Mucosal haemorrhage,,2021,Q4,1,I,20210827.0,20211006.0,20211015,20211015,EXP,DK-DKMA-WBS-0089077,DK-NOVOPROD-854242,NOVO NORDISK,,84.0,YR,,M,Y,84.0,KG,20211015.0,,MD,DK,DK,2021,Q4,Elderly
199587531,19958753,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,20210827.0,20211006.0,20211015,20211015,EXP,DK-DKMA-WBS-0089077,DK-NOVOPROD-854242,NOVO NORDISK,,84.0,YR,,M,Y,84.0,KG,20211015.0,,MD,DK,DK,2021,Q4,Elderly
199587531,19958753,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Pyrexia,,2021,Q4,1,I,20210827.0,20211006.0,20211015,20211015,EXP,DK-DKMA-WBS-0089077,DK-NOVOPROD-854242,NOVO NORDISK,,84.0,YR,,M,Y,84.0,KG,20211015.0,,MD,DK,DK,2021,Q4,Elderly
199587531,19958753,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Hypovolaemia,,2021,Q4,1,I,20210827.0,20211006.0,20211015,20211015,EXP,DK-DKMA-WBS-0089077,DK-NOVOPROD-854242,NOVO NORDISK,,84.0,YR,,M,Y,84.0,KG,20211015.0,,MD,DK,DK,2021,Q4,Elderly
199587531,19958753,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Renal failure,,2021,Q4,1,I,20210827.0,20211006.0,20211015,20211015,EXP,DK-DKMA-WBS-0089077,DK-NOVOPROD-854242,NOVO NORDISK,,84.0,YR,,M,Y,84.0,KG,20211015.0,,MD,DK,DK,2021,Q4,Elderly
199587531,19958753,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Hypotension,,2021,Q4,1,I,20210827.0,20211006.0,20211015,20211015,EXP,DK-DKMA-WBS-0089077,DK-NOVOPROD-854242,NOVO NORDISK,,84.0,YR,,M,Y,84.0,KG,20211015.0,,MD,DK,DK,2021,Q4,Elderly
199591014,19959101,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,Tablet,QD,2021,Q4,Injection site hypersensitivity,,2021,Q4,4,F,20210817.0,20211213.0,20211015,20211222,EXP,,NVSC2021CN220766,NOVARTIS,,63.0,YR,,F,Y,64.5,KG,20211222.0,,MD,CN,CN,2021,Q4,Adult
199591014,19959101,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,Tablet,QD,2021,Q4,Diabetes mellitus,,2021,Q4,4,F,20210817.0,20211213.0,20211015,20211222,EXP,,NVSC2021CN220766,NOVARTIS,,63.0,YR,,F,Y,64.5,KG,20211222.0,,MD,CN,CN,2021,Q4,Adult
199591014,19959101,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, QD",,,U,,,,,,,Tablet,QD,2021,Q4,Rotator cuff syndrome,,2021,Q4,4,F,20210817.0,20211213.0,20211015,20211222,EXP,,NVSC2021CN220766,NOVARTIS,,63.0,YR,,F,Y,64.5,KG,20211222.0,,MD,CN,CN,2021,Q4,Adult
199643222,19964322,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Pemphigoid,,2021,Q4,2,F,20211001.0,20211015.0,20211018,20211025,EXP,GB-MHRA-EYC 00262594,GB-TEVA-2021-GB-1965346,TEVA,,65.0,YR,E,M,Y,,,20211025.0,,PH,GB,GB,2021,Q4,Elderly
199644131,19964413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20211001.0,20211004.0,20211018,20211018,EXP,,DE-ASTRAZENECA-2021A760142,ASTRAZENECA,,23648.0,DY,,M,Y,,,20211018.0,,MD,DE,DE,2021,Q4,Elderly
199644131,19964413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211001.0,20211004.0,20211018,20211018,EXP,,DE-ASTRAZENECA-2021A760142,ASTRAZENECA,,23648.0,DY,,M,Y,,,20211018.0,,MD,DE,DE,2021,Q4,Elderly
199645911,19964591,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4790.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Fournier's gangrene,,2021,Q4,1,I,20210925.0,20211013.0,20211018,20211018,EXP,,DE-ASTRAZENECA-2021A770788,ASTRAZENECA,,62.0,YR,,M,Y,,,20211018.0,,MD,DE,DE,2021,Q4,Adult
199677741,19967774,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 dosage form, Once a Day (28 tablet, 1 only)",,,D,,,,,,,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210901.0,20211004.0,20211019,20211019,EXP,,DE-AUROBINDO-AUR-APL-2021-042301,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20211019.0,,MD,DE,DE,2021,Q4,Elderly
199677741,19967774,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 dosage form, Once a Day (28 tablet, 1 only)",,,D,,,,,,,,QD,2021,Q4,Tachycardia,,2021,Q4,1,I,20210901.0,20211004.0,20211019,20211019,EXP,,DE-AUROBINDO-AUR-APL-2021-042301,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20211019.0,,MD,DE,DE,2021,Q4,Elderly
199677741,19967774,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 dosage form, Once a Day (28 tablet, 1 only)",,,D,,,,,,,,QD,2021,Q4,Somnolence,,2021,Q4,1,I,20210901.0,20211004.0,20211019,20211019,EXP,,DE-AUROBINDO-AUR-APL-2021-042301,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20211019.0,,MD,DE,DE,2021,Q4,Elderly
199677741,19967774,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 dosage form, Once a Day (28 tablet, 1 only)",,,D,,,,,,,,QD,2021,Q4,Heart rate increased,,2021,Q4,1,I,20210901.0,20211004.0,20211019,20211019,EXP,,DE-AUROBINDO-AUR-APL-2021-042301,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20211019.0,,MD,DE,DE,2021,Q4,Elderly
199677741,19967774,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 dosage form, Once a Day (28 tablet, 1 only)",,,D,,,,,,,,QD,2021,Q4,Intentional self-injury,,2021,Q4,1,I,20210901.0,20211004.0,20211019,20211019,EXP,,DE-AUROBINDO-AUR-APL-2021-042301,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20211019.0,,MD,DE,DE,2021,Q4,Elderly
199677741,19967774,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 dosage form, Once a Day (28 tablet, 1 only)",,,D,,,,,,,,QD,2021,Q4,Suicide attempt,,2021,Q4,1,I,20210901.0,20211004.0,20211019,20211019,EXP,,DE-AUROBINDO-AUR-APL-2021-042301,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20211019.0,,MD,DE,DE,2021,Q4,Elderly
199677741,19967774,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 dosage form, Once a Day (28 tablet, 1 only)",,,D,,,,,,,,QD,2021,Q4,Intentional overdose,,2021,Q4,1,I,20210901.0,20211004.0,20211019,20211019,EXP,,DE-AUROBINDO-AUR-APL-2021-042301,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20211019.0,,MD,DE,DE,2021,Q4,Elderly
199677741,19967774,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 dosage form, Once a Day (28 tablet, 1 only)",,,D,,,,,,,,QD,2021,Q4,Vomiting,,2021,Q4,1,I,20210901.0,20211004.0,20211019,20211019,EXP,,DE-AUROBINDO-AUR-APL-2021-042301,AUROBINDO,,65.0,YR,,M,Y,90.0,KG,20211019.0,,MD,DE,DE,2021,Q4,Elderly
199682251,19968225,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210930.0,20211001.0,20211019,20211019,EXP,,JP-ASTRAZENECA-2021A759841,ASTRAZENECA,,74.0,YR,,M,Y,46.0,KG,20211019.0,,MD,JP,JP,2021,Q4,Elderly
199682251,19968225,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Loss of consciousness,,2021,Q4,1,I,20210930.0,20211001.0,20211019,20211019,EXP,,JP-ASTRAZENECA-2021A759841,ASTRAZENECA,,74.0,YR,,M,Y,46.0,KG,20211019.0,,MD,JP,JP,2021,Q4,Elderly
199682251,19968225,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210930.0,20211001.0,20211019,20211019,EXP,,JP-ASTRAZENECA-2021A759841,ASTRAZENECA,,74.0,YR,,M,Y,46.0,KG,20211019.0,,MD,JP,JP,2021,Q4,Elderly
199682251,19968225,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Loss of consciousness,,2021,Q4,1,I,20210930.0,20211001.0,20211019,20211019,EXP,,JP-ASTRAZENECA-2021A759841,ASTRAZENECA,,74.0,YR,,M,Y,46.0,KG,20211019.0,,MD,JP,JP,2021,Q4,Elderly
199683351,19968335,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",1745.0,MG,,,,,,5.0,MG,,QD,2021,Q4,Rhabdomyolysis,,2021,Q4,1,I,20190709.0,20211013.0,20211019,20211019,PER,,JP-AMGEN-JPNNI2021158449,AMGEN,,70.0,YR,E,F,Y,75.0,KG,20211019.0,,MD,JP,JP,2021,Q4,Elderly
199693129,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Blood pressure decreased,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Oedema peripheral,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Obesity,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Fatigue,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Diabetes mellitus,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Abdominal distension,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Hyperuricaemia,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Hypertension,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Blood pressure decreased,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Oedema peripheral,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Obesity,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Fatigue,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Diabetes mellitus,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Abdominal distension,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Hyperuricaemia,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199693129,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Hypertension,,2021,Q4,9,F,,20211209.0,20211019,20211213,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,95.0,KG,20211213.0,,MD,PL,PL,2021,Q4,Adult
199696281,19969628,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,RU-ASTRAZENECA-2021A771728,ASTRAZENECA,,50.0,YR,,F,Y,100.0,KG,20211019.0,,HP,RU,RU,2021,Q4,Adult
199696281,19969628,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Pancreatitis,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,RU-ASTRAZENECA-2021A771728,ASTRAZENECA,,50.0,YR,,F,Y,100.0,KG,20211019.0,,HP,RU,RU,2021,Q4,Adult
199700173,19970017,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,N,,,,202293.0,,,Tablet,,2021,Q4,Septic shock,,2021,Q4,3,F,20211005.0,20211014.0,20211019,20211025,EXP,,JP-ASTRAZENECA-2021A775097,ASTRAZENECA,,69.0,YR,,F,Y,,,20211025.0,,MD,JP,JP,2021,Q4,Elderly
199709182,19970918,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,QD,2021,Q4,Alanine aminotransferase increased,,2021,Q4,2,F,20210916.0,20211019.0,20211020,20211025,EXP,,CN-ROCHE-2938703,ROCHE,,66.0,YR,,M,Y,,,20211025.0,,MD,CN,CN,2021,Q4,Elderly
199709182,19970918,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,QD,2021,Q4,Aspartate aminotransferase increased,,2021,Q4,2,F,20210916.0,20211019.0,20211020,20211025,EXP,,CN-ROCHE-2938703,ROCHE,,66.0,YR,,M,Y,,,20211025.0,,MD,CN,CN,2021,Q4,Elderly
199715701,19971570,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Abdominal discomfort,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,DE-ASTRAZENECA-2021A773827,ASTRAZENECA,,53.0,YR,,F,Y,101.0,KG,20211019.0,,MD,DE,DE,2021,Q4,Adult
199715701,19971570,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Ill-defined disorder,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,DE-ASTRAZENECA-2021A773827,ASTRAZENECA,,53.0,YR,,F,Y,101.0,KG,20211019.0,,MD,DE,DE,2021,Q4,Adult
199715701,19971570,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Product adhesion issue,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,DE-ASTRAZENECA-2021A773827,ASTRAZENECA,,53.0,YR,,F,Y,101.0,KG,20211019.0,,MD,DE,DE,2021,Q4,Adult
199715701,19971570,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Hypothyroidism,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,DE-ASTRAZENECA-2021A773827,ASTRAZENECA,,53.0,YR,,F,Y,101.0,KG,20211019.0,,MD,DE,DE,2021,Q4,Adult
199726691,19972669,4,C,Dapagliflozin 5 mg QD,,2,,,,,,,,,,,,,,2021,Q4,Urticaria,,2021,Q4,1,I,20211017.0,,20211019,20211019,DIR,587237,,FDA-CTU,,76.0,YR,,M,N,,,20211019.0,N,PH,US,US,2021,Q4,Elderly
199726691,19972669,4,C,Dapagliflozin 5 mg QD,,2,,,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,20211017.0,,20211019,20211019,DIR,587237,,FDA-CTU,,76.0,YR,,M,N,,,20211019.0,N,PH,US,US,2021,Q4,Elderly
199726691,19972669,4,C,Dapagliflozin 5 mg QD,,2,,,,,,,,,,,,,,2021,Q4,Anaphylactic reaction,,2021,Q4,1,I,20211017.0,,20211019,20211019,DIR,587237,,FDA-CTU,,76.0,YR,,M,N,,,20211019.0,N,PH,US,US,2021,Q4,Elderly
199744792,19974479,19,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,28 tablet 1 only,,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Somnolence,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,19,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,28 tablet 1 only,,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Heart rate increased,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,19,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,28 tablet 1 only,,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Vomiting,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,19,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,28 tablet 1 only,,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Suicide attempt,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,19,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,28 tablet 1 only,,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Intentional self-injury,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,19,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,28 tablet 1 only,,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Intentional overdose,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,19,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,28 tablet 1 only,,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Tachycardia,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,19,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,28 tablet 1 only,,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, qd",,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Somnolence,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, qd",,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Heart rate increased,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, qd",,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Vomiting,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, qd",,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Suicide attempt,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, qd",,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Intentional self-injury,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, qd",,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Intentional overdose,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, qd",,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Tachycardia,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199744792,19974479,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, qd",,,D,,Unknown,,,,,Tablet,QD,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210901.0,20211022.0,20211020,20211029,EXP,,DE-PFIZER INC-202101321703,PFIZER,,65.0,YR,,M,Y,90.0,KG,20211029.0,,MD,DE,DE,2021,Q4,Elderly
199746501,19974650,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Arrhythmia,,2021,Q4,1,I,,20211012.0,20211020,20211020,EXP,,SI-ORGANON-O2110SVN001062,ORGANON,,80.0,YR,,M,Y,,,20211020.0,,MD,SI,SI,2021,Q4,Elderly
199775501,19977550,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,,,,,2021,Q4,COVID-19,,2021,Q4,1,I,,20211012.0,20211021,20211021,EXP,,ZA-NOVOPROD-858167,NOVO NORDISK,,56.0,YR,,F,Y,,,20211021.0,,CN,ZA,ZA,2021,Q4,Adult
199775501,19977550,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,,,,,2021,Q4,Cardiac operation,,2021,Q4,1,I,,20211012.0,20211021,20211021,EXP,,ZA-NOVOPROD-858167,NOVO NORDISK,,56.0,YR,,F,Y,,,20211021.0,,CN,ZA,ZA,2021,Q4,Adult
199778781,19977878,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,Y,,,,202293.0,,,Tablet,,2021,Q4,Pulmonary mass,,2021,Q4,1,I,20211005.0,20211012.0,20211020,20211020,EXP,,CN-ASTRAZENECA-2021A771810,ASTRAZENECA,,1931.0,WK,,M,Y,70.0,KG,20211020.0,,MD,CN,CN,2021,Q4,Elderly
199778781,19977878,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,Y,,,,202293.0,,,Tablet,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211005.0,20211012.0,20211020,20211020,EXP,,CN-ASTRAZENECA-2021A771810,ASTRAZENECA,,1931.0,WK,,M,Y,70.0,KG,20211020.0,,MD,CN,CN,2021,Q4,Elderly
199778781,19977878,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,Y,,,,202293.0,,,Tablet,,2021,Q4,Pleural thickening,,2021,Q4,1,I,20211005.0,20211012.0,20211020,20211020,EXP,,CN-ASTRAZENECA-2021A771810,ASTRAZENECA,,1931.0,WK,,M,Y,70.0,KG,20211020.0,,MD,CN,CN,2021,Q4,Elderly
199792631,19979263,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Breath sounds abnormal,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Gastric disorder,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Thirst,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Gait disturbance,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Dyspnoea,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Blood sodium increased,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Breath sounds abnormal,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Gastric disorder,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Thirst,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Fatigue,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Gait disturbance,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Drug ineffective,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199792631,19979263,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Blood sodium increased,,2021,Q4,1,I,20210801.0,20211013.0,20211021,20211021,EXP,,NVSC2021EG237546,NOVARTIS,,60.0,YR,,M,Y,,,20211021.0,,CN,EG,EG,2021,Q4,Adult
199793031,19979303,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,205649.0,,,Tablet,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,20210830.0,20211012.0,20211020,20211020,EXP,,PT-ASTRAZENECA-2021A769588,ASTRAZENECA,,77.0,YR,,F,Y,,,20211021.0,,MD,PT,PT,2021,Q4,Elderly
199793031,19979303,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,205649.0,,,Tablet,QD,2021,Q4,Urinary tract infection,,2021,Q4,1,I,20210830.0,20211012.0,20211020,20211020,EXP,,PT-ASTRAZENECA-2021A769588,ASTRAZENECA,,77.0,YR,,F,Y,,,20211021.0,,MD,PT,PT,2021,Q4,Elderly
199793031,19979303,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,205649.0,,,Tablet,QD,2021,Q4,Nausea,,2021,Q4,1,I,20210830.0,20211012.0,20211020,20211020,EXP,,PT-ASTRAZENECA-2021A769588,ASTRAZENECA,,77.0,YR,,F,Y,,,20211021.0,,MD,PT,PT,2021,Q4,Elderly
199793031,19979303,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,205649.0,,,Tablet,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210830.0,20211012.0,20211020,20211020,EXP,,PT-ASTRAZENECA-2021A769588,ASTRAZENECA,,77.0,YR,,F,Y,,,20211021.0,,MD,PT,PT,2021,Q4,Elderly
199793031,19979303,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,205649.0,,,Tablet,QD,2021,Q4,Pollakiuria,,2021,Q4,1,I,20210830.0,20211012.0,20211020,20211020,EXP,,PT-ASTRAZENECA-2021A769588,ASTRAZENECA,,77.0,YR,,F,Y,,,20211021.0,,MD,PT,PT,2021,Q4,Elderly
199793031,19979303,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,,,,205649.0,,,Tablet,QD,2021,Q4,Dysgeusia,,2021,Q4,1,I,20210830.0,20211012.0,20211020,20211020,EXP,,PT-ASTRAZENECA-2021A769588,ASTRAZENECA,,77.0,YR,,F,Y,,,20211021.0,,MD,PT,PT,2021,Q4,Elderly
199801391,19980139,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2200.0,MG,Y,,2104148,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Ketosis,,2021,Q4,1,I,20211006.0,20211016.0,20211021,20211021,EXP,,CN-ASTRAZENECA-2021A777228,ASTRAZENECA,,24919.0,DY,,M,Y,64.0,KG,20211021.0,,MD,CN,CN,2021,Q4,Elderly
199820711,19982071,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,take 1 tablet by mouth daily,,,,,,,,,,Tablet,QD,2021,Q4,Cardiac asthma,,2021,Q4,1,I,20210418.0,20211018.0,20211022,20211022,EXP,NL-LRB-00518426,NL-BAUSCH-BL-2021-034965,BAUSCH AND LOMB,,64.0,YR,,M,Y,90.0,KG,20211022.0,,MD,NL,NL,2021,Q4,Adult
199820711,19982071,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,take 1 tablet by mouth daily,,,,,,,,,,Tablet,QD,2021,Q4,Malaise,,2021,Q4,1,I,20210418.0,20211018.0,20211022,20211022,EXP,NL-LRB-00518426,NL-BAUSCH-BL-2021-034965,BAUSCH AND LOMB,,64.0,YR,,M,Y,90.0,KG,20211022.0,,MD,NL,NL,2021,Q4,Adult
199820711,19982071,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,take 1 tablet by mouth daily,,,,,,,,,,Tablet,QD,2021,Q4,Hyperkalaemia,,2021,Q4,1,I,20210418.0,20211018.0,20211022,20211022,EXP,NL-LRB-00518426,NL-BAUSCH-BL-2021-034965,BAUSCH AND LOMB,,64.0,YR,,M,Y,90.0,KG,20211022.0,,MD,NL,NL,2021,Q4,Adult
199820711,19982071,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,take 1 tablet by mouth daily,,,,,,,,,,Tablet,QD,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20210418.0,20211018.0,20211022,20211022,EXP,NL-LRB-00518426,NL-BAUSCH-BL-2021-034965,BAUSCH AND LOMB,,64.0,YR,,M,Y,90.0,KG,20211022.0,,MD,NL,NL,2021,Q4,Adult
199828532,19982853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2021,Q4,Tension,,2021,Q4,2,F,,20211122.0,20211021,20211130,EXP,,FR-AstraZeneca-2021A774884,ASTRAZENECA,,76.0,YR,,M,Y,,,20211130.0,,MD,FR,,2021,Q4,Elderly
199828532,19982853,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2021,Q4,Tension,,2021,Q4,2,F,,20211122.0,20211021,20211130,EXP,,FR-AstraZeneca-2021A774884,ASTRAZENECA,,76.0,YR,,M,Y,,,20211130.0,,MD,FR,,2021,Q4,Elderly
199828532,19982853,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2021,Q4,Tension,,2021,Q4,2,F,,20211122.0,20211021,20211130,EXP,,FR-AstraZeneca-2021A774884,ASTRAZENECA,,76.0,YR,,M,Y,,,20211130.0,,MD,FR,,2021,Q4,Elderly
199834911,19983491,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,QD,2021,Q4,Acidosis,,2021,Q4,1,I,,20211012.0,20211022,20211022,EXP,,PT-ASTRAZENECA-2021A768350,ASTRAZENECA,,69.0,YR,,F,Y,,,20211022.0,,MD,PT,PT,2021,Q4,Elderly
199834911,19983491,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211012.0,20211022,20211022,EXP,,PT-ASTRAZENECA-2021A768350,ASTRAZENECA,,69.0,YR,,F,Y,,,20211022.0,,MD,PT,PT,2021,Q4,Elderly
199846432,19984643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,Z548A,,202293.0,10.0,MG,Tablet,,2021,Q4,Nocturia,,2021,Q4,2,F,20211002.0,20211025.0,20211021,20211102,EXP,,DE-AstraZeneca-2021A770911,ASTRAZENECA,,36.0,YR,,M,Y,116.0,KG,20211102.0,,MD,DE,,2021,Q4,Adult
199846432,19984643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,Z548A,,202293.0,10.0,MG,Tablet,,2021,Q4,Pollakiuria,,2021,Q4,2,F,20211002.0,20211025.0,20211021,20211102,EXP,,DE-AstraZeneca-2021A770911,ASTRAZENECA,,36.0,YR,,M,Y,116.0,KG,20211102.0,,MD,DE,,2021,Q4,Adult
199846432,19984643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,Z548A,,202293.0,10.0,MG,Tablet,,2021,Q4,Urinary retention,,2021,Q4,2,F,20211002.0,20211025.0,20211021,20211102,EXP,,DE-AstraZeneca-2021A770911,ASTRAZENECA,,36.0,YR,,M,Y,116.0,KG,20211102.0,,MD,DE,,2021,Q4,Adult
199846432,19984643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,Z548A,,202293.0,10.0,MG,Tablet,,2021,Q4,Dysuria,,2021,Q4,2,F,20211002.0,20211025.0,20211021,20211102,EXP,,DE-AstraZeneca-2021A770911,ASTRAZENECA,,36.0,YR,,M,Y,116.0,KG,20211102.0,,MD,DE,,2021,Q4,Adult
199846432,19984643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,Z548A,,202293.0,10.0,MG,Tablet,,2021,Q4,Microalbuminuria,,2021,Q4,2,F,20211002.0,20211025.0,20211021,20211102,EXP,,DE-AstraZeneca-2021A770911,ASTRAZENECA,,36.0,YR,,M,Y,116.0,KG,20211102.0,,MD,DE,,2021,Q4,Adult
199854521,19985452,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,CA-JNJFOC-20211024096,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,,,20211022.0,,CN,CA,CA,2021,Q4,Elderly
199854521,19985452,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q4,Malaise,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,CA-JNJFOC-20211024096,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,,,20211022.0,,CN,CA,CA,2021,Q4,Elderly
199854521,19985452,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q4,Insomnia,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,CA-JNJFOC-20211024096,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,,,20211022.0,,CN,CA,CA,2021,Q4,Elderly
199854521,19985452,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,CA-JNJFOC-20211024096,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,,,20211022.0,,CN,CA,CA,2021,Q4,Elderly
199854521,19985452,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q4,Neck pain,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,CA-JNJFOC-20211024096,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,,,20211022.0,,CN,CA,CA,2021,Q4,Elderly
199854521,19985452,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,CA-JNJFOC-20211024096,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,,,20211022.0,,CN,CA,CA,2021,Q4,Elderly
199854521,19985452,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q4,Pain,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,CA-JNJFOC-20211024096,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,,,20211022.0,,CN,CA,CA,2021,Q4,Elderly
199854521,19985452,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q4,Myalgia,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,CA-JNJFOC-20211024096,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,,,20211022.0,,CN,CA,CA,2021,Q4,Elderly
199854521,19985452,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,CA-JNJFOC-20211024096,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,,,20211022.0,,CN,CA,CA,2021,Q4,Elderly
199854521,19985452,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,CA-JNJFOC-20211024096,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,,,20211022.0,,CN,CA,CA,2021,Q4,Elderly
199854521,19985452,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2021,Q4,Renal failure,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,CA-JNJFOC-20211024096,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,,,20211022.0,,CN,CA,CA,2021,Q4,Elderly
199873141,19987314,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Arrhythmia,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,SI-PFIZER INC-202101360164,PFIZER,,80.0,YR,,M,Y,,,20211022.0,,MD,SI,SI,2021,Q4,Elderly
199873141,19987314,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,1,I,,20211011.0,20211022,20211022,EXP,,SI-PFIZER INC-202101360164,PFIZER,,80.0,YR,,M,Y,,,20211022.0,,MD,SI,SI,2021,Q4,Elderly
199882251,19988225,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,,,Tablet,,2021,Q4,Congestive cardiomyopathy,,2021,Q4,1,I,,20211019.0,20211022,20211022,EXP,,DE-ASTRAZENECA-2021A781200,ASTRAZENECA,,57.0,YR,,F,Y,,,20211022.0,,MD,DE,DE,2021,Q4,Adult
199882251,19988225,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,,,Tablet,,2021,Q4,Ventricular fibrillation,,2021,Q4,1,I,,20211019.0,20211022,20211022,EXP,,DE-ASTRAZENECA-2021A781200,ASTRAZENECA,,57.0,YR,,F,Y,,,20211022.0,,MD,DE,DE,2021,Q4,Adult
199882251,19988225,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,,,Tablet,,2021,Q4,Hyperkalaemia,,2021,Q4,1,I,,20211019.0,20211022,20211022,EXP,,DE-ASTRAZENECA-2021A781200,ASTRAZENECA,,57.0,YR,,F,Y,,,20211022.0,,MD,DE,DE,2021,Q4,Adult
199886541,19988654,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg OD,3660.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20211011.0,20211012.0,20211024,20211024,EXP,,GB-ASTRAZENECA-2021A770378,ASTRAZENECA,,49.0,YR,,F,Y,,,20211024.0,,MD,GB,GB,2021,Q4,Adult
199886561,19988656,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Ketosis,,2021,Q4,1,I,20210728.0,20211015.0,20211024,20211024,EXP,,FR-ASTRAZENECA-2021A774482,ASTRAZENECA,,68.0,YR,,M,Y,60.0,KG,20211024.0,,MD,FR,FR,2021,Q4,Elderly
199886571,19988657,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10X1,,,U,,,,202293.0,,,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211018.0,20211024,20211024,EXP,,GR-ASTRAZENECA-2021A781658,ASTRAZENECA,"ROIDI D, MARAGKOUTI A. Euglycemic diabetic ketoacidosis immediately postoperatively in patient with antidiabetic treatment with dapagliflozin. 24th Panhellenic Congress of Anesthesiology 2021;",63.0,YR,,F,Y,80.0,KG,20211024.0,,MD,GR,GR,2021,Q4,Adult
199886742,19988674,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (2x1),,,,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Bladder cancer,,2021,Q4,2,F,,20211021.0,20211024,20211028,EXP,,TR-ASTRAZENECA-2021A779482,ASTRAZENECA,,52.0,YR,,M,Y,,,20211028.0,,MD,TR,TR,2021,Q4,Adult
199889081,19988908,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, eem 1 tablet in via de mond dagelijks",,,U,,,,,,,Tablet,,2021,Q4,Cardiac asthma,,2021,Q4,1,I,20210418.0,20211020.0,20211024,20211024,EXP,NL-LRB-00518426,NVSC2021NL240930,NOVARTIS,,64.0,YR,,M,Y,90.0,KG,20211025.0,,MD,NL,NL,2021,Q4,Adult
199889081,19988908,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, eem 1 tablet in via de mond dagelijks",,,U,,,,,,,Tablet,,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20210418.0,20211020.0,20211024,20211024,EXP,NL-LRB-00518426,NVSC2021NL240930,NOVARTIS,,64.0,YR,,M,Y,90.0,KG,20211025.0,,MD,NL,NL,2021,Q4,Adult
199889081,19988908,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, eem 1 tablet in via de mond dagelijks",,,U,,,,,,,Tablet,,2021,Q4,Hyperkalaemia,,2021,Q4,1,I,20210418.0,20211020.0,20211024,20211024,EXP,NL-LRB-00518426,NVSC2021NL240930,NOVARTIS,,64.0,YR,,M,Y,90.0,KG,20211025.0,,MD,NL,NL,2021,Q4,Adult
199889081,19988908,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, eem 1 tablet in via de mond dagelijks",,,U,,,,,,,Tablet,,2021,Q4,Malaise,,2021,Q4,1,I,20210418.0,20211020.0,20211024,20211024,EXP,NL-LRB-00518426,NVSC2021NL240930,NOVARTIS,,64.0,YR,,M,Y,90.0,KG,20211025.0,,MD,NL,NL,2021,Q4,Adult
199891201,19989120,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, Two Times a Day",,,U,,,,,5.0,MG,,BID,2021,Q4,Hyperkalaemia,,2021,Q4,1,I,,20210526.0,20211025,20211025,EXP,,ES-AUROBINDO-AUR-APL-2021-022189,AUROBINDO,"Marques Vidas M, Dura Gurpide B, Rubio E, Huerta A, Portoles Perez J. Dapagliflozin-induced hypercalcemia. Nefrologia. 2018;38(3):336-337",63.0,YR,,F,Y,,,20211025.0,,MD,ES,ES,2021,Q4,Adult
199891201,19989120,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, Two Times a Day",,,U,,,,,5.0,MG,,BID,2021,Q4,Orthostatic hypotension,,2021,Q4,1,I,,20210526.0,20211025,20211025,EXP,,ES-AUROBINDO-AUR-APL-2021-022189,AUROBINDO,"Marques Vidas M, Dura Gurpide B, Rubio E, Huerta A, Portoles Perez J. Dapagliflozin-induced hypercalcemia. Nefrologia. 2018;38(3):336-337",63.0,YR,,F,Y,,,20211025.0,,MD,ES,ES,2021,Q4,Adult
199891201,19989120,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, Two Times a Day",,,U,,,,,5.0,MG,,BID,2021,Q4,Hypercalcaemia,,2021,Q4,1,I,,20210526.0,20211025,20211025,EXP,,ES-AUROBINDO-AUR-APL-2021-022189,AUROBINDO,"Marques Vidas M, Dura Gurpide B, Rubio E, Huerta A, Portoles Perez J. Dapagliflozin-induced hypercalcemia. Nefrologia. 2018;38(3):336-337",63.0,YR,,F,Y,,,20211025.0,,MD,ES,ES,2021,Q4,Adult
199894801,19989480,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Daily, 1 DF, QD",,,U,,,,,,,Tablet,,2021,Q4,Hypertrophy,,2021,Q4,1,I,,20210504.0,20211025,20211025,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-296684,RANBAXY,,70.0,YR,,M,Y,,,20211025.0,,HP,PL,PL,2021,Q4,Elderly
199894801,19989480,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Daily, 1 DF, QD",,,U,,,,,,,Tablet,,2021,Q4,N-terminal prohormone brain natriuretic peptide abnormal,,2021,Q4,1,I,,20210504.0,20211025,20211025,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-296684,RANBAXY,,70.0,YR,,M,Y,,,20211025.0,,HP,PL,PL,2021,Q4,Elderly
199894801,19989480,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Daily, 1 DF, QD",,,U,,,,,,,Tablet,,2021,Q4,Cardiac failure chronic,,2021,Q4,1,I,,20210504.0,20211025,20211025,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-296684,RANBAXY,,70.0,YR,,M,Y,,,20211025.0,,HP,PL,PL,2021,Q4,Elderly
199894801,19989480,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Daily, 1 DF, QD",,,U,,,,,,,Tablet,,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,1,I,,20210504.0,20211025,20211025,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-296684,RANBAXY,,70.0,YR,,M,Y,,,20211025.0,,HP,PL,PL,2021,Q4,Elderly
199894801,19989480,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Daily, 1 DF, QD",,,U,,,,,,,Tablet,,2021,Q4,Renal atrophy,,2021,Q4,1,I,,20210504.0,20211025,20211025,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-296684,RANBAXY,,70.0,YR,,M,Y,,,20211025.0,,HP,PL,PL,2021,Q4,Elderly
199894801,19989480,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Daily, 1 DF, QD",,,U,,,,,,,Tablet,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20210504.0,20211025,20211025,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-296684,RANBAXY,,70.0,YR,,M,Y,,,20211025.0,,HP,PL,PL,2021,Q4,Elderly
199894801,19989480,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Daily, 1 DF, QD",,,U,,,,,,,Tablet,,2021,Q4,Dyspnoea exertional,,2021,Q4,1,I,,20210504.0,20211025,20211025,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-296684,RANBAXY,,70.0,YR,,M,Y,,,20211025.0,,HP,PL,PL,2021,Q4,Elderly
199894801,19989480,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Daily, 1 DF, QD",,,U,,,,,,,Tablet,,2021,Q4,Urosepsis,,2021,Q4,1,I,,20210504.0,20211025,20211025,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-296684,RANBAXY,,70.0,YR,,M,Y,,,20211025.0,,HP,PL,PL,2021,Q4,Elderly
199894801,19989480,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Daily, 1 DF, QD",,,U,,,,,,,Tablet,,2021,Q4,COVID-19 pneumonia,,2021,Q4,1,I,,20210504.0,20211025,20211025,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-296684,RANBAXY,,70.0,YR,,M,Y,,,20211025.0,,HP,PL,PL,2021,Q4,Elderly
199900241,19990024,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,Tablet,,2021,Q4,Cardiac dysfunction,,2021,Q4,1,I,20210629.0,20210812.0,20211025,20211025,EXP,,NVSJ2021JP012116,NOVARTIS,,50.0,YR,,F,Y,,,20211025.0,,MD,JP,JP,2021,Q4,Adult
199900241,19990024,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,Tablet,,2021,Q4,Cerebral infarction,,2021,Q4,1,I,20210629.0,20210812.0,20211025,20211025,EXP,,NVSJ2021JP012116,NOVARTIS,,50.0,YR,,F,Y,,,20211025.0,,MD,JP,JP,2021,Q4,Adult
199900241,19990024,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,Tablet,,2021,Q4,Intracardiac thrombus,,2021,Q4,1,I,20210629.0,20210812.0,20211025,20211025,EXP,,NVSJ2021JP012116,NOVARTIS,,50.0,YR,,F,Y,,,20211025.0,,MD,JP,JP,2021,Q4,Adult
199900241,19990024,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,Tablet,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,20210629.0,20210812.0,20211025,20211025,EXP,,NVSJ2021JP012116,NOVARTIS,,50.0,YR,,F,Y,,,20211025.0,,MD,JP,JP,2021,Q4,Adult
199904343,19990434,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, QD (started 2 years ago)",,,U,,,,,,,,QD,2021,Q4,Cardiac disorder,,2021,Q4,3,F,20210801.0,20211103.0,20211025,20211111,EXP,,NVSC2021CO241419,NOVARTIS,,62.0,YR,,F,Y,78.0,KG,20211111.0,,CN,CO,CO,2021,Q4,Adult
199904343,19990434,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, QD (started 2 years ago)",,,U,,,,,,,,QD,2021,Q4,Pain in extremity,,2021,Q4,3,F,20210801.0,20211103.0,20211025,20211111,EXP,,NVSC2021CO241419,NOVARTIS,,62.0,YR,,F,Y,78.0,KG,20211111.0,,CN,CO,CO,2021,Q4,Adult
199904343,19990434,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, QD (started 2 years ago)",,,U,,,,,,,,QD,2021,Q4,Breast mass,,2021,Q4,3,F,20210801.0,20211103.0,20211025,20211111,EXP,,NVSC2021CO241419,NOVARTIS,,62.0,YR,,F,Y,78.0,KG,20211111.0,,CN,CO,CO,2021,Q4,Adult
199904343,19990434,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, QD (started 2 years ago)",,,U,,,,,,,,QD,2021,Q4,Product supply issue,,2021,Q4,3,F,20210801.0,20211103.0,20211025,20211111,EXP,,NVSC2021CO241419,NOVARTIS,,62.0,YR,,F,Y,78.0,KG,20211111.0,,CN,CO,CO,2021,Q4,Adult
199904343,19990434,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, QD (started 2 years ago)",,,U,,,,,,,,QD,2021,Q4,Arrhythmia,,2021,Q4,3,F,20210801.0,20211103.0,20211025,20211111,EXP,,NVSC2021CO241419,NOVARTIS,,62.0,YR,,F,Y,78.0,KG,20211111.0,,CN,CO,CO,2021,Q4,Adult
199904343,19990434,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, QD (started 2 years ago)",,,U,,,,,,,,QD,2021,Q4,Fatigue,,2021,Q4,3,F,20210801.0,20211103.0,20211025,20211111,EXP,,NVSC2021CO241419,NOVARTIS,,62.0,YR,,F,Y,78.0,KG,20211111.0,,CN,CO,CO,2021,Q4,Adult
199912321,19991232,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211020.0,20211025,20211025,EXP,,CA-ASTRAZENECA-2021A781218,ASTRAZENECA,,67.0,YR,,M,Y,,,20211025.0,,MD,CA,CA,2021,Q4,Elderly
199925231,19992523,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Dyspnoea,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Orchitis,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Orchitis,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Dyspnoea,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Orchitis,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Orchitis,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199925231,19992523,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Fatigue,,2021,Q4,1,I,20200101.0,20211012.0,20211025,20211025,EXP,,NVSC2021EG235955,NOVARTIS,,71.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Coronary artery insufficiency,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Myocardial infarction,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Cardiomyopathy,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Myocardial necrosis marker increased,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Electrocardiogram abnormal,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Ejection fraction decreased,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Blood urea increased,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Thyroid function test abnormal,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Coronary artery stenosis,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Chest pain,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Coronary artery insufficiency,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Myocardial infarction,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Cardiomyopathy,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Myocardial necrosis marker increased,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Electrocardiogram abnormal,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Ejection fraction decreased,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Blood urea increased,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Thyroid function test abnormal,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Coronary artery stenosis,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199926941,19992694,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2021,Q4,Chest pain,,2021,Q4,1,I,20210709.0,20211016.0,20211025,20211025,EXP,,NVSC2021EG239617,NOVARTIS,,67.0,YR,,M,Y,,,20211025.0,,CN,EG,EG,2021,Q4,Elderly
199932852,19993285,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,2,F,20211003.0,20211021.0,20211026,20211026,EXP,,GB-ASTRAZENECA-2021A782482,ASTRAZENECA,,84.0,YR,,M,Y,63.0,KG,20211026.0,,MD,GB,GB,2021,Q4,Elderly
199948282,19994828,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,U,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,20210211.0,20211127.0,20211026,20211206,EXP,,DE-MYLANLABS-2021M1075466,MYLAN,,74.0,YR,,F,Y,145.0,KG,20211206.0,,MD,DE,DE,2021,Q4,Elderly
199948282,19994828,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,U,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,2,F,20210211.0,20211127.0,20211026,20211206,EXP,,DE-MYLANLABS-2021M1075466,MYLAN,,74.0,YR,,F,Y,145.0,KG,20211206.0,,MD,DE,DE,2021,Q4,Elderly
199948282,19994828,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,U,,,,,,,,2021,Q4,Ketonuria,,2021,Q4,2,F,20210211.0,20211127.0,20211026,20211206,EXP,,DE-MYLANLABS-2021M1075466,MYLAN,,74.0,YR,,F,Y,145.0,KG,20211206.0,,MD,DE,DE,2021,Q4,Elderly
199949132,19994913,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Portal fibrosis,,2021,Q4,2,F,,20211022.0,20211026,20211101,EXP,,GB-MYLANLABS-2021M1074905,MYLAN,,75.0,YR,,F,Y,87.0,KG,20211101.0,,HP,GB,GB,2021,Q4,Elderly
199949132,19994913,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,2,F,,20211022.0,20211026,20211101,EXP,,GB-MYLANLABS-2021M1074905,MYLAN,,75.0,YR,,F,Y,87.0,KG,20211101.0,,HP,GB,GB,2021,Q4,Elderly
199949132,19994913,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Hydronephrosis,,2021,Q4,2,F,,20211022.0,20211026,20211101,EXP,,GB-MYLANLABS-2021M1074905,MYLAN,,75.0,YR,,F,Y,87.0,KG,20211101.0,,HP,GB,GB,2021,Q4,Elderly
199949132,19994913,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Emphysema,,2021,Q4,2,F,,20211022.0,20211026,20211101,EXP,,GB-MYLANLABS-2021M1074905,MYLAN,,75.0,YR,,F,Y,87.0,KG,20211101.0,,HP,GB,GB,2021,Q4,Elderly
199949132,19994913,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Bladder trabeculation,,2021,Q4,2,F,,20211022.0,20211026,20211101,EXP,,GB-MYLANLABS-2021M1074905,MYLAN,,75.0,YR,,F,Y,87.0,KG,20211101.0,,HP,GB,GB,2021,Q4,Elderly
199949132,19994913,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Kidney fibrosis,,2021,Q4,2,F,,20211022.0,20211026,20211101,EXP,,GB-MYLANLABS-2021M1074905,MYLAN,,75.0,YR,,F,Y,87.0,KG,20211101.0,,HP,GB,GB,2021,Q4,Elderly
199949132,19994913,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Upper airway obstruction,,2021,Q4,2,F,,20211022.0,20211026,20211101,EXP,,GB-MYLANLABS-2021M1074905,MYLAN,,75.0,YR,,F,Y,87.0,KG,20211101.0,,HP,GB,GB,2021,Q4,Elderly
199949132,19994913,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Death,,2021,Q4,2,F,,20211022.0,20211026,20211101,EXP,,GB-MYLANLABS-2021M1074905,MYLAN,,75.0,YR,,F,Y,87.0,KG,20211101.0,,HP,GB,GB,2021,Q4,Elderly
199949132,19994913,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Cholelithiasis,,2021,Q4,2,F,,20211022.0,20211026,20211101,EXP,,GB-MYLANLABS-2021M1074905,MYLAN,,75.0,YR,,F,Y,87.0,KG,20211101.0,,HP,GB,GB,2021,Q4,Elderly
199949132,19994913,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,2,F,,20211022.0,20211026,20211101,EXP,,GB-MYLANLABS-2021M1074905,MYLAN,,75.0,YR,,F,Y,87.0,KG,20211101.0,,HP,GB,GB,2021,Q4,Elderly
199949132,19994913,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Postmortem blood drug level increased,,2021,Q4,2,F,,20211022.0,20211026,20211101,EXP,,GB-MYLANLABS-2021M1074905,MYLAN,,75.0,YR,,F,Y,87.0,KG,20211101.0,,HP,GB,GB,2021,Q4,Elderly
199949132,19994913,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Urinary tract infection,,2021,Q4,2,F,,20211022.0,20211026,20211101,EXP,,GB-MYLANLABS-2021M1074905,MYLAN,,75.0,YR,,F,Y,87.0,KG,20211101.0,,HP,GB,GB,2021,Q4,Elderly
199949132,19994913,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,2,F,,20211022.0,20211026,20211101,EXP,,GB-MYLANLABS-2021M1074905,MYLAN,,75.0,YR,,F,Y,87.0,KG,20211101.0,,HP,GB,GB,2021,Q4,Elderly
199960383,19996038,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2021,Q4,Drug-induced liver injury,,2021,Q4,3,F,20211015.0,20211117.0,20211025,20211122,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-110810,BRISTOL MYERS SQUIBB,,62.0,YR,,M,Y,133.0,KG,20211122.0,,HP,JP,JP,2021,Q4,Adult
199965821,19996582,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,Unknown,QD,2021,Q4,Clostridium difficile infection,,2021,Q4,1,I,,20211019.0,20211025,20211025,EXP,,US-FRESENIUS KABI-FK202111531,FRESENIUS KABI,"Cha B, Davoudi R, DiVita M, Fan A, Kamath M. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021 JAN;.",55.0,YR,,M,Y,,,20211025.0,,MD,US,US,2021,Q4,Adult
199965821,19996582,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,Unknown,QD,2021,Q4,Posterior reversible encephalopathy syndrome,,2021,Q4,1,I,,20211019.0,20211025,20211025,EXP,,US-FRESENIUS KABI-FK202111531,FRESENIUS KABI,"Cha B, Davoudi R, DiVita M, Fan A, Kamath M. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021 JAN;.",55.0,YR,,M,Y,,,20211025.0,,MD,US,US,2021,Q4,Adult
199965821,19996582,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,Unknown,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211019.0,20211025,20211025,EXP,,US-FRESENIUS KABI-FK202111531,FRESENIUS KABI,"Cha B, Davoudi R, DiVita M, Fan A, Kamath M. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021 JAN;.",55.0,YR,,M,Y,,,20211025.0,,MD,US,US,2021,Q4,Adult
199965821,19996582,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,QD,2021,Q4,Clostridium difficile infection,,2021,Q4,1,I,,20211019.0,20211025,20211025,EXP,,US-FRESENIUS KABI-FK202111531,FRESENIUS KABI,"Cha B, Davoudi R, DiVita M, Fan A, Kamath M. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021 JAN;.",55.0,YR,,M,Y,,,20211025.0,,MD,US,US,2021,Q4,Adult
199965821,19996582,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,QD,2021,Q4,Posterior reversible encephalopathy syndrome,,2021,Q4,1,I,,20211019.0,20211025,20211025,EXP,,US-FRESENIUS KABI-FK202111531,FRESENIUS KABI,"Cha B, Davoudi R, DiVita M, Fan A, Kamath M. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021 JAN;.",55.0,YR,,M,Y,,,20211025.0,,MD,US,US,2021,Q4,Adult
199965821,19996582,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211019.0,20211025,20211025,EXP,,US-FRESENIUS KABI-FK202111531,FRESENIUS KABI,"Cha B, Davoudi R, DiVita M, Fan A, Kamath M. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021 JAN;.",55.0,YR,,M,Y,,,20211025.0,,MD,US,US,2021,Q4,Adult
199971241,19997124,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210911.0,20211018.0,20211025,20211025,EXP,,FR-ASTRAZENECA-2021A777571,ASTRAZENECA,,72.0,YR,,M,Y,86.0,KG,20211026.0,,MD,FR,FR,2021,Q4,Elderly
199971241,19997124,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210911.0,20211018.0,20211025,20211025,EXP,,FR-ASTRAZENECA-2021A777571,ASTRAZENECA,,72.0,YR,,M,Y,86.0,KG,20211026.0,,MD,FR,FR,2021,Q4,Elderly
199971241,19997124,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Rhabdomyolysis,,2021,Q4,1,I,20210911.0,20211018.0,20211025,20211025,EXP,,FR-ASTRAZENECA-2021A777571,ASTRAZENECA,,72.0,YR,,M,Y,86.0,KG,20211026.0,,MD,FR,FR,2021,Q4,Elderly
199974362,19997436,8,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5/1000(bid),,,,,Unknown,,,,,,,2021,Q4,Anxiety,,2021,Q4,2,F,20210930.0,20211029.0,20211026,20211109,EXP,,BR-NOVOPROD-859720,NOVO NORDISK,,51.0,YR,,F,Y,92.8,KG,20211109.0,,MD,BR,BR,2021,Q4,Adult
199974362,19997436,8,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5/1000(bid),,,,,Unknown,,,,,,,2021,Q4,Hepatic steatosis,,2021,Q4,2,F,20210930.0,20211029.0,20211026,20211109,EXP,,BR-NOVOPROD-859720,NOVO NORDISK,,51.0,YR,,F,Y,92.8,KG,20211109.0,,MD,BR,BR,2021,Q4,Adult
199974362,19997436,8,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5/1000(bid),,,,,Unknown,,,,,,,2021,Q4,Asthenia,,2021,Q4,2,F,20210930.0,20211029.0,20211026,20211109,EXP,,BR-NOVOPROD-859720,NOVO NORDISK,,51.0,YR,,F,Y,92.8,KG,20211109.0,,MD,BR,BR,2021,Q4,Adult
199974362,19997436,8,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5/1000(bid),,,,,Unknown,,,,,,,2021,Q4,Abdominal distension,,2021,Q4,2,F,20210930.0,20211029.0,20211026,20211109,EXP,,BR-NOVOPROD-859720,NOVO NORDISK,,51.0,YR,,F,Y,92.8,KG,20211109.0,,MD,BR,BR,2021,Q4,Adult
199974362,19997436,8,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5/1000(bid),,,,,Unknown,,,,,,,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,2,F,20210930.0,20211029.0,20211026,20211109,EXP,,BR-NOVOPROD-859720,NOVO NORDISK,,51.0,YR,,F,Y,92.8,KG,20211109.0,,MD,BR,BR,2021,Q4,Adult
199974551,19997455,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, UNKNOWN",,,U,,,,,,,,,2021,Q4,Pulmonary congestion,,2021,Q4,1,I,20210601.0,20211015.0,20211026,20211026,EXP,,NVSC2021BG238569,NOVARTIS,,56.0,YR,,M,Y,,,20211026.0,,MD,BG,BG,2021,Q4,Adult
199974551,19997455,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, UNKNOWN",,,U,,,,,,,,,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20210601.0,20211015.0,20211026,20211026,EXP,,NVSC2021BG238569,NOVARTIS,,56.0,YR,,M,Y,,,20211026.0,,MD,BG,BG,2021,Q4,Adult
199974551,19997455,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, UNKNOWN",,,U,,,,,,,,,2021,Q4,Asthenia,,2021,Q4,1,I,20210601.0,20211015.0,20211026,20211026,EXP,,NVSC2021BG238569,NOVARTIS,,56.0,YR,,M,Y,,,20211026.0,,MD,BG,BG,2021,Q4,Adult
199974551,19997455,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, UNKNOWN",,,U,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20210601.0,20211015.0,20211026,20211026,EXP,,NVSC2021BG238569,NOVARTIS,,56.0,YR,,M,Y,,,20211026.0,,MD,BG,BG,2021,Q4,Adult
199974551,19997455,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, UNKNOWN",,,U,,,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,20210601.0,20211015.0,20211026,20211026,EXP,,NVSC2021BG238569,NOVARTIS,,56.0,YR,,M,Y,,,20211026.0,,MD,BG,BG,2021,Q4,Adult
199974551,19997455,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, UNKNOWN",,,U,,,,,,,,,2021,Q4,Oedema,,2021,Q4,1,I,20210601.0,20211015.0,20211026,20211026,EXP,,NVSC2021BG238569,NOVARTIS,,56.0,YR,,M,Y,,,20211026.0,,MD,BG,BG,2021,Q4,Adult
199974551,19997455,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, UNKNOWN",,,U,,,,,,,,,2021,Q4,Chest discomfort,,2021,Q4,1,I,20210601.0,20211015.0,20211026,20211026,EXP,,NVSC2021BG238569,NOVARTIS,,56.0,YR,,M,Y,,,20211026.0,,MD,BG,BG,2021,Q4,Adult
199974551,19997455,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, UNKNOWN",,,U,,,,,,,,,2021,Q4,Cardiac failure chronic,,2021,Q4,1,I,20210601.0,20211015.0,20211026,20211026,EXP,,NVSC2021BG238569,NOVARTIS,,56.0,YR,,M,Y,,,20211026.0,,MD,BG,BG,2021,Q4,Adult
199976472,19997647,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Circulatory collapse,,2021,Q4,2,F,20211020.0,20211202.0,20211026,20211206,EXP,,NVSC2021AU243065,NOVARTIS,,75.0,YR,,M,Y,,,20211206.0,,MD,AU,AU,2021,Q4,Elderly
199977561,19997756,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211020.0,20211026,20211026,EXP,,CA-ASTRAZENECA-2021A781215,ASTRAZENECA,,43.0,YR,,F,Y,,,20211026.0,,MD,CA,CA,2021,Q4,Adult
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Candida infection,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Blood pressure decreased,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Cyanosis,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Stomatitis,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Hypotension,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Diarrhoea,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Illness,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Behaviour disorder,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Hypotension,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Boredom,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Urinary tract infection,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Vomiting,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Nausea,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Nausea,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Micturition urgency,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Prerenal failure,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Vomiting,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Dysphagia,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199979292,19997929,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Immunodeficiency,,2021,Q4,2,F,20210901.0,20211104.0,20211026,20211117,EXP,,NVSC2021BR242611,NOVARTIS,,70.0,YR,,F,Y,,,20211117.0,,CN,BR,BR,2021,Q4,Elderly
199985531,19998553,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Drug interaction,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,GB-LDELTA-NLLD0034840,GB-DEXPHARM-20211782,DEXCEL,,75.0,YR,E,F,Y,87.0,KG,20211025.0,,HP,GB,GB,2021,Q4,Elderly
199985531,19998553,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Hydronephrosis,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,GB-LDELTA-NLLD0034840,GB-DEXPHARM-20211782,DEXCEL,,75.0,YR,E,F,Y,87.0,KG,20211025.0,,HP,GB,GB,2021,Q4,Elderly
199985531,19998553,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,GB-LDELTA-NLLD0034840,GB-DEXPHARM-20211782,DEXCEL,,75.0,YR,E,F,Y,87.0,KG,20211025.0,,HP,GB,GB,2021,Q4,Elderly
199985531,19998553,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Postmortem blood drug level increased,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,GB-LDELTA-NLLD0034840,GB-DEXPHARM-20211782,DEXCEL,,75.0,YR,E,F,Y,87.0,KG,20211025.0,,HP,GB,GB,2021,Q4,Elderly
199985531,19998553,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Upper airway obstruction,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,GB-LDELTA-NLLD0034840,GB-DEXPHARM-20211782,DEXCEL,,75.0,YR,E,F,Y,87.0,KG,20211025.0,,HP,GB,GB,2021,Q4,Elderly
199985531,19998553,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Emphysema,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,GB-LDELTA-NLLD0034840,GB-DEXPHARM-20211782,DEXCEL,,75.0,YR,E,F,Y,87.0,KG,20211025.0,,HP,GB,GB,2021,Q4,Elderly
199985531,19998553,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,GB-LDELTA-NLLD0034840,GB-DEXPHARM-20211782,DEXCEL,,75.0,YR,E,F,Y,87.0,KG,20211025.0,,HP,GB,GB,2021,Q4,Elderly
199985531,19998553,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,GB-LDELTA-NLLD0034840,GB-DEXPHARM-20211782,DEXCEL,,75.0,YR,E,F,Y,87.0,KG,20211025.0,,HP,GB,GB,2021,Q4,Elderly
199985531,19998553,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Cholelithiasis,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,GB-LDELTA-NLLD0034840,GB-DEXPHARM-20211782,DEXCEL,,75.0,YR,E,F,Y,87.0,KG,20211025.0,,HP,GB,GB,2021,Q4,Elderly
199985531,19998553,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Portal fibrosis,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,GB-LDELTA-NLLD0034840,GB-DEXPHARM-20211782,DEXCEL,,75.0,YR,E,F,Y,87.0,KG,20211025.0,,HP,GB,GB,2021,Q4,Elderly
199985531,19998553,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Urinary tract infection,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,GB-LDELTA-NLLD0034840,GB-DEXPHARM-20211782,DEXCEL,,75.0,YR,E,F,Y,87.0,KG,20211025.0,,HP,GB,GB,2021,Q4,Elderly
199985531,19998553,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Bladder trabeculation,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,GB-LDELTA-NLLD0034840,GB-DEXPHARM-20211782,DEXCEL,,75.0,YR,E,F,Y,87.0,KG,20211025.0,,HP,GB,GB,2021,Q4,Elderly
199985531,19998553,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Kidney fibrosis,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,GB-LDELTA-NLLD0034840,GB-DEXPHARM-20211782,DEXCEL,,75.0,YR,E,F,Y,87.0,KG,20211025.0,,HP,GB,GB,2021,Q4,Elderly
199989742,19998974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,140.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Dehydration,,2021,Q4,2,F,20210912.0,20211028.0,20211026,20211102,EXP,,JP-AstraZeneca-2021A769123,ASTRAZENECA,,87.0,YR,,M,Y,,,20211102.0,,MD,JP,,2021,Q4,Elderly
199989742,19998974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,140.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Cardiac arrest,,2021,Q4,2,F,20210912.0,20211028.0,20211026,20211102,EXP,,JP-AstraZeneca-2021A769123,ASTRAZENECA,,87.0,YR,,M,Y,,,20211102.0,,MD,JP,,2021,Q4,Elderly
199989742,19998974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,140.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Electrolyte imbalance,,2021,Q4,2,F,20210912.0,20211028.0,20211026,20211102,EXP,,JP-AstraZeneca-2021A769123,ASTRAZENECA,,87.0,YR,,M,Y,,,20211102.0,,MD,JP,,2021,Q4,Elderly
199989742,19998974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,140.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Hypernatraemia,,2021,Q4,2,F,20210912.0,20211028.0,20211026,20211102,EXP,,JP-AstraZeneca-2021A769123,ASTRAZENECA,,87.0,YR,,M,Y,,,20211102.0,,MD,JP,,2021,Q4,Elderly
199990373,19999037,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, 1x/day",,,Y,,Unknown,,,5.0,MG,,QD,2021,Q4,Metabolic acidosis,,2021,Q4,3,F,,20211101.0,20211026,20211115,EXP,,US-PFIZER INC-202101391978,PFIZER,"Cha, B.. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021;53 (8):2636-2639",55.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
199990373,19999037,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, 1x/day",,,Y,,Unknown,,,5.0,MG,,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,3,F,,20211101.0,20211026,20211115,EXP,,US-PFIZER INC-202101391978,PFIZER,"Cha, B.. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021;53 (8):2636-2639",55.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
199990373,19999037,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, 1x/day",,,Y,,Unknown,,,5.0,MG,,QD,2021,Q4,Acute kidney injury,,2021,Q4,3,F,,20211101.0,20211026,20211115,EXP,,US-PFIZER INC-202101391978,PFIZER,"Cha, B.. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021;53 (8):2636-2639",55.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
199990373,19999037,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, 1x/day",,,Y,,Unknown,,,5.0,MG,,QD,2021,Q4,Lactic acidosis,,2021,Q4,3,F,,20211101.0,20211026,20211115,EXP,,US-PFIZER INC-202101391978,PFIZER,"Cha, B.. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021;53 (8):2636-2639",55.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
199990373,19999037,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, 1x/day",,,Y,,Unknown,,,5.0,MG,,QD,2021,Q4,Shock,,2021,Q4,3,F,,20211101.0,20211026,20211115,EXP,,US-PFIZER INC-202101391978,PFIZER,"Cha, B.. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021;53 (8):2636-2639",55.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
199990373,19999037,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, 1x/day",,,Y,,Unknown,,,5.0,MG,,QD,2021,Q4,Respiratory alkalosis,,2021,Q4,3,F,,20211101.0,20211026,20211115,EXP,,US-PFIZER INC-202101391978,PFIZER,"Cha, B.. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021;53 (8):2636-2639",55.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
199990373,19999037,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day(10 mg/d and continued for 14 days )",,,Y,,Unknown,,,10.0,MG,,QD,2021,Q4,Metabolic acidosis,,2021,Q4,3,F,,20211101.0,20211026,20211115,EXP,,US-PFIZER INC-202101391978,PFIZER,"Cha, B.. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021;53 (8):2636-2639",55.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
199990373,19999037,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day(10 mg/d and continued for 14 days )",,,Y,,Unknown,,,10.0,MG,,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,3,F,,20211101.0,20211026,20211115,EXP,,US-PFIZER INC-202101391978,PFIZER,"Cha, B.. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021;53 (8):2636-2639",55.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
199990373,19999037,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day(10 mg/d and continued for 14 days )",,,Y,,Unknown,,,10.0,MG,,QD,2021,Q4,Acute kidney injury,,2021,Q4,3,F,,20211101.0,20211026,20211115,EXP,,US-PFIZER INC-202101391978,PFIZER,"Cha, B.. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021;53 (8):2636-2639",55.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
199990373,19999037,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day(10 mg/d and continued for 14 days )",,,Y,,Unknown,,,10.0,MG,,QD,2021,Q4,Lactic acidosis,,2021,Q4,3,F,,20211101.0,20211026,20211115,EXP,,US-PFIZER INC-202101391978,PFIZER,"Cha, B.. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021;53 (8):2636-2639",55.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
199990373,19999037,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day(10 mg/d and continued for 14 days )",,,Y,,Unknown,,,10.0,MG,,QD,2021,Q4,Shock,,2021,Q4,3,F,,20211101.0,20211026,20211115,EXP,,US-PFIZER INC-202101391978,PFIZER,"Cha, B.. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021;53 (8):2636-2639",55.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
199990373,19999037,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day(10 mg/d and continued for 14 days )",,,Y,,Unknown,,,10.0,MG,,QD,2021,Q4,Respiratory alkalosis,,2021,Q4,3,F,,20211101.0,20211026,20211115,EXP,,US-PFIZER INC-202101391978,PFIZER,"Cha, B.. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplantation Proceedings. 2021;53 (8):2636-2639",55.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
199992781,19999278,1,PS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 mg unknown frequency,,,Y,,,,202293.0,,,,,2021,Q4,Peripheral ischaemia,,2021,Q4,1,I,20210926.0,20211021.0,20211026,20211026,EXP,,GB-ASTRAZENECA-2021A782359,ASTRAZENECA,,74.0,YR,,M,Y,,,20211026.0,,MD,GB,GB,2021,Q4,Elderly
199993021,19999302,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211013.0,20211027,20211027,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-315268,RANBAXY,"Patel P, Patel T, PATIL S, Patel S, Ross Ang J. Considerations for sodium-glucose transporter 2 inhibitor therapy resulting in euglycemic diabetic ketoacidosis. Chest. 2021;Oct;160(Suppl4):981A-982A",40.0,YR,,M,Y,,,20211027.0,,HP,US,US,2021,Q4,Adult
200008431,20000843,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 DF (with meal),,,,,,,,,,Tablet,,2021,Q4,Incontinence,,2021,Q4,1,I,20210326.0,20210514.0,20211027,20211027,EXP,,NVSC2021MX112336,NOVARTIS,,78.0,YR,,F,Y,61.0,KG,20211027.0,,CN,MX,MX,2021,Q4,Elderly
200008431,20000843,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 DF (with meal),,,,,,,,,,Tablet,,2021,Q4,Cough,,2021,Q4,1,I,20210326.0,20210514.0,20211027,20211027,EXP,,NVSC2021MX112336,NOVARTIS,,78.0,YR,,F,Y,61.0,KG,20211027.0,,CN,MX,MX,2021,Q4,Elderly
200008431,20000843,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 DF (with meal),,,,,,,,,,Tablet,,2021,Q4,Malignant melanoma,,2021,Q4,1,I,20210326.0,20210514.0,20211027,20211027,EXP,,NVSC2021MX112336,NOVARTIS,,78.0,YR,,F,Y,61.0,KG,20211027.0,,CN,MX,MX,2021,Q4,Elderly
200008431,20000843,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 DF (with meal),,,,,,,,,,Tablet,,2021,Q4,Blood sodium decreased,,2021,Q4,1,I,20210326.0,20210514.0,20211027,20211027,EXP,,NVSC2021MX112336,NOVARTIS,,78.0,YR,,F,Y,61.0,KG,20211027.0,,CN,MX,MX,2021,Q4,Elderly
200014411,20001441,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,11800.0,MG,Y,,MM3585,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketosis,,2021,Q4,1,I,20210920.0,20211018.0,20211027,20211027,EXP,,CN-ASTRAZENECA-2021A780406,ASTRAZENECA,,22310.0,DY,,F,Y,,,20211027.0,,MD,CN,CN,2021,Q4,Elderly
200014411,20001441,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,11800.0,MG,Y,,MM3585,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketosis,,2021,Q4,1,I,20210920.0,20211018.0,20211027,20211027,EXP,,CN-ASTRAZENECA-2021A780406,ASTRAZENECA,,22310.0,DY,,F,Y,,,20211027.0,,MD,CN,CN,2021,Q4,Elderly
200014421,20001442,1,PS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 mg,,,Y,,,,202293.0,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211015.0,20211021.0,20211027,20211027,EXP,,GB-ASTRAZENECA-2021A782355,ASTRAZENECA,,62.0,YR,,M,Y,100.0,KG,20211027.0,,MD,GB,GB,2021,Q4,Adult
200014553,20001455,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3935.0,MG,Y,,,,,5.0,MG,Tablet,QD,2021,Q4,Weight increased,,2021,Q4,3,F,20211005.0,20211201.0,20211027,20211208,EXP,,JP-AstraZeneca-2021A782680,ASTRAZENECA,,32.0,YR,,F,Y,61.0,KG,20211208.0,,MD,JP,,2021,Q4,Young Adult
200014553,20001455,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3935.0,MG,Y,,,,,5.0,MG,Tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,3,F,20211005.0,20211201.0,20211027,20211208,EXP,,JP-AstraZeneca-2021A782680,ASTRAZENECA,,32.0,YR,,F,Y,61.0,KG,20211208.0,,MD,JP,,2021,Q4,Young Adult
200014553,20001455,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3935.0,MG,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Weight increased,,2021,Q4,3,F,20211005.0,20211201.0,20211027,20211208,EXP,,JP-AstraZeneca-2021A782680,ASTRAZENECA,,32.0,YR,,F,Y,61.0,KG,20211208.0,,MD,JP,,2021,Q4,Young Adult
200014553,20001455,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3935.0,MG,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,3,F,20211005.0,20211201.0,20211027,20211208,EXP,,JP-AstraZeneca-2021A782680,ASTRAZENECA,,32.0,YR,,F,Y,61.0,KG,20211208.0,,MD,JP,,2021,Q4,Young Adult
200016531,20001653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,Y,,,,211564.0,5.0,MG,,,2021,Q4,Seizure,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,Y,,,,211564.0,5.0,MG,,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,Y,,,,211564.0,5.0,MG,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,Y,,,,211564.0,5.0,MG,,,2021,Q4,Clostridium difficile infection,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,Y,,,,211564.0,5.0,MG,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,Y,,,,211564.0,5.0,MG,,,2021,Q4,Posterior reversible encephalopathy syndrome,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,Y,,,,211564.0,5.0,MG,,,2021,Q4,Respiratory alkalosis,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,Y,,,,211564.0,5.0,MG,,,2021,Q4,Shock,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,Y,,,,211564.0,5.0,MG,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,Y,,,,211564.0,10.0,MG,,,2021,Q4,Seizure,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,Y,,,,211564.0,10.0,MG,,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,Y,,,,211564.0,10.0,MG,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,Y,,,,211564.0,10.0,MG,,,2021,Q4,Clostridium difficile infection,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,Y,,,,211564.0,10.0,MG,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,Y,,,,211564.0,10.0,MG,,,2021,Q4,Posterior reversible encephalopathy syndrome,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,Y,,,,211564.0,10.0,MG,,,2021,Q4,Respiratory alkalosis,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,Y,,,,211564.0,10.0,MG,,,2021,Q4,Shock,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200016531,20001653,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,Y,,,,211564.0,10.0,MG,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211015.0,20211027,20211027,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068463,GLENMARK,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor-aAssociated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,115.0,KG,20211027.0,,MD,US,US,2021,Q4,Adult
200025271,20002527,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,unknown,,,U,,,,202293.0,,,Tablet,,2021,Q4,Anal abscess,,2021,Q4,1,I,,20211020.0,20211027,20211027,EXP,,CA-ASTRAZENECA-2021A781224,ASTRAZENECA,,69.0,YR,,M,Y,,,20211027.0,,MD,CA,CA,2021,Q4,Elderly
200025271,20002527,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,unknown,,,U,,,,202293.0,,,Tablet,,2021,Q4,Gangrene,,2021,Q4,1,I,,20211020.0,20211027,20211027,EXP,,CA-ASTRAZENECA-2021A781224,ASTRAZENECA,,69.0,YR,,M,Y,,,20211027.0,,MD,CA,CA,2021,Q4,Elderly
200032861,20003286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Gamma-glutamyltransferase increased,,2021,Q4,1,I,20210623.0,20211014.0,20211027,20211027,EXP,GB-MHRA-EYC 00262905,GB-PFIZER INC-202101369993,PFIZER,,69.0,YR,,F,Y,,,20211027.0,,PH,GB,GB,2021,Q4,Elderly
200032861,20003286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Death,,2021,Q4,1,I,20210623.0,20211014.0,20211027,20211027,EXP,GB-MHRA-EYC 00262905,GB-PFIZER INC-202101369993,PFIZER,,69.0,YR,,F,Y,,,20211027.0,,PH,GB,GB,2021,Q4,Elderly
200032861,20003286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Liver function test abnormal,,2021,Q4,1,I,20210623.0,20211014.0,20211027,20211027,EXP,GB-MHRA-EYC 00262905,GB-PFIZER INC-202101369993,PFIZER,,69.0,YR,,F,Y,,,20211027.0,,PH,GB,GB,2021,Q4,Elderly
200035661,20003566,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,Y,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211013.0,20211028,20211028,EXP,,US-UNICHEM PHARMACEUTICALS (USA) INC-UCM202110-000980,UNICHEM,,40.0,YR,A,M,Y,,,20211028.0,,HP,US,US,2021,Q4,Adult
200035661,20003566,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,Y,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211013.0,20211028,20211028,EXP,,US-UNICHEM PHARMACEUTICALS (USA) INC-UCM202110-000980,UNICHEM,,40.0,YR,A,M,Y,,,20211028.0,,HP,US,US,2021,Q4,Adult
200037921,20003792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Bladder cancer recurrent,,2021,Q4,1,I,,20211019.0,20211027,20211027,EXP,,GR-ASTRAZENECA-2021A783479,ASTRAZENECA,,70.0,YR,,M,Y,,,20211027.0,,MD,GR,GR,2021,Q4,Elderly
200058842,20005884,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Intracranial pressure increased,,2021,Q4,2,F,20210922.0,20211111.0,20211027,20211113,EXP,,NVSC2021HU244861,NOVARTIS,,69.0,YR,,M,Y,,,20211113.0,,HP,HU,HU,2021,Q4,Elderly
200058842,20005884,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Metastases to lung,,2021,Q4,2,F,20210922.0,20211111.0,20211027,20211113,EXP,,NVSC2021HU244861,NOVARTIS,,69.0,YR,,M,Y,,,20211113.0,,HP,HU,HU,2021,Q4,Elderly
200058842,20005884,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Colon cancer,,2021,Q4,2,F,20210922.0,20211111.0,20211027,20211113,EXP,,NVSC2021HU244861,NOVARTIS,,69.0,YR,,M,Y,,,20211113.0,,HP,HU,HU,2021,Q4,Elderly
200058842,20005884,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Epilepsy,,2021,Q4,2,F,20210922.0,20211111.0,20211027,20211113,EXP,,NVSC2021HU244861,NOVARTIS,,69.0,YR,,M,Y,,,20211113.0,,HP,HU,HU,2021,Q4,Elderly
200058842,20005884,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Metastases to central nervous system,,2021,Q4,2,F,20210922.0,20211111.0,20211027,20211113,EXP,,NVSC2021HU244861,NOVARTIS,,69.0,YR,,M,Y,,,20211113.0,,HP,HU,HU,2021,Q4,Elderly
200070992,20007099,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Nightmare,,2021,Q4,2,F,20211008.0,20211101.0,20211028,20211109,EXP,,GB-AstraZeneca-2021A782170,ASTRAZENECA,,74.0,YR,,M,Y,104.8,KG,20211109.0,,HP,GB,,2021,Q4,Elderly
200070992,20007099,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Panic attack,,2021,Q4,2,F,20211008.0,20211101.0,20211028,20211109,EXP,,GB-AstraZeneca-2021A782170,ASTRAZENECA,,74.0,YR,,M,Y,104.8,KG,20211109.0,,HP,GB,,2021,Q4,Elderly
200071082,20007108,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2021,Q4,Urinary tract infection,,2021,Q4,2,F,,20211022.0,20211028,20211029,EXP,GB-LDELTA-NLLD0034840,GB-TORRENT-00026652,TORRENT,,75.0,YR,E,F,Y,87.0,KG,20211029.0,,MD,GB,GB,2021,Q4,Elderly
200071082,20007108,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,2,F,,20211022.0,20211028,20211029,EXP,GB-LDELTA-NLLD0034840,GB-TORRENT-00026652,TORRENT,,75.0,YR,E,F,Y,87.0,KG,20211029.0,,MD,GB,GB,2021,Q4,Elderly
200071082,20007108,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2021,Q4,Cholelithiasis,,2021,Q4,2,F,,20211022.0,20211028,20211029,EXP,GB-LDELTA-NLLD0034840,GB-TORRENT-00026652,TORRENT,,75.0,YR,E,F,Y,87.0,KG,20211029.0,,MD,GB,GB,2021,Q4,Elderly
200071082,20007108,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2021,Q4,Kidney fibrosis,,2021,Q4,2,F,,20211022.0,20211028,20211029,EXP,GB-LDELTA-NLLD0034840,GB-TORRENT-00026652,TORRENT,,75.0,YR,E,F,Y,87.0,KG,20211029.0,,MD,GB,GB,2021,Q4,Elderly
200071082,20007108,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2021,Q4,Bladder trabeculation,,2021,Q4,2,F,,20211022.0,20211028,20211029,EXP,GB-LDELTA-NLLD0034840,GB-TORRENT-00026652,TORRENT,,75.0,YR,E,F,Y,87.0,KG,20211029.0,,MD,GB,GB,2021,Q4,Elderly
200071082,20007108,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2021,Q4,Portal fibrosis,,2021,Q4,2,F,,20211022.0,20211028,20211029,EXP,GB-LDELTA-NLLD0034840,GB-TORRENT-00026652,TORRENT,,75.0,YR,E,F,Y,87.0,KG,20211029.0,,MD,GB,GB,2021,Q4,Elderly
200071082,20007108,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2021,Q4,Death,,2021,Q4,2,F,,20211022.0,20211028,20211029,EXP,GB-LDELTA-NLLD0034840,GB-TORRENT-00026652,TORRENT,,75.0,YR,E,F,Y,87.0,KG,20211029.0,,MD,GB,GB,2021,Q4,Elderly
200071082,20007108,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2021,Q4,Hydronephrosis,,2021,Q4,2,F,,20211022.0,20211028,20211029,EXP,GB-LDELTA-NLLD0034840,GB-TORRENT-00026652,TORRENT,,75.0,YR,E,F,Y,87.0,KG,20211029.0,,MD,GB,GB,2021,Q4,Elderly
200071082,20007108,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,2,F,,20211022.0,20211028,20211029,EXP,GB-LDELTA-NLLD0034840,GB-TORRENT-00026652,TORRENT,,75.0,YR,E,F,Y,87.0,KG,20211029.0,,MD,GB,GB,2021,Q4,Elderly
200071082,20007108,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2021,Q4,Postmortem blood drug level increased,,2021,Q4,2,F,,20211022.0,20211028,20211029,EXP,GB-LDELTA-NLLD0034840,GB-TORRENT-00026652,TORRENT,,75.0,YR,E,F,Y,87.0,KG,20211029.0,,MD,GB,GB,2021,Q4,Elderly
200071082,20007108,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2021,Q4,Upper airway obstruction,,2021,Q4,2,F,,20211022.0,20211028,20211029,EXP,GB-LDELTA-NLLD0034840,GB-TORRENT-00026652,TORRENT,,75.0,YR,E,F,Y,87.0,KG,20211029.0,,MD,GB,GB,2021,Q4,Elderly
200071082,20007108,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2021,Q4,Emphysema,,2021,Q4,2,F,,20211022.0,20211028,20211029,EXP,GB-LDELTA-NLLD0034840,GB-TORRENT-00026652,TORRENT,,75.0,YR,E,F,Y,87.0,KG,20211029.0,,MD,GB,GB,2021,Q4,Elderly
200071082,20007108,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,2,F,,20211022.0,20211028,20211029,EXP,GB-LDELTA-NLLD0034840,GB-TORRENT-00026652,TORRENT,,75.0,YR,E,F,Y,87.0,KG,20211029.0,,MD,GB,GB,2021,Q4,Elderly
200084831,20008483,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,"UNKNOWN,UNKNOWN",,,5.0,MG,Unknown,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,"UNKNOWN,UNKNOWN",,,5.0,MG,Unknown,,2021,Q4,Seizure,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,"UNKNOWN,UNKNOWN",,,5.0,MG,Unknown,,2021,Q4,Clostridium difficile infection,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,"UNKNOWN,UNKNOWN",,,5.0,MG,Unknown,,2021,Q4,Shock,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,"UNKNOWN,UNKNOWN",,,5.0,MG,Unknown,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,"UNKNOWN,UNKNOWN",,,5.0,MG,Unknown,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,"UNKNOWN,UNKNOWN",,,5.0,MG,Unknown,,2021,Q4,Respiratory alkalosis,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,"UNKNOWN,UNKNOWN",,,5.0,MG,Unknown,,2021,Q4,Posterior reversible encephalopathy syndrome,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,"UNKNOWN,UNKNOWN",,,5.0,MG,Unknown,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg/d and continued for 14 days,,,Y,,"UNKNOWN,UNKNOWN",,,10.0,MG,Unknown,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg/d and continued for 14 days,,,Y,,"UNKNOWN,UNKNOWN",,,10.0,MG,Unknown,,2021,Q4,Seizure,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg/d and continued for 14 days,,,Y,,"UNKNOWN,UNKNOWN",,,10.0,MG,Unknown,,2021,Q4,Clostridium difficile infection,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg/d and continued for 14 days,,,Y,,"UNKNOWN,UNKNOWN",,,10.0,MG,Unknown,,2021,Q4,Shock,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg/d and continued for 14 days,,,Y,,"UNKNOWN,UNKNOWN",,,10.0,MG,Unknown,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg/d and continued for 14 days,,,Y,,"UNKNOWN,UNKNOWN",,,10.0,MG,Unknown,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg/d and continued for 14 days,,,Y,,"UNKNOWN,UNKNOWN",,,10.0,MG,Unknown,,2021,Q4,Respiratory alkalosis,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg/d and continued for 14 days,,,Y,,"UNKNOWN,UNKNOWN",,,10.0,MG,Unknown,,2021,Q4,Posterior reversible encephalopathy syndrome,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200084831,20008483,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg/d and continued for 14 days,,,Y,,"UNKNOWN,UNKNOWN",,,10.0,MG,Unknown,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211015.0,20211029,20211029,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-55743,HIKMA,,55.0,YR,,M,Y,,,20211029.0,,MD,US,US,2021,Q4,Adult
200094551,20009455,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 of 10 mg with meal,,,,,,,,10.0,MG,Tablet,,2021,Q4,Cough,,2021,Q4,1,I,20170101.0,20170516.0,20211029,20211029,EXP,,PHHY2017MX073365,NOVARTIS,,74.0,YR,,F,Y,61.0,KG,20211029.0,,CN,MX,MX,2021,Q4,Elderly
200094551,20009455,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 of 10 mg with meal,,,,,,,,10.0,MG,Tablet,,2021,Q4,Cough,,2021,Q4,1,I,20170101.0,20170516.0,20211029,20211029,EXP,,PHHY2017MX073365,NOVARTIS,,74.0,YR,,F,Y,61.0,KG,20211029.0,,CN,MX,MX,2021,Q4,Elderly
200094551,20009455,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 of 10 mg with meal,,,,,,,,10.0,MG,Tablet,,2021,Q4,Incontinence,,2021,Q4,1,I,20170101.0,20170516.0,20211029,20211029,EXP,,PHHY2017MX073365,NOVARTIS,,74.0,YR,,F,Y,61.0,KG,20211029.0,,CN,MX,MX,2021,Q4,Elderly
200094551,20009455,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 of 10 mg with meal,,,,,,,,10.0,MG,Tablet,,2021,Q4,Blood sodium decreased,,2021,Q4,1,I,20170101.0,20170516.0,20211029,20211029,EXP,,PHHY2017MX073365,NOVARTIS,,74.0,YR,,F,Y,61.0,KG,20211029.0,,CN,MX,MX,2021,Q4,Elderly
200094551,20009455,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 of 10 mg with meal,,,,,,,,10.0,MG,Tablet,,2021,Q4,Malignant melanoma,,2021,Q4,1,I,20170101.0,20170516.0,20211029,20211029,EXP,,PHHY2017MX073365,NOVARTIS,,74.0,YR,,F,Y,61.0,KG,20211029.0,,CN,MX,MX,2021,Q4,Elderly
200094791,20009479,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Cholelithiasis,,2021,Q4,1,I,,20211018.0,20211028,20211028,EXP,,GB-TEVA-2021-GB-1968608,TEVA,,75.0,YR,E,F,Y,87.0,KG,20211028.0,,HP,GB,GB,2021,Q4,Elderly
200094791,20009479,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211018.0,20211028,20211028,EXP,,GB-TEVA-2021-GB-1968608,TEVA,,75.0,YR,E,F,Y,87.0,KG,20211028.0,,HP,GB,GB,2021,Q4,Elderly
200094791,20009479,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,1,I,,20211018.0,20211028,20211028,EXP,,GB-TEVA-2021-GB-1968608,TEVA,,75.0,YR,E,F,Y,87.0,KG,20211028.0,,HP,GB,GB,2021,Q4,Elderly
200094791,20009479,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Kidney fibrosis,,2021,Q4,1,I,,20211018.0,20211028,20211028,EXP,,GB-TEVA-2021-GB-1968608,TEVA,,75.0,YR,E,F,Y,87.0,KG,20211028.0,,HP,GB,GB,2021,Q4,Elderly
200094791,20009479,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Upper airway obstruction,,2021,Q4,1,I,,20211018.0,20211028,20211028,EXP,,GB-TEVA-2021-GB-1968608,TEVA,,75.0,YR,E,F,Y,87.0,KG,20211028.0,,HP,GB,GB,2021,Q4,Elderly
200094791,20009479,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Urinary tract infection,,2021,Q4,1,I,,20211018.0,20211028,20211028,EXP,,GB-TEVA-2021-GB-1968608,TEVA,,75.0,YR,E,F,Y,87.0,KG,20211028.0,,HP,GB,GB,2021,Q4,Elderly
200094791,20009479,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Bladder trabeculation,,2021,Q4,1,I,,20211018.0,20211028,20211028,EXP,,GB-TEVA-2021-GB-1968608,TEVA,,75.0,YR,E,F,Y,87.0,KG,20211028.0,,HP,GB,GB,2021,Q4,Elderly
200094791,20009479,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,1,I,,20211018.0,20211028,20211028,EXP,,GB-TEVA-2021-GB-1968608,TEVA,,75.0,YR,E,F,Y,87.0,KG,20211028.0,,HP,GB,GB,2021,Q4,Elderly
200094791,20009479,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Postmortem blood drug level increased,,2021,Q4,1,I,,20211018.0,20211028,20211028,EXP,,GB-TEVA-2021-GB-1968608,TEVA,,75.0,YR,E,F,Y,87.0,KG,20211028.0,,HP,GB,GB,2021,Q4,Elderly
200094791,20009479,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Portal fibrosis,,2021,Q4,1,I,,20211018.0,20211028,20211028,EXP,,GB-TEVA-2021-GB-1968608,TEVA,,75.0,YR,E,F,Y,87.0,KG,20211028.0,,HP,GB,GB,2021,Q4,Elderly
200094791,20009479,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Emphysema,,2021,Q4,1,I,,20211018.0,20211028,20211028,EXP,,GB-TEVA-2021-GB-1968608,TEVA,,75.0,YR,E,F,Y,87.0,KG,20211028.0,,HP,GB,GB,2021,Q4,Elderly
200094791,20009479,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Hydronephrosis,,2021,Q4,1,I,,20211018.0,20211028,20211028,EXP,,GB-TEVA-2021-GB-1968608,TEVA,,75.0,YR,E,F,Y,87.0,KG,20211028.0,,HP,GB,GB,2021,Q4,Elderly
200095021,20009502,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Extremity necrosis,,2021,Q4,1,I,,20211020.0,20211028,20211028,EXP,,CA-ASTRAZENECA-2021A781198,ASTRAZENECA,,88.0,YR,,M,Y,82.0,KG,20211028.0,,MD,CA,CA,2021,Q4,Elderly
200101562,20010156,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2021,Q4,Lactic acidosis,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2021,Q4,Clostridium difficile infection,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2021,Q4,Acute kidney injury,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2021,Q4,Metabolic acidosis,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2021,Q4,Respiratory alkalosis,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2021,Q4,Posterior reversible encephalopathy syndrome,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2021,Q4,Shock,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2021,Q4,Seizure,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram(10 mg/d and continued for 14 days),,,Y,,,,,10.0,MG,,,2021,Q4,Lactic acidosis,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram(10 mg/d and continued for 14 days),,,Y,,,,,10.0,MG,,,2021,Q4,Clostridium difficile infection,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram(10 mg/d and continued for 14 days),,,Y,,,,,10.0,MG,,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram(10 mg/d and continued for 14 days),,,Y,,,,,10.0,MG,,,2021,Q4,Metabolic acidosis,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram(10 mg/d and continued for 14 days),,,Y,,,,,10.0,MG,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram(10 mg/d and continued for 14 days),,,Y,,,,,10.0,MG,,,2021,Q4,Respiratory alkalosis,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram(10 mg/d and continued for 14 days),,,Y,,,,,10.0,MG,,,2021,Q4,Posterior reversible encephalopathy syndrome,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram(10 mg/d and continued for 14 days),,,Y,,,,,10.0,MG,,,2021,Q4,Shock,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200101562,20010156,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram(10 mg/d and continued for 14 days),,,Y,,,,,10.0,MG,,,2021,Q4,Seizure,,2021,Q4,2,F,,20211025.0,20211029,20211109,EXP,,US-AUROBINDO-AUR-APL-2021-043470,AUROBINDO,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY.. Sodium-Glucose Cotransporter-2 Inhibitor???Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings.. 2021",55.0,YR,,M,Y,,,20211109.0,,MD,US,US,2021,Q4,Adult
200102451,20010245,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211013.0,20211028,20211028,EXP,,DE-ASTRAZENECA-2021A775745,ASTRAZENECA,,52.0,YR,,M,Y,,,20211028.0,,MD,DE,DE,2021,Q4,Adult
200102451,20010245,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,,20211013.0,20211028,20211028,EXP,,DE-ASTRAZENECA-2021A775745,ASTRAZENECA,,52.0,YR,,M,Y,,,20211028.0,,MD,DE,DE,2021,Q4,Adult
200102451,20010245,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211013.0,20211028,20211028,EXP,,DE-ASTRAZENECA-2021A775745,ASTRAZENECA,,52.0,YR,,M,Y,,,20211028.0,,MD,DE,DE,2021,Q4,Adult
200105091,20010509,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2021,Q4,Vomiting,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2021,Q4,Dizziness,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2021,Q4,Cataract,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2021,Q4,Cataract,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2021,Q4,Vertigo,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2021,Q4,Eye infarction,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200111501,20011150,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,,,,,2021,Q4,Hepatic enzyme increased,,2021,Q4,1,I,20211015.0,20211019.0,20211029,20211029,EXP,GB-MHRA-EYC 00263701,GB-DRREDDYS-SPO/UKI/21/0142862,DR REDDYS,,62.0,YR,A,M,Y,,,20211029.0,,MD,GB,GB,2021,Q4,Adult
200117311,20011731,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2780.0,MG,Y,,,,,10.0,MG,,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20211022.0,20211024.0,20211029,20211029,EXP,,GB-ASTRAZENECA-2021A783893,ASTRAZENECA,,52.0,YR,,M,Y,,,20211029.0,,MD,GB,GB,2021,Q4,Adult
200117321,20011732,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,202293.0,,,,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211011.0,20211025.0,20211029,20211029,EXP,,ES-ASTRAZENECA-2021A784171,ASTRAZENECA,,34.0,YR,,M,Y,,,20211029.0,,MD,ES,ES,2021,Q4,Young Adult
200123681,20012368,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2021,Q4,Blood glucose abnormal,,2021,Q4,1,I,,20211025.0,20211029,20211029,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110010391,ELI LILLY AND CO,,64.0,YR,,M,Y,83.0,KG,20211029.0,,CN,CN,CN,2021,Q4,Adult
200124411,20012441,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,,20211022.0,20211029,20211029,EXP,,DE-ASTRAZENECA-2021A785141,ASTRAZENECA,,56.0,YR,,M,Y,,,20211029.0,,MD,DE,DE,2021,Q4,Adult
200124411,20012441,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Pacemaker generated arrhythmia,,2021,Q4,1,I,,20211022.0,20211029,20211029,EXP,,DE-ASTRAZENECA-2021A785141,ASTRAZENECA,,56.0,YR,,M,Y,,,20211029.0,,MD,DE,DE,2021,Q4,Adult
200128982,20012898,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Shock,,2021,Q4,2,F,20210808.0,20211215.0,20211029,20211223,EXP,,JP-AstraZeneca-2021A785861,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20211223.0,,MD,JP,,2021,Q4,Elderly
200128982,20012898,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Sepsis,,2021,Q4,2,F,20210808.0,20211215.0,20211029,20211223,EXP,,JP-AstraZeneca-2021A785861,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20211223.0,,MD,JP,,2021,Q4,Elderly
200128982,20012898,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Fulminant type 1 diabetes mellitus,,2021,Q4,2,F,20210808.0,20211215.0,20211029,20211223,EXP,,JP-AstraZeneca-2021A785861,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20211223.0,,MD,JP,,2021,Q4,Elderly
200187891,20018789,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (take 1 tablet by mouth daily),,,,,,,,,,Tablet,,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20210418.0,20211018.0,20211101,20211101,EXP,,NL-AUROBINDO-AUR-APL-2021-043943,AUROBINDO,,64.0,YR,,M,Y,90.0,KG,20211101.0,,MD,NL,NL,2021,Q4,Adult
200187891,20018789,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (take 1 tablet by mouth daily),,,,,,,,,,Tablet,,2021,Q4,Cardiac asthma,,2021,Q4,1,I,20210418.0,20211018.0,20211101,20211101,EXP,,NL-AUROBINDO-AUR-APL-2021-043943,AUROBINDO,,64.0,YR,,M,Y,90.0,KG,20211101.0,,MD,NL,NL,2021,Q4,Adult
200187891,20018789,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (take 1 tablet by mouth daily),,,,,,,,,,Tablet,,2021,Q4,Hyperkalaemia,,2021,Q4,1,I,20210418.0,20211018.0,20211101,20211101,EXP,,NL-AUROBINDO-AUR-APL-2021-043943,AUROBINDO,,64.0,YR,,M,Y,90.0,KG,20211101.0,,MD,NL,NL,2021,Q4,Adult
200187891,20018789,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (take 1 tablet by mouth daily),,,,,,,,,,Tablet,,2021,Q4,Malaise,,2021,Q4,1,I,20210418.0,20211018.0,20211101,20211101,EXP,,NL-AUROBINDO-AUR-APL-2021-043943,AUROBINDO,,64.0,YR,,M,Y,90.0,KG,20211101.0,,MD,NL,NL,2021,Q4,Adult
200191701,20019170,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,90.0,MG,Y,,2103224 MM3083,,,10.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20211004.0,20211021.0,20211101,20211101,EXP,,CN-AstraZeneca-2021A784226,ASTRAZENECA,,70.0,YR,,F,Y,,,20211101.0,,MD,CN,,2021,Q4,Elderly
200191741,20019174,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,MM3086,,,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210927.0,20211022.0,20211101,20211101,EXP,,CN-AstraZeneca-2021A786111,ASTRAZENECA,,68.0,YR,,F,Y,36.0,KG,20211101.0,,MD,CN,,2021,Q4,Elderly
200191771,20019177,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211021.0,20211101,20211101,EXP,,JP-AstraZeneca-2021A784546,ASTRAZENECA,,64.0,YR,,F,Y,45.0,KG,20211101.0,,MD,JP,,2021,Q4,Adult
200197221,20019722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211025.0,20211101,20211101,EXP,,PL-AstraZeneca-2021A784022,ASTRAZENECA,,64.0,YR,,M,Y,,,20211101.0,,MD,PL,,2021,Q4,Adult
200197221,20019722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,1,I,,20211025.0,20211101,20211101,EXP,,PL-AstraZeneca-2021A784022,ASTRAZENECA,,64.0,YR,,M,Y,,,20211101.0,,MD,PL,,2021,Q4,Adult
200197221,20019722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Obesity,,2021,Q4,1,I,,20211025.0,20211101,20211101,EXP,,PL-AstraZeneca-2021A784022,ASTRAZENECA,,64.0,YR,,M,Y,,,20211101.0,,MD,PL,,2021,Q4,Adult
200197221,20019722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211025.0,20211101,20211101,EXP,,PL-AstraZeneca-2021A784022,ASTRAZENECA,,64.0,YR,,M,Y,,,20211101.0,,MD,PL,,2021,Q4,Adult
200197221,20019722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20211025.0,20211101,20211101,EXP,,PL-AstraZeneca-2021A784022,ASTRAZENECA,,64.0,YR,,M,Y,,,20211101.0,,MD,PL,,2021,Q4,Adult
200197221,20019722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Hyperuricaemia,,2021,Q4,1,I,,20211025.0,20211101,20211101,EXP,,PL-AstraZeneca-2021A784022,ASTRAZENECA,,64.0,YR,,M,Y,,,20211101.0,,MD,PL,,2021,Q4,Adult
200197221,20019722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Diabetes mellitus,,2021,Q4,1,I,,20211025.0,20211101,20211101,EXP,,PL-AstraZeneca-2021A784022,ASTRAZENECA,,64.0,YR,,M,Y,,,20211101.0,,MD,PL,,2021,Q4,Adult
200197221,20019722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Hypertension,,2021,Q4,1,I,,20211025.0,20211101,20211101,EXP,,PL-AstraZeneca-2021A784022,ASTRAZENECA,,64.0,YR,,M,Y,,,20211101.0,,MD,PL,,2021,Q4,Adult
200197221,20019722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211025.0,20211101,20211101,EXP,,PL-AstraZeneca-2021A784022,ASTRAZENECA,,64.0,YR,,M,Y,,,20211101.0,,MD,PL,,2021,Q4,Adult
200197221,20019722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,1,I,,20211025.0,20211101,20211101,EXP,,PL-AstraZeneca-2021A784022,ASTRAZENECA,,64.0,YR,,M,Y,,,20211101.0,,MD,PL,,2021,Q4,Adult
200202481,20020248,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211015.0,20211020.0,20211101,20211101,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110009192,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20211101.0,,CN,CN,CN,2021,Q4,Young Adult
200202481,20020248,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,20211015.0,20211020.0,20211101,20211101,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110009192,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20211101.0,,CN,CN,CN,2021,Q4,Young Adult
200202481,20020248,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Mobility decreased,,2021,Q4,1,I,20211015.0,20211020.0,20211101,20211101,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110009192,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20211101.0,,CN,CN,CN,2021,Q4,Young Adult
200202481,20020248,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,20211015.0,20211020.0,20211101,20211101,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110009192,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20211101.0,,CN,CN,CN,2021,Q4,Young Adult
200203921,20020392,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 5 mg,1745.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20211014.0,20211027.0,20211101,20211101,EXP,,DK-AstraZeneca-2021A786703,ASTRAZENECA,,85.0,YR,,F,Y,,,20211101.0,,MD,DK,,2021,Q4,Elderly
200203921,20020392,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 5 mg,1745.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Malaise,,2021,Q4,1,I,20211014.0,20211027.0,20211101,20211101,EXP,,DK-AstraZeneca-2021A786703,ASTRAZENECA,,85.0,YR,,F,Y,,,20211101.0,,MD,DK,,2021,Q4,Elderly
200203921,20020392,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 5 mg,1745.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Urinary tract infection,,2021,Q4,1,I,20211014.0,20211027.0,20211101,20211101,EXP,,DK-AstraZeneca-2021A786703,ASTRAZENECA,,85.0,YR,,F,Y,,,20211101.0,,MD,DK,,2021,Q4,Elderly
200203921,20020392,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 5 mg,1745.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Depressed level of consciousness,,2021,Q4,1,I,20211014.0,20211027.0,20211101,20211101,EXP,,DK-AstraZeneca-2021A786703,ASTRAZENECA,,85.0,YR,,F,Y,,,20211101.0,,MD,DK,,2021,Q4,Elderly
200205811,20020581,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,GB-AstraZeneca-2021A783789,ASTRAZENECA,,75.0,YR,,M,Y,65.4,KG,20211101.0,,MD,GB,,2021,Q4,Elderly
200205811,20020581,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,,,2021,Q4,Abnormal loss of weight,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,GB-AstraZeneca-2021A783789,ASTRAZENECA,,75.0,YR,,M,Y,65.4,KG,20211101.0,,MD,GB,,2021,Q4,Elderly
200205811,20020581,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,,,2021,Q4,Diabetic ketosis,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,GB-AstraZeneca-2021A783789,ASTRAZENECA,,75.0,YR,,M,Y,65.4,KG,20211101.0,,MD,GB,,2021,Q4,Elderly
200205811,20020581,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,,,2021,Q4,Thirst,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,GB-AstraZeneca-2021A783789,ASTRAZENECA,,75.0,YR,,M,Y,65.4,KG,20211101.0,,MD,GB,,2021,Q4,Elderly
200210341,20021034,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20210728.0,20211025.0,20211101,20211101,EXP,DE-BFARM-21007351,DE-MYLANLABS-2021M1076679,MYLAN,,54.0,YR,,M,Y,,,20211101.0,,MD,DE,DE,2021,Q4,Adult
200223561,20022356,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg (1 + 0 + 0),,,,,,,,,,,,2021,Q4,Non-proliferative retinopathy,,2021,Q4,1,I,,20211022.0,20211102,20211102,EXP,,BR-NOVOPROD-861060,NOVO NORDISK,,60.0,YR,,M,Y,85.8,KG,20211102.0,,MD,BR,BR,2021,Q4,Adult
200223561,20022356,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg (1 + 0 + 0),,,,,,,,,,,,2021,Q4,Polyneuropathy,,2021,Q4,1,I,,20211022.0,20211102,20211102,EXP,,BR-NOVOPROD-861060,NOVO NORDISK,,60.0,YR,,M,Y,85.8,KG,20211102.0,,MD,BR,BR,2021,Q4,Adult
200225681,20022568,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,Y,,unknown,,,5.0,MG,,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211019.0,20211102,20211102,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-21047,LUPIN,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis after orthotopic heart transplant in a prediabetic patient: A case report.. Transplantation Proceedings. 2021;53:2636?2639",55.0,YR,,M,Y,,,20211102.0,,MD,US,US,2021,Q4,Adult
200225681,20022568,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,Y,,unknown,,,5.0,MG,,QD,2021,Q4,Shock,,2021,Q4,1,I,,20211019.0,20211102,20211102,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-21047,LUPIN,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis after orthotopic heart transplant in a prediabetic patient: A case report.. Transplantation Proceedings. 2021;53:2636?2639",55.0,YR,,M,Y,,,20211102.0,,MD,US,US,2021,Q4,Adult
200225681,20022568,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,Y,,unknown,,,5.0,MG,,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211019.0,20211102,20211102,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-21047,LUPIN,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis after orthotopic heart transplant in a prediabetic patient: A case report.. Transplantation Proceedings. 2021;53:2636?2639",55.0,YR,,M,Y,,,20211102.0,,MD,US,US,2021,Q4,Adult
200225681,20022568,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,Y,,unknown,,,10.0,MG,,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211019.0,20211102,20211102,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-21047,LUPIN,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis after orthotopic heart transplant in a prediabetic patient: A case report.. Transplantation Proceedings. 2021;53:2636?2639",55.0,YR,,M,Y,,,20211102.0,,MD,US,US,2021,Q4,Adult
200225681,20022568,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,Y,,unknown,,,10.0,MG,,QD,2021,Q4,Shock,,2021,Q4,1,I,,20211019.0,20211102,20211102,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-21047,LUPIN,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis after orthotopic heart transplant in a prediabetic patient: A case report.. Transplantation Proceedings. 2021;53:2636?2639",55.0,YR,,M,Y,,,20211102.0,,MD,US,US,2021,Q4,Adult
200225681,20022568,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,Y,,unknown,,,10.0,MG,,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211019.0,20211102,20211102,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-21047,LUPIN,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis after orthotopic heart transplant in a prediabetic patient: A case report.. Transplantation Proceedings. 2021;53:2636?2639",55.0,YR,,M,Y,,,20211102.0,,MD,US,US,2021,Q4,Adult
200228101,20022810,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,,,,,2021,Q4,Portal fibrosis,,2021,Q4,1,I,,20211018.0,20211102,20211102,EXP,,GB-AUROBINDO-AUR-APL-2021-043679,AUROBINDO,,75.0,YR,,F,Y,87.0,KG,20211102.0,,MD,GB,GB,2021,Q4,Elderly
200228101,20022810,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,,,,,2021,Q4,Postmortem blood drug level increased,,2021,Q4,1,I,,20211018.0,20211102,20211102,EXP,,GB-AUROBINDO-AUR-APL-2021-043679,AUROBINDO,,75.0,YR,,F,Y,87.0,KG,20211102.0,,MD,GB,GB,2021,Q4,Elderly
200228101,20022810,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,,,,,2021,Q4,Urinary tract infection,,2021,Q4,1,I,,20211018.0,20211102,20211102,EXP,,GB-AUROBINDO-AUR-APL-2021-043679,AUROBINDO,,75.0,YR,,F,Y,87.0,KG,20211102.0,,MD,GB,GB,2021,Q4,Elderly
200228101,20022810,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,,,,,2021,Q4,Cholelithiasis,,2021,Q4,1,I,,20211018.0,20211102,20211102,EXP,,GB-AUROBINDO-AUR-APL-2021-043679,AUROBINDO,,75.0,YR,,F,Y,87.0,KG,20211102.0,,MD,GB,GB,2021,Q4,Elderly
200228101,20022810,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,1,I,,20211018.0,20211102,20211102,EXP,,GB-AUROBINDO-AUR-APL-2021-043679,AUROBINDO,,75.0,YR,,F,Y,87.0,KG,20211102.0,,MD,GB,GB,2021,Q4,Elderly
200228101,20022810,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,1,I,,20211018.0,20211102,20211102,EXP,,GB-AUROBINDO-AUR-APL-2021-043679,AUROBINDO,,75.0,YR,,F,Y,87.0,KG,20211102.0,,MD,GB,GB,2021,Q4,Elderly
200228101,20022810,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,,,,,2021,Q4,Emphysema,,2021,Q4,1,I,,20211018.0,20211102,20211102,EXP,,GB-AUROBINDO-AUR-APL-2021-043679,AUROBINDO,,75.0,YR,,F,Y,87.0,KG,20211102.0,,MD,GB,GB,2021,Q4,Elderly
200228101,20022810,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,,,,,2021,Q4,Bladder trabeculation,,2021,Q4,1,I,,20211018.0,20211102,20211102,EXP,,GB-AUROBINDO-AUR-APL-2021-043679,AUROBINDO,,75.0,YR,,F,Y,87.0,KG,20211102.0,,MD,GB,GB,2021,Q4,Elderly
200228101,20022810,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,,,,,2021,Q4,Kidney fibrosis,,2021,Q4,1,I,,20211018.0,20211102,20211102,EXP,,GB-AUROBINDO-AUR-APL-2021-043679,AUROBINDO,,75.0,YR,,F,Y,87.0,KG,20211102.0,,MD,GB,GB,2021,Q4,Elderly
200228101,20022810,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211018.0,20211102,20211102,EXP,,GB-AUROBINDO-AUR-APL-2021-043679,AUROBINDO,,75.0,YR,,F,Y,87.0,KG,20211102.0,,MD,GB,GB,2021,Q4,Elderly
200228101,20022810,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,,,,,2021,Q4,Hydronephrosis,,2021,Q4,1,I,,20211018.0,20211102,20211102,EXP,,GB-AUROBINDO-AUR-APL-2021-043679,AUROBINDO,,75.0,YR,,F,Y,87.0,KG,20211102.0,,MD,GB,GB,2021,Q4,Elderly
200228101,20022810,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,,,,,2021,Q4,Upper airway obstruction,,2021,Q4,1,I,,20211018.0,20211102,20211102,EXP,,GB-AUROBINDO-AUR-APL-2021-043679,AUROBINDO,,75.0,YR,,F,Y,87.0,KG,20211102.0,,MD,GB,GB,2021,Q4,Elderly
200246061,20024606,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"0.5 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20210830.0,20211025.0,20211102,20211102,EXP,,KR-KARYOPHARM-2021KPT001281,KARYOPHARM THERAPEUTICS,,68.0,YR,,F,Y,49.3,KG,20211102.0,,MD,KR,KR,2021,Q4,Elderly
200246061,20024606,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"0.5 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20210830.0,20211025.0,20211102,20211102,EXP,,KR-KARYOPHARM-2021KPT001281,KARYOPHARM THERAPEUTICS,,68.0,YR,,F,Y,49.3,KG,20211102.0,,MD,KR,KR,2021,Q4,Elderly
200246061,20024606,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"0.5 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Nausea,,2021,Q4,1,I,20210830.0,20211025.0,20211102,20211102,EXP,,KR-KARYOPHARM-2021KPT001281,KARYOPHARM THERAPEUTICS,,68.0,YR,,F,Y,49.3,KG,20211102.0,,MD,KR,KR,2021,Q4,Elderly
200246061,20024606,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"0.5 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Neutropenia,,2021,Q4,1,I,20210830.0,20211025.0,20211102,20211102,EXP,,KR-KARYOPHARM-2021KPT001281,KARYOPHARM THERAPEUTICS,,68.0,YR,,F,Y,49.3,KG,20211102.0,,MD,KR,KR,2021,Q4,Elderly
200246061,20024606,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"0.5 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Vomiting,,2021,Q4,1,I,20210830.0,20211025.0,20211102,20211102,EXP,,KR-KARYOPHARM-2021KPT001281,KARYOPHARM THERAPEUTICS,,68.0,YR,,F,Y,49.3,KG,20211102.0,,MD,KR,KR,2021,Q4,Elderly
200246061,20024606,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"0.5 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Septic shock,,2021,Q4,1,I,20210830.0,20211025.0,20211102,20211102,EXP,,KR-KARYOPHARM-2021KPT001281,KARYOPHARM THERAPEUTICS,,68.0,YR,,F,Y,49.3,KG,20211102.0,,MD,KR,KR,2021,Q4,Elderly
200246061,20024606,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"0.5 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Febrile neutropenia,,2021,Q4,1,I,20210830.0,20211025.0,20211102,20211102,EXP,,KR-KARYOPHARM-2021KPT001281,KARYOPHARM THERAPEUTICS,,68.0,YR,,F,Y,49.3,KG,20211102.0,,MD,KR,KR,2021,Q4,Elderly
200246061,20024606,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"0.5 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Thrombocytopenia,,2021,Q4,1,I,20210830.0,20211025.0,20211102,20211102,EXP,,KR-KARYOPHARM-2021KPT001281,KARYOPHARM THERAPEUTICS,,68.0,YR,,F,Y,49.3,KG,20211102.0,,MD,KR,KR,2021,Q4,Elderly
200258741,20025874,16,C,DAPAGLIFLOZINE/ Brand name not specified,,2,Oral,"1 Dosage forms Daily;  Therapy Start date :ASKU,Therapy End date :ASKU",,,,,Unknown,,,,,Tablet,,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20210418.0,20211024.0,20211102,20211102,EXP,,NL-TEVA-2021-NL-1971173,TEVA,,64.0,YR,A,M,Y,90.0,KG,20211102.0,,MD,NL,NL,2021,Q4,Adult
200258741,20025874,16,C,DAPAGLIFLOZINE/ Brand name not specified,,2,Oral,"1 Dosage forms Daily;  Therapy Start date :ASKU,Therapy End date :ASKU",,,,,Unknown,,,,,Tablet,,2021,Q4,Malaise,,2021,Q4,1,I,20210418.0,20211024.0,20211102,20211102,EXP,,NL-TEVA-2021-NL-1971173,TEVA,,64.0,YR,A,M,Y,90.0,KG,20211102.0,,MD,NL,NL,2021,Q4,Adult
200258741,20025874,16,C,DAPAGLIFLOZINE/ Brand name not specified,,2,Oral,"1 Dosage forms Daily;  Therapy Start date :ASKU,Therapy End date :ASKU",,,,,Unknown,,,,,Tablet,,2021,Q4,Hyperkalaemia,,2021,Q4,1,I,20210418.0,20211024.0,20211102,20211102,EXP,,NL-TEVA-2021-NL-1971173,TEVA,,64.0,YR,A,M,Y,90.0,KG,20211102.0,,MD,NL,NL,2021,Q4,Adult
200258741,20025874,16,C,DAPAGLIFLOZINE/ Brand name not specified,,2,Oral,"1 Dosage forms Daily;  Therapy Start date :ASKU,Therapy End date :ASKU",,,,,Unknown,,,,,Tablet,,2021,Q4,Cardiac asthma,,2021,Q4,1,I,20210418.0,20211024.0,20211102,20211102,EXP,,NL-TEVA-2021-NL-1971173,TEVA,,64.0,YR,A,M,Y,90.0,KG,20211102.0,,MD,NL,NL,2021,Q4,Adult
200259311,20025931,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,,20211028.0,20211102,20211102,EXP,,RO-AstraZeneca-2021A790459,ASTRAZENECA,,65.0,YR,,F,Y,,,20211102.0,,MD,RO,,2021,Q4,Elderly
200282491,20028249,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Urinary tract infection,,2021,Q4,1,I,,20211022.0,20211103,20211103,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316671,RANBAXY,,75.0,YR,,F,Y,87.0,KG,20211103.0,,HP,GB,GB,2021,Q4,Elderly
200282491,20028249,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Hydronephrosis,,2021,Q4,1,I,,20211022.0,20211103,20211103,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316671,RANBAXY,,75.0,YR,,F,Y,87.0,KG,20211103.0,,HP,GB,GB,2021,Q4,Elderly
200282491,20028249,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Portal fibrosis,,2021,Q4,1,I,,20211022.0,20211103,20211103,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316671,RANBAXY,,75.0,YR,,F,Y,87.0,KG,20211103.0,,HP,GB,GB,2021,Q4,Elderly
200282491,20028249,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Postmortem blood drug level increased,,2021,Q4,1,I,,20211022.0,20211103,20211103,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316671,RANBAXY,,75.0,YR,,F,Y,87.0,KG,20211103.0,,HP,GB,GB,2021,Q4,Elderly
200282491,20028249,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Emphysema,,2021,Q4,1,I,,20211022.0,20211103,20211103,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316671,RANBAXY,,75.0,YR,,F,Y,87.0,KG,20211103.0,,HP,GB,GB,2021,Q4,Elderly
200282491,20028249,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,1,I,,20211022.0,20211103,20211103,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316671,RANBAXY,,75.0,YR,,F,Y,87.0,KG,20211103.0,,HP,GB,GB,2021,Q4,Elderly
200282491,20028249,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,1,I,,20211022.0,20211103,20211103,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316671,RANBAXY,,75.0,YR,,F,Y,87.0,KG,20211103.0,,HP,GB,GB,2021,Q4,Elderly
200282491,20028249,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Upper airway obstruction,,2021,Q4,1,I,,20211022.0,20211103,20211103,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316671,RANBAXY,,75.0,YR,,F,Y,87.0,KG,20211103.0,,HP,GB,GB,2021,Q4,Elderly
200282491,20028249,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211022.0,20211103,20211103,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316671,RANBAXY,,75.0,YR,,F,Y,87.0,KG,20211103.0,,HP,GB,GB,2021,Q4,Elderly
200282491,20028249,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Kidney fibrosis,,2021,Q4,1,I,,20211022.0,20211103,20211103,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316671,RANBAXY,,75.0,YR,,F,Y,87.0,KG,20211103.0,,HP,GB,GB,2021,Q4,Elderly
200282491,20028249,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Death,,2021,Q4,1,I,,20211022.0,20211103,20211103,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316671,RANBAXY,,75.0,YR,,F,Y,87.0,KG,20211103.0,,HP,GB,GB,2021,Q4,Elderly
200282491,20028249,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Cholelithiasis,,2021,Q4,1,I,,20211022.0,20211103,20211103,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316671,RANBAXY,,75.0,YR,,F,Y,87.0,KG,20211103.0,,HP,GB,GB,2021,Q4,Elderly
200282491,20028249,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Bladder trabeculation,,2021,Q4,1,I,,20211022.0,20211103,20211103,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316671,RANBAXY,,75.0,YR,,F,Y,87.0,KG,20211103.0,,HP,GB,GB,2021,Q4,Elderly
200285404,20028540,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,No adverse event,,2021,Q4,4,F,20201030.0,20211217.0,20211103,20211223,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-115734,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,85.0,KG,20211223.0,,MD,SE,SE,2021,Q4,Elderly
200285631,20028563,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9400.0,MG,,,UNKNOWN,,,10.0,MG,"Tablet, Film Coated",QD,2021,Q4,Cholangitis,,2021,Q4,1,I,20211001.0,20211020.0,20211103,20211103,EXP,IT-MINISAL02-798905,IT-ROCHE-2941016,ROCHE,,75.0,YR,,M,Y,,,20211103.0,,MD,IT,IT,2021,Q4,Elderly
200285631,20028563,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9400.0,MG,,,UNKNOWN,,,10.0,MG,"Tablet, Film Coated",QD,2021,Q4,Asthenia,,2021,Q4,1,I,20211001.0,20211020.0,20211103,20211103,EXP,IT-MINISAL02-798905,IT-ROCHE-2941016,ROCHE,,75.0,YR,,M,Y,,,20211103.0,,MD,IT,IT,2021,Q4,Elderly
200285631,20028563,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9400.0,MG,,,UNKNOWN,,,10.0,MG,"Tablet, Film Coated",QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,20211001.0,20211020.0,20211103,20211103,EXP,IT-MINISAL02-798905,IT-ROCHE-2941016,ROCHE,,75.0,YR,,M,Y,,,20211103.0,,MD,IT,IT,2021,Q4,Elderly
200285631,20028563,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9400.0,MG,,,UNKNOWN,,,10.0,MG,"Tablet, Film Coated",QD,2021,Q4,Cholelithiasis,,2021,Q4,1,I,20211001.0,20211020.0,20211103,20211103,EXP,IT-MINISAL02-798905,IT-ROCHE-2941016,ROCHE,,75.0,YR,,M,Y,,,20211103.0,,MD,IT,IT,2021,Q4,Elderly
200285631,20028563,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9400.0,MG,,,UNKNOWN,,,10.0,MG,"Tablet, Film Coated",QD,2021,Q4,Transaminases increased,,2021,Q4,1,I,20211001.0,20211020.0,20211103,20211103,EXP,IT-MINISAL02-798905,IT-ROCHE-2941016,ROCHE,,75.0,YR,,M,Y,,,20211103.0,,MD,IT,IT,2021,Q4,Elderly
200309601,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Otitis externa,,2021,Q4,1,I,20200816.0,20211026.0,20211103,20211103,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20211103.0,,MD,JP,JP,2021,Q4,Elderly
200309601,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Blood thyroid stimulating hormone increased,,2021,Q4,1,I,20200816.0,20211026.0,20211103,20211103,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20211103.0,,MD,JP,JP,2021,Q4,Elderly
200309601,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Dermatitis psoriasiform,,2021,Q4,1,I,20200816.0,20211026.0,20211103,20211103,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20211103.0,,MD,JP,JP,2021,Q4,Elderly
200309601,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Dermatitis allergic,,2021,Q4,1,I,20200816.0,20211026.0,20211103,20211103,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20211103.0,,MD,JP,JP,2021,Q4,Elderly
200309601,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Malignant neoplasm progression,,2021,Q4,1,I,20200816.0,20211026.0,20211103,20211103,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20211103.0,,MD,JP,JP,2021,Q4,Elderly
200309601,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2021,Q4,Klebsiella infection,,2021,Q4,1,I,20200816.0,20211026.0,20211103,20211103,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20211103.0,,MD,JP,JP,2021,Q4,Elderly
200314651,20031465,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,1,I,20200701.0,20211019.0,20211103,20211103,EXP,,CO-ABBVIE-20K-036-3619994-00,ABBVIE,,70.0,YR,,F,Y,73.0,KG,20211029.0,,HP,COUNTRY NOT SPECIFIED,CO,2021,Q4,Elderly
200314651,20031465,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Inflammation,,2021,Q4,1,I,20200701.0,20211019.0,20211103,20211103,EXP,,CO-ABBVIE-20K-036-3619994-00,ABBVIE,,70.0,YR,,F,Y,73.0,KG,20211029.0,,HP,COUNTRY NOT SPECIFIED,CO,2021,Q4,Elderly
200314651,20031465,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20200701.0,20211019.0,20211103,20211103,EXP,,CO-ABBVIE-20K-036-3619994-00,ABBVIE,,70.0,YR,,F,Y,73.0,KG,20211029.0,,HP,COUNTRY NOT SPECIFIED,CO,2021,Q4,Elderly
200314651,20031465,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20200701.0,20211019.0,20211103,20211103,EXP,,CO-ABBVIE-20K-036-3619994-00,ABBVIE,,70.0,YR,,F,Y,73.0,KG,20211029.0,,HP,COUNTRY NOT SPECIFIED,CO,2021,Q4,Elderly
200314651,20031465,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Arthropathy,,2021,Q4,1,I,20200701.0,20211019.0,20211103,20211103,EXP,,CO-ABBVIE-20K-036-3619994-00,ABBVIE,,70.0,YR,,F,Y,73.0,KG,20211029.0,,HP,COUNTRY NOT SPECIFIED,CO,2021,Q4,Elderly
200314651,20031465,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Sciatica,,2021,Q4,1,I,20200701.0,20211019.0,20211103,20211103,EXP,,CO-ABBVIE-20K-036-3619994-00,ABBVIE,,70.0,YR,,F,Y,73.0,KG,20211029.0,,HP,COUNTRY NOT SPECIFIED,CO,2021,Q4,Elderly
200327892,20032789,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2021,Q4,Aortic valve incompetence,,2021,Q4,2,F,20211020.0,20211130.0,20211104,20211206,EXP,,NVSJ2021JP017892,NOVARTIS,,82.0,YR,,M,Y,,,20211206.0,,MD,JP,JP,2021,Q4,Elderly
200327892,20032789,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,2,F,20211020.0,20211130.0,20211104,20211206,EXP,,NVSJ2021JP017892,NOVARTIS,,82.0,YR,,M,Y,,,20211206.0,,MD,JP,JP,2021,Q4,Elderly
200327892,20032789,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2021,Q4,Cardiac failure,,2021,Q4,2,F,20211020.0,20211130.0,20211104,20211206,EXP,,NVSJ2021JP017892,NOVARTIS,,82.0,YR,,M,Y,,,20211206.0,,MD,JP,JP,2021,Q4,Elderly
200327892,20032789,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2021,Q4,Pulmonary valve incompetence,,2021,Q4,2,F,20211020.0,20211130.0,20211104,20211206,EXP,,NVSJ2021JP017892,NOVARTIS,,82.0,YR,,M,Y,,,20211206.0,,MD,JP,JP,2021,Q4,Elderly
200327892,20032789,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2021,Q4,Blood creatinine increased,,2021,Q4,2,F,20211020.0,20211130.0,20211104,20211206,EXP,,NVSJ2021JP017892,NOVARTIS,,82.0,YR,,M,Y,,,20211206.0,,MD,JP,JP,2021,Q4,Elderly
200327892,20032789,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2021,Q4,Mitral valve incompetence,,2021,Q4,2,F,20211020.0,20211130.0,20211104,20211206,EXP,,NVSJ2021JP017892,NOVARTIS,,82.0,YR,,M,Y,,,20211206.0,,MD,JP,JP,2021,Q4,Elderly
200334371,20033437,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,N,,,,,10.0,MG,,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20210409.0,20211029.0,20211104,20211104,EXP,,DE-AstraZeneca-2021A789308,ASTRAZENECA,,34.0,YR,,M,Y,105.0,KG,20211104.0,,MD,DE,,2021,Q4,Young Adult
200334381,20033438,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,MM3577,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketosis,,2021,Q4,1,I,20211016.0,20211026.0,20211104,20211104,EXP,,CN-AstraZeneca-2021A789430,ASTRAZENECA,,17167.0,DY,,M,Y,,,20211104.0,,MD,CN,,2021,Q4,Elderly
200334381,20033438,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,MM3577,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Urticaria,,2021,Q4,1,I,20211016.0,20211026.0,20211104,20211104,EXP,,CN-AstraZeneca-2021A789430,ASTRAZENECA,,17167.0,DY,,M,Y,,,20211104.0,,MD,CN,,2021,Q4,Elderly
200335772,20033577,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,2,F,,20211116.0,20211104,20211123,EXP,,PT-AstraZeneca-2021A788741,ASTRAZENECA,"Salvador F, Linhares F, Rodriguez M et al. PD 23 CETOACIDOSE DIABETICA EUGLICEMICA: THE DARK SIDE DOS INIBIDORES SGLT2. Centro Hospitalar de Tras-os-Montes e Alto Douro, EPE / Unidade Hospitalar de Chaves",60.0,YR,,M,Y,,,20211123.0,,MD,PT,,2021,Q4,Adult
200335772,20033577,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,2,F,,20211116.0,20211104,20211123,EXP,,PT-AstraZeneca-2021A788741,ASTRAZENECA,"Salvador F, Linhares F, Rodriguez M et al. PD 23 CETOACIDOSE DIABETICA EUGLICEMICA: THE DARK SIDE DOS INIBIDORES SGLT2. Centro Hospitalar de Tras-os-Montes e Alto Douro, EPE / Unidade Hospitalar de Chaves",60.0,YR,,M,Y,,,20211123.0,,MD,PT,,2021,Q4,Adult
200342471,20034247,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Impaired healing,,2021,Q4,1,I,,20211027.0,20211104,20211104,EXP,,ZA-AstraZeneca-2021A792057,ASTRAZENECA,,67.0,YR,,F,Y,,,20211104.0,,CN,ZA,,2021,Q4,Elderly
200342471,20034247,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Wound,,2021,Q4,1,I,,20211027.0,20211104,20211104,EXP,,ZA-AstraZeneca-2021A792057,ASTRAZENECA,,67.0,YR,,F,Y,,,20211104.0,,CN,ZA,,2021,Q4,Elderly
200345111,20034511,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Hyperuricaemia,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,NVSC2021PL249208,NOVARTIS,,64.0,YR,,M,Y,,,20211104.0,,MD,PL,PL,2021,Q4,Adult
200345111,20034511,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Hypertension,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,NVSC2021PL249208,NOVARTIS,,64.0,YR,,M,Y,,,20211104.0,,MD,PL,PL,2021,Q4,Adult
200345111,20034511,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,NVSC2021PL249208,NOVARTIS,,64.0,YR,,M,Y,,,20211104.0,,MD,PL,PL,2021,Q4,Adult
200345111,20034511,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,NVSC2021PL249208,NOVARTIS,,64.0,YR,,M,Y,,,20211104.0,,MD,PL,PL,2021,Q4,Adult
200345111,20034511,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,NVSC2021PL249208,NOVARTIS,,64.0,YR,,M,Y,,,20211104.0,,MD,PL,PL,2021,Q4,Adult
200345111,20034511,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Diabetes mellitus,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,NVSC2021PL249208,NOVARTIS,,64.0,YR,,M,Y,,,20211104.0,,MD,PL,PL,2021,Q4,Adult
200345111,20034511,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,NVSC2021PL249208,NOVARTIS,,64.0,YR,,M,Y,,,20211104.0,,MD,PL,PL,2021,Q4,Adult
200345111,20034511,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Obesity,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,NVSC2021PL249208,NOVARTIS,,64.0,YR,,M,Y,,,20211104.0,,MD,PL,PL,2021,Q4,Adult
200345111,20034511,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,NVSC2021PL249208,NOVARTIS,,64.0,YR,,M,Y,,,20211104.0,,MD,PL,PL,2021,Q4,Adult
200345111,20034511,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,NVSC2021PL249208,NOVARTIS,,64.0,YR,,M,Y,,,20211104.0,,MD,PL,PL,2021,Q4,Adult
200348781,20034878,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,170.0,MG,Y,,C19210458,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Micturition disorder,,2021,Q4,1,I,20210701.0,20211027.0,20211104,20211104,EXP,,CN-AstraZeneca-2021A792405,ASTRAZENECA,,19287.0,DY,,F,Y,55.0,KG,20211104.0,,MD,CN,,2021,Q4,Elderly
200352681,20035268,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211031.0,20211104,20211104,EXP,,PL-BAUSCH-BL-2021-036241,BAUSCH AND LOMB,,64.0,YR,,M,Y,95.0,KG,20211104.0,,MD,PL,PL,2021,Q4,Adult
200352681,20035268,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Hyperuricaemia,,2021,Q4,1,I,,20211031.0,20211104,20211104,EXP,,PL-BAUSCH-BL-2021-036241,BAUSCH AND LOMB,,64.0,YR,,M,Y,95.0,KG,20211104.0,,MD,PL,PL,2021,Q4,Adult
200352681,20035268,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,1,I,,20211031.0,20211104,20211104,EXP,,PL-BAUSCH-BL-2021-036241,BAUSCH AND LOMB,,64.0,YR,,M,Y,95.0,KG,20211104.0,,MD,PL,PL,2021,Q4,Adult
200352681,20035268,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Diabetes mellitus,,2021,Q4,1,I,,20211031.0,20211104,20211104,EXP,,PL-BAUSCH-BL-2021-036241,BAUSCH AND LOMB,,64.0,YR,,M,Y,95.0,KG,20211104.0,,MD,PL,PL,2021,Q4,Adult
200352681,20035268,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20211031.0,20211104,20211104,EXP,,PL-BAUSCH-BL-2021-036241,BAUSCH AND LOMB,,64.0,YR,,M,Y,95.0,KG,20211104.0,,MD,PL,PL,2021,Q4,Adult
200352681,20035268,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Obesity,,2021,Q4,1,I,,20211031.0,20211104,20211104,EXP,,PL-BAUSCH-BL-2021-036241,BAUSCH AND LOMB,,64.0,YR,,M,Y,95.0,KG,20211104.0,,MD,PL,PL,2021,Q4,Adult
200352681,20035268,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Hypertension,,2021,Q4,1,I,,20211031.0,20211104,20211104,EXP,,PL-BAUSCH-BL-2021-036241,BAUSCH AND LOMB,,64.0,YR,,M,Y,95.0,KG,20211104.0,,MD,PL,PL,2021,Q4,Adult
200352681,20035268,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,1,I,,20211031.0,20211104,20211104,EXP,,PL-BAUSCH-BL-2021-036241,BAUSCH AND LOMB,,64.0,YR,,M,Y,95.0,KG,20211104.0,,MD,PL,PL,2021,Q4,Adult
200352681,20035268,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211031.0,20211104,20211104,EXP,,PL-BAUSCH-BL-2021-036241,BAUSCH AND LOMB,,64.0,YR,,M,Y,95.0,KG,20211104.0,,MD,PL,PL,2021,Q4,Adult
200352681,20035268,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211031.0,20211104,20211104,EXP,,PL-BAUSCH-BL-2021-036241,BAUSCH AND LOMB,,64.0,YR,,M,Y,95.0,KG,20211104.0,,MD,PL,PL,2021,Q4,Adult
200353542,20035354,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 Milligram Daily;,,,Y,,,,,5.0,MG,,QD,2021,Q4,Acute kidney injury,,2021,Q4,2,F,,20211109.0,20211104,20211117,EXP,,US-TEVA-2021-US-1972584,TEVA,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplant-Proc 2021;:.",55.0,YR,A,M,Y,,,20211117.0,,MD,US,US,2021,Q4,Adult
200353542,20035354,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 Milligram Daily;,,,Y,,,,,5.0,MG,,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,,20211109.0,20211104,20211117,EXP,,US-TEVA-2021-US-1972584,TEVA,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplant-Proc 2021;:.",55.0,YR,A,M,Y,,,20211117.0,,MD,US,US,2021,Q4,Adult
200353542,20035354,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 Milligram Daily;,,,Y,,,,,5.0,MG,,QD,2021,Q4,Shock,,2021,Q4,2,F,,20211109.0,20211104,20211117,EXP,,US-TEVA-2021-US-1972584,TEVA,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplant-Proc 2021;:.",55.0,YR,A,M,Y,,,20211117.0,,MD,US,US,2021,Q4,Adult
200353542,20035354,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,Y,,,,,10.0,MG,,QD,2021,Q4,Acute kidney injury,,2021,Q4,2,F,,20211109.0,20211104,20211117,EXP,,US-TEVA-2021-US-1972584,TEVA,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplant-Proc 2021;:.",55.0,YR,A,M,Y,,,20211117.0,,MD,US,US,2021,Q4,Adult
200353542,20035354,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,Y,,,,,10.0,MG,,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,,20211109.0,20211104,20211117,EXP,,US-TEVA-2021-US-1972584,TEVA,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplant-Proc 2021;:.",55.0,YR,A,M,Y,,,20211117.0,,MD,US,US,2021,Q4,Adult
200353542,20035354,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,Y,,,,,10.0,MG,,QD,2021,Q4,Shock,,2021,Q4,2,F,,20211109.0,20211104,20211117,EXP,,US-TEVA-2021-US-1972584,TEVA,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report. Transplant-Proc 2021;:.",55.0,YR,A,M,Y,,,20211117.0,,MD,US,US,2021,Q4,Adult
200362711,20036271,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,,,2021,Q4,Sepsis,,2021,Q4,1,I,20210401.0,20211029.0,20211105,20211105,EXP,,AU-AstraZeneca-2021A793829,ASTRAZENECA,,81.0,YR,,M,Y,,,20211105.0,,MD,AU,,2021,Q4,Elderly
200378751,20037875,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Urinary tract infection staphylococcal,,2021,Q4,1,I,,20211027.0,20211105,20211105,EXP,CA- HEALTHCANVIG- E2B_04190950,CA-NOVOPROD-861529,NOVO NORDISK,,72.0,YR,,M,Y,,,20211105.0,,CN,CA,CA,2021,Q4,Elderly
200384111,20038411,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown dose every day,,,,,,,,,,,,2021,Q4,Cardiomegaly,,2021,Q4,1,I,,20211029.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A792325,ASTRAZENECA,,80.0,YR,,M,Y,,,20211105.0,,MD,DE,,2021,Q4,Elderly
200384111,20038411,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown dose every day,,,,,,,,,,,,2021,Q4,Mitral valve incompetence,,2021,Q4,1,I,,20211029.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A792325,ASTRAZENECA,,80.0,YR,,M,Y,,,20211105.0,,MD,DE,,2021,Q4,Elderly
200384111,20038411,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown dose every day,,,,,,,,,,,,2021,Q4,Ejection fraction,,2021,Q4,1,I,,20211029.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A792325,ASTRAZENECA,,80.0,YR,,M,Y,,,20211105.0,,MD,DE,,2021,Q4,Elderly
200384111,20038411,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown dose every day,,,,,,,,,,,,2021,Q4,Proteinuria,,2021,Q4,1,I,,20211029.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A792325,ASTRAZENECA,,80.0,YR,,M,Y,,,20211105.0,,MD,DE,,2021,Q4,Elderly
200384111,20038411,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown dose every day,,,,,,,,,,,,2021,Q4,Cardiac failure congestive,,2021,Q4,1,I,,20211029.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A792325,ASTRAZENECA,,80.0,YR,,M,Y,,,20211105.0,,MD,DE,,2021,Q4,Elderly
200384111,20038411,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown dose every day,,,,,,,,,,,,2021,Q4,Blood pressure systolic increased,,2021,Q4,1,I,,20211029.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A792325,ASTRAZENECA,,80.0,YR,,M,Y,,,20211105.0,,MD,DE,,2021,Q4,Elderly
200384111,20038411,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown dose every day,,,,,,,,,,,,2021,Q4,Pleural effusion,,2021,Q4,1,I,,20211029.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A792325,ASTRAZENECA,,80.0,YR,,M,Y,,,20211105.0,,MD,DE,,2021,Q4,Elderly
200384111,20038411,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown dose every day,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211029.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A792325,ASTRAZENECA,,80.0,YR,,M,Y,,,20211105.0,,MD,DE,,2021,Q4,Elderly
200384111,20038411,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown dose every day,,,,,,,,,,,,2021,Q4,Brain natriuretic peptide increased,,2021,Q4,1,I,,20211029.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A792325,ASTRAZENECA,,80.0,YR,,M,Y,,,20211105.0,,MD,DE,,2021,Q4,Elderly
200384111,20038411,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown dose every day,,,,,,,,,,,,2021,Q4,Pulmonary oedema,,2021,Q4,1,I,,20211029.0,20211105,20211105,EXP,,DE-AstraZeneca-2021A792325,ASTRAZENECA,,80.0,YR,,M,Y,,,20211105.0,,MD,DE,,2021,Q4,Elderly
200388181,20038818,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, 1x/day (1 tablet every 24 hours)",,,,,,,,,,Tablet,QD,2021,Q4,Hypotension,,2021,Q4,1,I,20210503.0,20211027.0,20211105,20211105,EXP,ES-AEMPS-1033179,ES-PFIZER INC-202101453673,PFIZER,,70.0,YR,,M,Y,,,20211105.0,,MD,ES,ES,2021,Q4,Elderly
200388321,20038832,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,,,Y2133A,,205649.0,,,Tablet,QD,2021,Q4,Vision blurred,,2021,Q4,1,I,20211004.0,20211029.0,20211105,20211105,EXP,,PT-AstraZeneca-2021A789288,ASTRAZENECA,,59.0,YR,,M,Y,75.0,KG,20211105.0,,MD,PT,,2021,Q4,Adult
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Lung opacity,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Malaise,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Brain natriuretic peptide increased,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Pollakiuria,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Oedema peripheral,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Pulmonary congestion,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Cardiac failure chronic,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Concomitant disease aggravated,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Insomnia,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Pallor,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Organising pneumonia,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Face oedema,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Chest discomfort,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200415691,20041569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Urinary retention,,2021,Q4,1,I,20210924.0,20211101.0,20211108,20211108,EXP,,NVSJ2021JP016226,NOVARTIS,,87.0,YR,,M,Y,54.0,KG,20211108.0,,MD,JP,JP,2021,Q4,Elderly
200419181,20041918,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,at a dosage of 10 milligram,,,U,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211031.0,20211108,20211108,EXP,,PL-TEVA-2021-PL-1975633,TEVA,,64.0,YR,A,M,Y,95.0,KG,20211108.0,,MD,PL,PL,2021,Q4,Adult
200419181,20041918,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,at a dosage of 10 milligram,,,U,,,,,,,,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211031.0,20211108,20211108,EXP,,PL-TEVA-2021-PL-1975633,TEVA,,64.0,YR,A,M,Y,95.0,KG,20211108.0,,MD,PL,PL,2021,Q4,Adult
200419181,20041918,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,at a dosage of 10 milligram,,,U,,,,,,,,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,1,I,,20211031.0,20211108,20211108,EXP,,PL-TEVA-2021-PL-1975633,TEVA,,64.0,YR,A,M,Y,95.0,KG,20211108.0,,MD,PL,PL,2021,Q4,Adult
200419181,20041918,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,at a dosage of 10 milligram,,,U,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211031.0,20211108,20211108,EXP,,PL-TEVA-2021-PL-1975633,TEVA,,64.0,YR,A,M,Y,95.0,KG,20211108.0,,MD,PL,PL,2021,Q4,Adult
200419181,20041918,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,at a dosage of 10 milligram,,,U,,,,,,,,,2021,Q4,Diabetes mellitus,,2021,Q4,1,I,,20211031.0,20211108,20211108,EXP,,PL-TEVA-2021-PL-1975633,TEVA,,64.0,YR,A,M,Y,95.0,KG,20211108.0,,MD,PL,PL,2021,Q4,Adult
200419181,20041918,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,at a dosage of 10 milligram,,,U,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20211031.0,20211108,20211108,EXP,,PL-TEVA-2021-PL-1975633,TEVA,,64.0,YR,A,M,Y,95.0,KG,20211108.0,,MD,PL,PL,2021,Q4,Adult
200419181,20041918,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,at a dosage of 10 milligram,,,U,,,,,,,,,2021,Q4,Acquired mixed hyperlipidaemia,,2021,Q4,1,I,,20211031.0,20211108,20211108,EXP,,PL-TEVA-2021-PL-1975633,TEVA,,64.0,YR,A,M,Y,95.0,KG,20211108.0,,MD,PL,PL,2021,Q4,Adult
200419181,20041918,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,at a dosage of 10 milligram,,,U,,,,,,,,,2021,Q4,Hyperuricaemia,,2021,Q4,1,I,,20211031.0,20211108,20211108,EXP,,PL-TEVA-2021-PL-1975633,TEVA,,64.0,YR,A,M,Y,95.0,KG,20211108.0,,MD,PL,PL,2021,Q4,Adult
200419181,20041918,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,at a dosage of 10 milligram,,,U,,,,,,,,,2021,Q4,Hypertension,,2021,Q4,1,I,,20211031.0,20211108,20211108,EXP,,PL-TEVA-2021-PL-1975633,TEVA,,64.0,YR,A,M,Y,95.0,KG,20211108.0,,MD,PL,PL,2021,Q4,Adult
200419181,20041918,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,at a dosage of 10 milligram,,,U,,,,,,,,,2021,Q4,Obesity,,2021,Q4,1,I,,20211031.0,20211108,20211108,EXP,,PL-TEVA-2021-PL-1975633,TEVA,,64.0,YR,A,M,Y,95.0,KG,20211108.0,,MD,PL,PL,2021,Q4,Adult
200425041,20042504,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,,20211103.0,20211108,20211108,EXP,,IT-AstraZeneca-2021A797008,ASTRAZENECA,,35.0,YR,,F,Y,,,20211108.0,,MD,IT,,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Malaise,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Urinary tract infection,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Nephrolithiasis,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Chronic hepatitis,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Headache,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Amylase increased,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Pyrexia,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Chills,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Cutaneous amyloidosis,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Lumbar spinal stenosis,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Nausea,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Diarrhoea,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Hepatic fibrosis,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200440171,20044017,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20211027.0,20211101.0,20211108,20211108,EXP,,GB-AstraZeneca-2021A792690,ASTRAZENECA,,73.0,YR,,M,Y,95.0,KG,20211108.0,,MD,GB,,2021,Q4,Elderly
200440191,20044019,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,202293.0,10.0,MG,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211028.0,20211102.0,20211108,20211108,EXP,,GB-AstraZeneca-2021A794540,ASTRAZENECA,,55.0,YR,,M,Y,,,20211108.0,,MD,GB,,2021,Q4,Adult
200440191,20044019,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,202293.0,10.0,MG,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20211028.0,20211102.0,20211108,20211108,EXP,,GB-AstraZeneca-2021A794540,ASTRAZENECA,,55.0,YR,,M,Y,,,20211108.0,,MD,GB,,2021,Q4,Adult
200440211,20044021,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20200201.0,20211028.0,20211108,20211108,EXP,,JP-AstraZeneca-2021A792033,ASTRAZENECA,"Tanaka K, Miyake T. P-21 Our experience in the use of dapagliflozin for type 1 diabetes mellitus.. Japanese journal of pharmaceutical and diabetes. 2021;(S):152-.",63.0,YR,,M,Y,,,20211108.0,,PH,JP,,2021,Q4,Adult
200440211,20044021,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20200201.0,20211028.0,20211108,20211108,EXP,,JP-AstraZeneca-2021A792033,ASTRAZENECA,"Tanaka K, Miyake T. P-21 Our experience in the use of dapagliflozin for type 1 diabetes mellitus.. Japanese journal of pharmaceutical and diabetes. 2021;(S):152-.",63.0,YR,,M,Y,,,20211108.0,,PH,JP,,2021,Q4,Adult
200440211,20044021,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20200201.0,20211028.0,20211108,20211108,EXP,,JP-AstraZeneca-2021A792033,ASTRAZENECA,"Tanaka K, Miyake T. P-21 Our experience in the use of dapagliflozin for type 1 diabetes mellitus.. Japanese journal of pharmaceutical and diabetes. 2021;(S):152-.",63.0,YR,,M,Y,,,20211108.0,,PH,JP,,2021,Q4,Adult
200440211,20044021,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20200201.0,20211028.0,20211108,20211108,EXP,,JP-AstraZeneca-2021A792033,ASTRAZENECA,"Tanaka K, Miyake T. P-21 Our experience in the use of dapagliflozin for type 1 diabetes mellitus.. Japanese journal of pharmaceutical and diabetes. 2021;(S):152-.",63.0,YR,,M,Y,,,20211108.0,,PH,JP,,2021,Q4,Adult
200453671,20045367,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,QD,2021,Q4,Abdominal pain upper,,2021,Q4,1,I,20210730.0,20211029.0,20211108,20211108,EXP,,JP-AstraZeneca-2021A788410,ASTRAZENECA,,77.0,YR,,M,Y,,,20211108.0,,MD,JP,,2021,Q4,Elderly
200453671,20045367,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Abdominal pain upper,,2021,Q4,1,I,20210730.0,20211029.0,20211108,20211108,EXP,,JP-AstraZeneca-2021A788410,ASTRAZENECA,,77.0,YR,,M,Y,,,20211108.0,,MD,JP,,2021,Q4,Elderly
200453671,20045367,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Abdominal pain upper,,2021,Q4,1,I,20210730.0,20211029.0,20211108,20211108,EXP,,JP-AstraZeneca-2021A788410,ASTRAZENECA,,77.0,YR,,M,Y,,,20211108.0,,MD,JP,,2021,Q4,Elderly
200458345,20045834,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNK",,,U,,,,,10.0,MG,,,2021,Q4,Diabetes mellitus,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNK",,,U,,,,,10.0,MG,,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNK",,,U,,,,,10.0,MG,,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNK",,,U,,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNK",,,U,,,,,10.0,MG,,,2021,Q4,Obesity,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNK",,,U,,,,,10.0,MG,,,2021,Q4,Oedema peripheral,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNK",,,U,,,,,10.0,MG,,,2021,Q4,Hyperuricaemia,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNK",,,U,,,,,10.0,MG,,,2021,Q4,Abdominal distension,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNK",,,U,,,,,10.0,MG,,,2021,Q4,Fatigue,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, UNK",,,U,,,,,10.0,MG,,,2021,Q4,Hypertension,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,21,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Diabetes mellitus,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,21,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,21,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,21,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,21,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Obesity,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,21,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Oedema peripheral,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,21,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Hyperuricaemia,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,21,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Abdominal distension,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,21,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Fatigue,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,21,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Hypertension,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,22,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Diabetes mellitus,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,22,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,22,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,22,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,22,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Obesity,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,22,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Oedema peripheral,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,22,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Hyperuricaemia,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,22,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Abdominal distension,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,22,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Fatigue,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,22,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Hypertension,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Diabetes mellitus,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Obesity,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Oedema peripheral,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Hyperuricaemia,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Abdominal distension,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Fatigue,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200458345,20045834,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2021,Q4,Hypertension,,2021,Q4,5,F,,20211208.0,20211108,20211221,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-316882,RANBAXY,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
200459052,20045905,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Hypokalaemia,,2021,Q4,2,F,20201224.0,20211216.0,20211108,20211222,EXP,,NVSJ2021JP018219,NOVARTIS,,83.0,YR,,F,Y,,,20211222.0,,MD,JP,JP,2021,Q4,Elderly
200459052,20045905,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,2,F,20201224.0,20211216.0,20211108,20211222,EXP,,NVSJ2021JP018219,NOVARTIS,,83.0,YR,,F,Y,,,20211222.0,,MD,JP,JP,2021,Q4,Elderly
200479682,20047968,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Hyperuricaemia,,2021,Q4,2,F,,20211127.0,20211109,20211207,EXP,PL-EMA-20211019-AUTODUP-1634596234728,PL-Accord-244537,ACCORD,,64.0,YR,,M,Y,,,20211207.0,,MD,PL,PL,2021,Q4,Adult
200479682,20047968,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Hypertension,,2021,Q4,2,F,,20211127.0,20211109,20211207,EXP,PL-EMA-20211019-AUTODUP-1634596234728,PL-Accord-244537,ACCORD,,64.0,YR,,M,Y,,,20211207.0,,MD,PL,PL,2021,Q4,Adult
200479682,20047968,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Diabetes mellitus,,2021,Q4,2,F,,20211127.0,20211109,20211207,EXP,PL-EMA-20211019-AUTODUP-1634596234728,PL-Accord-244537,ACCORD,,64.0,YR,,M,Y,,,20211207.0,,MD,PL,PL,2021,Q4,Adult
200479682,20047968,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Obesity,,2021,Q4,2,F,,20211127.0,20211109,20211207,EXP,PL-EMA-20211019-AUTODUP-1634596234728,PL-Accord-244537,ACCORD,,64.0,YR,,M,Y,,,20211207.0,,MD,PL,PL,2021,Q4,Adult
200479682,20047968,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Fatigue,,2021,Q4,2,F,,20211127.0,20211109,20211207,EXP,PL-EMA-20211019-AUTODUP-1634596234728,PL-Accord-244537,ACCORD,,64.0,YR,,M,Y,,,20211207.0,,MD,PL,PL,2021,Q4,Adult
200479682,20047968,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,2,F,,20211127.0,20211109,20211207,EXP,PL-EMA-20211019-AUTODUP-1634596234728,PL-Accord-244537,ACCORD,,64.0,YR,,M,Y,,,20211207.0,,MD,PL,PL,2021,Q4,Adult
200479682,20047968,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Oedema peripheral,,2021,Q4,2,F,,20211127.0,20211109,20211207,EXP,PL-EMA-20211019-AUTODUP-1634596234728,PL-Accord-244537,ACCORD,,64.0,YR,,M,Y,,,20211207.0,,MD,PL,PL,2021,Q4,Adult
200479682,20047968,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,2,F,,20211127.0,20211109,20211207,EXP,PL-EMA-20211019-AUTODUP-1634596234728,PL-Accord-244537,ACCORD,,64.0,YR,,M,Y,,,20211207.0,,MD,PL,PL,2021,Q4,Adult
200479682,20047968,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,2,F,,20211127.0,20211109,20211207,EXP,PL-EMA-20211019-AUTODUP-1634596234728,PL-Accord-244537,ACCORD,,64.0,YR,,M,Y,,,20211207.0,,MD,PL,PL,2021,Q4,Adult
200479682,20047968,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Abdominal distension,,2021,Q4,2,F,,20211127.0,20211109,20211207,EXP,PL-EMA-20211019-AUTODUP-1634596234728,PL-Accord-244537,ACCORD,,64.0,YR,,M,Y,,,20211207.0,,MD,PL,PL,2021,Q4,Adult
200485801,20048580,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,1,I,,20211028.0,20211109,20211109,EXP,,DE-AstraZeneca-2021A790047,ASTRAZENECA,,57.0,YR,,M,Y,82.0,KG,20211109.0,,MD,DE,,2021,Q4,Adult
200485801,20048580,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Ejection fraction decreased,,2021,Q4,1,I,,20211028.0,20211109,20211109,EXP,,DE-AstraZeneca-2021A790047,ASTRAZENECA,,57.0,YR,,M,Y,82.0,KG,20211109.0,,MD,DE,,2021,Q4,Adult
200490601,20049060,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Diabetes mellitus,,2021,Q4,1,I,,20211028.0,20211109,20211109,EXP,,PL-PFIZER INC-202101461662,PFIZER,,64.0,YR,,M,Y,,,20211109.0,,MD,PL,PL,2021,Q4,Adult
200490601,20049060,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211028.0,20211109,20211109,EXP,,PL-PFIZER INC-202101461662,PFIZER,,64.0,YR,,M,Y,,,20211109.0,,MD,PL,PL,2021,Q4,Adult
200490601,20049060,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211028.0,20211109,20211109,EXP,,PL-PFIZER INC-202101461662,PFIZER,,64.0,YR,,M,Y,,,20211109.0,,MD,PL,PL,2021,Q4,Adult
200490601,20049060,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20211028.0,20211109,20211109,EXP,,PL-PFIZER INC-202101461662,PFIZER,,64.0,YR,,M,Y,,,20211109.0,,MD,PL,PL,2021,Q4,Adult
200490601,20049060,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Hypertension,,2021,Q4,1,I,,20211028.0,20211109,20211109,EXP,,PL-PFIZER INC-202101461662,PFIZER,,64.0,YR,,M,Y,,,20211109.0,,MD,PL,PL,2021,Q4,Adult
200490601,20049060,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,1,I,,20211028.0,20211109,20211109,EXP,,PL-PFIZER INC-202101461662,PFIZER,,64.0,YR,,M,Y,,,20211109.0,,MD,PL,PL,2021,Q4,Adult
200490601,20049060,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Hyperuricaemia,,2021,Q4,1,I,,20211028.0,20211109,20211109,EXP,,PL-PFIZER INC-202101461662,PFIZER,,64.0,YR,,M,Y,,,20211109.0,,MD,PL,PL,2021,Q4,Adult
200490601,20049060,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,1,I,,20211028.0,20211109,20211109,EXP,,PL-PFIZER INC-202101461662,PFIZER,,64.0,YR,,M,Y,,,20211109.0,,MD,PL,PL,2021,Q4,Adult
200490601,20049060,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211028.0,20211109,20211109,EXP,,PL-PFIZER INC-202101461662,PFIZER,,64.0,YR,,M,Y,,,20211109.0,,MD,PL,PL,2021,Q4,Adult
200490601,20049060,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Obesity,,2021,Q4,1,I,,20211028.0,20211109,20211109,EXP,,PL-PFIZER INC-202101461662,PFIZER,,64.0,YR,,M,Y,,,20211109.0,,MD,PL,PL,2021,Q4,Adult
200498422,20049842,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,,20211221.0,20211109,20211229,EXP,,CA-AstraZeneca-2021A795855,ASTRAZENECA,,99.0,YR,,F,Y,,,20211229.0,,MD,CA,,2021,Q4,Elderly
200498422,20049842,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Intestinal obstruction,,2021,Q4,2,F,,20211221.0,20211109,20211229,EXP,,CA-AstraZeneca-2021A795855,ASTRAZENECA,,99.0,YR,,F,Y,,,20211229.0,,MD,CA,,2021,Q4,Elderly
200498422,20049842,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Hypophagia,,2021,Q4,2,F,,20211221.0,20211109,20211229,EXP,,CA-AstraZeneca-2021A795855,ASTRAZENECA,,99.0,YR,,F,Y,,,20211229.0,,MD,CA,,2021,Q4,Elderly
200504563,20050456,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Weight increased,,2021,Q4,3,F,,20211118.0,20211109,20211125,EXP,,NVSJ2021JP018045,NOVARTIS,,90.0,YR,,F,Y,41.2,KG,20211125.0,,MD,JP,JP,2021,Q4,Elderly
200504563,20050456,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,,20211118.0,20211109,20211125,EXP,,NVSJ2021JP018045,NOVARTIS,,90.0,YR,,F,Y,41.2,KG,20211125.0,,MD,JP,JP,2021,Q4,Elderly
200504563,20050456,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Right atrial enlargement,,2021,Q4,3,F,,20211118.0,20211109,20211125,EXP,,NVSJ2021JP018045,NOVARTIS,,90.0,YR,,F,Y,41.2,KG,20211125.0,,MD,JP,JP,2021,Q4,Elderly
200504563,20050456,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Chest pain,,2021,Q4,3,F,,20211118.0,20211109,20211125,EXP,,NVSJ2021JP018045,NOVARTIS,,90.0,YR,,F,Y,41.2,KG,20211125.0,,MD,JP,JP,2021,Q4,Elderly
200504563,20050456,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Left atrial enlargement,,2021,Q4,3,F,,20211118.0,20211109,20211125,EXP,,NVSJ2021JP018045,NOVARTIS,,90.0,YR,,F,Y,41.2,KG,20211125.0,,MD,JP,JP,2021,Q4,Elderly
200504563,20050456,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Cardiac failure,,2021,Q4,3,F,,20211118.0,20211109,20211125,EXP,,NVSJ2021JP018045,NOVARTIS,,90.0,YR,,F,Y,41.2,KG,20211125.0,,MD,JP,JP,2021,Q4,Elderly
200505051,20050505,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,,2104201,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211025.0,20211102.0,20211109,20211109,EXP,,CN-AstraZeneca-2021A796349,ASTRAZENECA,,19433.0,DY,,F,Y,50.0,KG,20211110.0,,MD,CN,,2021,Q4,Elderly
200513581,20051358,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,,QD,2021,Q4,Weight increased,,2021,Q4,1,I,20190710.0,20211029.0,20211110,20211110,PER,,US-TAKEDA-US201922865,TAKEDA,,71.0,YR,,F,Y,,,20211110.0,,MD,US,US,2021,Q4,Elderly
200513581,20051358,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,,QD,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,20190710.0,20211029.0,20211110,20211110,PER,,US-TAKEDA-US201922865,TAKEDA,,71.0,YR,,F,Y,,,20211110.0,,MD,US,US,2021,Q4,Elderly
200513581,20051358,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,,QD,2021,Q4,Muscle spasms,,2021,Q4,1,I,20190710.0,20211029.0,20211110,20211110,PER,,US-TAKEDA-US201922865,TAKEDA,,71.0,YR,,F,Y,,,20211110.0,,MD,US,US,2021,Q4,Elderly
200513581,20051358,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,,QD,2021,Q4,Alopecia,,2021,Q4,1,I,20190710.0,20211029.0,20211110,20211110,PER,,US-TAKEDA-US201922865,TAKEDA,,71.0,YR,,F,Y,,,20211110.0,,MD,US,US,2021,Q4,Elderly
200524441,20052444,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Brain natriuretic peptide increased,,2021,Q4,1,I,20210928.0,20211101.0,20211110,20211110,EXP,,NVSC2021EG254473,NOVARTIS,,64.0,YR,,F,Y,,,20211110.0,,CN,EG,EG,2021,Q4,Adult
200524441,20052444,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Drug effect less than expected,,2021,Q4,1,I,20210928.0,20211101.0,20211110,20211110,EXP,,NVSC2021EG254473,NOVARTIS,,64.0,YR,,F,Y,,,20211110.0,,CN,EG,EG,2021,Q4,Adult
200524441,20052444,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Ejection fraction decreased,,2021,Q4,1,I,20210928.0,20211101.0,20211110,20211110,EXP,,NVSC2021EG254473,NOVARTIS,,64.0,YR,,F,Y,,,20211110.0,,CN,EG,EG,2021,Q4,Adult
200530621,20053062,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10, Unknown",,,U,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211021.0,20211101.0,20211110,20211110,EXP,,GB-AstraZeneca-2021A792717,ASTRAZENECA,,47.0,YR,,M,Y,105.0,KG,20211110.0,,MD,GB,,2021,Q4,Adult
200530631,20053063,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211030.0,20211103.0,20211110,20211110,EXP,,GB-AstraZeneca-2021A796008,ASTRAZENECA,,57.0,YR,,F,Y,,,20211110.0,,MD,GB,,2021,Q4,Adult
200533602,20053360,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (one tablet daily beore breakfast)",,,,,,,,,,,QD,2021,Q4,Fatigue,,2021,Q4,2,F,20201001.0,20211117.0,20211110,20211119,EXP,,NVSC2021EG248452,NOVARTIS,,42.0,YR,,F,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200533602,20053360,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (one tablet daily beore breakfast)",,,,,,,,,,,QD,2021,Q4,Blood pressure systolic decreased,,2021,Q4,2,F,20201001.0,20211117.0,20211110,20211119,EXP,,NVSC2021EG248452,NOVARTIS,,42.0,YR,,F,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200533602,20053360,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (one tablet daily beore breakfast)",,,,,,,,,,,QD,2021,Q4,Bone pain,,2021,Q4,2,F,20201001.0,20211117.0,20211110,20211119,EXP,,NVSC2021EG248452,NOVARTIS,,42.0,YR,,F,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200533602,20053360,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (one tablet daily beore breakfast)",,,,,,,,,,,QD,2021,Q4,Decreased immune responsiveness,,2021,Q4,2,F,20201001.0,20211117.0,20211110,20211119,EXP,,NVSC2021EG248452,NOVARTIS,,42.0,YR,,F,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200533602,20053360,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (one tablet daily beore breakfast)",,,,,,,,,,,QD,2021,Q4,Pleurisy,,2021,Q4,2,F,20201001.0,20211117.0,20211110,20211119,EXP,,NVSC2021EG248452,NOVARTIS,,42.0,YR,,F,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200533602,20053360,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (one tablet daily beore breakfast)",,,,,,,,,,,QD,2021,Q4,Dyspnoea,,2021,Q4,2,F,20201001.0,20211117.0,20211110,20211119,EXP,,NVSC2021EG248452,NOVARTIS,,42.0,YR,,F,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200533602,20053360,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (one tablet daily beore breakfast)",,,,,,,,,,,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,2,F,20201001.0,20211117.0,20211110,20211119,EXP,,NVSC2021EG248452,NOVARTIS,,42.0,YR,,F,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200533602,20053360,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (one tablet daily beore breakfast)",,,,,,,,,,,QD,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,2,F,20201001.0,20211117.0,20211110,20211119,EXP,,NVSC2021EG248452,NOVARTIS,,42.0,YR,,F,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200533602,20053360,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (one tablet daily beore breakfast)",,,,,,,,,,,QD,2021,Q4,Dizziness,,2021,Q4,2,F,20201001.0,20211117.0,20211110,20211119,EXP,,NVSC2021EG248452,NOVARTIS,,42.0,YR,,F,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200533602,20053360,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (one tablet daily beore breakfast)",,,,,,,,,,,QD,2021,Q4,Nasopharyngitis,,2021,Q4,2,F,20201001.0,20211117.0,20211110,20211119,EXP,,NVSC2021EG248452,NOVARTIS,,42.0,YR,,F,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200533602,20053360,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (one tablet daily beore breakfast)",,,,,,,,,,,QD,2021,Q4,Balance disorder,,2021,Q4,2,F,20201001.0,20211117.0,20211110,20211119,EXP,,NVSC2021EG248452,NOVARTIS,,42.0,YR,,F,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200533602,20053360,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (one tablet daily beore breakfast)",,,,,,,,,,,QD,2021,Q4,Heavy menstrual bleeding,,2021,Q4,2,F,20201001.0,20211117.0,20211110,20211119,EXP,,NVSC2021EG248452,NOVARTIS,,42.0,YR,,F,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200552761,20055276,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,10.0,MG,,,2021,Q4,Left ventricular failure,,2021,Q4,1,I,,20211029.0,20211110,20211110,EXP,,IN-ELI_LILLY_AND_COMPANY-IN202111001130,ELI LILLY AND CO,,68.0,YR,,F,Y,86.0,KG,20211110.0,,CN,IN,IN,2021,Q4,Elderly
200552761,20055276,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,10.0,MG,,,2021,Q4,Vomiting,,2021,Q4,1,I,,20211029.0,20211110,20211110,EXP,,IN-ELI_LILLY_AND_COMPANY-IN202111001130,ELI LILLY AND CO,,68.0,YR,,F,Y,86.0,KG,20211110.0,,CN,IN,IN,2021,Q4,Elderly
200560331,20056033,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,,,Unknown,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200560331,20056033,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,,,Unknown,,,,,,,2021,Q4,Sensory loss,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200560331,20056033,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,,,Unknown,,,,,,,2021,Q4,Peripheral artery occlusion,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200560331,20056033,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,,,Unknown,,,,,,,2021,Q4,Pulmonary oedema,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200560331,20056033,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,,,Unknown,,,,,,,2021,Q4,Aortic valve replacement,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200560331,20056033,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,,,Unknown,,,,,,,2021,Q4,Stent placement,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200560331,20056033,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,,,Unknown,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,20120101.0,20211031.0,20211111,20211111,EXP,,BR-NOVOPROD-863479,NOVO NORDISK,,73.0,YR,,M,Y,90.3,KG,20211111.0,,MD,BR,BR,2021,Q4,Elderly
200571671,20057167,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211102.0,20211111,20211111,EXP,,JP-AstraZeneca-2021A797750,ASTRAZENECA,"Hosoi E, et al. O34-5 A case of SPIDDM with concomitant Basedow^s disease which was diagnosed triggered by euglycaemic DKA. The 58th Kinki Regional Meeting of The Japan Diabetes Society; 2021 Oct 30- 2021;127-.",58.0,YR,,F,Y,,,20211111.0,,MD,JP,,2021,Q4,Adult
200571671,20057167,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211102.0,20211111,20211111,EXP,,JP-AstraZeneca-2021A797750,ASTRAZENECA,"Hosoi E, et al. O34-5 A case of SPIDDM with concomitant Basedow^s disease which was diagnosed triggered by euglycaemic DKA. The 58th Kinki Regional Meeting of The Japan Diabetes Society; 2021 Oct 30- 2021;127-.",58.0,YR,,F,Y,,,20211111.0,,MD,JP,,2021,Q4,Adult
200571671,20057167,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,,20211102.0,20211111,20211111,EXP,,JP-AstraZeneca-2021A797750,ASTRAZENECA,"Hosoi E, et al. O34-5 A case of SPIDDM with concomitant Basedow^s disease which was diagnosed triggered by euglycaemic DKA. The 58th Kinki Regional Meeting of The Japan Diabetes Society; 2021 Oct 30- 2021;127-.",58.0,YR,,F,Y,,,20211111.0,,MD,JP,,2021,Q4,Adult
200571671,20057167,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2021,Q4,Palpitations,,2021,Q4,1,I,,20211102.0,20211111,20211111,EXP,,JP-AstraZeneca-2021A797750,ASTRAZENECA,"Hosoi E, et al. O34-5 A case of SPIDDM with concomitant Basedow^s disease which was diagnosed triggered by euglycaemic DKA. The 58th Kinki Regional Meeting of The Japan Diabetes Society; 2021 Oct 30- 2021;127-.",58.0,YR,,F,Y,,,20211111.0,,MD,JP,,2021,Q4,Adult
200571681,20057168,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,,,,Tablet,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,,20211102.0,20211111,20211111,EXP,,JP-AstraZeneca-2021A797539,ASTRAZENECA,"Watanabe H, et al.. O2-005 A case of postoperative ketoacidosis accompanied by hypoglycemia associated with dapagliflozin in patient who underwent transcatheter aortic valve replacement. The Journal of Japan Society for Clinical Anesthesia 2021;41(6):S189-..",83.0,YR,,F,Y,,,20211111.0,,MD,JP,,2021,Q4,Elderly
200571691,20057169,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211102.0,20211111,20211111,EXP,,JP-AstraZeneca-2021A797735,ASTRAZENECA,"Kimura N, et al. O4-1 A case of euglycaemic diabetic ketoacidosis in a patient with type 1 diabetes a short period of time after insulin discontinuation. The 58th Kinki Regional Meeting of the Japan Diabetes Society; 2021 Oct 30- 2021;97-.",23.0,YR,,F,Y,,,20211111.0,,MD,JP,,2021,Q4,Youth
200571701,20057170,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,,,,202293.0,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211104.0,20211111,20211111,EXP,,GB-AstraZeneca-2021A797088,ASTRAZENECA,,70.0,YR,,F,Y,,,20211111.0,,MD,GB,,2021,Q4,Elderly
200571731,20057173,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211029.0,20211111,20211111,EXP,,US-AstraZeneca-2021A802710,ASTRAZENECA,"Nair N, Awala O, Thadani P, Yasear Z et al. Management of the common within the uncommon: Euglycemic ketoacidosis in Bloom^s syndrome. Endocrine Abstracts 2021;",38.0,YR,,M,Y,,,20211111.0,,HP,US,,2021,Q4,Adult
200572881,20057288,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211015.0,20211111,20211111,EXP,,NL-AstraZeneca-2021A802699,ASTRAZENECA,"Patel P., Patel T., Patil S., Patel S., Ross Ang J.. CONSIDERATIONS FOR SODIUM-GLUCOSE TRANSPORTER 2 INHIBITOR THERAPY RESULTING IN EUGLYCEMIC DIABETIC KETOACIDOSIS. Chest 2021;160(4):981A-982A.",40.0,YR,,M,Y,,,20211111.0,,HP,NL,,2021,Q4,Adult
200594101,20059410,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",70.0,MG,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Toxic skin eruption,,2021,Q4,1,I,20211007.0,20211105.0,20211111,20211111,EXP,,JP-TAKEDA-2021TUS070394,TAKEDA,,71.0,YR,,M,Y,64.9,KG,20211111.0,,HP,JP,JP,2021,Q4,Elderly
200622911,20062291,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 DF, QD (1 only)",,,D,,,,,,,Tablet,QD,2021,Q4,Intentional overdose,,2021,Q4,1,I,20210901.0,20211004.0,20211112,20211112,EXP,,NVSC2021DE227533,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20211112.0,,MD,DE,DE,2021,Q4,Elderly
200622911,20062291,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 DF, QD (1 only)",,,D,,,,,,,Tablet,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210901.0,20211004.0,20211112,20211112,EXP,,NVSC2021DE227533,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20211112.0,,MD,DE,DE,2021,Q4,Elderly
200622911,20062291,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 DF, QD (1 only)",,,D,,,,,,,Tablet,QD,2021,Q4,Suicide attempt,,2021,Q4,1,I,20210901.0,20211004.0,20211112,20211112,EXP,,NVSC2021DE227533,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20211112.0,,MD,DE,DE,2021,Q4,Elderly
200622911,20062291,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 DF, QD (1 only)",,,D,,,,,,,Tablet,QD,2021,Q4,Heart rate increased,,2021,Q4,1,I,20210901.0,20211004.0,20211112,20211112,EXP,,NVSC2021DE227533,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20211112.0,,MD,DE,DE,2021,Q4,Elderly
200622911,20062291,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 DF, QD (1 only)",,,D,,,,,,,Tablet,QD,2021,Q4,Vomiting,,2021,Q4,1,I,20210901.0,20211004.0,20211112,20211112,EXP,,NVSC2021DE227533,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20211112.0,,MD,DE,DE,2021,Q4,Elderly
200622911,20062291,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 DF, QD (1 only)",,,D,,,,,,,Tablet,QD,2021,Q4,Somnolence,,2021,Q4,1,I,20210901.0,20211004.0,20211112,20211112,EXP,,NVSC2021DE227533,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20211112.0,,MD,DE,DE,2021,Q4,Elderly
200622911,20062291,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 DF, QD (1 only)",,,D,,,,,,,Tablet,QD,2021,Q4,Tachycardia,,2021,Q4,1,I,20210901.0,20211004.0,20211112,20211112,EXP,,NVSC2021DE227533,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20211112.0,,MD,DE,DE,2021,Q4,Elderly
200622911,20062291,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"28 DF, QD (1 only)",,,D,,,,,,,Tablet,QD,2021,Q4,Intentional self-injury,,2021,Q4,1,I,20210901.0,20211004.0,20211112,20211112,EXP,,NVSC2021DE227533,NOVARTIS,,65.0,YR,,M,Y,90.0,KG,20211112.0,,MD,DE,DE,2021,Q4,Elderly
200625441,20062544,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,Tablet,,2021,Q4,Cerebellar infarction,,2021,Q4,1,I,,20211104.0,20211112,20211112,EXP,,JP-AstraZeneca-2021A799182,ASTRAZENECA,,53.0,YR,,F,Y,,,20211112.0,,MD,JP,,2021,Q4,Adult
200625441,20062544,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,Tablet,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211104.0,20211112,20211112,EXP,,JP-AstraZeneca-2021A799182,ASTRAZENECA,,53.0,YR,,F,Y,,,20211112.0,,MD,JP,,2021,Q4,Adult
200625441,20062544,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,,,Tablet,,2021,Q4,Depressed level of consciousness,,2021,Q4,1,I,,20211104.0,20211112,20211112,EXP,,JP-AstraZeneca-2021A799182,ASTRAZENECA,,53.0,YR,,F,Y,,,20211112.0,,MD,JP,,2021,Q4,Adult
200626383,20062638,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1790.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Cardiac failure chronic,,2021,Q4,3,F,,20211119.0,20211112,20211124,EXP,,JP-AstraZeneca-2021A801922,ASTRAZENECA,,94.0,YR,,F,Y,,,20211124.0,,PH,JP,,2021,Q4,Elderly
200626383,20062638,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure chronic,,2021,Q4,3,F,,20211119.0,20211112,20211124,EXP,,JP-AstraZeneca-2021A801922,ASTRAZENECA,,94.0,YR,,F,Y,,,20211124.0,,PH,JP,,2021,Q4,Elderly
200631411,20063141,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 every day,,,Y,,Y18961,,,,,,,2021,Q4,Balanitis candida,,2021,Q4,1,I,20201201.0,20211104.0,20211112,20211112,EXP,,GB-AstraZeneca-2021A797073,ASTRAZENECA,,61.0,YR,,M,Y,69.0,KG,20211112.0,,MD,GB,,2021,Q4,Adult
200631411,20063141,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 every day,,,Y,,Y18961,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20201201.0,20211104.0,20211112,20211112,EXP,,GB-AstraZeneca-2021A797073,ASTRAZENECA,,61.0,YR,,M,Y,69.0,KG,20211112.0,,MD,GB,,2021,Q4,Adult
200631411,20063141,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 every day,,,Y,,Y18961,,,,,,,2021,Q4,Penile pain,,2021,Q4,1,I,20201201.0,20211104.0,20211112,20211112,EXP,,GB-AstraZeneca-2021A797073,ASTRAZENECA,,61.0,YR,,M,Y,69.0,KG,20211112.0,,MD,GB,,2021,Q4,Adult
200631411,20063141,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 every day,,,Y,,Y18961,,,,,,,2021,Q4,Skin lesion,,2021,Q4,1,I,20201201.0,20211104.0,20211112,20211112,EXP,,GB-AstraZeneca-2021A797073,ASTRAZENECA,,61.0,YR,,M,Y,69.0,KG,20211112.0,,MD,GB,,2021,Q4,Adult
200632251,20063225,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Benign prostatic hyperplasia,,2021,Q4,1,I,,20211105.0,20211112,20211112,EXP,,DE-AstraZeneca-2021A787405,ASTRAZENECA,,65.0,YR,,M,Y,99.0,KG,20211112.0,,MD,DE,,2021,Q4,Elderly
200632251,20063225,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211105.0,20211112,20211112,EXP,,DE-AstraZeneca-2021A787405,ASTRAZENECA,,65.0,YR,,M,Y,99.0,KG,20211112.0,,MD,DE,,2021,Q4,Elderly
200632251,20063225,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Pollakiuria,,2021,Q4,1,I,,20211105.0,20211112,20211112,EXP,,DE-AstraZeneca-2021A787405,ASTRAZENECA,,65.0,YR,,M,Y,99.0,KG,20211112.0,,MD,DE,,2021,Q4,Elderly
200632261,20063226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mgs,,,Y,,,,,,,Tablet,,2021,Q4,Necrotising fasciitis,,2021,Q4,1,I,20210911.0,20211105.0,20211112,20211112,EXP,,GB-AstraZeneca-2021A798616,ASTRAZENECA,,56.0,YR,,M,Y,112.0,KG,20211112.0,,MD,GB,,2021,Q4,Adult
200637451,20063745,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1200.0,MG,Y,,MA3247,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,1,I,20210828.0,20211106.0,20211112,20211112,EXP,,CN-AstraZeneca-2021A803474,ASTRAZENECA,,14455.0,DY,,M,Y,62.0,KG,20211112.0,,MD,CN,,2021,Q4,Elderly
200637451,20063745,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1200.0,MG,Y,,MA3247,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketosis,,2021,Q4,1,I,20210828.0,20211106.0,20211112,20211112,EXP,,CN-AstraZeneca-2021A803474,ASTRAZENECA,,14455.0,DY,,M,Y,62.0,KG,20211112.0,,MD,CN,,2021,Q4,Elderly
200639251,20063925,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211108.0,20211112,20211112,EXP,,GR-AstraZeneca-2021A804246,ASTRAZENECA,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R., Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation. Hellenic Diabetological Chronicles 2020;33(2):",74.0,YR,,F,Y,,,20211112.0,,MD,GR,,2021,Q4,Elderly
200639251,20063925,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Renal injury,,2021,Q4,1,I,,20211108.0,20211112,20211112,EXP,,GR-AstraZeneca-2021A804246,ASTRAZENECA,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R., Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation. Hellenic Diabetological Chronicles 2020;33(2):",74.0,YR,,F,Y,,,20211112.0,,MD,GR,,2021,Q4,Elderly
200639251,20063925,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211108.0,20211112,20211112,EXP,,GR-AstraZeneca-2021A804246,ASTRAZENECA,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R., Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation. Hellenic Diabetological Chronicles 2020;33(2):",74.0,YR,,F,Y,,,20211112.0,,MD,GR,,2021,Q4,Elderly
200646721,20064672,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211101.0,20211112,20211112,EXP,,RU-EMD Serono-9277425,EMD SERONO INC,"Pashkova E, Gezalyan M. It^s time to change stereotypes: a new look at fixed-mixtures insulins. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training].. 2021;10(3):59-65. doi:https://doi. org/10.33029/2304-9529-2021-10-3-59-65",60.0,YR,A,M,Y,,,20211112.0,,MD,RU,,2021,Q4,Adult
200646721,20064672,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211101.0,20211112,20211112,EXP,,RU-EMD Serono-9277425,EMD SERONO INC,"Pashkova E, Gezalyan M. It^s time to change stereotypes: a new look at fixed-mixtures insulins. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training].. 2021;10(3):59-65. doi:https://doi. org/10.33029/2304-9529-2021-10-3-59-65",60.0,YR,A,M,Y,,,20211112.0,,MD,RU,,2021,Q4,Adult
200647821,20064782,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"20 milligram, qd",,,Y,,,,,20.0,MG,,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20140401.0,20211101.0,20211112,20211112,EXP,BR-ANVISA-300045259,BR-009507513-2111BRA004074,MERCK,,70.0,YR,,M,Y,70.0,KG,20211112.0,,CN,BR,BR,2021,Q4,Elderly
200647821,20064782,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"20 milligram, qd",,,Y,,,,,20.0,MG,,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,20140401.0,20211101.0,20211112,20211112,EXP,BR-ANVISA-300045259,BR-009507513-2111BRA004074,MERCK,,70.0,YR,,M,Y,70.0,KG,20211112.0,,CN,BR,BR,2021,Q4,Elderly
200647821,20064782,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"20 milligram, qd",,,Y,,,,,20.0,MG,,QD,2021,Q4,Ischaemic stroke,,2021,Q4,1,I,20140401.0,20211101.0,20211112,20211112,EXP,BR-ANVISA-300045259,BR-009507513-2111BRA004074,MERCK,,70.0,YR,,M,Y,70.0,KG,20211112.0,,CN,BR,BR,2021,Q4,Elderly
200647821,20064782,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"20 milligram, qd",,,Y,,,,,20.0,MG,,QD,2021,Q4,Off label use,,2021,Q4,1,I,20140401.0,20211101.0,20211112,20211112,EXP,BR-ANVISA-300045259,BR-009507513-2111BRA004074,MERCK,,70.0,YR,,M,Y,70.0,KG,20211112.0,,CN,BR,BR,2021,Q4,Elderly
200656121,20065612,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Tendonitis,,2021,Q4,1,I,20211102.0,20211109.0,20211113,20211113,EXP,GB-MHRA-EYC 00265770,NVSC2021GB257037,NOVARTIS,,75.0,YR,,M,Y,71.0,KG,20211113.0,,MD,GB,GB,2021,Q4,Elderly
200668471,20066847,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Separation anxiety disorder,,2021,Q4,1,I,,20211102.0,20211115,20211115,EXP,,BR-NOVOPROD-864390,NOVO NORDISK,,53.0,YR,,M,Y,74.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668471,20066847,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Major depression,,2021,Q4,1,I,,20211102.0,20211115,20211115,EXP,,BR-NOVOPROD-864390,NOVO NORDISK,,53.0,YR,,M,Y,74.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668471,20066847,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Fungal infection,,2021,Q4,1,I,,20211102.0,20211115,20211115,EXP,,BR-NOVOPROD-864390,NOVO NORDISK,,53.0,YR,,M,Y,74.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200668471,20066847,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2021,Q4,Myocardial infarction,,2021,Q4,1,I,,20211102.0,20211115,20211115,EXP,,BR-NOVOPROD-864390,NOVO NORDISK,,53.0,YR,,M,Y,74.0,KG,20211115.0,,MD,BR,BR,2021,Q4,Adult
200670681,20067068,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 tablet every 24 hours,,,,,,,,,,Tablet,,2021,Q4,Hypotension,,2021,Q4,1,I,20210503.0,20211102.0,20211115,20211115,EXP,ES-AEMPS-1033179,ES-Accord-244913,ACCORD,,70.0,YR,E,M,Y,,,20211115.0,,MD,ES,ES,2021,Q4,Elderly
200670681,20067068,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 tablet every 24 hours,,,,,,,,,,Tablet,,2021,Q4,Drug interaction,,2021,Q4,1,I,20210503.0,20211102.0,20211115,20211115,EXP,ES-AEMPS-1033179,ES-Accord-244913,ACCORD,,70.0,YR,E,M,Y,,,20211115.0,,MD,ES,ES,2021,Q4,Elderly
200686711,20068671,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,U,2106099,,,5.0,MG,Tablet,QD,2021,Q4,Ketosis,,2021,Q4,1,I,20211021.0,20211028.0,20211115,20211115,EXP,,CN-AstraZeneca-2021A793580,ASTRAZENECA,,13975.0,DY,,M,Y,90.0,KG,20211115.0,,MD,CN,,2021,Q4,Elderly
200686731,20068673,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1045.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20191202.0,20211105.0,20211115,20211115,EXP,,JP-AstraZeneca-2021A800520,ASTRAZENECA,"Noguchi K, et al. O-6 Survey of the use of SGLT2 inhibitors (dapagliflozin) in type 1 diabetes mellitus. Japanese Journal of Pharmaceutical and Diabetes (not from Embase) 2021;(S):127.",46.0,YR,,F,Y,,,20211115.0,,PH,JP,,2021,Q4,Adult
200686751,20068675,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,890.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20211013.0,20211104.0,20211115,20211115,EXP,,FR-AstraZeneca-2021A801628,ASTRAZENECA,,70.0,YR,,M,Y,87.0,KG,20211115.0,,MD,FR,,2021,Q4,Elderly
200686761,20068676,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211027.0,20211109.0,20211115,20211115,EXP,,GB-AstraZeneca-2021A801520,ASTRAZENECA,,39.0,YR,,M,Y,,,20211115.0,,MD,GB,,2021,Q4,Adult
200686781,20068678,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211106.0,20211111.0,20211115,20211115,EXP,,GB-AstraZeneca-2021A805272,ASTRAZENECA,,60.0,YR,,F,Y,70.0,KG,20211115.0,,MD,GB,,2021,Q4,Adult
200716633,20071663,10,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Vertigo positional,,2021,Q4,3,F,,20211217.0,20211116,20211222,EXP,,NVSJ2021JP018756,NOVARTIS,,79.0,YR,,F,Y,,,20211223.0,,MD,JP,JP,2021,Q4,Elderly
200716633,20071663,10,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Blood pressure systolic increased,,2021,Q4,3,F,,20211217.0,20211116,20211222,EXP,,NVSJ2021JP018756,NOVARTIS,,79.0,YR,,F,Y,,,20211223.0,,MD,JP,JP,2021,Q4,Elderly
200716633,20071663,10,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Product use in unapproved indication,,2021,Q4,3,F,,20211217.0,20211116,20211222,EXP,,NVSJ2021JP018756,NOVARTIS,,79.0,YR,,F,Y,,,20211223.0,,MD,JP,JP,2021,Q4,Elderly
200737282,20073728,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Hepatic function abnormal,,2021,Q4,2,F,20210914.0,20211122.0,20211116,20211130,EXP,,JP-AstraZeneca-2021A789697,ASTRAZENECA,,72.0,YR,,M,Y,68.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
200737282,20073728,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Rheumatoid arthritis,,2021,Q4,2,F,20210914.0,20211122.0,20211116,20211130,EXP,,JP-AstraZeneca-2021A789697,ASTRAZENECA,,72.0,YR,,M,Y,68.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
200737623,20073762,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Pneumonia,,2021,Q4,3,F,20211109.0,20211210.0,20211116,20211216,EXP,,JP-ASTELLAS-2021JP021921,ASTELLAS,,68.0,YR,,F,Y,,,20211216.0,,MD,JP,JP,2021,Q4,Elderly
200741861,20074186,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,,5.0,MG,Tablet,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,,20211110.0,20211116,20211116,EXP,,DE-AstraZeneca-2021A803836,ASTRAZENECA,,56.0,YR,,F,Y,,,20211116.0,,MD,DE,,2021,Q4,Adult
200768292,20076829,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,2,F,20120101.0,20211101.0,20211116,20211119,EXP,BR-ANVISA-300045243,BR-009507513-2111BRA003501,MERCK,,63.0,YR,,F,Y,87.0,KG,20211119.0,,CN,BR,BR,2021,Q4,Adult
200768292,20076829,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Nausea,,2021,Q4,2,F,20120101.0,20211101.0,20211116,20211119,EXP,BR-ANVISA-300045243,BR-009507513-2111BRA003501,MERCK,,63.0,YR,,F,Y,87.0,KG,20211119.0,,CN,BR,BR,2021,Q4,Adult
200768292,20076829,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Ischaemic stroke,,2021,Q4,2,F,20120101.0,20211101.0,20211116,20211119,EXP,BR-ANVISA-300045243,BR-009507513-2111BRA003501,MERCK,,63.0,YR,,F,Y,87.0,KG,20211119.0,,CN,BR,BR,2021,Q4,Adult
200768292,20076829,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Weight decreased,,2021,Q4,2,F,20120101.0,20211101.0,20211116,20211119,EXP,BR-ANVISA-300045243,BR-009507513-2111BRA003501,MERCK,,63.0,YR,,F,Y,87.0,KG,20211119.0,,CN,BR,BR,2021,Q4,Adult
200768292,20076829,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Weight increased,,2021,Q4,2,F,20120101.0,20211101.0,20211116,20211119,EXP,BR-ANVISA-300045243,BR-009507513-2111BRA003501,MERCK,,63.0,YR,,F,Y,87.0,KG,20211119.0,,CN,BR,BR,2021,Q4,Adult
200768292,20076829,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Vomiting,,2021,Q4,2,F,20120101.0,20211101.0,20211116,20211119,EXP,BR-ANVISA-300045243,BR-009507513-2111BRA003501,MERCK,,63.0,YR,,F,Y,87.0,KG,20211119.0,,CN,BR,BR,2021,Q4,Adult
200768292,20076829,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, qd",,,Y,,,,,,,,QD,2021,Q4,Blood urea increased,,2021,Q4,2,F,20120101.0,20211101.0,20211116,20211119,EXP,BR-ANVISA-300045243,BR-009507513-2111BRA003501,MERCK,,63.0,YR,,F,Y,87.0,KG,20211119.0,,CN,BR,BR,2021,Q4,Adult
200775322,20077532,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Vascular stent occlusion,,2021,Q4,2,F,20130101.0,20211101.0,20211116,20211121,EXP,,BR-009507513-2111BRA003523,MERCK,,68.0,YR,,M,Y,86.0,KG,20211121.0,,PH,BR,BR,2021,Q4,Elderly
200775322,20077532,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20130101.0,20211101.0,20211116,20211121,EXP,,BR-009507513-2111BRA003523,MERCK,,68.0,YR,,M,Y,86.0,KG,20211121.0,,PH,BR,BR,2021,Q4,Elderly
200775322,20077532,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Influenza,,2021,Q4,2,F,20130101.0,20211101.0,20211116,20211121,EXP,,BR-009507513-2111BRA003523,MERCK,,68.0,YR,,M,Y,86.0,KG,20211121.0,,PH,BR,BR,2021,Q4,Elderly
200775322,20077532,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Arterial occlusive disease,,2021,Q4,2,F,20130101.0,20211101.0,20211116,20211121,EXP,,BR-009507513-2111BRA003523,MERCK,,68.0,YR,,M,Y,86.0,KG,20211121.0,,PH,BR,BR,2021,Q4,Elderly
200830011,20083001,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Genital pain,,2021,Q4,1,I,20210420.0,20211110.0,20211117,20211117,EXP,,GB-AstraZeneca-2021A342307,ASTRAZENECA,,76.0,YR,,M,Y,91.0,KG,20211117.0,,MD,GB,,2021,Q4,Elderly
200830011,20083001,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Genital pain,,2021,Q4,1,I,20210420.0,20211110.0,20211117,20211117,EXP,,GB-AstraZeneca-2021A342307,ASTRAZENECA,,76.0,YR,,M,Y,91.0,KG,20211117.0,,MD,GB,,2021,Q4,Elderly
200838631,20083863,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Gastrointestinal haemorrhage,,2021,Q4,1,I,20211101.0,20211115.0,20211118,20211118,EXP,,"CZ-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-138305",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20211118.0,,MD,CZ,CZ,2021,Q4,Elderly
200838631,20083863,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,20211101.0,20211115.0,20211118,20211118,EXP,,"CZ-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-138305",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20211118.0,,MD,CZ,CZ,2021,Q4,Elderly
200838631,20083863,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Chest pain,,2021,Q4,1,I,20211101.0,20211115.0,20211118,20211118,EXP,,"CZ-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-138305",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20211118.0,,MD,CZ,CZ,2021,Q4,Elderly
200850853,20085085,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,3,F,20190101.0,20211209.0,20211118,20211217,EXP,,NVSC2021GR261621,NOVARTIS,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal failure in the context of antidiabetic treatment with dapagliflozin and metformin. case description. HELLENIC DIABETOLOGICAL CHRONICLES. 2020;33(2):135",74.0,YR,,F,Y,,,20211217.0,,HP,GR,GR,2021,Q4,Elderly
200850853,20085085,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,3,F,20190101.0,20211209.0,20211118,20211217,EXP,,NVSC2021GR261621,NOVARTIS,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal failure in the context of antidiabetic treatment with dapagliflozin and metformin. case description. HELLENIC DIABETOLOGICAL CHRONICLES. 2020;33(2):135",74.0,YR,,F,Y,,,20211217.0,,HP,GR,GR,2021,Q4,Elderly
200850853,20085085,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,3,F,20190101.0,20211209.0,20211118,20211217,EXP,,NVSC2021GR261621,NOVARTIS,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal failure in the context of antidiabetic treatment with dapagliflozin and metformin. case description. HELLENIC DIABETOLOGICAL CHRONICLES. 2020;33(2):135",74.0,YR,,F,Y,,,20211217.0,,HP,GR,GR,2021,Q4,Elderly
200850853,20085085,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,3,F,20190101.0,20211209.0,20211118,20211217,EXP,,NVSC2021GR261621,NOVARTIS,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal failure in the context of antidiabetic treatment with dapagliflozin and metformin. case description. HELLENIC DIABETOLOGICAL CHRONICLES. 2020;33(2):135",74.0,YR,,F,Y,,,20211217.0,,HP,GR,GR,2021,Q4,Elderly
200850853,20085085,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Acidosis,,2021,Q4,3,F,20190101.0,20211209.0,20211118,20211217,EXP,,NVSC2021GR261621,NOVARTIS,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal failure in the context of antidiabetic treatment with dapagliflozin and metformin. case description. HELLENIC DIABETOLOGICAL CHRONICLES. 2020;33(2):135",74.0,YR,,F,Y,,,20211217.0,,HP,GR,GR,2021,Q4,Elderly
200853391,20085339,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,260.0,MG,Y,Y,MM2243/2103101,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Genital burning sensation,,2021,Q4,1,I,20211025.0,20211111.0,20211118,20211118,EXP,,CN-AstraZeneca-2021A806857,ASTRAZENECA,,27155.0,DY,,F,Y,58.2,KG,20211118.0,,MD,CN,,2021,Q4,Elderly
200853391,20085339,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,260.0,MG,Y,Y,MM2243/2103101,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Vulvovaginal pruritus,,2021,Q4,1,I,20211025.0,20211111.0,20211118,20211118,EXP,,CN-AstraZeneca-2021A806857,ASTRAZENECA,,27155.0,DY,,F,Y,58.2,KG,20211118.0,,MD,CN,,2021,Q4,Elderly
200869111,20086911,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Agranulocytosis,,2021,Q4,1,I,,20211112.0,20211118,20211118,EXP,FR-AFSSAPS-MA20212923,FR-MYLANLABS-2021M1083876,MYLAN,,57.0,YR,,M,Y,,,20211118.0,,PH,FR,FR,2021,Q4,Adult
200870981,20087098,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg/day,,,,,,,,,,,,2021,Q4,Coronary artery stenosis,,2021,Q4,1,I,,20211115.0,20211118,20211118,EXP,,JP-DSJP-DSJ-2021-138019,DAIICHI,,80.0,YR,,M,Y,67.0,KG,20211118.0,,MD,JP,JP,2021,Q4,Elderly
200870981,20087098,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg/day,,,,,,,,,,,,2021,Q4,Chest discomfort,,2021,Q4,1,I,,20211115.0,20211118,20211118,EXP,,JP-DSJP-DSJ-2021-138019,DAIICHI,,80.0,YR,,M,Y,67.0,KG,20211118.0,,MD,JP,JP,2021,Q4,Elderly
200872242,20087224,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Cardiac failure chronic,,2021,Q4,2,F,20210205.0,20211217.0,20211118,20211223,EXP,,JP-OTSUKA-2021_039488,OTSUKA,,59.0,YR,,M,Y,63.0,KG,20211223.0,,MD,JP,JP,2021,Q4,Adult
200872242,20087224,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Blood creatinine increased,,2021,Q4,2,F,20210205.0,20211217.0,20211118,20211223,EXP,,JP-OTSUKA-2021_039488,OTSUKA,,59.0,YR,,M,Y,63.0,KG,20211223.0,,MD,JP,JP,2021,Q4,Adult
200872242,20087224,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Blood potassium increased,,2021,Q4,2,F,20210205.0,20211217.0,20211118,20211223,EXP,,JP-OTSUKA-2021_039488,OTSUKA,,59.0,YR,,M,Y,63.0,KG,20211223.0,,MD,JP,JP,2021,Q4,Adult
200872242,20087224,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Product use in unapproved indication,,2021,Q4,2,F,20210205.0,20211217.0,20211118,20211223,EXP,,JP-OTSUKA-2021_039488,OTSUKA,,59.0,YR,,M,Y,63.0,KG,20211223.0,,MD,JP,JP,2021,Q4,Adult
200872242,20087224,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Cough variant asthma,,2021,Q4,2,F,20210205.0,20211217.0,20211118,20211223,EXP,,JP-OTSUKA-2021_039488,OTSUKA,,59.0,YR,,M,Y,63.0,KG,20211223.0,,MD,JP,JP,2021,Q4,Adult
200874461,20087446,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Death,,2021,Q4,1,I,20211022.0,20211115.0,20211118,20211118,EXP,,ZA-AstraZeneca-2021A809726,ASTRAZENECA,,23350.0,DY,,M,Y,,,20211118.0,,CN,ZA,,2021,Q4,Elderly
200882822,20088282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2021,Q4,Left ventricular dysfunction,,2021,Q4,2,F,20210601.0,20211125.0,20211118,20211202,EXP,,GB-AstraZeneca-2021A806044,ASTRAZENECA,,79.0,YR,,F,Y,54.0,KG,20211203.0,,MD,GB,,2021,Q4,Elderly
200882822,20088282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2021,Q4,Chest pain,,2021,Q4,2,F,20210601.0,20211125.0,20211118,20211202,EXP,,GB-AstraZeneca-2021A806044,ASTRAZENECA,,79.0,YR,,F,Y,54.0,KG,20211203.0,,MD,GB,,2021,Q4,Elderly
200882822,20088282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2021,Q4,Fatigue,,2021,Q4,2,F,20210601.0,20211125.0,20211118,20211202,EXP,,GB-AstraZeneca-2021A806044,ASTRAZENECA,,79.0,YR,,F,Y,54.0,KG,20211203.0,,MD,GB,,2021,Q4,Elderly
200882822,20088282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2021,Q4,Dyspnoea,,2021,Q4,2,F,20210601.0,20211125.0,20211118,20211202,EXP,,GB-AstraZeneca-2021A806044,ASTRAZENECA,,79.0,YR,,F,Y,54.0,KG,20211203.0,,MD,GB,,2021,Q4,Elderly
200882822,20088282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2021,Q4,Cardiomyopathy,,2021,Q4,2,F,20210601.0,20211125.0,20211118,20211202,EXP,,GB-AstraZeneca-2021A806044,ASTRAZENECA,,79.0,YR,,F,Y,54.0,KG,20211203.0,,MD,GB,,2021,Q4,Elderly
200882822,20088282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,2,F,20210601.0,20211125.0,20211118,20211202,EXP,,GB-AstraZeneca-2021A806044,ASTRAZENECA,,79.0,YR,,F,Y,54.0,KG,20211203.0,,MD,GB,,2021,Q4,Elderly
200882822,20088282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2021,Q4,Suspected COVID-19,,2021,Q4,2,F,20210601.0,20211125.0,20211118,20211202,EXP,,GB-AstraZeneca-2021A806044,ASTRAZENECA,,79.0,YR,,F,Y,54.0,KG,20211203.0,,MD,GB,,2021,Q4,Elderly
200890791,20089079,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Daily",,,U,,,,,,,,,2021,Q4,Hypersensitivity,,2021,Q4,1,I,20211103.0,20211105.0,20211119,20211119,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318219,RANBAXY,,65.0,YR,,F,Y,86.0,KG,20211119.0,,MD,GB,GB,2021,Q4,Elderly
200890791,20089079,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Daily",,,U,,,,,,,,,2021,Q4,Myalgia,,2021,Q4,1,I,20211103.0,20211105.0,20211119,20211119,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318219,RANBAXY,,65.0,YR,,F,Y,86.0,KG,20211119.0,,MD,GB,GB,2021,Q4,Elderly
200890791,20089079,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Daily",,,U,,,,,,,,,2021,Q4,Skin reaction,,2021,Q4,1,I,20211103.0,20211105.0,20211119,20211119,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318219,RANBAXY,,65.0,YR,,F,Y,86.0,KG,20211119.0,,MD,GB,GB,2021,Q4,Elderly
200894311,20089431,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211105.0,20211119,20211119,EXP,,AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-317232,RANBAXY,Figtree P. Deprescribing diabetes meds with a low-carb approach. CLINICAL FOCUS CASE REPORT. -;-:-,72.0,YR,,M,Y,131.0,KG,20211119.0,,MD,AU,AU,2021,Q4,Elderly
200894311,20089431,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,,,2021,Q4,Dizziness postural,,2021,Q4,1,I,,20211105.0,20211119,20211119,EXP,,AU-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-317232,RANBAXY,Figtree P. Deprescribing diabetes meds with a low-carb approach. CLINICAL FOCUS CASE REPORT. -;-:-,72.0,YR,,M,Y,131.0,KG,20211119.0,,MD,AU,AU,2021,Q4,Elderly
200895171,20089517,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Coronary artery disease,,2021,Q4,1,I,,20211108.0,20211119,20211119,EXP,,BR-NOVOPROD-865078,NOVO NORDISK,,69.0,YR,,F,Y,59.0,KG,20211119.0,,MD,BR,BR,2021,Q4,Elderly
200895171,20089517,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Proteinuria,,2021,Q4,1,I,,20211108.0,20211119,20211119,EXP,,BR-NOVOPROD-865078,NOVO NORDISK,,69.0,YR,,F,Y,59.0,KG,20211119.0,,MD,BR,BR,2021,Q4,Elderly
200895171,20089517,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211108.0,20211119,20211119,EXP,,BR-NOVOPROD-865078,NOVO NORDISK,,69.0,YR,,F,Y,59.0,KG,20211119.0,,MD,BR,BR,2021,Q4,Elderly
200895171,20089517,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Dyslipidaemia,,2021,Q4,1,I,,20211108.0,20211119,20211119,EXP,,BR-NOVOPROD-865078,NOVO NORDISK,,69.0,YR,,F,Y,59.0,KG,20211119.0,,MD,BR,BR,2021,Q4,Elderly
200895171,20089517,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,1,I,,20211108.0,20211119,20211119,EXP,,BR-NOVOPROD-865078,NOVO NORDISK,,69.0,YR,,F,Y,59.0,KG,20211119.0,,MD,BR,BR,2021,Q4,Elderly
200895171,20089517,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Urinary tract infection,,2021,Q4,1,I,,20211108.0,20211119,20211119,EXP,,BR-NOVOPROD-865078,NOVO NORDISK,,69.0,YR,,F,Y,59.0,KG,20211119.0,,MD,BR,BR,2021,Q4,Elderly
200895191,20089519,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210301.0,20211109.0,20211119,20211119,EXP,,BR-NOVOPROD-865922,NOVO NORDISK,,73.0,YR,,M,Y,65.7,KG,20211119.0,,MD,BR,BR,2021,Q4,Elderly
200895191,20089519,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Coronary revascularisation,,2021,Q4,1,I,20210301.0,20211109.0,20211119,20211119,EXP,,BR-NOVOPROD-865922,NOVO NORDISK,,73.0,YR,,M,Y,65.7,KG,20211119.0,,MD,BR,BR,2021,Q4,Elderly
200896711,20089671,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,U,,21041552,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Rash,,2021,Q4,1,I,20211107.0,20211113.0,20211119,20211119,EXP,,CN-AstraZeneca-2021A809993,ASTRAZENECA,,47.0,YR,,F,Y,54.0,KG,20211119.0,,MD,CN,,2021,Q4,Adult
200896711,20089671,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,U,,21041552,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Pruritus,,2021,Q4,1,I,20211107.0,20211113.0,20211119,20211119,EXP,,CN-AstraZeneca-2021A809993,ASTRAZENECA,,47.0,YR,,F,Y,54.0,KG,20211119.0,,MD,CN,,2021,Q4,Adult
200898411,20089841,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20210517.0,20211109.0,20211119,20211119,EXP,,NVSC2021EG258012,NOVARTIS,,43.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200898411,20089841,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Renal impairment,,2021,Q4,1,I,20210517.0,20211109.0,20211119,20211119,EXP,,NVSC2021EG258012,NOVARTIS,,43.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200898411,20089841,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Dizziness,,2021,Q4,1,I,20210517.0,20211109.0,20211119,20211119,EXP,,NVSC2021EG258012,NOVARTIS,,43.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200898411,20089841,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20210517.0,20211109.0,20211119,20211119,EXP,,NVSC2021EG258012,NOVARTIS,,43.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200898411,20089841,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Intracardiac thrombus,,2021,Q4,1,I,20210517.0,20211109.0,20211119,20211119,EXP,,NVSC2021EG258012,NOVARTIS,,43.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200898411,20089841,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Embolism,,2021,Q4,1,I,20210517.0,20211109.0,20211119,20211119,EXP,,NVSC2021EG258012,NOVARTIS,,43.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200898411,20089841,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Hypotension,,2021,Q4,1,I,20210517.0,20211109.0,20211119,20211119,EXP,,NVSC2021EG258012,NOVARTIS,,43.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200898411,20089841,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Mood altered,,2021,Q4,1,I,20210517.0,20211109.0,20211119,20211119,EXP,,NVSC2021EG258012,NOVARTIS,,43.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200898411,20089841,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Coma,,2021,Q4,1,I,20210517.0,20211109.0,20211119,20211119,EXP,,NVSC2021EG258012,NOVARTIS,,43.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200902641,20090264,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Anaemia,,2021,Q4,1,I,20210915.0,20211112.0,20211119,20211119,EXP,,JP-AstraZeneca-2021A747599,ASTRAZENECA,,28866.0,DY,,F,Y,51.0,KG,20211119.0,,MD,JP,,2021,Q4,Elderly
200902641,20090264,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Dehydration,,2021,Q4,1,I,20210915.0,20211112.0,20211119,20211119,EXP,,JP-AstraZeneca-2021A747599,ASTRAZENECA,,28866.0,DY,,F,Y,51.0,KG,20211119.0,,MD,JP,,2021,Q4,Elderly
200902641,20090264,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Anaemia,,2021,Q4,1,I,20210915.0,20211112.0,20211119,20211119,EXP,,JP-AstraZeneca-2021A747599,ASTRAZENECA,,28866.0,DY,,F,Y,51.0,KG,20211119.0,,MD,JP,,2021,Q4,Elderly
200902641,20090264,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Dehydration,,2021,Q4,1,I,20210915.0,20211112.0,20211119,20211119,EXP,,JP-AstraZeneca-2021A747599,ASTRAZENECA,,28866.0,DY,,F,Y,51.0,KG,20211119.0,,MD,JP,,2021,Q4,Elderly
200902641,20090264,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Anaemia,,2021,Q4,1,I,20210915.0,20211112.0,20211119,20211119,EXP,,JP-AstraZeneca-2021A747599,ASTRAZENECA,,28866.0,DY,,F,Y,51.0,KG,20211119.0,,MD,JP,,2021,Q4,Elderly
200902641,20090264,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Dehydration,,2021,Q4,1,I,20210915.0,20211112.0,20211119,20211119,EXP,,JP-AstraZeneca-2021A747599,ASTRAZENECA,,28866.0,DY,,F,Y,51.0,KG,20211119.0,,MD,JP,,2021,Q4,Elderly
200902641,20090264,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Anaemia,,2021,Q4,1,I,20210915.0,20211112.0,20211119,20211119,EXP,,JP-AstraZeneca-2021A747599,ASTRAZENECA,,28866.0,DY,,F,Y,51.0,KG,20211119.0,,MD,JP,,2021,Q4,Elderly
200902641,20090264,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Dehydration,,2021,Q4,1,I,20210915.0,20211112.0,20211119,20211119,EXP,,JP-AstraZeneca-2021A747599,ASTRAZENECA,,28866.0,DY,,F,Y,51.0,KG,20211119.0,,MD,JP,,2021,Q4,Elderly
200904352,20090435,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,,20211126.0,20211119,20211206,EXP,,GR-BAUSCH-BL-2021-037962,BAUSCH AND LOMB,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation. Hellenic Diabetological Chronicles. 2020;33(2):135.",74.0,YR,,F,Y,,,20211206.0,,HP,GR,GR,2021,Q4,Elderly
200904352,20090435,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,2,F,,20211126.0,20211119,20211206,EXP,,GR-BAUSCH-BL-2021-037962,BAUSCH AND LOMB,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation. Hellenic Diabetological Chronicles. 2020;33(2):135.",74.0,YR,,F,Y,,,20211206.0,,HP,GR,GR,2021,Q4,Elderly
200904352,20090435,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,2,F,,20211126.0,20211119,20211206,EXP,,GR-BAUSCH-BL-2021-037962,BAUSCH AND LOMB,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation. Hellenic Diabetological Chronicles. 2020;33(2):135.",74.0,YR,,F,Y,,,20211206.0,,HP,GR,GR,2021,Q4,Elderly
200904511,20090451,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,,5.0,MG,Tablet,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,,20211110.0,20211119,20211119,EXP,,DE-AstraZeneca-2021A805989,ASTRAZENECA,,69.0,YR,,M,Y,,,20211119.0,,MD,DE,,2021,Q4,Elderly
200904551,20090455,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,120.0,MG,Y,,2104250,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211105.0,20211113.0,20211119,20211119,EXP,,CN-AstraZeneca-2021A809464,ASTRAZENECA,,39.0,YR,,M,Y,49.9,KG,20211119.0,,MD,CN,,2021,Q4,Adult
200904572,20090457,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,290.0,MG,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,2,F,20210730.0,20211130.0,20211119,20211208,EXP,,FR-AstraZeneca-2021A810975,ASTRAZENECA,,18234.0,DY,,M,Y,99.0,KG,20211208.0,,MD,FR,,2021,Q4,Elderly
200905481,20090548,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1930.0,MG,Y,,2105099,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Ketosis,,2021,Q4,1,I,20211109.0,20211113.0,20211119,20211119,EXP,,CN-AstraZeneca-2021A809461,ASTRAZENECA,,21185.0,DY,,M,Y,81.0,KG,20211119.0,,MD,CN,,2021,Q4,Elderly
200905481,20090548,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1930.0,MG,Y,,2105099,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Glucose urine present,,2021,Q4,1,I,20211109.0,20211113.0,20211119,20211119,EXP,,CN-AstraZeneca-2021A809461,ASTRAZENECA,,21185.0,DY,,M,Y,81.0,KG,20211119.0,,MD,CN,,2021,Q4,Elderly
200907131,20090713,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,,20211111.0,20211119,20211119,EXP,,AU-AstraZeneca-2021A805922,ASTRAZENECA,,74.0,YR,,M,Y,,,20211119.0,,MD,AU,,2021,Q4,Elderly
200907131,20090713,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211111.0,20211119,20211119,EXP,,AU-AstraZeneca-2021A805922,ASTRAZENECA,,74.0,YR,,M,Y,,,20211119.0,,MD,AU,,2021,Q4,Elderly
200911511,20091151,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Weight increased,,2021,Q4,1,I,20160301.0,20211111.0,20211119,20211119,EXP,,DE-AstraZeneca-2021A805942,ASTRAZENECA,,52.0,YR,,F,Y,124.0,KG,20211119.0,,MD,DE,,2021,Q4,Adult
200911511,20091151,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,20160301.0,20211111.0,20211119,20211119,EXP,,DE-AstraZeneca-2021A805942,ASTRAZENECA,,52.0,YR,,F,Y,124.0,KG,20211119.0,,MD,DE,,2021,Q4,Adult
200911511,20091151,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Insulin resistance,,2021,Q4,1,I,20160301.0,20211111.0,20211119,20211119,EXP,,DE-AstraZeneca-2021A805942,ASTRAZENECA,,52.0,YR,,F,Y,124.0,KG,20211119.0,,MD,DE,,2021,Q4,Adult
200916551,20091655,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20210201.0,20211110.0,20211119,20211119,EXP,,NVSC2021EG259250,NOVARTIS,,46.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200916551,20091655,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20210201.0,20211110.0,20211119,20211119,EXP,,NVSC2021EG259250,NOVARTIS,,46.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200916551,20091655,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Blood cholesterol increased,,2021,Q4,1,I,20210201.0,20211110.0,20211119,20211119,EXP,,NVSC2021EG259250,NOVARTIS,,46.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200916551,20091655,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 DF, QD",,,,,,,,,,Tablet,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20210201.0,20211110.0,20211119,20211119,EXP,,NVSC2021EG259250,NOVARTIS,,46.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200916712,20091671,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,2,F,20200916.0,20211118.0,20211119,20211122,EXP,,ES-SA-2020SA266247,SANOFI AVENTIS,,70.0,YR,E,M,Y,73.0,KG,20211122.0,,MD,ES,ES,2021,Q4,Elderly
200916712,20091671,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2021,Q4,Malignant neoplasm progression,,2021,Q4,2,F,20200916.0,20211118.0,20211119,20211122,EXP,,ES-SA-2020SA266247,SANOFI AVENTIS,,70.0,YR,E,M,Y,73.0,KG,20211122.0,,MD,ES,ES,2021,Q4,Elderly
200921411,20092141,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3670.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Ketonuria,,2021,Q4,1,I,20210108.0,20211111.0,20211119,20211119,EXP,,RU-AstraZeneca-2021A808157,ASTRAZENECA,,13901.0,DY,,F,Y,118.0,KG,20211119.0,,CN,RU,,2021,Q4,Elderly
200948211,20094821,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg,,,,,unk,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20201127.0,20211110.0,20211122,20211122,EXP,,BR-NOVOPROD-865886,NOVO NORDISK,,67.0,YR,,F,Y,58.0,KG,20211122.0,,MD,BR,BR,2021,Q4,Elderly
200948211,20094821,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg,,,,,unk,,,,,,,2021,Q4,Chest pain,,2021,Q4,1,I,20201127.0,20211110.0,20211122,20211122,EXP,,BR-NOVOPROD-865886,NOVO NORDISK,,67.0,YR,,F,Y,58.0,KG,20211122.0,,MD,BR,BR,2021,Q4,Elderly
200948211,20094821,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg,,,,,unk,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,20201127.0,20211110.0,20211122,20211122,EXP,,BR-NOVOPROD-865886,NOVO NORDISK,,67.0,YR,,F,Y,58.0,KG,20211122.0,,MD,BR,BR,2021,Q4,Elderly
200948211,20094821,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg,,,,,unk,,,,,,,2021,Q4,Pain,,2021,Q4,1,I,20201127.0,20211110.0,20211122,20211122,EXP,,BR-NOVOPROD-865886,NOVO NORDISK,,67.0,YR,,F,Y,58.0,KG,20211122.0,,MD,BR,BR,2021,Q4,Elderly
200950631,20095063,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Syncope,,2021,Q4,1,I,,20211110.0,20211122,20211122,EXP,,RU-AstraZeneca-2021A807473,ASTRAZENECA,,56.0,YR,,M,Y,,,20211122.0,,HP,RU,,2021,Q4,Adult
200950631,20095063,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20211110.0,20211122,20211122,EXP,,RU-AstraZeneca-2021A807473,ASTRAZENECA,,56.0,YR,,M,Y,,,20211122.0,,HP,RU,,2021,Q4,Adult
200950631,20095063,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211110.0,20211122,20211122,EXP,,RU-AstraZeneca-2021A807473,ASTRAZENECA,,56.0,YR,,M,Y,,,20211122.0,,HP,RU,,2021,Q4,Adult
200962311,20096231,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2021,Q4,Death,,2021,Q4,1,I,20210101.0,20211118.0,20211122,20211122,EXP,,HU-AstraZeneca-2021A812009,ASTRAZENECA,,75.0,YR,,M,Y,,,20211122.0,,HP,HU,,2021,Q4,Elderly
200966142,20096614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2021,Q4,Left ventricular dysfunction,,2021,Q4,2,F,20210601.0,20211125.0,20211122,20211203,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-TEVA-2021-GB-1979211,TEVA,,79.0,YR,E,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
200966142,20096614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,2,F,20210601.0,20211125.0,20211122,20211203,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-TEVA-2021-GB-1979211,TEVA,,79.0,YR,E,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
200966142,20096614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2021,Q4,Suspected COVID-19,,2021,Q4,2,F,20210601.0,20211125.0,20211122,20211203,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-TEVA-2021-GB-1979211,TEVA,,79.0,YR,E,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
200966142,20096614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,2,F,20210601.0,20211125.0,20211122,20211203,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-TEVA-2021-GB-1979211,TEVA,,79.0,YR,E,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
200966142,20096614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2021,Q4,Chest pain,,2021,Q4,2,F,20210601.0,20211125.0,20211122,20211203,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-TEVA-2021-GB-1979211,TEVA,,79.0,YR,E,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
200966142,20096614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2021,Q4,Fatigue,,2021,Q4,2,F,20210601.0,20211125.0,20211122,20211203,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-TEVA-2021-GB-1979211,TEVA,,79.0,YR,E,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
200966142,20096614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,U,,,,,,,,2021,Q4,Cardiomyopathy,,2021,Q4,2,F,20210601.0,20211125.0,20211122,20211203,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-TEVA-2021-GB-1979211,TEVA,,79.0,YR,E,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
200966981,20096698,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,10.0,MG,,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211111.0,20211122,20211122,EXP,,GB-AstraZeneca-2021A804497,ASTRAZENECA,,31.0,YR,,M,Y,,,20211122.0,,MD,GB,,2021,Q4,Young Adult
200967951,20096795,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,,MM3606,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211019.0,20211112.0,20211122,20211122,EXP,,CN-AstraZeneca-2021A808546,ASTRAZENECA,,24837.0,DY,,M,Y,65.0,KG,20211122.0,,MD,CN,,2021,Q4,Elderly
200968721,20096872,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,MF2889,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211104.0,20211112.0,20211122,20211122,EXP,,CN-AstraZeneca-2021A809492,ASTRAZENECA,,52.0,YR,,F,Y,66.0,KG,20211122.0,,MD,CN,,2021,Q4,Adult
200968721,20096872,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,MF2889,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Dehydration,,2021,Q4,1,I,20211104.0,20211112.0,20211122,20211122,EXP,,CN-AstraZeneca-2021A809492,ASTRAZENECA,,52.0,YR,,F,Y,66.0,KG,20211122.0,,MD,CN,,2021,Q4,Adult
200968741,20096874,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211117.0,20211122,20211122,EXP,,CA-AstraZeneca-2021A810104,ASTRAZENECA,,62.0,YR,,F,Y,62.0,KG,20211122.0,,MD,CA,,2021,Q4,Adult
200971232,20097123,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Interstitial lung disease,,2021,Q4,2,F,,20211117.0,20211122,20211124,EXP,,JP-009507513-2111JPN007179,MERCK,"Ichimura T, et al.. Effectiveness of corticosteroids on immune checkpoint inhibitor-induced interstitial pneumonia among patients with a history of interstitial pneumonia: A case series.. SAGE Open Medical Case. 2021;9:1-5",68.0,YR,,M,Y,67.9,KG,20211124.0,,PH,JP,JP,2021,Q4,Elderly
200980641,20098064,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram,,,,,,,,10.0,MG,Unknown,,2021,Q4,Platelet count decreased,,2021,Q4,1,I,20170518.0,20211117.0,20211122,20211122,EXP,,PA-CELGENEUS-PAN-20170902116,CELGENE,,49.0,YR,,F,Y,,,20211122.0,,HP,PA,PA,2021,Q4,Adult
200981392,20098139,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Intraocular pressure increased,,2021,Q4,2,F,20210801.0,20211121.0,20211122,20211126,EXP,,RU-009507513-2111RUS007368,MERCK,,5.0,DEC,,F,Y,,,20211126.0,,MD,RU,RU,2021,Q4,Child
200981392,20098139,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,2,F,20210801.0,20211121.0,20211122,20211126,EXP,,RU-009507513-2111RUS007368,MERCK,,5.0,DEC,,F,Y,,,20211126.0,,MD,RU,RU,2021,Q4,Child
200981392,20098139,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Prescribed underdose,,2021,Q4,2,F,20210801.0,20211121.0,20211122,20211126,EXP,,RU-009507513-2111RUS007368,MERCK,,5.0,DEC,,F,Y,,,20211126.0,,MD,RU,RU,2021,Q4,Child
200981392,20098139,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,2,F,20210801.0,20211121.0,20211122,20211126,EXP,,RU-009507513-2111RUS007368,MERCK,,5.0,DEC,,F,Y,,,20211126.0,,MD,RU,RU,2021,Q4,Child
200998231,20099823,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211112.0,20211123,20211123,EXP,,NL-AUROBINDO-AUR-APL-2021-047915,AUROBINDO,"Patel P., Patel T., Patil S., Patel S., Ross Ang J.. CONSIDERATIONS FOR SODIUM-GLUCOSE TRANSPORTER 2 INHIBITOR THERAPY RESULTING IN EUGLYCEMIC DIABETIC KETOACIDOSIS.. Chest. 2021;160(4):981A-982A",40.0,YR,,M,Y,,,20211123.0,,HP,NL,NL,2021,Q4,Adult
201000212,20100021,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Interstitial lung disease,,2021,Q4,2,F,,20211117.0,20211123,20211126,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-072418,BRISTOL MYERS SQUIBB,"Ichimura T, Hinata M, Ichikura D, Suzuki S. Effectiveness of corticosteroids on immune checkpoint inhibitor-induced interstitial pneumonia among patients with a history of interstitial pneumonia: a case series. SAGE Open Medical Case Reports. 2021;9:1-5",68.0,YR,,M,Y,67.9,KG,20211126.0,,PH,JP,JP,2021,Q4,Elderly
201000591,20100059,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,unk,,,,,,,2021,Q4,Death,,2021,Q4,1,I,20211022.0,20211115.0,20211123,20211123,EXP,,ZA-NOVOPROD-868044,NOVO NORDISK,,63.0,YR,,M,Y,,,20211123.0,,CN,ZA,ZA,2021,Q4,Adult
201005613,20100561,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2021,Q4,Cardiac failure,,2021,Q4,3,F,,20211113.0,20211123,20211208,EXP,,NVSC2021TH261031,NOVARTIS,,23.0,YR,,M,Y,,,20211208.0,,MD,TH,TH,2021,Q4,Youth
201006212,20100621,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Toxicity to various agents,,2021,Q4,2,F,,20211130.0,20211123,20211208,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20211208.0,,MD,JP,,2021,Q4,Elderly
201006212,20100621,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Hypophagia,,2021,Q4,2,F,,20211130.0,20211123,20211208,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20211208.0,,MD,JP,,2021,Q4,Elderly
201006212,20100621,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Atrial flutter,,2021,Q4,2,F,,20211130.0,20211123,20211208,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20211208.0,,MD,JP,,2021,Q4,Elderly
201006212,20100621,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Weight decreased,,2021,Q4,2,F,,20211130.0,20211123,20211208,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20211208.0,,MD,JP,,2021,Q4,Elderly
201006212,20100621,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Dehydration,,2021,Q4,2,F,,20211130.0,20211123,20211208,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20211208.0,,MD,JP,,2021,Q4,Elderly
201010732,20101073,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,2,F,20210601.0,20211125.0,20211123,20211204,EXP,GB-MHRA-ADR 26191305,GB-Accord-245515,ACCORD,,79.0,YR,,F,Y,54.0,KG,20211204.0,,PH,GB,GB,2021,Q4,Elderly
201010732,20101073,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Cardiomyopathy,,2021,Q4,2,F,20210601.0,20211125.0,20211123,20211204,EXP,GB-MHRA-ADR 26191305,GB-Accord-245515,ACCORD,,79.0,YR,,F,Y,54.0,KG,20211204.0,,PH,GB,GB,2021,Q4,Elderly
201010732,20101073,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,2,F,20210601.0,20211125.0,20211123,20211204,EXP,GB-MHRA-ADR 26191305,GB-Accord-245515,ACCORD,,79.0,YR,,F,Y,54.0,KG,20211204.0,,PH,GB,GB,2021,Q4,Elderly
201010732,20101073,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Chest pain,,2021,Q4,2,F,20210601.0,20211125.0,20211123,20211204,EXP,GB-MHRA-ADR 26191305,GB-Accord-245515,ACCORD,,79.0,YR,,F,Y,54.0,KG,20211204.0,,PH,GB,GB,2021,Q4,Elderly
201010732,20101073,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Left ventricular dysfunction,,2021,Q4,2,F,20210601.0,20211125.0,20211123,20211204,EXP,GB-MHRA-ADR 26191305,GB-Accord-245515,ACCORD,,79.0,YR,,F,Y,54.0,KG,20211204.0,,PH,GB,GB,2021,Q4,Elderly
201010732,20101073,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Suspected COVID-19,,2021,Q4,2,F,20210601.0,20211125.0,20211123,20211204,EXP,GB-MHRA-ADR 26191305,GB-Accord-245515,ACCORD,,79.0,YR,,F,Y,54.0,KG,20211204.0,,PH,GB,GB,2021,Q4,Elderly
201010732,20101073,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,2,F,20210601.0,20211125.0,20211123,20211204,EXP,GB-MHRA-ADR 26191305,GB-Accord-245515,ACCORD,,79.0,YR,,F,Y,54.0,KG,20211204.0,,PH,GB,GB,2021,Q4,Elderly
201011761,20101176,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,Tablet,BID,2021,Q4,General physical health deterioration,,2021,Q4,1,I,20211006.0,20211115.0,20211123,20211123,EXP,,DE-AstraZeneca-2021A811949,ASTRAZENECA,,82.0,YR,,M,Y,,,20211123.0,,MD,DE,,2021,Q4,Elderly
201011761,20101176,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,Tablet,BID,2021,Q4,Chronic obstructive pulmonary disease,,2021,Q4,1,I,20211006.0,20211115.0,20211123,20211123,EXP,,DE-AstraZeneca-2021A811949,ASTRAZENECA,,82.0,YR,,M,Y,,,20211123.0,,MD,DE,,2021,Q4,Elderly
201011761,20101176,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,Tablet,BID,2021,Q4,Vitamin B12 deficiency,,2021,Q4,1,I,20211006.0,20211115.0,20211123,20211123,EXP,,DE-AstraZeneca-2021A811949,ASTRAZENECA,,82.0,YR,,M,Y,,,20211123.0,,MD,DE,,2021,Q4,Elderly
201011761,20101176,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,Tablet,BID,2021,Q4,Hypertensive crisis,,2021,Q4,1,I,20211006.0,20211115.0,20211123,20211123,EXP,,DE-AstraZeneca-2021A811949,ASTRAZENECA,,82.0,YR,,M,Y,,,20211123.0,,MD,DE,,2021,Q4,Elderly
201011761,20101176,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,Tablet,BID,2021,Q4,Dry skin,,2021,Q4,1,I,20211006.0,20211115.0,20211123,20211123,EXP,,DE-AstraZeneca-2021A811949,ASTRAZENECA,,82.0,YR,,M,Y,,,20211123.0,,MD,DE,,2021,Q4,Elderly
201012821,20101282,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (Vormedikation von Ambulanz)",,,,,,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211114.0,20211119.0,20211123,20211123,EXP,DE-BFARM-21010717,NVSC2021DE266574,NOVARTIS,,63.0,YR,,F,Y,70.0,KG,20211123.0,,MD,DE,DE,2021,Q4,Adult
201012961,20101296,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,D,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,20211003.0,20211115.0,20211123,20211123,EXP,,FR-AstraZeneca-2021A806555,ASTRAZENECA,,64.0,YR,,M,Y,67.0,KG,20211123.0,,MD,FR,,2021,Q4,Adult
201013861,20101386,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,1,I,20210601.0,20211112.0,20211123,20211123,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,NVSC2021GB260366,NOVARTIS,,79.0,YR,,F,Y,54.0,KG,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201013861,20101386,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20210601.0,20211112.0,20211123,20211123,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,NVSC2021GB260366,NOVARTIS,,79.0,YR,,F,Y,54.0,KG,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201013861,20101386,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20210601.0,20211112.0,20211123,20211123,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,NVSC2021GB260366,NOVARTIS,,79.0,YR,,F,Y,54.0,KG,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201013861,20101386,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Suspected COVID-19,,2021,Q4,1,I,20210601.0,20211112.0,20211123,20211123,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,NVSC2021GB260366,NOVARTIS,,79.0,YR,,F,Y,54.0,KG,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201013861,20101386,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Cardiomyopathy,,2021,Q4,1,I,20210601.0,20211112.0,20211123,20211123,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,NVSC2021GB260366,NOVARTIS,,79.0,YR,,F,Y,54.0,KG,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201013861,20101386,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,20210601.0,20211112.0,20211123,20211123,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,NVSC2021GB260366,NOVARTIS,,79.0,YR,,F,Y,54.0,KG,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201013861,20101386,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Chest pain,,2021,Q4,1,I,20210601.0,20211112.0,20211123,20211123,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,NVSC2021GB260366,NOVARTIS,,79.0,YR,,F,Y,54.0,KG,20211123.0,,PH,GB,GB,2021,Q4,Elderly
201017361,20101736,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,MM3601/2104152,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Rash,,2021,Q4,1,I,20211108.0,20211116.0,20211123,20211123,EXP,,CN-AstraZeneca-2021A811266,ASTRAZENECA,,49.0,YR,,M,Y,81.2,KG,20211123.0,,MD,CN,,2021,Q4,Adult
201017361,20101736,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,MM3601/2104152,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Pruritus,,2021,Q4,1,I,20211108.0,20211116.0,20211123,20211123,EXP,,CN-AstraZeneca-2021A811266,ASTRAZENECA,,49.0,YR,,M,Y,81.2,KG,20211123.0,,MD,CN,,2021,Q4,Adult
201054731,20105473,2,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,Pre-medication from outpatient department,,,,,,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211114.0,20211119.0,20211124,20211124,EXP,DE-BFARM-21010717,DE-BAUSCH-BL-2021-038409,BAUSCH AND LOMB,,63.0,YR,,F,Y,70.0,KG,20211124.0,,MD,DE,DE,2021,Q4,Adult
201064802,20106480,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Fatigue,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201064802,20106480,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201064802,20106480,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Cardiomyopathy,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201064802,20106480,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Chest pain,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201064802,20106480,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Left ventricular dysfunction,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201064802,20106480,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Suspected COVID-19,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201064802,20106480,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201064802,20106480,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Fatigue,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201064802,20106480,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201064802,20106480,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Cardiomyopathy,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201064802,20106480,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Chest pain,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201064802,20106480,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Left ventricular dysfunction,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201064802,20106480,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Suspected COVID-19,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201064802,20106480,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,2,F,20210601.0,20211125.0,20211124,20211203,EXP,,GB-AUROBINDO-AUR-APL-2021-047730,AUROBINDO,,79.0,YR,,F,Y,54.0,KG,20211203.0,,PH,GB,GB,2021,Q4,Elderly
201069851,20106985,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,2103228,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Urine ketone body present,,2021,Q4,1,I,20211022.0,20211116.0,20211124,20211124,EXP,,CN-AstraZeneca-2021A811323,ASTRAZENECA,,31315.0,DY,,F,Y,55.0,KG,20211124.0,,MD,CN,,2021,Q4,Elderly
201069851,20106985,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,2103228,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20211022.0,20211116.0,20211124,20211124,EXP,,CN-AstraZeneca-2021A811323,ASTRAZENECA,,31315.0,DY,,F,Y,55.0,KG,20211124.0,,MD,CN,,2021,Q4,Elderly
201069851,20106985,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,2103228,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Nausea,,2021,Q4,1,I,20211022.0,20211116.0,20211124,20211124,EXP,,CN-AstraZeneca-2021A811323,ASTRAZENECA,,31315.0,DY,,F,Y,55.0,KG,20211124.0,,MD,CN,,2021,Q4,Elderly
201071661,20107166,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,U,UNKNOWN,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,1,I,20210601.0,20211113.0,20211124,20211124,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MICRO LABS LIMITED-ML2021-03497,MICRO LABS,,79.0,YR,,F,Y,54.0,KG,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201071661,20107166,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,U,UNKNOWN,,,,,,,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,20210601.0,20211113.0,20211124,20211124,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MICRO LABS LIMITED-ML2021-03497,MICRO LABS,,79.0,YR,,F,Y,54.0,KG,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201071661,20107166,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,U,UNKNOWN,,,,,,,2021,Q4,Cardiomyopathy,,2021,Q4,1,I,20210601.0,20211113.0,20211124,20211124,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MICRO LABS LIMITED-ML2021-03497,MICRO LABS,,79.0,YR,,F,Y,54.0,KG,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201071661,20107166,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,U,UNKNOWN,,,,,,,2021,Q4,Chest pain,,2021,Q4,1,I,20210601.0,20211113.0,20211124,20211124,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MICRO LABS LIMITED-ML2021-03497,MICRO LABS,,79.0,YR,,F,Y,54.0,KG,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201071661,20107166,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,U,UNKNOWN,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20210601.0,20211113.0,20211124,20211124,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MICRO LABS LIMITED-ML2021-03497,MICRO LABS,,79.0,YR,,F,Y,54.0,KG,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201071661,20107166,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,U,UNKNOWN,,,,,,,2021,Q4,Suspected COVID-19,,2021,Q4,1,I,20210601.0,20211113.0,20211124,20211124,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MICRO LABS LIMITED-ML2021-03497,MICRO LABS,,79.0,YR,,F,Y,54.0,KG,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201071661,20107166,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,U,UNKNOWN,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20210601.0,20211113.0,20211124,20211124,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MICRO LABS LIMITED-ML2021-03497,MICRO LABS,,79.0,YR,,F,Y,54.0,KG,20211124.0,,PH,GB,GB,2021,Q4,Elderly
201076711,20107671,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Pre-medication from outpatient department,,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211114.0,20211119.0,20211124,20211124,EXP,,DE-AstraZeneca-2021A814214,ASTRAZENECA,,63.0,YR,,F,Y,70.0,KG,20211124.0,,MD,DE,,2021,Q4,Adult
201086721,20108672,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10,,,N,,,,202293.0,,,Tablet,,2021,Q4,Hyponatraemia,,2021,Q4,1,I,20211110.0,20211116.0,20211124,20211124,EXP,,GB-AstraZeneca-2021A809009,ASTRAZENECA,,85.0,YR,,F,Y,55.0,KG,20211124.0,,MD,GB,,2021,Q4,Elderly
201093092,20109309,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,,,1220421,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Dry mouth,,2021,Q4,2,F,20211026.0,20211129.0,20211124,20211207,EXP,,RU-AstraZeneca-2021A821010,ASTRAZENECA,,15548.0,DY,,F,Y,120.0,KG,20211207.0,,MD,RU,,2021,Q4,Elderly
201093092,20109309,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,,,1220421,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Blood pressure increased,,2021,Q4,2,F,20211026.0,20211129.0,20211124,20211207,EXP,,RU-AstraZeneca-2021A821010,ASTRAZENECA,,15548.0,DY,,F,Y,120.0,KG,20211207.0,,MD,RU,,2021,Q4,Elderly
201093092,20109309,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,,,1220421,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Fatigue,,2021,Q4,2,F,20211026.0,20211129.0,20211124,20211207,EXP,,RU-AstraZeneca-2021A821010,ASTRAZENECA,,15548.0,DY,,F,Y,120.0,KG,20211207.0,,MD,RU,,2021,Q4,Elderly
201093092,20109309,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,,,1220421,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Drug ineffective,,2021,Q4,2,F,20211026.0,20211129.0,20211124,20211207,EXP,,RU-AstraZeneca-2021A821010,ASTRAZENECA,,15548.0,DY,,F,Y,120.0,KG,20211207.0,,MD,RU,,2021,Q4,Elderly
201097321,20109732,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Ventricular tachycardia,,2021,Q4,1,I,,20211115.0,20211124,20211124,EXP,,NVSC2021RS263949,NOVARTIS,,27.0,YR,,M,Y,,,20211124.0,,MD,RS,RS,2021,Q4,Young Adult
201097321,20109732,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20211115.0,20211124,20211124,EXP,,NVSC2021RS263949,NOVARTIS,,27.0,YR,,M,Y,,,20211124.0,,MD,RS,RS,2021,Q4,Young Adult
201097441,20109744,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Cyanosis,,2021,Q4,1,I,20210401.0,20211117.0,20211124,20211124,EXP,,ES-AstraZeneca-2021A809388,ASTRAZENECA,,62.0,YR,,M,Y,71.0,KG,20211124.0,,MD,ES,,2021,Q4,Adult
201103751,20110375,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Microalbuminuria,,2021,Q4,1,I,,20211116.0,20211124,20211124,EXP,,AU-AstraZeneca-2021A811866,ASTRAZENECA,,62.0,YR,,M,Y,,,20211124.0,,MD,AU,,2021,Q4,Adult
201103751,20110375,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,1,I,,20211116.0,20211124,20211124,EXP,,AU-AstraZeneca-2021A811866,ASTRAZENECA,,62.0,YR,,M,Y,,,20211124.0,,MD,AU,,2021,Q4,Adult
201106301,20110630,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,Y,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Pruritus,,2021,Q4,1,I,20210814.0,20211117.0,20211124,20211124,EXP,,CH-AstraZeneca-2021A820368,ASTRAZENECA,,31919.0,DY,,M,Y,,,20211124.0,,MD,CH,,2021,Q4,Elderly
201106301,20110630,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,Y,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20210814.0,20211117.0,20211124,20211124,EXP,,CH-AstraZeneca-2021A820368,ASTRAZENECA,,31919.0,DY,,M,Y,,,20211124.0,,MD,CH,,2021,Q4,Elderly
201106321,20110632,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10, Daily",,,,,,,202293.0,,,Tablet,,2021,Q4,Phimosis,,2021,Q4,1,I,20210105.0,20211117.0,20211124,20211124,EXP,,DE-AstraZeneca-2021A809303,ASTRAZENECA,,52.0,YR,,M,Y,96.0,KG,20211124.0,,MD,DE,,2021,Q4,Adult
201106321,20110632,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10, Daily",,,,,,,202293.0,,,Tablet,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,20210105.0,20211117.0,20211124,20211124,EXP,,DE-AstraZeneca-2021A809303,ASTRAZENECA,,52.0,YR,,M,Y,96.0,KG,20211124.0,,MD,DE,,2021,Q4,Adult
201127171,20112717,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211117.0,20211125,20211125,EXP,,CA-AstraZeneca-2021A810080,ASTRAZENECA,,20.0,YR,,F,Y,,,20211125.0,,MD,CA,,2021,Q4,Youth
201127661,20112766,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q4,Angina unstable,,2021,Q4,1,I,,20211116.0,20211125,20211125,EXP,CA-MHPD-E2B_03478037,CA-Accord-245829,ACCORD,,56.0,YR,,M,Y,82.0,KG,20211125.0,,MD,CA,CA,2021,Q4,Adult
201127661,20112766,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q4,Myalgia,,2021,Q4,1,I,,20211116.0,20211125,20211125,EXP,CA-MHPD-E2B_03478037,CA-Accord-245829,ACCORD,,56.0,YR,,M,Y,82.0,KG,20211125.0,,MD,CA,CA,2021,Q4,Adult
201127661,20112766,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q4,Coronary artery stenosis,,2021,Q4,1,I,,20211116.0,20211125,20211125,EXP,CA-MHPD-E2B_03478037,CA-Accord-245829,ACCORD,,56.0,YR,,M,Y,82.0,KG,20211125.0,,MD,CA,CA,2021,Q4,Adult
201127661,20112766,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q4,Blood parathyroid hormone increased,,2021,Q4,1,I,,20211116.0,20211125,20211125,EXP,CA-MHPD-E2B_03478037,CA-Accord-245829,ACCORD,,56.0,YR,,M,Y,82.0,KG,20211125.0,,MD,CA,CA,2021,Q4,Adult
201127661,20112766,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q4,Acute coronary syndrome,,2021,Q4,1,I,,20211116.0,20211125,20211125,EXP,CA-MHPD-E2B_03478037,CA-Accord-245829,ACCORD,,56.0,YR,,M,Y,82.0,KG,20211125.0,,MD,CA,CA,2021,Q4,Adult
201127661,20112766,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q4,Blood creatine phosphokinase increased,,2021,Q4,1,I,,20211116.0,20211125,20211125,EXP,CA-MHPD-E2B_03478037,CA-Accord-245829,ACCORD,,56.0,YR,,M,Y,82.0,KG,20211125.0,,MD,CA,CA,2021,Q4,Adult
201127661,20112766,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q4,Blood cholesterol increased,,2021,Q4,1,I,,20211116.0,20211125,20211125,EXP,CA-MHPD-E2B_03478037,CA-Accord-245829,ACCORD,,56.0,YR,,M,Y,82.0,KG,20211125.0,,MD,CA,CA,2021,Q4,Adult
201127661,20112766,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211116.0,20211125,20211125,EXP,CA-MHPD-E2B_03478037,CA-Accord-245829,ACCORD,,56.0,YR,,M,Y,82.0,KG,20211125.0,,MD,CA,CA,2021,Q4,Adult
201127661,20112766,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q4,Low density lipoprotein increased,,2021,Q4,1,I,,20211116.0,20211125,20211125,EXP,CA-MHPD-E2B_03478037,CA-Accord-245829,ACCORD,,56.0,YR,,M,Y,82.0,KG,20211125.0,,MD,CA,CA,2021,Q4,Adult
201127661,20112766,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q4,Blood triglycerides increased,,2021,Q4,1,I,,20211116.0,20211125,20211125,EXP,CA-MHPD-E2B_03478037,CA-Accord-245829,ACCORD,,56.0,YR,,M,Y,82.0,KG,20211125.0,,MD,CA,CA,2021,Q4,Adult
201127661,20112766,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q4,High density lipoprotein decreased,,2021,Q4,1,I,,20211116.0,20211125,20211125,EXP,CA-MHPD-E2B_03478037,CA-Accord-245829,ACCORD,,56.0,YR,,M,Y,82.0,KG,20211125.0,,MD,CA,CA,2021,Q4,Adult
201127661,20112766,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q4,Myopathy,,2021,Q4,1,I,,20211116.0,20211125,20211125,EXP,CA-MHPD-E2B_03478037,CA-Accord-245829,ACCORD,,56.0,YR,,M,Y,82.0,KG,20211125.0,,MD,CA,CA,2021,Q4,Adult
201127661,20112766,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2021,Q4,Total cholesterol/HDL ratio increased,,2021,Q4,1,I,,20211116.0,20211125,20211125,EXP,CA-MHPD-E2B_03478037,CA-Accord-245829,ACCORD,,56.0,YR,,M,Y,82.0,KG,20211125.0,,MD,CA,CA,2021,Q4,Adult
201133151,20113315,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Renal pain,,2021,Q4,1,I,,20211117.0,20211125,20211125,EXP,,CA-AstraZeneca-2021A810073,ASTRAZENECA,,69.0,YR,,M,Y,,,20211125.0,,MD,CA,,2021,Q4,Elderly
201138852,20113885,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,250.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Infection,,2021,Q4,2,F,20211101.0,20211130.0,20211125,20211208,EXP,,FR-AstraZeneca-2021A824135,ASTRAZENECA,,870.0,MON,,F,Y,90.0,KG,20211208.0,,MD,FR,,2021,Q4,Elderly
201138852,20113885,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,250.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Anal abscess,,2021,Q4,2,F,20211101.0,20211130.0,20211125,20211208,EXP,,FR-AstraZeneca-2021A824135,ASTRAZENECA,,870.0,MON,,F,Y,90.0,KG,20211208.0,,MD,FR,,2021,Q4,Elderly
201138852,20113885,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,250.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Fournier's gangrene,,2021,Q4,2,F,20211101.0,20211130.0,20211125,20211208,EXP,,FR-AstraZeneca-2021A824135,ASTRAZENECA,,870.0,MON,,F,Y,90.0,KG,20211208.0,,MD,FR,,2021,Q4,Elderly
201138852,20113885,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,250.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Perineal pain,,2021,Q4,2,F,20211101.0,20211130.0,20211125,20211208,EXP,,FR-AstraZeneca-2021A824135,ASTRAZENECA,,870.0,MON,,F,Y,90.0,KG,20211208.0,,MD,FR,,2021,Q4,Elderly
201138852,20113885,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,250.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Anal blister,,2021,Q4,2,F,20211101.0,20211130.0,20211125,20211208,EXP,,FR-AstraZeneca-2021A824135,ASTRAZENECA,,870.0,MON,,F,Y,90.0,KG,20211208.0,,MD,FR,,2021,Q4,Elderly
201150673,20115067,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Cerebral infarction,,2021,Q4,3,F,20211118.0,20211202.0,20211125,20211210,EXP,,JP-AstraZeneca-2021A821397,ASTRAZENECA,,90.0,YR,,M,Y,,,20211210.0,,MD,JP,,2021,Q4,Elderly
201152512,20115251,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,2,F,20210601.0,20211125.0,20211125,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318606,RANBAXY,,79.0,YR,,F,Y,54.0,KG,20211210.0,,PH,GB,GB,2021,Q4,Elderly
201152512,20115251,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Cardiomyopathy,,2021,Q4,2,F,20210601.0,20211125.0,20211125,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318606,RANBAXY,,79.0,YR,,F,Y,54.0,KG,20211210.0,,PH,GB,GB,2021,Q4,Elderly
201152512,20115251,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Left ventricular dysfunction,,2021,Q4,2,F,20210601.0,20211125.0,20211125,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318606,RANBAXY,,79.0,YR,,F,Y,54.0,KG,20211210.0,,PH,GB,GB,2021,Q4,Elderly
201152512,20115251,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,2,F,20210601.0,20211125.0,20211125,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318606,RANBAXY,,79.0,YR,,F,Y,54.0,KG,20211210.0,,PH,GB,GB,2021,Q4,Elderly
201152512,20115251,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Fatigue,,2021,Q4,2,F,20210601.0,20211125.0,20211125,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318606,RANBAXY,,79.0,YR,,F,Y,54.0,KG,20211210.0,,PH,GB,GB,2021,Q4,Elderly
201152512,20115251,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Chest pain,,2021,Q4,2,F,20210601.0,20211125.0,20211125,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318606,RANBAXY,,79.0,YR,,F,Y,54.0,KG,20211210.0,,PH,GB,GB,2021,Q4,Elderly
201152512,20115251,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Suspected COVID-19,,2021,Q4,2,F,20210601.0,20211125.0,20211125,20211210,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-318606,RANBAXY,,79.0,YR,,F,Y,54.0,KG,20211210.0,,PH,GB,GB,2021,Q4,Elderly
201189621,20118962,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Pollakiuria,,2021,Q4,1,I,20211101.0,20211119.0,20211126,20211126,EXP,,CN-AstraZeneca-2021A825577,ASTRAZENECA,,20454.0,DY,,M,Y,83.0,KG,20211126.0,,MD,CN,,2021,Q4,Elderly
201189621,20118962,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Blood pressure increased,,2021,Q4,1,I,20211101.0,20211119.0,20211126,20211126,EXP,,CN-AstraZeneca-2021A825577,ASTRAZENECA,,20454.0,DY,,M,Y,83.0,KG,20211126.0,,MD,CN,,2021,Q4,Elderly
201189621,20118962,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Condition aggravated,,2021,Q4,1,I,20211101.0,20211119.0,20211126,20211126,EXP,,CN-AstraZeneca-2021A825577,ASTRAZENECA,,20454.0,DY,,M,Y,83.0,KG,20211126.0,,MD,CN,,2021,Q4,Elderly
201189621,20118962,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Back pain,,2021,Q4,1,I,20211101.0,20211119.0,20211126,20211126,EXP,,CN-AstraZeneca-2021A825577,ASTRAZENECA,,20454.0,DY,,M,Y,83.0,KG,20211126.0,,MD,CN,,2021,Q4,Elderly
201189621,20118962,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Dysuria,,2021,Q4,1,I,20211101.0,20211119.0,20211126,20211126,EXP,,CN-AstraZeneca-2021A825577,ASTRAZENECA,,20454.0,DY,,M,Y,83.0,KG,20211126.0,,MD,CN,,2021,Q4,Elderly
201190111,20119011,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,110.0,MG,Y,,21040961,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Genital pain,,2021,Q4,1,I,20211101.0,20211119.0,20211126,20211126,EXP,,CN-AstraZeneca-2021A823787,ASTRAZENECA,,28257.0,DY,,M,Y,87.0,KG,20211126.0,,MD,CN,,2021,Q4,Elderly
201190111,20119011,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,110.0,MG,Y,,21040961,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Genital erythema,,2021,Q4,1,I,20211101.0,20211119.0,20211126,20211126,EXP,,CN-AstraZeneca-2021A823787,ASTRAZENECA,,28257.0,DY,,M,Y,87.0,KG,20211126.0,,MD,CN,,2021,Q4,Elderly
201190111,20119011,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,110.0,MG,Y,,21040961,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Dysuria,,2021,Q4,1,I,20211101.0,20211119.0,20211126,20211126,EXP,,CN-AstraZeneca-2021A823787,ASTRAZENECA,,28257.0,DY,,M,Y,87.0,KG,20211126.0,,MD,CN,,2021,Q4,Elderly
201190111,20119011,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,110.0,MG,Y,,21040961,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Pruritus genital,,2021,Q4,1,I,20211101.0,20211119.0,20211126,20211126,EXP,,CN-AstraZeneca-2021A823787,ASTRAZENECA,,28257.0,DY,,M,Y,87.0,KG,20211126.0,,MD,CN,,2021,Q4,Elderly
201190111,20119011,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,110.0,MG,Y,,21040961,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Genital erosion,,2021,Q4,1,I,20211101.0,20211119.0,20211126,20211126,EXP,,CN-AstraZeneca-2021A823787,ASTRAZENECA,,28257.0,DY,,M,Y,87.0,KG,20211126.0,,MD,CN,,2021,Q4,Elderly
201196431,20119643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,ML3010,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211023.0,20211117.0,20211126,20211126,EXP,,CN-AstraZeneca-2021A815399,ASTRAZENECA,,37.0,YR,,M,Y,77.0,KG,20211126.0,,MD,CN,,2021,Q4,Adult
201196442,20119644,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Pneumonia,,2021,Q4,2,F,20211110.0,20211206.0,20211126,20211214,EXP,,DE-AstraZeneca-2021A816572,ASTRAZENECA,,23349.0,DY,,F,Y,95.0,KG,20211214.0,,MD,DE,,2021,Q4,Elderly
201196442,20119644,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Ketoacidosis,,2021,Q4,2,F,20211110.0,20211206.0,20211126,20211214,EXP,,DE-AstraZeneca-2021A816572,ASTRAZENECA,,23349.0,DY,,F,Y,95.0,KG,20211214.0,,MD,DE,,2021,Q4,Elderly
201196442,20119644,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Dehydration,,2021,Q4,2,F,20211110.0,20211206.0,20211126,20211214,EXP,,DE-AstraZeneca-2021A816572,ASTRAZENECA,,23349.0,DY,,F,Y,95.0,KG,20211214.0,,MD,DE,,2021,Q4,Elderly
201196442,20119644,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Upper limb fracture,,2021,Q4,2,F,20211110.0,20211206.0,20211126,20211214,EXP,,DE-AstraZeneca-2021A816572,ASTRAZENECA,,23349.0,DY,,F,Y,95.0,KG,20211214.0,,MD,DE,,2021,Q4,Elderly
201196501,20119650,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Pre-medication given by ambulance,,,,,,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211114.0,20211122.0,20211126,20211126,EXP,DE-BFARM-21010717,DE-EMD Serono-E2B_90085887,EMD SERONO INC,,63.0,YR,A,F,Y,70.0,KG,20211126.0,,MD,DE,DE,2021,Q4,Adult
201213881,20121388,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211117.0,20211127,20211127,EXP,GB-MHRA-EYC 00266570,GB-EMD Serono-E2B_90085840,EMD SERONO INC,,63.0,YR,A,M,Y,,,20211127.0,,MD,GB,,2021,Q4,Adult
201235031,20123503,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (Vormedikation von Ambulanz)",,,,,,,,10.0,MG,Film Coated Tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211114.0,20211117.0,20211129,20211129,EXP,,DE-AUROBINDO-AUR-APL-2021-048527,AUROBINDO,,63.0,YR,,F,Y,70.0,KG,20211129.0,,MD,DE,DE,2021,Q4,Adult
201235841,20123584,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,Unknown,,,,,,,2021,Q4,Surgery,,2021,Q4,1,I,,20211117.0,20211129,20211129,EXP,,BR-NOVOPROD-869031,NOVO NORDISK,,56.0,YR,,M,Y,,,20211129.0,,MD,BR,BR,2021,Q4,Adult
201235841,20123584,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,Unknown,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,,20211117.0,20211129,20211129,EXP,,BR-NOVOPROD-869031,NOVO NORDISK,,56.0,YR,,M,Y,,,20211129.0,,MD,BR,BR,2021,Q4,Adult
201243361,20124336,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211117.0,20211129,20211129,EXP,GB-MHRA-EYC 00266570,GB-TEVA-2021-GB-1980716,TEVA,,63.0,YR,A,M,Y,,,20211126.0,,MD,GB,GB,2021,Q4,Adult
201244582,20124458,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 Milligram Daily;,,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Rib fracture,,2021,Q4,2,F,20211106.0,20211202.0,20211129,20211209,EXP,,JP-TEVA-2021-JP-005922J,TEVA,,74.0,YR,E,M,Y,,,20211209.0,,PH,JP,JP,2021,Q4,Elderly
201244582,20124458,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 Milligram Daily;,,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Fall,,2021,Q4,2,F,20211106.0,20211202.0,20211129,20211209,EXP,,JP-TEVA-2021-JP-005922J,TEVA,,74.0,YR,E,M,Y,,,20211209.0,,PH,JP,JP,2021,Q4,Elderly
201248354,20124835,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2021,Q4,Abdominal distension,,2021,Q4,4,F,,20211216.0,20211129,20211221,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
201248354,20124835,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2021,Q4,Oedema peripheral,,2021,Q4,4,F,,20211216.0,20211129,20211221,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
201248354,20124835,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2021,Q4,Blood pressure decreased,,2021,Q4,4,F,,20211216.0,20211129,20211221,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
201248354,20124835,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,4,F,,20211216.0,20211129,20211221,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
201248354,20124835,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2021,Q4,Obesity,,2021,Q4,4,F,,20211216.0,20211129,20211221,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
201248354,20124835,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2021,Q4,Hypertension,,2021,Q4,4,F,,20211216.0,20211129,20211221,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
201248354,20124835,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2021,Q4,Hyperuricaemia,,2021,Q4,4,F,,20211216.0,20211129,20211221,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
201248354,20124835,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2021,Q4,Diabetes mellitus,,2021,Q4,4,F,,20211216.0,20211129,20211221,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
201248354,20124835,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,4,F,,20211216.0,20211129,20211221,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
201248354,20124835,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2021,Q4,Fatigue,,2021,Q4,4,F,,20211216.0,20211129,20211221,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,,,20211221.0,,MD,PL,PL,2021,Q4,Adult
201249161,20124916,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg once a day,,,,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20211122.0,20211124.0,20211129,20211129,EXP,,GB-AstraZeneca-2021A831951,ASTRAZENECA,,66.0,YR,,F,Y,63.5,KG,20211129.0,,MD,GB,,2021,Q4,Elderly
201260911,20126091,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK; ;,,,U,U,,,,,,,,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,20210601.0,20211125.0,20211129,20211129,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MYLANLABS-2021M1088150,MYLAN,,79.0,YR,,F,Y,54.0,KG,20211129.0,,PH,GB,GB,2021,Q4,Elderly
201260911,20126091,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK; ;,,,U,U,,,,,,,,2021,Q4,Cardiomyopathy,,2021,Q4,1,I,20210601.0,20211125.0,20211129,20211129,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MYLANLABS-2021M1088150,MYLAN,,79.0,YR,,F,Y,54.0,KG,20211129.0,,PH,GB,GB,2021,Q4,Elderly
201260911,20126091,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK; ;,,,U,U,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20210601.0,20211125.0,20211129,20211129,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MYLANLABS-2021M1088150,MYLAN,,79.0,YR,,F,Y,54.0,KG,20211129.0,,PH,GB,GB,2021,Q4,Elderly
201260911,20126091,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK; ;,,,U,U,,,,,,,,2021,Q4,Suspected COVID-19,,2021,Q4,1,I,20210601.0,20211125.0,20211129,20211129,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MYLANLABS-2021M1088150,MYLAN,,79.0,YR,,F,Y,54.0,KG,20211129.0,,PH,GB,GB,2021,Q4,Elderly
201260911,20126091,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK; ;,,,U,U,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20210601.0,20211125.0,20211129,20211129,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MYLANLABS-2021M1088150,MYLAN,,79.0,YR,,F,Y,54.0,KG,20211129.0,,PH,GB,GB,2021,Q4,Elderly
201260911,20126091,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK; ;,,,U,U,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,1,I,20210601.0,20211125.0,20211129,20211129,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MYLANLABS-2021M1088150,MYLAN,,79.0,YR,,F,Y,54.0,KG,20211129.0,,PH,GB,GB,2021,Q4,Elderly
201260911,20126091,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK; ;,,,U,U,,,,,,,,2021,Q4,Chest pain,,2021,Q4,1,I,20210601.0,20211125.0,20211129,20211129,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-MYLANLABS-2021M1088150,MYLAN,,79.0,YR,,F,Y,54.0,KG,20211129.0,,PH,GB,GB,2021,Q4,Elderly
201286041,20128604,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,U,,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211117.0,20211130,20211130,EXP,,GB-AUROBINDO-AUR-APL-2021-048536,AUROBINDO,,63.0,YR,,M,Y,,,20211130.0,,MD,GB,GB,2021,Q4,Adult
201293611,20129361,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20210701.0,20211129.0,20211130,20211130,PER,,US-ELI_LILLY_AND_COMPANY-US202111012439,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201293611,20129361,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,20210701.0,20211129.0,20211130,20211130,PER,,US-ELI_LILLY_AND_COMPANY-US202111012439,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201293611,20129361,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Injection site pain,,2021,Q4,1,I,20210701.0,20211129.0,20211130,20211130,PER,,US-ELI_LILLY_AND_COMPANY-US202111012439,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201293611,20129361,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Food craving,,2021,Q4,1,I,20210701.0,20211129.0,20211130,20211130,PER,,US-ELI_LILLY_AND_COMPANY-US202111012439,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211130.0,,HP,US,US,2021,Q4,Adult
201295561,20129556,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,U,,2104091,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Marasmus,,2021,Q4,1,I,20211121.0,20211124.0,20211130,20211130,EXP,,CN-AstraZeneca-2021A832847,ASTRAZENECA,,21378.0,DY,,M,Y,56.0,KG,20211130.0,,MD,CN,,2021,Q4,Elderly
201297502,20129750,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Rib fracture,,2021,Q4,2,F,20211106.0,20211202.0,20211130,20211206,EXP,,JP-TAKEDA-2021TJP123348,TAKEDA,,74.0,YR,,M,Y,,,20211206.0,,PH,JP,JP,2021,Q4,Elderly
201297502,20129750,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,Tablet,QD,2021,Q4,Fall,,2021,Q4,2,F,20211106.0,20211202.0,20211130,20211206,EXP,,JP-TAKEDA-2021TJP123348,TAKEDA,,74.0,YR,,M,Y,,,20211206.0,,PH,JP,JP,2021,Q4,Elderly
201304832,20130483,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,eem 1 tablet in via de mond  dagelijks,,,,,,,,,,Tablet,,2021,Q4,Hyperkalaemia,,2021,Q4,2,F,20210418.0,20211127.0,20211130,20211202,EXP,NL-LRB-00518426,NL-MYLANLABS-2021M1088876,MYLAN,,64.0,YR,,M,Y,90.0,KG,20211202.0,,MD,NL,NL,2021,Q4,Adult
201304832,20130483,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,eem 1 tablet in via de mond  dagelijks,,,,,,,,,,Tablet,,2021,Q4,Cardiac asthma,,2021,Q4,2,F,20210418.0,20211127.0,20211130,20211202,EXP,NL-LRB-00518426,NL-MYLANLABS-2021M1088876,MYLAN,,64.0,YR,,M,Y,90.0,KG,20211202.0,,MD,NL,NL,2021,Q4,Adult
201304832,20130483,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,eem 1 tablet in via de mond  dagelijks,,,,,,,,,,Tablet,,2021,Q4,Cardiac arrest,,2021,Q4,2,F,20210418.0,20211127.0,20211130,20211202,EXP,NL-LRB-00518426,NL-MYLANLABS-2021M1088876,MYLAN,,64.0,YR,,M,Y,90.0,KG,20211202.0,,MD,NL,NL,2021,Q4,Adult
201304832,20130483,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,eem 1 tablet in via de mond  dagelijks,,,,,,,,,,Tablet,,2021,Q4,Malaise,,2021,Q4,2,F,20210418.0,20211127.0,20211130,20211202,EXP,NL-LRB-00518426,NL-MYLANLABS-2021M1088876,MYLAN,,64.0,YR,,M,Y,90.0,KG,20211202.0,,MD,NL,NL,2021,Q4,Adult
201305371,20130537,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,JP-AstraZeneca-2021A821426,ASTRAZENECA,,90.0,YR,,M,Y,49.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
201305371,20130537,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Urine output decreased,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,JP-AstraZeneca-2021A821426,ASTRAZENECA,,90.0,YR,,M,Y,49.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
201305371,20130537,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Nausea,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,JP-AstraZeneca-2021A821426,ASTRAZENECA,,90.0,YR,,M,Y,49.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
201305371,20130537,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Malaise,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,JP-AstraZeneca-2021A821426,ASTRAZENECA,,90.0,YR,,M,Y,49.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
201305371,20130537,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,JP-AstraZeneca-2021A821426,ASTRAZENECA,,90.0,YR,,M,Y,49.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
201305371,20130537,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Electrocardiogram QT prolonged,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,JP-AstraZeneca-2021A821426,ASTRAZENECA,,90.0,YR,,M,Y,49.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
201305371,20130537,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Fluid intake reduced,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,JP-AstraZeneca-2021A821426,ASTRAZENECA,,90.0,YR,,M,Y,49.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
201305371,20130537,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Pulmonary congestion,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,JP-AstraZeneca-2021A821426,ASTRAZENECA,,90.0,YR,,M,Y,49.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
201305371,20130537,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Pneumonia,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,JP-AstraZeneca-2021A821426,ASTRAZENECA,,90.0,YR,,M,Y,49.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
201305371,20130537,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,JP-AstraZeneca-2021A821426,ASTRAZENECA,,90.0,YR,,M,Y,49.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
201305371,20130537,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Colon cancer,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,JP-AstraZeneca-2021A821426,ASTRAZENECA,,90.0,YR,,M,Y,49.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
201305371,20130537,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Somnolence,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,JP-AstraZeneca-2021A821426,ASTRAZENECA,,90.0,YR,,M,Y,49.0,KG,20211130.0,,MD,JP,,2021,Q4,Elderly
201306441,20130644,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,Unknown,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,20210901.0,20211116.0,20211130,20211130,EXP,FR-AFSSAPS-MA20214856,FR-PFIZER INC-202101589393,PFIZER,,62.0,YR,,M,Y,81.0,KG,20211130.0,,MD,FR,FR,2021,Q4,Adult
201306441,20130644,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,Unknown,,,,,,,2021,Q4,Renal failure,,2021,Q4,1,I,20210901.0,20211116.0,20211130,20211130,EXP,FR-AFSSAPS-MA20214856,FR-PFIZER INC-202101589393,PFIZER,,62.0,YR,,M,Y,81.0,KG,20211130.0,,MD,FR,FR,2021,Q4,Adult
201306441,20130644,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,Unknown,,,,,,,2021,Q4,Blood creatine phosphokinase increased,,2021,Q4,1,I,20210901.0,20211116.0,20211130,20211130,EXP,FR-AFSSAPS-MA20214856,FR-PFIZER INC-202101589393,PFIZER,,62.0,YR,,M,Y,81.0,KG,20211130.0,,MD,FR,FR,2021,Q4,Adult
201311601,20131160,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Blood creatine phosphokinase increased,,2021,Q4,1,I,20211026.0,20211124.0,20211130,20211130,EXP,FR-AFSSAPS-MA20214855,FR-009507513-2111FRA008526,MERCK,,62.0,YR,,M,Y,81.0,KG,20211130.0,,MD,FR,FR,2021,Q4,Adult
201311941,20131194,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,20200201.0,20211122.0,20211130,20211130,EXP,,DE-AstraZeneca-2021A825055,ASTRAZENECA,,55.0,YR,,F,Y,,,20211130.0,,MD,DE,,2021,Q4,Adult
201311941,20131194,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,,,2021,Q4,Pneumonia,,2021,Q4,1,I,20200201.0,20211122.0,20211130,20211130,EXP,,DE-AstraZeneca-2021A825055,ASTRAZENECA,,55.0,YR,,F,Y,,,20211130.0,,MD,DE,,2021,Q4,Adult
201311941,20131194,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,,,2021,Q4,Cardiac failure,,2021,Q4,1,I,20200201.0,20211122.0,20211130,20211130,EXP,,DE-AstraZeneca-2021A825055,ASTRAZENECA,,55.0,YR,,F,Y,,,20211130.0,,MD,DE,,2021,Q4,Adult
201311941,20131194,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,,,2021,Q4,Genital discomfort,,2021,Q4,1,I,20200201.0,20211122.0,20211130,20211130,EXP,,DE-AstraZeneca-2021A825055,ASTRAZENECA,,55.0,YR,,F,Y,,,20211130.0,,MD,DE,,2021,Q4,Adult
201311941,20131194,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,,,2021,Q4,Pleural effusion,,2021,Q4,1,I,20200201.0,20211122.0,20211130,20211130,EXP,,DE-AstraZeneca-2021A825055,ASTRAZENECA,,55.0,YR,,F,Y,,,20211130.0,,MD,DE,,2021,Q4,Adult
201316652,20131665,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure congestive,,2021,Q4,2,F,,20211126.0,20211130,20211203,EXP,,JP-AstraZeneca-2021A835825,ASTRAZENECA,,74.0,YR,,M,Y,,,20211203.0,,MD,JP,,2021,Q4,Elderly
201318831,20131883,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Death,,2021,Q4,1,I,20211031.0,20211125.0,20211130,20211130,EXP,,AU-AstraZeneca-2021A832998,ASTRAZENECA,,29598.0,DY,,F,Y,,,20211130.0,,HP,AU,,2021,Q4,Elderly
201325671,20132567,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,Unknown,,,,,Tablet,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20211015.0,20211122.0,20211130,20211130,EXP,,NVSC2021EG267344,NOVARTIS,,52.0,YR,,F,Y,,,20211201.0,,CN,EG,EG,2021,Q4,Adult
201325671,20132567,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,Unknown,,,,,Tablet,QD,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,20211015.0,20211122.0,20211130,20211130,EXP,,NVSC2021EG267344,NOVARTIS,,52.0,YR,,F,Y,,,20211201.0,,CN,EG,EG,2021,Q4,Adult
201325671,20132567,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,Unknown,,,,,Tablet,QD,2021,Q4,Somnolence,,2021,Q4,1,I,20211015.0,20211122.0,20211130,20211130,EXP,,NVSC2021EG267344,NOVARTIS,,52.0,YR,,F,Y,,,20211201.0,,CN,EG,EG,2021,Q4,Adult
201349681,20134968,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd, pre-medication from ambulance",,,,,,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211114.0,20211126.0,20211201,20211201,EXP,DE-BFARM-21010717,DE-009507513-2111DEU009463,MERCK,,63.0,YR,,F,Y,70.0,KG,20211201.0,,MD,DE,DE,2021,Q4,Adult
201351294,20135129,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Diabetes mellitus,,2021,Q4,4,F,20211127.0,20211206.0,20211201,20211217,EXP,,NVSC2021KR272983,NOVARTIS,,61.0,YR,,F,Y,59.3,KG,20211217.0,,MD,KR,KR,2021,Q4,Adult
201353401,20135340,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1555.0,MG,Y,,2103224MM3083,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Fungal infection,,2021,Q4,1,I,20211111.0,20211123.0,20211201,20211201,EXP,,CN-AstraZeneca-2021A834600,ASTRAZENECA,,31777.0,DY,,M,Y,50.0,KG,20211201.0,,MD,CN,,2021,Q4,Elderly
201354271,20135427,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",80.0,MG,Y,,Unknown,,,10.0,MG,,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,20211016.0,20211126.0,20211201,20211201,EXP,FR-AFSSAPS-PC20215239,NVSC2021FR273038,NOVARTIS,,73.0,YR,,F,Y,43.0,KG,20211201.0,,MD,FR,FR,2021,Q4,Elderly
201354271,20135427,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",80.0,MG,Y,,Unknown,,,10.0,MG,,QD,2021,Q4,Hypovolaemic shock,,2021,Q4,1,I,20211016.0,20211126.0,20211201,20211201,EXP,FR-AFSSAPS-PC20215239,NVSC2021FR273038,NOVARTIS,,73.0,YR,,F,Y,43.0,KG,20211201.0,,MD,FR,FR,2021,Q4,Elderly
201354451,20135445,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,2104147,,,10.0,MG,Tablet,QD,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20211128.0,20211201,20211201,EXP,,CN-SA-2021SA400910,SANOFI AVENTIS,,57.0,YR,A,F,Y,61.0,KG,20211201.0,,HP,CN,CN,2021,Q4,Adult
201354451,20135445,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,2104147,,,10.0,MG,Tablet,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211128.0,20211201,20211201,EXP,,CN-SA-2021SA400910,SANOFI AVENTIS,,57.0,YR,A,F,Y,61.0,KG,20211201.0,,HP,CN,CN,2021,Q4,Adult
201366261,20136626,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,90.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,20211016.0,20211126.0,20211201,20211201,EXP,,FR-AstraZeneca-2021A837756,ASTRAZENECA,,73.0,YR,,F,Y,43.0,KG,20211201.0,,MD,FR,,2021,Q4,Elderly
201366261,20136626,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,90.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Hypovolaemic shock,,2021,Q4,1,I,20211016.0,20211126.0,20211201,20211201,EXP,,FR-AstraZeneca-2021A837756,ASTRAZENECA,,73.0,YR,,F,Y,43.0,KG,20211201.0,,MD,FR,,2021,Q4,Elderly
201381532,20138153,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2021,Q4,COVID-19,,2021,Q4,2,F,20211026.0,20211213.0,20211202,20211216,EXP,,DE-ROCHE-2958533,ROCHE,,61.0,YR,,M,Y,87.0,KG,20211216.0,,MD,DE,,2021,Q4,Adult
201385741,20138574,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,D,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20200916.0,20211122.0,20211202,20211202,EXP,,ES-AUROBINDO-AUR-APL-2020-051055,AUROBINDO,,70.0,YR,,M,Y,73.0,KG,20211202.0,,MD,ES,ES,2021,Q4,Elderly
201385741,20138574,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,D,,,,,,,,,2021,Q4,Malignant neoplasm progression,,2021,Q4,1,I,20200916.0,20211122.0,20211202,20211202,EXP,,ES-AUROBINDO-AUR-APL-2020-051055,AUROBINDO,,70.0,YR,,M,Y,73.0,KG,20211202.0,,MD,ES,ES,2021,Q4,Elderly
201386251,20138625,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Oedema,,2021,Q4,1,I,20211101.0,20211129.0,20211202,20211202,EXP,,DE-AstraZeneca-2021A849094,ASTRAZENECA,,82.0,YR,,F,Y,,,20211202.0,,MD,DE,,2021,Q4,Elderly
201386251,20138625,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,20211101.0,20211129.0,20211202,20211202,EXP,,DE-AstraZeneca-2021A849094,ASTRAZENECA,,82.0,YR,,F,Y,,,20211202.0,,MD,DE,,2021,Q4,Elderly
201386251,20138625,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211101.0,20211129.0,20211202,20211202,EXP,,DE-AstraZeneca-2021A849094,ASTRAZENECA,,82.0,YR,,F,Y,,,20211202.0,,MD,DE,,2021,Q4,Elderly
201386251,20138625,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Cardiac failure,,2021,Q4,1,I,20211101.0,20211129.0,20211202,20211202,EXP,,DE-AstraZeneca-2021A849094,ASTRAZENECA,,82.0,YR,,F,Y,,,20211202.0,,MD,DE,,2021,Q4,Elderly
201399731,20139973,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,2105202,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Lipids increased,,2021,Q4,1,I,20211113.0,20211124.0,20211202,20211202,EXP,,CN-AstraZeneca-2021A833088,ASTRAZENECA,,16664.0,DY,,M,Y,80.0,KG,20211202.0,,MD,CN,,2021,Q4,Elderly
201399781,20139978,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1080.0,MG,Y,,2104090,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Urinary tract infection,,2021,Q4,1,I,20211116.0,20211124.0,20211202,20211202,EXP,,CN-AstraZeneca-2021A844240,ASTRAZENECA,,75.0,YR,,F,Y,55.0,KG,20211202.0,,MD,CN,,2021,Q4,Elderly
201399781,20139978,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1080.0,MG,Y,,2104090,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Vulvovaginal pruritus,,2021,Q4,1,I,20211116.0,20211124.0,20211202,20211202,EXP,,CN-AstraZeneca-2021A844240,ASTRAZENECA,,75.0,YR,,F,Y,55.0,KG,20211202.0,,MD,CN,,2021,Q4,Elderly
201400961,20140096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Gastrointestinal carcinoma,,2021,Q4,1,I,,20211125.0,20211202,20211202,EXP,,RU-AstraZeneca-2021A846278,ASTRAZENECA,,60.0,YR,,M,Y,,,20211202.0,,HP,RU,,2021,Q4,Adult
201401492,20140149,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Melaena,,2021,Q4,2,F,20211111.0,20211214.0,20211202,20211222,EXP,,JP-AstraZeneca-2021A836479,ASTRAZENECA,,42.0,YR,,M,Y,,,20211222.0,,MD,JP,,2021,Q4,Adult
201401492,20140149,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Aphasia,,2021,Q4,2,F,20211111.0,20211214.0,20211202,20211222,EXP,,JP-AstraZeneca-2021A836479,ASTRAZENECA,,42.0,YR,,M,Y,,,20211222.0,,MD,JP,,2021,Q4,Adult
201401492,20140149,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Cerebral infarction,,2021,Q4,2,F,20211111.0,20211214.0,20211202,20211222,EXP,,JP-AstraZeneca-2021A836479,ASTRAZENECA,,42.0,YR,,M,Y,,,20211222.0,,MD,JP,,2021,Q4,Adult
201405351,20140535,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,35.0,MG,U,,MM3072,,,5.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211122.0,20211123.0,20211202,20211202,EXP,,CN-AstraZeneca-2021A833051,ASTRAZENECA,,15706.0,DY,,F,Y,80.0,KG,20211202.0,,MD,CN,,2021,Q4,Elderly
201412361,20141236,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,180.0,MG,Y,,MJ3061//2012196,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Pruritus,,2021,Q4,1,I,20210816.0,20211124.0,20211202,20211202,EXP,,CN-AstraZeneca-2021A836542,ASTRAZENECA,,21557.0,DY,,F,Y,70.0,KG,20211202.0,,MD,CN,,2021,Q4,Elderly
201418381,20141838,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Lung disorder,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Lung disorder,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Lung disorder,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Lung disorder,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418381,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,1,I,20210301.0,20211119.0,20211202,20211202,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20211202.0,,MD,PL,PL,2021,Q4,Elderly
201418821,20141882,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,N,,,,,10.0,MG,Tablet,,2021,Q4,Condition aggravated,,2021,Q4,1,I,20210916.0,20211124.0,20211202,20211202,EXP,,FR-AstraZeneca-2021A825409,ASTRAZENECA,,72.0,YR,,M,Y,82.0,KG,20211202.0,,MD,FR,,2021,Q4,Elderly
201418821,20141882,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,N,,,,,10.0,MG,Tablet,,2021,Q4,Leg amputation,,2021,Q4,1,I,20210916.0,20211124.0,20211202,20211202,EXP,,FR-AstraZeneca-2021A825409,ASTRAZENECA,,72.0,YR,,M,Y,82.0,KG,20211202.0,,MD,FR,,2021,Q4,Elderly
201434751,20143475,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211119.0,20211203,20211203,EXP,,IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-319334,RANBAXY,"Vadi S, Lad V, Kapoor D. Perioperative Implication of Sodium-glucose Cotransporter-2 Inhibitor in a Patient Following Major Surgery. Indian J Crit Care Med. 2021;25(8):959-960",56.0,YR,,M,Y,,,20211203.0,,HP,IN,IN,2021,Q4,Adult
201442481,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Metabolic alkalosis,,2021,Q4,1,I,,20211129.0,20211203,20211203,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20211203.0,,PH,CA,CA,2021,Q4,Adult
201442481,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211129.0,20211203,20211203,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20211203.0,,PH,CA,CA,2021,Q4,Adult
201442481,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Renal failure,,2021,Q4,1,I,,20211129.0,20211203,20211203,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20211203.0,,PH,CA,CA,2021,Q4,Adult
201442481,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211129.0,20211203,20211203,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20211203.0,,PH,CA,CA,2021,Q4,Adult
201442481,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211129.0,20211203,20211203,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20211203.0,,PH,CA,CA,2021,Q4,Adult
201442481,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211129.0,20211203,20211203,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20211203.0,,PH,CA,CA,2021,Q4,Adult
201442481,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Nausea,,2021,Q4,1,I,,20211129.0,20211203,20211203,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20211203.0,,PH,CA,CA,2021,Q4,Adult
201442481,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Dehydration,,2021,Q4,1,I,,20211129.0,20211203,20211203,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20211203.0,,PH,CA,CA,2021,Q4,Adult
201442481,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Vomiting,,2021,Q4,1,I,,20211129.0,20211203,20211203,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20211203.0,,PH,CA,CA,2021,Q4,Adult
201442481,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Asthenia,,2021,Q4,1,I,,20211129.0,20211203,20211203,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20211203.0,,PH,CA,CA,2021,Q4,Adult
201445021,20144502,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9470.0,MG,,,UNKNOWN,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20211008.0,20211118.0,20211203,20211203,EXP,IT-MINISAL02-809250,IT-ROCHE-2960853,ROCHE,,75.0,YR,,M,Y,,,20211203.0,,MD,IT,IT,2021,Q4,Elderly
201445021,20144502,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9470.0,MG,,,UNKNOWN,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20211008.0,20211118.0,20211203,20211203,EXP,IT-MINISAL02-809250,IT-ROCHE-2960853,ROCHE,,75.0,YR,,M,Y,,,20211203.0,,MD,IT,IT,2021,Q4,Elderly
201445021,20144502,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9470.0,MG,,,UNKNOWN,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Myocardial ischaemia,,2021,Q4,1,I,20211008.0,20211118.0,20211203,20211203,EXP,IT-MINISAL02-809250,IT-ROCHE-2960853,ROCHE,,75.0,YR,,M,Y,,,20211203.0,,MD,IT,IT,2021,Q4,Elderly
201445021,20144502,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9470.0,MG,,,UNKNOWN,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,20211008.0,20211118.0,20211203,20211203,EXP,IT-MINISAL02-809250,IT-ROCHE-2960853,ROCHE,,75.0,YR,,M,Y,,,20211203.0,,MD,IT,IT,2021,Q4,Elderly
201445021,20144502,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9470.0,MG,,,UNKNOWN,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Hepatitis toxic,,2021,Q4,1,I,20211008.0,20211118.0,20211203,20211203,EXP,IT-MINISAL02-809250,IT-ROCHE-2960853,ROCHE,,75.0,YR,,M,Y,,,20211203.0,,MD,IT,IT,2021,Q4,Elderly
201445021,20144502,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9470.0,MG,,,UNKNOWN,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Ventricular dysfunction,,2021,Q4,1,I,20211008.0,20211118.0,20211203,20211203,EXP,IT-MINISAL02-809250,IT-ROCHE-2960853,ROCHE,,75.0,YR,,M,Y,,,20211203.0,,MD,IT,IT,2021,Q4,Elderly
201445021,20144502,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9470.0,MG,,,UNKNOWN,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20211008.0,20211118.0,20211203,20211203,EXP,IT-MINISAL02-809250,IT-ROCHE-2960853,ROCHE,,75.0,YR,,M,Y,,,20211203.0,,MD,IT,IT,2021,Q4,Elderly
201451691,20145169,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,2104147,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,20211117.0,20211128.0,20211203,20211203,EXP,,CN-AstraZeneca-2021A848055,ASTRAZENECA,,2987.0,WK,,F,Y,,,20211203.0,,MD,CN,,2021,Q4,Elderly
201451691,20145169,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,2104147,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20211117.0,20211128.0,20211203,20211203,EXP,,CN-AstraZeneca-2021A848055,ASTRAZENECA,,2987.0,WK,,F,Y,,,20211203.0,,MD,CN,,2021,Q4,Elderly
201455941,20145594,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Pre-medication from outpatient department , 10 mg",,,,,Unknown,,,10.0,MG,Film-coated tablet,,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211114.0,20211124.0,20211203,20211203,EXP,DE-BFARM-21010717,DE-TEVA-2021-DE-1982557,TEVA,,63.0,YR,A,F,Y,70.0,KG,20211203.0,,MD,DE,DE,2021,Q4,Adult
201461401,20146140,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,,,,,,UNKNOWN,,,,,Film-coated tablet,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210624.0,20211129.0,20211203,20211203,EXP,ES-AEMPS-1054858,ES-Fresenius Kabi-FK202113349,FRESENIUS KABI,,75.0,YR,,M,Y,,,20211203.0,,HP,NL,,2021,Q4,Elderly
201480911,20148091,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",80.0,MG,Y,,,,,10.0,MG,,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,20211016.0,20211124.0,20211204,20211204,EXP,,FR-AUROBINDO-AUR-APL-2021-049490,AUROBINDO,,73.0,YR,,F,Y,43.0,KG,20211204.0,,MD,FR,FR,2021,Q4,Elderly
201480911,20148091,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",80.0,MG,Y,,,,,10.0,MG,,QD,2021,Q4,Hypovolaemic shock,,2021,Q4,1,I,20211016.0,20211124.0,20211204,20211204,EXP,,FR-AUROBINDO-AUR-APL-2021-049490,AUROBINDO,,73.0,YR,,F,Y,43.0,KG,20211204.0,,MD,FR,FR,2021,Q4,Elderly
201487071,20148707,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20210831.0,20211129.0,20211204,20211204,EXP,DK-DKMA-WBS-0087827,NVSC2021DK273341,NOVARTIS,,65.0,YR,,M,Y,140.0,KG,20211204.0,,MD,DK,DK,2021,Q4,Elderly
201493161,20149316,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211125.0,20211205,20211205,EXP,,CA-TEVA-2021-CA-1983162,TEVA,,52.0,YR,A,F,Y,,,20211205.0,,PH,CA,CA,2021,Q4,Adult
201493161,20149316,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211125.0,20211205,20211205,EXP,,CA-TEVA-2021-CA-1983162,TEVA,,52.0,YR,A,F,Y,,,20211205.0,,PH,CA,CA,2021,Q4,Adult
201493161,20149316,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211125.0,20211205,20211205,EXP,,CA-TEVA-2021-CA-1983162,TEVA,,52.0,YR,A,F,Y,,,20211205.0,,PH,CA,CA,2021,Q4,Adult
201493161,20149316,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Metabolic alkalosis,,2021,Q4,1,I,,20211125.0,20211205,20211205,EXP,,CA-TEVA-2021-CA-1983162,TEVA,,52.0,YR,A,F,Y,,,20211205.0,,PH,CA,CA,2021,Q4,Adult
201493161,20149316,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Dehydration,,2021,Q4,1,I,,20211125.0,20211205,20211205,EXP,,CA-TEVA-2021-CA-1983162,TEVA,,52.0,YR,A,F,Y,,,20211205.0,,PH,CA,CA,2021,Q4,Adult
201493161,20149316,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Asthenia,,2021,Q4,1,I,,20211125.0,20211205,20211205,EXP,,CA-TEVA-2021-CA-1983162,TEVA,,52.0,YR,A,F,Y,,,20211205.0,,PH,CA,CA,2021,Q4,Adult
201493161,20149316,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Nausea,,2021,Q4,1,I,,20211125.0,20211205,20211205,EXP,,CA-TEVA-2021-CA-1983162,TEVA,,52.0,YR,A,F,Y,,,20211205.0,,PH,CA,CA,2021,Q4,Adult
201493161,20149316,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211125.0,20211205,20211205,EXP,,CA-TEVA-2021-CA-1983162,TEVA,,52.0,YR,A,F,Y,,,20211205.0,,PH,CA,CA,2021,Q4,Adult
201493161,20149316,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Vomiting,,2021,Q4,1,I,,20211125.0,20211205,20211205,EXP,,CA-TEVA-2021-CA-1983162,TEVA,,52.0,YR,A,F,Y,,,20211205.0,,PH,CA,CA,2021,Q4,Adult
201493161,20149316,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Renal failure,,2021,Q4,1,I,,20211125.0,20211205,20211205,EXP,,CA-TEVA-2021-CA-1983162,TEVA,,52.0,YR,A,F,Y,,,20211205.0,,PH,CA,CA,2021,Q4,Adult
201493172,20149317,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,2,F,,20211217.0,20211205,20211224,EXP,,GR-TEVA-2021-GR-1983552,TEVA,Prokopiou D. Euglycemic diabetic ketoacidosis and acute renal failure in the context of antidiabetic treatment with dapagliflozin and metformin. Case description. 34th Panhellenic Congress of the Diabetes Association of Northern Greece. 2021 NOV 10;135-135.,74.0,YR,E,F,Y,,,20211224.0,,MD,GR,GR,2021,Q4,Elderly
201493172,20149317,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,2,F,,20211217.0,20211205,20211224,EXP,,GR-TEVA-2021-GR-1983552,TEVA,Prokopiou D. Euglycemic diabetic ketoacidosis and acute renal failure in the context of antidiabetic treatment with dapagliflozin and metformin. Case description. 34th Panhellenic Congress of the Diabetes Association of Northern Greece. 2021 NOV 10;135-135.,74.0,YR,E,F,Y,,,20211224.0,,MD,GR,GR,2021,Q4,Elderly
201498151,20149815,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20111001.0,20211124.0,20211206,20211206,EXP,,BR-NOVOPROD-871290,NOVO NORDISK,,71.0,YR,,M,Y,84.9,KG,20211206.0,,MD,BR,BR,2021,Q4,Elderly
201498151,20149815,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,20111001.0,20211124.0,20211206,20211206,EXP,,BR-NOVOPROD-871290,NOVO NORDISK,,71.0,YR,,M,Y,84.9,KG,20211206.0,,MD,BR,BR,2021,Q4,Elderly
201504002,20150400,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Altered state of consciousness,,2021,Q4,2,F,,20211129.0,20211206,20211209,EXP,,JP-009507513-2112JPN001700,MERCK,"Ikeda K, et al. A case of hypoglycaemic attack fostered by polypharmacy. The 245th Tokai Regional Meeting of the Japanese Society of Internal Medicine. 2021;39",68.0,YR,,F,Y,,,20211209.0,,MD,JP,JP,2021,Q4,Elderly
201504002,20150400,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Altered state of consciousness,,2021,Q4,2,F,,20211129.0,20211206,20211209,EXP,,JP-009507513-2112JPN001700,MERCK,"Ikeda K, et al. A case of hypoglycaemic attack fostered by polypharmacy. The 245th Tokai Regional Meeting of the Japanese Society of Internal Medicine. 2021;39",68.0,YR,,F,Y,,,20211209.0,,MD,JP,JP,2021,Q4,Elderly
201504002,20150400,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,,20211129.0,20211206,20211209,EXP,,JP-009507513-2112JPN001700,MERCK,"Ikeda K, et al. A case of hypoglycaemic attack fostered by polypharmacy. The 245th Tokai Regional Meeting of the Japanese Society of Internal Medicine. 2021;39",68.0,YR,,F,Y,,,20211209.0,,MD,JP,JP,2021,Q4,Elderly
201504002,20150400,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,5 mg,,,U,,,,,5.0,MG,,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,,20211129.0,20211206,20211209,EXP,,JP-009507513-2112JPN001700,MERCK,"Ikeda K, et al. A case of hypoglycaemic attack fostered by polypharmacy. The 245th Tokai Regional Meeting of the Japanese Society of Internal Medicine. 2021;39",68.0,YR,,F,Y,,,20211209.0,,MD,JP,JP,2021,Q4,Elderly
201504261,20150426,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Death,,2021,Q4,1,I,20211201.0,20211201.0,20211206,20211206,EXP,,ZA-AstraZeneca-2021A852775,ASTRAZENECA,,20668.0,DY,,M,Y,,,20211206.0,,CN,ZA,,2021,Q4,Elderly
201510381,20151038,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Suspected COVID-19,,2021,Q4,1,I,20210601.0,20211125.0,20211206,20211206,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-BAXTER-2021BAX036182,BAXTER,,79.0,YR,,F,Y,54.0,KG,20211206.0,,PH,GB,GB,2021,Q4,Elderly
201510381,20151038,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Cardiac failure,,2021,Q4,1,I,20210601.0,20211125.0,20211206,20211206,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-BAXTER-2021BAX036182,BAXTER,,79.0,YR,,F,Y,54.0,KG,20211206.0,,PH,GB,GB,2021,Q4,Elderly
201510381,20151038,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Chest pain,,2021,Q4,1,I,20210601.0,20211125.0,20211206,20211206,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-BAXTER-2021BAX036182,BAXTER,,79.0,YR,,F,Y,54.0,KG,20211206.0,,PH,GB,GB,2021,Q4,Elderly
201510381,20151038,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20210601.0,20211125.0,20211206,20211206,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-BAXTER-2021BAX036182,BAXTER,,79.0,YR,,F,Y,54.0,KG,20211206.0,,PH,GB,GB,2021,Q4,Elderly
201510381,20151038,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Cardiomyopathy,,2021,Q4,1,I,20210601.0,20211125.0,20211206,20211206,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-BAXTER-2021BAX036182,BAXTER,,79.0,YR,,F,Y,54.0,KG,20211206.0,,PH,GB,GB,2021,Q4,Elderly
201510381,20151038,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Arteriosclerosis,,2021,Q4,1,I,20210601.0,20211125.0,20211206,20211206,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-BAXTER-2021BAX036182,BAXTER,,79.0,YR,,F,Y,54.0,KG,20211206.0,,PH,GB,GB,2021,Q4,Elderly
201510381,20151038,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,20210601.0,20211125.0,20211206,20211206,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-BAXTER-2021BAX036182,BAXTER,,79.0,YR,,F,Y,54.0,KG,20211206.0,,PH,GB,GB,2021,Q4,Elderly
201510381,20151038,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20210601.0,20211125.0,20211206,20211206,EXP,GB-MHRA-WEBCOVID-202111111101583620-TZUGS,GB-BAXTER-2021BAX036182,BAXTER,,79.0,YR,,F,Y,54.0,KG,20211206.0,,PH,GB,GB,2021,Q4,Elderly
201512891,20151289,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Asthenia,,2021,Q4,1,I,20211107.0,20211129.0,20211206,20211206,EXP,,NVSC2021EG274996,NOVARTIS,,75.0,YR,,M,Y,,,20211206.0,,CN,EG,EG,2021,Q4,Elderly
201512891,20151289,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20211107.0,20211129.0,20211206,20211206,EXP,,NVSC2021EG274996,NOVARTIS,,75.0,YR,,M,Y,,,20211206.0,,CN,EG,EG,2021,Q4,Elderly
201512891,20151289,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Hypotension,,2021,Q4,1,I,20211107.0,20211129.0,20211206,20211206,EXP,,NVSC2021EG274996,NOVARTIS,,75.0,YR,,M,Y,,,20211206.0,,CN,EG,EG,2021,Q4,Elderly
201513091,20151309,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg once daily,,,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211122.0,20211125.0,20211206,20211206,EXP,,GB-AstraZeneca-2021A841140,ASTRAZENECA,,43.0,YR,,M,Y,,,20211206.0,,MD,GB,,2021,Q4,Adult
201513101,20151310,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,90.0,MG,U,,mp2418,,,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211118.0,20211127.0,20211206,20211206,EXP,,CN-AstraZeneca-2021A849934,ASTRAZENECA,,25568.0,DY,,M,Y,,,20211206.0,,MD,CN,,2021,Q4,Elderly
201540662,20154066,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (10)",,,U,,,,,,,,QD,2021,Q4,Cardiac failure chronic,,2021,Q4,2,F,,20211126.0,20211207,20211210,EXP,,NVSC2021TH272674,NOVARTIS,,54.0,YR,,M,Y,,,20211210.0,,MD,TH,TH,2021,Q4,Adult
201540662,20154066,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (10)",,,U,,,,,,,,QD,2021,Q4,Hypotension,,2021,Q4,2,F,,20211126.0,20211207,20211210,EXP,,NVSC2021TH272674,NOVARTIS,,54.0,YR,,M,Y,,,20211210.0,,MD,TH,TH,2021,Q4,Adult
201540662,20154066,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (10)",,,U,,,,,,,,QD,2021,Q4,Ejection fraction decreased,,2021,Q4,2,F,,20211126.0,20211207,20211210,EXP,,NVSC2021TH272674,NOVARTIS,,54.0,YR,,M,Y,,,20211210.0,,MD,TH,TH,2021,Q4,Adult
201540662,20154066,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (10)",,,U,,,,,,,,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,2,F,,20211126.0,20211207,20211210,EXP,,NVSC2021TH272674,NOVARTIS,,54.0,YR,,M,Y,,,20211210.0,,MD,TH,TH,2021,Q4,Adult
201542231,20154223,4,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,,,,,,,,Film Coated Tablet,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210624.0,20211129.0,20211207,20211207,EXP,,ES-AUROBINDO-AUR-APL-2021-049778,AUROBINDO,,75.0,YR,,M,Y,,,20211207.0,,PH,ES,ES,2021,Q4,Elderly
201555951,20155595,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 TABLET EVERY 24 HOURS,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,20210503.0,20211201.0,20211207,20211207,EXP,ES-AEMPS-1033179,ES-MYLANLABS-2021M1089964,MYLAN,,70.0,YR,,M,Y,,,20211207.0,,MD,ES,ES,2021,Q4,Elderly
201555951,20155595,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 TABLET EVERY 24 HOURS,,,,,,,,,,,,2021,Q4,Drug interaction,,2021,Q4,1,I,20210503.0,20211201.0,20211207,20211207,EXP,ES-AEMPS-1033179,ES-MYLANLABS-2021M1089964,MYLAN,,70.0,YR,,M,Y,,,20211207.0,,MD,ES,ES,2021,Q4,Elderly
201557781,20155778,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,Y,,2008005,,,,,Tablet,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211123.0,20211207,20211207,EXP,,CN-AstraZeneca-2021A837900,ASTRAZENECA,"Sun Jingbo, Xue Wenxin, et al.. A case of diabetic ketoacidosis caused by dapagliflozin. Chinese Journal of Drug Application and Monitoring 2021;18(5):345 to 348.",54.0,YR,,M,Y,,,20211207.0,,HP,CN,,2021,Q4,Adult
201568231,20156823,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown UNKNOWN,,,U,,,,202293.0,,,,,2021,Q4,Peripheral arterial occlusive disease,,2021,Q4,1,I,20211001.0,20211129.0,20211207,20211207,EXP,,FR-AstraZeneca-2021A845677,ASTRAZENECA,,58.0,YR,,M,Y,,,20211207.0,,MD,FR,,2021,Q4,Adult
201568231,20156823,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown UNKNOWN,,,U,,,,202293.0,,,,,2021,Q4,Lung disorder,,2021,Q4,1,I,20211001.0,20211129.0,20211207,20211207,EXP,,FR-AstraZeneca-2021A845677,ASTRAZENECA,,58.0,YR,,M,Y,,,20211207.0,,MD,FR,,2021,Q4,Adult
201568231,20156823,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown UNKNOWN,,,U,,,,202293.0,,,,,2021,Q4,Infection,,2021,Q4,1,I,20211001.0,20211129.0,20211207,20211207,EXP,,FR-AstraZeneca-2021A845677,ASTRAZENECA,,58.0,YR,,M,Y,,,20211207.0,,MD,FR,,2021,Q4,Adult
201572261,20157226,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,unk,,,,,,,2021,Q4,Candida infection,,2021,Q4,1,I,,20211123.0,20211207,20211207,EXP,,BR-NOVOPROD-873159,NOVO NORDISK,,75.0,YR,,F,Y,73.0,KG,20211207.0,,MD,BR,BR,2021,Q4,Elderly
201572261,20157226,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,unk,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,,20211123.0,20211207,20211207,EXP,,BR-NOVOPROD-873159,NOVO NORDISK,,75.0,YR,,F,Y,73.0,KG,20211207.0,,MD,BR,BR,2021,Q4,Elderly
201572261,20157226,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,unk,,,,,,,2021,Q4,Carotid artery stenosis,,2021,Q4,1,I,,20211123.0,20211207,20211207,EXP,,BR-NOVOPROD-873159,NOVO NORDISK,,75.0,YR,,F,Y,73.0,KG,20211207.0,,MD,BR,BR,2021,Q4,Elderly
201595101,20159510,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10,,,Y,,,,202293.0,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,20211103.0,20211203.0,20211208,20211208,EXP,,GB-AstraZeneca-2021A854049,ASTRAZENECA,,74.0,YR,,M,Y,83.0,KG,20211208.0,,MD,GB,,2021,Q4,Elderly
201598262,20159826,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Malaise,,2021,Q4,2,F,20211121.0,20211208.0,20211208,20211216,EXP,,UA-AstraZeneca-2021A851977,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,UA,,2021,Q4,Elderly
201598262,20159826,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Dizziness,,2021,Q4,2,F,20211121.0,20211208.0,20211208,20211216,EXP,,UA-AstraZeneca-2021A851977,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,UA,,2021,Q4,Elderly
201598262,20159826,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Asthenia,,2021,Q4,2,F,20211121.0,20211208.0,20211208,20211216,EXP,,UA-AstraZeneca-2021A851977,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,UA,,2021,Q4,Elderly
201598262,20159826,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,General physical health deterioration,,2021,Q4,2,F,20211121.0,20211208.0,20211208,20211216,EXP,,UA-AstraZeneca-2021A851977,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,UA,,2021,Q4,Elderly
201598262,20159826,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Depressed mood,,2021,Q4,2,F,20211121.0,20211208.0,20211208,20211216,EXP,,UA-AstraZeneca-2021A851977,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,UA,,2021,Q4,Elderly
201610581,20161058,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1dd10mg,360.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211123.0,20211203.0,20211208,20211208,EXP,,NL-AstraZeneca-2021A852487,ASTRAZENECA,,43.0,YR,,F,Y,67.0,KG,20211208.0,,MD,NL,,2021,Q4,Adult
201618991,20161899,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,630.0,MG,Y,,2104099,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Ketosis,,2021,Q4,1,I,20210929.0,20211130.0,20211208,20211208,EXP,,CN-AstraZeneca-2021A853352,ASTRAZENECA,,11855.0,DY,,M,Y,75.0,KG,20211208.0,,MD,CN,,2021,Q4,Elderly
201618991,20161899,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,630.0,MG,Y,,2104099,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,20210929.0,20211130.0,20211208,20211208,EXP,,CN-AstraZeneca-2021A853352,ASTRAZENECA,,11855.0,DY,,M,Y,75.0,KG,20211208.0,,MD,CN,,2021,Q4,Elderly
201653701,20165370,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 every day,,,U,,,,202293.0,,,Tablet,,2021,Q4,Fatigue,,2021,Q4,1,I,20210914.0,20211203.0,20211209,20211209,EXP,,GB-AstraZeneca-2021A852306,ASTRAZENECA,,73.0,YR,,M,Y,129.0,KG,20211209.0,,MD,GB,,2021,Q4,Elderly
201653701,20165370,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 every day,,,U,,,,202293.0,,,Tablet,,2021,Q4,Dizziness,,2021,Q4,1,I,20210914.0,20211203.0,20211209,20211209,EXP,,GB-AstraZeneca-2021A852306,ASTRAZENECA,,73.0,YR,,M,Y,129.0,KG,20211209.0,,MD,GB,,2021,Q4,Elderly
201658491,20165849,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,140.0,MG,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210714.0,20211201.0,20211209,20211209,EXP,,AU-AstraZeneca-2021A852047,ASTRAZENECA,,18822.0,DY,,M,Y,98.0,KG,20211209.0,,MD,AU,,2021,Q4,Elderly
201665913,20166591,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Hypertrophic cardiomyopathy,,2021,Q4,3,F,,20211127.0,20211209,20211225,EXP,,NVSC2021TH272545,NOVARTIS,,66.0,YR,,M,Y,65.8,KG,20211225.0,,MD,TH,TH,2021,Q4,Elderly
201665913,20166591,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Hypotension,,2021,Q4,3,F,,20211127.0,20211209,20211225,EXP,,NVSC2021TH272545,NOVARTIS,,66.0,YR,,M,Y,65.8,KG,20211225.0,,MD,TH,TH,2021,Q4,Elderly
201665913,20166591,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Blood creatine increased,,2021,Q4,3,F,,20211127.0,20211209,20211225,EXP,,NVSC2021TH272545,NOVARTIS,,66.0,YR,,M,Y,65.8,KG,20211225.0,,MD,TH,TH,2021,Q4,Elderly
201665913,20166591,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Acquired cardiac septal defect,,2021,Q4,3,F,,20211127.0,20211209,20211225,EXP,,NVSC2021TH272545,NOVARTIS,,66.0,YR,,M,Y,65.8,KG,20211225.0,,MD,TH,TH,2021,Q4,Elderly
201665913,20166591,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Myocardial infarction,,2021,Q4,3,F,,20211127.0,20211209,20211225,EXP,,NVSC2021TH272545,NOVARTIS,,66.0,YR,,M,Y,65.8,KG,20211225.0,,MD,TH,TH,2021,Q4,Elderly
201665913,20166591,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Ejection fraction decreased,,2021,Q4,3,F,,20211127.0,20211209,20211225,EXP,,NVSC2021TH272545,NOVARTIS,,66.0,YR,,M,Y,65.8,KG,20211225.0,,MD,TH,TH,2021,Q4,Elderly
201665913,20166591,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Tricuspid valve incompetence,,2021,Q4,3,F,,20211127.0,20211209,20211225,EXP,,NVSC2021TH272545,NOVARTIS,,66.0,YR,,M,Y,65.8,KG,20211225.0,,MD,TH,TH,2021,Q4,Elderly
201665913,20166591,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Mitral valve incompetence,,2021,Q4,3,F,,20211127.0,20211209,20211225,EXP,,NVSC2021TH272545,NOVARTIS,,66.0,YR,,M,Y,65.8,KG,20211225.0,,MD,TH,TH,2021,Q4,Elderly
201665913,20166591,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,3,F,,20211127.0,20211209,20211225,EXP,,NVSC2021TH272545,NOVARTIS,,66.0,YR,,M,Y,65.8,KG,20211225.0,,MD,TH,TH,2021,Q4,Elderly
201665913,20166591,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,3,F,,20211127.0,20211209,20211225,EXP,,NVSC2021TH272545,NOVARTIS,,66.0,YR,,M,Y,65.8,KG,20211225.0,,MD,TH,TH,2021,Q4,Elderly
201666392,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,2,F,,20211209.0,20211209,20211215,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
201666392,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Hypertension,,2021,Q4,2,F,,20211209.0,20211209,20211215,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
201666392,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Oedema peripheral,,2021,Q4,2,F,,20211209.0,20211209,20211215,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
201666392,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Abdominal distension,,2021,Q4,2,F,,20211209.0,20211209,20211215,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
201666392,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Diabetes mellitus,,2021,Q4,2,F,,20211209.0,20211209,20211215,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
201666392,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,2,F,,20211209.0,20211209,20211215,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
201666392,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Hyperuricaemia,,2021,Q4,2,F,,20211209.0,20211209,20211215,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
201666392,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Obesity,,2021,Q4,2,F,,20211209.0,20211209,20211215,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
201666392,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Fatigue,,2021,Q4,2,F,,20211209.0,20211209,20211215,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
201666392,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,2,F,,20211209.0,20211209,20211215,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20211215.0,,MD,PL,PL,2021,Q4,Adult
201685781,20168578,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Malaise,,2021,Q4,1,I,20211113.0,20211206.0,20211210,20211210,EXP,FR-AFSSAPS-NY20215297,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132432,BRISTOL MYERS SQUIBB,,84.0,YR,,M,Y,,,20211210.0,,CN,FR,FR,2021,Q4,Elderly
201685781,20168578,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,20211113.0,20211206.0,20211210,20211210,EXP,FR-AFSSAPS-NY20215297,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132432,BRISTOL MYERS SQUIBB,,84.0,YR,,M,Y,,,20211210.0,,CN,FR,FR,2021,Q4,Elderly
201706911,20170691,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,20190101.0,20211201.0,20211210,20211210,EXP,,GR-AstraZeneca-2021A849717,ASTRAZENECA,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal impairment in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation. Hellenic Diabetological Chronicles 2020;33(2):",74.0,YR,,F,Y,,,20211210.0,,MD,GR,,2021,Q4,Elderly
201706911,20170691,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20190101.0,20211201.0,20211210,20211210,EXP,,GR-AstraZeneca-2021A849717,ASTRAZENECA,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal impairment in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation. Hellenic Diabetological Chronicles 2020;33(2):",74.0,YR,,F,Y,,,20211210.0,,MD,GR,,2021,Q4,Elderly
201706911,20170691,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2021,Q4,Renal impairment,,2021,Q4,1,I,20190101.0,20211201.0,20211210,20211210,EXP,,GR-AstraZeneca-2021A849717,ASTRAZENECA,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal impairment in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation. Hellenic Diabetological Chronicles 2020;33(2):",74.0,YR,,F,Y,,,20211210.0,,MD,GR,,2021,Q4,Elderly
201706921,20170692,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,2101211,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketosis,,2021,Q4,1,I,20211112.0,20211203.0,20211210,20211210,EXP,,CN-AstraZeneca-2021A855380,ASTRAZENECA,,20703.0,DY,,F,Y,,,20211210.0,,MD,CN,,2021,Q4,Elderly
201708651,20170865,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1190.0,MG,Y,,MT3057,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Blood ketone body increased,,2021,Q4,1,I,20211111.0,20211202.0,20211210,20211210,EXP,,CN-AstraZeneca-2021A855113,ASTRAZENECA,,19532.0,DY,,M,Y,68.0,KG,20211210.0,,MD,CN,,2021,Q4,Elderly
201708651,20170865,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1190.0,MG,Y,,MT3057,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,20211111.0,20211202.0,20211210,20211210,EXP,,CN-AstraZeneca-2021A855113,ASTRAZENECA,,19532.0,DY,,M,Y,68.0,KG,20211210.0,,MD,CN,,2021,Q4,Elderly
201708651,20170865,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1190.0,MG,Y,,MT3057,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Muscular weakness,,2021,Q4,1,I,20211111.0,20211202.0,20211210,20211210,EXP,,CN-AstraZeneca-2021A855113,ASTRAZENECA,,19532.0,DY,,M,Y,68.0,KG,20211210.0,,MD,CN,,2021,Q4,Elderly
201711011,20171101,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Death,,2021,Q4,1,I,20211203.0,20211206.0,20211210,20211210,EXP,,SE-AstraZeneca-2021A858673,ASTRAZENECA,,63.0,YR,,F,Y,,,20211210.0,,HP,SE,,2021,Q4,Adult
201730641,20173064,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211101.0,20211206.0,20211211,20211211,EXP,,NVSC2021DE280138,NOVARTIS,,82.0,YR,,F,Y,,,20211211.0,,MD,DE,DE,2021,Q4,Elderly
201730641,20173064,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,,,,,,,,2021,Q4,Oedema,,2021,Q4,1,I,20211101.0,20211206.0,20211211,20211211,EXP,,NVSC2021DE280138,NOVARTIS,,82.0,YR,,F,Y,,,20211211.0,,MD,DE,DE,2021,Q4,Elderly
201730641,20173064,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,20211101.0,20211206.0,20211211,20211211,EXP,,NVSC2021DE280138,NOVARTIS,,82.0,YR,,F,Y,,,20211211.0,,MD,DE,DE,2021,Q4,Elderly
201730641,20173064,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,,,,,,,,2021,Q4,Cardiac failure,,2021,Q4,1,I,20211101.0,20211206.0,20211211,20211211,EXP,,NVSC2021DE280138,NOVARTIS,,82.0,YR,,F,Y,,,20211211.0,,MD,DE,DE,2021,Q4,Elderly
201733671,20173367,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Varicose vein,,2021,Q4,1,I,20211101.0,20211204.0,20211211,20211211,EXP,,NVSC2021EG278868,NOVARTIS,,69.0,YR,,M,Y,,,20211211.0,,CN,EG,EG,2021,Q4,Elderly
201733671,20173367,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Loss of consciousness,,2021,Q4,1,I,20211101.0,20211204.0,20211211,20211211,EXP,,NVSC2021EG278868,NOVARTIS,,69.0,YR,,M,Y,,,20211211.0,,CN,EG,EG,2021,Q4,Elderly
201733671,20173367,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Skin ulcer,,2021,Q4,1,I,20211101.0,20211204.0,20211211,20211211,EXP,,NVSC2021EG278868,NOVARTIS,,69.0,YR,,M,Y,,,20211211.0,,CN,EG,EG,2021,Q4,Elderly
201733671,20173367,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Fall,,2021,Q4,1,I,20211101.0,20211204.0,20211211,20211211,EXP,,NVSC2021EG278868,NOVARTIS,,69.0,YR,,M,Y,,,20211211.0,,CN,EG,EG,2021,Q4,Elderly
201733671,20173367,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Intentional product misuse,,2021,Q4,1,I,20211101.0,20211204.0,20211211,20211211,EXP,,NVSC2021EG278868,NOVARTIS,,69.0,YR,,M,Y,,,20211211.0,,CN,EG,EG,2021,Q4,Elderly
201742251,20174225,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,unknown,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211202.0,20211213,20211213,EXP,,BR-NOVOPROD-873923,NOVO NORDISK,,71.0,YR,,M,Y,104.3,KG,20211213.0,,MD,BR,BR,2021,Q4,Elderly
201742251,20174225,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,unknown,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211202.0,20211213,20211213,EXP,,BR-NOVOPROD-873923,NOVO NORDISK,,71.0,YR,,M,Y,104.3,KG,20211213.0,,MD,BR,BR,2021,Q4,Elderly
201742251,20174225,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,unknown,,,,,,,2021,Q4,Neurological symptom,,2021,Q4,1,I,,20211202.0,20211213,20211213,EXP,,BR-NOVOPROD-873923,NOVO NORDISK,,71.0,YR,,M,Y,104.3,KG,20211213.0,,MD,BR,BR,2021,Q4,Elderly
201744261,20174426,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,unknown,,,10.0,MG,,,2021,Q4,Chest discomfort,,2021,Q4,1,I,20211129.0,20211129.0,20211213,20211213,EXP,,ZA-LUPIN PHARMACEUTICALS INC.-2021-24201,LUPIN,,71.0,YR,,M,Y,,,20211213.0,,CN,ZA,ZA,2021,Q4,Elderly
201744261,20174426,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,unknown,,,10.0,MG,,,2021,Q4,Asthma,,2021,Q4,1,I,20211129.0,20211129.0,20211213,20211213,EXP,,ZA-LUPIN PHARMACEUTICALS INC.-2021-24201,LUPIN,,71.0,YR,,M,Y,,,20211213.0,,CN,ZA,ZA,2021,Q4,Elderly
201746751,20174675,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,1,I,,20211130.0,20211213,20211213,EXP,PL-EMA-20211104-AUTODUP-1635982106387,PL-Accord-247066,ACCORD,,64.0,YR,,M,Y,,,20211213.0,,MD,PL,PL,2021,Q4,Adult
201746751,20174675,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Hyperuricaemia,,2021,Q4,1,I,,20211130.0,20211213,20211213,EXP,PL-EMA-20211104-AUTODUP-1635982106387,PL-Accord-247066,ACCORD,,64.0,YR,,M,Y,,,20211213.0,,MD,PL,PL,2021,Q4,Adult
201746751,20174675,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Diabetes mellitus,,2021,Q4,1,I,,20211130.0,20211213,20211213,EXP,PL-EMA-20211104-AUTODUP-1635982106387,PL-Accord-247066,ACCORD,,64.0,YR,,M,Y,,,20211213.0,,MD,PL,PL,2021,Q4,Adult
201746751,20174675,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211130.0,20211213,20211213,EXP,PL-EMA-20211104-AUTODUP-1635982106387,PL-Accord-247066,ACCORD,,64.0,YR,,M,Y,,,20211213.0,,MD,PL,PL,2021,Q4,Adult
201746751,20174675,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20211130.0,20211213,20211213,EXP,PL-EMA-20211104-AUTODUP-1635982106387,PL-Accord-247066,ACCORD,,64.0,YR,,M,Y,,,20211213.0,,MD,PL,PL,2021,Q4,Adult
201746751,20174675,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Obesity,,2021,Q4,1,I,,20211130.0,20211213,20211213,EXP,PL-EMA-20211104-AUTODUP-1635982106387,PL-Accord-247066,ACCORD,,64.0,YR,,M,Y,,,20211213.0,,MD,PL,PL,2021,Q4,Adult
201746751,20174675,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211130.0,20211213,20211213,EXP,PL-EMA-20211104-AUTODUP-1635982106387,PL-Accord-247066,ACCORD,,64.0,YR,,M,Y,,,20211213.0,,MD,PL,PL,2021,Q4,Adult
201746751,20174675,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,1,I,,20211130.0,20211213,20211213,EXP,PL-EMA-20211104-AUTODUP-1635982106387,PL-Accord-247066,ACCORD,,64.0,YR,,M,Y,,,20211213.0,,MD,PL,PL,2021,Q4,Adult
201746751,20174675,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Hypertension,,2021,Q4,1,I,,20211130.0,20211213,20211213,EXP,PL-EMA-20211104-AUTODUP-1635982106387,PL-Accord-247066,ACCORD,,64.0,YR,,M,Y,,,20211213.0,,MD,PL,PL,2021,Q4,Adult
201746751,20174675,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211130.0,20211213,20211213,EXP,PL-EMA-20211104-AUTODUP-1635982106387,PL-Accord-247066,ACCORD,,64.0,YR,,M,Y,,,20211213.0,,MD,PL,PL,2021,Q4,Adult
201762571,20176257,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,-,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211126.0,20211203.0,20211213,20211213,EXP,,GB-AstraZeneca-2021A852188,ASTRAZENECA,,67.0,YR,,M,Y,75.0,KG,20211213.0,,MD,GB,,2021,Q4,Elderly
201763351,20176335,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,190.0,MG,Y,Y,2101211,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketosis,,2021,Q4,1,I,20210911.0,20211203.0,20211213,20211213,EXP,,CN-AstraZeneca-2021A856528,ASTRAZENECA,,74.0,YR,,F,Y,,,20211213.0,,MD,CN,,2021,Q4,Elderly
201772151,20177215,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dyspnoea exertional,,2021,Q4,1,I,,20211207.0,20211213,20211213,EXP,,NVSC2021AU283910,NOVARTIS,,43.0,YR,,M,Y,,,20211213.0,,MD,AU,AU,2021,Q4,Adult
201772151,20177215,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,,20211207.0,20211213,20211213,EXP,,NVSC2021AU283910,NOVARTIS,,43.0,YR,,M,Y,,,20211213.0,,MD,AU,AU,2021,Q4,Adult
201772151,20177215,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Gait disturbance,,2021,Q4,1,I,,20211207.0,20211213,20211213,EXP,,NVSC2021AU283910,NOVARTIS,,43.0,YR,,M,Y,,,20211213.0,,MD,AU,AU,2021,Q4,Adult
201772151,20177215,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Ejection fraction decreased,,2021,Q4,1,I,,20211207.0,20211213,20211213,EXP,,NVSC2021AU283910,NOVARTIS,,43.0,YR,,M,Y,,,20211213.0,,MD,AU,AU,2021,Q4,Adult
201772151,20177215,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211207.0,20211213,20211213,EXP,,NVSC2021AU283910,NOVARTIS,,43.0,YR,,M,Y,,,20211213.0,,MD,AU,AU,2021,Q4,Adult
201772151,20177215,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Cardiomyopathy,,2021,Q4,1,I,,20211207.0,20211213,20211213,EXP,,NVSC2021AU283910,NOVARTIS,,43.0,YR,,M,Y,,,20211213.0,,MD,AU,AU,2021,Q4,Adult
201772151,20177215,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dilatation ventricular,,2021,Q4,1,I,,20211207.0,20211213,20211213,EXP,,NVSC2021AU283910,NOVARTIS,,43.0,YR,,M,Y,,,20211213.0,,MD,AU,AU,2021,Q4,Adult
201772151,20177215,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Cardiac ventricular thrombosis,,2021,Q4,1,I,,20211207.0,20211213,20211213,EXP,,NVSC2021AU283910,NOVARTIS,,43.0,YR,,M,Y,,,20211213.0,,MD,AU,AU,2021,Q4,Adult
201786051,20178605,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Uveitis,,2021,Q4,1,I,20210820.0,20211207.0,20211214,20211214,EXP,GB-MHRA-EYC 00267949,GB-ABBVIE-21K-167-4197100-00,ABBVIE,,77.0,YR,,M,Y,55.0,KG,20211214.0,,HP,GB,GB,2021,Q4,Elderly
201786341,20178634,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6400.0,MG,Y,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211101.0,20211210.0,20211214,20211214,EXP,,DK-AstraZeneca-2021A866604,ASTRAZENECA,,69.0,YR,,M,Y,,,20211214.0,,MD,DK,,2021,Q4,Elderly
201786341,20178634,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6400.0,MG,Y,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20211101.0,20211210.0,20211214,20211214,EXP,,DK-AstraZeneca-2021A866604,ASTRAZENECA,,69.0,YR,,M,Y,,,20211214.0,,MD,DK,,2021,Q4,Elderly
201786341,20178634,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6400.0,MG,Y,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Pulmonary embolism,,2021,Q4,1,I,20211101.0,20211210.0,20211214,20211214,EXP,,DK-AstraZeneca-2021A866604,ASTRAZENECA,,69.0,YR,,M,Y,,,20211214.0,,MD,DK,,2021,Q4,Elderly
201786341,20178634,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6400.0,MG,Y,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,20211101.0,20211210.0,20211214,20211214,EXP,,DK-AstraZeneca-2021A866604,ASTRAZENECA,,69.0,YR,,M,Y,,,20211214.0,,MD,DK,,2021,Q4,Elderly
201786341,20178634,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6400.0,MG,Y,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Rales,,2021,Q4,1,I,20211101.0,20211210.0,20211214,20211214,EXP,,DK-AstraZeneca-2021A866604,ASTRAZENECA,,69.0,YR,,M,Y,,,20211214.0,,MD,DK,,2021,Q4,Elderly
201786341,20178634,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6400.0,MG,Y,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Respiratory disorder,,2021,Q4,1,I,20211101.0,20211210.0,20211214,20211214,EXP,,DK-AstraZeneca-2021A866604,ASTRAZENECA,,69.0,YR,,M,Y,,,20211214.0,,MD,DK,,2021,Q4,Elderly
201793851,20179385,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Depressed mood,,2021,Q4,1,I,20211025.0,20211207.0,20211214,20211214,EXP,,GB-AstraZeneca-2021A859593,ASTRAZENECA,,89.0,YR,,M,Y,71.0,KG,20211214.0,,MD,GB,,2021,Q4,Elderly
201793851,20179385,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211025.0,20211207.0,20211214,20211214,EXP,,GB-AstraZeneca-2021A859593,ASTRAZENECA,,89.0,YR,,M,Y,71.0,KG,20211214.0,,MD,GB,,2021,Q4,Elderly
201793851,20179385,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Fatigue,,2021,Q4,1,I,20211025.0,20211207.0,20211214,20211214,EXP,,GB-AstraZeneca-2021A859593,ASTRAZENECA,,89.0,YR,,M,Y,71.0,KG,20211214.0,,MD,GB,,2021,Q4,Elderly
201793851,20179385,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2021,Q4,Depressed mood,,2021,Q4,1,I,20211025.0,20211207.0,20211214,20211214,EXP,,GB-AstraZeneca-2021A859593,ASTRAZENECA,,89.0,YR,,M,Y,71.0,KG,20211214.0,,MD,GB,,2021,Q4,Elderly
201793851,20179385,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211025.0,20211207.0,20211214,20211214,EXP,,GB-AstraZeneca-2021A859593,ASTRAZENECA,,89.0,YR,,M,Y,71.0,KG,20211214.0,,MD,GB,,2021,Q4,Elderly
201793851,20179385,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2021,Q4,Fatigue,,2021,Q4,1,I,20211025.0,20211207.0,20211214,20211214,EXP,,GB-AstraZeneca-2021A859593,ASTRAZENECA,,89.0,YR,,M,Y,71.0,KG,20211214.0,,MD,GB,,2021,Q4,Elderly
201796451,20179645,23,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Pyrexia,,2021,Q4,1,I,20210120.0,20211209.0,20211214,20211214,EXP,FI-FIMEA-20217060,FI-SA-2021SA413483,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20211214.0,,MD,FI,FI,2021,Q4,Elderly
201796451,20179645,23,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Malaise,,2021,Q4,1,I,20210120.0,20211209.0,20211214,20211214,EXP,FI-FIMEA-20217060,FI-SA-2021SA413483,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20211214.0,,MD,FI,FI,2021,Q4,Elderly
201796451,20179645,23,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Confusional state,,2021,Q4,1,I,20210120.0,20211209.0,20211214,20211214,EXP,FI-FIMEA-20217060,FI-SA-2021SA413483,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20211214.0,,MD,FI,FI,2021,Q4,Elderly
201796451,20179645,23,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Headache,,2021,Q4,1,I,20210120.0,20211209.0,20211214,20211214,EXP,FI-FIMEA-20217060,FI-SA-2021SA413483,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20211214.0,,MD,FI,FI,2021,Q4,Elderly
201812322,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Lung disorder,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Lung disorder,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Lung disorder,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,45,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1x/day",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1x/day",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1x/day",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1x/day",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1x/day",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1x/day",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Lung disorder,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1x/day",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Lung disorder,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812322,20181232,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,2,F,20210301.0,20211223.0,20211214,20211230,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20211230.0,,MD,PL,PL,2021,Q4,Elderly
201812761,20181276,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,Unknown,,,10.0,MG,,QD,2021,Q4,Affective disorder,,2021,Q4,1,I,20211109.0,20211130.0,20211214,20211214,EXP,FR-AFSSAPS-AN20214528,FR-PFIZER INC-202101691656,PFIZER,,75.0,YR,,M,Y,,,20211214.0,,MD,FR,FR,2021,Q4,Elderly
201814211,20181421,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211207.0,20211214,20211214,EXP,,CA-AstraZeneca-2021A858343,ASTRAZENECA,,25.0,YR,,F,Y,,,20211214.0,,MD,CA,,2021,Q4,Young Adult
201814231,20181423,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7310.0,MG,Y,,,,,10.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211115.0,20211206.0,20211214,20211214,EXP,,NO-AstraZeneca-2021A854564,ASTRAZENECA,,84.0,YR,,M,Y,,,20211214.0,,MD,NO,,2021,Q4,Elderly
201814241,20181424,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,,10.0,MG,Tablet,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20190101.0,20211208.0,20211214,20211214,EXP,,GB-AstraZeneca-2021A863391,ASTRAZENECA,,28.0,YR,,M,Y,98.0,KG,20211214.0,,MD,GB,,2021,Q4,Young Adult
201817332,20181733,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Toxic skin eruption,,2021,Q4,2,F,20211007.0,20211207.0,20211214,20211230,EXP,,JP-AstraZeneca-2021A867137,ASTRAZENECA,,71.0,YR,,M,Y,65.0,KG,20211230.0,,MD,JP,,2021,Q4,Elderly
201817691,20181769,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,Tablet,QD,2021,Q4,Hypertension,,2021,Q4,1,I,20210420.0,20210426.0,20211214,20211214,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-134744,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,56.8,KG,20211214.0,,MD,JP,JP,2021,Q4,Elderly
201817691,20181769,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,Tablet,QD,2021,Q4,Dehydration,,2021,Q4,1,I,20210420.0,20210426.0,20211214,20211214,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-134744,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,56.8,KG,20211214.0,,MD,JP,JP,2021,Q4,Elderly
201817691,20181769,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,Tablet,QD,2021,Q4,Palmar-plantar erythrodysaesthesia syndrome,,2021,Q4,1,I,20210420.0,20210426.0,20211214,20211214,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-134744,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,56.8,KG,20211214.0,,MD,JP,JP,2021,Q4,Elderly
201817691,20181769,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,Tablet,QD,2021,Q4,Malaise,,2021,Q4,1,I,20210420.0,20210426.0,20211214,20211214,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-134744,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,56.8,KG,20211214.0,,MD,JP,JP,2021,Q4,Elderly
201817691,20181769,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,Tablet,QD,2021,Q4,Feeling abnormal,,2021,Q4,1,I,20210420.0,20210426.0,20211214,20211214,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-134744,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,56.8,KG,20211214.0,,MD,JP,JP,2021,Q4,Elderly
201817691,20181769,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,Tablet,QD,2021,Q4,Hyperthyroidism,,2021,Q4,1,I,20210420.0,20210426.0,20211214,20211214,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-134744,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,56.8,KG,20211214.0,,MD,JP,JP,2021,Q4,Elderly
201819751,20181975,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2021,Q4,Pancreatitis acute,,2021,Q4,1,I,,20211208.0,20211214,20211214,EXP,,LB-AstraZeneca-2021A864382,ASTRAZENECA,,50.0,YR,,M,Y,,,20211214.0,,MD,LB,,2021,Q4,Adult
201837491,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211208.0,20211214,20211214,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20211214.0,,MD,PL,PL,2021,Q4,Adult
201837491,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Diabetes mellitus,,2021,Q4,1,I,,20211208.0,20211214,20211214,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20211214.0,,MD,PL,PL,2021,Q4,Adult
201837491,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20211208.0,20211214,20211214,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20211214.0,,MD,PL,PL,2021,Q4,Adult
201837491,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Nonalcoholic fatty liver disease,,2021,Q4,1,I,,20211208.0,20211214,20211214,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20211214.0,,MD,PL,PL,2021,Q4,Adult
201837491,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211208.0,20211214,20211214,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20211214.0,,MD,PL,PL,2021,Q4,Adult
201837491,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211208.0,20211214,20211214,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20211214.0,,MD,PL,PL,2021,Q4,Adult
201837491,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Obesity,,2021,Q4,1,I,,20211208.0,20211214,20211214,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20211214.0,,MD,PL,PL,2021,Q4,Adult
201837491,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Type V hyperlipidaemia,,2021,Q4,1,I,,20211208.0,20211214,20211214,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20211214.0,,MD,PL,PL,2021,Q4,Adult
201837491,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Hyperuricaemia,,2021,Q4,1,I,,20211208.0,20211214,20211214,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20211214.0,,MD,PL,PL,2021,Q4,Adult
201837491,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2021,Q4,Hypertension,,2021,Q4,1,I,,20211208.0,20211214,20211214,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20211214.0,,MD,PL,PL,2021,Q4,Adult
201875142,20187514,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,2,F,,20211214.0,20211215,20211222,EXP,,AU-BAUSCH-BL-2021-040982,BAUSCH AND LOMB,,74.0,YR,,M,Y,,,20211222.0,,CN,AU,AU,2021,Q4,Elderly
201875142,20187514,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2021,Q4,Renal impairment,,2021,Q4,2,F,,20211214.0,20211215,20211222,EXP,,AU-BAUSCH-BL-2021-040982,BAUSCH AND LOMB,,74.0,YR,,M,Y,,,20211222.0,,CN,AU,AU,2021,Q4,Elderly
201876061,20187606,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20211207.0,20211207.0,20211215,20211215,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202109012192,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20211215.0,,CN,JP,JP,2021,Q4,Elderly
201876061,20187606,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Gastric cancer,,2021,Q4,1,I,20211207.0,20211207.0,20211215,20211215,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202109012192,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20211215.0,,CN,JP,JP,2021,Q4,Elderly
201876061,20187606,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Blood lactic acid increased,,2021,Q4,1,I,20211207.0,20211207.0,20211215,20211215,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202109012192,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20211215.0,,CN,JP,JP,2021,Q4,Elderly
201883521,20188352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2.0,MG,Y,,"MM3593,2104091",,202293.0,1.0,MG,Tablet,QD,2021,Q4,Vomiting,,2021,Q4,1,I,20211128.0,20211207.0,20211215,20211215,EXP,,CN-AstraZeneca-2021A866993,ASTRAZENECA,,21623.0,DY,,F,Y,,,20211215.0,,MD,CN,,2021,Q4,Elderly
201883521,20188352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2.0,MG,Y,,"MM3593,2104091",,202293.0,1.0,MG,Tablet,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20211128.0,20211207.0,20211215,20211215,EXP,,CN-AstraZeneca-2021A866993,ASTRAZENECA,,21623.0,DY,,F,Y,,,20211215.0,,MD,CN,,2021,Q4,Elderly
201883521,20188352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2.0,MG,Y,,"MM3593,2104091",,202293.0,1.0,MG,Tablet,QD,2021,Q4,Dizziness,,2021,Q4,1,I,20211128.0,20211207.0,20211215,20211215,EXP,,CN-AstraZeneca-2021A866993,ASTRAZENECA,,21623.0,DY,,F,Y,,,20211215.0,,MD,CN,,2021,Q4,Elderly
201883521,20188352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2.0,MG,Y,,"MM3593,2104091",,202293.0,1.0,MG,Tablet,QD,2021,Q4,Nausea,,2021,Q4,1,I,20211128.0,20211207.0,20211215,20211215,EXP,,CN-AstraZeneca-2021A866993,ASTRAZENECA,,21623.0,DY,,F,Y,,,20211215.0,,MD,CN,,2021,Q4,Elderly
201883521,20188352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2.0,MG,Y,,"MM3593,2104091",,202293.0,1.0,MG,Tablet,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211128.0,20211207.0,20211215,20211215,EXP,,CN-AstraZeneca-2021A866993,ASTRAZENECA,,21623.0,DY,,F,Y,,,20211215.0,,MD,CN,,2021,Q4,Elderly
201888661,20188866,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20211130.0,20211206.0,20211215,20211215,EXP,,GB-AstraZeneca-2021A856324,ASTRAZENECA,,68.0,YR,,F,Y,,,20211215.0,,MD,GB,,2021,Q4,Elderly
201890961,20189096,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20190101.0,20211213.0,20211215,20211215,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20211215.0,,HP,GR,GR,2021,Q4,Elderly
201890961,20189096,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Acidosis,,2021,Q4,1,I,20190101.0,20211213.0,20211215,20211215,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20211215.0,,HP,GR,GR,2021,Q4,Elderly
201890961,20189096,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20190101.0,20211213.0,20211215,20211215,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20211215.0,,HP,GR,GR,2021,Q4,Elderly
201890961,20189096,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,20190101.0,20211213.0,20211215,20211215,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20211215.0,,HP,GR,GR,2021,Q4,Elderly
201890961,20189096,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,20190101.0,20211213.0,20211215,20211215,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20211215.0,,HP,GR,GR,2021,Q4,Elderly
201900581,20190058,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,U,,,,,,,,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,,20211212.0,20211215,20211215,EXP,,"GB-Breckenridge Pharmaceutical, Inc.-2123060",BRECKENRIDGE,,78.0,YR,,F,Y,,,20211215.0,,HP,ES,GB,2021,Q4,Elderly
201900581,20190058,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,U,,,,,,,,2021,Q4,Cardiac failure,,2021,Q4,1,I,,20211212.0,20211215,20211215,EXP,,"GB-Breckenridge Pharmaceutical, Inc.-2123060",BRECKENRIDGE,,78.0,YR,,F,Y,,,20211215.0,,HP,ES,GB,2021,Q4,Elderly
201900581,20190058,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,U,,,,,,,,2021,Q4,Atrioventricular block complete,,2021,Q4,1,I,,20211212.0,20211215,20211215,EXP,,"GB-Breckenridge Pharmaceutical, Inc.-2123060",BRECKENRIDGE,,78.0,YR,,F,Y,,,20211215.0,,HP,ES,GB,2021,Q4,Elderly
201900581,20190058,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,U,,,,,,,,2021,Q4,Hypomagnesaemia,,2021,Q4,1,I,,20211212.0,20211215,20211215,EXP,,"GB-Breckenridge Pharmaceutical, Inc.-2123060",BRECKENRIDGE,,78.0,YR,,F,Y,,,20211215.0,,HP,ES,GB,2021,Q4,Elderly
201900581,20190058,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,U,,,,,,,,2021,Q4,Hypocalcaemia,,2021,Q4,1,I,,20211212.0,20211215,20211215,EXP,,"GB-Breckenridge Pharmaceutical, Inc.-2123060",BRECKENRIDGE,,78.0,YR,,F,Y,,,20211215.0,,HP,ES,GB,2021,Q4,Elderly
201939411,20193941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Back pain,,2021,Q4,1,I,20210614.0,20211208.0,20211216,20211216,EXP,,RU-AstraZeneca-2021A868342,ASTRAZENECA,,56.0,YR,,F,Y,112.0,KG,20211216.0,,MD,RU,,2021,Q4,Adult
201939411,20193941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,20210614.0,20211208.0,20211216,20211216,EXP,,RU-AstraZeneca-2021A868342,ASTRAZENECA,,56.0,YR,,F,Y,112.0,KG,20211216.0,,MD,RU,,2021,Q4,Adult
201939411,20193941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Face oedema,,2021,Q4,1,I,20210614.0,20211208.0,20211216,20211216,EXP,,RU-AstraZeneca-2021A868342,ASTRAZENECA,,56.0,YR,,F,Y,112.0,KG,20211216.0,,MD,RU,,2021,Q4,Adult
201939411,20193941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Genital candidiasis,,2021,Q4,1,I,20210614.0,20211208.0,20211216,20211216,EXP,,RU-AstraZeneca-2021A868342,ASTRAZENECA,,56.0,YR,,F,Y,112.0,KG,20211216.0,,MD,RU,,2021,Q4,Adult
201939411,20193941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Angioedema,,2021,Q4,1,I,20210614.0,20211208.0,20211216,20211216,EXP,,RU-AstraZeneca-2021A868342,ASTRAZENECA,,56.0,YR,,F,Y,112.0,KG,20211216.0,,MD,RU,,2021,Q4,Adult
201939411,20193941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Dry mouth,,2021,Q4,1,I,20210614.0,20211208.0,20211216,20211216,EXP,,RU-AstraZeneca-2021A868342,ASTRAZENECA,,56.0,YR,,F,Y,112.0,KG,20211216.0,,MD,RU,,2021,Q4,Adult
201940931,20194093,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,20211113.0,20211208.0,20211216,20211216,EXP,,FR-AstraZeneca-2021A860803,ASTRAZENECA,,84.0,YR,,M,Y,,,20211216.0,,MD,FR,,2021,Q4,Elderly
201940931,20194093,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Malaise,,2021,Q4,1,I,20211113.0,20211208.0,20211216,20211216,EXP,,FR-AstraZeneca-2021A860803,ASTRAZENECA,,84.0,YR,,M,Y,,,20211216.0,,MD,FR,,2021,Q4,Elderly
201952061,20195206,19,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,UNKNOWN,,,,,Tablet,,2021,Q4,Febrile neutropenia,,2021,Q4,1,I,,20211206.0,20211216,20211216,EXP,,CA-Fresenius Kabi-FK202113999,FRESENIUS KABI,,60.0,YR,,M,Y,97.0,KG,20211216.0,,HP,CA,CA,2021,Q4,Adult
201952061,20195206,19,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,UNKNOWN,,,,,Tablet,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211206.0,20211216,20211216,EXP,,CA-Fresenius Kabi-FK202113999,FRESENIUS KABI,,60.0,YR,,M,Y,97.0,KG,20211216.0,,HP,CA,CA,2021,Q4,Adult
201952401,20195240,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Lung disorder,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Lung disorder,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Lung disorder,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Congestive cardiomyopathy,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Lung disorder,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,N-terminal prohormone brain natriuretic peptide increased,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201952401,20195240,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Glomerular filtration rate abnormal,,2021,Q4,1,I,20210301.0,20211208.0,20211216,20211216,EXP,,PL-AstraZeneca-2021A859992,ASTRAZENECA,,71.0,YR,,M,Y,,,20211216.0,,MD,PL,,2021,Q4,Elderly
201956112,20195611,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,Y,,Unknown,,,,,Film-coated tablet,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,2,F,20211113.0,20211206.0,20211216,20211220,EXP,FR-AFSSAPS-NY20215297,FR-PFIZER INC-202101734508,PFIZER,,84.0,YR,,M,Y,,,20211220.0,,CN,FR,FR,2021,Q4,Elderly
201956112,20195611,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,Y,,Unknown,,,,,Film-coated tablet,,2021,Q4,Accidental overdose,,2021,Q4,2,F,20211113.0,20211206.0,20211216,20211220,EXP,FR-AFSSAPS-NY20215297,FR-PFIZER INC-202101734508,PFIZER,,84.0,YR,,M,Y,,,20211220.0,,CN,FR,FR,2021,Q4,Elderly
201956112,20195611,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,Y,,Unknown,,,,,Film-coated tablet,,2021,Q4,Malaise,,2021,Q4,2,F,20211113.0,20211206.0,20211216,20211220,EXP,FR-AFSSAPS-NY20215297,FR-PFIZER INC-202101734508,PFIZER,,84.0,YR,,M,Y,,,20211220.0,,CN,FR,FR,2021,Q4,Elderly
201962171,20196217,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,Tablets,,2021,Q4,Hepatic encephalopathy,,2021,Q4,1,I,20201109.0,20211209.0,20211216,20211216,PER,,KR-Eisai Medical Research-EC-2021-104876,EISAI,,75.0,YR,E,M,Y,63.7,KG,20211216.0,,MD,KR,,2021,Q4,Elderly
201968681,20196868,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Myocardial infarction,,2021,Q4,1,I,,20211207.0,20211217,20211217,EXP,,IT-AUROBINDO-AUR-APL-2021-051357,AUROBINDO,"Acanfora C.. Fibrillazione Atriale, Diabete Mellito e Cardiopatia Ischemica. Un caso clinico complesso.. Cardiolink Scientific News. 2021",64.0,YR,,M,Y,97.0,KG,20211217.0,,MD,IT,IT,2021,Q4,Adult
201968681,20196868,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Ventricular fibrillation,,2021,Q4,1,I,,20211207.0,20211217,20211217,EXP,,IT-AUROBINDO-AUR-APL-2021-051357,AUROBINDO,"Acanfora C.. Fibrillazione Atriale, Diabete Mellito e Cardiopatia Ischemica. Un caso clinico complesso.. Cardiolink Scientific News. 2021",64.0,YR,,M,Y,97.0,KG,20211217.0,,MD,IT,IT,2021,Q4,Adult
201968681,20196868,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2021,Q4,Chest pain,,2021,Q4,1,I,,20211207.0,20211217,20211217,EXP,,IT-AUROBINDO-AUR-APL-2021-051357,AUROBINDO,"Acanfora C.. Fibrillazione Atriale, Diabete Mellito e Cardiopatia Ischemica. Un caso clinico complesso.. Cardiolink Scientific News. 2021",64.0,YR,,M,Y,97.0,KG,20211217.0,,MD,IT,IT,2021,Q4,Adult
201976891,20197689,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,Film Coated Tablet,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,20211113.0,20211204.0,20211217,20211217,EXP,,FR-AUROBINDO-AUR-APL-2021-050958,AUROBINDO,,84.0,YR,,M,Y,,,20211217.0,,CN,FR,FR,2021,Q4,Elderly
201976891,20197689,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,Film Coated Tablet,,2021,Q4,Malaise,,2021,Q4,1,I,20211113.0,20211204.0,20211217,20211217,EXP,,FR-AUROBINDO-AUR-APL-2021-050958,AUROBINDO,,84.0,YR,,M,Y,,,20211217.0,,CN,FR,FR,2021,Q4,Elderly
201978331,20197833,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (1 tablet in a day)",,,U,,,,,,,Tablet,QD,2021,Q4,Pain,,2021,Q4,1,I,20210826.0,20211210.0,20211217,20211217,EXP,DE-EMA-20211029-AUTODUP-1635459173137,NVSC2021DE285108,NOVARTIS,,52.0,YR,,M,Y,,,20211217.0,,MD,DE,DE,2021,Q4,Adult
201978331,20197833,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (1 tablet in a day)",,,U,,,,,,,Tablet,QD,2021,Q4,Herpes zoster,,2021,Q4,1,I,20210826.0,20211210.0,20211217,20211217,EXP,DE-EMA-20211029-AUTODUP-1635459173137,NVSC2021DE285108,NOVARTIS,,52.0,YR,,M,Y,,,20211217.0,,MD,DE,DE,2021,Q4,Adult
201978331,20197833,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (1 tablet in a day)",,,U,,,,,,,Tablet,QD,2021,Q4,Vaccination failure,,2021,Q4,1,I,20210826.0,20211210.0,20211217,20211217,EXP,DE-EMA-20211029-AUTODUP-1635459173137,NVSC2021DE285108,NOVARTIS,,52.0,YR,,M,Y,,,20211217.0,,MD,DE,DE,2021,Q4,Adult
201978331,20197833,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (1 tablet in a day)",,,U,,,,,,,Tablet,QD,2021,Q4,Rash,,2021,Q4,1,I,20210826.0,20211210.0,20211217,20211217,EXP,DE-EMA-20211029-AUTODUP-1635459173137,NVSC2021DE285108,NOVARTIS,,52.0,YR,,M,Y,,,20211217.0,,MD,DE,DE,2021,Q4,Adult
201991951,20199195,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25.0,MG,Y,,2104151,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Urine ketone body present,,2021,Q4,1,I,20211125.0,20211209.0,20211217,20211217,EXP,,CN-AstraZeneca-2021A872153,ASTRAZENECA,,19902.0,DY,,M,Y,65.0,KG,20211217.0,,MD,CN,,2021,Q4,Elderly
201991951,20199195,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25.0,MG,Y,,2104151,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Blood ketone body increased,,2021,Q4,1,I,20211125.0,20211209.0,20211217,20211217,EXP,,CN-AstraZeneca-2021A872153,ASTRAZENECA,,19902.0,DY,,M,Y,65.0,KG,20211217.0,,MD,CN,,2021,Q4,Elderly
202003981,20200398,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20190501.0,20211212.0,20211217,20211217,EXP,GB-MHRA-EYC 00268465,GB-drreddys-SPO/UKI/21/0144838,DR REDDYS,,78.0,YR,E,F,Y,,,20211217.0,,PH,GB,GB,2021,Q4,Elderly
202003981,20200398,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,10.0,MG,Tablet,QD,2021,Q4,Atrioventricular block complete,,2021,Q4,1,I,20190501.0,20211212.0,20211217,20211217,EXP,GB-MHRA-EYC 00268465,GB-drreddys-SPO/UKI/21/0144838,DR REDDYS,,78.0,YR,E,F,Y,,,20211217.0,,PH,GB,GB,2021,Q4,Elderly
202003981,20200398,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,10.0,MG,Tablet,QD,2021,Q4,Hypomagnesaemia,,2021,Q4,1,I,20190501.0,20211212.0,20211217,20211217,EXP,GB-MHRA-EYC 00268465,GB-drreddys-SPO/UKI/21/0144838,DR REDDYS,,78.0,YR,E,F,Y,,,20211217.0,,PH,GB,GB,2021,Q4,Elderly
202003981,20200398,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,10.0,MG,Tablet,QD,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,20190501.0,20211212.0,20211217,20211217,EXP,GB-MHRA-EYC 00268465,GB-drreddys-SPO/UKI/21/0144838,DR REDDYS,,78.0,YR,E,F,Y,,,20211217.0,,PH,GB,GB,2021,Q4,Elderly
202003981,20200398,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,10.0,MG,Tablet,QD,2021,Q4,Hypocalcaemia,,2021,Q4,1,I,20190501.0,20211212.0,20211217,20211217,EXP,GB-MHRA-EYC 00268465,GB-drreddys-SPO/UKI/21/0144838,DR REDDYS,,78.0,YR,E,F,Y,,,20211217.0,,PH,GB,GB,2021,Q4,Elderly
202004991,20200499,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,20211113.0,20211209.0,20211217,20211217,EXP,,FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2021-014758,VALIDUS,,84.0,YR,,M,Y,,,20211217.0,,CN,FR,FR,2021,Q4,Elderly
202004991,20200499,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Malaise,,2021,Q4,1,I,20211113.0,20211209.0,20211217,20211217,EXP,,FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2021-014758,VALIDUS,,84.0,YR,,M,Y,,,20211217.0,,CN,FR,FR,2021,Q4,Elderly
202032922,20203292,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Q24H",,,D,,,,,,,,,2021,Q4,Diabetes mellitus,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Q24H",,,D,,,,,,,,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Q24H",,,D,,,,,,,,,2021,Q4,Cardiac failure,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Q24H",,,D,,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Q24H",,,D,,,,,,,,,2021,Q4,COVID-19,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Q24H",,,D,,,,,,,,,2021,Q4,Infarction,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Diabetes mellitus,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Cardiac failure,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,COVID-19,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Infarction,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Diabetes mellitus,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Cardiac failure,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,COVID-19,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Infarction,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Diabetes mellitus,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Cardiac failure,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,COVID-19,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202032922,20203292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2021,Q4,Infarction,,2021,Q4,2,F,20211121.0,20211221.0,20211218,20211227,EXP,,NVSC2021MX290641,NOVARTIS,,63.0,YR,,M,Y,80.0,KG,20211227.0,,CN,MX,MX,2021,Q4,Adult
202033201,20203320,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK (One tablet daily after dinner),,,,,,,,,,Tablet,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20211122.0,20211211.0,20211218,20211218,EXP,,NVSC2021EG286362,NOVARTIS,,76.0,YR,,M,Y,,,20211218.0,,CN,EG,EG,2021,Q4,Elderly
202033201,20203320,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK (One tablet daily after dinner),,,,,,,,,,Tablet,,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20211122.0,20211211.0,20211218,20211218,EXP,,NVSC2021EG286362,NOVARTIS,,76.0,YR,,M,Y,,,20211218.0,,CN,EG,EG,2021,Q4,Elderly
202033201,20203320,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK (One tablet daily after dinner),,,,,,,,,,Tablet,,2021,Q4,Insomnia,,2021,Q4,1,I,20211122.0,20211211.0,20211218,20211218,EXP,,NVSC2021EG286362,NOVARTIS,,76.0,YR,,M,Y,,,20211218.0,,CN,EG,EG,2021,Q4,Elderly
202033201,20203320,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK (One tablet daily after dinner),,,,,,,,,,Tablet,,2021,Q4,High density lipoprotein decreased,,2021,Q4,1,I,20211122.0,20211211.0,20211218,20211218,EXP,,NVSC2021EG286362,NOVARTIS,,76.0,YR,,M,Y,,,20211218.0,,CN,EG,EG,2021,Q4,Elderly
202036931,20203693,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Alopecia universalis,,2021,Q4,1,I,,20210705.0,20211219,20211219,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-04434,ALKEM,"Kohlmann J, Ferrer RA, Markovic A, Illes M, et.al. Alopecia areata universalis under treatment with sitagliptin : Possible immunological effect of dipeptidyl peptidase-4 inhibitors?. Hautarzt. 2021;72(7):607-609",64.0,YR,,M,Y,,,20211220.0,,HP,DE,DE,2021,Q4,Adult
202042021,20204202,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,Y,U,,,,10.0,MG,,QD,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211101.0,20211208.0,20211220,20211220,EXP,DK-DKMA-WBS-0092116,DK-NOVOPROD-874467,NOVO NORDISK,,69.0,YR,,M,Y,,,20211220.0,,MD,DK,DK,2021,Q4,Elderly
202042021,20204202,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,Y,U,,,,10.0,MG,,QD,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,20211101.0,20211208.0,20211220,20211220,EXP,DK-DKMA-WBS-0092116,DK-NOVOPROD-874467,NOVO NORDISK,,69.0,YR,,M,Y,,,20211220.0,,MD,DK,DK,2021,Q4,Elderly
202042021,20204202,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,Y,U,,,,10.0,MG,,QD,2021,Q4,Respiratory disorder,,2021,Q4,1,I,20211101.0,20211208.0,20211220,20211220,EXP,DK-DKMA-WBS-0092116,DK-NOVOPROD-874467,NOVO NORDISK,,69.0,YR,,M,Y,,,20211220.0,,MD,DK,DK,2021,Q4,Elderly
202042021,20204202,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,Y,U,,,,10.0,MG,,QD,2021,Q4,Pulmonary embolism,,2021,Q4,1,I,20211101.0,20211208.0,20211220,20211220,EXP,DK-DKMA-WBS-0092116,DK-NOVOPROD-874467,NOVO NORDISK,,69.0,YR,,M,Y,,,20211220.0,,MD,DK,DK,2021,Q4,Elderly
202042021,20204202,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,Y,U,,,,10.0,MG,,QD,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20211101.0,20211208.0,20211220,20211220,EXP,DK-DKMA-WBS-0092116,DK-NOVOPROD-874467,NOVO NORDISK,,69.0,YR,,M,Y,,,20211220.0,,MD,DK,DK,2021,Q4,Elderly
202042021,20204202,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,Y,U,,,,10.0,MG,,QD,2021,Q4,Rales,,2021,Q4,1,I,20211101.0,20211208.0,20211220,20211220,EXP,DK-DKMA-WBS-0092116,DK-NOVOPROD-874467,NOVO NORDISK,,69.0,YR,,M,Y,,,20211220.0,,MD,DK,DK,2021,Q4,Elderly
202043541,20204354,6,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5/1000 12/12 h,,,,,,,,,,,,2021,Q4,Angioplasty,,2021,Q4,1,I,20211021.0,20211209.0,20211220,20211220,EXP,,BR-NOVOPROD-876301,NOVO NORDISK,,61.0,YR,,M,Y,106.2,KG,20211220.0,,MD,BR,BR,2021,Q4,Adult
202066821,20206682,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10,,,Y,,,,202293.0,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20211209.0,20211216.0,20211220,20211220,EXP,,GB-AstraZeneca-2021A881663,ASTRAZENECA,,61.0,YR,,F,Y,,,20211220.0,,MD,GB,,2021,Q4,Adult
202066841,20206684,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,20190101.0,20211210.0,20211220,20211220,EXP,,GR-AstraZeneca-2021A867691,ASTRAZENECA,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal failure in the context of antidiabetic treatment with dapagliflozin and metformin.. Case presentation. Hellenic Diabetological Chronicles 2020;33(2):135.",74.0,YR,,F,Y,,,20211220.0,,MD,GR,,2021,Q4,Elderly
202066841,20206684,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20190101.0,20211210.0,20211220,20211220,EXP,,GR-AstraZeneca-2021A867691,ASTRAZENECA,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal failure in the context of antidiabetic treatment with dapagliflozin and metformin.. Case presentation. Hellenic Diabetological Chronicles 2020;33(2):135.",74.0,YR,,F,Y,,,20211220.0,,MD,GR,,2021,Q4,Elderly
202066841,20206684,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20190101.0,20211210.0,20211220,20211220,EXP,,GR-AstraZeneca-2021A867691,ASTRAZENECA,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal failure in the context of antidiabetic treatment with dapagliflozin and metformin.. Case presentation. Hellenic Diabetological Chronicles 2020;33(2):135.",74.0,YR,,F,Y,,,20211220.0,,MD,GR,,2021,Q4,Elderly
202066841,20206684,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,20190101.0,20211210.0,20211220,20211220,EXP,,GR-AstraZeneca-2021A867691,ASTRAZENECA,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal failure in the context of antidiabetic treatment with dapagliflozin and metformin.. Case presentation. Hellenic Diabetological Chronicles 2020;33(2):135.",74.0,YR,,F,Y,,,20211220.0,,MD,GR,,2021,Q4,Elderly
202066841,20206684,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,,,2021,Q4,Acidosis,,2021,Q4,1,I,20190101.0,20211210.0,20211220,20211220,EXP,,GR-AstraZeneca-2021A867691,ASTRAZENECA,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal failure in the context of antidiabetic treatment with dapagliflozin and metformin.. Case presentation. Hellenic Diabetological Chronicles 2020;33(2):135.",74.0,YR,,F,Y,,,20211220.0,,MD,GR,,2021,Q4,Elderly
202067691,20206769,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,U,UNKNOWN,,,900.0,MG,Tablet,TID,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211215.0,20211220,20211220,EXP,,DE-drreddys-SPO/GER/21/0144954,DR REDDYS,,69.0,YR,E,M,Y,86.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202067691,20206769,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,U,UNKNOWN,,,900.0,MG,Tablet,TID,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211215.0,20211220,20211220,EXP,,DE-drreddys-SPO/GER/21/0144954,DR REDDYS,,69.0,YR,E,M,Y,86.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202067691,20206769,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,U,UNKNOWN,,,900.0,MG,Tablet,TID,2021,Q4,Pain,,2021,Q4,1,I,,20211215.0,20211220,20211220,EXP,,DE-drreddys-SPO/GER/21/0144954,DR REDDYS,,69.0,YR,E,M,Y,86.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202067691,20206769,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,U,UNKNOWN,,,900.0,MG,Tablet,TID,2021,Q4,Nausea,,2021,Q4,1,I,,20211215.0,20211220,20211220,EXP,,DE-drreddys-SPO/GER/21/0144954,DR REDDYS,,69.0,YR,E,M,Y,86.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202067691,20206769,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,U,U,UNKNOWN,,,900.0,MG,Tablet,TID,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211215.0,20211220,20211220,EXP,,DE-drreddys-SPO/GER/21/0144954,DR REDDYS,,69.0,YR,E,M,Y,86.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202069281,20206928,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211213.0,20211220,20211220,EXP,,NL-MYLANLABS-2021M1092812,MYLAN,"Patel P., Patel T., Patil S., Patel S., Ross Ang J.. CONSIDERATIONS FOR SODIUM-GLUCOSE TRANSPORTER 2 INHIBITOR THERAPY RESULTING IN EUGLYCEMIC DIABETIC KETOACIDOSIS. Chest. 2021;160 (4):981A-982A",40.0,YR,,M,Y,,,20211220.0,,HP,NL,NL,2021,Q4,Adult
202075472,20207547,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Hypomagnesaemia,,2021,Q4,2,F,20190509.0,20211222.0,20211220,20211229,EXP,GB-MHRA-EYC 00268465,GB-MYLANLABS-2021M1092770,MYLAN,,78.0,YR,,F,Y,,,20211229.0,,PH,GB,GB,2021,Q4,Elderly
202075472,20207547,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,2,F,20190509.0,20211222.0,20211220,20211229,EXP,GB-MHRA-EYC 00268465,GB-MYLANLABS-2021M1092770,MYLAN,,78.0,YR,,F,Y,,,20211229.0,,PH,GB,GB,2021,Q4,Elderly
202075472,20207547,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Atrioventricular block complete,,2021,Q4,2,F,20190509.0,20211222.0,20211220,20211229,EXP,GB-MHRA-EYC 00268465,GB-MYLANLABS-2021M1092770,MYLAN,,78.0,YR,,F,Y,,,20211229.0,,PH,GB,GB,2021,Q4,Elderly
202075472,20207547,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Hypocalcaemia,,2021,Q4,2,F,20190509.0,20211222.0,20211220,20211229,EXP,GB-MHRA-EYC 00268465,GB-MYLANLABS-2021M1092770,MYLAN,,78.0,YR,,F,Y,,,20211229.0,,PH,GB,GB,2021,Q4,Elderly
202075472,20207547,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Left ventricular dysfunction,,2021,Q4,2,F,20190509.0,20211222.0,20211220,20211229,EXP,GB-MHRA-EYC 00268465,GB-MYLANLABS-2021M1092770,MYLAN,,78.0,YR,,F,Y,,,20211229.0,,PH,GB,GB,2021,Q4,Elderly
202076581,20207658,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd, (Vormedikation von Ambulanz)",,,,,,,,10.0,MG,Film-coated tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211114.0,20211216.0,20211220,20211220,EXP,DE-BFARM-21010717,DE-MYLANLABS-2021M1094224,MYLAN,,63.0,YR,,F,Y,70.0,KG,20211220.0,,MD,DE,DE,2021,Q4,Adult
202076721,20207672,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Skin exfoliation,,2021,Q4,1,I,20211123.0,20211211.0,20211220,20211220,EXP,GB-MHRA-EYC 00268388,GB-PFIZER INC-202101769011,PFIZER,,52.0,YR,,F,Y,88.0,KG,20211220.0,,CN,GB,GB,2021,Q4,Adult
202076721,20207672,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20211123.0,20211211.0,20211220,20211220,EXP,GB-MHRA-EYC 00268388,GB-PFIZER INC-202101769011,PFIZER,,52.0,YR,,F,Y,88.0,KG,20211220.0,,CN,GB,GB,2021,Q4,Adult
202076721,20207672,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,1,I,20211123.0,20211211.0,20211220,20211220,EXP,GB-MHRA-EYC 00268388,GB-PFIZER INC-202101769011,PFIZER,,52.0,YR,,F,Y,88.0,KG,20211220.0,,CN,GB,GB,2021,Q4,Adult
202076721,20207672,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Hypersensitivity,,2021,Q4,1,I,20211123.0,20211211.0,20211220,20211220,EXP,GB-MHRA-EYC 00268388,GB-PFIZER INC-202101769011,PFIZER,,52.0,YR,,F,Y,88.0,KG,20211220.0,,CN,GB,GB,2021,Q4,Adult
202076721,20207672,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Contusion,,2021,Q4,1,I,20211123.0,20211211.0,20211220,20211220,EXP,GB-MHRA-EYC 00268388,GB-PFIZER INC-202101769011,PFIZER,,52.0,YR,,F,Y,88.0,KG,20211220.0,,CN,GB,GB,2021,Q4,Adult
202076721,20207672,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,20211123.0,20211211.0,20211220,20211220,EXP,GB-MHRA-EYC 00268388,GB-PFIZER INC-202101769011,PFIZER,,52.0,YR,,F,Y,88.0,KG,20211220.0,,CN,GB,GB,2021,Q4,Adult
202084061,20208406,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Skin exfoliation,,2021,Q4,1,I,20211123.0,20211210.0,20211220,20211220,EXP,GB-MHRA-EYC 00268388,GB-TEVA-2021-GB-1988177,TEVA,,52.0,YR,A,F,Y,88.0,KG,20211220.0,,CN,GB,GB,2021,Q4,Adult
202084061,20208406,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Contusion,,2021,Q4,1,I,20211123.0,20211210.0,20211220,20211220,EXP,GB-MHRA-EYC 00268388,GB-TEVA-2021-GB-1988177,TEVA,,52.0,YR,A,F,Y,88.0,KG,20211220.0,,CN,GB,GB,2021,Q4,Adult
202084061,20208406,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,20211123.0,20211210.0,20211220,20211220,EXP,GB-MHRA-EYC 00268388,GB-TEVA-2021-GB-1988177,TEVA,,52.0,YR,A,F,Y,88.0,KG,20211220.0,,CN,GB,GB,2021,Q4,Adult
202084061,20208406,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Hypersensitivity,,2021,Q4,1,I,20211123.0,20211210.0,20211220,20211220,EXP,GB-MHRA-EYC 00268388,GB-TEVA-2021-GB-1988177,TEVA,,52.0,YR,A,F,Y,88.0,KG,20211220.0,,CN,GB,GB,2021,Q4,Adult
202084061,20208406,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,1,I,20211123.0,20211210.0,20211220,20211220,EXP,GB-MHRA-EYC 00268388,GB-TEVA-2021-GB-1988177,TEVA,,52.0,YR,A,F,Y,88.0,KG,20211220.0,,CN,GB,GB,2021,Q4,Adult
202084061,20208406,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20211123.0,20211210.0,20211220,20211220,EXP,GB-MHRA-EYC 00268388,GB-TEVA-2021-GB-1988177,TEVA,,52.0,YR,A,F,Y,88.0,KG,20211220.0,,CN,GB,GB,2021,Q4,Adult
202094171,20209417,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Skin exfoliation,,2021,Q4,1,I,20211123.0,20211210.0,20211220,20211220,EXP,,GB-AUROBINDO-AUR-APL-2021-051765,AUROBINDO,,52.0,YR,,F,Y,88.0,KG,20211221.0,,CN,GB,GB,2021,Q4,Adult
202094171,20209417,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Hypersensitivity,,2021,Q4,1,I,20211123.0,20211210.0,20211220,20211220,EXP,,GB-AUROBINDO-AUR-APL-2021-051765,AUROBINDO,,52.0,YR,,F,Y,88.0,KG,20211221.0,,CN,GB,GB,2021,Q4,Adult
202094171,20209417,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Contusion,,2021,Q4,1,I,20211123.0,20211210.0,20211220,20211220,EXP,,GB-AUROBINDO-AUR-APL-2021-051765,AUROBINDO,,52.0,YR,,F,Y,88.0,KG,20211221.0,,CN,GB,GB,2021,Q4,Adult
202094171,20209417,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,1,I,20211123.0,20211210.0,20211220,20211220,EXP,,GB-AUROBINDO-AUR-APL-2021-051765,AUROBINDO,,52.0,YR,,F,Y,88.0,KG,20211221.0,,CN,GB,GB,2021,Q4,Adult
202094171,20209417,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20211123.0,20211210.0,20211220,20211220,EXP,,GB-AUROBINDO-AUR-APL-2021-051765,AUROBINDO,,52.0,YR,,F,Y,88.0,KG,20211221.0,,CN,GB,GB,2021,Q4,Adult
202094171,20209417,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,20211123.0,20211210.0,20211220,20211220,EXP,,GB-AUROBINDO-AUR-APL-2021-051765,AUROBINDO,,52.0,YR,,F,Y,88.0,KG,20211221.0,,CN,GB,GB,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Body mass index increased,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Polyuria,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Limb discomfort,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Chronic kidney disease,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Mitral valve incompetence,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Dyspnoea paroxysmal nocturnal,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Hypervolaemia,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Bundle branch block left,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Orthopnoea,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Cardiomyopathy,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Histamine level increased,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Echocardiogram abnormal,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Palpitations,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Ejection fraction decreased,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107211,20210721,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211208.0,20211221,20211221,EXP,,NVSC2021AU284342,NOVARTIS,,50.0,YR,,M,Y,,,20211221.0,,MD,AU,AU,2021,Q4,Adult
202107971,20210797,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5|850 mg, 1-1-0.5-0",,,U,,,,,,,Tablet,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286017,NOVARTIS,,69.0,YR,,M,Y,86.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202107971,20210797,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5|850 mg, 1-1-0.5-0",,,U,,,,,,,Tablet,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286017,NOVARTIS,,69.0,YR,,M,Y,86.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202107971,20210797,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5|850 mg, 1-1-0.5-0",,,U,,,,,,,Tablet,,2021,Q4,Pain,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286017,NOVARTIS,,69.0,YR,,M,Y,86.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202107971,20210797,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5|850 mg, 1-1-0.5-0",,,U,,,,,,,Tablet,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286017,NOVARTIS,,69.0,YR,,M,Y,86.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202107971,20210797,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5|850 mg, 1-1-0.5-0",,,U,,,,,,,Tablet,,2021,Q4,Nausea,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286017,NOVARTIS,,69.0,YR,,M,Y,86.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202117401,20211740,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10,mg,daily",1220.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Polycythaemia,,2021,Q4,1,I,20161001.0,20211216.0,20211221,20211221,EXP,,FI-AstraZeneca-2021A878497,ASTRAZENECA,,64.0,YR,,M,Y,,,20211221.0,,MD,FI,,2021,Q4,Adult
202132131,20213213,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,,QD,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421841,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202132131,20213213,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,,QD,2021,Q4,Gastrointestinal haemorrhage,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421841,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202132131,20213213,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,,QD,2021,Q4,Balance disorder,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421841,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202132131,20213213,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,,QD,2021,Q4,Anaemia,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421841,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202132131,20213213,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211215.0,20211221,20211221,EXP,,DE-SA-2021SA421841,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202133361,20213336,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,,,,,,10.0,MG,Tablet,QD,2021,Q4,Duodenitis,,2021,Q4,1,I,20211203.0,20211213.0,20211221,20211221,EXP,,GB-AstraZeneca-2021A855326,ASTRAZENECA,,26002.0,DY,,M,Y,,,20211221.0,,MD,GB,,2021,Q4,Elderly
202133361,20213336,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,,,,,,10.0,MG,Tablet,QD,2021,Q4,Diarrhoea haemorrhagic,,2021,Q4,1,I,20211203.0,20211213.0,20211221,20211221,EXP,,GB-AstraZeneca-2021A855326,ASTRAZENECA,,26002.0,DY,,M,Y,,,20211221.0,,MD,GB,,2021,Q4,Elderly
202133471,20213347,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5 mg / 850 mg, x2.5 qd (1-1-0.5-0)",,,,,,,,,,,QD,2021,Q4,Pain,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,DE-ADRED-07485-01,DE-DSJP-DSE-2021-141665,DAIICHI,,69.0,YR,,M,Y,86.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202133471,20213347,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5 mg / 850 mg, x2.5 qd (1-1-0.5-0)",,,,,,,,,,,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,DE-ADRED-07485-01,DE-DSJP-DSE-2021-141665,DAIICHI,,69.0,YR,,M,Y,86.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202133471,20213347,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5 mg / 850 mg, x2.5 qd (1-1-0.5-0)",,,,,,,,,,,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,DE-ADRED-07485-01,DE-DSJP-DSE-2021-141665,DAIICHI,,69.0,YR,,M,Y,86.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202133471,20213347,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5 mg / 850 mg, x2.5 qd (1-1-0.5-0)",,,,,,,,,,,QD,2021,Q4,Nausea,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,DE-ADRED-07485-01,DE-DSJP-DSE-2021-141665,DAIICHI,,69.0,YR,,M,Y,86.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202133471,20213347,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5 mg / 850 mg, x2.5 qd (1-1-0.5-0)",,,,,,,,,,,QD,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,DE-ADRED-07485-01,DE-DSJP-DSE-2021-141665,DAIICHI,,69.0,YR,,M,Y,86.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202137041,20213704,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2021,Q4,Renal cyst,,2021,Q4,1,I,20210901.0,20211213.0,20211221,20211221,EXP,,RU-AstraZeneca-2021A887007,ASTRAZENECA,,65.0,YR,,F,Y,,,20211221.0,,HP,RU,,2021,Q4,Elderly
202137041,20213704,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2021,Q4,Weight decreased,,2021,Q4,1,I,20210901.0,20211213.0,20211221,20211221,EXP,,RU-AstraZeneca-2021A887007,ASTRAZENECA,,65.0,YR,,F,Y,,,20211221.0,,HP,RU,,2021,Q4,Elderly
202138091,20213809,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,10.0,MG,,QD,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,GR-EMD Serono-9287742,EMD SERONO INC,"Roidi D, Maragkouti E, Mougjouli T. IMMEDIATE POSTOPERATIVE EUGLYCEMIC DIABETIC KETOACIDOSIS IN PATIENT WITH ANTIDIABETIC TREATMENT WITH DAPAGLIFLOZIN 30 SEPTEMBER-2 OCTOBER 2021. The 24th PANHELLENIC CONGRESS OF ANAESTHESIOLOGY, 30 SEPTEMBER-2 OCTOBER 2021. 2021;.",63.0,YR,A,F,Y,80.0,KG,20211221.0,,MD,GR,,2021,Q4,Adult
202149051,20214905,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK (10 mg, 1-0-0-0)",,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052304,AUROBINDO,,68.0,YR,,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202149051,20214905,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK (10 mg, 1-0-0-0)",,,,,,,,,,,,2021,Q4,Gastrointestinal haemorrhage,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052304,AUROBINDO,,68.0,YR,,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202149051,20214905,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK (10 mg, 1-0-0-0)",,,,,,,,,,,,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052304,AUROBINDO,,68.0,YR,,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202149051,20214905,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK (10 mg, 1-0-0-0)",,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052304,AUROBINDO,,68.0,YR,,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202149051,20214905,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK (10 mg, 1-0-0-0)",,,,,,,,,,,,2021,Q4,Balance disorder,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052304,AUROBINDO,,68.0,YR,,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202158241,20215824,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (10 mg, 1-0-0-0, tablets)",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Anaemia,,2021,Q4,1,I,,20211214.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052606,AUROBINDO,,45.0,YR,,M,Y,82.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Adult
202158241,20215824,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (10 mg, 1-0-0-0, tablets)",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,International normalised ratio abnormal,,2021,Q4,1,I,,20211214.0,20211222,20211222,EXP,,DE-AUROBINDO-AUR-APL-2021-052606,AUROBINDO,,45.0,YR,,M,Y,82.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Adult
202160501,20216050,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; each morning, continued",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,20190501.0,20211212.0,20211222,20211222,EXP,GB-MHRA-EYC 00268465,GB-TEVA-2021-GB-1988769,TEVA,,78.0,YR,E,F,Y,,,20211222.0,,PH,GB,GB,2021,Q4,Elderly
202160501,20216050,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; each morning, continued",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Atrioventricular block complete,,2021,Q4,1,I,20190501.0,20211212.0,20211222,20211222,EXP,GB-MHRA-EYC 00268465,GB-TEVA-2021-GB-1988769,TEVA,,78.0,YR,E,F,Y,,,20211222.0,,PH,GB,GB,2021,Q4,Elderly
202160501,20216050,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; each morning, continued",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20190501.0,20211212.0,20211222,20211222,EXP,GB-MHRA-EYC 00268465,GB-TEVA-2021-GB-1988769,TEVA,,78.0,YR,E,F,Y,,,20211222.0,,PH,GB,GB,2021,Q4,Elderly
202160501,20216050,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; each morning, continued",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Hypocalcaemia,,2021,Q4,1,I,20190501.0,20211212.0,20211222,20211222,EXP,GB-MHRA-EYC 00268465,GB-TEVA-2021-GB-1988769,TEVA,,78.0,YR,E,F,Y,,,20211222.0,,PH,GB,GB,2021,Q4,Elderly
202160501,20216050,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; each morning, continued",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Hypomagnesaemia,,2021,Q4,1,I,20190501.0,20211212.0,20211222,20211222,EXP,GB-MHRA-EYC 00268465,GB-TEVA-2021-GB-1988769,TEVA,,78.0,YR,E,F,Y,,,20211222.0,,PH,GB,GB,2021,Q4,Elderly
202160851,20216085,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Atrioventricular block complete,,2021,Q4,1,I,20190501.0,20211212.0,20211222,20211222,EXP,GB-MHRA-ADR 26298128,GB-Accord-247618,ACCORD,,78.0,YR,,F,Y,,,20211222.0,,PH,GB,GB,2021,Q4,Elderly
202160851,20216085,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Hypomagnesaemia,,2021,Q4,1,I,20190501.0,20211212.0,20211222,20211222,EXP,GB-MHRA-ADR 26298128,GB-Accord-247618,ACCORD,,78.0,YR,,F,Y,,,20211222.0,,PH,GB,GB,2021,Q4,Elderly
202160851,20216085,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,20190501.0,20211212.0,20211222,20211222,EXP,GB-MHRA-ADR 26298128,GB-Accord-247618,ACCORD,,78.0,YR,,F,Y,,,20211222.0,,PH,GB,GB,2021,Q4,Elderly
202160851,20216085,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Hypocalcaemia,,2021,Q4,1,I,20190501.0,20211212.0,20211222,20211222,EXP,GB-MHRA-ADR 26298128,GB-Accord-247618,ACCORD,,78.0,YR,,F,Y,,,20211222.0,,PH,GB,GB,2021,Q4,Elderly
202160851,20216085,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20190501.0,20211212.0,20211222,20211222,EXP,GB-MHRA-ADR 26298128,GB-Accord-247618,ACCORD,,78.0,YR,,F,Y,,,20211222.0,,PH,GB,GB,2021,Q4,Elderly
202168631,20216863,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,360.0,MG,U,,,,202293.0,10.0,MG,,QD,2021,Q4,Muscle atrophy,,2021,Q4,1,I,20210706.0,20211214.0,20211222,20211222,EXP,,FR-AstraZeneca-2021A871932,ASTRAZENECA,,68.0,YR,,F,Y,,,20211222.0,,MD,FR,,2021,Q4,Elderly
202168631,20216863,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,360.0,MG,U,,,,202293.0,10.0,MG,,QD,2021,Q4,Weight decreased,,2021,Q4,1,I,20210706.0,20211214.0,20211222,20211222,EXP,,FR-AstraZeneca-2021A871932,ASTRAZENECA,,68.0,YR,,F,Y,,,20211222.0,,MD,FR,,2021,Q4,Elderly
202168631,20216863,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,360.0,MG,U,,,,202293.0,10.0,MG,,QD,2021,Q4,Myalgia,,2021,Q4,1,I,20210706.0,20211214.0,20211222,20211222,EXP,,FR-AstraZeneca-2021A871932,ASTRAZENECA,,68.0,YR,,F,Y,,,20211222.0,,MD,FR,,2021,Q4,Elderly
202168631,20216863,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,360.0,MG,U,,,,202293.0,10.0,MG,,QD,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210706.0,20211214.0,20211222,20211222,EXP,,FR-AstraZeneca-2021A871932,ASTRAZENECA,,68.0,YR,,F,Y,,,20211222.0,,MD,FR,,2021,Q4,Elderly
202168631,20216863,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,360.0,MG,U,,,,202293.0,10.0,MG,,QD,2021,Q4,Nausea,,2021,Q4,1,I,20210706.0,20211214.0,20211222,20211222,EXP,,FR-AstraZeneca-2021A871932,ASTRAZENECA,,68.0,YR,,F,Y,,,20211222.0,,MD,FR,,2021,Q4,Elderly
202168631,20216863,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,360.0,MG,U,,,,202293.0,10.0,MG,,QD,2021,Q4,Asthenia,,2021,Q4,1,I,20210706.0,20211214.0,20211222,20211222,EXP,,FR-AstraZeneca-2021A871932,ASTRAZENECA,,68.0,YR,,F,Y,,,20211222.0,,MD,FR,,2021,Q4,Elderly
202170381,20217038,6,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/850 mg, 1-1-0.5-0",,,U,,,,,,,Tablet,,2021,Q4,Nausea,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07485-01,DE-TORRENT-00021698,TORRENT,,69.0,YR,E,M,Y,86.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170381,20217038,6,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/850 mg, 1-1-0.5-0",,,U,,,,,,,Tablet,,2021,Q4,Pain,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07485-01,DE-TORRENT-00021698,TORRENT,,69.0,YR,E,M,Y,86.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170381,20217038,6,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/850 mg, 1-1-0.5-0",,,U,,,,,,,Tablet,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07485-01,DE-TORRENT-00021698,TORRENT,,69.0,YR,E,M,Y,86.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170381,20217038,6,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/850 mg, 1-1-0.5-0",,,U,,,,,,,Tablet,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07485-01,DE-TORRENT-00021698,TORRENT,,69.0,YR,E,M,Y,86.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170381,20217038,6,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/850 mg, 1-1-0.5-0",,,U,,,,,,,Tablet,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07485-01,DE-TORRENT-00021698,TORRENT,,69.0,YR,E,M,Y,86.0,KG,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170431,20217043,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,UNK,QD,2021,Q4,Anaemia,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07658-02,DE-TORRENT-00021707,TORRENT,,68.0,YR,E,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170431,20217043,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,UNK,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07658-02,DE-TORRENT-00021707,TORRENT,,68.0,YR,E,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170431,20217043,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,UNK,QD,2021,Q4,Balance disorder,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07658-02,DE-TORRENT-00021707,TORRENT,,68.0,YR,E,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170431,20217043,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,UNK,QD,2021,Q4,Gastrointestinal haemorrhage,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07658-02,DE-TORRENT-00021707,TORRENT,,68.0,YR,E,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202170431,20217043,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,UNK,QD,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-07658-02,DE-TORRENT-00021707,TORRENT,,68.0,YR,E,M,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202171111,20217111,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20210112.0,20211216.0,20211222,20211222,EXP,,SE-AstraZeneca-2021A878251,ASTRAZENECA,,51.0,YR,,M,Y,,,20211222.0,,MD,SE,,2021,Q4,Adult
202171111,20217111,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20210112.0,20211216.0,20211222,20211222,EXP,,SE-AstraZeneca-2021A878251,ASTRAZENECA,,51.0,YR,,M,Y,,,20211222.0,,MD,SE,,2021,Q4,Adult
202171111,20217111,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20210112.0,20211216.0,20211222,20211222,EXP,,SE-AstraZeneca-2021A878251,ASTRAZENECA,,51.0,YR,,M,Y,,,20211222.0,,MD,SE,,2021,Q4,Adult
202171111,20217111,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20210112.0,20211216.0,20211222,20211222,EXP,,SE-AstraZeneca-2021A878251,ASTRAZENECA,,51.0,YR,,M,Y,,,20211222.0,,MD,SE,,2021,Q4,Adult
202171111,20217111,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20210112.0,20211216.0,20211222,20211222,EXP,,SE-AstraZeneca-2021A878251,ASTRAZENECA,,51.0,YR,,M,Y,,,20211222.0,,MD,SE,,2021,Q4,Adult
202171111,20217111,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20210112.0,20211216.0,20211222,20211222,EXP,,SE-AstraZeneca-2021A878251,ASTRAZENECA,,51.0,YR,,M,Y,,,20211222.0,,MD,SE,,2021,Q4,Adult
202171151,20217115,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,U,,MP2444,,,10.0,MG,Tablet,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211017.0,20211213.0,20211222,20211222,EXP,,CN-AstraZeneca-2021A882411,ASTRAZENECA,,12419.0,DY,,M,Y,,,20211222.0,,MD,CN,,2021,Q4,Elderly
202183421,20218342,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,20140204,,,10.0,MG,Tablet,QD,2021,Q4,Micturition urgency,,2021,Q4,1,I,20211110.0,20211214.0,20211222,20211222,EXP,,CN-AstraZeneca-2021A882329,ASTRAZENECA,,84.0,YR,,F,Y,44.0,KG,20211222.0,,MD,CN,,2021,Q4,Elderly
202183421,20218342,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,20140204,,,10.0,MG,Tablet,QD,2021,Q4,Urinary tract infection,,2021,Q4,1,I,20211110.0,20211214.0,20211222,20211222,EXP,,CN-AstraZeneca-2021A882329,ASTRAZENECA,,84.0,YR,,F,Y,44.0,KG,20211222.0,,MD,CN,,2021,Q4,Elderly
202183421,20218342,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,20140204,,,10.0,MG,Tablet,QD,2021,Q4,Dysuria,,2021,Q4,1,I,20211110.0,20211214.0,20211222,20211222,EXP,,CN-AstraZeneca-2021A882329,ASTRAZENECA,,84.0,YR,,F,Y,44.0,KG,20211222.0,,MD,CN,,2021,Q4,Elderly
202183421,20218342,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,20140204,,,10.0,MG,Tablet,QD,2021,Q4,White blood cells urine positive,,2021,Q4,1,I,20211110.0,20211214.0,20211222,20211222,EXP,,CN-AstraZeneca-2021A882329,ASTRAZENECA,,84.0,YR,,F,Y,44.0,KG,20211222.0,,MD,CN,,2021,Q4,Elderly
202183421,20218342,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,20140204,,,10.0,MG,Tablet,QD,2021,Q4,Pollakiuria,,2021,Q4,1,I,20211110.0,20211214.0,20211222,20211222,EXP,,CN-AstraZeneca-2021A882329,ASTRAZENECA,,84.0,YR,,F,Y,44.0,KG,20211222.0,,MD,CN,,2021,Q4,Elderly
202193412,20219341,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"One tablet, QD",,,,,,,,,,Tablet,QD,2021,Q4,Ejection fraction decreased,,2021,Q4,2,F,20211004.0,20211225.0,20211222,20211231,EXP,,NVSC2021EG289688,NOVARTIS,,76.0,YR,,F,Y,,,20211231.0,,CN,EG,EG,2021,Q4,Elderly
202193412,20219341,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"One tablet, QD",,,,,,,,,,Tablet,QD,2021,Q4,Blood pressure fluctuation,,2021,Q4,2,F,20211004.0,20211225.0,20211222,20211231,EXP,,NVSC2021EG289688,NOVARTIS,,76.0,YR,,F,Y,,,20211231.0,,CN,EG,EG,2021,Q4,Elderly
202193412,20219341,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"One tablet, QD",,,,,,,,,,Tablet,QD,2021,Q4,Wrong technique in product usage process,,2021,Q4,2,F,20211004.0,20211225.0,20211222,20211231,EXP,,NVSC2021EG289688,NOVARTIS,,76.0,YR,,F,Y,,,20211231.0,,CN,EG,EG,2021,Q4,Elderly
202193412,20219341,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"One tablet, QD",,,,,,,,,,Tablet,QD,2021,Q4,Dyspnoea exertional,,2021,Q4,2,F,20211004.0,20211225.0,20211222,20211231,EXP,,NVSC2021EG289688,NOVARTIS,,76.0,YR,,F,Y,,,20211231.0,,CN,EG,EG,2021,Q4,Elderly
202193412,20219341,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"One tablet, QD",,,,,,,,,,Tablet,QD,2021,Q4,Cough,,2021,Q4,2,F,20211004.0,20211225.0,20211222,20211231,EXP,,NVSC2021EG289688,NOVARTIS,,76.0,YR,,F,Y,,,20211231.0,,CN,EG,EG,2021,Q4,Elderly
202201811,20220181,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day, each morning, continued",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,20190501.0,20211212.0,20211223,20211223,EXP,,GB-AUROBINDO-AUR-APL-2021-051946,AUROBINDO,,78.0,YR,,F,Y,,,20211223.0,,PH,GB,GB,2021,Q4,Elderly
202201811,20220181,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day, each morning, continued",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Hypocalcaemia,,2021,Q4,1,I,20190501.0,20211212.0,20211223,20211223,EXP,,GB-AUROBINDO-AUR-APL-2021-051946,AUROBINDO,,78.0,YR,,F,Y,,,20211223.0,,PH,GB,GB,2021,Q4,Elderly
202201811,20220181,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day, each morning, continued",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20190501.0,20211212.0,20211223,20211223,EXP,,GB-AUROBINDO-AUR-APL-2021-051946,AUROBINDO,,78.0,YR,,F,Y,,,20211223.0,,PH,GB,GB,2021,Q4,Elderly
202201811,20220181,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day, each morning, continued",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Atrioventricular block complete,,2021,Q4,1,I,20190501.0,20211212.0,20211223,20211223,EXP,,GB-AUROBINDO-AUR-APL-2021-051946,AUROBINDO,,78.0,YR,,F,Y,,,20211223.0,,PH,GB,GB,2021,Q4,Elderly
202201811,20220181,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day, each morning, continued",,,U,,,,,10.0,MG,Tablet,QD,2021,Q4,Hypomagnesaemia,,2021,Q4,1,I,20190501.0,20211212.0,20211223,20211223,EXP,,GB-AUROBINDO-AUR-APL-2021-051946,AUROBINDO,,78.0,YR,,F,Y,,,20211223.0,,PH,GB,GB,2021,Q4,Elderly
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Cardiac dysfunction,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Pleural effusion,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Seizure,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Ejection fraction decreased,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Blood creatine phosphokinase increased,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Body mass index increased,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Influenza like illness,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Cardiomyopathy,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Suspected COVID-19,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210011,20221001,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Dyslipidaemia,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07692,ALKEM,,18.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Youth
202210021,20221002,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Pleural effusion,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07695,ALKEM,,28.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Young Adult
202210021,20221002,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07695,ALKEM,,28.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Young Adult
202210021,20221002,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07695,ALKEM,,28.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Young Adult
202210021,20221002,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07695,ALKEM,,28.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Young Adult
202210021,20221002,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Cardiomyopathy,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07695,ALKEM,,28.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Young Adult
202210021,20221002,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Body mass index increased,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07695,ALKEM,,28.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Young Adult
202210021,20221002,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Cardiac dysfunction,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07695,ALKEM,,28.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Young Adult
202210021,20221002,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07695,ALKEM,,28.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Young Adult
202210021,20221002,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Ejection fraction decreased,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07695,ALKEM,,28.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Young Adult
202210021,20221002,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Blood creatine phosphokinase increased,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07695,ALKEM,,28.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Young Adult
202210021,20221002,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Seizure,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07695,ALKEM,,28.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Young Adult
202210021,20221002,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Dyslipidaemia,,2021,Q4,1,I,,20211208.0,20211223,20211223,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2021-07695,ALKEM,,28.0,YR,,M,Y,,,20211223.0,,HP,AU,AU,2021,Q4,Young Adult
202218091,20221809,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,MT3040,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Ketosis,,2021,Q4,1,I,20211208.0,20211215.0,20211223,20211223,EXP,,CN-AstraZeneca-2021A886502,ASTRAZENECA,,12214.0,DY,,M,Y,,,20211223.0,,MD,CN,,2021,Q4,Elderly
202220351,20222035,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Number of separate dosages unknown10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Pleural effusion,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,JP-AstraZeneca-2021A885788,ASTRAZENECA,,85.0,YR,,F,Y,,,20211223.0,,MD,JP,,2021,Q4,Elderly
202220351,20222035,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Number of separate dosages unknown10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,JP-AstraZeneca-2021A885788,ASTRAZENECA,,85.0,YR,,F,Y,,,20211223.0,,MD,JP,,2021,Q4,Elderly
202220351,20222035,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Number of separate dosages unknown10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,JP-AstraZeneca-2021A885788,ASTRAZENECA,,85.0,YR,,F,Y,,,20211223.0,,MD,JP,,2021,Q4,Elderly
202220351,20222035,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Number of separate dosages unknown10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2021,Q4,Dehydration,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,JP-AstraZeneca-2021A885788,ASTRAZENECA,,85.0,YR,,F,Y,,,20211223.0,,MD,JP,,2021,Q4,Elderly
202221011,20222101,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD (1-0-0-0, Tabletten)",,,U,,,,,5.0,MG,Tablet,QD,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211217.0,20211223,20211223,EXP,,NVSC2021DE291307,NOVARTIS,,78.0,YR,,F,Y,85.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202221011,20222101,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD (1-0-0-0, Tabletten)",,,U,,,,,5.0,MG,Tablet,QD,2021,Q4,Nausea,,2021,Q4,1,I,,20211217.0,20211223,20211223,EXP,,NVSC2021DE291307,NOVARTIS,,78.0,YR,,F,Y,85.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202221011,20222101,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD (1-0-0-0, Tabletten)",,,U,,,,,5.0,MG,Tablet,QD,2021,Q4,Dizziness,,2021,Q4,1,I,,20211217.0,20211223,20211223,EXP,,NVSC2021DE291307,NOVARTIS,,78.0,YR,,F,Y,85.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202222781,20222278,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,,2103096,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Transaminases increased,,2021,Q4,1,I,20211208.0,20211215.0,20211223,20211223,EXP,,CN-AstraZeneca-2021A882468,ASTRAZENECA,,77.0,YR,,M,Y,50.0,KG,20211223.0,,MD,CN,,2021,Q4,Elderly
202225372,20222537,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg for 2-3 months,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Epilepsy,,2021,Q4,2,F,20210710.0,20211222.0,20211223,20211230,EXP,,CN-AstraZeneca-2021A883036,ASTRAZENECA,,14435.0,DY,,M,Y,85.0,KG,20211230.0,,CN,CN,,2021,Q4,Elderly
202225372,20222537,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,one tablet at noon,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Epilepsy,,2021,Q4,2,F,20210710.0,20211222.0,20211223,20211230,EXP,,CN-AstraZeneca-2021A883036,ASTRAZENECA,,14435.0,DY,,M,Y,85.0,KG,20211230.0,,CN,CN,,2021,Q4,Elderly
202232391,20223239,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211214.0,20211223,20211223,EXP,,JP-AstraZeneca-2021A882485,ASTRAZENECA,,50.0,YR,,M,Y,,,20211223.0,,PH,JP,,2021,Q4,Adult
202234821,20223482,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,N,,,,202293.0,,,Tablet,,2021,Q4,Drug eruption,,2021,Q4,1,I,20211203.0,20211216.0,20211223,20211223,EXP,,GB-AstraZeneca-2021A881705,ASTRAZENECA,,56.0,YR,,M,Y,78.0,KG,20211223.0,,MD,GB,,2021,Q4,Adult
202235001,20223500,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Haematoma,,2021,Q4,1,I,20200806.0,20211221.0,20211223,20211223,EXP,,ES-MYLANLABS-2021M1065900,MYLAN,,77.0,YR,,M,Y,66.2,KG,20211223.0,,HP,ES,ES,2021,Q4,Elderly
202235001,20223500,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2021,Q4,Prescribed underdose,,2021,Q4,1,I,20200806.0,20211221.0,20211223,20211223,EXP,,ES-MYLANLABS-2021M1065900,MYLAN,,77.0,YR,,M,Y,66.2,KG,20211223.0,,HP,ES,ES,2021,Q4,Elderly
202235691,20223569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,,QD,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,20190501.0,20211212.0,20211223,20211223,EXP,GB-MHRA-EYC 00268465,GB-LABORATORIOS LICONSA S.A.-2112GB03217,INSUD PHARMA,,78.0,YR,,F,Y,,,20211223.0,,PH,GB,GB,2021,Q4,Elderly
202235691,20223569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,,QD,2021,Q4,Hypocalcaemia,,2021,Q4,1,I,20190501.0,20211212.0,20211223,20211223,EXP,GB-MHRA-EYC 00268465,GB-LABORATORIOS LICONSA S.A.-2112GB03217,INSUD PHARMA,,78.0,YR,,F,Y,,,20211223.0,,PH,GB,GB,2021,Q4,Elderly
202235691,20223569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,,QD,2021,Q4,Atrioventricular block complete,,2021,Q4,1,I,20190501.0,20211212.0,20211223,20211223,EXP,GB-MHRA-EYC 00268465,GB-LABORATORIOS LICONSA S.A.-2112GB03217,INSUD PHARMA,,78.0,YR,,F,Y,,,20211223.0,,PH,GB,GB,2021,Q4,Elderly
202235691,20223569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20190501.0,20211212.0,20211223,20211223,EXP,GB-MHRA-EYC 00268465,GB-LABORATORIOS LICONSA S.A.-2112GB03217,INSUD PHARMA,,78.0,YR,,F,Y,,,20211223.0,,PH,GB,GB,2021,Q4,Elderly
202235691,20223569,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,,QD,2021,Q4,Hypomagnesaemia,,2021,Q4,1,I,20190501.0,20211212.0,20211223,20211223,EXP,GB-MHRA-EYC 00268465,GB-LABORATORIOS LICONSA S.A.-2112GB03217,INSUD PHARMA,,78.0,YR,,F,Y,,,20211223.0,,PH,GB,GB,2021,Q4,Elderly
202237441,20223744,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",80.0,MG,Y,U,,,,10.0,MG,,QD,2021,Q4,Hypovolaemic shock,,2021,Q4,1,I,20211016.0,20211220.0,20211223,20211223,EXP,FR-AFSSAPS-PC20215239,FR-MYLANLABS-2021M1094710,MYLAN,,73.0,YR,,F,Y,43.0,KG,20211223.0,,MD,FR,FR,2021,Q4,Elderly
202237441,20223744,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",80.0,MG,Y,U,,,,10.0,MG,,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,20211016.0,20211220.0,20211223,20211223,EXP,FR-AFSSAPS-PC20215239,FR-MYLANLABS-2021M1094710,MYLAN,,73.0,YR,,F,Y,43.0,KG,20211223.0,,MD,FR,FR,2021,Q4,Elderly
202239381,20223938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Hypopituitarism,,2021,Q4,1,I,20210601.0,20211213.0,20211223,20211223,EXP,,JP-AstraZeneca-2021A882864,ASTRAZENECA,,24617.0,DY,,M,Y,73.0,KG,20211223.0,,MD,JP,,2021,Q4,Elderly
202239381,20223938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Adrenal insufficiency,,2021,Q4,1,I,20210601.0,20211213.0,20211223,20211223,EXP,,JP-AstraZeneca-2021A882864,ASTRAZENECA,,24617.0,DY,,M,Y,73.0,KG,20211223.0,,MD,JP,,2021,Q4,Elderly
202239381,20223938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,,,,,202293.0,5.0,MG,Tablet,QD,2021,Q4,Thyroiditis,,2021,Q4,1,I,20210601.0,20211213.0,20211223,20211223,EXP,,JP-AstraZeneca-2021A882864,ASTRAZENECA,,24617.0,DY,,M,Y,73.0,KG,20211223.0,,MD,JP,,2021,Q4,Elderly
202243412,20224341,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2021,Q4,Facial paresis,,2021,Q4,2,F,20211208.0,20211222.0,20211223,20211230,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112008119,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20211230.0,,CN,DE,DE,2021,Q4,Adult
202257481,20225748,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,,,,,2021,Q4,Postoperative wound infection,,2021,Q4,1,I,,20211214.0,20211224,20211224,EXP,,ZA-NOVOPROD-877470,NOVO NORDISK,,61.0,YR,,F,Y,,,20211224.0,,CN,ZA,ZA,2021,Q4,Adult
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Acne,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Colitis ulcerative,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Product dose omission issue,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Rash,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Balance disorder,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Somnolence,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Feeling drunk,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Petechiae,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Malaise,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Feeling jittery,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202259261,20225926,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Faeces soft,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046802,APOTEX,,69.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Elderly
202263361,20226336,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,U,,,,202293.0,10.0,MG,,QD,2021,Q4,Ketoacidosis,,2021,Q4,1,I,20211207.0,20211216.0,20211224,20211224,EXP,,DE-AstraZeneca-2021A878486,ASTRAZENECA,,64.0,YR,,M,Y,58.0,KG,20211224.0,,MD,DE,,2021,Q4,Adult
202263361,20226336,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,U,,,,202293.0,10.0,MG,,QD,2021,Q4,Coma,,2021,Q4,1,I,20211207.0,20211216.0,20211224,20211224,EXP,,DE-AstraZeneca-2021A878486,ASTRAZENECA,,64.0,YR,,M,Y,58.0,KG,20211224.0,,MD,DE,,2021,Q4,Adult
202263371,20226337,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNKNOWN,,,U,,,,202293.0,,,,,2021,Q4,Perineal abscess,,2021,Q4,1,I,20211208.0,20211216.0,20211224,20211224,EXP,,FR-AstraZeneca-2021A878575,ASTRAZENECA,,74.0,YR,,F,Y,68.0,KG,20211224.0,,MD,FR,,2021,Q4,Elderly
202264321,20226432,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,at night,,,,,,,,,,Tablet,QD,2021,Q4,Cataract,,2021,Q4,1,I,20210901.0,20211214.0,20211224,20211224,EXP,,BR-PFIZER INC-202101795614,PFIZER,,67.0,YR,,F,Y,,,20211224.0,,CN,BR,BR,2021,Q4,Elderly
202267861,20226786,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,,,2021,Q4,Hyponatraemia,,2021,Q4,1,I,20211201.0,20211216.0,20211224,20211224,EXP,,GB-AstraZeneca-2021A881621,ASTRAZENECA,,78.0,YR,,M,Y,73.4,KG,20211224.0,,MD,GB,,2021,Q4,Elderly
202277331,20227733,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,90.0,MG,Y,,2101204,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Fungal infection,,2021,Q4,1,I,20210603.0,20211217.0,20211224,20211224,EXP,,CN-AstraZeneca-2021A889720,ASTRAZENECA,,57.0,YR,,M,Y,75.0,KG,20211224.0,,MD,CN,,2021,Q4,Adult
202277331,20227733,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,90.0,MG,Y,,2101204,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Balanoposthitis,,2021,Q4,1,I,20210603.0,20211217.0,20211224,20211224,EXP,,CN-AstraZeneca-2021A889720,ASTRAZENECA,,57.0,YR,,M,Y,75.0,KG,20211224.0,,MD,CN,,2021,Q4,Adult
202279301,20227930,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"30 mg, QD",,,U,,,,,30.0,MG,,QD,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"30 mg, QD",,,U,,,,,30.0,MG,,QD,2021,Q4,Arrhythmia,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"30 mg, QD",,,U,,,,,30.0,MG,,QD,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"30 mg, QD",,,U,,,,,30.0,MG,,QD,2021,Q4,COVID-19 pneumonia,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"30 mg, QD",,,U,,,,,30.0,MG,,QD,2021,Q4,Palpitations,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"30 mg, QD",,,U,,,,,30.0,MG,,QD,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"30 mg, QD",,,U,,,,,30.0,MG,,QD,2021,Q4,Chronic kidney disease,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"30 mg, QD",,,U,,,,,30.0,MG,,QD,2021,Q4,COVID-19,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279801,20227980,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,once daily,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211221.0,20211224,20211224,EXP,,TR-AstraZeneca-2021A893042,ASTRAZENECA,"Cure E, Sirin H, Cure MC, Sahin DA.. Dapagliflozin-induced long-term and severe anorexia and weight loss: An extraordinary case. Indian J Pharmacol 2021;53:174-5.",47.0,YR,,F,Y,,,20211224.0,,MD,TR,,2021,Q4,Adult
202279801,20227980,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,once daily,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211221.0,20211224,20211224,EXP,,TR-AstraZeneca-2021A893042,ASTRAZENECA,"Cure E, Sirin H, Cure MC, Sahin DA.. Dapagliflozin-induced long-term and severe anorexia and weight loss: An extraordinary case. Indian J Pharmacol 2021;53:174-5.",47.0,YR,,F,Y,,,20211224.0,,MD,TR,,2021,Q4,Adult
202279801,20227980,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,once daily,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211221.0,20211224,20211224,EXP,,TR-AstraZeneca-2021A893042,ASTRAZENECA,"Cure E, Sirin H, Cure MC, Sahin DA.. Dapagliflozin-induced long-term and severe anorexia and weight loss: An extraordinary case. Indian J Pharmacol 2021;53:174-5.",47.0,YR,,F,Y,,,20211224.0,,MD,TR,,2021,Q4,Adult
202279801,20227980,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,once daily,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211221.0,20211224,20211224,EXP,,TR-AstraZeneca-2021A893042,ASTRAZENECA,"Cure E, Sirin H, Cure MC, Sahin DA.. Dapagliflozin-induced long-term and severe anorexia and weight loss: An extraordinary case. Indian J Pharmacol 2021;53:174-5.",47.0,YR,,F,Y,,,20211224.0,,MD,TR,,2021,Q4,Adult
202279801,20227980,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,once daily,,,Y,,,,202293.0,,,Tablet,,2021,Q4,Ulcerative gastritis,,2021,Q4,1,I,,20211221.0,20211224,20211224,EXP,,TR-AstraZeneca-2021A893042,ASTRAZENECA,"Cure E, Sirin H, Cure MC, Sahin DA.. Dapagliflozin-induced long-term and severe anorexia and weight loss: An extraordinary case. Indian J Pharmacol 2021;53:174-5.",47.0,YR,,F,Y,,,20211224.0,,MD,TR,,2021,Q4,Adult
202282521,20228252,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Prerenal failure,,2021,Q4,1,I,20211001.0,20211216.0,20211224,20211224,EXP,,DK-AstraZeneca-2021A878321,ASTRAZENECA,,51.0,YR,,M,Y,,,20211224.0,,MD,DK,,2021,Q4,Adult
202282521,20228252,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Vomiting,,2021,Q4,1,I,20211001.0,20211216.0,20211224,20211224,EXP,,DK-AstraZeneca-2021A878321,ASTRAZENECA,,51.0,YR,,M,Y,,,20211224.0,,MD,DK,,2021,Q4,Adult
202282521,20228252,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Hypotension,,2021,Q4,1,I,20211001.0,20211216.0,20211224,20211224,EXP,,DK-AstraZeneca-2021A878321,ASTRAZENECA,,51.0,YR,,M,Y,,,20211224.0,,MD,DK,,2021,Q4,Adult
202282521,20228252,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Diarrhoea,,2021,Q4,1,I,20211001.0,20211216.0,20211224,20211224,EXP,,DK-AstraZeneca-2021A878321,ASTRAZENECA,,51.0,YR,,M,Y,,,20211224.0,,MD,DK,,2021,Q4,Adult
202303421,20230342,28,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 milligram,,,,,,,,5.0,MG,Tablet,,2021,Q4,Death,,2021,Q4,1,I,20190402.0,20211215.0,20211226,20211226,PER,,JP-AMGEN-JPNCT2020046688,AMGEN,,83.0,YR,E,M,Y,,,20211226.0,,MD,JP,JP,2021,Q4,Elderly
202303421,20230342,28,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 milligram,,,,,,,,5.0,MG,Tablet,,2021,Q4,Cardiac failure congestive,,2021,Q4,1,I,20190402.0,20211215.0,20211226,20211226,PER,,JP-AMGEN-JPNCT2020046688,AMGEN,,83.0,YR,E,M,Y,,,20211226.0,,MD,JP,JP,2021,Q4,Elderly
202303421,20230342,28,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 milligram,,,,,,,,5.0,MG,Tablet,,2021,Q4,Cardiac failure congestive,,2021,Q4,1,I,20190402.0,20211215.0,20211226,20211226,PER,,JP-AMGEN-JPNCT2020046688,AMGEN,,83.0,YR,E,M,Y,,,20211226.0,,MD,JP,JP,2021,Q4,Elderly
202304791,20230479,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Hepatic function abnormal,,2021,Q4,1,I,,20211222.0,20211227,20211227,EXP,,NVSJ2021JP021296,NOVARTIS,,78.0,YR,,M,Y,,,20211227.0,,MD,JP,JP,2021,Q4,Elderly
202304791,20230479,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Dehydration,,2021,Q4,1,I,,20211222.0,20211227,20211227,EXP,,NVSJ2021JP021296,NOVARTIS,,78.0,YR,,M,Y,,,20211227.0,,MD,JP,JP,2021,Q4,Elderly
202304791,20230479,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211222.0,20211227,20211227,EXP,,NVSJ2021JP021296,NOVARTIS,,78.0,YR,,M,Y,,,20211227.0,,MD,JP,JP,2021,Q4,Elderly
202307241,20230724,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,unknown,,,,,,,2021,Q4,Haematemesis,,2021,Q4,1,I,,20211216.0,20211227,20211227,EXP,CA-HEALTHCANVIG-000963333,CA-NOVOPROD-877282,NOVO NORDISK,,53.0,YR,,M,Y,165.0,KG,20211227.0,,CN,CA,CA,2021,Q4,Adult
202307241,20230724,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,unknown,,,,,,,2021,Q4,Heart rate increased,,2021,Q4,1,I,,20211216.0,20211227,20211227,EXP,CA-HEALTHCANVIG-000963333,CA-NOVOPROD-877282,NOVO NORDISK,,53.0,YR,,M,Y,165.0,KG,20211227.0,,CN,CA,CA,2021,Q4,Adult
202310191,20231019,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Heart rate decreased,,2021,Q4,1,I,,20211222.0,20211227,20211227,EXP,,NVSC2021DE295544,NOVARTIS,,77.0,YR,,M,Y,,,20211227.0,,CN,DE,DE,2021,Q4,Elderly
202310191,20231019,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211222.0,20211227,20211227,EXP,,NVSC2021DE295544,NOVARTIS,,77.0,YR,,M,Y,,,20211227.0,,CN,DE,DE,2021,Q4,Elderly
202310191,20231019,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211222.0,20211227,20211227,EXP,,NVSC2021DE295544,NOVARTIS,,77.0,YR,,M,Y,,,20211227.0,,CN,DE,DE,2021,Q4,Elderly
202329621,20232962,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (each morning, continued)",,,U,,,,,10.0,MG,,QD,2021,Q4,Atrioventricular block complete,,2021,Q4,1,I,20190501.0,20211212.0,20211227,20211227,EXP,GB-MHRA-EYC 00268465,NVSC2021GB285047,NOVARTIS,,78.0,YR,,F,Y,,,20211227.0,,PH,GB,GB,2021,Q4,Elderly
202329621,20232962,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (each morning, continued)",,,U,,,,,10.0,MG,,QD,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,20190501.0,20211212.0,20211227,20211227,EXP,GB-MHRA-EYC 00268465,NVSC2021GB285047,NOVARTIS,,78.0,YR,,F,Y,,,20211227.0,,PH,GB,GB,2021,Q4,Elderly
202329621,20232962,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (each morning, continued)",,,U,,,,,10.0,MG,,QD,2021,Q4,Cardiac failure,,2021,Q4,1,I,20190501.0,20211212.0,20211227,20211227,EXP,GB-MHRA-EYC 00268465,NVSC2021GB285047,NOVARTIS,,78.0,YR,,F,Y,,,20211227.0,,PH,GB,GB,2021,Q4,Elderly
202329621,20232962,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (each morning, continued)",,,U,,,,,10.0,MG,,QD,2021,Q4,Hypocalcaemia,,2021,Q4,1,I,20190501.0,20211212.0,20211227,20211227,EXP,GB-MHRA-EYC 00268465,NVSC2021GB285047,NOVARTIS,,78.0,YR,,F,Y,,,20211227.0,,PH,GB,GB,2021,Q4,Elderly
202329621,20232962,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (each morning, continued)",,,U,,,,,10.0,MG,,QD,2021,Q4,Hypomagnesaemia,,2021,Q4,1,I,20190501.0,20211212.0,20211227,20211227,EXP,GB-MHRA-EYC 00268465,NVSC2021GB285047,NOVARTIS,,78.0,YR,,F,Y,,,20211227.0,,PH,GB,GB,2021,Q4,Elderly
202332151,20233215,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Hypokalaemia,,2021,Q4,1,I,20211207.0,20211216.0,20211227,20211227,EXP,,JP-AstraZeneca-2021A886186,ASTRAZENECA,,71.0,YR,,F,Y,,,20211227.0,,MD,JP,,2021,Q4,Elderly
202332151,20233215,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Electrocardiogram QT prolonged,,2021,Q4,1,I,20211207.0,20211216.0,20211227,20211227,EXP,,JP-AstraZeneca-2021A886186,ASTRAZENECA,,71.0,YR,,F,Y,,,20211227.0,,MD,JP,,2021,Q4,Elderly
202353921,20235392,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day (5 mg, 1-0-0-0, Tabletten)",,,U,,,,,5.0,MG,Tablet,QD,2021,Q4,Nausea,,2021,Q4,1,I,,20211215.0,20211228,20211228,EXP,,DE-AUROBINDO-AUR-APL-2021-052771,AUROBINDO,,78.0,YR,,F,Y,85.0,KG,20211228.0,,PH,DE,DE,2021,Q4,Elderly
202353921,20235392,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day (5 mg, 1-0-0-0, Tabletten)",,,U,,,,,5.0,MG,Tablet,QD,2021,Q4,Dizziness,,2021,Q4,1,I,,20211215.0,20211228,20211228,EXP,,DE-AUROBINDO-AUR-APL-2021-052771,AUROBINDO,,78.0,YR,,F,Y,85.0,KG,20211228.0,,PH,DE,DE,2021,Q4,Elderly
202353921,20235392,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day (5 mg, 1-0-0-0, Tabletten)",,,U,,,,,5.0,MG,Tablet,QD,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211215.0,20211228,20211228,EXP,,DE-AUROBINDO-AUR-APL-2021-052771,AUROBINDO,,78.0,YR,,F,Y,85.0,KG,20211228.0,,PH,DE,DE,2021,Q4,Elderly
202366881,20236688,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram Daily;   1-0-0-0,,,,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,Anaemia,,2021,Q4,1,I,,20211221.0,20211228,20211228,EXP,,DE-TEVA-2021-DE-1993881,TEVA,,45.0,YR,A,M,Y,82.0,KG,20211228.0,,PH,DE,DE,2021,Q4,Adult
202366881,20236688,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram Daily;   1-0-0-0,,,,,Unknown,,,10.0,MG,Tablet,QD,2021,Q4,International normalised ratio abnormal,,2021,Q4,1,I,,20211221.0,20211228,20211228,EXP,,DE-TEVA-2021-DE-1993881,TEVA,,45.0,YR,A,M,Y,82.0,KG,20211228.0,,PH,DE,DE,2021,Q4,Adult
202371911,20237191,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,Tablet,,2021,Q4,Atrioventricular block complete,,2021,Q4,1,I,20190501.0,20211213.0,20211228,20211228,EXP,GB-MHRA-EYC 00268465,GB-DEXPHARM-20212192,DEXCEL,,78.0,YR,,F,Y,,,20211228.0,,HP,GB,GB,2021,Q4,Elderly
202371911,20237191,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,Tablet,,2021,Q4,Drug interaction,,2021,Q4,1,I,20190501.0,20211213.0,20211228,20211228,EXP,GB-MHRA-EYC 00268465,GB-DEXPHARM-20212192,DEXCEL,,78.0,YR,,F,Y,,,20211228.0,,HP,GB,GB,2021,Q4,Elderly
202371911,20237191,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,Tablet,,2021,Q4,Hypomagnesaemia,,2021,Q4,1,I,20190501.0,20211213.0,20211228,20211228,EXP,GB-MHRA-EYC 00268465,GB-DEXPHARM-20212192,DEXCEL,,78.0,YR,,F,Y,,,20211228.0,,HP,GB,GB,2021,Q4,Elderly
202371911,20237191,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,Tablet,,2021,Q4,Left ventricular dysfunction,,2021,Q4,1,I,20190501.0,20211213.0,20211228,20211228,EXP,GB-MHRA-EYC 00268465,GB-DEXPHARM-20212192,DEXCEL,,78.0,YR,,F,Y,,,20211228.0,,HP,GB,GB,2021,Q4,Elderly
202371911,20237191,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,Tablet,,2021,Q4,Hypocalcaemia,,2021,Q4,1,I,20190501.0,20211213.0,20211228,20211228,EXP,GB-MHRA-EYC 00268465,GB-DEXPHARM-20212192,DEXCEL,,78.0,YR,,F,Y,,,20211228.0,,HP,GB,GB,2021,Q4,Elderly
202371911,20237191,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"each morning, continued",,,,,,,,10.0,MG,Tablet,,2021,Q4,Cardiac failure,,2021,Q4,1,I,20190501.0,20211213.0,20211228,20211228,EXP,GB-MHRA-EYC 00268465,GB-DEXPHARM-20212192,DEXCEL,,78.0,YR,,F,Y,,,20211228.0,,HP,GB,GB,2021,Q4,Elderly
202390061,20239006,4,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210624.0,20211220.0,20211228,20211228,EXP,ES-AEMPS-1054858,ES-MYLANLABS-2021M1094888,MYLAN,,75.0,YR,,M,Y,,,20211228.0,,PH,ES,ES,2021,Q4,Elderly
202446011,20244601,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, Unknown",,,,,,,,10.0,MG,,,2021,Q4,Electrocardiogram QT prolonged,,2021,Q4,1,I,20210101.0,20211208.0,20211229,20211229,PER,JP-ONO-2021JP031390,JP-AMGEN-JPNSP2021205953,AMGEN,,71.0,YR,E,F,Y,,,20211228.0,,MD,JP,JP,2021,Q4,Elderly
202446011,20244601,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, Unknown",,,,,,,,10.0,MG,,,2021,Q4,Heart rate decreased,,2021,Q4,1,I,20210101.0,20211208.0,20211229,20211229,PER,JP-ONO-2021JP031390,JP-AMGEN-JPNSP2021205953,AMGEN,,71.0,YR,E,F,Y,,,20211228.0,,MD,JP,JP,2021,Q4,Elderly
202446011,20244601,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, Unknown",,,,,,,,10.0,MG,,,2021,Q4,Hypokalaemia,,2021,Q4,1,I,20210101.0,20211208.0,20211229,20211229,PER,JP-ONO-2021JP031390,JP-AMGEN-JPNSP2021205953,AMGEN,,71.0,YR,E,F,Y,,,20211228.0,,MD,JP,JP,2021,Q4,Elderly
202461801,20246180,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Fatigue,,2021,Q4,1,I,20211010.0,20211226.0,20211229,20211229,EXP,,NVSC2021EG297410,NOVARTIS,,53.0,YR,,M,Y,,,20211229.0,,CN,EG,EG,2021,Q4,Adult
202461801,20246180,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20211010.0,20211226.0,20211229,20211229,EXP,,NVSC2021EG297410,NOVARTIS,,53.0,YR,,M,Y,,,20211229.0,,CN,EG,EG,2021,Q4,Adult
202461801,20246180,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2021,Q4,Dyspnoea exertional,,2021,Q4,1,I,20211010.0,20211226.0,20211229,20211229,EXP,,NVSC2021EG297410,NOVARTIS,,53.0,YR,,M,Y,,,20211229.0,,CN,EG,EG,2021,Q4,Adult
202469271,20246927,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, unknown",,,,,,,,,,,,2021,Q4,Microalbuminuria,,2021,Q4,1,I,20211111.0,20211222.0,20211229,20211229,EXP,GB-MHRA-EYC 00269707,GB-ELI_LILLY_AND_COMPANY-GB202112010707,ELI LILLY AND CO,,53.0,YR,,M,Y,85.0,KG,20211229.0,,CN,GB,GB,2021,Q4,Adult
202474011,20247401,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,Film-coated tablet,,2021,Q4,Malaise,,2021,Q4,1,I,20211113.0,20211223.0,20211229,20211229,EXP,FR-AFSSAPS-NY20215297,FR-MYLANLABS-2021M1096086,MYLAN,,84.0,YR,,M,Y,,,20211229.0,,CN,FR,FR,2021,Q4,Elderly
202474011,20247401,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,Film-coated tablet,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,20211113.0,20211223.0,20211229,20211229,EXP,FR-AFSSAPS-NY20215297,FR-MYLANLABS-2021M1096086,MYLAN,,84.0,YR,,M,Y,,,20211229.0,,CN,FR,FR,2021,Q4,Elderly
202474961,20247496,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Film-coated tablet,QD,2021,Q4,Guillain-Barre syndrome,,2021,Q4,1,I,20211108.0,20211227.0,20211229,20211229,EXP,FR-AFSSAPS-NY20215559,NVSC2021FR297694,NOVARTIS,,55.0,YR,,M,Y,113.6,KG,20211229.0,,HP,FR,FR,2021,Q4,Adult
202496471,20249647,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 1-0-0-0,,,,,,,,10.0,MG,,QD,2021,Q4,Anaemia,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992231,TEVA,,68.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202496471,20249647,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 1-0-0-0,,,,,,,,10.0,MG,,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992231,TEVA,,68.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202496471,20249647,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 1-0-0-0,,,,,,,,10.0,MG,,QD,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992231,TEVA,,68.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202496471,20249647,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 1-0-0-0,,,,,,,,10.0,MG,,QD,2021,Q4,Balance disorder,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992231,TEVA,,68.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202496471,20249647,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 1-0-0-0,,,,,,,,10.0,MG,,QD,2021,Q4,Gastrointestinal haemorrhage,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992231,TEVA,,68.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202498361,20249836,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|850 mg, 1-1-0.5-0",,,U,,Unknown,,,,,Tablet,,2021,Q4,Pain,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992234,TEVA,,69.0,YR,E,M,Y,86.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202498361,20249836,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|850 mg, 1-1-0.5-0",,,U,,Unknown,,,,,Tablet,,2021,Q4,Nausea,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992234,TEVA,,69.0,YR,E,M,Y,86.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202498361,20249836,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|850 mg, 1-1-0.5-0",,,U,,Unknown,,,,,Tablet,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992234,TEVA,,69.0,YR,E,M,Y,86.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202498361,20249836,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|850 mg, 1-1-0.5-0",,,U,,Unknown,,,,,Tablet,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992234,TEVA,,69.0,YR,E,M,Y,86.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202498361,20249836,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|850 mg, 1-1-0.5-0",,,U,,Unknown,,,,,Tablet,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992234,TEVA,,69.0,YR,E,M,Y,86.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202540791,20254079,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Film-coated tablet,QD,2021,Q4,Guillain-Barre syndrome,,2021,Q4,1,I,20211108.0,20211226.0,20211230,20211230,EXP,FR-AFSSAPS-NY20215559,FR-BAUSCH-BL-2021-042611,BAUSCH AND LOMB,,55.0,YR,,M,Y,113.6,KG,20211230.0,,HP,FR,FR,2021,Q4,Adult
202546021,20254602,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (),,,U,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20190101.0,20211215.0,20211230,20211230,EXP,,GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322122,RANBAXY,,74.0,YR,,F,Y,,,20211230.0,,HP,GR,GR,2021,Q4,Elderly
202546021,20254602,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (),,,U,,,,,,,,,2021,Q4,Acidosis,,2021,Q4,1,I,20190101.0,20211215.0,20211230,20211230,EXP,,GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322122,RANBAXY,,74.0,YR,,F,Y,,,20211230.0,,HP,GR,GR,2021,Q4,Elderly
202546021,20254602,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (),,,U,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,20190101.0,20211215.0,20211230,20211230,EXP,,GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322122,RANBAXY,,74.0,YR,,F,Y,,,20211230.0,,HP,GR,GR,2021,Q4,Elderly
202546021,20254602,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (),,,U,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20190101.0,20211215.0,20211230,20211230,EXP,,GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322122,RANBAXY,,74.0,YR,,F,Y,,,20211230.0,,HP,GR,GR,2021,Q4,Elderly
202546021,20254602,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (),,,U,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,20190101.0,20211215.0,20211230,20211230,EXP,,GR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322122,RANBAXY,,74.0,YR,,F,Y,,,20211230.0,,HP,GR,GR,2021,Q4,Elderly
202559631,20255963,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,,,,Tablet,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211221.0,20211230,20211230,EXP,,JP-AstraZeneca-2021A899622,ASTRAZENECA,"Tokioka R, et al.. 2-5-05 A case of type 1 diabetes mellitus who developed euglycaemic ketoacidosis due to SGLT2 inhibitor.. The 59th Kyushu Regional Meeting of Japan Diabetes Society; 2021;168.",39.0,YR,,M,Y,,,20211230.0,,MD,JP,,2021,Q4,Adult
202576721,20257672,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,,QD,2021,Q4,Chest pain,,2021,Q4,1,I,,20211223.0,20211230,20211230,EXP,,IT-MYLANLABS-2021M1096341,MYLAN,"Acanfora C.. Fibrillazione Atriale, Diabete Mellito e Cardiopatia Ischemica. Un caso clinico complesso.. Cardiolink Scientific News.. 2021",64.0,YR,,M,Y,97.0,KG,20211230.0,,MD,IT,IT,2021,Q4,Adult
202576721,20257672,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,,QD,2021,Q4,Ventricular fibrillation,,2021,Q4,1,I,,20211223.0,20211230,20211230,EXP,,IT-MYLANLABS-2021M1096341,MYLAN,"Acanfora C.. Fibrillazione Atriale, Diabete Mellito e Cardiopatia Ischemica. Un caso clinico complesso.. Cardiolink Scientific News.. 2021",64.0,YR,,M,Y,97.0,KG,20211230.0,,MD,IT,IT,2021,Q4,Adult
202576721,20257672,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,,QD,2021,Q4,Myocardial infarction,,2021,Q4,1,I,,20211223.0,20211230,20211230,EXP,,IT-MYLANLABS-2021M1096341,MYLAN,"Acanfora C.. Fibrillazione Atriale, Diabete Mellito e Cardiopatia Ischemica. Un caso clinico complesso.. Cardiolink Scientific News.. 2021",64.0,YR,,M,Y,97.0,KG,20211230.0,,MD,IT,IT,2021,Q4,Adult
202626011,20262601,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,,20211222.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04447392,CA-NOVOPROD-878854,NOVO NORDISK,,20.0,YR,,F,Y,,,20211231.0,,HP,CA,CA,2021,Q4,Youth
202626011,20262601,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211222.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04447392,CA-NOVOPROD-878854,NOVO NORDISK,,20.0,YR,,F,Y,,,20211231.0,,HP,CA,CA,2021,Q4,Youth
202626011,20262601,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,,20211222.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04447392,CA-NOVOPROD-878854,NOVO NORDISK,,20.0,YR,,F,Y,,,20211231.0,,HP,CA,CA,2021,Q4,Youth
202626371,20262637,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"Strength:5 mg / 850 mg, 56 film-coated tablets",,,,,,,,,,Film-coated tablet,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210624.0,20211224.0,20211231,20211231,EXP,ES-AEMPS-1054858,ES-Accord-248575,ACCORD,,75.0,YR,E,M,Y,,,20211231.0,,PH,ES,ES,2021,Q4,Elderly
202644881,20264488,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily;  each morning, continued",,,,,,,,10.0,MG,Tablet,QD,2021,Q4,Hypocalcaemia,,2021,Q4,1,I,20210101.0,20211222.0,20211231,20211231,EXP,,GB-TEVA-2021-GB-1993509,TEVA,,78.0,YR,E,F,Y,,,20211231.0,,PH,GB,GB,2021,Q4,Elderly
202645781,20264578,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,MP2447,,202293.0,10.0,MG,Tablet,QD,2021,Q4,Renal injury,,2021,Q4,1,I,20211023.0,20211223.0,20211231,20211231,EXP,,CN-AstraZeneca-2021A902031,ASTRAZENECA,,18674.0,DY,,M,Y,69.5,KG,20211231.0,,MD,CN,,2021,Q4,Elderly
202646221,20264622,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2021,Q4,Eosinophil count increased,,2021,Q4,1,I,,20211224.0,20211231,20211231,EXP,,FR-AstraZeneca-2021A899965,ASTRAZENECA,,74.0,YR,,M,Y,,,20211231.0,,MD,FR,,2021,Q4,Elderly
202646341,20264634,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2021,Q4,Dyslipidaemia,,2021,Q4,1,I,,20211222.0,20211231,20211231,PER,,AU-AMGEN-AUSSP2021204239,AMGEN,,78.0,YR,E,M,Y,,,20211231.0,,MD,AU,AU,2021,Q4,Elderly
202646341,20264634,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2021,Q4,Chronic kidney disease,,2021,Q4,1,I,,20211222.0,20211231,20211231,PER,,AU-AMGEN-AUSSP2021204239,AMGEN,,78.0,YR,E,M,Y,,,20211231.0,,MD,AU,AU,2021,Q4,Elderly
202646341,20264634,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2021,Q4,Body mass index abnormal,,2021,Q4,1,I,,20211222.0,20211231,20211231,PER,,AU-AMGEN-AUSSP2021204239,AMGEN,,78.0,YR,E,M,Y,,,20211231.0,,MD,AU,AU,2021,Q4,Elderly
202646341,20264634,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2021,Q4,Microalbuminuria,,2021,Q4,1,I,,20211222.0,20211231,20211231,PER,,AU-AMGEN-AUSSP2021204239,AMGEN,,78.0,YR,E,M,Y,,,20211231.0,,MD,AU,AU,2021,Q4,Elderly
202646341,20264634,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2021,Q4,Hypertension,,2021,Q4,1,I,,20211222.0,20211231,20211231,PER,,AU-AMGEN-AUSSP2021204239,AMGEN,,78.0,YR,E,M,Y,,,20211231.0,,MD,AU,AU,2021,Q4,Elderly
